This is a list of all the questions and their associated study carrel identifiers. One can learn a lot of the "aboutness" of a text simply by reading the questions.
| identifier | question |
|---|---|
| cord-011813-lm105z6n | When is the world going to realize that we must be better prepared for events that are occurring all too regularly? |
| cord-018106-5giapmcf | Can the health- care system meet the challenge of pandemic flu? |
| cord-009153-zxx4m1kz | www.thelancet.com COMMENTARY poliovirus vaccine production sites be effective for global certification? |
| cord-015503-j99cgsjt | If the L type is more aggressive than the S type, why did the relative frequency of the L type decrease compared to the S type in other places after the initial breakout in Wuhan? |
| cord-023473-ofwdzu5t | Managing the impact of a catastrophic event Risk, uncertainty and profit Is the panic worse than the disease? |
| cord-022473-l4jniccw | I wondered"Am I going to be the next?" |
| cord-015183-1eytelxn | People say:'Only a 4% mortality rate, so few people have died, why worry?' cord-007567-vst954ef With the outbreak of SARS, theA"now stands for"Are,"as in"Are we all protected? |
| cord-012424-z3mkp9y9 | Does SARS- Cov-2 invade the brain? |
| cord-019076-4qu9j953 | 2 lineage Coronavirus mRNA synthesis involves fusion of non- contiguous sequences Genetic analysis of Murine hepatitis virus nsp4 in virus replication Dodecamer structure of severe acute respiratory syndrome coronavirus nonstructural protein nsp10 Deubiquitination, a new function of the severe acute respiratory syndrome coronavirus papain- like protease? |
| cord-024649-y7nqz6vk | Covid-19 in patients presenting with influenza- like symptoms Bejjing hospital confirms nervous system infections by novel coronavirus Endotracheal intubation following diazepam or lorazepam in status epilepticus Incidence of thrombotic complications in critically ill ICU patients with COVID-19 Guillain- Barre syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-017224-naromr0a | the Will Terrorists Turn to Poison? |
| cord-022003-cvawdes6 | The social context shaping bioweapons( non)proliferation Genome projects and gene therapy: gateways to next generation biological weapons Is all fair in biological warfare? |
| cord-021805-2j07zw6q | Human coronaviruses: what do they cause? |
| cord-017942-og0b2l6b | What are the differences in connectivity between personal and geographical contacts in the construction of contact networks for the diseases which transmit not only through personal contacts? |
| cord-017942-og0b2l6b | What are the differences in network topology between one- mode networks with only patients and multi- mode networks with patients and geographical locations for disease investigation? |
| cord-024317-w1ep0wq8 | Is COVID-19 receiving ADE from other coronaviruses? |
| cord-024317-w1ep0wq8 | New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-009573-ghv9uezx | : cord-009573-ghv9uezx authors: Karlberg, J; Lai, WYY title: Do sensational media reports about severe acute respiratory syndrome affect the mindset of healthcare workers? |
| cord-020769-elzkwyz0 | Inexpensive labor is appealing but what if you can not find employees to complete an order( Jeter, 1999)? |
| cord-008841-r17qhfsj | Why did these two groups of studies give such different results? |
| cord-022084-hap7flng | The Argentinian experience Regional perspectives on influenza surveillance in South America Clinical and epidemiologic importance of influenza A viruses resistant to amantadine and rimantadine Pandemic influenza: Is an antiviral response realistic? |
| cord-026792-jsqa4pmu | ( SARS- CoV-2) from a symptomatic patient Evidence of airborne transmission of the severe acute respiratory syndrome virus Imbalance of the renin- angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target? |
| cord-007560-nck4f5ny | 2009 influenza A/ H1N1v Factors associated with nosocomial SARS- CoV transmission among healthcare workers in Hanoi Can breathing circuit filters help prevent the spread of influenza A( H1N1) virus from intubated patients? |
| cord-007560-nck4f5ny | The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single- cell transcriptomes Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus- infected pneumonia in Wuhan, China Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids Factors associated with transmission of severe acute respiratory syndrome among health- care workers in Singapore Which preventive measures might protect health care workers from SARS? |
| cord-016990-ot1wi3xi | : a review of ten years'experience Pulmonary complications of solid organ and hematopoietic stem cell transplantation Lungs are a major organ site of cytomegalovirus latency and recurrence Spectrum of pulmonary diseases associated with the acquired immune deficiency syndrome Cytomegalovirus- induced alveolar hemorrhage in patients with AIDS: a new clinical entity? |
| cord-016990-ot1wi3xi | How do viral infections predispose patients to bacterial infections? |
| cord-025794-ckrclrwz | symptomlose Kontaktpersonen, Screening, …?) |
| cord-015009-3o90pzw7 | How and who does SARS kill? |
| cord-004634-pkrxiipo | but fast enough? |
| cord-021847-wea0qpq2 | Human Services H1N1 influenza Quantitative assessment of preventive behaviors in France during the Fukushima nuclear crisis Was mandatory quarantine necessary in China for controlling the 2009 H1N1 pandemic? |
| cord-021847-wea0qpq2 | Who Is in Charge? |
| cord-026130-ki7bn67o | : What has CT taught us? |
| cord-015376-z739ifu5 | Identification of critical determinants on ACE2 for SARS- CoV entry and development of a potent entry inhibitor Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry Human Coronavirus hCoV-229E enters susceptible cells via the endocytic pathway Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-015376-z739ifu5 | This bioinformatic analysis of drug/ enzyme docking provides interesting insights on the use of HIV-1 protease inhibitors as lead compounds for development of 3Clpro inhibitors Old drugs as lead compounds for a new disease? |
| cord-029547-9ei1ram3 | A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person- to- person transmission: a study of a family cluster Characteristics of ocular findings of patients with coronavirus disease 2019( COVID-19 Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-015613-ls9qus8y | But which way is forward? |
| cord-015613-ls9qus8y | Is infectious disease generally a matter for concern by conservation biologists? |
| cord-006890-81wv1s33 | Thus, the main issues to be critically addressed are dealing with vaccine safety and may be summarized in two questions: how to achieve an acceptable balance between requested speed and safety aspects? |
| cord-006890-81wv1s33 | how to assess quickly but reliably immunogenicity and efficacy of candidate vaccines or more specifically, in the absence of a relevant animal model, what is the minimal acceptable fast- track toxicity program ethically acceptable before going to Phase I trial? |
| cord-025623-1v9614f8 | Is the coronavirus airborne? |
| cord-022234-jjaqlyo5 | Are there approaches you would use that would be different from those undertaken in the case studies? |
| cord-022234-jjaqlyo5 | If you were a destination marketer in SE Asia how would you have approached the management of SARS and the Bali bombing? |
| cord-022234-jjaqlyo5 | In what ways has media coverage impacted the perception of tourism destinations since the development of global media broadcasting through networks such as CNN Analyze and compare the effectiveness of the three campaigns examined in this chapter To what extent to you attribute the reconstitution of ASEAN Tourism Marketing as a reactive measure to tourism crisis or a proactive approach to recovery? |
| cord-030420-pgdmz69j | The expression and localization of 74 the human placental prorenin/ renin- angiotensin system throughout pregnancy: roles in 75 trophoblast invasion and angiogenesis? |
| cord-031079-9lxhvyyb | In vitro inhibition of human influenza A virus replication by chloroquine Chloroquine is a potent inhibitor of SARS coronavirus infection and spread Anti- malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-030535-8o7rzb98 | Constrained Peptides'Time to Shine? |
| cord-021152-6znmkvy9 | How does africa's most hunted bat vary across the continent? |
| cord-021152-6znmkvy9 | Marburgvirus resurgence in Kitaka mine bat population after extermination attempts Isolation of genetically diverse Marburg viruses from Egyptian fruit bats Is Marburg virus enzootic in Gabon? |
| cord-018441-r6wwpfcy | Where did the virus come from? |
| cord-018441-r6wwpfcy | Where did this virus come from and how did it arise? |
| cord-018441-r6wwpfcy | Why did this outbreak occur in 1993? |
| cord-033592-j1c2brb4 | DRB1* 16:02 is associated with anti- NMDAR encephalitis Immune- epidemiological parameters of the novel coronavirus-a perspective Autoinflammatory and autoimmune conditions at the crossroad of COVID-19 Defining causality in COVID-19 and neurological disorders Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-032811-sdbj26ca | * Jason T. Kimata, PhD b* Abhijit Chakraborty, PhD a Sanjiv Sur, MD a Pulmonary edema in COVID-19: explained by bradykinin? |
| cord-018057-p1l6xtsq | -but why? |
| cord-018057-p1l6xtsq | If the world's largest epidemic of streptococcal infection in pigs could be spread among the public, what would the result be? |
| cord-018057-p1l6xtsq | Why, then, did a SARS laboratory infection transmit to the public in April of 2004? |
| cord-033901-itj6v1jl | Discharge criteria for confirmed COVID-19 cases-When is it safe to discharge COVID-19 cases from the hospital or end home isolation? |
| cord-032222-i6gfp4me | A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus( 2019-nCoV) infected pneumonia( standard version) Drug treatment options for the 2019-new coronavirus( 2019-nCoV) Use of convalescent plasma therapy in SARS patients in Hong Kong Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A( H1N1) 2009 virus infection Meta- analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? |
| cord-016921-64mfqks9 | Gesellschaft Eine andere Wissenschaft des Sozialen? |
| cord-016921-64mfqks9 | Was also zeichnet das Virus vor diesem Hintergrund aus? |
| cord-033311-e5axxrm1 | a retrospective case series study Guillain- Barré syndrome associated with SARS- CoV2 infection: causality or coincidence? |
| cord-027499-mvqoarsh | a Dual'Ocular Route'Exist? |
| cord-027499-mvqoarsh | authors: Navel, Valentin; Chiambaretta, Frédéric; Dutheil, Frédéric title: Coronavirus: good or bad news for ocular diseases? |
| cord-018101-zd4v222b | The evolutionary significance of parasitism: Do parasite- driven genetic dynamics occur et silico? |
| cord-018101-zd4v222b | University of Texas Medical Branch at Galveston Are SARS superspreaders cloud adults? |
| cord-026811-6bdzut3d | Country& Technical Guidance-Coronavirus disease( COVID-19) Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six- day follow up: a pilot observational study Risk factors associated with acute respiratory distress syndrome and death in patients with corona virus disease 2019 pneumonia in Wuhan, China Compassionate use of remdesivir for patients with severe COVID-19 COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-026811-6bdzut3d | The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta- analysis Meta- analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? |
| cord-031061-48xwfr9i | : can we go from bench to bedside? |
| cord-031061-48xwfr9i | Hark back: passive immunotherapy for influenza and other serious infections Mumps; use of convalescent serum in the treatment and prophylaxis of orchitis Meta- analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? |
| cord-035067-ic843wr9 | title: COVID-19 and the gastrointestinal tract: what do we already know? |
| cord-026806-pn4lwhr7 | COVID-19 and Italy: what next? |
| cord-026806-pn4lwhr7 | The SARS epidemic in Hong Kong: what lessons have we learned? |
| cord-031001-x4iiqq5e | Seroprevalence of Immunoglobulin M and G Antibodies Against SARS- CoV-2 in China Which preventive measures might protect health care workers from SARS? |
| cord-028363-7pmro8bu | EACTS) Province and Health Commission of Guangdong Province for Chloroquine in the Treatment of Novel Coronavirus Pneumonia Recurrent pericarditis: autoimmune or autoinflammatory? |
| cord-028363-7pmro8bu | Yale title: Acute pericarditis due to COVID-19 infection: An underdiagnosed disease? |
| cord-023510-gd4phncm | Can a significant discriminant function be developed to interpret the differences between respondents who did and did not visit theme parks during the SARS outbreak period in Taiwan on the basis of their personal characteristics? |
| cord-023510-gd4phncm | How accurately can respondents be classified into the two categories by the developed discriminant function? |
| cord-023510-gd4phncm | What marketing implications can be derived from theme park visitors'different patronage decisions in response to the SARS outbreak? |
| cord-023510-gd4phncm | Which characteristics contribute to most of the inter- group differences? |
| cord-033951-77tfhm5b | In other words, do the reported IC 50 values of ebselen, disulfiram, tideglusib, carmofur, shikonin, and PX-12 against SARS- CoV-2 M pro reflect specific enzymatic inhibition, or are they due to nonspecific inactivation of the enzyme? |
| cord-025119-201ac32t | A trial of lopinavir- ritonavir in adults hospitalized with severe covid-19 Is it reliable to take the molecular docking top scoring position as the best solution without considering available structural data? |
| cord-025119-201ac32t | a tool for high- throughput crystallography of protein- ligand complexes QSAR modelling of rat acute toxicity on the basis of PASS prediction SwissADME: a free web tool to evaluate pharmacokinetics, drug- likeness and medicinal chemistry friendliness of small molecules Optimized hydrophobic interactions and hydrogen bonding at the target- ligand interface leads the pathways of drug- designing LigRMSD: a web server for automatic structure matching and RMSD calculations among identical and similar compounds in protein- ligand docking World Health Organization declares global emergency: a review of the 2019 novel coronavirus( COVID-19) New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-025251-evnfvc0l | Inhaled therapeutics for prevention and treatment of pneumonia Rapid- response vaccines- does DNA offer a solution? |
| cord-025251-evnfvc0l | influenza virus infection Lung epithelial GM- CSF improves host defense function and epithelial repair in influenza virus pneumonia- a new therapeutic strategy? |
| cord-029450-4rnrq78l | An evolutionary conserved fuel for inflammaging The immunology of COVID-19: is immune modulation an option for treatment? |
| cord-029450-4rnrq78l | Why is hyperglycaemia worsening COVID-19 and its prognosis? |
| cord-102920-z5q3wo7v | Insight from ACE2-S- Protein Interactions Middle East respiratory syndrome coronavirus( MERS- CoV): animal to human interaction MERS- CoV: the intermediate host identified? |
| cord-033780-184e64tr | ( COVID-19) CT findings: a systematic review and meta- analysis Correlation of chest CT and RT- PCR testing for coronavirus disease 2019( COVID-19) in China: a report of 1014 cases Diagnosis of the coronavirus disease( COVID-19): rRT- PCR or CT? |
| cord-033780-184e64tr | The incubation period of coronavirus disease 2019( COVID-19) from publicly reported confirmed cases: estimation and application Age- dependent effects in the transmission and control of COVID-19 epidemics Are children less susceptible to COVID-19? |
| cord-032928-m0awip9y | Can the coronavirus disease 2019( COVID-19) affect the eyes? |
| cord-032928-m0awip9y | Covid-19 pandemic and the skin- what should dermatologists know? |
| cord-027582-ygforvya | Can patients in isolation precautions with COVID-19 infection be removed from precautions prior to current guidelines? |
| cord-027582-ygforvya | if they previously had a COVID-19 infection, met criteria for removal from isolation precautions, and they have SARS- CoV-2 PCR- positive respiratory tract specimens over the next several weeks? |
| cord-029167-bq6ogxyq | A device for disinfecting PPEs and the method there of Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents Face touching: a frequent habit that has implications for hand hygiene Can N95 respirators be reused after disinfection? |
| cord-029167-bq6ogxyq | How many times? |
| cord-146091-kpvxdhcu | -and it's big First cases of coronavirus disease 2019( COVID-19) in the WHO European Region Mortality burden of the 1918- 1919 influenza pandemic in Europe Spatial- temporal excess mortality patterns of the 1918- 1919 influenza pandemic in Spain Low ambient humidity impairs barrier function and innate resistance against influenza infection Seasonality of Respiratory Viral Infections A Nice Day for an Infection? |
| cord-016897-t71f10kv | A potential source of infection? |
| cord-016897-t71f10kv | Should noninvasive ventilation be considered a high- risk procedure during an epidemic? |
| cord-016897-t71f10kv | The airbone transmission of infection in hospital buildings: fact or fi ction? |
| cord-016897-t71f10kv | Why did outbreaks of severe acute respiratory syndrome occur in some hospitals wards an not others? |
| cord-102456-6jt4ksha | Version 1 Conducting Clinical Research During the COVID-19 Pandemic Protecting Scientific Integrity Pulmonary fibrosis secondary to COVID-19: a call to arms? |
| cord-102456-6jt4ksha | Will the pandemic's effects sneak into their data? |
| cord-013269-u1e0kzmm | And what can we do to getting better outcomes? |
| cord-013269-u1e0kzmm | Are we today at the end of the story? |
| cord-013269-u1e0kzmm | Could the same occur in nursing homes, day centers and in air conditioned wards? |
| cord-013269-u1e0kzmm | Digital contact tracing: could it be useful? |
| cord-013269-u1e0kzmm | Why so many problems in the approach to the pandemia, and in Lombardy and surroundings as well? |
| cord-017070-05vlz5dn | Neutralizing antibodies in patients with severe acute respiratory syndrome- associated coronavirus infection Antibody responses against SARS- coronavirus and its nucleocaspid in SARS patients Development of a safe neutralization assay for SARS- CoV and characterization of S- glycoprotein SARS corona virus peptides recognized by antibodies in the sera of convalescent cases S protein of severe acute respiratory syndrome- associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys Treating severe acute respiratory syndrome with hyperimmune globulins SARS: what have we learned? |
| cord-017070-05vlz5dn | The neurological manifestations of Nipah virus encephalitis, a novel paramyxovirus Nipah viral encephalitis or Japanese encephalitis? |
| cord-017070-05vlz5dn | The prospects for vaccines against HIV-1: more than a field of long- term nonprogression? |
| cord-017070-05vlz5dn | and the hMAb combination 4E10/2F5/2G12 Neutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine design Identifying epitopes of HIV-1 that induce protective antibodies Antibodies: can they protect against HIV infection? |
| cord-103872-yzqic5vt | Identifying future zoonotic disease threats: Where are the 253 gaps in our understanding of primate infectious diseases? |
| cord-024613-yump76qu | How might it impact on clinical practice in the foreseeable future? ► |
| cord-024613-yump76qu | What are the new findings? ► |
| cord-024613-yump76qu | What to do next to control the 2019-nCoV epidemic? |
| cord-103662-a4ok5wqc | Are Associated with a Decreased Risk of Progression to AIDS- Related Complex or AIDS Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control Preferential CTL targeting of Gag is associated with relative viral control in long- term surviving HIV-1 infected former plasma donors from China Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1 Cell- mediated anti- Gag immunity in pharmacologically induced functional cure of simian AIDS: a'bottleneck effect'? |
| cord-103662-a4ok5wqc | How will country- based mitigation measures influence the course of the COVID-19 epidemic? |
| cord-033334-p7szd86k | A novel coronavirus from patients with pneumonia in China Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Virology, epidemiology, pathogenesis, and control of COVID-19 A review of SARS- CoV-2 and the ongoing clinical trials Remdesivir for the treatment of Covid-19: preliminary report Structural and functional basis of SARS- CoV-2 entry by using human ACE2 Estimating the asymptomatic proportion of coronavirus disease 2019( COVID-19) cases on board the Diamond Princess cruise ship COVID-19: immunopathology and its implications for therapy Hypothesis for potential pathogenesis of SARSCoV-2 infection- a review of immune changes in patients with viral pneumonia Implications of gastrointestinal manifestations of COVID-19 Renal complications in COVID-19: a systematic review and meta- analysis Rhabdomyolysis and acute renal failure in an adolescent with coronavirus disease 2019 Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China COVID-19 gone bad: a new character in the spectrum of the hyperferritinemic syndrome? |
| cord-033334-p7szd86k | COVID-19: consider cytokine storm syndromes and immunosuppression Hemophagocytosis causes a consumptive anemia of inflammation Macrophages: a Trojan horse in COVID-19? |
| cord-033334-p7szd86k | What is new in lysozyme research and its application in food industry? |
| cord-031518-1w14wr0i | I and II studies, in our opinion, there is a serious ambiguity as to whether it is reasonable to enter the phase II/ III clinical trials on SARS- CoV-2 infected patients using the active sACE2? |
| cord-031518-1w14wr0i | Our suggestion: how to use the therapeutic potential of free ACE2? |
| cord-196265-mvnkkcow | Conformationally active integrin endocytosis and traffic: why, where, when and how? |
| cord-214854-ck61ja2t | A new coronavirus associated with human respiratory disease in China Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle Diagnosis of the Coronavirus disease( COVID-19): rRT- PCR or CT? |
| cord-228152-k4bw8w5g | What Is High- Throughput Virtual Screening? |
| cord-138439-wvynetna | 2 fit in? |
| cord-138439-wvynetna | Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? |
| cord-034371-j3xxmkjd | ( NSAIDs) Uncertainty surrounds use of OTC anti- inflammatory drugs in patients with COVID-19 Updated: WHO now does n't recommend avoiding ibuprofen for COVID-19 symptoms What we have learnt from the SARS epidemics in mainland China? |
| cord-034371-j3xxmkjd | First respiratory transmitted food borne outbreak? |
| cord-034371-j3xxmkjd | Pediatrics[ serial online Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-196608-k4f79dr4 | R&D Systems Covid-19 and angiotensin- converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence? |
| cord-251581-8ubyveyt | A yellow fever epidemic a new global health emergency? |
| cord-124012-5zxkd2jy | Concretely, our experiments aimed to answer the following questions: 1 What is the expected predictive performance of the various clinical predictive models in predicting( i) SARS- CoV-2 test results for presenting patients,( ii) hospital admission for SARS- CoV-2 positive patients, and( iii) ICU admission for SARS- CoV-2 positive patients? 2 Which clinical, demographic and blood analysis features were most important for the respective best encountered predictive models for each clinical prediction task? |
| cord-124012-5zxkd2jy | Concretely, our experiments aimed to answer the following questions: 1 What is the expected predictive performance of the various clinical predictive models in predicting( i) SARS- CoV-2 test results for presenting patients,( ii) hospital admission for SARS- CoV-2 positive patients, and( iii) ICU admission for SARS- CoV-2 positive patients? 2 Which clinical, demographic and blood analysis features were most important for the respective best encountered predictive models for each clinical prediction task? |
| cord-161674-nk0wie0w | So Far? |
| cord-161674-nk0wie0w | The role of microRNAs in respiratory viral infection: friend or foe? |
| cord-222664-4qyrtzhu | What Is the Evidence? |
| cord-252033-43fbfglt | key: cord-252033- 43fbfglt authors: Plebani, Mario; Padoan, Andrea; Negrini, Davide; Carpinteri, Benedetta; Sciacovelli, Laura title: Diagnostic performances and thresholds: the key to harmonization in serological SARS- CoV-2 assays? |
| cord-017463-repm1vw9 | ;( 2) the resources used to operate the system, including funding sources, adequately trained staff and information technology; and( 3) the usefulness and quality of surveillance information, using the following indicators: Usefulness of Data Do the data and information disseminated to data providers and users contain comprehensible facts and findings and useful recommendations to improve control measures and guide programme management? |
| cord-017463-repm1vw9 | Are these requirements met? |
| cord-017463-repm1vw9 | Has the system detected outbreaks? |
| cord-017463-repm1vw9 | How many of the detected outbreaks were investigated and controlled in a timely manner? |
| cord-017463-repm1vw9 | Timeliness of Data and Other Information Is data dissemination timely and regular? |
| cord-252597-ea78sjcs | Why do rna viruses recombine? |
| cord-252473-i4pmux28 | key: cord-252473-i4pmux28 authors: Rogers, Sharon title: Why ca n't I visit? |
| cord-252232-vgq6gjpx | Structural illustrations were prepared using the program Povscript[ 2] Evolutionary relationships between bat coronaviruses and their hosts POVScript?: a program for model and data visualization using persistence of vision raytracing Improved methods for building protein models in electron density maps and the location of errors in these models |
| cord-030999-27wennun | Should we be devoting extensive attention to the details of T- cell immunity if the data suggest that neutralizing antibody titre is itself a candidate correlate of protection? |
| cord-030999-27wennun | Which cells have produced the response and to what specific viral stimulus? |
| cord-030999-27wennun | infection, immunology research has been placed in the spotlight, with intense curiosity and scrutiny about many specific aspects of the immune response to this viral infection: when does immunity develop, what are the correlates of protection, what is the temporal relationship between immunity and infectivity, do all develop protective immunity and can reinfection occur, what part is played by immunopathology in pathological damage to the lungs and other organs? |
| cord-252456-971d0sir | Pathog Dis Novel coronavirus takes flight from bats? |
| cord-203191-7ftg6bfx | How Far Are We? |
| cord-203191-7ftg6bfx | The landscape of lung bronchoalveolar immune cells in COVID-19 revealed by single- cell RNA sequencing Renovation as innovation: is repurposing the future of drug discovery research? |
| cord-224516-t5zubl1p | SARS- CoV-2, a Threat to Privacy? |
| cord-104507-xx7t26rl | The Lancet Respiratory medicine Proinflammatory versus anti- inflammatory response in sepsis patients: looking at the cytokines Cytopathology or immunopathology? |
| cord-104507-xx7t26rl | collaborative analysis of 137 cases of a nationwide German registry Are there any association between COVID-19 severity and immunosuppressive therapy? |
| cord-103545-2v89ku4o | Is it the newest spark in the TORCH? |
| cord-103545-2v89ku4o | Should We Worry? |
| cord-103545-2v89ku4o | What Are the Data? |
| cord-252857-vaq0kwln | What can Parkinson's disease teach us about COVID-19? |
| cord-126015-zc7u3g34 | Donor- Recipient Pairs Killer Immunoglobulin- Like Receptor- Ligand Interactions Predict Clinical Outcomes following Unrelated Donor Transplantations Stem cell transplantation as a dynamical system: are clinical outcomes deterministic? |
| cord-126015-zc7u3g34 | The narrowing of the CD8 T cell repertoire in old age Diversity and clonal selection in the human T- cell repertoire Mechanisms shaping the naïve T cell repertoire in the elderly-thymic involution or peripheral homeostatic proliferation? |
| cord-193136-7g6qr73e | What are the key aspects of this pandemic that is influencing the society at large? |
| cord-193136-7g6qr73e | What are the key papers that captures the most relevant research, areas and topics on COVID-19? |
| cord-193136-7g6qr73e | What is the knowledge base that influences current research on this pandemic? |
| cord-179749-qdbmpi7j | How valid are these assumptions? |
| cord-179749-qdbmpi7j | What can we learn about SARS- CoV-2 prevalence from testing and hospital data? |
| cord-103659-wpwfqhp2 | Subjective neurological symptoms frequently occur in patients with SARS- CoV2 infection Mood, anxiety and olfactory dysfunction in COVID-19: evidence of central nervous system involvement? |
| cord-103659-wpwfqhp2 | The Lancet Psychiatry New onset neurologic events in people with COVID-19 infection in three regions in China Neurologic Involvement in COVID-19: Cause or Coincidence? |
| cord-103659-wpwfqhp2 | Underestimated Opportunistic Pathogens of the Central Nervous System? |
| cord-103659-wpwfqhp2 | Which lessons can we learn? |
| cord-252550-yaosufpm | SARS- CoV-2 receptor and regulator of the renin- angiotensin system: celebrating the 20th anniversary of the discovery of ACE2 Severe respiratory SARS- CoV2 infection: Does ACE2 receptor matter? |
| cord-252919-647zcjgu | NL63: a clinically important virus? |
| cord-193133-puqcbf8t | Can companion animals become infected with COVID-19? |
| cord-193133-puqcbf8t | Can companion animals become infected with COVID-19? |
| cord-193133-puqcbf8t | What Does Plant- Based Vaccine Technology Offer to the Fight against COVID-19? |
| cord-252933-bu4oihem | Hemostasis( SISET) Coagulopathy and antiphospholipid antibodies in patients with CoVID-19 COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow- up D- dimer is associated with severity of coronavirus disease 2019: a pooled analysis Case report of CoVID-19 in a kidney transplant recipient: does immunosuppression alter the clinical presentation? |
| cord-104500-m0kfom0x | Events Soluble Receptor Potentiates Receptor- Independent Infection by Murine Coronavirus Heterogeneities in the transmission of infectious agents: Implications for the design of control programs Identification of a Novel Antibody Associated with Autoimmune Pancreatitis Helicobacter pylori and autoimmune pancreatitis: role of carbonic anhydrase via molecular mimicry? |
| cord-104500-m0kfom0x | Genomic and protein structure modelling analysis depicts the origin and infectivity of 2019-nCoV COVID-19, SARS and MERS: are they closely related? |
| cord-104500-m0kfom0x | The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China Convalescent plasma in Covid-19: Possible mechanisms of action COVID-19 âȂŤ toward a comprehensive understanding of the disease Time course quantitative detection of SARS- CoV-2 in Parisian wastewaters correlates with COVID-19 confirmed cases Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin Cannabidiol as prophylaxis for SARS- CoV-2 and COVID-19? Unfounded claims versus potential risks of medications during the pandemic Amplification of the basic reproduction number in cattle farm networks |
| cord-104500-m0kfom0x | Why Systematic Review rather than Narrative Review? |
| cord-253380-oymg1bba | Covid-19 and immunomodulation in IBD Immunosuppression for hyperinflammation in COVID-19: a double- edged sword? |
| cord-197818-asd39zbj | /Hel real- time reverse transcription- PCR assay validated in vitro and with clinical specimens The epidemiology, diagnosis and treatment of COVID-19 Diagnosis of the Coronavirus disease( COVID-19): rRT- PCR or CT? |
| cord-197818-asd39zbj | Why are n't they being put to commercialization? |
| cord-197818-asd39zbj | where are these nanobiosensors when the world is fighting a global health pandemic? |
| cord-035163-tqh5wv12 | Aside from the characteristics described in Table 1, what other commonalities exist for these emerging/ re- emerging zoonotic viruses? |
| cord-035163-tqh5wv12 | Can we use these commonalities as the basis for proposing approaches for IPAC? |
| cord-035163-tqh5wv12 | How can airborne transmission of COVID-19 indoors be minimized? |
| cord-035163-tqh5wv12 | Survival characteristics of airborne human coronavirus Should test methods for disinfectants use vertebrate virus dried on carriers to advance virucidal claims? |
| cord-104162-fe51v2pt | Does the comparative method rule? |
| cord-104162-fe51v2pt | Is conservation necessarily a good indicator of likely therapeutic success? |
| cord-104162-fe51v2pt | The heart of the HIV RNA packaging signal? |
| cord-017354-cndb031c | Molecular virology: was the 1918 flu avian in origin? |
| cord-017354-cndb031c | The Parsimony Ratchet, a New Method for Rapid Parsimony Analysis Large- Scale Sequence Analysis of Avian Influenza Isolates Making Better Influenza Virus Vaccines? |
| cord-017354-cndb031c | Understanding the Impact on Animal and Human Health Phylogenetic analysis of nucleoproteins suggests that human influenza A viruses emerged from a 19th century avian ancestor Pandemic Planning and Preparedness Feldblyum and 14 others, Large- scale sequencing of human influenza reveals the dynamic nature of viral genome evolution Was the 1918 pandemic caused by a bird flu? |
| cord-017354-cndb031c | When are phylogency estimates from molecular and morphological data incongruent? |
| cord-017354-cndb031c | bound algorithms to determine minimal evolutionary trees Pandemics and Pandemic Scares in the 20th Century Part 2 Public Health Guidance for State and Local Partners Is Sparse Taxon Sampling a Problem for Phylogenetic Inference? |
| cord-017354-cndb031c | other data Optimization Alignment: the end of multiple sequence alignment in phylogenetics? |
| cord-252980-1e28zj1d | Given the use of pangolins use in traditional medicine and for food, what kind of role do the pangolins play in the cross- species evolution and transmission of the novel coronavirus? |
| cord-252771-6kwfulqe | The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus Voluntary collective isolation as a best response to COVID-19 for indigenous populations? |
| cord-252991-gvlyn6j7 | The Lancet Respiratory Medicine Is loss of sense of smell a diagnostic marker in COVID-19: A systematic review and meta- analysis Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say? |
| cord-102833-hh4641o0 | And for how many times?, medRxiv Decontamination of face masks and filtering facepiece respirators via ultraviolet germicidal irradiation, hydrogen peroxide vaporisation, and use of dry heat inactivates an infectious SARS- CoV-2 surrogate virus Disinfection of N95 Respirators with Ozone, medRxiv Quantitative form and fit of N95 filtering facepiece respirators are retained and coronavirus surrogate is inactivated after heat treatments, |
| cord-102833-hh4641o0 | Can Masks Be Reused After Hot Water Decontamination During the COVID-19 Pandemic? |
| cord-102833-hh4641o0 | Can N95 respirators be reused after disinfection? |
| cord-102833-hh4641o0 | The Effect of Ultraviolet C Radiation Against SARS- CoV-2 Inoculated N95 Respirators, medRxiv Is the fit of N95 facial masks effected by disinfection? |
| cord-253502-v2hh3w3r | Ribavirin inhibits viral- induced macrophage production of TNF, IL-1, the procoagulant fgl 2 prothrombinase and preserves Th 1 cytokine production but inhibits Th 2 cytokine response Antiviral treatment of SARS: can we draw any conclusions? |
| cord-252714-idlyl4ga | Interim Infection Prevention and Control Recommendations for Patients with Confirmed 2019 Novel Coronavirus( 2019-nCoV) or Persons Under Investigation for 2019-nCoV in Healthcare Settings Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards Airborne or droplet precautions for health workers treating coronavirus disease 2019? |
| cord-252714-idlyl4ga | Spain's coronavirus death toll surpasses China as world struggles with containment COVID-19 How many healthcare workers are infected? |
| cord-208426-wz3jan5d | Airborne or droplet precautions for health workers treating coronavirus disease 2019? |
| cord-208426-wz3jan5d | Does COVID-19 transmit via expiratory particles? |
| cord-253438-k8iqv1jb | A novel coronavirus from patients with pneumonia in China Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Are pangolins the intermediate host of the 2019 novel coronavirus( SARS- CoV-2)? |
| cord-253876-2dc9jq79 | key: cord-253876- 2dc9jq79 authors: Pitocco, Dario; Tartaglione, Linda; Viti, Luca; Di Leo, Mauro; Manto, Andrea; Caputo, Salvatore; Pontecorvi, Alfredo title: Lack of type 1 diabetes involvement in SARS- COV-2 population: Only a particular coincidence? |
| cord-252528-rgnhfcbx | What is the role of hydroxychloroquine in reducing thrombotic risk in patients with antiphospholipid antibodies? |
| cord-252528-rgnhfcbx | attenuates coagulation activation in experimental endotoxemia in chimpanzees Cytokine- induced alteration of platelet and hemostatic function Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment Endothelial activation and apoptosis mediated by neutrophil- dependent interleukin 6 trans- signalling: a novel target for systemic sclerosis? |
| cord-252557-f89m6xv5 | Close contact with suspected or confirmed COVID-19 individual? |
| cord-252557-f89m6xv5 | Cough/ sore throat/ respiratory problems? |
| cord-252557-f89m6xv5 | High- risk area? |
| cord-254120-1q8tqeg7 | what next? |
| cord-253665-1dn3ek34 | interferon? |
| cord-253671-g3ypisig | Does SARS- Cov-2 invade the brain? |
| cord-035292-pan415s7 | Drug repurposing approach Structure of M pro from SARS- CoV-2 and discovery of its inhibitors ZINC 15-Ligand discovery for everyone MTiOpenScreen: a web server for structure- based virtual screening LigPlot?: |
| cord-035292-pan415s7 | The interaction between the top- ranked hits, according to its docking score and SARS- CoV-2 M pro, has been explored using ligplot? |
| cord-035292-pan415s7 | To explore more the interaction between our target and top- ranked ligands, we used Ligplot? |
| cord-035292-pan415s7 | multiple ligand- protein interaction diagrams for drug discovery Mechanism of antiviral and cytotoxic action of(? |
| cord-253252-s8fm5rfa | A close shave? |
| cord-253252-s8fm5rfa | Droplet fate in indoor environments, or can we prevent the spread of infection? |
| cord-253987-83h861lp | bioRxiv Could the D614 G substitution in the SARS- CoV-2 spike( S) protein be associated with higher COVID-19 mortality? |
| cord-253457-gawn4s9g | and What Should We Do? |
| cord-103899-6tqm99g1 | COVID-19, SARS and MERS: are they closely related? |
| cord-103899-6tqm99g1 | MicroRNAs in inflammatory lung disease- master regulators or target practice? |
| cord-103899-6tqm99g1 | The role of microRNAs in respiratory viral infection: friend or foe? |
| cord-103899-6tqm99g1 | The role of microRNAs in respiratory viral infection: friend or foe? |
| cord-103899-6tqm99g1 | targeting TGFβ1 enhances antimicrobial capacity in Mycobacterium tuberculosis infected mice COVID-19 in the heart and the lungs: could we"Notch"the inflammatory storm? |
| cord-253777-h8wy0coq | Procalcitonin( ng/ ml, normal<0.5); Tn= troponin- n( ng/ ml, normal<19);VBG: venous blood gas; WBC: white blood cells( per mm 3);?: unknown because of decreased consciousness |
| cord-252389-xrdbmosj | A prospective clinical study of detailed neurological manifestations in patients with COVID-19 Comorbidity between neurological illness and psychiatric disorders Bidirectional relations among common psychiatric and neurologic comorbidities and epilepsy: do they have an impact on the course of the seizure disorder? |
| cord-252389-xrdbmosj | Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? |
| cord-253456-u9num2o9 | What did the researchers do and find? |
| cord-253456-u9num2o9 | Why was this study done? |
| cord-253422-m18ngwbt | COVID-19 and acute kidney injury in pediatric subjects: is there a place for eculizumab treatment? |
| cord-254079-pvl44u4d | The stethoscope: a potential source of nosocomial infection? |
| cord-253993-ynrthadj | The possible mechanisms of action of 4-aminoquinolines( chloroquine/ hydroxychloroquine) against Sars- Cov-2 infection( COVID-19): A role for iron homeostasis? |
| cord-253606-o8a0jhx2 | Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2( SARS- CoV-2) Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS- CoV-2 infection in vitro Hydroxychloroquine for treatment of SARS- CoV-2 infection? |
| cord-254668-szxhlejx | COVID-19, SARS and MERS: are they closely related? |
| cord-253844-y6xdcf20 | SARS coronavirus entry into host cells through a novel clathrin- and caveolae- independent endocytic pathway Targeting the endocytic pathway and autophagy process as a novel therapeutic strategy in COVID-19 The lung macrophage in SARS- CoV-2 infection: a friend or a foe? |
| cord-253844-y6xdcf20 | why 2 meters/6 feet of inter- personal distance could not be enough Consideration of the aerosol transmission for COVID-19 and public health Asymptomatic carriage and transmission of SARS- CoV-2: what do we know? |
| cord-254884-5rmnwcfd | Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? |
| cord-254395-tu4aqczj | Why are lopinavir and ritonavir effective against the newly emerged coronavirus 2019? |
| cord-253990-m75xwrz9 | In- hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19 Teaching old drugs new tricks: statins for COVID-19? |
| cord-253990-m75xwrz9 | Is a"Cytokine Storm"relevant to COVID-19? |
| cord-253431-fjds5cdr | The perspectives on immune responses World Health Organization declares global emergency: A review of the 2019 novel coronavirus( COVID-19) Chloroquine in fighting COVID-19: Good, bad, or both? |
| cord-253431-fjds5cdr | inhibitors of the renin- angiotensin system be withdrawn in patients with COVID-19? |
| cord-254505-mjj8xrer | there Is Something More than D614 G? |
| cord-254825-c5d0wul9 | Why did outbreaks of severe acute respiratory syndrome occur in some hospital wards but not in others? |
| cord-252965-30pl5tx3 | How does the timing of the implementation of lock- down periods and facemask adoption by the public influence the models'outcomes? |
| cord-252965-30pl5tx3 | New Zealand 2020 Pattern of early human- to- human transmission of Wuhan Preliminary estimating the reproduction number of the coronavirus disease( COVID-19) outbreak in Republic of Korea and Italy by 5 COVID-19 R0: magic number or conundrum? |
| cord-252965-30pl5tx3 | the simulations driving the world's response to COVID-19 An interactive web- based dashboard to track COVID-19 in real time Whose coronavirus strategy worked best? |
| cord-254968-czrgzyr3 | the intermediate host of the 2019 novel coronavirus( SARS- CoV-2)? |
| cord-254957-jqp1gto6 | Given Twice Daily 640 to Patients With Advanced Solid Tumors Measurement of sorafenib plasma concentration by highperformance liquid chromatography in patients with advanced hepatocellular carcinoma: is it useful the application in clinical practice? |
| cord-022316-mh4pslnv | China Peace over the Taiwan Strait? |
| cord-022316-mh4pslnv | How do the main tourist markets see the safety and security situation in China, and how do they perceive it as a tourist destination? |
| cord-022316-mh4pslnv | What are the main factors regarding safety and security affecting the tourism industry? |
| cord-022316-mh4pslnv | What factors have caused disruptions in tourism growth? |
| cord-022316-mh4pslnv | What might be the implications of those issues for destinations? |
| cord-022316-mh4pslnv | Why did the SARS outbreak have such a repercussion on China's tourism sector? |
| cord-253862-jl1zhg13 | Teicoplanin: an alternative drug for the treatment of COVID-19? |
| cord-253862-jl1zhg13 | what next? |
| cord-254318-w8wrn9lx | Is COVID-19 receiving ADE from other coronaviruses? |
| cord-253077-61fmul8c | ( COVID-19): A Review Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-253077-61fmul8c | :( 1) what is the contribution of T cells to initial virus control and tissue damage in the context of COVID-19, and( 2) how do memory T cells established thereafter contribute to protective immunity upon re- infection? |
| cord-253077-61fmul8c | Cytoplasmic Origin SARS- CoV-2 is sensitive to type I interferon pretreatment Prediction and Evolution of B Cell Epitopes of Surface Protein in SARS- CoV-2 Serology characteristics of SARS- CoV-2 infection since the exposure and post symptoms onset Quantifying treatment effects of hydroxychloroquine and azithromycin for COVID-19: a secondary analysis of an open label non- randomized clinical trial Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Adjuvant corticosteroid therapy for critically ill patients with COVID-19( medRxiv) Meta- Analysis: Convalescent Blood Products for Spanish Influenza Pneumonia: A Future H5N1 Treatment? |
| cord-035026-2qcsfd87 | : FDA warns that DPP-4 inhibitors for type 2 diabetes may cause joint pain Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus- EMC Covid 19 and Diabetes: can DPP4 inhibition play a role? |
| cord-035026-2qcsfd87 | Does COVID-19 Have Any Direct Effect on the Pancreas? |
| cord-035026-2qcsfd87 | Does the above implication mean better efficacy of DPP4 inhibitors in diabetic patients with COVID-19? |
| cord-035026-2qcsfd87 | Does zinc supplementation enhance the clinical efficacy of chloroquine/ hydroxychloroquine to win today's battle against COVID-19? |
| cord-035026-2qcsfd87 | Obesity New insights into insulin: the anti- inflammatory effect and its clinical relevance Outcomes in patients with hyperglycemia affected by COVID-19: can we do more on glycemic control? |
| cord-035026-2qcsfd87 | Should anti- diabetic medications be reconsidered amid COVID-19 pandemic? |
| cord-254900-fg5wd0nh | Sialylated or not? |
| cord-245161-xbw72k4m | Can N95 Respirators Be Reused after Disinfection? |
| cord-245161-xbw72k4m | How Many Times? |
| cord-245161-xbw72k4m | The iron- sulfur clusters of dehydratases are primary intracellular targets of copper toxicity Effects of temperature and humidity on the efficacy of methicillin- resistant Staphylococcus aureus challenged antimicrobial materials containing silver and copper Inactivation of murine norovirus on a range of copper alloy surfaces is accompanied by loss of capsid integrity Inactivation of norovirus on dry copper alloy surfaces Inactivation of influenza A virus on copper versus stainless steel surfaces Self- Disinfecting Copper Beds Sustain Terminal Cleaning and Disinfection Effects throughout Patient Care Photocatalytic disinfection using titanium dioxide: spectrum and mechanism of antimicrobial activity Understanding the antimicrobial mechanism of TiO₂-based nanocomposite films in a pathogenic bacterium Fabrication of Visible Light- Induced Antibacterial and Self- Cleaning Cotton Fabrics Using Manganese Doped TiO2 Nanoparticles Virus and Bacteria Self- Shielding System Self- disinfecting surfaces: review of current methodologies and future prospects Hygienic hand antiseptics: should they not have activity and label claims against viruses? |
| cord-245161-xbw72k4m | What determines the drop size in sprays? |
| cord-245161-xbw72k4m | you're out: how many swipes are needed to decontaminate plastic with disposable wipes? |
| cord-253970-sbj869yy | Readiness for responding to a severe pandemic 100 years after 1918 Coronavirus disease 2019( COVID-19): a systematic review of imaging findings in 919 patients Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan China Imaging in neurological disease of hospitalized COVID-19 patients: an Italian multicenter retrospective observational study Cerebral venous thrombosis associated with COVID-19 COVID-19-associated diffuse leukoencephalopathy and microhemorrhages Neurologic features in severe SARS- CoV-2 infection COVID-19 associated encephalopathies and cerebrovascular disease: the New Orleans experience Brain MRI Findings in severe COVID-19: a retrospective observational study Hemorrhagic posterior reversible encephalopathy syndrome as a manifestation of COVID-19 infection Anosmia in COVID-19 associated with injury to the olfactory bulbs evident on MRI Guillain- Barrè syndrome associated with SARS- CoV-2 infecion: causality or coincidence? |
| cord-253970-sbj869yy | The immunology of COVID-19: is immune modulation an option for treatment? |
| cord-255474-7fq9culd | Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-254916-y1rw9q11 | The antiviral compound remdesivir potently inhibits RNA- dependent RNA polymerase from middle East respiratory syndrome coronavirus Structural basis for inhibition of the RNA- dependent RNA polymerase from SARS- CoV-2 by remdesivir Remdesivir and SARS- CoV-2: structural requirements at both nsp12 RdRP and nsp14 exonuclease active- sites First case of 2019 novel coronavirus in the United States A rush to judgment? |
| cord-255413-8o884nyp | Eosinophils Drafted to Join the Th17 Team The protective and pathogenic roles of IL-17 in viral infections: friend or foe? |
| cord-255413-8o884nyp | responses also explain coronavirusvaccine immune enhancement( Fig. 1)? |
| cord-254162-tu81j66h | Do neutrophil extracellular traps contribute to the heightened risk of thrombosis in inflammatory diseases? |
| cord-254162-tu81j66h | Does augmentation with alpha1-antitrypsin affect neutrophil extracellular traps formation? |
| cord-254162-tu81j66h | Geographical overlap between alpha-1 antitrypsin deficiency and COVID-19 infection in Italy: Casual or causal? |
| cord-252818-1gms4zw3 | Beyond its basic strategy to hijack our cell machinery, does SARS- CoV-2 influence our behaviour to make it more likely to spread? |
| cord-252818-1gms4zw3 | Case clustering emerges as key pandemic puzzle The coronavirus pandemic and aerosols: Does COVID-19 transmit via expiratory particles? |
| cord-252818-1gms4zw3 | key to the successful global spread of the new Coronavirus SARS‐Cov‐2? |
| cord-015552-pm9kdqdw | 38'Inside the WHO as it mobilized to fight battle to control SARS Dutiful agents, rogue actors, or both? |
| cord-015552-pm9kdqdw | And with what consequences? |
| cord-015552-pm9kdqdw | Reconfiguring global health governance after SARS: WHO prevails? |
| cord-015552-pm9kdqdw | The politics of global health governance From International Sanitary Conventions to global health security: the new International Health Regulations WHO decides on the exception? |
| cord-015552-pm9kdqdw | What changed? |
| cord-015552-pm9kdqdw | Why and with what consequences do actors choose to contest norms through actions rather than words? |
| cord-015552-pm9kdqdw | Why did both the WHO and China resort to behavioural rather than discursive contestation? |
| cord-015552-pm9kdqdw | Why did the WHO's behavioural contestation of the sovereignty norm lead to a normative shift in global health governance, whereas China's attempt at opposition and preservation of the primacy of sovereignty remained futile? |
| cord-015552-pm9kdqdw | Why did the actors resort to behavioural rather than discursive contestation? |
| cord-255883-mz6nyisw | Could SARS- CoV-2-induced hyperinflammation magnify the severity of coronavirus disease( CoViD-19) leading to acute respiratory distress syndrome? |
| cord-252264-d9i19h8q | Early Guillain- Barre syndrome in coronavirus disease 2019( COVID-19): a case report from an Italian COVID- hospital Guillain- Barre syndrome during SARS- CoV-2 pandemic: a case report and review of recent literature Guillain- Barre syndrome related to COVID-19 infection Guillain- Barre syndrome as a complication of SARS- CoV-2 infection Guillain- Barre syndrome following COVID-19: new infection, old complication? |
| cord-252264-d9i19h8q | Guillain- Barre syndrome associated with SARS- CoV-2 infection Guillain- Barre syndrome associated with SARS- CoV-2 Guillain Barre syndrome associated with COVID-19 infection: a case report Guillain- Barre syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-252264-d9i19h8q | Postinfectious Guillain- Barre syndrome related to SARS- CoV-2 infection: a case report SARS- CoV-2-associated Guillain- Barre syndrome with dysautonomia Guillain- Barre syndrome in the COVID-19 era: just an occasional cluster? |
| cord-252264-d9i19h8q | The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases-2008 Infections and autoimmunity- friends or foes? |
| cord-029332-yn603pvb | COVID-19 pneumonia: a random association? |
| cord-029332-yn603pvb | COVID-19 pneumonia: a random association? |
| cord-029332-yn603pvb | Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Direct oral anticoagulants for the treatment of left ventricular thrombus- a new indication? |
| cord-029332-yn603pvb | Intraventricular thrombus and severe mitral regurgitation in the acute phase of Takotsubo cardiomyopathy: two case reports Endothelial cell infection and endotheliitis in COVID-19 ISTH interim guidance on recognition and management of coagulopathy in COVID-19 Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia Acute pulmonary embolism and COVID-19 pneumonia: a random association? |
| cord-029332-yn603pvb | The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS- CoV-2 Soluble angiotensin- converting enzyme 2: a potential approach for coronavirus infection therapy? |
| cord-029332-yn603pvb | what next? |
| cord-029332-yn603pvb | what next? |
| cord-029332-yn603pvb | where are the heart attacks and strokes? |
| cord-255586-wshvvgxg | Will we see protection or reinfection in COVID-19? |
| cord-252049-rgdynmla | Are higher levels of expression of 3CL pro in MERS- CoV- infected cells necessary to allow formation of active dimer?"Are other mechanisms such as substrate- or ligand- induced dimerizations involved in activating 3CL pro? |
| cord-252049-rgdynmla | Are higher levels of expression of 3CL pro in MERS- CoV- infected cells necessary to allow formation of active dimer?"Are other mechanisms such as substrate- or ligand- induced dimerizations involved in activating 3CL pro? |
| cord-252049-rgdynmla | Is dimerization required for the catalytic activity of bacterial biotin carboxylase? |
| cord-252049-rgdynmla | the beginning of another SARS- like pandemic? |
| cord-255997-oer5lxxr | from chronic viral infections to cancer SARS- CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines Chloroquine and COVID-19, where do we stand? |
| cord-255791-ghrlj6b2 | GISAID's innovative 586 contribution to global health Is the expression of deoxynucleoside kinases and 5'-nucleotidases in animal tissues 588 related to the biological effects of nucleoside analogs? |
| cord-016160-ugc7ce21 | A crucial question was how effective were these various measures at warding off the arrival of swine flu, verifying its severity and preventing or deterring its spread? |
| cord-016160-ugc7ce21 | But was the virus that was killing the cells the SARS virus, that is, was it the cause of the disease, or did it just happen to be present? |
| cord-016160-ugc7ce21 | Could you come over and visit us? |
| cord-016160-ugc7ce21 | How was Hong Kong able to keep H7N9 at bay? |
| cord-016160-ugc7ce21 | I know your work, Hedley said, could I persuade you to get interested in SARS? |
| cord-016160-ugc7ce21 | In reality, did the virus originate from the community or from hospitals?" |
| cord-016160-ugc7ce21 | Still, the question was, where did this new virus come from? |
| cord-016160-ugc7ce21 | This virus? |
| cord-016160-ugc7ce21 | Were domestic animals also responsible for SARS? |
| cord-016160-ugc7ce21 | animal- or animals- carried the virus that mutated and was able to infect people? |
| cord-048335-5fl0rk90 | Are health care workers duty- bound to care for the ill in a pandemic when they may have competing familial obligations? |
| cord-048335-5fl0rk90 | Challenging beliefs and ethical concepts: the collateral damage of SARS Zlotnick Shaul R: Ethics and SARS: lessons from Toronto SARS and hosptial priority setting: a qualitative case study and evaluation Comparative risk assessment: where does the public fit in? |
| cord-048335-5fl0rk90 | Setting priorities in health care organisations: criteria, processes, and parameters of success Priority setting in hospitals: fairness, inclusiveness, and the problem of institutional power differences Health care priority setting: principles, practice and challenges Psychosocial effects of SARS on hospital staff: survey of a large tertiary care institution On pandemics and the duty to care: whose duty? who cares? |
| cord-048335-5fl0rk90 | Setting priorities in health care organisations: criteria, processes, and parameters of success Priority setting in hospitals: fairness, inclusiveness, and the problem of institutional power differences Health care priority setting: principles, practice and challenges Psychosocial effects of SARS on hospital staff: survey of a large tertiary care institution On pandemics and the duty to care: whose duty? who cares? |
| cord-048335-5fl0rk90 | Thinking beyond Borders Ethical challenges in preparing for bioterrorism: barriers within the health care system Ethical resources distribution after biological, chemical or radiological terrorism Terrorism and the ethics of emergency medical care Disaster prepardeness and triage: justice and the common good Overwhelming casualties: medical ethics in a time of terror Bioterrorism, bioethics and the emergency physician Accountability for reasonableness Priority setting in hospitals: fairness, inclusiveness and the problem of institutional power differences Tragic choices in health care: lessons from the Child B case Procedures for priority setting and mechanisms of appeal in the Norwegian health care system:; Amsterdam Setting limits fairly: can we learn to share scarce resources? |
| cord-048335-5fl0rk90 | When should hospitals cancel elective surgeries or restrict hospital visitation? |
| cord-048335-5fl0rk90 | Who should get the limited supply of antivirals? |
| cord-048335-5fl0rk90 | Who will be prioritized for scarce ventilated hospital beds? |
| cord-255872-e2b7ox6b | : Is This Possible to Affect Their Antigenicity and Immunogenicity? |
| cord-254094-ed1epul1 | COVID-19: what does viral RNA load really mean? |
| cord-254094-ed1epul1 | Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2 Is aberrant CD8+ T cell activation by hypertension associated with cardiac injury in severe cases of COVID-19? |
| cord-254094-ed1epul1 | converting enzyme 2( ACE2) gene play a role in coronavirus disease 2019( COVID-19)? |
| cord-254630-ed5gawoj | Pennsylvania: ECRI Institute, Health devices Contamination of single- use bronchoscopes in critically ill patients With the current COVID-19 pandemic: should we use singleuse flexible bronchoscopes instead of conventional bronchoscopes? |
| cord-254630-ed5gawoj | cord-254630-ed5gawoj authors: Barron, Sarah P.; Kennedy, Marcus P. title: Single- Use( Disposable) Flexible Bronchoscopes: The Future of Bronchoscopy? |
| cord-235691-en6fgilb | For example, what individual- level attributes and behaviors lead to SSEs, and how to identify them quickly? |
| cord-235691-en6fgilb | King County COVID-19 pandemic on cruise ships Crowding and the epidemic intensity of COVID-19 transmission Closed environments facilitate secondary transmission of coronavirus disease What settings have been linked to SARS- CoV-2 transmission clusters? |
| cord-235691-en6fgilb | The airborne lifetime of small speech droplets and their potential importance in SARS- CoV-2 transmission COVID-19: faecal- oral transmission? |
| cord-235691-en6fgilb | When will it be over?" |
| cord-022266-nezgzovk | Have airlines responded appropriately to the risks of DVT among passengers? |
| cord-022266-nezgzovk | In what ways are issues of health a major concern for the tourism industry? |
| cord-022266-nezgzovk | The health- development link: Travel as a public health issue Off the beaten track: The health implications of the development of special interest tourism activities in South East Asia and the South Pacifi c Linkages between holiday taking travel risk and insurance claims: Evidence from New Zealand Sex, tourism and sex tourism: Fulfi lling similar needs? |
| cord-022266-nezgzovk | Tourists'health: Could the travel industry do more? |
| cord-022266-nezgzovk | Was there an over- reaction to the threat of SARS by tourists and the tourism industry in generating countries and could this have been avoided? |
| cord-022266-nezgzovk | What are the principal types of health- related crises that accommodation How do health questions impact on the work of destination marketing organizations? |
| cord-022266-nezgzovk | What preventive strategies can be employed by the tourism industry regarding the contracting of illness and disease by tourists and what will their success depend on? |
| cord-255909-m94j1rh4 | the beginning of another SARS- like pandemic? |
| cord-255895-6at9gelt | Good or bad? |
| cord-255602-3pzh5ur9 | The pilot quantitative study? |
| cord-255602-3pzh5ur9 | Who falls for fake news? |
| cord-255284-ffh1jl40 | How contagious are common respiratory tract infections? |
| cord-255284-ffh1jl40 | Y a- t- il des porteurs sains? |
| cord-255697-trig04hd | How long do nosocomial pathogens persist on inanimate surfaces? |
| cord-253201-r6vsa0pw | Does SARS Cov 2 invade the brain? |
| cord-253201-r6vsa0pw | Specific EEG Encephalopathy Pattern in SARS- CoV-2 Patients Brain MRI findings in patients in the intensive care unit with COVID-19 infection Cerebrovascular and Neurological Dysfunction under the Threat of COVID-19: Is There a Comorbid Role for Smoking and Vaping? |
| cord-253201-r6vsa0pw | The Journal of infectious diseases Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2 Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-253201-r6vsa0pw | Underestimated Opportunistic Pathogens of the Central Nervous System? |
| cord-253201-r6vsa0pw | What should radiologists need to know? |
| cord-255264-2kj961en | COVID-19 Preparedness How to reduce infection risk of coronavirus? |
| cord-255264-2kj961en | cord-255264- 2kj961en authors: Hasan, Syed Shahzad; Kow, Chia Siang; Zaidi, Syed Tabish Razi title: Social distancing and the use of PPE by community pharmacy personnel: Does evidence support these measures? |
| cord-256152-8wla6ne4 | How Scientific Community Should be Prepared? |
| cord-026340-2nf97zvc | : what to expect for COVID-19? |
| cord-026340-2nf97zvc | Does CQ have anti- viral effects? |
| cord-026340-2nf97zvc | How did COVID-19 originate? |
| cord-026340-2nf97zvc | How does CQ help eliminate malarial parasite? |
| cord-026340-2nf97zvc | How effective can be CQ against SARS? |
| cord-026340-2nf97zvc | How long has it been since we know chloroquine( CQ, 9-aminoquinoline)? |
| cord-026340-2nf97zvc | PPT1 promotes tumor growth and is the molecular target of chloroquine derivatives in cancer Inhibition of betulinic acid to growth and angiogenesis of human colorectal cancer cell in nude mice Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-026340-2nf97zvc | What are the possible ways SARS- CoV2 infect a host cell? |
| cord-026340-2nf97zvc | What are the symptoms of COVID-19? |
| cord-026340-2nf97zvc | What governs the affinity of a virus towards the human host cell? |
| cord-026340-2nf97zvc | What is COVID-19? |
| cord-256872-jekx1czw | Conflict or serendipity? |
| cord-254446-yxqbe1dj | : Facts and myths Impact of corticosteroid therapy on outcomes of persons with SARS- CoV-2, SARS- CoV, or MERS- CoV infection: a systematic review and meta- analysis COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? |
| cord-254446-yxqbe1dj | Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS- CoV-2: an observational cohort study Viral dynamics of SARS- CoV-2 across a spectrum of disease severity in COVID-19 Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes Comparisons of viral shedding time of SARS- CoV-2 of different samples in ICU and non- ICU patients Lack of dyspnea in patients with Covid-19: another neurological conundrum? |
| cord-254446-yxqbe1dj | The facts during the third epidemic Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long- term immunosuppression Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation? |
| cord-257008-7q5s1vu1 | Can the legacy of industrial pollution influence antimicrobial resistance in estuarine sediments? |
| cord-256023-21b5hanj | For the UMAP projection we set<=>? |
| cord-256156-mywhe6w9 | How good is automated protein docking? |
| cord-256156-mywhe6w9 | True Receptors or Adaptation Bias? |
| cord-256888-tdx12ccj | different respiratory treatments for different phenotypes? |
| cord-220618-segffkbn | How effective has been the spanish lockdown to battle covid-19? |
| cord-220618-segffkbn | Too many patients? |
| cord-220618-segffkbn | Will the coronavirus end globalization as we know it? |
| cord-220618-segffkbn | medRxiv Finding patient zero: Learning contagion source with graph neural networks Infectious diseases of humans: dynamics and control The mathematics of infectious diseases Estimating the establishment of local transmission and the cryptic phase of the covid-19 Assessment of the sars- cov-2 basic reproduction number, r0, based on the early phase of covid-19 outbreak in italy Countries test tactics in? |
| cord-220618-segffkbn | medRxiv How often should people be tested for corona to avoid a shutdown? |
| cord-220618-segffkbn | medRxiv Next flu pandemic: what to do until the vaccine arrives? |
| cord-220618-segffkbn | medRxiv The state of the nation: A 50-state covid-19 survey report# 4 Attacking the covid-19 with the isingmodel and the fermi- dirac distribution function Predictability: Can the turning point and end of an expanding epidemic be precisely forecast? |
| cord-252279-0gozdv43 | Can we use interleukin-6( IL-6) blockade for coronavirus disease 2019( COVID-19)-induced cytokine release syndrome( CRS)? |
| cord-252279-0gozdv43 | Cardiac complications attributed to chloroquine and hydroxychloroquine: a systematic review of the literature Retinal pigment epithelium cell culture as a model for evaluation of the toxicity of tamoxifen and chloroquine Increased incidence of gastrointestinal side effects in patients taking hydroxychloroquine: a brand- related issue? |
| cord-252279-0gozdv43 | Chloroquine and hydroxychloroquine as available weapons to fight COVID-19 Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities Bioavailability of hydroxychloroquine tablets in healthy volunteers Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases Pharmacokinetics and cellular uptake of 4-aminoquinoline antimalarials CANDO and the infinite drug discovery frontier Paths to a malaria vaccine illuminated by parasite genomics Malaria vaccine: a future hope to curtail the global malaria burden Antimalarial drug discovery: in silico structural biology and rational drug design Genome- scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms Antimalarial drug discovery: approaches and progress towards new medicines Medical need, scientific opportunity and the drive for antimalarial drugs Natural products from synthetic biology High- level semisynthetic production of the potent antimalarial artemisinin Mobile phones and malaria: modeling human and parasite travel Big data opportunities for global infectious disease surveillance Smooth or risky revisit of an old malaria drug for COVID-19? |
| cord-252279-0gozdv43 | Reduced activation of CD4? |
| cord-252922-cdhnlvxv | Corona Immunitas is a research program coordinated by SSPH?, conducting longitudinal, population- based seroprevalence studies covering a number of Swiss Cantons as well as several seroepidemiological studies in specific subpopulations. |
| cord-252922-cdhnlvxv | For specific groups of interest( e.g., age group 65? or any subpopulation), and considering a serological test with 98% sensitivity and 99% specificity, a minimum population of 200 persons with an observed seroprevalence of 5% will yield 90% credible intervals of ± 2.5% for a posterior prevalence of 4.6%, of ± 3.5% for a posterior seroprevalence of 9.7%( observed prevalence 10%) and of ± 4.6% for a posterior seroprevalence of 19.9%( observed prevalence 20%). |
| cord-252922-cdhnlvxv | The directorate of SSPH? |
| cord-252922-cdhnlvxv | This study was funded by several sources( full funding details in Supplementary Materials) that includes, but is not limited to, SSPH? and Swiss Federal Office of Public Health. |
| cord-252922-cdhnlvxv | We thank SSPH? |
| cord-256893-3sh87h2x | COVID-19: risk for cytokine targeting in chronic inflammatory diseases? |
| cord-254777-h8hw4m9f | Immunopathology in COVID-19 Is the HScore useful in COVID-19? |
| cord-254777-h8hw4m9f | The JAK/ STAT signaling pathway Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure Baricitinib for COVID-19: a suitable treatment? |
| cord-254777-h8hw4m9f | The Lancet Infectious Diseases JAK Inhibition as a New Treatment Strategy for Patients with COVID-19 Janus kinase inhibitor baricitinib is not an ideal option for management of COVID-19 Baricitinib for COVID-19: a suitable treatment? |
| cord-256374-l492w2i2 | The willingness of U.S. Emergency Medical Technicians to respond to terrorist incidents Risk perception and impact of Severe Acute Respiratory Syndrome( SARS) on work and personal lives of healthcare workers in Singapore: what can we learn? |
| cord-256374-l492w2i2 | authors: Mackler, Niklas; Wilkerson, William; Cinti, Sandro title: Will First- Responders Show Up for Work During a Pandemic? |
| cord-255101-l5ssz750 | Avez- vous totalement récupéré les capacités olfactives que vous aviez avant le début de l'apparition des symptômes de COVID-19? ») |
| cord-255101-l5ssz750 | Avez- vous totalement récupéré les capacités olfactives que vous aviez avant le début de l'apparition des symptômes de COVID-19? ») |
| cord-255101-l5ssz750 | « Avez- vous totalement récupéré les capacités olfactives que vous aviez avant le début de l'apparition des symptômes de COVID-19? ») |
| cord-255665-srvz2ay0 | : Is There One? |
| cord-255665-srvz2ay0 | Emerging key laboratory tests for patients with COVID-19 Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing Hematologic parameters in patients with COVID-19 infection A role for CT in COVID-19? |
| cord-255665-srvz2ay0 | Which sampling method for the upper respiratory tract specimen should be taken to diagnose patient with COVID-19? |
| cord-255476-p0gyyl3c | : Should We Worry? |
| cord-255476-p0gyyl3c | Has Sweden's controversial covid-19 strategy been successful? |
| cord-255476-p0gyyl3c | Outcomes of first nine cases in an inner city London hospital Screening for COVID-19 at childbirth: does it deliver? |
| cord-256092-bph9ys72 | Shahrukh K. title: Role of testosterone in COVID-19 patients- a double- edged sword? |
| cord-256092-bph9ys72 | The novel Angiotensin- Converting Enzyme( ACE) homolog, ACE2, is selectively expressed by adult Leydig cells of the testis Worse progression of COVID-19 in men: Is testosterone a key factor? |
| cord-257732-3xuy6tbn | what next? |
| cord-257169-1lk737lw | The key to harmonization in serological SARS- CoV-2 assays? |
| cord-257533-i85dyg8n | What are the Underlying Transmission Patterns of COVID-19 Outbreak? |
| cord-256233-k9hdq3z8 | Are men vulnerable and women protected? |
| cord-256233-k9hdq3z8 | Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? |
| cord-256233-k9hdq3z8 | The RECOVERY Trial: Dexamethasone for COVID-19? |
| cord-256020-wrui3i2l | The importance of recognising early possible ocular manifestation and using protective eyewear Can the Coronavirus Disease 2019( COVID-19) affect the eyes? |
| cord-256020-wrui3i2l | Worldometers( https://www. worldometers.info/coronavirus/?). |
| cord-256385-g1wcfrfi | SARS- CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor Extracorporeal membrane oxygenation( ECMO): Does it have a role in the treatment of severe COVID-19? |
| cord-256385-g1wcfrfi | What drives neutrophils to the alveoli in ARDS? |
| cord-256385-g1wcfrfi | What's new? |
| cord-257135-xt4w0baw | Wuhan, China: a descriptive study Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? |
| cord-257600-0plhquk9 | Do patients with cancer have a poorer prognosis of COVID-19? |
| cord-033204-v17d98c9 | Amid high uncertainty, how to make collective sense of this crisis as a society? |
| cord-033204-v17d98c9 | Here's the difference between asymptomatic and pre- symptomatic spread The secrete behind 8.5 times of mask production in 3 months: How did Taiwan do it? |
| cord-033204-v17d98c9 | How do the public perceive the risks? |
| cord-033204-v17d98c9 | Room for industrial upgrade? |
| cord-033204-v17d98c9 | That is, how to cope with the uncertainty brought by or embedded in this crisis? |
| cord-033204-v17d98c9 | There is obviously huge demand for facemasks during this crisis, but why is n't there corresponding supply? |
| cord-033204-v17d98c9 | What are the lessons policymakers can learn from Taiwan's experience? |
| cord-033204-v17d98c9 | What explains Taiwan's success? |
| cord-033204-v17d98c9 | Why ca n't other countries mass- produce facemasks like Taiwan does? |
| cord-033204-v17d98c9 | is privacy respected? |
| cord-257611-z0sng9sx | The SARS, MERS and novel coronavirus( COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
| cord-256761-rjss51sq | Can Chinese medicine be used for prevention of Corona virus disease 2019( COVID-19)? |
| cord-256761-rjss51sq | Developing new drugs or repurposing old ones? |
| cord-258307-nsdhvc8w | Avian influenza: a new pandemic threat? |
| cord-256051-87alqfkd | A role for CT in COVID-19? |
| cord-256051-87alqfkd | Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA- Secondary Publication Is There a Role for Lung Ultrasound During the COVID-19 Pandemic? |
| cord-256051-87alqfkd | pneumonia: a random association? |
| cord-255631-516epnjw | Any unique image biomarkers associated with COVID-19? |
| cord-255631-516epnjw | COVID-19: Are We Ready for the Second Wave? |
| cord-255631-516epnjw | The case of China An evaluation of mathematical models for the outbreak of COVID-19 Mathematical modeling and the transmission dynamics in predicting the Covid-19-What next in combating the pandemic Caution Warranted: Using the Institute for Health Metrics and Evaluation Model for Predicting the Course of the COVID-19 Pandemic Diagnosis of the Coronavirus disease( COVID-19): rRT- PCR or CT? |
| cord-255631-516epnjw | a pilot study Generalizability of Deep Learning Tuberculosis Classifier to COVID-19 Chest Radiographs: New Tricks for an Old Algorithm? |
| cord-256217-fnjer0e0 | At this stage, can the ocular immune system represent a valid model upon which to rely in order to hypothesize a possible therapeutic strategy? |
| cord-256217-fnjer0e0 | Can the coronavirus disease 2019( COVID-19) affect the eyes? |
| cord-256217-fnjer0e0 | Do corticosteroids have a role in treating Ebola virus disease? |
| cord-256217-fnjer0e0 | Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-255972-u7v0es5w | An Effective Intervention at the Global Level? |
| cord-255972-u7v0es5w | To what extent do children transmit SARS- CoV-2 virus? |
| cord-255972-u7v0es5w | Who's minding the kids? |
| cord-256904-uq6gy24x | : Is There One? |
| cord-256904-uq6gy24x | COVID-19: Serology-where are we? |
| cord-257613-o0q7hvn3 | 6.3| What can we expect to learn from this pandemic( with new clinical trials approved)? |
| cord-258576-ywbyflas | China Extracellular DNA traps promote thrombosis Thrombosis: tangled up in NETs What has the COVID-19 pandemic taught us so far? |
| cord-257058-wf6oxzrk | What is occurring now? |
| cord-032552-rjuug7er | Are all factual statements correct, and are statements and arguments made adequately supported by citations? |
| cord-032552-rjuug7er | Could this observation mean that it is not necessarily the public health interventions that have driven the low mortality in SSA but potentially other factors? |
| cord-032552-rjuug7er | From bad to good( and back again?) |
| cord-032552-rjuug7er | Is the rationale for the Open Letter provided in sufficient detail? |
| cord-032552-rjuug7er | Partly Where applicable, are recommendations and next steps explained clearly for others to follow? |
| cord-032552-rjuug7er | Table 2, what does the sociocultural challenge"suspicion of harmful and unethical interventions"mean? |
| cord-032552-rjuug7er | What are the harmful and unethical interventions and why and who offered the harmful and unethical interventions to whom?What are"faith- related rumors"? |
| cord-032552-rjuug7er | Why is There Low Morbidity and Mortality of COVID-19 in Africa? |
| cord-032552-rjuug7er | potential solutions Reference Source Is the rationale for the Open Letter provided in sufficient detail? |
| cord-256224-qprj8vlc | : cord-256224-qprj8vlc authors: Boixeda, R.; Campins, L.; Juanola, J.; Force, L. title: Is chronic obstructive pulmonary disease a protective factor in SARS- CoV-2 infection? |
| cord-256224-qprj8vlc | la infección por SARS- CoV-2? |
| cord-258160-v08cs51n | Two key questions remain: What is the natural reservoir host for the outbreak SARS- CoV strains, and how were the viruses transmitted to civets or other intermediate hosts? |
| cord-258595-bk35vxlr | Umwelt SARS- CoV-2 from faeces to wastewater treatment: What do we know? |
| cord-257789-pdybfft6 | gold Open Access which fosters wider collaboration and increased citations maximum visibility for your research: over 100 M website views per year submit your research? |
| cord-258128-qtmjgrml | a prospective observational study Clinical practice guidelines for diagnosis and management of cough- Chinese Thoracic Society( CTS) Asthma Consortium Pharmacology of dextromethorphan: relevance to dextromethorphan/ quinidine( Nuedexta ®) clinical use Hypothesis: angiotensin- converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19 SARS- CoV2: should inhibitors of the renin- angiotensin system be withdrawn in patients with COVID-19? |
| cord-256303-bpa571ys | What constitutes a neglected tropical disease? |
| cord-256303-bpa571ys | Will COVID-19 become the next neglected tropical disease? |
| cord-257805-pcp3qgn0 | Viruses Why are pregnant women susceptible to COVID-19? |
| cord-032751-pmclolvh | If your healthcare provider strongly recommended a COVID-19 vaccine in the next year, how likely is it that you'd get vaccinated? |
| cord-032751-pmclolvh | A Bayesian meta- analysis with focus on the Ajzen- Fishbein Model in the field of environmental behavior What is herd immunity, and how does it relate to pediatric vaccination uptake? |
| cord-032751-pmclolvh | Framing HPV to influence vaccination intentions among college students Does changing behavioral intentions engender behavior change? |
| cord-032751-pmclolvh | Perceived threat to physical health was measured with a single item:"If you got infected with COVID-19, how threatening would it be to your physical health?" |
| cord-032751-pmclolvh | Personal susceptibility was measured with a single item:"how likely do you believe it is that you will get infected with COVID-19?" |
| cord-032751-pmclolvh | Reexamining the major tenets of the extended parallel process model Theory- based predictors of influenza vaccination among pregnant women Red media, blue media: Evidence of ideological selectivity in media use Americans'trust in health information sources: Trends and sociodemographic predictors HPV vaccine promotion: Does referring to both cervical cancer and genital warts affect intended and actual vaccination behavior? |
| cord-032751-pmclolvh | Results from the National Immunization Survey- Teen Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? |
| cord-032751-pmclolvh | These two vaccine intent items included"How likely is it that you'll get a COVID-19 vaccine, if it becomes available?" |
| cord-032751-pmclolvh | What are the SARS- CoV-2 vaccine behavioral intentions of adults in the U.S. when a health care provider recommends the vaccine? |
| cord-032751-pmclolvh | What are the SARS- CoV-2 vaccine behavioral intentions of adults in the U.S.? |
| cord-032751-pmclolvh | What factors are associated with SARS- CoV-2 vaccine behavioral intentions of adults in the United States? |
| cord-032751-pmclolvh | Who is to blame? |
| cord-257105-vrwuaknf | May be a potential inflammatory mediator for SarS- coV-2 infection? |
| cord-257105-vrwuaknf | S: dopamine reward circuitry: Two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex Sniffing out the contributions of the olfactory tubercle to the sense of smell: Hedonics, sensory integration, and more? |
| cord-257105-vrwuaknf | coV 2 infection? |
| cord-258624-041cf99j | What is the predictive value of animal models for vaccine efficacy in humans? |
| cord-255907-t7gpi2vo | How is this mechanism similar to, or distinct from, that associated with the emergence of SARS- CoV and MERS- CoV? |
| cord-255907-t7gpi2vo | How prevalent is the virus in its natural host, and does it possess the ability to infect other animals? |
| cord-255907-t7gpi2vo | Since coronaviruses can experience rapid mutation and frequent recombination, will these activities generate novel strains with heightened transmissibility and pathogenicity? |
| cord-255907-t7gpi2vo | What is the molecular mechanism underlying the interspecies transmission of 2019-nCoV? |
| cord-255907-t7gpi2vo | What is the role played by point mutation and recombination in the evolution of 2019-nCoV? |
| cord-259852-skhoro95 | The question then arises that, beyond the current containment efforts by various African countries, could they have done better to prevent the spread of this viral infection into and within the continent based on previous experiences with other emerging and re- emerging pathogens? |
| cord-259347-3acsko74 | Is SARS- CoV-2 likely to be present in the central nervous system? |
| cord-258431-8zgwj2fa | Does SARS- Cov-2 invade the brain? |
| cord-258172-p54j4zzo | : What Is the Evidence? |
| cord-258844-b4d79m1f | How does the Hospital and Anxiety and Depression Scale measure anxiety and depression in healthy subjects? |
| cord-259907-yqmi0cqy | Critically ill patients with severe acute respiratory syndrome Antepartum pneumonia in pregnancy Pneumonia during pregnancy: has modern technology improved maternal and fetal outcome? |
| cord-258722-1o6zhnnj | In vitro testing of hydroxychloroquine and azithromycin on SARS- CoV-2 shows 1 synergistic effect 2 Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open- label non- randomized clinical trial Should chloroquine and hydroxychloroquine be used to treat COVID-19? |
| cord-258722-1o6zhnnj | Kerstin title: Should azithromycin be used to treat COVID-19? |
| cord-257258-hu9oxea1 | Are IL-6 inhibitors one key to COVID-19? |
| cord-257258-hu9oxea1 | What are the prospects for dealing with COVID‐19 more effectively in the future? |
| cord-257258-hu9oxea1 | What are the prospects for dealing with this virus more effectively in the future? |
| cord-258724-1qhen1bj | Distinct immune response in two MERS- CoV- infected patients: can we go from bench to bedside? |
| cord-256537-axbyav1m | But, what of influenza? |
| cord-256537-axbyav1m | Is it simply that we are more able, with our new technologies, to detect them? |
| cord-256537-axbyav1m | Or are there forces at work that are fostering this trend? |
| cord-256537-axbyav1m | So what explains the apparent increased pace of emergence of new human infections? |
| cord-258873-l9oxmqdp | A case report Characteristics of COVID-19 disease in multiple sclerosis patients COVID-19 outcomes in MS: early experience from NYU multiple sclerosis comprehensive care center Rapid generation of neutralizing antibody responses in COVID-19 patients SARS- CoV-2 neutralizing human recombinant antibodies selected from prepandemic healthy donors binding at RBD- ACE2 interface Effect of convalescent plasma therapy on viral shedding and survival in COVID-19 patients Treatment with convalescent plasma for COVID-19 patients in Wuhan Two X- linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover A possible role for B- cells in COVID-19? |
| cord-258873-l9oxmqdp | An Italian programme for COVID-19 infection in multiple sclerosis Clinical characteristics and outcomes in patients with coronavirus disease 2019 and multiple sclerosis COVID-19 in 7 multiple sclerosis patients in treatment with anti CD20 therapies Attenuation of antibody response to SARS- CoV-2 in a patient on ocrelizumab with hypogammaglobulinemia Negative SARS- CoV-2 antibody testing following COVID-19 infection in two MS patients treated with ocrelizumab Is serological response to SARS- CoV-2 preserved in MS patients on ocrelizumab treatment? |
| cord-256688-yy7abob9 | A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person- to- person transmission: a study of a family cluster Clinical characteristics of Coronavirus Disease 2019 in China Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus- infected pneumonia in Wuhan, China Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross- sectional, multicenter study Clinical management of severe acute respiratory infection when novel coronavirus( nCoV) infection is suspected COVID-19) Interim Infection Prevention and Control Recommendations Novel Coronavirus( 2019-nCoV) healthcare infection prevention and control FAQs for COVID-19 COVID-19: what is next for public health? |
| cord-256688-yy7abob9 | How does the new coronavirus compare with the flu? |
| cord-256688-yy7abob9 | What are the risks of COVID-19 infection in pregnant women? |
| cord-256688-yy7abob9 | molecular mechanisms and potential therapeutic target Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-252305-rstxyofq | Can this product be delivered through multiple modalities to allow for flexibility( spray bottle with dry wipe packs vs. saturating wipe rolls in a A c c e p t e d M a n u s c r i p t 11 bucket, etc.)? |
| cord-252305-rstxyofq | Does the product have potential for toxicity or irritation? |
| cord-252305-rstxyofq | Does this product have an emerging viral pathogen claim? |
| cord-252305-rstxyofq | Is this product currently commercially available, and will it remain available for repurchase? |
| cord-252305-rstxyofq | Is this product economical for the healthcare institution? |
| cord-252305-rstxyofq | What is the method of delivery( pre- moistened wipe, spray, concentrate requiring dilution, etc.)? |
| cord-252305-rstxyofq | What is the pH of the product? |
| cord-252305-rstxyofq | What is the wet- contact time required to kill SARS- CoV-2? |
| cord-252305-rstxyofq | What surface types/ equipment is the disinfectant compatible with? |
| cord-258914-g6pv8zz9 | The current state of H5N1 vaccines and the use of 553 the ferret model for influenza therapeutic and prophylactic development Antiviral Efficacies of FDA- Approved Drugs against SARS-557 SARS- CoV-2 vaccines: should we focus on mucosal immunity? |
| cord-256458-3fyul3k2 | Could COVID-19 represent a negative prognostic factor in patients with stroke? |
| cord-256458-3fyul3k2 | Is our COVID-19-focused health care system and media currently providing less attention to other serious conditions and emergencies like acute stroke? |
| cord-256458-3fyul3k2 | Is there a true decrease in stroke incidence? |
| cord-256458-3fyul3k2 | Where are all these people? |
| cord-259993-hlsvu1cg | where was the virus from? |
| cord-258221-pn8gh73b | Interferon- stimulated genes: What do they all do? |
| cord-258221-pn8gh73b | What can target kidney fibrosis? |
| cord-258221-pn8gh73b | inhibit hepatitis C virus infection Five decades later, are mesenchymal stem cells still relevant? |
| cord-259396-vmc2q1bi | Aerosolized SARS- CoV-2 transmission risk: Surgical or N95 masks? |
| cord-259566-qtlq7a6l | The reproductive number of COVID-19 is higher compared to SARS coronavirus Perinatal transmission of COVID-19 associated SARS- CoV-2: should we worry? |
| cord-258268-7ypq0t3d | Could Sars- coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects Advances in the research of cytokine storm mechanism induced by Corona virus disease 2019 and the corresponding immunotherapies Detection of 2019 novel coronavirus( 2019-nCoV) by real- time RT- PCR Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? |
| cord-258268-7ypq0t3d | Guillain- Barrè syndrome associated with SARS- CoV-2 infecion: causality or coincidence? |
| cord-260191-0u0pu0br | an die Surveillance neu auftretender Infektionskrankheiten gerecht? |
| cord-260054-iihgc5nr | Could the D614 G substitution in the SARS- CoV-2 spike( S) protein be associated with higher COVID-19 mortality? |
| cord-259747-sl9q63oc | COVID-19 pneumonia: ARDS or not? |
| cord-258435-lhn34tc4 | Did quarantine help? |
| cord-258435-lhn34tc4 | Is the Quarantine Act relevant? |
| cord-258435-lhn34tc4 | When is quarantine a useful control strategy for emerging infectious diseases? |
| cord-258708-da6x5rxa | A double- edged sword? |
| cord-258708-da6x5rxa | The epidemiology and pathogenesis of coronavirus disease( COVID-19) outbreak Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome Recognition and Initial Management of Fulminant Myocarditis: A Scientific Statement From the COVID-19 and acute myocardial injury: the heart of the matter or an innocent bystander? |
| cord-259033-op94wuy4 | Can SARS- CoV-2 trigger reactive arthritis? |
| cord-259033-op94wuy4 | How and why are rheumatologists relevant to COVID-19? |
| cord-259471-lsdodl0a | Protecting health care workers during the COVID-19 coronavirus outbreak: lessons from Taiwan's SARS response Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-259471-lsdodl0a | key: cord-259471-lsdodl0a authors: Pagliano, Pasquale; Piazza, Ornella; De Caro, Francesco; Ascione, Tiziana; Filippelli, Amelia title: Is Hydroxychloroquine a Possible Postexposure Prophylaxis Drug to Limit the Transmission to Healthcare Workers Exposed to Coronavirus Disease 2019? |
| cord-260048-yis26g81 | The species 645 Severe acute respiratory syndrome- related coronavirus: classifying 2019-nCoV and naming it SARS-646 CoV-2 Could the D614 G substitution in the 648 SARS- CoV-2 spike( S) protein be associated with higher COVID-19 mortality? |
| cord-257766-z7vcdtcq | Could we already have an effective and scalable live attenuated vaccine, with attenuation done by dose- reduction to a non- infective titer? |
| cord-257766-z7vcdtcq | Palm A- K E and Henry C SARS- CoV-2 antibody responses determine disease severity in COVID-19 infected individuals Stimulated innate resistance of lung epithelium protects mice broadly against bacteria and fungi Natural polyreactive secretory immunoglobulin A autoantibodies as a possible barrier to infection in humans From Natural Polyreactive Autoantibodies to À La Carte Monoreactive Antibodies to Infectious Agents: Is It a Small World after All? |
| cord-257766-z7vcdtcq | The discovery of secretory IgA and the mucosal immune system two separate but related systems of immune defence? |
| cord-258725-z79gel8h | Medium Will children reveal their secret? |
| cord-258725-z79gel8h | medRxiv preprint Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study What have been the fatal risks of Covid, particularly to children and younger adults? |
| cord-258725-z79gel8h | medRxiv preprint exposure to children perhaps enhance the efficacy of SARS- CoV-2 vaccines? |
| cord-259619-sco0d5cc | HOW CAN WE MOST SAFELY AND RAPIDLY REVERT TO"NORMAL"? |
| cord-259619-sco0d5cc | The epidemiological characteristics of an outbreak of Economic downturns, universal health coverage, and cancer mortality in high- income and middle- income countries, 1990- 2010: a longitudinal analysis How many infants likely died in Africa as a result of the 2008- 2009 global financial crisis? |
| cord-259933-ggx4v0bz | key: cord-259933-ggx4v0bz authors: Dalan, Rinkoo; Bornstein, Stefan R.; El- Armouche, Ali; Rodionov, Roman N; Markov, Alexander; Wielockx, Ben; Beuschlein, Felix; Boehm, Bernhard O. title: The ACE-2 in COVID-19: Foe or Friend? |
| cord-257729-s0vo7dlk | COVID19 Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-257729-s0vo7dlk | Can SARS- CoV-2 infection be acquired in utero? |
| cord-257729-s0vo7dlk | What are the risks of COVID-19 infection in pregnant women? |
| cord-257729-s0vo7dlk | retrospective, single- centre, observational cohort study Risk factors for failed conversion of labor epidural analgesia to cesarean delivery anesthesia: a systematic review and meta- analysis of observational trials Perinatal transmission of COVID-19 associated SARS- CoV-2: should we worry? |
| cord-259869-kwzsdhrr | : What can saliva tell us? |
| cord-259869-kwzsdhrr | acute and/or chronic sialadenitis Saliva- Friend and Foe in the COVID-19 Outbreak A review of salivary diagnostics and its potential implication in detection of Covid-19 Rapid detection of SARS- CoV-2 in saliva: Can an endodontist take the lead in point- of- care COVID-19 testing? |
| cord-258011-19yfwvki | : should we worry? |
| cord-258011-19yfwvki | Anaesthesia SARS- CoV2( COVID-19) infection: is fetal surgery in times of national disasters reasonable? |
| cord-258011-19yfwvki | What does this study add? |
| cord-258011-19yfwvki | cord-258011- 19yfwvki authors: Deprest, Jan; Van Ranst, Marc; Lannoo, Lore; Bredaki, Emma; Ryan, Greg; David, Anna; Richter, Jute; Van Mieghem, Tim title: SARS‐CoV2( COVID‐19) infection: is fetal surgery in times of national disasters reasonable? |
| cord-260772-n5q2yi7j | Is this the missing link of the well- recognized comorbidity risk factors, diabetes mellitus, obesity, chronic liver diseases and age and outcome of COVID-19 in human? 6 |
| cord-260057-2m6jdvtc | COVID-19) Sars- Cov-2 interference in HEME production: is it the time for an early predictive biomarker? |
| cord-259223-6b07qiw2 | melatonin reduce the severity of COVID-19 pandemic? |
| cord-259223-6b07qiw2 | the scientific rationale Protective effect of melatonin against polymicrobial sepsis is mediated by the anti- bacterial effect of neutrophils Effect of melatonin on the expression of VEGF- A and on the degeneration of follicle reserve in rat ovary ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19: Implications for COVID-19 COVID-19: social distancing, ACE 2 receptors, protease inhibitors and beyond? |
| cord-259523-92hz534s | And, if such a deferral is necessary, how soon can these patients be transplanted? |
| cord-259523-92hz534s | Despite the establishment of such guidelines, questions remain: Is it important to defer transplant for candidates who are positive for COVID-19? |
| cord-259523-92hz534s | Time to get excited? |
| cord-260697-oepk0b1d | Twice? |
| cord-261279-6mef38eo | The emergence of human coronavirus emc: How scared should we be? |
| cord-016120-pz2q62i7 | Can you go home after work?she asked a nurse this seemingly obvious question. |
| cord-016120-pz2q62i7 | What did you say to her? |
| cord-016120-pz2q62i7 | What would you have done? |
| cord-016120-pz2q62i7 | Why are your friends all old men?asked one of Chai"friendlier"audiences in the book release conference. |
| cord-016120-pz2q62i7 | Breaking into tears, the boy muttered,"… How are you?" |
| cord-016120-pz2q62i7 | Can you tell us from the perspective of a patient what it feels like to have this disease?" |
| cord-016120-pz2q62i7 | Have you ever thought what you want to do the most when you are discharged? |
| cord-016120-pz2q62i7 | In another occasion, Chai asked a doctor,"You knew the risk of working here, but why did you volunteer to stay?" |
| cord-016120-pz2q62i7 | In fact, one of her colleagues confronted her,"Why did you wipe his tears?" |
| cord-016120-pz2q62i7 | What do you think of this?" |
| cord-016120-pz2q62i7 | When Chai was interviewed for her CCTV position, she was asked,"What concerns you the most when you do news?" |
| cord-016120-pz2q62i7 | When interviewing the cousin of the girl who committed suicide, Chai asked,"Have you talked to her[ since her death]?" |
| cord-016120-pz2q62i7 | and he asked me,'Mom, what were you doing when SARS broke out?' |
| cord-257820-4qmajxtb | Front Herpes simplex virus type 1 in brain and risk of Alzheimer's disease APOE4 leads to blood- brain barrier dysfunction predicting cognitive decline Antiviral agents in Alzheimer's disease: Hope for the future? |
| cord-257820-4qmajxtb | More prevalent than appreciated? |
| cord-257820-4qmajxtb | Ther Are HHV-6A and HHV-7 really more abundant in Alzheimer's disease? |
| cord-260238-2p209g2p | An influenza epicentre? |
| cord-260238-2p209g2p | Severe acute respiratory syndrome- related coronavirus is inhibited by interferon- α The antiviral effect of interferon- β against SARS coronavirus is not mediated by MxA protein Old drugs as lead compounds for a new disease? |
| cord-260238-2p209g2p | What does the peripheral blood tell you in SARS? |
| cord-261634-vfe1lawl | Is your phone bugged? |
| cord-258382-ep73us0e | , China Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-258382-ep73us0e | COVID-19, a pandemic or not? |
| cord-258382-ep73us0e | However, one fundamental question remains- why are hypertensive patients more susceptible to severe COVID-19? |
| cord-258382-ep73us0e | In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases Soluble angiotensin- converting enzyme 2: a potential approach for coronavirus infection therapy? |
| cord-258382-ep73us0e | inhibitors of the renin- angiotensin system be withdrawn in patients with COVID-19? Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin ii receptor blockers with mortality among patients with hypertension hospitalized with COVID-19 Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19 Angiotensin II increases the permeability and PV-1 expression of endothelial cells Effects of angiotensin- II on brain endothelial cell permeability via PPARalpha regulation of para- and trans- cellular pathways Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation- related pathways Angiotensin-(1- 7) counteracts angiotensin II- induced dysfunction in cerebral endothelial cells via modulating Nox2/ ROS and PI3K/ NO pathways |
| cord-262068-9ixq8hwb | Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long- term immunosuppression What to do next to control the 2019-nCoV epidemic? |
| cord-255734-038xu4hq | Can the virus establish persistent infection and can humans be repeatedly infected? |
| cord-255734-038xu4hq | Finally, if SARS fails to return, how will vaccine manufacturers test candidate vaccines for efficacy? |
| cord-255734-038xu4hq | If we define the ability of the virus to replicate in monocytes/ macrophages can we be assured that antibody- dependent enhancement will not be a problem for a SARS vaccine? |
| cord-255734-038xu4hq | What are the viral virulence factors and can we use this information to develop an attenuated strain? |
| cord-255734-038xu4hq | What is the role of lymphocytic infiltrates and do alveolar macrophages enhance disease or control infection? |
| cord-256508-ce59ovan | Are reinfections less severe than the first? |
| cord-256508-ce59ovan | How does COVID-19 kill? |
| cord-256508-ce59ovan | This case lead to several open questions: How frequent is reinfection? |
| cord-256508-ce59ovan | Tracking down RNA synthesis Viral load dynamics and disease severity in patients infected with SARS- CoV-2 in Zhejiang province, China Pathological findings of COVID-19 associated with acute respiratory distress syndrome A Novel Coronavirus from Patients with Pneumonia in China Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19 Treatment of hepatitis C virus infection with direct- acting antiviral agents: 100% cure? |
| cord-256508-ce59ovan | Where does the virus replicate? |
| cord-256508-ce59ovan | Will vaccine protect against reinfections? |
| cord-259925-g28sx9qu | Are pangolins the intermediate host of the 2019 novel coronavirus( SARS- CoV-2)? |
| cord-259925-g28sx9qu | Health Care News Coronaviruses as DNA wannabes: a new model for the regulation of RNA virus replication fidelity Synthesis and characterization of a native, oligomeric form of recombinant severe acute respiratory syndrome coronavirus spike glycoprotein The epidemic emergence of HIV: what novel enabling factors were involved? |
| cord-259925-g28sx9qu | Will there be a cure for Ebola? |
| cord-257142-q79yy6o5 | -A potential clue to the role of androgens in COVID-19 severity What does androgenetic alopecia have to do with COVID-19? |
| cord-257142-q79yy6o5 | COVID-19 infection in a paucisymptomatic infant: Raising the index of suspicion in epidemic settings Sex- based differences in susceptibility to severe acute respiratory syndrome coronavirus infection Sex hormones promote opposite effects on ACE and ACE2 activity, hypertrophy and cardiac contractility in spontaneously hypertensive rats Responding to Covid-19-A once- in- a- century pandemic? |
| cord-257142-q79yy6o5 | The first doctor to notify the emergence of the SARS- CoV-2,( COVID-19), outbreak Does cigarette smoking protect against SARS- CoV-2 infection? |
| cord-257142-q79yy6o5 | and COVID-19: Serendipity or Opportunity for Intervention? |
| cord-262000-k32cb9ym | ACE2 level mean increased risk of SARS- CoV-2 infection and increased fatality rate of COVID-19? |
| cord-260793-bb4h255w | Would a rose by another name smell as sweet? |
| cord-261025-y49su5uc | Have you been asked about your travel history today? |
| cord-261025-y49su5uc | in the past 2 weeks OR Had close contact with someone who has traveled and is ill with fever or cough or has difficulty breathing? |
| cord-260429-5wsj003j | Situation update worldwide, as 262 of 29 How will country-265 based mitigation measures influence the course of the COVID-19 epidemic? |
| cord-260429-5wsj003j | Would everyone wearing face masks help us slow the pandemic?: |
| cord-262029-zzn74cjr | A trial of lopinavir- ritonavir in adults hospitalized with severe COVID-19 Long- term safety and durable antiretroviral activity of lopinavir/ ritonavir in treatment- naive patients: 4 year follow- up study Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six- day follow up: a pilot observational study Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open- label non- randomized clinical trial A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19 Cardiac complications attributed to chloroquine and hydroxychloroquine: a systematic review of the literature Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS- CoV-2 infection Hydroxychloroquine for treatment of SARS- CoV-2 infection? |
| cord-260559-n8i52e8q | What can we expect from first- generation COVID-19 vaccines? |
| cord-260559-n8i52e8q | Will vaccines that protect healthy young adults also protect groups vulnerable to severe disease such as older adults and those with comorbidities? |
| cord-262180-t4akem15 | How many patients with anti- JEV IgM in cerebrospinal fluid really have Japanese encephalitis? |
| cord-260886-v1ei9im8 | How Many Homeless People Are There? |
| cord-260886-v1ei9im8 | In: Helping America's Homeless: Emergency Shelter or Affordable Housing? |
| cord-258792-4lakgpxp | The Scandal over Taiwan', International Herald Tribune Health, Civilisation and the State: A History of Public Health from Ancient to Modern Times Building Our New Geat Wall-On the Great Spirit of Resisting and Attacking SARS', People's Daily, 15 May Is SARS China's Chernobyl or Much Ado About Nothing? |
| cord-258792-4lakgpxp | This leads to the following questions: What were the factors that inhibited and then facilitated the collaboration during the outbreak? |
| cord-258792-4lakgpxp | What eventually brought China back to'business as usual'after the outbreak? |
| cord-258792-4lakgpxp | What ultimately motivates the government's agenda and actions towards infectious diseases? |
| cord-261472-qcu73sdu | Why are"natively unfolded"proteins unstructured under physiologic conditions? |
| cord-258681-66ct8nod | Should Covid-19 concern nephrologists? |
| cord-258681-66ct8nod | Soluble angiotensin- converting enzyme 2: a potential approach for coronavirus infection therapy? |
| cord-258681-66ct8nod | The emerging impasse of angiotensin blockade Hydroxychloroquine: from malaria to autoimmunity Satchell K: soluble angiotensin- converting enzyme 2: a potential approach for coronavirus infection therapy? |
| cord-258681-66ct8nod | Why and to what extent? |
| cord-258548-1u7v1nlr | Can COVID 2019 disease induces a specific cardiovascular damage or it exacerbates pre- existing cardiovascular diseases? |
| cord-258548-1u7v1nlr | Can SARS- CoV-2 induce new heart conditions or can it only exacerbate pre- existing cardiovascular diseases? |
| cord-258548-1u7v1nlr | Covid-19 COVID-19 and Angiotensin- Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence? |
| cord-258548-1u7v1nlr | The Potential for QT Interval Prolongation with Chronic Azithromycin Therapy in Adult Cystic Fibrosis Patients Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-260854-v7wgb6mr | Can DPP4 inhibition play a role? |
| cord-260854-v7wgb6mr | Environment impacts innate immune ontogeny Interplay of strain and race/ ethnicity in the innate immune response to M. tuberculosis Associations between demographic variables and multiple measles- specific innate and cell- mediated immune responses after measles vaccination Is COVID-19 receiving ADE from other coronaviruses? |
| cord-260854-v7wgb6mr | key: cord-260854-v7wgb6mr authors: Colafrancesco, Serena; Alessandri, Cristiano; Conti, Fabrizio; Priori, Roberta title: COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome? |
| cord-262428-erlmyzwn | What Can We Learn? |
| cord-000333-4prvgmvt | : What's in a word? |
| cord-000333-4prvgmvt | How could you fail to thrive and develop as a new Faculty member under such inspiring and utterly humane leadership? |
| cord-000333-4prvgmvt | Is Toni Hoffmann a 21 st Century nurse hero? |
| cord-000333-4prvgmvt | Is heroism a legitimate part of nursing, or are nurses simply'just doing their job'even when facing extreme personal danger? |
| cord-000333-4prvgmvt | The business of Nursing? |
| cord-000333-4prvgmvt | The lessons of SARS Duty of Care or Medical Heroism? |
| cord-000333-4prvgmvt | Was this heroism and heroic actions on their part, or were they'just doing their job'? |
| cord-000333-4prvgmvt | What of the other contemporary meaning of heroism and heroes? |
| cord-000333-4prvgmvt | Who are our nursing heroes? |
| cord-000333-4prvgmvt | Who are the heroes on your list and why? |
| cord-000333-4prvgmvt | Who are the nursing giants upon whose shoulders we have stood and who continue to inspire us today? |
| cord-000333-4prvgmvt | Who are the nursing heroes that we tell our students about so that they can understand the best of Nursing's history? |
| cord-000333-4prvgmvt | Who are they to emulate if they want to be the best nurse possible? |
| cord-000333-4prvgmvt | [ 24] Would Emergency Department nurses see themselves as'heroes'? |
| cord-262090-nbxzyjvf | Guillain- Barre syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-262090-nbxzyjvf | In vitro detection of apoptosis in monocytes/ macrophages infected with human coronavirus Neurotropism of SARS- CoV 2: mechanisms and manifestations Assembly of coronavirus spike protein into trimers and its role in epitope expression Activation of human monocytes after infection by human coronavirus 229E Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans Human coronaviruses: viral and cellular factors involved in neuroinvasiveness and neuropathogenesis Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? |
| cord-262760-mf1pn587 | Could RNA- RNA recombination have played a role? |
| cord-262766-ndn6iwre | It's not all swine flu … are we missing opportunities to diagnose primary HIV infection in patients with flu symptoms? |
| cord-257958-yehnlabq | -A fatal relationship? |
| cord-257958-yehnlabq | Is copper beneficial for COVID-19 patients? |
| cord-257958-yehnlabq | Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus( 2019-nCoV) in vitro Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS- CoV-2 infection in vitro Artesunate: could be an alternative drug to chloroquine in COVID-19 treatment? |
| cord-257958-yehnlabq | SARS- Cov-2, bioRxiv Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure? |
| cord-257958-yehnlabq | a critical review Effects of early corticosteroid treatment on plasma SARS- associated Coronavirus RNA concentrations in adult patients Analysis of therapeutic targets for SARS- CoV-2 and discovery of potential drugs by computational methods Peripheral Blood Examination Findings in SARS- CoV-2 Infection Drug Repositioning Suggests a Role for the Heat Shock Protein 90 Inhibitor Geldanamycin in Treating COVID-19 Infection Hypothesis: mPGES-1-Derived Prostaglandin E2, a So Far Missing Link in COVID-19 Pathophysiology? |
| cord-262467-epqqd8n8 | Negative nasopharyngeal and oropharyngeal swab does not rule out COVID-19 Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients Middle east respiratory syndrome coronavirus infection dynamics and antibody responses among clinically diverse patients, Saudi Arabia Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome Profiling early humoral response to diagnose novel coronavirus disease( COVID-19) portable tests come online to curb coronavirus pandemic Serology- based tests for COVID-19 Good IgA bad IgG in SARS- CoV-2 infection? |
| cord-261941-xf1k5uj1 | Will it be possible to develop a treatment or neutralizing vaccine that the virus does n't circumvent through mutation? |
| cord-261941-xf1k5uj1 | Will the disease become more or less virulent over time? |
| cord-261075-wqtxhiy8 | COVID-19: consider cytokine storm syndromes and immunosuppression Cytokine storms in COVID-19 cases? |
| cord-261075-wqtxhiy8 | Does SARS- CoV-2 infection cause chronic neurological complications? |
| cord-261075-wqtxhiy8 | My Clinical Case and Review of the Literature Neurologic Features in Severe SARS- CoV-2 Infection Focal status epilepticus as unique clinical feature of COVID-19: A case report Self- reported olfactory and taste disorders in SARS- CoV-2 patients: a cross- sectional study Olfactory and gustatory dysfunctions as a clinical presentation of mild- to- moderate forms of the coronavirus disease( COVID-19): a multicenter European study Comparative genetic analysis of the novel coronavirus( 2019-nCoV/ SARS- CoV-2) receptor ACE2 in different populations Guillain- Barré syndrome: a century of progress Guillain Barre syndrome associated with COVID-19 infection: A case report Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-260871-dtn5t8ka | Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-260871-dtn5t8ka | Should We Be Concerned about the Nervous System? |
| cord-262556-gpnp06je | What is the impact on the healthcare system if access to bariatric surgery is delayed? |
| cord-262550-oip5m9br | The SARS, MERS and novel coronavirus( COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
| cord-262958-tmp6yxlv | How good are my data and what is the 693 resolution? |
| cord-258242-xblxjlb5 | A Kinase for All Pathways? |
| cord-258242-xblxjlb5 | A Review of its Pharmacology, Toxicity and Pharmacokinetics Neutrophil in viral infections, friend or foe? |
| cord-258242-xblxjlb5 | Sepsis and septic shock COVID-19 and its implications for thrombosis and anticoagulation Late- Onset Neonatal Sepsis in a Patient with Covid-19 COVID-19 Hyperinflammation: What about Neutrophils? |
| cord-258242-xblxjlb5 | Severe COVID-19 and aging: are monocytes the key? |
| cord-258242-xblxjlb5 | The immunopathology of sepsis and potential therapeutic targets Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last? |
| cord-258242-xblxjlb5 | The unleashing of the immune system in COVID-19 and sepsis: the calm before the storm? |
| cord-023488-jf2xl3vl | : can we ever expect the unexpected? |
| cord-023488-jf2xl3vl | And when did HIV spread from the first human cases to become a global plague? |
| cord-023488-jf2xl3vl | Are camels the main source of human infections? |
| cord-023488-jf2xl3vl | From an epidemiological viewpoint, why did this outbreak of Ebola explode into a massive pandemic, in contrast to the many prior outbreaks that were limited to no more than a few hundred cases at most? |
| cord-023488-jf2xl3vl | How do camels become infected? |
| cord-023488-jf2xl3vl | Is computer modeling a useful adjunct to the analysis or control of emerging viral diseases? |
| cord-023488-jf2xl3vl | Is this an evolving outbreak, and if so, what is driving it? |
| cord-023488-jf2xl3vl | The emergence of HIV may be divided into two phases: What was the zoonotic source of HIV and when did it cross into humans? |
| cord-023488-jf2xl3vl | The first question that confronts the investigator faced with a disease of unknown etiology is whether or not it has an infectious etiology? |
| cord-023488-jf2xl3vl | What has caused this disease to emerge in 2012, or had it preexisted but was just recognized at that time? |
| cord-023488-jf2xl3vl | What is the origin of this new disease? |
| cord-023488-jf2xl3vl | Where did it come from? |
| cord-023488-jf2xl3vl | Where will it end? |
| cord-023488-jf2xl3vl | Why did it cause a pandemic? |
| cord-023488-jf2xl3vl | Why did the international health community fail to control it? |
| cord-023488-jf2xl3vl | Why then did poliomyelitis emerge abruptly as an epidemic disease? |
| cord-262499-68vmdqky | COVID-19 Cases from the Hospital or end Home Isolation? |
| cord-262043-66qle52a | bioRxiv Is it reliable to use common molecular docking methods for comparing the binding affinities of enantiomer pairs for their protein target? |
| cord-262043-66qle52a | protein Are scoring functions in protein Àprotein docking ready to predict interactomes? |
| cord-259603-bh198xgl | 4 G is sufficient to support cap- independent translation in the absence of eIF4E Genome- wide analysis of protein- protein interactions and involvement of viral proteins in SARS- CoV replication Nidovirus transcription: how to make sen- se …? |
| cord-259603-bh198xgl | CORONAVIRUS nsp7- 10: SMALL BUT CRITICAL REGULATORY SUBUNITS? |
| cord-259603-bh198xgl | Clearly, both the role of nsp8( primase or processivity factor?) and the initiation mechanism employed by the nsp12-RdRp require further study. |
| cord-259603-bh198xgl | The broadspectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen Ribavirin's antiviral mechanism of action: lethal mutagenesis? 0 |
| cord-259603-bh198xgl | mRNA stability SARS coronavirus accessory proteins Biochemical characterization of arterivirus nonstructural protein 11 reveals the nidovirus- wide conservation of a replicative endoribonuclease Arterivirus Nsp1 modulates the accumulation of minus- strand templates to control the relative abundance of viral mRNAs Does form meet function in the coronavirus replicative organelle? |
| cord-258223-8dhtwf03 | ( 2) How has frontline COVID-19 work impacted your personal lives, your families and your relationships with your patients? |
| cord-258223-8dhtwf03 | How did the film make you feel about the current COVID-19 situation? |
| cord-258223-8dhtwf03 | How do you feel about the public's response to the COVID-19 pandemic? |
| cord-258223-8dhtwf03 | In response to individuals who had reservations about working in isolation wards, one participant reflected,"We entered this profession for a reason … in a time of need, how can others refuse to do their duty?" |
| cord-263245-2qub96mz | , the new European test virus for enveloped viruses Can vaccinia virus be replaced by MVA virus for testing virucidal activity of chemical disinfectants? |
| cord-262863-f07v5uk8 | SARS- CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine"storm"and risk factor for damage of hematopoietic stem cells Detection of pyroptosis by measuring released lactate dehydrogenase activity Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? |
| cord-263764-2ewz8ok4 | How contagious are common respiratory tract infections? |
| cord-261876-7rsc803x | Does SARS- CoV-2 has a longer incubation period than SARS and MERS? |
| cord-261876-7rsc803x | NL63: a clinically important virus? |
| cord-261876-7rsc803x | when is an exposed individual known to be disease free? |
| cord-260618-k0y0fz7k | Ernest title: Coronavirus mapping in scientific publications: When science advances rapidly and collectively, is access to this knowledge open to society? |
| cord-260618-k0y0fz7k | Is the United States losing ground in science? |
| cord-260618-k0y0fz7k | and now the 2019-novel CoV: Have we investigated enough about coronaviruses? |
| cord-260866-bzdd4f5h | Can smartphome technology be used for detecting viruses in wastewaters? |
| cord-260866-bzdd4f5h | SARS- CoV-2 from feces to wastewater treatment: What do we know? |
| cord-260866-bzdd4f5h | Why not using both approaches for WBE? |
| cord-260866-bzdd4f5h | a Paper- Based Device Trace COVID-19 Sources with Wastewater- Based Epidemiology? |
| cord-263167-es806qhz | What do our results suggest for SARS- CoV-2 vaccine design? |
| cord-262904-0b0ljjq1 | Learn more biomedcentral.com/submissions Ready to submit your research Ready to submit your research? |
| cord-260247-akujsk0s | Viral relapse, reinfection or inflammatory rebound? |
| cord-260247-akujsk0s | What are the rates of recurrent rt- PCR SARS- CoV-2 positive results of more than 21 days, and what are the population characteristics? |
| cord-260247-akujsk0s | What is the maximum number of days in between positive swab results? |
| cord-260247-akujsk0s | in Older Patients: A Description of Three Cases Recurrence of positive SARS- CoV-2 RNA in COVID-19: A case report Is novel coronavirus 2019 reinfection possible? |
| cord-263576-pn2zieek | A systematic drug repurposing approach to identify promising inhibitors against 3C- like Proteinase and 2'-O- RiboseMethyltransferase Identification of chymotrypsin- like protease inhibitors of SARS- CoV-2 via integrated computational approach Drug repurposing: A better approach for infectious disease drug discovery? |
| cord-263508-row2mn17 | Introduction: the"new SARS"? |
| cord-261615-p81l6zvz | Immunsuppression-ein Risiko für schwere Verlaufsformen einer COVID-19-Erkrankung? |
| cord-261615-p81l6zvz | SARS- CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases? |
| cord-261615-p81l6zvz | umdenken? |
| cord-262104-oig3qrr7 | A Sneeze England and Wales see 20 000 excess deaths in care homes Wearing Face Masks in the Community During the COVID-19 Pandemic: Altruism and Solidarity Comparative tropism, replication kinetics, and cell damage profiling of SARS- CoV-2 and SARS- CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study Impact assessment of non- pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study 2020) Pandemics and the great evolutionary mismatch Rapid implementation of mobile technology for real- time epidemiology of COVID-19 Assessment of Deaths From COVID-19 and From Seasonal Influenza Coast- to- coast spread of SARS- CoV-2 during the early epidemic in the United States Asymptomatic Transmission, the Achilles'Heel of Current Strategies to Control Covid-19 Face Masks for the Public During the covid-19 Crisis Spread of SARS- CoV-2 in the Icelandic Population Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards Temporal dynamics in viral shedding and transmissibility of COVID-19 Estimates of global seasonal influenza- associated respiratory mortality: a modelling study Where are the ECDC and the EU- wide responses in the COVID-19 pandemic? |
| cord-262104-oig3qrr7 | The Economist Presymptomatic SARS- CoV-2 Infections and Transmission in a Skilled Nursing Facility Airborne or Droplet Precautions for Health Workers Treating COVID-19? Utility of hyposmia and hypogeusia for the diagnosis of COVID-19 Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study Investigation of a COVID-19 outbreak in Germany resulting from a single travel- associated primary case: a case series |
| cord-262104-oig3qrr7 | a modelling impact assessment Is the Coronavirus Airborne? |
| cord-260257-phmd0u6d | On the front lines of coronavirus: the Italian response to covid-19 Self- testing for HIV: a new option for HIV prevention? |
| cord-260257-phmd0u6d | Proposed protocol to keep COVID-19 out of hospitals Self- Service Diagnosis of COVID-19-Ready for Prime Time? |
| cord-260257-phmd0u6d | The lancet HIV Self- Collected versus Clinician- Collected Sampling for Chlamydia and Gonorrhea Screening: A Systemic Review and Meta- Analysis Self- Service Diagnosis of COVID-19-Ready for Prime Time? |
| cord-260257-phmd0u6d | Virtually perfect? |
| cord-263090-29n9tsk9 | Identifying SARS- CoV-2 related coronaviruses in Malayan pangolins Structure, Function, and Evolution of Coronavirus Spike Proteins Cryo- EM structure of the 2019-nCoV spike in the prefusion conformation Structure, Function, and Antigenicity of the SARS- CoV-2 Spike Glycoprotein Structural basis for the recognition of SARS- CoV-2 by full- length human ACE2 Cryo- electron microscopy structures of the SARS- CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding The 3.1-Angstrom Cryo- electron Microscopy Structure of the Porcine Epidemic Diarrhea Virus Spike Protein in the Prefusion Conformation Cryo- EM structures of MERS- CoV and SARS- CoV spike glycoproteins reveal the dynamic receptor binding domains SARS- CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor A highly conserved cryptic epitope in the receptor- binding domains of SARS- CoV-2 and SARS- CoV Topological and energetic factors: what determines the structural details of the transition state ensemble and"en- route"intermediates for protein folding? |
| cord-263090-29n9tsk9 | Identifying SARS- CoV-2 related coronaviruses in Malayan pangolins Structure, Function, and Evolution of Coronavirus Spike Proteins Cryo- EM structure of the 2019-nCoV spike in the prefusion conformation Structure, Function, and Antigenicity of the SARS- CoV-2 Spike Glycoprotein Structural basis for the recognition of SARS- CoV-2 by full- length human ACE2 Cryo- electron microscopy structures of the SARS- CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding The 3.1-Angstrom Cryo- electron Microscopy Structure of the Porcine Epidemic Diarrhea Virus Spike Protein in the Prefusion Conformation Cryo- EM structures of MERS- CoV and SARS- CoV spike glycoproteins reveal the dynamic receptor binding domains SARS- CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor A highly conserved cryptic epitope in the receptor- binding domains of SARS- CoV-2 and SARS- CoV Topological and energetic factors: what determines the structural details of the transition state ensemble and"en- route"intermediates for protein folding? |
| cord-260673-gf028lf6 | Active inference: a process theory Updating beliefs under perceived threat Prospect theory in times of a pandemic: the effects of gain versus loss framing on policy preferences and emotional responses during the 2020 coronavirus outbreak Unrealistic optimism about future life events: a cautionary note Influence of trust on two different risk perceptions as an affective and cognitive dimension during middle east respiratory syndrome coronavirus( MERS- CoV) outbreak in South Korea: serial cross- sectional surveys What is unrealistic optimism? |
| cord-260673-gf028lf6 | Does the Coronavirus Epidemic Take Advantage of Human Optimism Bias? |
| cord-260673-gf028lf6 | Unrealistic optimism in the time of coronavirus pandemic: may it help to kill, if so- whom: disease or the person? |
| cord-260673-gf028lf6 | explorations of how and why children wait and its linkages to outcomes over the life course Are people excessively pessimistic about the risk of coronavirus infection? |
| cord-263583-a1zon98c | Is oro/ nasopharyngeal swab for SARS- CoV-2 detection a safe procedure? |
| cord-263123-5y8cc5eb | Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-263308-q0iriid8 | Respiration Affective temperament, attachment style, and the psychological impact of the COVID-19 outbreak: an early report on the Italian general population Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China Studies of illness in the aged: the index of ADL: a standardized measure of biological and psychosocial function Renin- angiotensin- aldosterone system inhibitors in patients with Covid-19 Clinical characteristics of coronavirus disease 2019 in China COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role? |
| cord-264052-uph136sn | Underestimated opportunistic pathogens of the central nervous system? |
| cord-263844-ixgejst2 | key: cord-263844-ixgejst2 authors: Majdic, Gregor title: Could Sex/ Gender Differences in ACE2 Expression in the Lungs Contribute to the Large Gender Disparity in the Morbidity and Mortality of Patients Infected With the SARS- CoV-2 Virus? |
| cord-264477-2onwu92a | What can we do to Support our ACHD Patients through the Covid-19 Pandemic? |
| cord-264646-d7qexyav | i clinical trial? |
| cord-263224-osf0tkzr | : What can we learn? |
| cord-260981-647wfa8z | A Protective Mechanism from Beta Chain Hemoglobin Defects? |
| cord-260981-647wfa8z | Could we hypothesize a protective mechanism of BCH modified? |
| cord-260981-647wfa8z | The role of ORF viral proteins, essential both in viral replication and inflammation, and the interaction with the BCH and porphyrins might be one of the links to the epidemiologic distribution and mortality among hemoglobinopathic patients? |
| cord-260981-647wfa8z | Thus, might abnormalities of BCH, quantitative in thalassemias, and qualitative in Sickle- Cell- Disease( SCD), influence the outcome? |
| cord-263719-a9mnjr3s | a9mnjr3s nan Wuhan novel coronavirus: why global control is challenging? |
| cord-263719-a9mnjr3s | why global control is challenging? |
| cord-264260-8p6pvjkn | A pneumonia outbreak associated with a new coronavirus of probable bat origin The SARS, MERS and novel coronavirus( COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
| cord-263457-puf8gjir | The imbalance between tissue factor and tissue factor pathway inhibitor in sepsis Cytokines and thrombosis Inflammatory cytokines and thrombosis Effects of TNFalpha and curcumin on the expression of thrombomodulin and endothelial protein C receptor in human endothelial cells Effects of IL-1b, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity Cytokines in coagulation and thrombosis: a preclinical and clinical review Single nucleotide polymorphisms in inflammation- related genes are associated with venous thromboembolism Coexistence of a huge venous thromboembolism and bleeding tendency in cytokine release syndrome during CAR- T therapy Platelets and the innate immune system: mechanisms of bacterial- induced platelet activation Aberrant coagulation causes a hyperinflammatory response in severe influenza pneumonia Procoagulant activity of endothelial cells after infection with respiratory viruses Review: viral infections and mechanisms of thrombosis and bleeding Platelet- TLR7 mediates host survival and platelet count during viral infection in the absence of platelet- dependent thrombosis Complement and coagulation: strangers or partners in crime? |
| cord-265111-d44ireu5 | Might the double X- chromosome in females be protective against SARS- CoV-2 compared to the single X- chromosome in males? |
| cord-264013-8jnae6ig | He F, Deng Y, Li W. Coronavirus Disease 2019( COVID-19): What we know? |
| cord-265191-unk6rt7u | Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? |
| cord-264614-2x7cdul3 | what next? |
| cord-264709-p835wf4f | The official Brazilian classification of 116 ethnicity recognizes five groups, based on the question:"What is your race or color?" |
| cord-263965-i8yutik6 | Why wo n't the WHO call the coronavirus by its name, SARS- CoV-2? |
| cord-265329-bsypo08l | What are pathogens, and what have they done to and for us? |
| cord-264031-0y7xbgun | I deficiency? |
| cord-264031-0y7xbgun | Who is most likely to be infected with SARS- CoV-2? |
| cord-263532-q044i7ym | Back to the Future? |
| cord-263532-q044i7ym | ult s? |
| cord-265599-903w782b | COVID-19 Testing Predicting the sensitivity and specificity of published realtime PCR assays Performing the nasopharyngeal and oropharyngeal swab for 2019-novel coronavirus( SARS- CoV-2) safely: How to dress, undress, and technical notes How to Obtain a Nasopharyngeal Swab Specimen Validity testing of a three- dimensionally printed endoscopic sinonasal surgery simulator Normal Nasopharyngeal Measurement by Computed Tomography in Adult Reflections and new developments within the COVID-19 pandemic How to Obtain a Nasopharyngeal Swab Specimen Comparison of SARS- CoV-2 detection from nasopharyngeal swab samples by the Roche cobas 6800 SARS- CoV-2 test and a laboratory- developed real- time RT- PCR test Covid-19 diagnosis: clinical recommendations and performance of nasopharyngeal swab- PCR] PCR testing for COVID-19: where to swab?: |
| cord-265350-k9yus2sv | What is the relationship between the pangolin CoVs and SARS- CoV-2? |
| cord-258701-jyzxu9nk | Any history of cough or fever or shortness of breath and being a health care worker working at Covid designated area? |
| cord-258701-jyzxu9nk | Any history of cough or fever or shortness of breath and history of travel in past 14 days? 2. |
| cord-258701-jyzxu9nk | Any history of cough or fever or shortness of breath with contact with a lab confirmed case? 3. |
| cord-258701-jyzxu9nk | Any history of severe acute respiratory illness? |
| cord-258701-jyzxu9nk | Are you coming from a hotspot/ cluster area/ large migraƟon/ evacuee centres? |
| cord-258701-jyzxu9nk | How long do nosocomial pathogens persist on inanimate surfaces? |
| cord-258701-jyzxu9nk | SARS- CoV-2 is an enveloped and positive- sense single- stranded RNA(? ssRNA) virus[ 6]. |
| cord-262250-o7qhncic | Alternatively, if this is a general effect, is the SARS- CoV-2 virus in some way subverting CD8+ T- cell responsiveness? |
| cord-262250-o7qhncic | An alternative explanation is, of course, that T- cell effectors are being generated but are localised to, and perhaps'consumed- in'( driven to apoptosis?) |
| cord-262250-o7qhncic | Are SARS- CoV-2-specific CD8+ T- cells present in uninfected people? |
| cord-262250-o7qhncic | If so, are HLA- A*02:01 individuals at higher relative risk? |
| cord-262250-o7qhncic | Is this apparent CD8+ T- cell response defect limited to these particular epitopes? |
| cord-265242-y8t37p0b | Global update on SARS cases Faster … but fast enough? |
| cord-265322-3854ddb9 | Twelve Years after Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease Epidemiological, clinical characteristics of cases of SARS- CoV-2 infection with abnormal imaging findings Prevalence of comorbidities in the novel Wuhan coronavirus( COVID-19) infection: a systematic review and meta- analysis Natural small molecules as inhibitors of coronavirus lipid- dependent attachment to host cells: a possible strategy for reducing SARS- COV-2 infectivity? |
| cord-265322-3854ddb9 | Would a rose by another name smell as sweet? |
| cord-262598-zk192s0x | Guillain- Barré syndrome in the COVID-19 era: just an occasional cluster? |
| cord-262598-zk192s0x | The neuroinvasive potential of SARS- CoV2 may play a role in the respiratory failure of COVID-19 patients Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-262598-zk192s0x | We read with interest the letter from Gigli et al. entitled'Guillain- Barré syndrome in the COVID-19 era: just an occasional cluster?' |
| cord-262598-zk192s0x | cord-262598-zk192s0x authors: Tatu, Laurent; Nono, Sandra; Grácio, Simone; Koçer, Serdar title: Guillain – Barré syndrome in the COVID-19 era: another occasional cluster? |
| cord-265262-r01u4jr6 | Does a male polycystic ovarian syndrome equivalent exist? |
| cord-265262-r01u4jr6 | What is the evidence? |
| cord-266450-g9vihgbk | key: cord-266450-g9vihgbk authors: Tran, Michael; Sheth, Chirag; Bhandari, Rohan; Cameron, Scott J.; Hornacek, Deborah title: SARS- CoV-2 and pulmonary embolism: who stole the platelets? |
| cord-261029-befymalm | ( 2) How should IBD be managed in an environment of COVID-19? |
| cord-261029-befymalm | And( 3) How should IBD patients with known or suspected COVID-19 be treated? |
| cord-261029-befymalm | COVID-19: Gastrointestinal Manifestations and Potential Fecal- Oral Transmission Prolonged presence of SARS- CoV-2 viral RNA in faecal samples Are patients with inflammatory bowel disease at increased risk for Covid-19 infection? |
| cord-261029-befymalm | Expert opinion has focused on several core questions:( 1) Are IBD patients at greater risk for contracting COVID-19? |
| cord-261029-befymalm | Imbalance of the renin- angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target? |
| cord-264051-ps0x2es1 | Phosphodiesterase Inhibitors: Could They Be Beneficial for the Treatment of COVID-19? |
| cord-264051-ps0x2es1 | T T Ischaemic stroke and SARS- CoV-2 infection: A causal or incidental association? |
| cord-264915-g5ar0pwb | Miller fisher syndrome and polyneuritis cranialis in COVID-19 Syndrome of inappropriate secretion of antidiuretic hormone preceding Guillain- Barre syndrome Mycoplasma pneumoniae triggering the Guillain- Barre syndrome: a case- control study Guillain- Barre syndrome following COVID-19: new infection, old complication? |
| cord-264915-g5ar0pwb | a case report Intravenous immunoglobulin therapy results in post- infusional hyperproteinemia, increased serum viscosity, and pseudohyponatremia Hematological findings and complications of COVID-19 Guillain- Barre syndrome associated with SARS- CoV-2 Guillain- Barre syndrome Challenges of convalescent plasma therapy on COVID-19 Guillain- Barre syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-266156-xmf4emln | SARS- CoV-2 serology: test, test, test, but interpret with caution COVID-19 pandemic- a focused review for clinicians Multitiered screening and diagnosis strategy for COVID-19: a model for sustainable testing capacity in response to pandemic Waiting for certainty on Covid-19 antibody tests-at what cost? |
| cord-265724-fdt00qw1 | Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease Physiological and pathological regulation of ACE2, the SARS- CoV-2 receptor High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa Oral cancer and periodontal disease increase the risk of COVID 19? |
| cord-265697-bbvlowyo | animal to human interaction MERS- CoV: the intermediate host identified? |
| cord-265022-p5cab562 | Vascular aspects of cognitive impairment and dementia Can angiotensin- converting enzyme inhibitors impact cognitive decline in early stages of Alzheimer's disease? |
| cord-265022-p5cab562 | yes or no? |
| cord-262412-bs7quwov | A distinctive skin rash associated with coronavirus disease 2019? |
| cord-262412-bs7quwov | A vasculopathy- related symptom? |
| cord-262412-bs7quwov | Acral cutaneous lesions in the time of COVID-19 ¿ COVID19 en forma de sabañones? |
| cord-262412-bs7quwov | COVID-19 frequent or not? |
| cord-262412-bs7quwov | Has viral infection a role in drug induced exanthemas? |
| cord-262412-bs7quwov | y adolescentes Varicella- like exanthem associated with COVID-19 in an 8-year- old girl: A diagnostic clue? |
| cord-263840-1t4ykc01 | COVID-19 and angiotensin- converting enzyme inhibitors and 446 angiotensin receptor blockers: what is the evidence? |
| cord-263840-1t4ykc01 | clinical- grade soluble human ACE2 Human coronavirus EMC does not require the SARS- coronavirus 437 receptor and maintains broad replicative capability in mammalian cell lines Renovation as innovation: is repurposing 439 the future of drug discovery research? |
| cord-263840-1t4ykc01 | methods and applications Tocilizumab for the treatment of chimeric antigen 411 receptor T cell- induced cytokine release syndrome A crucial role of angiotensin converting enzyme 2( ACE2) in SARS coronavirus- induced lung 414 injury Drug repurposing: a better approach for 416 infectious disease drug discovery? |
| cord-262282-9xh51cd1 | : What have we learned? |
| cord-262282-9xh51cd1 | A review of Dengvaxia ®: Development to deployment DNA vaccines: Technology and application as anti- parasite and anti- microbial agents DNA vaccines- How far from clinical use? |
| cord-262282-9xh51cd1 | Can a virus transmit even more actively than SARS- CoV-2? |
| cord-262282-9xh51cd1 | Can more active transmission be accompanied by higher virulence? |
| cord-262282-9xh51cd1 | What factors shape phage pharmacokinetics and bioavailability? |
| cord-262730-1dxeg8ci | ---CoV---2 epidemic? |
| cord-262730-1dxeg8ci | A novel syndrome? |
| cord-262730-1dxeg8ci | Olfaction, Brain Infection, and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection First ultrastructural autoptic findings of SARS--- Cov---2 in olfactory pathways and brainstem Is the brain a reservoir organ for SARS2---CoV2? |
| cord-262730-1dxeg8ci | What it comes down to? |
| cord-262730-1dxeg8ci | Would a rose by another name smell as sweet? |
| cord-263803-0n41gylj | How does the quality of phospholipidosis data influence the predictivity of structural alerts? |
| cord-263803-0n41gylj | This raised a compelling question: do the pharmacological treatment of these patients play a role in the observed protective effect? |
| cord-266113-3fp46sov | The use of anti- inflammatory drugs in the treatment of people with severe coronavirus disease 2019( COVID-19): the experience of immunologists from China Inflammation, immunity, and HMG- CoA reductase inhibitors: statins as antiinflammatory agents? |
| cord-266536-4frv2vb7 | cord-266536- 4frv2vb7 authors: Martel, Jan; Ko, Yun- Fei; Young, John D.; Ojcius, David M. title: Could nitric oxide help to prevent or treat COVID-19? |
| cord-261470-sqxdwu6j | Dexamethasone- induced immunosuppression: Mechanisms and implications for immunotherapy Dexamethasone for COVID-19? |
| cord-261470-sqxdwu6j | Extrapulmonary manifestations of COVID-19 Kidney disease is associated with in- hospital death of patients with COVID-19 COVID-19-associated nephritis: early warning for disease severity and complications? |
| cord-261470-sqxdwu6j | Is COVID-19 an Endothelial Disease? |
| cord-261470-sqxdwu6j | Should COVID-19 Concern Nephrologists? |
| cord-261470-sqxdwu6j | Why and to What Extent? |
| cord-261470-sqxdwu6j | a controlled study Inhibition of smoking- induced platelet aggregation by aspirin and pycnogenol Pine bark extract reduces platelet aggregation Coronavirus disease 2019 induces multi- lineage, morphologic changes in peripheral blood cells Acute pulmonary embolism and COVID-19 pneumonia: a random association? |
| cord-265155-jbvrcjx8 | Many additional questions remain, including: does the virus lead to long- term damage to the gut and predispose patients to conditions such as post- infection irritable bowel syndrome and gastroparesis? |
| cord-265155-jbvrcjx8 | What is the optimal evidence- based management of immunosuppressive medications patients with liver transplantation and inflammatory bowel disease? |
| cord-267013-nbwrl4g3 | A case of subacute thyroiditis associated with Covid-19 infection SARS- CoV-2: a potential trigger for subacute thyroiditis? |
| cord-265278-wf5pbvvt | Dr. Kathy M. Tran( Medicine): Dr. Maggiore, would you tell us how you would manage this patient's immunosuppressive regimen? |
| cord-265278-wf5pbvvt | How should I manage immunosuppression in a kidney transplant patient with COVID-19? |
| cord-266090-f40v4039 | Is the world ready for the coronavirus? |
| cord-266090-f40v4039 | New numerical simulations for some real world problems with Atangana- Baleanu fractional derivative A mathematical model for simulating the phase- based transmissibility of a novel coronavirus Reproduction numbers and sub- threshold endemic equilibria for compartmental models of disease transmission Early transmission dynamics in Wuhan, China, of novel coronavirus- infected pneumonia Mathematical analysis of dengue fever outbreak by novel fractional operators with field data Application of fractional calculus to epidemiology Modelling the spread of COVID-19 with new fractal- fractional operators: can the lockdown save mankind before vaccination? |
| cord-264148-qpcvxwti | Can Chinese medicine be used for prevention of corona virus disease 2019( COVID-19)? |
| cord-264148-qpcvxwti | What we know? |
| cord-266996-knwpkyg6 | Do children need a longer time to shed SARS- CoV-2 in stool than adults? |
| cord-266869-fs8dn7ir | WHO Director- General's opening remarks at the mission briefing on COVID-19-11 A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person- to- person transmission: a study of a family cluster Aerosol and Surface Stability of SARS- CoV-2 as Compared with SARS- CoV-1 Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-264976-6n9cdex6 | ( COVID-19) A familial cluster, including a kidney transplant recipient, of Coronavirus Disease 2019( COVID-19) in Wuhan, China First case of COVID-19 in a kidney transplant recipient treated with belatacept COVID-19 in kidney transplant recipients Coronavirus disease 2019 pneumonia in immunosuppressed renal transplant recipients: a summary of 10 confirmed cases in Wuhan, China Severe COVID-19 in a renal transplant recipient: A focus on pharmacokinetics Case report: a kidney transplant patient with mild COVID-19 COVID-19 infection in kidney transplant recipients A single center observational study of the clinical characteristics and short- term outcome of 20 kidney transplant patients admitted for SARS- CoV2 pneumonia Two distinct cases with COVID-19 in kidney transplant recipients A catabolic state in a kidney transplant recipient with COVID-19 COVID-19 in kidney transplant recipients Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation? |
| cord-264976-6n9cdex6 | A possible role for B cells in COVID-19? |
| cord-264976-6n9cdex6 | Would they be predisposed to developing severe COVID-19, and thus manifest a higher mortality rate than others? |
| cord-266983-hpwebkbi | Consensus report: preventive measures for Crimean- Congo hemorrhagic fever during Eid- al- Adha festival Crimean- Congo haemorrhagic fever virus and Eid- Ul- Adha festival in Pakistan Predicting the angiotensin converting enzyme 2( ACE2) utilizing capability as the receptor of SARS- CoV-2 COVID-19: animals, veterinary and zoonotic links First respiratory transmitted food borne outbreak? |
| cord-266987-ikt8r2o1 | Exclusivity testing showed that 229E, OC43 and MERS, 229E, HKU1, NL63, OC43 yielded negative results( https://www.who.int/docs/defaultsource/coronaviruse/peiris-protocol-16-1-20.pdf? |
| cord-260503-yq4dtf8n | , within the last 10 days( that is, the incubation period for SARS), traveled internationally or visited an area where documented or suspected community transmission of SARS is occurring? |
| cord-260503-yq4dtf8n | Also, will those exposed to the virus be carriers of the disease in the face of a new infection? |
| cord-260503-yq4dtf8n | How good are hand- washing practices? |
| cord-260503-yq4dtf8n | How many will be silent healthy carriers of the virus? |
| cord-260503-yq4dtf8n | Will an emergent strain or strains behave similarly to the older counterpart? |
| cord-260503-yq4dtf8n | how contagious are common respiratory tract infections? |
| cord-260503-yq4dtf8n | you come into contact with a patient with SARS in the past 10 days? |
| cord-260503-yq4dtf8n | you experienced a recent onset of a respiratory problem, such as a cough or difficulty breathing? |
| cord-260503-yq4dtf8n | you have fever? |
| cord-265887-g5zhoyo9 | Alternatively, does the lipid- composition specificity of the C- terminal determine the conformational uptake and the eventual functional topology? |
| cord-265887-g5zhoyo9 | Do these hydrophobic interactions prompt the downstream oligomerization events to the formation of the membrane- associated multimers? |
| cord-265887-g5zhoyo9 | Does the C- terminal induce the initial docking of the protein to the host membranes? |
| cord-267115-6jqdi417 | Does the human placenta express the canonical cell entry mediators for SARS- CoV-2? |
| cord-266512-xh6zed03 | In conclusion, atopic status seems to protect against the most severe, often fatal A NovelCoronavirus from Patients with Pneumonia in China Favorable outcome of COVID19 in two patients with X- linked agammaglobulinemia Type 2 cytokines: mechanisms and therapeutic strategies Th1 and Th2 responses: what are they? |
| cord-266512-xh6zed03 | Influence of Atopy on the Clinical Manifestations of Coronavirus Infection in Adult Volunteers Association of respiratory allergy, asthma and expression of the SARS- CoV-2 receptor, ACE2 Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus- Infected Pneumonia in Wuhan Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Mapping the innate signalling cascade essential for cytokine storm during influenza virus infection Is asthma protective against COVID-19? |
| cord-266710-3wdy16tw | Will our economy die from coronavirus? |
| cord-266135-jbc9nml0 | SARS- Cov-2 invade the brain? |
| cord-266135-jbc9nml0 | clinical and radiological manifestations, pathophysiology, and outstanding questions Hemorrhagic posterior reversible encephalopathy syndrome as a manifestation of COVID-19 infection Coronavirus disease 2019( COVID-19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin- converting enzyme inhibitors/ angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 infection Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? |
| cord-266036-qhlo99l7 | Clin Infect Dis Diagnosis of the Coronavirus disease( COVID-19): rRT- PCR or CT? |
| cord-266036-qhlo99l7 | Molecular Testing Diagnostic performance between CT and initial real- time RT- PCR for clinically suspected 2019 coronavirus disease( COVID-19) patients outside Wuhan, China Testing for SARS- CoV-2: Can We Stop at Two? |
| cord-265855-zf52vl11 | A public health problem? |
| cord-265855-zf52vl11 | Chloroquine is a zinc ionophore New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-260565-cdthfl5f | : an essay Countries jumped tenfold in the last five years What China wants from Africa? |
| cord-260565-cdthfl5f | A Letter Report Wartime public health crises cause more deaths than weapons, so why do n't we pay more attention? |
| cord-260565-cdthfl5f | Is Africa going backwards on democracy? |
| cord-260565-cdthfl5f | Many of these poor outcomes are especially related to air pollution in re- defining hazardous air by WHO Standards as"acceptable,"and prompting many in China and the world to ask"at what price? |
| cord-260565-cdthfl5f | What is the point of equality? |
| cord-260565-cdthfl5f | Why is Iran's reported mortality rate for coronavirus higher than in other countries? |
| cord-260565-cdthfl5f | Will China's unilateral decisions just be a temporary stay as it was post- SARS, or is China capable of adopting, without conditions, the WHO public health requirements they have so far ignored? |
| cord-260565-cdthfl5f | Will this just be a temporary stay as it was post- SARS, or is China capable of adopting, without conditions, the WHO public health requirements they have ignored to date? |
| cord-264057-z5arb1k5 | 16 Pediatric emergencies at a tertiary care hospital in India Severe acute respiratory syndrome( SARS): an old virus jumping into a new host or a new creation? |
| cord-264057-z5arb1k5 | Do you have one or more of the following symptoms: cough, shortness of breath, difficult breathing? |
| cord-264057-z5arb1k5 | Have you been in contact with a person with respiratory symptoms in the last 10 days? |
| cord-264057-z5arb1k5 | The security guards directed patients with respiratory symptoms to the principal investigator, who asked them and their relatives the SARS screening questions specified in the WHO protocol, i.e. Do you have a fever? |
| cord-264974-hspek930 | What to do to increase resilience of primary health care and increase access? |
| cord-264974-hspek930 | what have we learned/ can we learn and how can we improve our systems? |
| cord-264974-hspek930 | when confronted with a crisis for which they are not prepared, as articulated in the generic cry: why do not we have a vaccine for this, why do not we have a drug for that? |
| cord-266480-u8o4eitu | Three family members charged in shooting death of security guard who told a customer to put on a face mask Should schools reopen? |
| cord-266480-u8o4eitu | Why do some COVID-19 patients infect many others, whereas most do n't spread the virus at all? |
| cord-263970-9w6ciglv | And finally, what is the functional oligomeric form of ORF3a? |
| cord-263970-9w6ciglv | Is the cytosolic domain necessary for conduction? |
| cord-263970-9w6ciglv | What is the functional relevance of anions populating the central polar cavity? |
| cord-263970-9w6ciglv | Which route cations take to cross the membrane, and what is the role of Orf3a in transport? |
| cord-267436-mivxm8oh | clinical outcome and prognostic correlates Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong Children hospitalized with severe acute respiratory syndrome- related illness in Toronto Antiviral treatment of SARS: can we draw any conclusions? |
| cord-265221-qtkwciym | After corona: there is life after the pandemic Detection of SARS- CoV-2 in Different Types of Clinical Specimens Test performance evaluation of SARS- CoV-2 serological assays Pre- print Medrxiv clinical- management- of- severe- acute- respiratory- infection- when- novel- coronavirus-(ncov)-infection- is- suspected Orchitis: A complication of severe acute respiratory syndrome( SARS) COVID-19: should we continue to cryopreserve sperm during the pandemic? |
| cord-265221-qtkwciym | It is unlikely that SARS- CoV-2 could replicate in the male reproductive tract Considering SARS- CoV-2 infected male patients, is there a possibility that a virus with a size of 70- 90 nm may breach the blood- testis barrier? |
| cord-265221-qtkwciym | MedRxiv Deaths involving COVID-19, England and Wales: deaths occurring in No evidence of SARS- CoV-2 in semen of males recovering from COVID-19 Viral load of SARS- CoV-2 in clinical samples Mumpsorchitis in the non- immune post- pubertal male: a resurgent threat to male fertility? |
| cord-265221-qtkwciym | that ACE2 could be absorbing the entire SARS- CoV-2 viruses, in which case should we be analysing the alterations to the ACE-2 receptor sites instead? |
| cord-265899-skpkuzyu | A prospective study of cytomegalovirus, herpes simplex virus 1 and coronary heart disease Cytomegalovirus infection and thrombosis: a causative association? |
| cord-265899-skpkuzyu | The monumental question is how to singularly exploit TF as an antiviral target and to diminish inflammation when its roles in physiology are vast? |
| cord-265899-skpkuzyu | pneumonia: a random association? |
| cord-266695-ktbgm0p9 | If a coronavirus vaccine arrives, can the world make enough? |
| cord-266695-ktbgm0p9 | its nature, presence, and ethical implications for research COVID-19 human challenge trials How informed is declared altruism in clinical trials? |
| cord-267566-gdjl0qmu | Is There One? |
| cord-267373-nzxbogga | New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-264916-c4n0kyog | The severe acute respiratory syndrome coronavirus in tears Tears and conjunctival scrapings for coronavirus in patients with SARS Ocular screening in severe acute respiratory syndrome SARS virus in tears? |
| cord-264916-c4n0kyog | Therefore, a question arises: if the receptors for the virus are present in ocular surface tissues, why the incidence of ocular surface infection is so low and isolating the virus from ocular surfaces presents such a challenge? |
| cord-264916-c4n0kyog | Would a rose by another name smell as sweet? |
| cord-264916-c4n0kyog | breath condensate pH in adult Croatian population without respiratory disorders: how healthy a population should be to provide normative data? |
| cord-266923-hd1tjj6b | The electrodiagnosis of Guillain- Barré syndrome subtypes: where do we stand? |
| cord-266923-hd1tjj6b | authors: Padroni, Marina; Mastrangelo, Vincenzo; Asioli, Gian Maria; Pavolucci, Lucia; Abu- Rumeileh, Samir; Piscaglia, Maria Grazia; Querzani, Pietro; Callegarini, Claudio; Foschi, Matteo title: Guillain- Barré syndrome following COVID-19: new infection, old complication? |
| cord-267610-bzbr9ios | a descriptive study Clinical features of patients infected with 2019 novel coronavirus in Wuhan Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus- infected pneumonia in Wuhan, China Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults Multi- system inflammatory syndrome in children( MIS- C) following SARS- CoV-2 infection: review of clinical presentation, hypothetical pathogenesis, and proposed management COVID-19 in children: initial characterization of the pediatric disease Epidemiology of COVID-19 among children in China Are children less susceptible to COVID-19? |
| cord-266616-boeb1xcp | COVID‐19? date: 2020- 08- 06 journal: |
| cord-266616-boeb1xcp | regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice Regulatory T cells: A potential weapon to combat COVID-19? |
| cord-266616-boeb1xcp | regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases? |
| cord-266034-811lov8f | A first case of meningitis/ encephalitis associated with SARS- coronavirus-2 Hematological findings and complications of COVID-19 Toxic and acquired metabolic encephalopathies: MRI appearance Immune regulation of antibody access to neuronal tissues Detection of SARS- CoV-2 in different types of clinical specimens How many patients with anti- JEV IgM in cerebrospinal fluid really have Japanese encephalitis? |
| cord-266034-811lov8f | Importance of cerebrospinal fluid investigation during dengue infection in Brazilian Amazonia region Detection of human parvovirus 4 DNA in the patients with acute encephalitis syndrome during seasonal outbreaks of the disease in Gorakhpur Long- term follow- up after treatment of rabies by induction of coma Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? |
| cord-259808-82drb14x | Are there lessons to be learnt for the digestive tract from the interactions between SARS- CoV and ACE2 in the respiratory system?. |
| cord-259808-82drb14x | For example, might the EECs of the organoid differ in some way from the native EEC, preventing viral entry? |
| cord-259808-82drb14x | How could SARS- CoV-2 induce nausea and vomiting?. |
| cord-259808-82drb14x | Management of Chemotherapy- Induced Nausea and Vomiting Current knowledge and research priorities in the digestive manifestations of COVID-19 Real- time tracking of self- reported symptoms to predict potential COVID-19 Rapid implementation of mobile technology for real- time epidemiology of COVID-19 GDF15 induces anorexia through nausea and emesis Food refusal: a sign of nausea? |
| cord-259808-82drb14x | So, what of SARS- CoV-2? |
| cord-259808-82drb14x | What is the severity of the nausea? |
| cord-259808-82drb14x | Why ca n't rodents vomit? |
| cord-259808-82drb14x | other digestive tract symptoms in COVID-19? |
| cord-259808-82drb14x | zazhi= Chin Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia Detection of Covid-19 in children in early Imaging and clinical features of patients with 2019 novel coronavirus SARS- CoV-2 Clinical features of 2019 novel coronavirus pneumonia presented gastrointestinal symptoms but without fever onset Diarrhea is associated with prolonged symptoms and viral carriage in COVID-19 Epidemiological and clinical characteristics of COVID-19 patients in Hengyang Are gastrointestinal symptoms specific for COVID-19 infection? |
| cord-267533-nmgtan4e | The outbreaks of COVID-19 The SARS, MERS and novel coronavirus( COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
| cord-266031-tlrsco40 | Can new tools keep them afloat? |
| cord-266031-tlrsco40 | Mapping the science behind ebola Estimation of covid-19 dynamics"on a back- of- envelope": Does the simplest sir model provide quantitative parameters and predictions? |
| cord-262786-otxpc46a | Immediate and long- term consequences of COVID-19 infections for the development of neurological disease Cranial neuropathies and COVID-19: neurotropism and autoimmunity Large artery ischaemic stroke in severe acute respiratory syndrome( SARS) Is the collapse of the respiratory center in the brain responsible for respiratory breakdown in COVID-19 patients? |
| cord-262786-otxpc46a | Neurological involvement in SARS- CoV-2 infection: a clinical systematic review Impact of SARS- CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic? |
| cord-262786-otxpc46a | SARS- CoV-2 can induce brain and spine demyelinating lesions Cerebrovascular disease in COVID-19 Disease in COVID-19: Is there a higher risk of stroke? |
| cord-262786-otxpc46a | The cognitive consequences of the COVID-19 epidemic: collateral damage? |
| cord-262786-otxpc46a | commonly The hypothalamus as a hub for SARS- CoV-2 brain infection and pathogenesis Cerebrovascular and neurological dysfunction under the threat of COVID-19: is there a comorbid role for smoking and vaping? |
| cord-266696-w9sb038q | Impaired in Patients with Severe Acute Respiratory Syndrome? |
| cord-266696-w9sb038q | w9sb038q nan Severe Acute Respiratory Syndrome? |
| cord-268075-kbislbx0 | The association between pneumococcal pneumonia and acute cardiac events Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019( COVID-19) Do hypertensive individuals have enlarged aortic root diameters? |
| cord-267690-g0kesgjm | False negative tests for SARS- CoV-2 infection- challenges and implications Antibody responses to SARS- CoV-2 in patients of novel coronavirus disease False- negative results of initial RT- PCR assays for COVID-19: a systematic review2019 Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections Pre- procedural COVID-19 screening: do rhinologic patients carry a unique risk burden for false negative results? |
| cord-267762-mzon01fd | they effective and safe in rheumatic diseases? |
| cord-267917-belkwihy | How Long Will Coronavirus Live on Surfaces or in the Air Around You? |
| cord-267971-xgwmda8e | is fever an adequate screening for the 448 returning travelers? |
| cord-267613-hsc2x36j | A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm? |
| cord-268329-apl6n6jl | key: cord-268329-apl6n6jl authors: Antunes, Douglas Eulálio; Goulart, Isabela Maria Bernardes; Goulart, Luiz Ricardo title: Will cases of leprosy reaction increase with COVID-19 infection? |
| cord-264919-0jlg2gkc | In this context, one should ask: How realistic is it, in view of the patients'constitution that coronavirus components encounter heme and following up on this, what might be the consequences of such an interaction, if any? |
| cord-264919-0jlg2gkc | Is there an association between COVID-19 mortality and the renin- angiotensin system? |
| cord-264919-0jlg2gkc | The regulation of platelet aggregation in vitro by interleukin-1beta and tumor necrosis factor- alpha: changes in pregnancy and in pre- eclampsia Clinical applications of hemolytic markers in the differential diagnosis and management of hemolytic anemia Heme degradation and vascular injury Sars- CoV-2 Envelope and Membrane proteins: differences from closely related proteins linked to crossspecies transmission? |
| cord-264919-0jlg2gkc | Their roles in pathogenesis Co- protoporphyrin IX and Sn- protoporphyrin IX inactivate Zika, Chikungunya and other arboviruses by targeting the viral envelope Characterization of spike glycoprotein of SARS- CoV-2 on virus entry and its immune cross- reactivity with SARS- CoV HeMoQuest: a webserver for qualitative prediction of transient heme binding to protein motifs Analysis of ACE2 in polarized epithelial cells: surface expression and function as receptor for severe acute respiratory syndrome- associated coronavirus Complement as a target in COVID-19? Heme: Modulator of plasma systems in hemolytic diseases |
| cord-268065-mxvbbkc4 | ; so how about COVID-19? |
| cord-268049-7xqln70d | Why Did Outbreaks of Severe Acute Respiratory Syndrome Occur in Some Hospital Wards but Not in Others? |
| cord-267666-i7uuf3ck | Asian 1396 Pacific journal of tropical medicine Coronaviruses: Candidate Drugs for SARS- CoV-2 Treatment? |
| cord-267666-i7uuf3ck | CD4+ regulatory T cells: mechanisms of 1036 induction and effector function Atypical MHC class II- expressing antigen- presenting 1224 cells: can anything replace a dendritic cell? |
| cord-264266-6xvj9zey | Are Biological and Environmental Factors Helping to Stem the Incidence and Severity? |
| cord-264266-6xvj9zey | Cell COVID-19: faecal- oral transmission? |
| cord-264266-6xvj9zey | Comparative analyses of SAR- CoV2 genomes from different geographical locations and other coronavirus family genomes reveals unique features potentially consequential to host- virus interaction and pathogenesis Detection of SARS- CoV-2 in Different Types of Clinical Specimens Morvan's syndrome- is a pathogen behind the curtain? |
| cord-264266-6xvj9zey | Human coronaviruses: what do they cause? |
| cord-264266-6xvj9zey | Such a scenario brings us to the critical question; what is the actual attributable mortality of COVID-19? |
| cord-268324-86a0n0dc | -what should anaethesiologists and intensivists know about it? |
| cord-267402-kca05rvz | Is COVID-19 directly contributing to stroke incidence? |
| cord-267402-kca05rvz | Is ethnicity linked to incidence or outcomes of covid-19? Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study Clinical and imaging findings in patients with severe acute respiratory syndrome CT correlation with outcomes in 15 patients with acute Middle East respiratory syndrome coronavirus |
| cord-263002-f3itn0sb | Could nicotine be a therapeutic option? |
| cord-263002-f3itn0sb | Hemolysis- induced Lung Vascular Leakage Contributes to the Development of Pulmonary Hypertension Cell- free hemoglobin increases inflammation, lung apoptosis, and microvascular permeability in murine polymicrobial sepsis Heme impairs alveolar epithelial sodium channels post toxic gas inhalation Coagulation abnormalities and thrombosis in patients with COVID-19 Will Complement Inhibition be the New Target in Treating COVID-19 Related Systemic Thrombosis? |
| cord-263002-f3itn0sb | How can we prevent or attenuate these pulmonary complications? |
| cord-263002-f3itn0sb | The good, the bad, and the ugly? |
| cord-263002-f3itn0sb | The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel? |
| cord-263002-f3itn0sb | The macrophage heme- heme oxygenase-1 system and its role in inflammation Low heme oxygenase-1 levels in patients with systemic sclerosis are associated with an altered Toll- like receptor response: Another role for CXCL4? |
| cord-263002-f3itn0sb | The missing link? |
| cord-268071-ow2aijmj | Why are RNA virus mutation rates so damn high? |
| cord-265813-2onv9mvl | : a case report Acral cutaneous lesions in the time of COVID-19 Histological pattern in Covid-19 induced viral rash Cutaneous clinico- pathological findings in three COVID-19-positive patients observed in the metropolitan area of Cutaneous lesions in a patient with COVID-19: are they related? |
| cord-265813-2onv9mvl | COVID-19 frequent or not? |
| cord-265813-2onv9mvl | First report from the Middle East Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro- ischemia Clinical observation and management of COVID-19 patients Acute acro- ischemia in the child at the time of COVID-19 Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases Calzavara- Pinton P. Varicella- like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients A dermatologic manifestation of COVID-19: transient livedo reticularis Cutaneous manifestations in COVID-19: a new contribution A distinctive skin rash associated with coronavirus disease 2019? |
| cord-265813-2onv9mvl | what can we learn from severe acute respiratory syndrome? |
| cord-255495-xnoppq3y | Are there neutralized antibodies or protective reaction induced by the SARS- CoV-2 infection? |
| cord-255495-xnoppq3y | But what one can say about the duration of these entry events for SARS- CoV-2( COVID-19), whose spike protein has 10- 20 fold higher affinity for ACE2 more than that of SARS- CoV( Wrapp et al., 2020)? |
| cord-255495-xnoppq3y | COVID-19 patients infectious? |
| cord-255495-xnoppq3y | Communicated by Ramaswamy H. Sarma Are we ready to the fact that we must adapt ourselves to live with COVID-19 and, perhaps, for a long time? |
| cord-255495-xnoppq3y | How should such recovered patients which were retested positive for SARS- CoV-2 be managed? |
| cord-255495-xnoppq3y | Is such scenario could be mimicked by the Vero E6 infection with SARS- CoV? |
| cord-255495-xnoppq3y | Is this"Trojan horse"strategy of the release of the SARS- CoV-2-loaded exosomes or EDMVs represent a reasonable explanation for the appearance of the viral RNA in the recovered COVID-19 patients 7- 14 day post discharge? |
| cord-255495-xnoppq3y | May we target double membrane vesicles and oxysterol- binding protein to combat SARS- CoV-2 infection? |
| cord-255495-xnoppq3y | The life cycle of SARS coronavirus in Vero E6 cells Viral effects on the content and function of extracellular vesicles Complement as a target in COVID-19? |
| cord-255495-xnoppq3y | The role of extracellular vesicles in COVID-19 virus infection Recurrence of positive SARS- CoV-2 in patients recovered from COVID-19 Retest positive for SARS- CoV-2 RNA of"recovered"patients with COVID-19: Persistence, sampling issues, or re- infection? |
| cord-255495-xnoppq3y | This case raised a fundamental question, from what she has died: Was it from the virus or some other cause? |
| cord-255495-xnoppq3y | This opportunity raised several critical questions, such as what are the reasons for the reappearance of SARS- CoV-2 RNA in some patients recovered from COVID-19 and what are the mechanisms of such reinfection, reactivation, and relapse? |
| cord-255495-xnoppq3y | What one can find in such hidden exosomes/ EDMVs, if they do exists, and where do they hide during the"silence"time period; i.e. after the recovered patients discharge from the hospitals and before the viral RNA starts to reappear again, reflecting the COVID-19 reinfection/ reactivation but now under the conditions of the primed acquired immune response? |
| cord-255495-xnoppq3y | Will we see protection or reinfection in COVID-19? |
| cord-255495-xnoppq3y | the hidden SARS- CoV-2 RNA is coming from? |
| cord-255495-xnoppq3y | vaccines work on such reinfected, relapsed, or reactivated COVID-19 patients? |
| cord-259229-e8m8m4ut | A potential approach for coronavirus infection therapy? |
| cord-259229-e8m8m4ut | Admitted to ICUs of the Lombardy Region Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-259229-e8m8m4ut | Compared to the Single X- Chromosome in Males? |
| cord-259229-e8m8m4ut | Deleterious? |
| cord-259229-e8m8m4ut | Direct regulation of interleukin-6 expression by Notch signaling in macrophages COVID-19 in the heart and the lungs: Could we"Notch"the inflammatory storm? |
| cord-259229-e8m8m4ut | Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia Urinary angiotensin- converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker Renin- Angiotensin- Aldosterone System Blockers and the Risk of Covid-19 Inhibitors of the Renin- Angiotensin- Aldosterone System and Covid-19 Renin- Angiotensin- Aldosterone System Inhibitors and Risk of Covid-19 SARS- coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS COVID-19 Illness and Heart Failure: A Missing Link? |
| cord-259229-e8m8m4ut | The COVID-19 pandemic in the USA: What might we expect? |
| cord-259229-e8m8m4ut | The cardiac renin- angiotensin system: Conceptual, or a regulator of cardiac function? |
| cord-259229-e8m8m4ut | The role of the Notch pathway The Notch pathway: A novel target for myocardial remodelling therapy? |
| cord-268561-vq1uhj5i | A Prospective Cohort Study Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease Likelihood of survival of coronavirus disease Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome Cutaneous small- vessel vasculitis associated with novel 2019 coronavirus SARS- CoV-2 infection( COVID-19) Cutaneous manifestations in COVID-19: a first perspective Cutaneous manifestations of COVID-19: A review of the published literature Olfactory and gustatory dysfunctions as a clinical presentation of mild- to- moderate forms of the coronavirus disease Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease( COVID-19) Pneumonia: A Multicenter Study Clinical characteristics of 140 patients infected with SARS- CoV-2 in Wuhan Diagnosis of the Coronavirus disease( COVID-19): rRT- PCR or CT? |
| cord-268501-z4oztgi0 | , Clarisa B. title: What Would Jenner and Pasteur Have Done About COVID-19 Coronavirus? |
| cord-268476-3lxsh1zz | The chronology of the 2002- 2003 SARS mini pandemic Cluster of severe acute respiratory syndrome cases among protected health care workers- Toronto Tracheostomy in a patient with severe acute respiratory syndrome Safe tracheostomy for patients with severe acute respiratory syndrome Precautions for endoscopic transnasal skull base surgery during the COVID-19 pandemic More than 60 doctors in Italy have died in COVID-19 pandemic How many medical workers have contracted COVID-19? |
| cord-268370-kfjujs4z | Will the SARS epidemic recur? |
| cord-264924-ds6jv5ek | Do we isolate all patients who were in the same ward as patients with SARS, even if they did not have direct contact with the infected patients? |
| cord-264924-ds6jv5ek | Do we isolate these patients for the duration of their hospital stay in spite of normal chest radiographs and alternative explanations for their fevers? |
| cord-264924-ds6jv5ek | How contagious are common respiratory tract infections? |
| cord-264924-ds6jv5ek | What should be the patient management protocol? |
| cord-264924-ds6jv5ek | severe acute respiratory syndrome- Singapore Laboratory- acquired severe acute respiratory syndrome Sealing the net: how effective was isolation of suspect SARS cases not fulfilling WHO criteria and can we afford it the next time around? |
| cord-268540-wrjzr3ws | ( COVID-19) Chloroquine is a potent inhibitor of SARS coronavirus infection and spread Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS- CoV-2: what molecular dynamics studies of virus- host interactions reveal Deployment of convalescent plasma for the prevention and treatment of COVID-19 Plasma therapy against infectious pathogens, as of yesterday, today and tomorrow Meta- analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? |
| cord-268760-31i0mpvn | A novel syndrome? |
| cord-268492-0rbmqarx | a report from China Coronaviruses in cats and other companion animals: where does SARS- CoV-2/ COVID-19 fit? |
| cord-254419-qw83atrx | Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-254419-qw83atrx | Can we use interleukin-6( IL-6) blockade for coronavirus disease( COVID-19)-induced cytokine release syndrome( CRS)? |
| cord-254419-qw83atrx | Clinical features suggestive of macrophage activation syndrome( MAS) associated with low CD4? |
| cord-254419-qw83atrx | Cytokine and anti- cytokine interventions Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019( COVID-19) Dysregulation of immune response in patients with COVID-19 in Wuhan, China Will complement inhibition be the new target in treating COVID-19-related systemic thrombosis? |
| cord-254419-qw83atrx | Disease severity has been found to positively correlate with serum levels of TNFa, IL6, and IL10, and there was also a strong negative correlation of levels of TNFa and IL6 with the number of CD4?, CD8? |
| cord-254419-qw83atrx | Disease severity has been found to positively correlate with serum levels of TNFa, IL6, and IL10, and there was also a strong negative correlation of levels of TNFa and IL6 with the number of CD4?, CD8? |
| cord-254419-qw83atrx | In another study, lymphocyte subset analysis in COVID-19 patients showed a statistically significant lower number of CD4? |
| cord-254419-qw83atrx | In this study, patients with severe disease( 32% cases) had significantly lower CD4? |
| cord-254419-qw83atrx | In- hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19 Convalescent plasma: new evidence for an old therapeutic tool? |
| cord-254419-qw83atrx | Lupus anticoagulant is frequent in patients with Covid-19 Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case report Complement- associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19 Acute pulmonary embolism and COVID-19 pneumonia: a random association? |
| cord-254419-qw83atrx | Pulm Ther immune responses in COVID-19? |
| cord-254419-qw83atrx | T- cells, CD19? B- cells, and NK cells were found in all the patients. |
| cord-254419-qw83atrx | Why tocilizumab could be an effective treatment for severe COVID-19? High- dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with coronavirus disease 2019 |
| cord-254419-qw83atrx | and CD8? |
| cord-254419-qw83atrx | helper T cells, CD8? |
| cord-268468-036i1082 | Can we use interleukin-6( IL-6) blockade for coronavirus disease 2019( COVID-19)-induced cytokine release syndrome( CRS)? |
| cord-268468-036i1082 | Why tocilizumab could be an effective treatment for severe COVID-19? |
| cord-269202-re2djjrc | What are the priorities of pathologists'activities during COVID-19 emergency? |
| cord-267134-5gz2dotn | Could BCG vaccination induce protective trained immunity for SARS- CoV-2? |
| cord-267134-5gz2dotn | Host signaling and proteolytic pathways in the resolution or the exacerbation of coronavirus( CoV-2) infection in COVID-19 disease: what therapeutic targets? |
| cord-267134-5gz2dotn | Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS- CoV-2 in Covid-19: Key Therapeutic Targets? |
| cord-268935-4obwu75u | Why did outbreaks of severe acute respiratory syndrome occur in some hospital wards but not in others? |
| cord-262673-j2ot35lt | Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? |
| cord-262673-j2ot35lt | H1N1 influenza in the United States Severe morbidity and mortality associated with respiratory syncytial virus versus influenza infection in hospitalized older adults Respiratory syncytial virus infection in elderly and high- risk adults Clinical characteristics and outcomes of human rhinovirus positivity in hospitalized children Detection of human rhinoviruses in the lower respiratory tract of lung transplant recipients Upper and lower respiratory tract infections by human enterovirus and rhinovirus in adult patients with hematological malignancies Middle East respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocytederived macrophages and dendritic cells Macrophages: a Trojan horse in COVID-19? |
| cord-262673-j2ot35lt | How the SARS coronavirus causes disease: host or organism? |
| cord-262673-j2ot35lt | Middle East respiratory syndrome coronavirus( MERS- CoV) causes transient lower respiratory tract infection in rhesus macaques Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission SARS- CoV2: should inhibitors of the renin- angiotensin system be withdrawn in patients with COVID-19? |
| cord-262673-j2ot35lt | Spatiotemporal interplay of severe acute respiratory syndrome coronavirus and respiratory mucosal cells drives viral dissemination in rhesus macaques Location or origin? |
| cord-262673-j2ot35lt | The involvement of natural killer cells in the pathogenesis of severe acute respiratory syndrome Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome SARS- CoV-2 infection in children: transmission dynamics and clinical characteristics Will children reveal their secret? |
| cord-262673-j2ot35lt | The role of neutrophil extracellular traps in Covid-19: only an hypothesis or a potential new field of research? |
| cord-262673-j2ot35lt | What is critical for macrophage propagation of lung fibrosis? |
| cord-268817-wx96wwpg | A New Coronavirus Associated with Human Respiratory Disease in China Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus- Infected Pneumonia Clinical Characteristics of Coronavirus Disease 2019 in China Antibody Responses to SARS- CoV-2 in Patients with COVID-19 Waiting for Certainty on COVID-19 Antibody Tests- At What Cost? |
| cord-263438-9ra94uda | At the end of the victory over SARS, the nagging question therefore remains: even after the impressive efforts at rearmament since 1992, how prepared is the international community for upcoming emerging diseases? |
| cord-263438-9ra94uda | For example, should priority be given to those diseases for which the human immune response gives grounds for optimism thaton the basis of historical experience-a safe and effective vaccine can be developed( e.g. influenza and dengue)? |
| cord-263438-9ra94uda | Have we been forever changed? |
| cord-263438-9ra94uda | Or should other strategies be followed with respect to diseases for which the human immune response makes the development of a vaccine a far more arduous and unpredictable endeavor( e.g. cholera and malaria)? |
| cord-263438-9ra94uda | The Surgeon General's Report on Health Promotion and Disease Prevention Health, Human Rights, and the New War on the Poor Infections and Inequalities: The Modern Plagues Could a tuberculosis epidemic occur in London as it did in New York? |
| cord-263438-9ra94uda | What could possibly have led to such overweening confidence in the power of science, technology, and civilization to vanquish communicable disease? |
| cord-263438-9ra94uda | Will we be ready when it returns? |
| cord-266702-6oxtlzqo | Ace of Aces? |
| cord-266702-6oxtlzqo | Biochemical and Biophysical Research Communications Ace2 Receptor Expression and Severe Acute Respiratory Syndrome Coronavirus Infection Depend on Differentiation of Human Airway Epithelia Are Patients with Hypertension and Diabetes Mellitus at Increased Risk for Covid-19 Infection? |
| cord-266702-6oxtlzqo | Should Covid-19 Concern Nephrologists? |
| cord-266702-6oxtlzqo | Why and to What Extent? |
| cord-269087-f9hyntvf | Different points from adults Are children less susceptible to COVID-19? |
| cord-268886-mpceglk1 | On target, but missing the point? |
| cord-269143-8j3m03gc | How to manage therapy in AR children affected by COVID-19? |
| cord-268140-s5lailkp | Can we use interleukin-6( IL-6) blockade for coronavirus disease 2019( COVID-19)-induced cytokine release syndrome( CRS)? |
| cord-268140-s5lailkp | This overwhelming fascination with hydroxychloroquine until recently has continued across the globe from USA, Europe to China and India, perhaps due to the drug being inexpensive? |
| cord-268140-s5lailkp | key: cord-268140-s5lailkp authors: Atal, Shubham; Fatima, Zeenat title: IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy? |
| cord-267261-8z4aqfff | Avian influenza A virus( H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands Additional glycosylation at the receptor binding site of the hemagglutinin( HA) for H5 and H7 viruses may be an adaptation to poultry hosts, but does it influence pathogenicity? |
| cord-267261-8z4aqfff | Characterization of H9 subtype influenza viruses from the ducks of southern China: a candidate for the next influenza pandemic in humans? |
| cord-267261-8z4aqfff | H3N2 influenza A viruses in pigs in southeastern China: potential for genetic reassortment? |
| cord-267261-8z4aqfff | Nipah virus- a potential agent of bioterrorism? |
| cord-265233-v5sq5epy | How Long for SARS- CoV-2? |
| cord-265233-v5sq5epy | How many times? |
| cord-265233-v5sq5epy | N95 respirators Is the fit of N95 facial masks affected by disinfection? |
| cord-265233-v5sq5epy | Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation Stability of SARS- CoV-2 in different environmental conditions Aerosol and surface stability of SARS- CoV-2 as compared with SARS- CoV-1 Evaluation of multiple( 3-cycle) decontamination processing for filtering facepiece respirators Can N95 respirators be reused after disinfection? |
| cord-265233-v5sq5epy | Where Do We Stand? |
| cord-265233-v5sq5epy | Where do we stand with regard to its efficacy, safety, and role? |
| cord-268653-mje0rysp | COVID-19: what is next for public health? |
| cord-268653-mje0rysp | Is the trophoblast an immune regulator? |
| cord-269555-29t956ik | What prevents this highly contagious virus from reaching the fetus? ” |
| cord-268795-tjmx6msm | Trends in biochemical sciences Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-268206-ino9srb6 | : 2019-nCoV Could chloroquine/hydroxychloroquine be harmful in coronavirus disease 2019( COVID-19) treatment? |
| cord-268206-ino9srb6 | a systematic review Full- genome evolutionary analysis of the novel corona virus( 2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event Severe acute respiratory syndrome Obesity and COVID-19 severity in a Intranasal immunization with inactivated SARS- CoV( SARS- associated coronavirus) induced local and serum antibodies in mice Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses Nitazoxanide: a first- in- class broad- spectrumantiviral agent Nitazoxanide, a new drug candidate forthe treatment of Middle East respiratorysyndrome coronavirus Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-268330-mo5myrz4 | The exciting prospects of new therapies with mesenchymal stromal cells Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open- label phase 2a proof- of- concept study Mesenchymal stem( stromal) cells for treatment of ARDS: a phase 1 clinical trial Characteristics and potentiality of human adipose- derived stem cells( hASCs) obtained from enzymatic digestion of fat graft Plasticity of adipose tissue: A promising therapeutic avenue in the treatment of cardiovascular and blood diseases? |
| cord-268330-mo5myrz4 | the combined use of enhanced stromal vascular fraction and platelet- rich plasma improves fat grafting maintenance in breast reconstruction Breast reconstruction with enhanced stromal vascular fraction fat grafting: what is the best method? |
| cord-263292-qjfe2t9v | A current review of COVID-19 for the cardiovascular specialist Is there an impact of the COVID-19 pandemic on male fertility? |
| cord-263292-qjfe2t9v | COVID-19: is there a link between the course of infection and pharmacological agents in diabetes? |
| cord-263292-qjfe2t9v | COVID-19: the perspective of Italian embryologists managing the IVF laboratory in pandemic emergency COVID-19 and Human Reproduction Joint Statement: ASRM/ ESHRE/ IFFS Navel V( 2020) PTSD as the second tsunami of the SARS- Cov-2 pandemic COVID-19 pandemic and impending global mental health implications Psychological status and behavior changes of the public during the COVID-19 epidemic in China Mental health consequences during the initial stage of the 2020 COronavirus pandemic( COVID-19) in Spain Lessons learned from 9/11: mental health perspectives on the COVID-19 pandemic Post- traumatic stress disorder, coping strategies and type 2 diabetes: psychometric assessment after L'Aquila earthquake Changes in sexual behaviors of young women and men during the coronavirus disease 2019 outbreak: a convenience sample from the epidemic area Effect of the COVID-19 pandemic on female sexual behavior Challenges in the practice of sexual medicine in the time of COVID-19 COVID-19, or the triumph of monogamy? |
| cord-263292-qjfe2t9v | Folate: a possible role in erectile dysfunction? |
| cord-263292-qjfe2t9v | Johns Hopkins Coronavirus Research Center COVID-19 pandemic ARDS survivors: pain after the Storm? |
| cord-263292-qjfe2t9v | Might erectile dysfunction be due to the thermolabile variant of methylenetetrahydrofolate reductase? |
| cord-263292-qjfe2t9v | Minerva Endocrinol Risk factors associated with primary and secondary reduced libido in male patients with sexual dysfunction Onset of effects of testosterone treatment and time span until maximum effects are achieved Pulmonary fibrosis secondary to COVID-19: a call to arms? |
| cord-263292-qjfe2t9v | Type 1 diabetes triggered by COVID-19 pandemic: a potential outbreak? |
| cord-263292-qjfe2t9v | Why can patients with erectile dysfunction be considered lucky? |
| cord-263292-qjfe2t9v | is COVID-19 an endothelial disease? |
| cord-268645-5op2m7pu | Hendra and Nipah viruses: why are they so deadly? |
| cord-268645-5op2m7pu | The SARS coronavirus: a postgenomic era Global trends in emerging infectious diseases Identification and complete genome analysis of three novel paramyxoviruses, Tuhoko virus 1, 2 and 3, in fruit bats from China Fruit bats as reservoirs of Ebola virus Bat guano virome: predominance of dietary viruses from insects and plants plus novel mammalian viruses Circovirus in tissues of dogs with vasculitis and hemorrhage Bats are natural reservoirs of SARS- like coronaviruses Prevalence and genetic diversity of adenoassociated viruses in bats from China Epidemic dynamics at the human- animal interface A comparison of bats and rodents as reservoirs of zoonotic viruses: are bats special? |
| cord-262119-s6hc7fxs | 2019 Longitudinal analyses reveal immunological misfiring in severe COVID-19 Is a"Cytokine Storm"Relevant to COVID-19? |
| cord-262119-s6hc7fxs | : What do we know about children? |
| cord-262119-s6hc7fxs | : Why Children Fare Better than Adults? |
| cord-262119-s6hc7fxs | Antivirals? |
| cord-262119-s6hc7fxs | Apossible smart targeting of the autophagy pathway Open questions for harnessing autophagy- modulating drugs in the SARS- CoV-2 war: hope or hype? |
| cord-262119-s6hc7fxs | As Two Sides of the Same Coin: Friends or Foes? |
| cord-262119-s6hc7fxs | Compared to the Single X- Chromosome in Males? |
| cord-262119-s6hc7fxs | Pre- exposure prophylaxis? |
| cord-262119-s6hc7fxs | Vaccine? |
| cord-269130-zsem29ss | : why are children overwhelmingly spared? |
| cord-269130-zsem29ss | Immunosenescence and inflamm- aging as two sides of the same coin: friends or foes? |
| cord-269825-k685efoh | if yes to any of the following: Have you had any recent fever, cough, shortness of breath, contact with known coronavirus patient, or international travel? |
| cord-269766-arjoemla | But how many infected patients carry the virus in their tears? |
| cord-270112-o2exvfy5 | Possible central nervous system infection by SARS coronavirus Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? |
| cord-269902-sbp18486 | Fowler's Zoo and Wild Animal Medicine Is COVID-19 the first pandemic that evolves into a panzootic? |
| cord-270122-xijsj0d8 | A first case of meningitis/ encephalitis associated with SARS- Coronavirus-2 Focal status epilepticus as unique clinical feature of COVID-19: a case report Acute symptomatic seizures in critically ill patients with COVID-19: is there an association? |
| cord-268406-3v309r41 | A missing link between SARS- CoV-2 and the eye?: |
| cord-268406-3v309r41 | A missing link between SARS‐CoV‐2 and the eye?: |
| cord-268406-3v309r41 | Expression of the COVID-19 receptor ACE2 in the human conjunctiva SARS- CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes Can the coronavirus disease 2019( COVID-19) affect the eyes? |
| cord-268453-87b298uk | : chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies Kinetic mechanism of quinone oxidoreductase 2 and its inhibition by the antimalarial quinolines Avian influenza and sialic acid receptors: more than meets the eye? |
| cord-268453-87b298uk | New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-268453-87b298uk | key: cord-268453- 87b298uk authors: Ibáñez, Sebastián; Martínez, Oriela; Valenzuela, Francisca; Silva, Francisco; Valenzuela, Omar title: Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy? |
| cord-270123-m8utyd1m | be harmful in coronavirus disease 2019( COVID-19) treatment? |
| cord-270035-1e1wzdri | The surgical manifestations of the intestinal tract in Kawasaki disease Gallbladder hydrops associated with Kawasaki disease: a case report and literature review Intestinal involvement in Kawasaki disease Gastrointestinal presentation of Kawasaki disease: a red flag for severe disease? |
| cord-249166-0w0t631x | 10: What to learn and what to do? |
| cord-249166-0w0t631x | A first natural question to ask is, then: why do"active"nests persist and reappear? |
| cord-249166-0w0t631x | First the target population needs to be determined: whom do we intend to protect? |
| cord-249166-0w0t631x | For how long is the preventive effect to last? |
| cord-249166-0w0t631x | Hence it seems natural to analyse its present characteristics in the light of the facts we have described in the Sections 4-9 above and to ask ourselves: which lessons can we draw regarding the control strategies to be applied now? |
| cord-249166-0w0t631x | In particular, is there a way to predict aspects of the future evolution of f, having observed the values f(t) for a while? |
| cord-249166-0w0t631x | Let us take up the first one, namely: What can be learnt from the epidemic? |
| cord-249166-0w0t631x | Next, what are the health deficiencies we want to prevent? |
| cord-249166-0w0t631x | Next, what should be done? |
| cord-249166-0w0t631x | Next, what will be the objective? |
| cord-249166-0w0t631x | Or everybody coming from a region where cases exist? |
| cord-249166-0w0t631x | Or those who complain about symptoms? |
| cord-249166-0w0t631x | Subjects who had a contact with infected people? |
| cord-249166-0w0t631x | This comment leads us to the second part of our"outlook", namely: What to do in the future? |
| cord-249166-0w0t631x | Thus we are asking: why are the dynamics and control of Covid-19 most interesting for mathematicians and why are mathematicians urgently needed for controlling the pandemic? |
| cord-249166-0w0t631x | To discover the presence of the virus or that of some kind of antibodies? |
| cord-249166-0w0t631x | We are asking: why are the dynamics and control of Covid-19 most interesting for mathematicians and why are mathematicians urgently needed for controlling the pandemic? |
| cord-249166-0w0t631x | What can we learn about the mechanism of C by observing f(t)? |
| cord-249166-0w0t631x | Who will be tested? |
| cord-269939-8nvrt5y7 | Author query AQ1 Is the change to the text OK? |
| cord-270458-7imgvale | what lessons have we learned? |
| cord-257751-n7w1psr4 | 14, 35, 36, 38 IS 6 FEET DISTANCING STRICTLY NECESSARY? |
| cord-257751-n7w1psr4 | A fiasco in the making? |
| cord-257751-n7w1psr4 | Can you get Covid-19 twice? |
| cord-257751-n7w1psr4 | Center for Global Development blog post Is it safe to reopen schools? |
| cord-257751-n7w1psr4 | In most places, the data say no For COVID-19, will the HIC blueprint work in LMICs? |
| cord-257751-n7w1psr4 | Is our fight against coronavirus worse than the disease? |
| cord-257751-n7w1psr4 | It's dangerous to be ruled by fear Five ways to conquer your covid-19 fears Coronavirus: can latex gloves protect you from catching deadly virus? |
| cord-257751-n7w1psr4 | MOVING TOWARD HERD IMMUNITY? |
| cord-257751-n7w1psr4 | Models project sharp rise in deaths as states reopen Do lockdowns save many lives? |
| cord-257751-n7w1psr4 | Pandemic school closures: risks and opportunities Back to school? |
| cord-257751-n7w1psr4 | The Politic Covid-19 in Nepal: where are we after 9 weeks of lockdown? |
| cord-257751-n7w1psr4 | The Scientist Could'innate immunology'save us from the coronavirus? |
| cord-257751-n7w1psr4 | The case for reopening schools this fall Should schools reopen? |
| cord-257751-n7w1psr4 | The missing link? |
| cord-257751-n7w1psr4 | What's the strange ailment affecting children with Covid-19? |
| cord-257751-n7w1psr4 | Why are some people so much more infectious than others? |
| cord-257751-n7w1psr4 | Will coronavirus pandemic diminish by summer? |
| cord-270355-5mljrk1h | à faire face à de nouvelles pandémies du même type, telles la grippe aviaire? |
| cord-269474-94c1mudi | Pediatrics Neurodevelopmental outcomes after preterm birth Is attrition bias a problem in neonatal follow- up? |
| cord-269474-94c1mudi | What happened? |
| cord-269756-tid8a464 | At this concentration, what are the changes in the structural dynamics, curvature and hydration of the lipids and in the thermodynamic parameters of the membranes that lead to membrane fusion? |
| cord-269756-tid8a464 | a hairpin Structure and function of membrane fusion peptides Are fusion peptides a good model to study viral cell fusion? |
| cord-269537-h3lzl1un | Using Extracellular Vesicles for Potential Therapy of COVID-19 COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options COVID-19 and diabetes management: What should be considered? |
| cord-269537-h3lzl1un | a potential cancer therapeutic agent isolated from Andrographis paniculata Is there a future for andrographolide to be an antiinflammatory drug? |
| cord-266558-vd41u2t1 | ACE2 deficiency: a central role in SARS- CoV-2 infection? |
| cord-266558-vd41u2t1 | ACE2: angels or devils? |
| cord-266558-vd41u2t1 | Angiotensin receptor blockers as tentative SARS- CoV-2 therapeutics SARS- CoV2: should inhibitors of the renin- angiotensin system be withdrawn in patients with COVID-19? |
| cord-266558-vd41u2t1 | Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-266558-vd41u2t1 | Can angiotensin receptor- blocking drugs perhaps be harmful in the COVID-19 pandemic? |
| cord-266558-vd41u2t1 | What does it happen to ACE2 after SARS- Cov binding? |
| cord-266558-vd41u2t1 | is sufficient to increase the susceptibility to heart disease COVID-19: consider cytokine storm syndromes and immunosuppression COVID-19 and the Heart Substituting Angiotensin-(1- 7) to Prevent Lung Damage in SARSCoV2 Infection? |
| cord-268622-3jireyep | Do chronic respiratory diseases or their treatment affect the risk of SARS- CoV-2 infection? |
| cord-268622-3jireyep | Might renin- angiotensin system blockers play a role in the COVID-19 pandemic? |
| cord-268622-3jireyep | What lessons have we learned? |
| cord-270550-if748w2n | Why weight? |
| cord-268483-joiajgs4 | : what to expect for COVID-19? |
| cord-268483-joiajgs4 | : where are we? |
| cord-268483-joiajgs4 | Chloroquine is a potent inhibitor of SARS coronavirus infection and spread Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-268483-joiajgs4 | Clinical features of patients infected with 2019 novel coronavirus in Wuhan A phase 3, single- arm, prospective study of remestemcel- l, ex vivo culture- expanded adult human mesenchymal stromal cells for the treatment of pediatric patients who failed to respond to steroid treatment for acute graft- versus- host disease Remestemcel- L: Human mesenchymal stem cells as an emerging therapy for Crohn's disease Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia Mesoblast To Evaluate Anti- Inflammatory Cell Therapy Remestemcel- L for Treatment of Covid-19 Lung Disease Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-270510-z6qg48nz | Chapter of Gastroenterologists professional guidance on risk mitigation for gastrointestinal endoscopy during COVID-19 pandemic in Singapore COVID-19 in Endoscopy: Time to do more? |
| cord-270591-0szbkhiz | Is a"cytokine storm"relevant to COVID-19? |
| cord-268425-xg8xnjf9 | Adenosine regulates the proinflammatory signaling function of thrombin in endothelial cells Bench- to- bedside review: adenosine receptors-- promising targets in acute lung injury? |
| cord-268425-xg8xnjf9 | Beta Glucan: Supplement or Drug? |
| cord-268425-xg8xnjf9 | Does vitamin D status impact mortality from SARS- CoV-2 infection? |
| cord-268425-xg8xnjf9 | Hypomagnesemia Impact on the Outcome of Patients Admitted to the Intensive Care Unit? |
| cord-267511-tb69dwg8 | Hence, one could imagine the realization of an oral multi- modal NANOvaccine for targeted delivery of a synthetic mRNA of the virus to the respiratory tract, with the purpose of enhancing the immunostimulatory activity of the vaccine, by simply including antibodies or small molecules that could target the interaction sites between ACE2 and SARS- CoV. NANO- based Anti- virals as Potential Alternatives? |
| cord-267511-tb69dwg8 | Where Are We at with NANOvaccines? |
| cord-267511-tb69dwg8 | Why Go NANO on COVID-19 Pandemic? |
| cord-267511-tb69dwg8 | Why ca n't we make them very small, make them of little wires, little elements, and by little, I mean little?''1 |
| cord-267723-loj718vd | A potential outbreak? |
| cord-267723-loj718vd | Altered macrophage and dendritic cell response in Mif-/-mice reveals a role of Mif for inflammatory- Th1 response in type 1 diabetes Diabetes propels the risk for cardiovascular disease: sweet monocytes becoming aggressive? |
| cord-267723-loj718vd | How nicotine can inhibit cytokine storm in the lungs and prevent or lessen the severity of COVID-19 infection? |
| cord-267723-loj718vd | an epidemiological study Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-267723-loj718vd | title: Macrophages in diabetes mellitus( DM) and COVID-19: do they trigger DM? |
| cord-270886-m9na7cbm | An interactive web- based dashboard to track COVID-19 in real time Correlation of chest CT and RT- PCR testing in coronavirus disease 2019( COVID-19) in China: a report of 1014 cases Can nanotechnology help in the fight against COVID-19? |
| cord-270935-t9pym9k0 | Does Universal Testing for COVID-19 Work for Everyone? |
| cord-267307-kyh0xsrp | Do you think COVID-19 infection is a major problem in your community?" |
| cord-267307-kyh0xsrp | Perceived likelihood of infection was measured by asking participants"How likely do you believe it is that you will get infected with COVID-19?" |
| cord-267307-kyh0xsrp | Perceived threat to physical health was measured by asking participants"If you got infected with COVID-19, how threatening would it be to your physical health?" |
| cord-267307-kyh0xsrp | Public perceptions of non pharmaceutical interventions for reducing transmission of respiratory infection: systematic review and synthesis of qualitative studies Trust during the early stages of the 2009 H1N1 pandemic Public engagement as a means of restoring public trust in science- hitting the notes, but missing the music? |
| cord-267307-kyh0xsrp | What states require face masks in public? |
| cord-267307-kyh0xsrp | Who's Wearing a Mask? |
| cord-270588-c9rxmo44 | Fibroblasts and myofibroblasts: what are we talking about? |
| cord-270880-azslipmp | induces vision loss VEGF receptor signalling? |
| cord-271174-886xc1n3 | Prevalence of comorbidities in the novel Wuhan coronavirus( COVID-19) infection: a systematic review and meta- analysis Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-270919-0hldozml | National 391 Science Review Is COVID-19 receiving ADE from other coronaviruses?' |
| cord-271469-lozvq3y6 | Covid-19: Who are the forgotten victims?. |
| cord-271411-h3k7r2ia | using povidone- iodine oral antiseptic rinse Prevention of upper respiratory tract infections by gargling: a randomized trial The effect of 1% povidone iodine as a preprocedural mouthrinse in 20 patients with varying degrees of oral hygiene Topical povidone- iodine as an adjunctive treatment for recalcitrant chronic rhinosinusitis Preventing surgical site infections: a randomized, open- label trial of nasal mupirocin ointment and nasal povidone- iodine solution Antimicrobial effectiveness of povidone- iodine and consequences for new application areas Povidone iodine skin absorption: an ex- vivo study Is povidone iodine mouthwash effective against SARS- CoV-2? |
| cord-269835-mz7i66qp | Disinfection of Environments in Healthcare and Nonhealthcare Settings Potentially Contaminated with SARS Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents Clinical features of patients infected with 2019 novel coronavirus in Wuhan Effect of tight control management on Crohn's disease( CALM): a multicentre, randomised, controlled phase 3 trial Fecal calprotectin levels predict histological healing in ulcerative colitis Review article: faecal calprotectin and histologic remission in ulcerative colitis Epidemiological, clinical and virological characteristics of 74 cases of coronavirus- infected disease 2019( COVID-19) with gastrointestinal symptoms Faecal calprotectin indicates intestinal inflammation in COVID-19 Management of acute severe colitis in the era of biologicals and small molecules Cortisone in ulcerative colitis; final report on a therapeutic trial Predicting outcome in severe ulcerative colitis Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirusinfected pneumonia in Wuhan, China Relationship between cytomegalovirus infection and steroid resistance in inflammatory bowel disease: a meta- analysis Ulcerative colitis and cytomegalovirus infection: from A to Z Identification of clinically relevant cytomegalovirus infections in patients with inflammatory bowel disease Cytomegalovirus in inflammatory bowel disease: pathogen or innocent bystander? |
| cord-269835-mz7i66qp | part 1: definitions, diagnosis, extra- intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo- anal pouch disorders European evidence- based consensus: inflammatory bowel disease and malignancies Use of cross- sectional imaging for tight monitoring of inflammatory bowel diseases Uselessness of serum p53 antibody for detecting colitis- associated cancer in the era of immunosuppressive therapy Consecutive negative findings on colonoscopy during surveillance predict a low risk of advanced neoplasia in patients with inflammatory bowel disease with long- standing colitis: results of a 15-year multicentre, multinational cohort study European Crohn's and Colitis Organisation topical review on prediction, diagnosis and management of fibrostenosing Crohn's disease Efficacy of home telemonitoring versus conventional follow- up: a randomized controlled trial among teenagers with inflammatory bowel disease Is home monitoring of inflammatory bowel disease feasible? |
| cord-270888-8j17ul7k | Infección Por Sars- Cov-2 Como Desencadenante De Un Síndrome Inflamatorio Sistémico? |
| cord-266755-y2lf7ssp | 2 infection SARS- CoV-2: ACE inhibitors, disastrous or desirable? |
| cord-266755-y2lf7ssp | A H5N1 infections Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-266755-y2lf7ssp | Might renin- angiotensin system blockers play a role in the COVID-19 pandemic? |
| cord-266755-y2lf7ssp | Record- linkage study in Italy Structure analysis of the receptor binding of 2019-nCoV Soluble angiotensin- converting enzyme 2: a potential approach for coronavirus infection therapy? |
| cord-266755-y2lf7ssp | The epidemiology and pathogenesis of coronavirus disease( COVID-19) outbreak Structure, function, and antigenicity of the SARS- CoV-2 spike glycoprotein Pathogenesis of severe acute respiratory syndrome Should Covid-19 concern nephrologists? |
| cord-266755-y2lf7ssp | Why and to what extent? |
| cord-266755-y2lf7ssp | a single- centered, retrospective, observational study Clinical characteristics of 2019 novel coronavirus infection in China Is drug choice by general practitioners influenced by exposure to specialists? |
| cord-267782-4pjfnund | Could the smoking gun in the fight against COVID-19 be the( rh)ACE-2? World Health Organization. |
| cord-267782-4pjfnund | How might this impact on policy or clinical practice in the foreseeable future? |
| cord-267782-4pjfnund | What are the new findings? ► |
| cord-267782-4pjfnund | What is already known about this subject? ► |
| cord-271930-9a18h2tr | ACE2 Do chronic respiratory diseases or their treatment affect the risk of SARS- CoV-2 infection? |
| cord-268874-ldja6aa4 | -3rd update Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendationsscientific brief Controversies in respiratory protective equipment selection and use during COVID-19 Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination Preventing transmission of pandemic influenza and other viral respiratory diseases: personal protective equipment for healthcare personnel Recognition of aerosol transmission of infectious agents: a commentary How far droplets can move in indoor environments-- revisiting the Wells evaporation- falling curve Airborne or droplet precautions for health workers treating COVID-19? |
| cord-268874-ldja6aa4 | How well do N95 respirators protect healthcare providers against aerosolized influenza virus? |
| cord-268874-ldja6aa4 | Implementing fit testing for N95 filtering facepiece respirators: practical information from a large cohort of hospital workers Assigned protection factors: for the revised respirtory protection standard Respirator- fit testing: does it ensure the protection of healthcare workers against respirable particles carrying pathogens? |
| cord-268874-ldja6aa4 | The use and effectiveness of powered air purifying respirators in health care: workshop summary Performance of an improperly sized and stretched- out loose- fitting powered air- purifying respirator: Manikin- based study To PAPR or not to PAPR? |
| cord-271188-ewlxy5po | Does venesection reduce HIV viral load in patients with hereditary haemochromatosis? |
| cord-271871-8grkln6o | COVID-19: What proportion are asymptomatic? |
| cord-270116-r2rnnsfh | Available at Comparative Performance of SARS- CoV-2 Detection Assays using Seven Different Primer/ Probe Sets and One Assay Kit Clinical laboratory and SARS- CoV-2 infection: where do we stand? |
| cord-270116-r2rnnsfh | Targeting SARS- CoV-2 Clinical evaluation of the cobas SARS- CoV-2 test and a diagnostic platform switch during 48 hours in the midst of the COVID-19 Basic problems of serological laboratory diagnosis Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease( COVID-19) Analytical performances of a chemiluminescence immunoassay for 2019-nCov IgM/ IgG and antibody kinetics Assessment of immune response to SARS- CoV-2 with fully- automated MA- GLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019 Detection of antibodies against SARS- CoV-2 in patients with COVID-19 Serological immunochromatographic approach in diagnosis with SARS- CoV-2 infected COVID-19 patients Good IgA bad IgG in SARS- CoV-2 infection? |
| cord-270116-r2rnnsfh | The critical role of laboratory medicine during coronavirus disease 2019( COVID-19) and other viral outbreaks Coronavirus, the"immunity license"in Veneto: carpet antibody test COVID-19 and Italy: what next? |
| cord-271723-8qoozmgk | Should Clinicians Use chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or treatment of COVID-19? |
| cord-271090-91lzr4tz | In the face of the outbreak, would a vaccine that is 50% efficacious be acceptable for licensing? |
| cord-272318-8yfg1j0o | causative or coincidental? |
| cord-267856-t3ksa18w | Direct airway injury results in elevated levels of sulfidopeptide leukotrienes, detectable in airway secretions Leukotrienes and lipoxins: structures, biosynthesis, and biological effects Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? |
| cord-267856-t3ksa18w | If leukotrienes( LTs) have such potent inflammationpromoting actions, why have they not been considered so far? |
| cord-267856-t3ksa18w | Mounting clues suggest the coronavirus might trigger diabetes COVID-19: consider cytokine storm syndromes and immunosuppression Pivotal role of the 5-lipoxygenase pathway in lung injury after experimental sepsis Cysteinyl leukotriene 2 receptor- mediated vascular permeability via transendothelial vesicle transport Electrospray ionization and tandem mass spectrometry of eicosanoids SnapShot: COVID-19 Androgen- mediated sex bias impairs efficiency of leukotriene biosynthesis inhibitors in males Inflammation resolution: a dual- pronged approach to averting cytokine storms in COVID-19? ERK- mediated regulation of leukotriene biosynthesis by androgens: a molecular basis for gender differences in inflammation and asthma Leukotrienes: underappreciated mediators of innate immune responses Dexamethasone in hospitalized patients with COVID-19-preliminary report |
| cord-267856-t3ksa18w | Should we stimulate or suppress immune responses in COVID-19? |
| cord-267856-t3ksa18w | after COVID-19 indicates a potential therapeutic role for montelukast Storm, typhoon, cyclone or hurricane in patients with COVID-19? |
| cord-269909-1cso5cl4 | A case report of neonatal COVID-19 infection in China Perinatal transmission of COVID-19 associated SARS- CoV-2: should we worry? |
| cord-269909-1cso5cl4 | Can SARS- CoV-2 infection be acquired in utero? |
| cord-269909-1cso5cl4 | Why is COVID-19 so mild in children? |
| cord-272241-2fwz8z8n | the beginning of another SARS- like pandemic? |
| cord-271211-frkk6w0a | Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-271211-frkk6w0a | What are the risks of COVID-19 infection in pregnant women? |
| cord-272405-jmwn8pdn | when and why? |
| cord-272602-rywg9mek | potential hospital infection problem? |
| cord-272135-a09bf50o | : do we need a change? |
| cord-270857-8424oq4x | The severe acute respiratory syndrome Evidence of airborne transmission of the severe acute respiratory syndrome virus Detection of airborne severe acute respiratory syndrome( SARS) coronavirus and environmental contamination in SARS outbreak units Viral load distribution in SARS outbreak Temporal- spatial analysis of severe acute respiratory syndrome among hospital inpatients Dispersal of respiratory droplets with open vs closed oxygen delivery masks: implications for the transmission of severe acute respiratory syndrome Airflows around oxygen masks: a potential source of infection? |
| cord-270857-8424oq4x | Why did outbreaks of severe acute respiratory syndrome occur in some hospital wards but not in others? |
| cord-271813-nroflfmc | First case of 2019 novel coronavirus in the United States Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-271536-pscw933i | what next? |
| cord-272759-dqkjofw2 | :"Were SARS superspreaders anomalies, or are super- spreaders characteristic of most infectious diseases?" |
| cord-271648-m2c5bvuj | A Review of Virus- Host Interactions Human coronaviruses: What do they cause? |
| cord-271648-m2c5bvuj | medRxiv 2020 Comparing mask fit and usability of traditional and nanofibre N95 filtering facepiece respirators before and after nursing procedures A close shave? |
| cord-271815-yr1dq258 | Nosocomial transmission of SARS Severe acute respiratory syndrome coronavirus on hospital surfaces Contamination, disinfection, and crosscolonization: are hospital surfaces reservoirs for nosocomial infection? |
| cord-271815-yr1dq258 | Why did outbreaks of severe acute respiratory syndrome occur in some hospital wards but not in others? |
| cord-272902-kdkyzfjv | Could it be the case for different varieties of the coronavirus? |
| cord-273182-djb0ozrt | Situation update worldwide Global patterns in coronavirus diversity Sars- CoV-2 envelope and membrane proteins: structural differences linked to virus characteristics? |
| cord-273451-xnce010o | For example, if there is one remaining ventilator and several patients in need, will the individual who is experiencing homelessness and using illicit drugs be the one selected? |
| cord-269563-2979u47a | Can Zn Be a Critical Element in COVID-19 Treatment? |
| cord-269563-2979u47a | Does zinc supplementation enhance the clinical efficacy of chloroquine/ hydroxychloroquine to win todays battle against COVID-19? |
| cord-269563-2979u47a | Have anti glycoprotein antibodies a role? |
| cord-269563-2979u47a | In other words, they do not respond the question"how exactly do ABH antigens correlate with infection and cardiovascular pathophysiology?". |
| cord-269563-2979u47a | The ABO blood group system and Plasmodium falciparum malaria Effect of the ABO blood group on susceptibility to severe malaria: A systematic review and meta- analysis Plasmodium falciparum malaria and ABO blood group: is there any relationship? |
| cord-272626-bw9lbzvt | in vitro Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-271495-5906wju4 | Are SARS superspreaders cloud adults? |
| cord-271495-5906wju4 | cord-271495- 5906wju4 authors: Beldomenico, Pablo M. title: Do superspreaders generate new superspreaders? |
| cord-271495-5906wju4 | vicious circles? |
| cord-272573-wxqly479 | As The Pandemic Spreads, Will There Be Enough Ventilators? |
| cord-272573-wxqly479 | In: GOV.UK[ Internet Google Docs Testing the efficacy of homemade masks: would they protect in an influenza pandemic? |
| cord-272566-rtnhndw3 | Among Vulnerable HIV- Negative Gay and Bisexual Men, Transmen, and Transwomen Who Have Sex With Men: Protocol for an Observational Cohort Study Seeing is believing? |
| cord-271944-oxtus5vb | Cureus Acute Symptomatic Seizures in Critically Ill Patients with COVID-19: Is There an Association? |
| cord-270661-e83xe4sp | Could SARS- CoV-2 be transmitted via speech droplets? |
| cord-270661-e83xe4sp | In a number of studies, the SARS- CoV-2 genome was identified in blood samples from a number of patients with COVID-19( 15, 16), and subsequently raised the question: Is SARS- CoV-2 transmitted through transfusion? |
| cord-270661-e83xe4sp | The presence of SARS- CoV-2 RNA in the feces of COVID-19 patients Do n't overlook digestive symptoms in patients with 2019 novel coronavirus disease( COVID-19) Perinatal transmission of COVID-19 associated SARS- CoV-2: should we worry? |
| cord-272009-yxjhfg7m | : what can they teach us about the severe acute respiratory syndrome? |
| cord-272009-yxjhfg7m | Evolutionary Strong population substructure is correlated with morphology and ecology in a migratory bat Error thresholds and the constraints to RNA virus evolution What links bats to emerging infectious diseases? |
| cord-270399-yfko8mpc | COVID-19 Should COVID-19 concern nephrologists? |
| cord-270399-yfko8mpc | Why and to what extent? |
| cord-270399-yfko8mpc | implications for albuminuria in diabetes IL-6, and SARS- CoV-2( COVID-19) infection: may all fit together? |
| cord-268939-ws74xprt | How do extracellular pathogens cross the blood- brain barrier? |
| cord-268939-ws74xprt | Is this just a lot of hot air? |
| cord-268939-ws74xprt | May we deliver neuro- oncology in difficult times( e.g. COVID-19)? |
| cord-268939-ws74xprt | The perioperative immune response Does major surgery induce immune suppression and increase the risk of postoperative infection? |
| cord-268939-ws74xprt | as Compared with SARS- CoV-1 Letter: Rongeurs, Neurosurgeons, and COVID-19: How Do We Protect Health Care Personnel During Neurosurgical Operations in the Midst of Aerosol- Generation From High- Speed Drills? |
| cord-272019-4uua0zgp | Decreased fibrinolytic potential in patients with idiopathic avascular necrosis and transient osteoporosis of the hip Hypofibrinolysis, thrombophilia, osteonecrosis The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis Thrombophilia and hypofibrinolysis: pathophysiologies of osteonecrosis Epidemiological risk factors for non- traumatic osteonecrosis Anticardiolipin antibodies and osteonecrosis of the femoral head Antithrombin III deficiency in a patient with multifocal osteonecrosis Hypofibrinolysis, lipoprotein( a) and plasminogen activator inhibitor Thromboembolic complications associated with ACTH and cortisone therapy Coagulopathies and osteonecrosis Factor V leiden and prothrombin gene mutation: risk factors for osteonecrosis of the femoral head in adults Genetic background of osteonecrosis: associated with thrombophilic mutations? |
| cord-272019-4uua0zgp | In: Schafer M( ed) Instructional course lectures 43 Microvascular obstruction in avascular necrosis: immunohistochemistry of 14 femoral heads Risk factors potentially activating intravascular coagulation and causing nontraumatic osteonecrosis Procoagulants and Osteonecrosis Role of thrombosis in osteonecrosis Severe thrombotic disease in a young man with bone marrow and skeletal changes and with a high content of an inhibitor in the fibrinolytic system Familial high plasminogen activator inhibitor with hypofibrinolysis, a new pathophysiologic cause of osteonecrosis? |
| cord-268718-tt07cwrf | ( b) Which ACE2-expressing organs are prone to SARS- CoV-2 infection? |
| cord-268718-tt07cwrf | ( c) Is higher expression level of ACE2 equal to greater COVID-19 susceptibility? |
| cord-268718-tt07cwrf | Potential T- cell and B- cell epitopes of 2019-nCoV Rapid- response vaccines- does DNA offer a solution? |
| cord-268718-tt07cwrf | The neuroinvasive potential of SARS- CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study Self- reported olfactory and taste disorders in patients with severe acute respiratory coronavirus 2 infection: a cross- sectional study High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa SARS- CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes SARS- CoV-2: recent reports on antiviral therapies based on lopinavir/ ritonavir, darunavir/ umifenovir, hydroxychloroquine, remdesivir, favipiravir and other drugs for the treatment of the new coronavirus Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia( COVID-19): an empirical study from Wuhan Remdesivir in covid-19 Vitamin effects on the immune system: vitamins a and D take centre stage Vitamin D and influenza- prevention or therapy? |
| cord-268718-tt07cwrf | Therefore, the following questions regarding ACE2 expression in relation to COVID-19 susceptibility can be asked:( a) Which parts of the body express ACE2? |
| cord-268718-tt07cwrf | driving pulses of zoonotic viruses in reservoir- host populations Global patterns in coronavirus diversity Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history Bat- to- human: spike features determining'host jump'of coronaviruses SARS- CoV, MERS- CoV, and beyond Link of a ubiquitous human coronavirus to dromedary camels Cross- host evolution of severe acute respiratory syndrome coronavirus in palm civet and human MERS coronavirus neutralizing antibodies in camels Pangolins harbor SARS- CoV-2-related coronaviruses Are pangolins the intermediate host of the 2019 novel coronavirus( 2019-nCoV)? |
| cord-268718-tt07cwrf | is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-269009-0i2bvt77 | Coagulation, fibrinolysis, and fibrin deposition in acute lung injury Pulmonary thrombosis: a clinical pathological entity distinct from pulmonary embolism? |
| cord-269009-0i2bvt77 | Is the recommendation to use high- dose heparin for thromboprophylaxis justified? |
| cord-269009-0i2bvt77 | Practical guidance for the prevention of thrombosis and management of coagulopathy and disseminated intravascular coagulation of patients infected with COVID-19: Thrombosis- UK; 2020 Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia Pulmonary thrombosis in 2019-nCoV pneumonia? |
| cord-269009-0i2bvt77 | The versatile heparin in COVID-19 Pulmonary embolism or pulmonary thrombosis in COVID-19? |
| cord-269009-0i2bvt77 | the putative receptor of Wuhan Is COVID-19 an endothelial disease? |
| cord-273882-tqdcb3oo | Could an unrelated live attenuated vaccine serve as a preventive measure to dampen septic inflammation associated with COVID-19 infection? |
| cord-271781-cfv0ta10 | ) TMPRSS2 and COVID-19: serendipity or opportunity for intervention? |
| cord-271781-cfv0ta10 | Detectable SARS- CoV-2 viral RNA in feces of three children during recovery period of COVID-19 pneumonia Detection of SARS- CoV-2 by RT- PCR in anal from patients who have recovered from coronavirus disease 2019 Isolation of 2019-nCoV from a stool specimen of a laboratory- confirmed case of the coronavirus disease Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-271781-cfv0ta10 | First confirmed detection of SARS- CoV-2 in untreated wastewater in Australia: a proof of concept for the wastewater surveillance of COVID-19 in the community Can SARS- CoV-2 infection be acquired in utero? |
| cord-272501-byfxqsbu | : The need for combination therapy with non- anti- SARS- CoV-2 agents? |
| cord-272501-byfxqsbu | Where Are Influenza Virus and Rhinovirus/ Enterovirus? |
| cord-272681-u3p0hsla | Alberto title: Ageusia and anosmia, a common sign of COVID-19? |
| cord-272681-u3p0hsla | The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system Guillain- Barre syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-270858-ozvdz9ew | For any country contemplating these issues, another crucial question is how solid is the assumption that antibodies to SARS- CoV-2 spike protein equate to functional protection? |
| cord-270858-ozvdz9ew | Furthermore, if presence of these antibodies is protective, how can it be decided what proportion of the population requires these antibodies to mitigate subsequent waves of cases of COVID-19? |
| cord-270858-ozvdz9ew | How can one determine how much herd immunity is sufficient to mitigate subsequent substantial outbreaks of COVID-19? |
| cord-270858-ozvdz9ew | How long is immunity to COVID-19 likely to last? |
| cord-271259-6kkzh1tp | How does"immature"M pro release itself from the precursor polyproteins without forming the mature dimer structure? |
| cord-271259-6kkzh1tp | What is the difference between the proteolytic autocleavage and transcleavage mechanisms of SARS- CoV M pro? |
| cord-271259-6kkzh1tp | What we find puzzling is why the N- terminal autocleavage activity of M pro is independent from the dimer structure that is vital to trans- cleavage activity of the protease? |
| cord-274114-fglyfz8p | A possible role for B cells in COVID-19? |
| cord-274090-eab7i4f6 | : cord-274090-eab7i4f6 authors: Gaspari, Valeria; Lanzoni, Anna; Patrizi, Annalisa; Orioni, Gionathan; Viviani, Filippo; Bardazzi, Federico title: Can Covid‐19 be a sexually transmitted disease? |
| cord-274459-781by93r | Why does Japan have so few cases of COVID-19? |
| cord-272211-nkv6irr7 | What are the implications for public health practice? |
| cord-272211-nkv6irr7 | What is added by this report? |
| cord-272211-nkv6irr7 | What is already known about this topic? |
| cord-274007-zndtddty | Can coronavirus pass from mother to baby? |
| cord-274396-l611eisi | ␣ of Middle East respiratory syndrome Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen Antimalarial drug chloroquine counteracts activation of indoleamine( 2,3)-dioxygenase activity in human PBMC Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS- CoV-2 infection in vitro Hydroxychloroquine for SARS- CoV-2 infection: how did we get here? |
| cord-274343-y9zqbefu | a narrative review Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village Clinical and epidemiological features of 36 children with coronavirus disease 2019( COVID-19) in Zhejiang, China: an observational cohort study SARS- CoV-2( COVID-19): what do we know about children? |
| cord-273349-penb65x7 | Clinical characteristics of 2019 novel coronavirus infection in China What to do next to control the 2019-nCoV epidemic? |
| cord-273349-penb65x7 | Clinical course and outcomes of critically ill patients with SARS- CoV-2 pneumonia in Wuhan, China: a single- centered, retrospective, observational study Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-269289-6uog10j4 | A few small studies have demonstrated that SARS- CoV-2 can affect the kidneys directly, but it is unclear if this is a key mechanism in acute kidney injury seen in patients with SARS- CoV-2 infection? |
| cord-269289-6uog10j4 | This study claimed that hypokalaemia was prevalent amongst SARS- CoV-2 infected patients, affecting 108 of 175 patients( 62%) that had a serum potassium of 4.0 mmol/ l which is the value required for those with myocardial dysfunction.Hypokalaemia affected 62% of patients with a K less than 3.5? |
| cord-269289-6uog10j4 | Are all factual statements correct and adequately supported by citations? |
| cord-269289-6uog10j4 | Does this significantly alter management in these patients, outside of a research context? |
| cord-269289-6uog10j4 | Partly Are arguments sufficiently supported by evidence from the published literature? |
| cord-269289-6uog10j4 | What is the evidence for hypokalaemia in SARS- CoV-2 infection so far? |
| cord-035015-slgywe0c | :"Mitohormesis"for health and vitality Is There a Link between Mitochondrial Reserve Respiratory Capacity and Aging? |
| cord-035015-slgywe0c | A Meta- Analysis Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS- CoV-2 Related Disease( COVID-19) Mitochondria accumulate large amounts of quercetin: prevention of mitochondrial damage and release upon oxidation of the extramitochondrial fraction of the flavonoid Quercetin induces mitochondrial biogenesis through activation of HO-1 in HepG2 cells From sunscreens to medicines: Can a dissipation hypothesis explain the beneficial aspects of many plant compounds? |
| cord-035015-slgywe0c | A Systematic Review and Meta- Analysis Caloric Restriction Reprograms the Single- Cell Transcriptional Landscape of Rattus norvegicus Mitochondria-- a nexus for aging, calorie restriction, and sirtuins? |
| cord-035015-slgywe0c | Can an Old Ally Defeat a New Enemy? |
| cord-035015-slgywe0c | Can we test the hypothesis that mitochondrial health= immune health and enhanced resistance to the virus? |
| cord-035015-slgywe0c | Could damaged mitochondria in the lung and/or heart lead to an exacerbation of symptoms if too much oxygen is given to a patient? |
| cord-035015-slgywe0c | Does SARS- CoV-2 modulate mitochondrial function, either indirectly or directly, and if so, in what cells? |
| cord-035015-slgywe0c | Does mitochondrial function explain why morbidity may be greater among men than women? |
| cord-035015-slgywe0c | For instance, would measured VO 2 max show an inverse relationship with morbidity? |
| cord-035015-slgywe0c | In contrast, would those populations showing the highest fitness levels and functioning be more resistant? |
| cord-035015-slgywe0c | Insights into Oxidative Damage Is exercise protective against influenza- associated mortality? |
| cord-035015-slgywe0c | Interplay between MAPK signaling pathway and mitochondrial dynamics Cyclosporine and COVID-19: Risk or favorable? |
| cord-035015-slgywe0c | Intracellular redox state as target for anti- influenza therapy: are antioxidants always effective? |
| cord-035015-slgywe0c | Is there a link between mitochondrial haplotype and resistance? |
| cord-035015-slgywe0c | Mild depolarization of the inner mitochondrial membrane is a crucial component of an anti- aging program Redox- optimized ROS balance: a unifying hypothesis Redox- optimized ROS balance and the relationship between mitochondrial respiration and ROS Mitochondrial uncoupling and longevity-A role for mitokines? |
| cord-035015-slgywe0c | Neuropilin-1 is a host factor for SARS- CoV-2 infection Immune cell extracellular vesicles and their mitochondrial content decline with ageing T cells with dysfunctional mitochondria induce multimorbidity and premature senescence Antigen- specific adaptive immunity to SARS- CoV-2 in acute COVID-19 and associations with age and disease severity Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19 Mitochondrial Dysfunction and the Aging Immune System immunosenescence and inflammaging: a role for mitokines? |
| cord-035015-slgywe0c | Pandemic Lifestyle- induced metabolic inflexibility and accelerated ageing syndrome: insulin resistance, friend or foe? |
| cord-035015-slgywe0c | So why would SARS- CoV-2 do this? |
| cord-035015-slgywe0c | This therefore raises the question, would enhancing/ supporting mitochondrial health help in this population if they become infected and would understanding the role of mitochondria help in deciding treatment regimens? |
| cord-035015-slgywe0c | Thus, would blood- derived epigenetic markers of metabolic age correlate with disease severity before, during and after infection? |
| cord-035015-slgywe0c | What are the SARS- CoV-2 receptors and where are they found? |
| cord-035015-slgywe0c | Why is Life the way it is? |
| cord-035015-slgywe0c | Would pollution lower resistance to the virus? |
| cord-035015-slgywe0c | a modelling study Inflammation resolution: a dual- pronged approach to averting cytokine storms in COVID-19? |
| cord-264828-6w13xo2a | Are such effects dangerous, neutral or even useful in older, COVID-19-affected patients? |
| cord-264828-6w13xo2a | Are these two drug classes( ARBs, ACE- Is or other antihypertensive drugs) acting differently from each other in the pathogenetic evolution of SARS- CoV-2 infection? |
| cord-264828-6w13xo2a | COVID-19 pneumonia: a random association? |
| cord-264828-6w13xo2a | Could ACE- Is or ARBs eventually be resulting in neutral, useful, or even dangerous in terms of cardiovascular protection in the clinical course of SARS- CoV-2 frail, comorbid infected patients? |
| cord-264828-6w13xo2a | Do ACE- Is and ARBs display similar or quantitatively divergent effects in COVID-19 patients? |
| cord-264828-6w13xo2a | Do they act on multiple cell types? |
| cord-264828-6w13xo2a | Do they affect infection of different cell types? |
| cord-264828-6w13xo2a | How they affect infection of the numerous different type of ACE2 positive cells in the organism throughout the human body? |
| cord-264828-6w13xo2a | Vascular angiotensinconverting enzyme 2: lord of the ring? |
| cord-264828-6w13xo2a | We claim the need of adequately powered, prospective studies aimed at answering the following questions of paramount importance for cardiovascular, internal and emergency medicine: Do ACE- Is and ARBs exert similar or different effects on infection or disease course? |
| cord-264828-6w13xo2a | up- regulates angiotensin I- converting enzyme( ACE), but down- regulates ACE2 via the AT1-ERK/ p38 MAP kinase pathway Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-273913-xem3alih | : what should dermatologists know? |
| cord-273913-xem3alih | Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus( 2019-nCoV) in vitro Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open- label non- randomized clinical trial A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19 Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial Should chloroquine and hydroxychloroquine be used to treat COVID-19? |
| cord-274028-dvsvtsn0 | Accessed on Key findings from the Atahualpa Project: what should we learn? |
| cord-274313-mrvk9r4w | when were the first cytokines released and what were they? |
| cord-274366-t138l6px | How deadly is COVID-19? |
| cord-273382-7w8fli6w | Does exposure to laser plume place the surgeon at high risk for acquiring clinical human papillomavirus infection? |
| cord-273382-7w8fli6w | [ Laryngeal papillomatosis- first recognition in Germany as an occupational disease in an operating room nurse Floating aerial blood mists in the operating room Endoscopic skull base and transoral surgery during COVID-19 pandemic: minimizing droplet spread with negative- pressure otolaryngology viral isolation drape Comparison of outcomes between endoscopic surgery and conventional nasal packing for epistaxis in the posterior fornix of the inferior nasal meatus Outcomes analysis in epistaxis management: development of a therapeutic algorithm Surgical smoke and ultrafine particles Epistaxis and conjunctival contamination- are our ENT trainees at risk? |
| cord-272690-r8lv1zzx | Do you have one or more of the following symptoms: cough, shortness of breath, difficulty breathing? |
| cord-272690-r8lv1zzx | Have you been in contact with a SARS- affected person in the last 10 days? |
| cord-272690-r8lv1zzx | Three questions were added to both HANs: Do you have a fever? |
| cord-274708-w6gmscv4 | NL63 and HKU1 Emerging respiratory agents: new viruses for old diseases? |
| cord-274122-n9jnu2ah | deubiquitinase inhibitors blocks SARS virus replication Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex Deubiquitination, a new function of the severe acute respiratory syndrome coronavirus papain- like protease? |
| cord-274707-mxh38hwd | How will country- based mitigation measures influence the course of the COVID-19 epidemic? |
| cord-272419-y3ebt4jm | A suggested new protocol for COVID-19 early management Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 Treatment Guidelines Off- label use of medicines for COVID-19 Clinical Management of COVID-19-Interim Guidance Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control? |
| cord-272419-y3ebt4jm | COVID-19: A recommendation to examine the effect of hydroxychloroquine in preventing infection and progression New insights on the antiviral effects of chloroquine against coronavirus: What to expect for COVID-19? |
| cord-272419-y3ebt4jm | Nowadays, one of the critical issues still to be pointed out regards COVID-19 treatment regimens and timing: which drug, in which phase, for how long? |
| cord-274542-fpzk5k79 | should we be limiting their use in the clinical setting? |
| cord-269275-b7xxk48t | Clinical Characteristics of Coronavirus Disease 2019 in China Clinical characteristics of 50 466 hospitalized patients with 2019-nCoV infection SARS diagnosis and treatment protocol Clinical analysis of 260 cases of SARS in GuangZhou Management and prevention of SARS in China Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? |
| cord-269275-b7xxk48t | Diagnosis and treatment of the novel coronavirus pneumonia Protection and disinfection policies against SARS- CoV-2( COVID-19) Digestive system involvement of novel coronavirus infection: prevention and control infection from a gastroenterology perspective Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-269275-b7xxk48t | Looking ahead: The risk of neurologic complications due to COVID-19 Coronavirus infections and immune responses IgM in microbial infections: taken for granted? |
| cord-269275-b7xxk48t | Peripheral nerve function in sepsis and multiple organ failure ICU- acquired weakness: should medical sovereignty belong to any specialist? |
| cord-269275-b7xxk48t | Possible central nervous system infection by SARS coronavirus Diagnosis and management of sensory polyneuropathy Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-269275-b7xxk48t | neurology Human immune system variation Clinical characteristics of 2019 novel coronavirus infection in China Regulatory T cells in arterivirus and coronavirus infections: do they protect against disease or enhance it? |
| cord-269612-pmzdovna | -that people and governments have never learned anything from history, or acted upon principles deduced from it"? |
| cord-269612-pmzdovna | How severe a test did SARS pose? |
| cord-269612-pmzdovna | Is this'core'up to the job? |
| cord-269612-pmzdovna | Were we lucky? |
| cord-269612-pmzdovna | What lessons can we learn from SARS? |
| cord-269612-pmzdovna | What lessons can we learn from SARS? |
| cord-269612-pmzdovna | What lessons does SARS teach? |
| cord-274252-h4occy7h | the beginning of another SARS- like pandemic? |
| cord-274648-e0daf8w6 | Catheterization and Cardiovascular Intervention Role of the ACE2/ angiotensin 1- 7 axis of the renin- angiotensin system in heart failure COVID-19 and the cardiovascular system Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases Kawasaki- like disease: emerging complication during the COVID-19 pandemic Circulating plasma concentrations of angiotensin- converting enzyme 2 in men and women with heart failure and effects of reninangiotensin- aldosterone inhibitors Protecting older people from COVID-19: should the United Kingdom start at age 60? |
| cord-274184-hm516x6p | Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-274184-hm516x6p | is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-271551-bj2db91j | An outbreak of the severe acute respiratory syndrome: predictors of health behaviors and effect of community prevention measures in Hong Kong, China Psychosocial factors influencing the practice of preventive behaviors against the severe acute respiratory syndrome among older Chinese in Hong Kong Multiple substance use patterns in adolescents-a multilevel latent class analysis Latent classes of polysubstance use among adolescents-a systematic review Who is seeking whom? |
| cord-271551-bj2db91j | How likely will you become infected?"; 0 to 100%) and anticipated fear["How afraid would you feel if you became infected?"; 1( not at all) to 5( very)]. |
| cord-271551-bj2db91j | How likely will you become infected?"; 0 to 100%) and anticipated fear["How afraid would you feel if you became infected?"; 1( not at all) to 5( very)]. |
| cord-271551-bj2db91j | The impact of community psychological responses on outbreak control for severe acute respiratory syndrome in Hong Kong Scientific and ethical basis for socialdistancing interventions against COVID-19 Conceptualizing stigma Comparative stigma of HIV/ AIDS, SARS, and tuberculosis in Hong Kong What infection control measures will people carry out to reduce transmission of pandemic influenza? |
| cord-271551-bj2db91j | critical review of the English language literature Targeted social distancing designs for pandemic influenza Integrating emergency risk communication( ERC) into the public health system response: systematic review of literature to aid formulation of the 2017 WHO Guideline for ERC policy and practice The perceived threat of SARS and its impact on precautionary actions and adverse consequences: a qualitative study among Chinese communities in the United Kingdom and the Netherlands Effect of individual protective behaviors on influenza transmission: an agent- based model Simulation suggests that rapid activation of social distancing can arrest epidemic development due to a novel strain of influenza Psychosocial impact among the public of the severe acute respiratory syndrome epidemic in Taiwan Will novel virus go pandemic or be contained? |
| cord-269726-z0frgm7s | ( SARS- CoV-2) be infected again? |
| cord-269726-z0frgm7s | : Report from a designated transfer hospital in Chongqing Recurrence of positive SARS- CoV-2 RNA in COVID-19: a case report Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound? |
| cord-269726-z0frgm7s | Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound? |
| cord-269726-z0frgm7s | Is novel coronavirus 2019 reinfection possible? |
| cord-269726-z0frgm7s | Is recurrence possible in coronavirus disease 2019( COVID-19)? |
| cord-269726-z0frgm7s | The clinical features and outcomes of discharged coronavirus disease 2019 patients: a prospective cohort study Re- infection by COVID-19: a real threat for the future management of pandemia? |
| cord-269726-z0frgm7s | The dilemma of COVID-19 recurrence after clinical recovery Persistent positivity and fluctuations of SARS- CoV-2 RNA in clinically- recovered COVID-19 patients Probable causes and risk factors for positive SARS- CoV-2 test in recovered patients: evidence from Brunei Darussalam Epidemiological characteristics of COVID-19 patients in convalescence period Chest CT study of fifteen COVID-19 patients with positive RT- PCR retest results after discharge Rate of re- positive RT- PCR test among patients recovered from COVID-19 Discontinuation of antiviral drugs may be the reason for recovered COVID-19 patients testing positive again Changes in serum virus- specific IgM/ IgG antibody in asymptomatic and discharged patients with reoccurring positive COVID-19 nucleic acid test( RPNAT) Chest CT and clinical follow- up of discharged patients with COVID-19 in Wenzhou City A cluster of the Corona Virus Disease 2019 caused by incubation period transmission in Wuxi Re- positive coronavirus disease 2019 PCR test: could it be a reinfection? |
| cord-269726-z0frgm7s | The issue of recurrently positive patients who recovered from COVID-19 according to the current discharge criteria: investigation of patients from multiple medical institutions in Wuhan Positive RT- PCR nasopharyngeal swab in patients recovered from COVID-19 disease: when does quarantine really end? |
| cord-272956-0yumc7em | Can angiotensin receptor- blocking drugs perhaps be harmful in the COVID-19 pandemic? |
| cord-272956-0yumc7em | What is the evidence? |
| cord-272956-0yumc7em | the cardiovascular system Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-274841-rcdoewwv | Is COVID-19 receiving ADE from other coronaviruses? |
| cord-272414-oo8kcuf3 | Can cats become infected with Covid-19? Downregulation of neuronal vasoactive intestinal polypeptide in Parkinson's disease and chronic constipation Pathology of experimental SARS coronavirus infection in cats and ferrets |
| cord-272414-oo8kcuf3 | Can companion animals become infected with Covid-19? Transmission of SARS- CoV-2 in domestic cats Belgian Cat Infected by Owner. |
| cord-272414-oo8kcuf3 | Does SARS- Cov-2 invade the brain? |
| cord-272414-oo8kcuf3 | Why does SARS- CoV-2 invade the gastrointestinal epithelium? |
| cord-269206-160ddfsc | Can trade policies soften the economic impacts of an avian influenza outbreak? |
| cord-269206-160ddfsc | How does household spending respond to an epidemic? |
| cord-269206-160ddfsc | If more and more people get unemployed in every sector, how can countries maintain rising consumption demand? |
| cord-269206-160ddfsc | Should we focus on the sustainability of the existing economic system or should we focus on maintenance of income levels not to distract economic activities? |
| cord-269206-160ddfsc | What does n't kill you makes you stronger? |
| cord-269206-160ddfsc | What should be avoided? |
| cord-273408-jtpaue0z | : Is there a link? |
| cord-273408-jtpaue0z | On discharge, the patient's oxygen saturation was 95%, and his To what extent has pain in the last 3 months impaired free- time activities or activities with family or friends? |
| cord-273408-jtpaue0z | To what extent has pain in the last 3 months impaired your capacity to do work( including housework)? |
| cord-274008-p3st70u3 | M1-like monocytes are a major immunological determinant of severity in previously healthy adults with life- threatening influenza Progression of whole- blood transcriptional signatures from interferon- induced to neutrophil- associated patterns in severe influenza Risks versus benefits of cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators? |
| cord-274008-p3st70u3 | T cells in the lungs of patients with HIV infection and T- cell alveolitis Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection Host adaptive immunity deficiency in severe pandemic influenza Misguided drug advice for COVID-19 Nonsteroidal anti- inflammatory drugs increase TNF production in rheumatoid synovial membrane cultures and whole blood Complement as a target in COVID-19? |
| cord-273505-pcsw3vmx | A possible role for B cells in COVID-19? |
| cord-273505-pcsw3vmx | Impaired inhibitory Fcgamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy Recapitulation of IVIG anti- inflammatory activity with a recombinant IgG Fc Identification of a receptor required for the anti- inflammatory activity of IVIG Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway Intravenous immunoglobulin therapy: how does IgG modulate the immune system? |
| cord-273505-pcsw3vmx | Tregitope update: mechanism of action parallels IVIg Mechanisms of immune regulation by IVIG Tregitope peptides: the active pharmaceutical ingredient of IVIG? |
| cord-273505-pcsw3vmx | an operational recommendation of Peking Union Medical College Hospital Is dosing of therapeutic immunoglobulins optimal? |
| cord-274602-q9i2k304 | Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? |
| cord-274602-q9i2k304 | COVID-19: What proportion are asymptomatic? |
| cord-271504-t3y1w9ef | , its homologue ACE2 and neprilysin in angiotensin peptide metabolism COVID-19 and angiotensinconverting enzyme inhibitors and angiotensin receptor Blockers Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-271504-t3y1w9ef | : lessons from severe acute respiratory syndrome and Middle East respiratory syndrome Radiology of severe acute respiratory syndrome( SARS): the emerging pathologic- radiologic correlates of an emerging disease Middle East respiratory syndrome coronavirus: what does a radiologist need to know? |
| cord-271504-t3y1w9ef | A human monoclonal antibody blocking SARS- CoV-2 infection Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes IgM in microbial infections: taken for granted? |
| cord-271504-t3y1w9ef | The SARS- coronavirus papain- like protease: structure, function and inhibition by designed antiviral compounds Crystal Structures of the Main Peptidase from the SARS Coronavirus Inhibited by a Substrate- like Aza- peptide Epoxide Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry Protease inhibitors targeting coronavirus and filovirus entry Efficacy of camostat mesilate compared with famotidine for treatment of functional dyspepsia: is camostat mesilate effective? |
| cord-271504-t3y1w9ef | The broad- spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen Signatures of nucleotide analog incorporation by an RNA- dependent rna polymerase revealed using high- throughput magnetic tweezers Ribavirin in the treatment of SARS: a new trick for an old drug? |
| cord-271504-t3y1w9ef | What happens to people's lungs when they get coronavirus? |
| cord-275348-jna496x7 | How can we explain the greater potency of the single- cycle vectors relative to replication- competent vectors given i.m.? |
| cord-274528-mr81o9cu | a 25 promising approach for uncovering early COVID-19 drug therapies TMPRSS2 and COVID-19: 28 Serendipity or Opportunity for Intervention? |
| cord-271920-1dzkgt6w | Archives of Iranian medicine Coronavirus disease-2019: Is fever an adequate screening for the returning travelers? |
| cord-271920-1dzkgt6w | Do we know the diagnostic properties of the tests used in COVID-19? |
| cord-271920-1dzkgt6w | The Lancet Digital Health Sensitivity of Chest CT for COVID-19: Comparison to RT- PCR Diagnosis of the Coronavirus disease( COVID-19): rRT- PCR or CT? |
| cord-271920-1dzkgt6w | When should a new test become the current reference standard? |
| cord-275404-hv3y4x4g | Why did outbreaks of severe acute respiratory syndrome occur in some hospital wards but not in others? |
| cord-273906-s7l0yxc0 | : How do classical and non- classical HLA alleles modulate immune response to human immunodeficiency virus and hepatitis C virus infections? |
| cord-273906-s7l0yxc0 | Does this mean that the S protein might function as a double- edged sword- that is, being crucial for viral entry into the host cell, but also important for overstimulating the immune responses, causing severe inflammation that aids the spread of the virus to surrounding cells? |
| cord-273906-s7l0yxc0 | The RCSB Protein Data Bank: New resources for research and education Rosetta FlexPepDock web server- High resolution modeling of peptide- protein interactions Deciphering the structural effects of activating EGFR somatic mutations with molecular dynamics simulation Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB Comparison of simple potential functions for simulating liquid water Visual Molecular Dynamics Software for processing and analysis of molecular dynamics trajectory data UCSF Chimera- A visualization system for exploratory research and analysis Friends or foes? |
| cord-274591-p34kk4up | But has the response to SARS had any lasting effect on the probability of new infectious agents emerging, being detected at an early stage of emergence, and being effectively controlled? |
| cord-274591-p34kk4up | Does genetic diversity limit disease spread in natural host populations? |
| cord-270528-3rsv3jlh | 3rsv3jlh authors: Yazdanpanah, Fereshteh; Hamblin, Michael R.; Rezaei, Nima title: The immune system and COVID-19: Friend or foe? |
| cord-270528-3rsv3jlh | Borderless collaboration is needed for COVID-19; a disease that knows no borders Can an effective SARS- CoV-2 vaccine be developed for the older population? |
| cord-270528-3rsv3jlh | Can we use interleukin-6( IL-6) blockade for coronavirus disease 2019( COVID-19)-induced cytokine release syndrome( CRS)? |
| cord-270528-3rsv3jlh | Coronavirus infections and immune responses Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome? |
| cord-270528-3rsv3jlh | Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients? |
| cord-274141-vujx538o | Can herbal medicine assist against avian flu? |
| cord-274141-vujx538o | The roles of direct recognition by animal lectins in antiviral immunity and viral pathogenesis Phytochemical analysis and in vitro antiviral activities of the essential oils of seven Lebanon species Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Ethnomedicinal wisdom: an approach for antiviral drug development Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus Drug repurposing for viral infectious diseases: how far are we? |
| cord-274141-vujx538o | what next? |
| cord-275128-620wf0pb | An Open Question: Is It Rational to Inhibit the mTor- Dependent Pathway as COVID-19 Therapy? |
| cord-275128-620wf0pb | and COVID-19: Serendipity or Opportunity for Intervention? |
| cord-275506-3t5gf66c | The trinity of COVID-19: immunity, inflammation and intervention Endothelial cell infection and endotheliitis in COVID-19 COVID-19 and its implications for thrombosis and anticoagulation n COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia? |
| cord-266307-w56rii2p | : Is Testosterone a key factor? |
| cord-266307-w56rii2p | Compared to the Single X- Chromosome in Males? |
| cord-266307-w56rii2p | How is the outbreak growing? |
| cord-266307-w56rii2p | Protected? |
| cord-266307-w56rii2p | Renin- angiotensin inhibitors reprogram tumor immune microenvironment: a comprehensive view of the influences on anti- tumor immunity Angiotensin II and angiotensin 1- 7: which is their role in atrial fibrillation? |
| cord-266307-w56rii2p | Truncates to Target the Kidney Renin- Angiotensin- System( RAS) Role of the ACE2-Ang-(1- 7)-Mas axis in blood pressure regulation and its potential as an antihypertensive in functional foods Compensation of ACE2 function for possible clinical management of 2019-nCoVinduced acute lung injury Renin angiotensin system in liver diseases: Friend or foe? |
| cord-266307-w56rii2p | Who decides when to cleave an ectodomain? |
| cord-266307-w56rii2p | Why Men are More Vulnerable to Covid-19 Than Women? |
| cord-266307-w56rii2p | adipokines and inflammation Targeting the Renin- Angiotensin- Aldosterone System in Fibrosis Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19 Age and sex differences in soluble ACE2 may give insights for COVID-19 Soluble angiotensin- converting enzyme 2: a potential approach for coronavirus infection therapy? |
| cord-266307-w56rii2p | disulfide isomerase: the key to regulated cellsurface protein ectodomain shedding? |
| cord-275191-lgze4zex | The enlightenment from two cases of asymptomatic infection with SARS- CoV-2: is it safe after 14 days of isolation? |
| cord-275199-y7b12vml | Human Coronavirus NL63 Crohn's disease Ulcerative colitis Management of IBD during the COVID-19 outbreak: resetting clinical priorities Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection? |
| cord-275862-1aqtqaod | Additional instructions for a patient with 2019 nCoV Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-274513-0biyfhab | Can we contain the COVID-19 outbreak with the same measures as for SARS? |
| cord-274513-0biyfhab | How will country- based mitigation measures influence the course of the COVID-19 epidemic? |
| cord-274513-0biyfhab | The effect of travel restrictions on the spread of the 2019 novel coronavirus COVID-19 in Brazil: advantages of a socialized unified health system and preparation to contain cases COVID-19 spreading in Rio de Janeiro, Brazil: do the policies of social isolation really work? |
| cord-264814-v4wnmg03 | Antigenspecific human T- cell responses and T cell- dependent production of human antibodies in a humanized mouse model A mouse model of SARS- CoV-2 infection and pathogenesis Adaptation of SARS- CoV-2 in BALB/ c mice for testing vaccine efficacy Vaccine adjuvants: smart components to boost the immune system Correlates of adjuvanticity: a review on adjuvants in licensed vaccines Potential adjuvants for the development of a SARS- CoV-2 vaccine based on experimental results from similar coronaviruses Development of SARS- CoV-2 vaccines: should we focus on mucosal immunity? |
| cord-264814-v4wnmg03 | Available online at A single- dose live- attenuated YF17D- vectored SARS- CoV2 vaccine candidate DNA vaccines- how far from clinical use? |
| cord-264814-v4wnmg03 | COVID-19: are neutralizing antibodies neutralizing enough? |
| cord-264814-v4wnmg03 | Is BCG vaccination causally related to reduced COVID-19 mortality? |
| cord-264814-v4wnmg03 | Protection or Hyper- Activation? |
| cord-264814-v4wnmg03 | T Cell Adaptive Immunity: Protection, Immune Suppression or Disease Enhancement? |
| cord-264814-v4wnmg03 | The Spread of COVID-19 and the BCG Vaccine: a Natural Experiment in Reunified Germany SARS- CoV-2 rates in BCGvaccinated and unvaccinated young adults BCG- induced trained immunity: can it offer protection against COVID-19? |
| cord-264814-v4wnmg03 | With Task Force Vaccine Safety Expert A controlled human infection model of group a streptococcus pharyngitis: which strain and why? |
| cord-264814-v4wnmg03 | a six- year follow- up study Recovery from the middle east respiratory syndrome is associated with antibody and T- cell responses Immune cell profiling of COVID-19 patients in the recovery stage by single- cell sequencing Immunology of COVID-19: current state of the science Molecular basis of coronavirus virulence and vaccine development SARS vaccines: where are we? |
| cord-264814-v4wnmg03 | how first exposure shapes lifelong anti- influenza virus immune responses Original antigenic sin and respiratory syncytial virus vaccines What about the original antigenic sin of the humans versus SARS- CoV-2? |
| cord-264814-v4wnmg03 | mSphere Regulatory T cells in arterivirus and coronavirus infections: do they protect against disease or enhance it? |
| cord-274788-oyk8js16 | However, the same principle of early tracing, isolating, and testing of the contacts was effectively applied to control the outbreak at multiple fitness centers in a city with population of 650,000.? |
| cord-274788-oyk8js16 | ®): is the"fitness- party"a good workout? |
| cord-275784-n6jv72l7 | the infection control literature Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus- Infected Pneumonia in Wuhan COVID-19: protecting health- care workers The impact of the COVID-19 pandemic on the provision of surgical care Time- Sensitive Procedures: A Scoring System to Ethically and Efficiently Manage Resource Scarcity and Provider Risk During the COVID-19 Pandemic How to risk- stratify elective surgery during the COVID-19 pandemic? |
| cord-274521-u8p5lz9o | A systematic review of health effects of electronic cigarettes Are E- cigarettes a safe and good alternative to cigarette smoking? |
| cord-274521-u8p5lz9o | Results from two randomized clinical trials Will chronic e- cigarette use cause lung disease? |
| cord-274521-u8p5lz9o | Risk for increased susceptibility to SARS- CoV-2 infection? |
| cord-273426-55vu6b3u | Different respiratory treatments for different phenotypes? |
| cord-273426-55vu6b3u | For information regarding this article, E- mail: toshiiba@juntendo.ac.jp Acute pulmonary embolism and COVID-19 pneumonia: A random association? |
| cord-273426-55vu6b3u | Prominent changes in blood coagulation of patients with SARS- CoV-2 infection Will complement inhibition be the new target in treating COVID-19 related systemic thrombosis? |
| cord-272653-01wck9f3 | Do facemasks protect against COVID-19? |
| cord-272653-01wck9f3 | Has COVID-19 subverted global health? |
| cord-272653-01wck9f3 | Should I be worried about carrying the virus that causes COVID-19 home on my clothes? |
| cord-272653-01wck9f3 | what did we do well, what should we have done better, how do we make the best of the current situation? |
| cord-276132-tv5y1eqc | Do patients with cancer have a poorer prognosis of COVID-19? |
| cord-276147-30buoweg | Five staff members of the Dermatology Department were exclusively assigned to assist the admitted patients that Covid Toes: Phenomenon or Epiphenomenon? |
| cord-276058-1mpp7sbt | Does SARS- CoV-2 has a longer incubation period than SARS and MERS? |
| cord-274520-c674wkmt | : how infectious is it? |
| cord-274520-c674wkmt | Environmental particulate matter induces murine intestinal inflammatory responses and alters the gut microbiome Ambient air pollution correlates with hospitalizations for inflammatory bowel disease Inhalational exposure to particulate matter air pollution alters the composition of the gut microbiome Exposure to trafficrelated air pollution and the composition of the gut microbiota in overweight and obese adolescents Long- term exposure to fine particulate matter and incidence of type 2 diabetes mellitus in a cohort study: effects of total and traffic- specific air pollution e gut microbiota: a major player in the toxicity of environmental pollutants? |
| cord-274520-c674wkmt | e respiratory microbiome: an underappreciated player in the human response to inhaled pollutants? |
| cord-275185-9br8lwma | The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta- analysis Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A( H1N1) 2009 virus infection Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience Clinical characteristics of 26 human cases of highly pathogenic avian influenza A( H5N1) virus infection in China Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea Treatment of 5 critically Ill patients With COVID-19 with convalescent plasma Effectiveness of convalescent plasma therapy in severe COVID-19 patients Treatment with convalescent plasma for critically Ill patients with SARS- CoV-2 infection Treatment with convalescent plasma for COVID-19 patients in Wuhan Use of convalescent plasma therapy in two COVID-19 patients with acute respiratory distress syndrome in Korea clinicalmanagement- of- severe- acute- respiratory- infection- when- novel- coronavirus-(ncov)-infection- is- suspected Guideline for diagnosis and treatment for novel coronavirus pneumonia Establishment and validation of a pseudovirus neutralization assay for SARS- CoV-2 Meta- analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? |
| cord-275185-9br8lwma | why and how? |
| cord-276870-gxtvlji7 | Covid-19-a once- in- a- century pandemic? |
| cord-276361-77cylm1o | Clinical presentations and outcome of severe acute respiratory syndrome in children Antiviral treatment of SARS: can we draw any conclusions? |
| cord-269723-gm65p1op | Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? |
| cord-269723-gm65p1op | Covid-19? |
| cord-269723-gm65p1op | Front Are chronic periodontitis and gingivitis associated with dementia? |
| cord-269723-gm65p1op | Neurología( English Edition Long- term psychological and occupational effects of providing hospital healthcare during SARS outbreak Taiwan's healthcare report 2010 Is weight control surgery associated with increased risk of newly onset psychiatric disorders? |
| cord-269723-gm65p1op | a nationwide cohort study Are Anticholinergic medications associated with increased risk of dementia and behavioral and psychological symptoms of dementia? |
| cord-269723-gm65p1op | suicide and the psychological undercurrent of COVID-19 Elderly suicide and the 2003 SARS epidemic in Hong Kong Impact of severe acute respiratory syndrome( SARS) outbreaks on the use of emergency department medical resources Factors associated with psychosis among patients with severe acute respiratory syndrome: a case- control study Coping responses of emergency physicians and nurses to the 2003 severe acute respiratory syndrome outbreak Impact of SARS- CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic? |
| cord-269723-gm65p1op | title: What could we learn from SARS when facing the mental health issues related to the COVID-19 outbreak? |
| cord-275552-ijxxeo27 | Can hypothetical questions reveal true values? |
| cord-275552-ijxxeo27 | Knowing what you know now, would you pay$ X out of pocket for such a vaccine?'' |
| cord-274326-msbdrp3e | COVID-19 Concern Nephrologists? |
| cord-274326-msbdrp3e | The emerging impasse of angiotensin blockade Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China Pathological findings of COVID-19 associated with acute respiratory distress syndrome A promising anti- cytokine- storm targeted therapy for COVID-19: the artificial- liver blood- purification system Dual role of immune cells in the testis: protective or pathogenic for germ cells? |
| cord-274326-msbdrp3e | Why and to What Extent? |
| cord-274416-bmvazgj7 | How? |
| cord-274416-bmvazgj7 | Where? |
| cord-274416-bmvazgj7 | Where? |
| cord-274416-bmvazgj7 | Where? |
| cord-277239-cedoi5jr | Initial report from the US epicenter HLA antibody detection with solid phase assays: great expectations or expectations too great? |
| cord-277039-yo5ojr0s | An important source of emerging viruses capable of infecting humans Host and viral traits predict zoonotic spillover from mammals Evolutionary insights into the ecology of coronaviruses Human coronaviruses: What do they cause? |
| cord-275438-drywzvx8 | : Is there a role for targeted therapies? |
| cord-275438-drywzvx8 | Coronavirus COV-19/ SARS- CoV-2 affects women less than men: clinical response to viral infection COVID-19 induced by SARS- CoV-2 causes Kawasaki- like disease in children: role of pro- inflammatory and anti- inflammatory cytokines Dexamethasone for COVID-19? |
| cord-275438-drywzvx8 | Not so fast Induction of pro- inflammatory cytokines( IL-1 and IL-6) and lung inflammation by Coronavirus-19( COVI-19 or SARS- CoV-2): anti- inflammatory strategies How to reduce the likelihood of coronavirus-19( CoV-19 or SARS- CoV-2) infection and lung inflammation mediated by IL-1 Mast cells contribute to coronavirus- induced inflammation: new anti- inflammatory strategy SARS- CoV-2, which induces COVID-19, causes kawasaki- like disease in children: role of pro- inflammatory and anti- inflammatory cytokines Preventing mortality in COVID-19 patients: which cytokine to target in a raging storm? |
| cord-275340-q8d7rvnj | Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-275340-q8d7rvnj | they effective and safe in rheumatic diseases? |
| cord-275454-an8xvow3 | ( SARS- CoV-2) Screening With Specimen Pools: Time to Swim, or Too Deep for Comfort? |
| cord-275454-an8xvow3 | This leads to a second and possibly more important question: what does a negative or positive result mean? |
| cord-276630-qci7khki | New uses for old drugs Drug repositioning: Re- investigating existing drugs for new therapeutic indications Are the Statins promising antifungal agents against invasive candidiasis? |
| cord-277357-lpurk7pe | Infect Dis Reliability of real- time reverse- transcription PCR in clinical diagnostics: gold standard or substandard? |
| cord-276403-yomjm2gg | Lethal H5N1 influenza viruses escape host antiviral cytokine responses Characterization of H9 subtype influenza viruses from the ducks of southern China: a candidate for the next influenza pandemic in humans? |
| cord-269213-tsm6zoe3 | An information need or question stated that is about any topic related to control of the outbreak( e.g.,''Has the virus peaked?''). |
| cord-269213-tsm6zoe3 | Can you tell me how you learned about this?'' |
| cord-269213-tsm6zoe3 | For example, did you buy a facemask, vitamins, or do something else?''''Why did you decide to[ repeat preparation given by respondent]?'' |
| cord-269213-tsm6zoe3 | For example, did you buy a facemask, vitamins, or do something else?''''Why did you decide to[ repeat preparation given by respondent]?'' |
| cord-269213-tsm6zoe3 | How does social pressure affect decisions? |
| cord-269213-tsm6zoe3 | I said, what is going on with the market? |
| cord-269213-tsm6zoe3 | Participants, notably the Toronto residents, expressed suspicion about a possible cover- up of outbreaks,( i.e.,''why did this occur in Toronto and not in the US?''). |
| cord-269213-tsm6zoe3 | We linked lay understanding to information sources using probes, for example,''How does SARS affect a personÕs body?''followed by'' |
| cord-269213-tsm6zoe3 | What are laypersonsÕ decisions based on? |
| cord-269213-tsm6zoe3 | What motivates active searching of information? |
| cord-269213-tsm6zoe3 | and''How is[ repeat preparation given by respondent] going to help prevent SARS?'' |
| cord-277188-t33nw4zb | Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019( COVID-19)? |
| cord-275252-4e3cn50u | Viruses, microRNAs and cancer RNA virus microRNA that mimics a B- cell oncomiR Viruses and microRNAs Virus- specific host miRNAs: antiviral defenses or promoters of persistent infection? |
| cord-275252-4e3cn50u | myocardial fibrosis and heart failure microRNAs in heart disease: putative novel therapeutic targets? |
| cord-276784-8lmg97zc | ( SARS- CoV-2) Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open- label non- randomized clinical trial A Rush to Judgment? |
| cord-276784-8lmg97zc | COVID-19 in a MS patient treated with ocrelizumab: Does immunosuppression have a protective role? |
| cord-277731-thazunob | Can bioactive lipids inactivate coronavirus( COVID-19)? |
| cord-276493-hoaxv5e0 | a casepopulation study Anti- HCV, nucleotide inhibitors, repurposing against COVID-19 Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-277137-k3jj5vom | : what is new? |
| cord-277253-vy0mvzeb | Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019( COVID-19)? |
| cord-276797-86hc3lbi | Cumulative number of reported probably cases of SARS Infants born to mothers with severe acute respiratory syndrome but fast enough? |
| cord-276797-86hc3lbi | The outbreak of West Nile virus infection in the New York City area in 1999 West Nile virus encephalitis in America West Nile virus West Nile virus: Where are we now? |
| cord-277014-iz8jo44e | Diagnosis Hyponatremia, IL-6, and SARS- CoV-2( COVID-19) infection: may all fit together? |
| cord-277014-iz8jo44e | Electrolyte imbalances in patients with severe coronavirus disease Is low sodium intake a risk factor for severe and fatal COVID-19 infection? |
| cord-277486-12uah5qi | When Is it Safe to Discharge Cases Form the Hospital or End Home Isolation? |
| cord-277110-e27lm7rr | Clinical and epidemiological features of 36 children with coronavirus disease 2019( COVID-19) in Zhejiang, China: an observational cohort study Detection of COVID-19 in Children in Early Late- Onset Neonatal Sepsis in a Patient with COVID-19 Cutaneous manifestations in COVID-19: Lessons learned from current evidence Varicella- like exanthem associated with COVID-19 in an 8-year- old girl: A diagnostic clue? |
| cord-277110-e27lm7rr | Did Whatsapp ® reveal a new cutaneous COVID-19 manifestation? |
| cord-277796-9ddi0mm9 | Hypertension ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin- induced diabetic mice Human recombinant ACE2 reduces the progression of diabetic nephropathy Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-276895-p85obwp2 | : a report of five cases Will complement inhibition be the new target in treating COVID-19 related systemic thrombosis? |
| cord-276895-p85obwp2 | Is there room for peritoneal dialysis in the treatment of COVID-19-related AKI? |
| cord-274824-kaefedl1 | : Is there an association? |
| cord-274824-kaefedl1 | : Where are we now? |
| cord-274824-kaefedl1 | Angiotensin- converting enzyme 2: an ally or a Trojan horse? |
| cord-274824-kaefedl1 | Frontiers in Immunology Perspective: Should vitamin E recommendations for older adults be increased? |
| cord-274284-mi4n7xty | An International Multicenter Study Acute smell and taste loss in outpatients: all infected with SARS- CoV-2? |
| cord-274284-mi4n7xty | Clin Infect Dis Psychophysical olfactory testing in COVID-19: is smell function really impaired in nearly all patients? |
| cord-274284-mi4n7xty | Covid-19 in patients presenting with influenza- like symptoms Objective evaluation of anosmia and ageusia in COVID-19 patients: single- center experience on 72 cases Prevalence and duration of acute loss of smell or taste in COVID-19 patients Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? |
| cord-274284-mi4n7xty | Neurologic manifestations of hospitalized patients With coronavirus disease 2019 in Wuhan, China Olfactory and gustatory outcomes in COVID-19: a prospective evaluation in nonhospitalized subjects Accuracy of emergency department clinical findings for diagnosis of coronavirus disease 2019 Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: a retrospective cohort study Alterations in smell or taste- classic coronavirus disease 2019? |
| cord-276402-ymxvtyll | Should cyclosporine be useful in renal transplant recipients affected by SARS- CoV-2? |
| cord-276402-ymxvtyll | a twocentre descriptive study On the use of corticosteroids for 2019-nCoV pneumonia Elevation of serum ferritin levels for predicting a poor outcome in hospitalized patients with influenza infection Could ferritin help the screening for COVID-19 in hemodialysis patients? |
| cord-276969-mdry8qzv | Might the many positive COVID19 subjects in Italy have been caused by resident bat- derived zoonotic β- coronaviruses instead of the Wuhan( China) outbreak? |
| cord-276969-mdry8qzv | Might the many positive COVID19 subjects in Italy have been caused by resident bat‐derived zoonotic β‐coronaviruses instead of the Wuhan( China) outbreak? |
| cord-274510-fo7p98np | Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People? |
| cord-274510-fo7p98np | The use of Gc protein- derived macrophage activating factor for management of thyroid cancer Defective lymphocyte glycosidases in the macrophage activation cascade of juvenile osteopetrosis Deglycosylation of serum vitamin D3-binding protein by alpha- N- acetylgalactosaminidase detected in the plasma of patients with systemic lupus erythematosus Case report: GcMAF treatment in a patient with multiple sclerosis Initial observations of elevated alpha- Nacetylgalactosaminidase activity associated with autism and observed reductions from Gc protein-- macrophage activating factor injections Current pharmacological treatments for COVID-19: what's next? |
| cord-274510-fo7p98np | on angiogenesis and human peripheral blood mononuclear cell proliferation and signaling Can angiogenesis be exploited to improve stroke outcome? |
| cord-274510-fo7p98np | precursor activity Is chondroitin sulfate responsible for the biological effects attributed to the GC protein- derived Macrophage Activating Factor( GcMAF)? |
| cord-274510-fo7p98np | the key to curing cancer? |
| cord-277443-mv7sk5aa | Did this apparent moderation of the inflammatory response both in the lungs and on the surface of the lungs due correlate with a reduction of virus replication in the lungs of infected mice, the presence of virus protein the likely culprit for inducing edema? |
| cord-278050-wl83d6gs | Ribavirin in the treatment of SARS: a new trick for an old drug? |
| cord-274948-ze6scnae | Chauves- souris Civette palmiste masquée Chauves- souris Pangolin? |
| cord-274948-ze6scnae | Chauves- souris Dromadaire Rongeurs? |
| cord-274948-ze6scnae | Chauves- souris? |
| cord-278249-vvhq9vgp | Is a"cytokine storm"relevant to COVID-19? |
| cord-277440-9nehpbg2 | authors: Grimm, Christian; Tang, Rachel title: Could an endo- lysosomal ion channel be the Achilles heel of SARS- CoV2? |
| cord-278106-ev1nx60h | Does SARS- CoV-2 has a longer incubation period than SARS and MERS? |
| cord-270951-6nq3jwgr | COVID-19 and psoriasis: is it time to limit treatment with immunosuppressants? |
| cord-270951-6nq3jwgr | COVID‐19 and psoriasis: Should we fear for patients treated with biologics? |
| cord-270951-6nq3jwgr | Coronaviruses post- SARS: update on replication and pathogenesis MERS- CoV infection in humans is associated with a pro- inflammatory Th1 and Th17 cytokine profile Identification of common biological pathways and drug targets across multiple respiratory viruses based on human host gene expression analysis Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study Clinical and laboratory findings of SARS in Singapore Drug repurposing for viral infectious diseases: how far are we? |
| cord-270951-6nq3jwgr | Francesca Prignano https://orcid.org/0000-0002-5997-2045 Evaluation and Treatment Coronavirus( COVID-19) COVID-19 Coronavirus pandemic Immunogenicity of anti- TNFα therapy in psoriasis: a clinical issue? |
| cord-270951-6nq3jwgr | How should we treat them during COVID-19 pandemic? |
| cord-270951-6nq3jwgr | Should we fear for our psoriasis patients treated with biologicals? |
| cord-270951-6nq3jwgr | The facts during the third epidemic Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long- term immunosuppression Expressive suppression and negative affect, pathways of emotional dysregulation in psoriasis patients PSOCUBE, a multidimensional assessment of psoriasis patients as a both clinically/ practically sustainable and evidence- based algorithm COVID-19 and psoriasis: Should we fear for patients treated with biologics? |
| cord-270951-6nq3jwgr | The origin, transmission and clinical therapies on coronavirus disease 2019( COVID-19) outbreak-an update on the status Comment on"COVID-19 and psoriasis: is it time to limit treatment with immunosuppressants? |
| cord-270951-6nq3jwgr | What about patients with inflammatory conditions? |
| cord-270951-6nq3jwgr | from Wuhan, China Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center's observational study New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-277399-0w8is9xm | The effect of human chorionic gonadotropin- based hormonal therapy on intratesticular testosterone levels and spermatogonial DNA synthesis in men with non- obstructive azoospermia Optimization of spermatogenesis- regulating hormones in patients with non- obstructive azoospermia and its impact on sperm retrieval: a multicentre study Hormonal stimulation of spermatogenesis: a new way to treat the infertile male with non- obstructive azoospermia? |
| cord-277399-0w8is9xm | What is a clean room? |
| cord-277830-6fsz9iy7 | The InterPro Database, 2003 brings increased coverage and new features Refinement of macromolecular structures by the maximum- likelihood method SCOP: a structural classification of proteins database for the investigation of sequences and structures Processing of X- ray diffraction data collected in oscillation mode Sequence requirements for RNA strand transfer during nidovirus discontinuous subgenomic RNA synthesis Precise excision of intervening sequences from precursor tRNAs by a membrane- associated yeast endonuclease MacroH2A, a core histone containing a large nonhistone region Evolutionary conservation of histone macroH2A subtypes and domains Coronavirus as a possible cause of severe acute respiratory syndrome Pre- tRNA splicing: variation on a theme or exception to the rule? |
| cord-277313-5f5lrn3c | What are the risks of COVID-19 infection in pregnant women? |
| cord-277313-5f5lrn3c | What is SARS- CoV-2? |
| cord-275336-lnhkux0m | COVID-19 and molecular mimicry: the Columbus'egg? |
| cord-275336-lnhkux0m | Chlamydia trachomatis infection and anti- Hsp60 immunity: the two sides of the coin HSP60: a story as long as life on the earth Does SARS- CoV-2 trigger stress- induced autoimmunity by molecular mimicry? |
| cord-275336-lnhkux0m | I alleles are associated with peptide- binding repertoires of different size, affinity, and immunogenicity Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes Cytokine release syndrome in COVID-19 patients, a new scenario for an old concern: the fragile balance between infections and autoimmunity Sub- epitopic dissection of HCV E1 315- 328 HRMAWDMMMNWSPT sequence by similarity analysis COVID-19 deaths: are we sure it is pneumonia? |
| cord-275336-lnhkux0m | Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena? |
| cord-275336-lnhkux0m | the culprit in the autoimmune haemolytic anaemia affecting patients with COVID-19? |
| cord-278467-c0jw9dkw | What is a pandemic? |
| cord-275088-wbqznzj7 | A possible strategy for reducing SARS- COV-2 infectivity? |
| cord-275088-wbqznzj7 | Can siRNAs conquer SARS? |
| cord-275088-wbqznzj7 | Designing inhaled protein therapeutics for topical lung delivery: what are the next steps? |
| cord-275088-wbqznzj7 | Towards greener medical applications? |
| cord-278945-q5lzf5o4 | the trigger? |
| cord-277683-9cg90zbo | Since asthma 72 sufferers tend to be younger than those with other co- morbidities, is age a factor in explaining 73 why asthma patients may not be at greater risk? |
| cord-277683-9cg90zbo | What are the Important Questions? |
| cord-277309-kelebqr6 | : what can they teach us about the severe acute respiratory syndrome? |
| cord-277309-kelebqr6 | A comparison of bats and rodents as reservoirs of zoonotic viruses: are bats special? |
| cord-277309-kelebqr6 | Current Opinion in Virology 2019, 34:79- 89 Bats as a continuing source of emerging infections in humans Mass extinctions, biodiversity and mitochondrial function: are bats'special'as reservoirs for emerging viruses? |
| cord-279260-tdvb0fhv | The pathogenicity of SARS- CoV-2 in hACE2 transgenic mice Rapid generation of a mouse model for Middle East respiratory syndrome Correlates of protection induced by vaccination Correlates of protection to influenza virus, where do we go from here? |
| cord-276267-77903fld | The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single- cell transcriptomes Imbalance of the renin- angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target? |
| cord-276267-77903fld | The safety of vedolizumab for ulcerative colitis and Crohn's disease Differential expression of adhesion molecules and chemokines between nasal and small intestinal mucosae: implications for T- and sIgA+ B- lymphocyte recruitment Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial Herpes zoster infection in patients with ulcerative colitis receiving tofacitinib Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open- label, long- term extension study Tofacitinib as induction and maintenance therapy for ulcerative colitis Growing evidence of the safety of JAK inhibitors in patients with rheumatoid arthritis Real- world experience with tofacitinib in IBD at a Tertiary Center COVID-19: combining antiviral and anti- inflammatory treatments Guidance for discharge and ending isolation in the context of widespread community transmission of COVID-19-first update Infection- related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases Nonpharmaceutical measures for pandemic influenza in nonhealthcare settings- social distancing measures Effectiveness of workplace social distancing measures in reducing influenza transmission: a systematic review Virtually perfect? |
| cord-276267-77903fld | initial virological and clinical findings Treatment with lopinavir/ ritonavir or interferon- beta1b improves outcome of MERS- CoV infection in a nonhuman primate model of common marmoset A trial of lopinavir- ritonavir in adults hospitalized with severe Covid-19 New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-273828-557vlq9d | Are the liver parenchymal changes due to the systemic disease consequences or a direct effect of SARS- CoV-2? |
| cord-273828-557vlq9d | Are these abnormalities correlated with COVID-19 disease severity? |
| cord-273828-557vlq9d | Can increased serum aminotransferase levels reflect the degree of injury? |
| cord-273828-557vlq9d | May drug use for COVID-19 be the cause of liver injury? |
| cord-273828-557vlq9d | What can we affirm? |
| cord-273828-557vlq9d | What do histopathological findings suggest? |
| cord-273828-557vlq9d | What is the liver enzymes'curve and how often do they rise above the upper limit of normal( ULN) serum level? |
| cord-273828-557vlq9d | What is the liver injury frequency in cases with a severe course of disease with complications and death? |
| cord-276234-2nkeq4ud | Can the Coronavirus Disease 2019( COVID-19) Affect the Eyes? |
| cord-276234-2nkeq4ud | Do you show any of the following COVID-19 symptoms[ 39-42]? |
| cord-276234-2nkeq4ud | Have you travelled internationally within the last 14 days? |
| cord-276234-2nkeq4ud | Patients should be asked the following: ▪ Have you been in contact with people diagnosed with or showing symptoms of COVID-19 within the last 14 days? |
| cord-277076-yvsyo4l9 | Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets Bats, civets and the emergence of SARS Wet marketsÀA continuing source of severe acute respiratory syndrome and influenza? |
| cord-277076-yvsyo4l9 | Interest soon focused on these early index cases: was there any characteristic these patients had in common that could point to a source of their SARS- CoV infection? |
| cord-277076-yvsyo4l9 | Is the fact that the first pandemic of the twenty- first century was quickly contained reason to take comfort in the knowledge that the history of humankind has reached a phase in which biomedical sciences and information technology are able to deal with such threats? |
| cord-277076-yvsyo4l9 | The evolvability of emerging viruses Development of antiviral therapy for severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection Identification of a novel coronavirus in patients with severe acute respiratory syndrome Severe acute respiratory syndrome: Identification of the etiological agent Evaluation of advanced reverse transcription- PCR assays and an alternative PCR target region for detection of severe acute respiratory syndrome- associated coronavirus Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China Bats are natural reservoirs of SARS- like coronaviruses Viral zoonosesÀA threat under control? |
| cord-277585-evw3pu87 | Azithromycin induces anti- viral effects in cultured bronchial epithelial cells from COPD patients Is cellular senescence involved in cystic fibrosis? |
| cord-277585-evw3pu87 | Small extracellular vesicles deliver miR-21 and miR-217 as pro- senescence effectors to endothelial cells Senolytics improve physical function and increase lifespan in old age Exosome Biogenesis and Biological Function in Response to Viral Infections An antiviral defense that is tumor suppressive? |
| cord-278509-k62bsk9b | Two metres or one: what is the evidence for physical distancing in covid-19? |
| cord-278509-k62bsk9b | cord-278509-k62bsk9b authors: Manikandan, Natesan title: Are social distancing, hand washing and wearing masks can mitigate the transmission of COVID-19? |
| cord-275926-rj23z7po | Do you modify surgical indications if the patient is nCoV positive for non- emergency surgery( e.g. chronic subdural hematoma, tumors?) |
| cord-275926-rj23z7po | May we deliver neuro- oncology in difficult times( e.g. COVID-19)? |
| cord-275926-rj23z7po | Part of the Disease? |
| cord-275926-rj23z7po | you modify your modus operandi in treating aneurysmal subarachnoid hemorrhage? |
| cord-279750-if9vphb2 | Aneurysmal subarachnoid hemorrhage in a SARS- CoV-2 positive testing: casual or causal? |
| cord-278540-gy65bvot | The NLRP3 inflammasome: a sensor for metabolic danger? |
| cord-278540-gy65bvot | activation in bronchial cells Antioxidant properties of MitoTEMPOL and its hydroxylamine NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? |
| cord-279363-4almssg6 | What we know? |
| cord-277679-sc9hugxr | Imaging of acute disseminated encephalomyelitis COVID-19: consider cytokine storm syndromes and immunosuppression Why now? |
| cord-277679-sc9hugxr | the beginning of another SARS- like pandemic? |
| cord-279132-florvm7z | A Bayesian approach for monitoring epidemics in presence of undetected cases Using the COVID-19 to influenza ratio to estimate early pandemic spread in Wuhan, China and Seattle Time series modelling to forecast the confirmed and recovered cases of COVID-19 Forecasting the patterns of COVID-19 and causal impacts of lockdown in top five affected countries using Bayesian Structural Time Series Models Was school closure effective in mitigating coronavirus disease 2019( COVID-19)? |
| cord-279132-florvm7z | Why is it difficult to accurately predict the COVID-19 epidemic? |
| cord-279754-95zawygq | : what did we do and what have we learned? |
| cord-278406-n5e3a09i | At the"heart"of COVID-19 is a lung disease, and a question that has still not been raised often enough is: what exactly is the nature of the lung disease caused by SARS- CoV-2? |
| cord-278406-n5e3a09i | More specifically, when progression to lung involvement appears, what would one see under the microscope in a section of lung tissue? |
| cord-278939-z6kiee09 | Can Chinese medicine be used for prevention of corona virus disease 2019( COVID-19)? |
| cord-279435-ffgd2ets | Emerg Infect Dis Can the coronavirus disease 2019( COVID-19) affect the eyes? |
| cord-279691-v5kpmk0b | How are the nsps of CoVs able to induce the observed membrane rearrangements? |
| cord-278370-fuu20ae7 | Guillain- Barré syndrome related to COVID-19 infection Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-278370-fuu20ae7 | Should we expect neurological symptoms in the SARS- CoV-2 epidemic? |
| cord-279932-bilr71ay | ( SARS- CoV-2) is protective, and thus to accelerate its use? |
| cord-280029-g1k3zlax | COVID-19: what is next for public health? |
| cord-278182-75u57fw1 | Predicting binding regions within disordered proteins Sequence complexity of disordered protein Mining alpha- helix- forming molecular recognition features with cross species sequence alignments Coupled folding and binding with alpha- helix- forming molecular recognition elements Viral disorder or disordered viruses: do viral proteins possess unique features? |
| cord-278182-75u57fw1 | Since both SARS- CoV and SARS- CoV-2 have intermediate respiratory transmission potentials, how do we account for the greater contagiousness of the latter? |
| cord-278182-75u57fw1 | Why are"natively unfolded"proteins unstructured under the physiological conditions? |
| cord-279443-2e4gz2bo | The role of the nsp2 and nsp3 in its pathogenesis Nsp3 of coronaviruses: structures and functions of a large multi- domain protein On the origin and continuing evolution of SARS- CoV-2 Are pangolins the intermediate host of the 2019 novel coronavirus( SARS- CoV-2)? |
| cord-279443-2e4gz2bo | Why tocilizumab could be an effective treatment for severe COVID-19? |
| cord-275979-cx2h5bsw | A case- control study Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis SGLT-2 inhibitors for COVID-19-a miracle waiting to happen or just another beat around the bush? |
| cord-275979-cx2h5bsw | A thorough description of the clinical characteristics and their impact on outcome of patients with diabetes mellitus and COVID-19 Obesity aggravates COVID-19: a systematic review and meta- analysis Two things about COVID-19 might need attention Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: role of epigenetic histone modifications Endothelial cell dysfunction and the pathobiology of atherosclerosis Are certain drugs associated with enhanced mortality in COVID-19? |
| cord-275979-cx2h5bsw | A very interesting comprehensive analysis of the pathomechanisms of COVID-19, also discussing its clinical implication What's new in the renin- angiotensin system? |
| cord-275979-cx2h5bsw | CARDIOVID registry Association of angiotensin- converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality Is the use of ACE inb/ ARBs associated with higher in- hospital mortality in Covid-19 pneumonia patients? |
| cord-275979-cx2h5bsw | The role of physical activity in primary stroke prevention Does high cardiorespiratory fitness confer some protection against pro- inflammatory responses after infection by SARS- CoV-2? |
| cord-279629-t1xjy12y | An evolutionary RGD motif in the spike protein of SARS- CoV-2 may serve as a potential high risk factor for virus infection? |
| cord-279629-t1xjy12y | When will a coronavirus vaccine be ready?". |
| cord-280172-6o1gqe8v | How good is automated protein docking? |
| cord-277539-xt2nt11e | A systematic review of the effect of different models of after- hours primary medical care services on clinical outcome, medical workload, and patient and GP satisfaction Guidelines for dental care Provision during the COVID-19 pandemic Characteristics of endodontic emergencies during Covid-19 Outbreak IN Wuhan Could air filtration reduce COVID-19 severity and spread? |
| cord-277539-xt2nt11e | Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-277539-xt2nt11e | Can we contain the COVID-19 outbreak with the same measures as for SARS? |
| cord-277539-xt2nt11e | medRxiv 2020.04.16 COVID-19 patients with respiratory failure: what can we learn from aviation medicine? |
| cord-280062-1qrav1d5 | COVID-19 meets Cystic Fibrosis: for better or worse? |
| cord-274097-11hvriqy | 23 Would the clinical picture resemble that of respiratory infection when parenterally transmitted? |
| cord-274097-11hvriqy | But what is our index of suspicion for recognition of TTD? |
| cord-274097-11hvriqy | COVID-19: what proportion are asymptomatic? |
| cord-274097-11hvriqy | Can we mine the electronic medical records of hospitalized COVID-19 patients and appropriate controls in high- incidence communities for a history of recent transfusion? |
| cord-274097-11hvriqy | How would we recognize it if it happened in the face of exponentially increasing caseloads in stressed acute health care venues? |
| cord-274097-11hvriqy | Is SARS‐CoV‐2 transfusion transmitted? |
| cord-274097-11hvriqy | So, what are our options? |
| cord-274097-11hvriqy | When there is no statistical association of transfusion with SARS- CoV infection would such information suffice to"prove"the negative? |
| cord-274097-11hvriqy | Would it enhance our approach to donor call- back for development of illness from 2 to 4 days to longer? |
| cord-279989-swsxez0a | COVID-19 or clozapine induced? |
| cord-280662-gakayv6e | an update on mechanisms of physiology and pathophysiology Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-277260-7se220oz | COVID-19 and surgery Timing of breast cancer surgery- how much does it matter? |
| cord-277260-7se220oz | Could intravenous immunoglobulin collected from recovered coronavirus patients protect against COVID-19 and strengthen the immune system of new patients? |
| cord-277260-7se220oz | TMPRSS2 CD24 and Fc fusion protein protects SIVmac239-infected Chinese rhesus macaque against progression to AIDS Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an openlabel non- randomized clinical trial Should chloroquine and hydroxychloroquine be used to treat COVID-19? |
| cord-277260-7se220oz | a case series Is there a role for tissue plasminogen activator( tPA) as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome( ARDS)? |
| cord-277260-7se220oz | an opportunity for combination with cytokines? |
| cord-278260-3o91v72a | 19 vaccines sensitize humans to antibody dependent enhanced( ADE) breakthrough infections? |
| cord-278260-3o91v72a | : Should we fear ADE? |
| cord-278618-7tu5c7m1 | The important issues of clinical relevance that remain to be addressed are: what is the infective dose to contaminate a person by inhalation? |
| cord-278618-7tu5c7m1 | What is the impact of air ventilation on indoor contamination during the patient hospitalization? |
| cord-278618-7tu5c7m1 | title: Sustainability of SARS- CoV-2 in aerosols: Should we worry about airborne transmission? |
| cord-280043-bm0qkrod | A novel coronavirus from patients with pneumonia in China Clinical features of patients infected with 2019 novel coronavirus in Wuhan Characteristics of and important lessons from the Coronavirus Disease 2019( COVID-19) outbreak in China: summary of a report of 72314 cases from the chinese center for disease control and prevention Clinical characteristics of Coronavirus disease 2019 in China Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirusinfected pneumonia in Wuhan, China Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis Understanding of COVID-19 based on current evidence Recommendations for the prevention, mitigation and containment of the emerging SARS- CoV-2( COVID-19) pandemic in haemodialysis centres Use of population- based data to demonstrate how waitlist- based metrics overestimate geographic disparities in access to liver transplant care Prevention of SARS- CoV-2 infection in patients with decompensated cirrhosis People Who Are at Higher Risk for Severe Illness COVID-19 in solid organ transplant recipients: a single- center case series from Spain Coronavirus Disease 2019 pneumonia in immunosuppressed renal transplant recipients: a summary of 10 confirmed cases in Wuhan, China Early description of Coronavirus 2019 disease in kidney transplant recipients in New York COVID-19 in solid organ transplant recipients: initial report from the US epicenter Covid-19 and kidney transplantation Health status of liver transplanted patients during the coronavirus outbreak in Italy: a large single center experience from milan RNA respiratory viral infections in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long- term immunosuppression Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation? |
| cord-280043-bm0qkrod | a case report COVID-19: consider cytokine storm syndromes and immunosuppression COVID-19 in long- term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy COVID-19 and calcineurin inhibitors: should they get left out in the storm? |
| cord-278271-rpq62xhl | A preliminary investigation on the serological and epidemiological characteristics of severe acute respiratory syndrome in children Detection and analysis of SARS coronavirus- specific antibodies in sera from non- SARS children Serological analysis of SARS Coronavirus in children diagnosed clinically as severe acute respiratory syndrome cases during SARS epidemic in Beijing New research from scientific research unit shows that SARS antibodies are found in 40% of children Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China Structure, Function, and Antigenicity of the SARS- CoV-2 Spike Glycoprotein Exploring preventive measures for COVID-19 based on the existing virus vaccines( in Chinese, Epub ahead of print TB vaccine steel the immune system against the new coronavirus? |
| cord-278271-rpq62xhl | Reflection on lower rates of COVID-19 in children: does childhood immunizations offer unexpected protection? |
| cord-278271-rpq62xhl | Whether the relatively weak function or low expression of ACE2 receptor in children leads to the limited invasion pathway of the virus? |
| cord-279290-wtnnlp4i | A novel coronavirus from patients with pneumonia in China Pituitary macroadenoma apoplexy in a severe acute respiratory syndrome- coronavirus-2-positive testing: Causal or casual? |
| cord-279290-wtnnlp4i | Causal or casual? |
| cord-279290-wtnnlp4i | Neurological complications due to coronavirus and COVID-19 Autonomic brain centers and pathophysiology of COVID-19 Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-280280-9jr7ekbu | Diagnosis, Treatment and Prevention Options in Children Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus Coronavirus Disease 2019 in Critically Ill Children: A Narrative Review of the Literature Epidemiology and clinical features of coronavirus disease 2019 in children COVID-19 virus and children: What do we know? |
| cord-278721-g5zqebju | : What Is the Evidence? |
| cord-278721-g5zqebju | Is COVID-19 an Endothelial Disease? |
| cord-278721-g5zqebju | what next? |
| cord-277889-8u685f45 | Could myo- inositol treatment downregulate inflammation and cytokine release syndrome in SARS- CoV-2? |
| cord-277889-8u685f45 | The IL-17 Family of Cytokines in Health and Disease Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus Distinct immune response in two MERS- CoV- infected patients: can we go from bench to bedside? |
| cord-277889-8u685f45 | odd one out or part of the family? |
| cord-277889-8u685f45 | r o o f amplified? |
| cord-281005-6gi18vka | Why are RNA virus mutation rates so damn high? |
| cord-278649-ge9ike2c | The text message read:"Has your sense of smell or taste reduced in the last month? |
| cord-278649-ge9ike2c | This included the question"Do you have a loss of smell/ taste?". |
| cord-278649-ge9ike2c | Why was this study done? |
| cord-277529-z2r14w2k | Anti- IL1 treatment in colchicine- resistant paediatric FMF patients: real life data from the HELIOS registry Repositioning PARP inhibitors for SARS- CoV-2 infection( COVID-19); a new multi- pronged therapy for ARDS? |
| cord-277529-z2r14w2k | Cytokine and anticytokine interventions Colchicine may not be effective in COVID-19 infection; it may even be harmful? |
| cord-277529-z2r14w2k | Lapping or biting? |
| cord-277529-z2r14w2k | Should we stimulate or suppress immune responses in COVID-19? |
| cord-277529-z2r14w2k | cord-277529-z2r14w2k authors: Stella, Alessandro; Lamkanfi, Mohamed; Portincasa, Piero title: Familial Mediterranean Fever and COVID-19: Friends or Foes? |
| cord-281393-96j70n2z | a population- based study Are SARS- CoV-2 seroprevalence estimates biased? |
| cord-280819-z6ucnwk0 | New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-276013-8dhqa2gj | A role for CT in COVID-19? |
| cord-276013-8dhqa2gj | Pneumonia associated with 2019 novel coronavirus: can computed tomographic findings help predict the prognosis of the disease? |
| cord-276013-8dhqa2gj | The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/ β1 heterodimer Teicoplanin: an alternative drug for the treatment of COVID-19? |
| cord-276013-8dhqa2gj | What data really tell us so far Chest CT findings in 2019 novel coronavirus( 2019-nCoV) infections from Wuhan, China: key points for the radiologist Outbreak of novel coronavirus( COVID-19): what is the role of radiologists? |
| cord-276013-8dhqa2gj | a recent recombination event Emergence of SARS- like coronavirus poses new challenge in China Early transmission dynamics in Wuhan, China, of novel coronavirus- infected pneumonia 2019-nCoV transmission through the ocular surface must not be ignored The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single- cell transcriptomes COVID-19: faecal- oral transmission? |
| cord-276013-8dhqa2gj | the beginning of another SARS- like pandemic? |
| cord-281161-u896icp9 | Any future? |
| cord-279642-0j5828ah | Are patients with hypertension and diabetes mellitus at increased 251 risk for COVID-19 infection? |
| cord-279642-0j5828ah | COVID-19 and angiotensin- converting enzyme inhibitors and angiotensin 249 receptor blockers: What is the evidence? |
| cord-279642-0j5828ah | The Pharmacological Basis of Therapeutics Are all angiotensin- converting enzyme inhibitors interchangeable? |
| cord-281285-5g1rw202 | SARS- CoV-2, ACE2, and hydroxychloroquine: cardiovascular complications, therapeutics, and clinical readouts in the current settings Chloroquine or hydroxychloroquine for COVID-19: is cardiotoxicity a concern? |
| cord-281551-0aj2zwx8 | It is unknown whether or not those second waves will occur and if they do, will they occur in persons who have already been exposed to the SARS- CoV-2 virus or in naïve persons? |
| cord-280970-gy0kfhy6 | COVID-19: too little, too late? |
| cord-280970-gy0kfhy6 | What to do next to control the 2019-nCoV epidemic? |
| cord-270866-olc5r2yx | A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis? |
| cord-270866-olc5r2yx | An update of a meta- analysis Changes in Gambling Behavior during the COVID-19 Pandemic- A Web Survey Study in Sweden Gambling during the COVID-19 crisis-A cause for concern? |
| cord-270866-olc5r2yx | Do smokers of specialty and conventional cigarettes differ in their dependence on nicotine? |
| cord-270866-olc5r2yx | Has there been an increased interest in smoking cessation during the first months of the COVID-19 pandemic? |
| cord-270866-olc5r2yx | Mild but prolonged elevation of serum angiotensin converting enzyme( ACE) activity in alcoholics Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population?: |
| cord-270866-olc5r2yx | Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? |
| cord-270866-olc5r2yx | The Need for Prevention and Early Intervention Who smokes in Europe? |
| cord-270866-olc5r2yx | The use of significance testing leads to an erroneous conclusion Public health concerns and unsubstantiated claims at the intersection of vaping and COVID-19 Mitigating and learning from the impact of COVID-19 infection on addictive disorders Which lessons shall we learn from the 2019 novel coronavirus outbreak? |
| cord-270866-olc5r2yx | Use Look Like During the COVID-19 Pandemic? |
| cord-270866-olc5r2yx | Will the Current COVID-19 Pandemic Impact on Long- Term Cannabis Buying Practices? |
| cord-281248-z2gisufl | The Missing Link? |
| cord-279001-l5ogbl5p | : cord-279001-l5ogbl5p authors: Wilder- Smith, Annelies; Chiew, Calvin J; Lee, Vernon J title: Can we contain the COVID-19 outbreak with the same measures as for SARS? |
| cord-279001-l5ogbl5p | Can COVID19 be controlled by these same measures? |
| cord-279001-l5ogbl5p | So why have the case numbers of COVID19 already surpassed those of SARS by Jan 30, 2020? |
| cord-280922-w6a5ec06 | May Cause False- Positive Results in Serological Assays EF- Tu binding peptides identified, dissected, and affinity optimized by phage display Virus Bioresistor( VBR) for Detection of Bladder Cancer Marker DJ-1 in Urine at 10 pM in One Minute Heat Inactivation of Different Types of SARS- CoV-2 Samples: What Protocols for Biosafety, Molecular Detection and Serological Diagnostics? |
| cord-280922-w6a5ec06 | Which Cytokine to Target in a Raging Storm? |
| cord-280671-0b1qcdwk | Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? |
| cord-280671-0b1qcdwk | title: Selective Estrogen Receptor Modulators in COVID-19: A Possible Therapeutic Option? |
| cord-281686-edpyn8fd | : cord-281686-edpyn8fd authors: Dalamaga, Maria; Karampela, Irene; Mantzoros, Christos S. title: 19 treatment regimens? |
| cord-280350-ay4cnzn5 | : what have we learned? |
| cord-280350-ay4cnzn5 | Antiviral or proviral action of mycophenolic acid in hepatitis B infection? |
| cord-280350-ay4cnzn5 | Bioequivalence of enteric- coated mycophenolate sodium and mycophenolate mofetil: a metaanalysis of three studies in stable renal transplant recipients Ribavirin in the treatment of SARS: a new trick for an old bug? |
| cord-282058-it0ojdk3 | What are the risks of COVID-19 infection in pregnant women? |
| cord-281754-auqh3vtr | Threat under Control? |
| cord-281561-r10y2sgb | : what's next? |
| cord-281106-vzb5xzza | Is the recommendation to use highdose heparin for thromboprophylaxis justified? |
| cord-281106-vzb5xzza | Pulmonary embolism or pulmonary thrombosis in COVID-19? |
| cord-280528-7ivw72l0 | Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome Regulatory T cells in arterivirus and coronavirus infections: do they protect against disease or enhance it? |
| cord-280528-7ivw72l0 | The Lancet TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib Mavrilimumab: a unique insight and update on the current status in the treatment of rheumatoid arthritis Associations between immune- suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence Treatment outcomes for patients with Middle Eastern respiratory syndrome coronavirus( MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia Safety of Ibuprofen in Patients with COVID-19: causal or confounded? |
| cord-277669-uujny2dm | A Potential Approach for Coronavirus Infection Therapy? |
| cord-277669-uujny2dm | COVID-19 and Cardiovascular Disease: From Basic Mechanisms to Clinical Perspectives Macrophages: A Trojan Horse in COVID-19? |
| cord-277669-uujny2dm | Turk Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS- CoV-2 in Covid-19: Key Therapeutic Targets? |
| cord-277669-uujny2dm | an Angiotensin II Receptor Blocker Are Patients With Hypertension and Diabetes Mellitus at Increased Risk for COVID-19 Infection? |
| cord-277669-uujny2dm | to Prevent Lung Damage in SARS- CoV-2 Infection? |
| cord-280068-rszu1c48 | /CD147 as a direct SARS- CoV-2 spike binding receptor Vanderbilt HiJAKing SARS- CoV-2? |
| cord-280068-rszu1c48 | Roche provides an update on the phase III COVACTA trial of Actemra/ RoActemra in hospitalised patients with severe COVID-19 associated pneumonia Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS- CoV-2 in Covid-19: Key Therapeutic Targets? |
| cord-280068-rszu1c48 | the Common Denominator? |
| cord-281679-xmbnpawj | Emerg Infect Dis Is COVID-19 the first pandemic that evolves into a panzootic? |
| cord-281679-xmbnpawj | a Neglected Transmission Route of SARS- CoV-2? |
| cord-282750-d9sb7o63 | Results from the phase III, double- blinded, placebo- and active comparator- controlled VOYAGE 1 trial COVID-19: risk for cytokine targeting in chronic inflammatory diseases? |
| cord-281281-knelqmzx | A fight for supremacy Type 1 interferons and the virus- host relationship: A lesson in détente Viruses and Interferons Recent insights into emerging coronaviruses Clinical characteristics of coronavirus disease 2019 in China Coronavirus infections and immune responses Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis Complement as a target in COVID-19? |
| cord-281281-knelqmzx | Should we stimulate or suppress immune responses in COVID-19? |
| cord-282449-7mxp3sdy | : Should We Worry? |
| cord-281113-t450ccnq | Breath tests for gastrointestinal disease: the real deal or just a lot of hot air? |
| cord-281113-t450ccnq | Breath tests for gastrointestinal diseases- will it be safe to conduct breath tests after the COVID-19 pandemic? |
| cord-279940-i2rgjpxf | In conclusion, if an increase in HEME production pathway brings increased precursor synthesis, could we routinely dose marker for lead exposure or porphyria, such as serum porphobilinogen and aminolaevulinic acid, as biomarkers in the stages of infection? |
| cord-279940-i2rgjpxf | Will complement inhibition be the new target in treating COVID-19 related systemic thrombosis? |
| cord-279940-i2rgjpxf | key: cord-279940-i2rgjpxf authors: Comentale, Giuseppe; Manzo, Rachele; Pilato, Emanuele title: Sars- Cov-2 interference in HEME production: is it the time for an early predictive biomarker? |
| cord-267397-b7ogeokm | : Was the newborn isolated away from mother in another area in hospital( postnatal ward, special care nursery, NICU or special ward)? |
| cord-267397-b7ogeokm | A Review of International Registries Can SARS- CoV-2 Infection Be Acquired In Utero?: |
| cord-267397-b7ogeokm | Any congenital anomalies in the record? |
| cord-267397-b7ogeokm | Core Variables, Prospective Meta- Analyses for Perinatal COVID-19 Version Date: 08-NOV-20 of birth? |
| cord-267397-b7ogeokm | If answer"Yes"to Q12": What was the date of ICU admission/ critical care? |
| cord-267397-b7ogeokm | If answer"Yes"to Q8": Was the mother admitted to an intensive care unit( ICU) or administered critical care for COVID-19? |
| cord-267397-b7ogeokm | If answer"Yes"to Q8": What was the date of ICU discharge/ end of critical care? |
| cord-267397-b7ogeokm | If answer"Yes"to Q8": What was the date of hospital discharge? |
| cord-267397-b7ogeokm | If answer"Yes"to Q8": what was the respiratory status of the patient while hospitalized? |
| cord-267397-b7ogeokm | If answered"Yes"to Q1: • Date- time of neonatal/ infant death? |
| cord-267397-b7ogeokm | If diagnosed as a probable COVID-19 case, by which criteria was diagnosis made? |
| cord-267397-b7ogeokm | If diagnosed as a probable COVID-19 case, by which criteria where you diagnosed? |
| cord-267397-b7ogeokm | If diagnosed as a probable COVID-19 case, by which criteria where you diagnosed? |
| cord-267397-b7ogeokm | Neonatal/ infant death? |
| cord-267397-b7ogeokm | Was the patient admitted to an intensive care unit( ICU) or administered critical care for COVID-19? |
| cord-267397-b7ogeokm | What was the date of ICU admission/ critical care? |
| cord-267397-b7ogeokm | What was the date of ICU discharge/ end of critical care? |
| cord-267397-b7ogeokm | What was the date of hospital discharge? |
| cord-267397-b7ogeokm | Which studies should harmonize data? |
| cord-279131-1unb0z79 | Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents Heparin and modified heparin inhibit complement activation in vivo Complement as a target in COVID-19? |
| cord-279131-1unb0z79 | True receptors or adaptation bias? |
| cord-279131-1unb0z79 | Will Complement Inhibition be the new target in treating COVID-19 related systemic thrombosis? |
| cord-281512-79g22dk6 | Are Bats Special? |
| cord-281512-79g22dk6 | As the world continues to struggle with the unprecedented ramifications of COVID-19, two central questions are being asked: Where did this novel virus come from and how can we prevent future pandemics? |
| cord-281501-ca9oxl7f | Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy Guillain- Barré syndrome associated with SARS- CoV-2 Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin- converting enzyme 2 virus receptor Objective evaluation of anosmia and ageusia in COVID-19 patients: single- center experience on 72 cases Structural and functional basis of SARS- CoV-2 entry by using human ACE2 Potential neurological symptoms of COVID-19 SARS- CoV-2 and stroke in a new york healthcare system Association of chemosensory dysfunction and covid-19 in patients presenting with influenza- like symptoms Concomitant neurological symptoms observed in a patient diagnosed with coronavirus disease 2019 Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-281501-ca9oxl7f | Can the enteric nervous system be an alternative entrance door in SARS- CoV2 neuroinvasion? |
| cord-281501-ca9oxl7f | causative or coincidental? |
| cord-280996-anq680a1 | Can high- flow nasal cannula reduce the rate of endotracheal intubation in adult patients with acute respiratory failure compared with conventional oxygen therapy and noninvasive positive pressure ventilation? |
| cord-280996-anq680a1 | Using a human patient simulator programmed to different severities of lung injury in a negative pressure room with 20? |
| cord-280996-anq680a1 | Why did outbreaks of severe acute respiratory syndrome occur in some hospital wards but not in others? |
| cord-283152-wav0d0ws | The FDA- approved drug ivermectin inhibits the replication of SARS- CoV-2 in vitro Coronavirus disease( COVID-19): a primer for emergency physicians New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-283193-8qj41kpp | increases the 714 risk of secondary infections and ARDS in hospitalized patients with COVID-19: coincidence or 715 underestimated risk factor? |
| cord-280231-jo3grxd5 | COVID-19-associated nephritis: early warning for disease severity and complications? |
| cord-280231-jo3grxd5 | Can the history of Arrowsmith help us further? |
| cord-280231-jo3grxd5 | Finally, are disease- specific treatment modalities for those requiring renal replacement therapies indicated? |
| cord-280231-jo3grxd5 | The question remains whether or not Covid-19 renal disease is specific? |
| cord-281726-s1o5l7ns | Were there any alternative explanations for the particular pattern of distribution? |
| cord-282920-s4yixzuy | Can SARS- CoV-2 infection be acquired in utero? |
| cord-282571-ilf73g71 | Di Yi Jun Yi Da Xue Xue Bao Neutralization of SARS- CoV-2 spike pseudotyped virus by recombinant ACE2-Ig Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus- specific human monoclonal antibody A hexapeptide of the receptor- binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2 Effect of angiotensin- converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin- converting enzyme 2 Angiotensin receptor blockers as tentative SARS- CoV-2 therapeutics Angiotensin II receptor blocker as a novel therapy in acute lung injury induced by avian influenza A H5N1 virus infection in mouse Population- based study of statins, angiotensin II receptor blockers, and angiotensin- converting enzyme inhibitors on pneumonia- related outcomes Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-276481-os1nf3cs | Do you think whether you are likely to be infected with SARS in this hospital? cord-276481-os1nf3cs There was a question asking whether the information about SARS infection management in the unit assuaged the respondent's fear of SARS infection control in the hospital:"Was this information about the unit useful to alleviate your fears about SARS infection control in this hospital after you read it?" |
| cord-276481-os1nf3cs | There was one question asking respondents'fear of death from SARS infection as the perceived severity:Do you fear death from SARS? |
| cord-276481-os1nf3cs | How can we improve the quality of health care in Japan? |
| cord-276481-os1nf3cs | There was one question asking intention of outpatient visits when a SARS patient was admitted to the hospital:"When a SARS patient is admitted to this hospital, do you intend to continue outpatient visits to this hospital? |
| cord-276481-os1nf3cs | There were two questions asking about perceived knowledge about the likelihood of SARS infection by direct infection or indirect infection:"Do you suppose that SARS is likely to be transmitted by exposure of respiratory secretions from SARS patients?" |
| cord-276481-os1nf3cs | and"Do you suppose that SARS is likely to be transmitted by surface contamination by touching a handrail? |
| cord-281619-fhyamruq | A major question remains to be addressed, though: why only a percentage of severe COVID-19 patients develop thrombosis, despite the disease's proven hypercoagulable state? |
| cord-281619-fhyamruq | Are Preexisting Thrombophilic Risk Profiles Responsible for Heterogenous Thrombotic Events? |
| cord-283705-ia65pade | pour la grippe, les mêmes questions se posent pour le SARS- CoV2: détecter de l'ARN viral est- il synonyme de contagiosité? |
| cord-018460-wbtaoo0o | ( Reversibility:?) |
| cord-018460-wbtaoo0o | ( Reversibility:?) |
| cord-018460-wbtaoo0o | ( Reversibility:?) |
| cord-018460-wbtaoo0o | ( Reversibility:?) |
| cord-018460-wbtaoo0o | ( Reversibility:?) |
| cord-018460-wbtaoo0o | ( Reversibility:?) |
| cord-018460-wbtaoo0o | ( Reversibility:?) |
| cord-018460-wbtaoo0o | ( Reversibility:?) |
| cord-018460-wbtaoo0o | ( Reversibility:?) |
| cord-018460-wbtaoo0o | ( Reversibility:?) |
| cord-018460-wbtaoo0o | ( Reversibility:?) |
| cord-018460-wbtaoo0o | ( Reversibility:?) |
| cord-018460-wbtaoo0o | ( Reversibility:?) |
| cord-018460-wbtaoo0o | ( Reversibility:?) |
| cord-018460-wbtaoo0o | ( Reversibility:?) |
| cord-018460-wbtaoo0o | ( Reversibility:?) |
| cord-018460-wbtaoo0o | ( Reversibility:?) |
| cord-018460-wbtaoo0o | ( Reversibility:?) |
| cord-018460-wbtaoo0o | ( Reversibility:?) |
| cord-018460-wbtaoo0o | ( Reversibility:?) |
| cord-018460-wbtaoo0o | ( Reversibility:?) |
| cord-018460-wbtaoo0o | ( Reversibility:?) |
| cord-018460-wbtaoo0o | ( Reversibility:?) |
| cord-018460-wbtaoo0o | ( Reversibility:?) |
| cord-018460-wbtaoo0o | ( Reversibility:?) |
| cord-018460-wbtaoo0o | ( Reversibility:?) |
| cord-018460-wbtaoo0o | ( Reversibility:?) |
| cord-018460-wbtaoo0o | ( Reversibility:?) |
| cord-018460-wbtaoo0o | [ 28] P? |
| cord-018460-wbtaoo0o | [ 31, 42, 49] P? Substrates and products S( Ala- Arg- Leu- Gln- NH) 2[ 15] P AAVLQ+ SGF- NH |
| cord-018460-wbtaoo0o | [ 31] P? |
| cord-018460-wbtaoo0o | [ 31] P? |
| cord-018460-wbtaoo0o | [ 6, 7, 27, 31, 33, 42, 49] P? |
| cord-018460-wbtaoo0o | mutant is present almost exclusively in the monomeric form Structure of the SARS coronavirus main proteinase as an active C2 crystallographic dimer Old drugs as lead compounds for a new disease? |
| cord-279180-xad53zht | How does the Aarogya Setu app work? |
| cord-279180-xad53zht | How is COVID-19 impacting the environment around us? |
| cord-279180-xad53zht | Official site of Immuni app Increase of online usage( 2020) Are gamers breaking the internet during quarantine? |
| cord-279180-xad53zht | What is the probability of the ineffectiveness of a medication for a specific person or group? |
| cord-279180-xad53zht | What is the risk of extreme COVID-19 symptoms or complications requiring hospitalization or intensive care of a specific patient or group? |
| cord-279180-xad53zht | What is the risk of having COVID-19 for a specific person or group? |
| cord-283376-6wolrfvk | What are the risks of COVID-19 infection in pregnant women? |
| cord-282732-qym6wji7 | A Distinct Entity? |
| cord-282732-qym6wji7 | Jindrich title: COVID-19-Related Coagulopathy — Is Transferrin a Missing Link? |
| cord-282043-cs1oyohu | Inflammasome activation and IL-1beta and IL-18 processing during infection Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? |
| cord-282043-cs1oyohu | a meta- analysis of more than 20 000 patients Multifaceted effects of hydroxychloroquine in human disease Acute pulmonary embolism and COVID-19 pneumonia: a random association? |
| cord-282858-zikoui4h | as Compared with SARS- CoV-1 Is the coronavirus airborne? |
| cord-281684-m3m4mhye | A SARS- CoV-2 infection model in mice demonstrates protection by neutralizing antibodies Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS- CoV-2 in golden Syrian hamsters Identification of oxidative stress and Toll- like receptor 4 signaling as a key pathway of acute lung injury SARS- CoV-2 and myocardial injury: a role for Nox2? |
| cord-281684-m3m4mhye | Prospects for the use of regulators of oxidative stress in the comprehensive treatment of the novel Coronavirus Disease 2019( COVID-19) and its complications Is macrophages heterogeneity important in determining COVID-19 lethality? |
| cord-283116-ib5c3lbi | The experience of the 2003 SARS outbreak as a traumatic stress among frontline healthcare workers in Toronto: lessons learnt Risk perception and impact of Severe Acute Respiratory Syndrome( SARS) on work and personal lives of healthcare workers in Singapore: what can we learn? |
| cord-283116-ib5c3lbi | What lessons can we learn from SARS? |
| cord-281793-tj4m01s4 | Could such antibodies be cross- reactive with other SARS- related CoVs( SARSr- CoVs)? |
| cord-281793-tj4m01s4 | Could such cross- reactive antibodies have neutralizing activities for all SARSr- CoVs? |
| cord-281793-tj4m01s4 | What would be ideal targets or epitopes for cross- neutralizing antibodies? |
| cord-282133-5dzzm9s8 | Can atmospheric pollution be considered a cofactor in extremely high level of SARS- CoV-2 lethality in Northern Italy? |
| cord-282133-5dzzm9s8 | Characterization of spike glycoprotein of SARS- CoV-2 on virus entry and its immune cross- reactivity with SARS- CoV Air Pollution, Autophagy, and Skin Aging: Impact of Particulate Matter( PM10) on Human Dermal Fibroblasts Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein COVID-19, SARS and MERS: are they closely related? |
| cord-282133-5dzzm9s8 | nitrogen dioxide( NO2) levels as a contributing factor to coronavirus( COVID-19) fatality Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population? |
| cord-280774-r2xm164s | A case report with histopathologic findings COVID-19 a proteiform disease inducing also molecular mimicry phenomena? |
| cord-280774-r2xm164s | The Columbus'egg? |
| cord-280774-r2xm164s | Why some children who come into contact with the SARS- CoV-2 do not develop striking respiratory symptoms but present pernio- like lesions with negativity on diagnostic tests? |
| cord-283948-rb9rrkxb | what lessons have we learned? |
| cord-283310-5wam14aa | Can you catch the coronavirus twice? |
| cord-283138-18q23z8l | Why is COVID-19 so mild in children? |
| cord-283138-18q23z8l | the population dynamics of influenza and the common cold Are children less susceptible to COVID-19? |
| cord-284302-odvv2yn3 | Checklist for hospitals preparing for the reception and care of coronavirus Implementation of an organizational infrastructure paediatric plan adapted to bronchiolitis epidemics Preparedness planning for pandemic influenza among large US maternity hospitals Pediatric Hospital Medicine Management, Staffing, and well- being in the face of COVID-19 How Should U.S. Hospitals prepare for coronavirus disease 2019( COVID-19)? |
| cord-284008-vlwdtjbe | What are the positive effects of corticosteroids? |
| cord-282317-k9mtf6yl | Glycyrrhizin, an active component of liquorice roots, and replication of SARS- associated coronavirus Responding to Covid-19-a once- in- a- century pandemic? |
| cord-282317-k9mtf6yl | How will country- based mitigation measures influence the course of the COVID-19 epidemic? |
| cord-282771-iwpx02v3 | Science Is the coronavirus airborne? |
| cord-284398-rhfwbyav | What does the coronavirus mean for the U.S. health care system? |
| cord-283491-y6t64pux | How good are my data and what is the resolution? |
| cord-282867-kbyxdegu | How should the rehabilitation community prepare for 2019-nCoV? |
| cord-280003-ndpuezpo | Are there any meaningful differences between patients with short and long incubation period? |
| cord-280003-ndpuezpo | How many patients would raise antibody response and how long will the antibody convert to be positive since the exposure? |
| cord-280003-ndpuezpo | Is there any temporal association between the antibody response and the decline of viral load? |
| cord-280003-ndpuezpo | What are the sensitivities of antibody detection for patients in different illness stages? |
| cord-275858-46jzw94p | How can we manipulate the unique airway pathology of COPD patients and the ACE-2 system to identify novel therapeutics? |
| cord-275858-46jzw94p | Is telerehabilitation a safe and viable option for patients with COPD? |
| cord-275858-46jzw94p | Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta- analysis Angiotensin- converting enzyme 2 is a functional receptor for the SARS coronavirus SARS- CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor Functional assessment of cell entry and receptor usage for SARS- CoV-2 and other lineage B betacoronaviruses Structure, Function, and Antigenicity of the SARS- CoV-2 Spike Glycoprotein A pneumonia outbreak associated with a new coronavirus of probable bat origin ACE-2 Expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19 Tobacco smoking increases the lung gene expression of ACE2, the receptor of SARS- CoV-2 Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19 Expression of the SARS- CoV-2 ACE2 receptor in the human airway epithelium COVID-19 and nicotine as a mediator of ACE-2 COVID-19 and smoking: is nicotine the hidden link? |
| cord-275858-46jzw94p | What can we learn from the experience of virtual care to COPD patients during this pandemic that can be applied in future scenarios to reach isolated patient populations and resource limited settings? |
| cord-275858-46jzw94p | What is the role of inhaled substances( e.g. tobacco, cannabis and e- cigarettes) and air pollution in increasing the susceptibility of COPD patients to COVID-19? |
| cord-275858-46jzw94p | What will the impact of post- COVID-19 infection disability be in COPD patients and what resources will be required to adequately support the transition of COPD patients from the hospital to home after COVID-19? |
| cord-275858-46jzw94p | does COVID-19 infection in each of these phenotypes present and behave differently? |
| cord-275858-46jzw94p | if so, how? |
| cord-275858-46jzw94p | • Are routine medications used in COPD such as inhaled and systemic corticosteroids, β 2-agonists, muscarinic antagonists and chronic azithromycin protective or harmful in the setting of COVID-19 infection? |
| cord-284444-mgxxbm0u | Is the coronavirus airborne? |
| cord-283956-zgrtux7i | One Health Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-283413-xapzer5s | Can social media bridge the gap between research and practice? |
| cord-283413-xapzer5s | it the new standard? |
| cord-284163-3jmqzemf | What is the rationale to use the Seraph ® 100 in COVID-19 patients? |
| cord-284163-3jmqzemf | and rationale for extracorporeal therapies Detectable serum SARS- CoV-2 viral load( RNAaemia) is closely correlated with drastically elevated interleukin 6( IL-6) level in critically ill COVID-19 patients Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis Early therapeutic plasma exchange in septic shock: a prospective open- label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers Effect of therapeutic plasma exchange on endothelial activation and coagulation- related parameters in septic shock Effectiveness of convalescent plasma therapy in severe COVID-19 patients International registry on the use of the CytoSorb ® adsorber in ICU patients: study protocol and preliminary results Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRA- TES randomized clinical trial Heparin: an essential drug for modern medicine Heparin and heparan sulfate: analyzing structure and microheterogeneity Heparan sulfate: biosynthesis, structure, and function Heparan sulfate proteoglycans and viral attachment: true receptors or adaptation bias? |
| cord-276820-l7bd5y8y | ( 2) How likely is it that you would survive if you were infected with SARS? |
| cord-276820-l7bd5y8y | ( 3) How confident are you in your doctor's ability to diagnose SARS? |
| cord-276820-l7bd5y8y | ( 5) Does the level of knowledge or beliefs about SARS affect the types of precautionary measures used by older adults? |
| cord-276820-l7bd5y8y | Three questions aimed at determining the participants'beliefs about their likelihood of contracting SARS were developed:( 1) How likely is it that you will become infected SARS? |
| cord-276820-l7bd5y8y | What demographic variables influenced older adults'knowledge level, beliefs, and precautionary measures taken to prevent transmission of SARS? |
| cord-276820-l7bd5y8y | What precautionary measures were taken by older adults to prevent the transmission of SARS? |
| cord-276820-l7bd5y8y | What was the knowledge level of older adults about the transmission routes of SARS? |
| cord-276820-l7bd5y8y | What were the beliefs of older adults about the possibility of becoming infected with SARS? |
| cord-282878-8qgsq2km | Can We Do More on Glycemic Control? |
| cord-282878-8qgsq2km | The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1 Viral infections in type 1 diabetes mellitus-- why the β cells? |
| cord-281887-b511bjdy | Have you had close or home contact in the last 7 days with a laboratory- confirmed case for COVID-19? |
| cord-281887-b511bjdy | How to risk- stratify elective surgery during the COVID-19 pandemic? |
| cord-281887-b511bjdy | Prehospital screening( telephone or other remote technology) shortness of breath, runny nose, headache, loss of smell or taste, body pain, chills or fever in the last 14 days? |
| cord-281887-b511bjdy | primeiro tratamento de paciente com neoplasia maligna comprovada e estabelece prazo para seu início Cancer patient management during the COVID-19 Pandemic COVID-19 global pandemic: options for management of gynecologic cancers Alternative management for gynecological cancer care during the COVID-2019 pandemic: a Latin American survey Which preventive measures might protect health care workers from SARS? |
| cord-282108-hhnnloxp | Could an endo- lysosomal ion channel be the Achilles heel of SARS- CoV2? |
| cord-282108-hhnnloxp | Tissue concentrations: do we ever learn? |
| cord-282108-hhnnloxp | Which lab animals can help defeat the new coronavirus? |
| cord-281346-bjhdy8mg | Considering the patients'clinical symptoms, when should a 2019-nCoV case be labeled as suspected, probable or confirmed? |
| cord-281346-bjhdy8mg | One of the most widely used preventive measures is face masks, but can they stop the propagation? |
| cord-281346-bjhdy8mg | The next big threat to global health? |
| cord-281346-bjhdy8mg | What advice can we give to travellers? |
| cord-281346-bjhdy8mg | Who are most susceptible to the infection? |
| cord-283779-mudwcypl | Compared to Standard of Care Treatment Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Covid-19: trials of four potential treatments to generate"robust data"of what works Covid-19: what treatments are being investigated? |
| cord-283779-mudwcypl | How will COVID-19 and global trends in physical inactivity and sedentary behavior affect one another? |
| cord-284028-l0r7f9sr | Influenza pandemic planning: review of a collaborative state and national process Epidemic and pandemic'flu Ready for the next influenza pandemic? |
| cord-284028-l0r7f9sr | Should I stay or should I go? |
| cord-284734-qioy7eso | Intravenous immunoglobulin treatment of the post- polio syndrome: sustained effects on quality of life variables and cytokine expression after one year follow up Mumps; use of convalescent serum in the treatment and prophylaxis of orchitis The prophylactic use of measles convalescent serum Use of convalescent measles serum to control measles in a preparatory school Meta- analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? |
| cord-284559-g9szoh3g | the missing link? |
| cord-284042-awl5bb0j | First report from the Middle East Are chilblain- like acral skin lesions really indicative of COVID-19? |
| cord-284925-vy2li9lz | Available at NIOSH- approved particulate filtering facepiece respirators Filter performance of N99 and N95 facepiece respirators against viruses and ultrafine particles Effect of particle size on the performance of an N95 filtering facepiece respirator and a surgical mask at various breathing conditions How does breathing frequency affect the performance of an N95 filtering facepiece respirator and a surgical mask against surrogates of viral particles? |
| cord-281487-x0a9qgjs | COVID-19: abnormal liver function tests Kidney disease is associated with in- hospital death of patients with COVID-19 Management of acute kidney injury in patients with COVID-19 Is the kidney a target of SARS- CoV-2? |
| cord-281487-x0a9qgjs | Current evidence on vitamin D deficiency and kidney transplant: what's new? |
| cord-281487-x0a9qgjs | Incidence of thrombotic complications in critically ill ICU patients with COVID-19 Coagulation abnormalities and thrombosis in patients with COVID-19 Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China Co- infections among patients with COVID-19: the need for combination therapy with non- anti- SARS- CoV-2 agents? |
| cord-281487-x0a9qgjs | The association of 25-hydroxyvitamin D levels with late cytomegalovirus infection in kidney transplant recipients: the Wisconsin Allograft Recipient Database Acute respiratory tract infection and 25-hydroxyvitamin D concentration: a systematic review and meta- analysis Vitamin D and critical illness: what endocrinology can learn from intensive care and vice versa High dose vitamin D administration in ventilated intensive care unit patients: a pilot double blind randomized controlled trial Early high- dose vitamin D(3) for critically ill, vitamin D- deficient patients Can melatonin reduce the severity of COVID-19 pandemic? |
| cord-281487-x0a9qgjs | an updated overview for emergency clinicians Association of angiotensin- converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality Association of Inpatient use of angiotensin- converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19 Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms Suppression of coronavirus replication by cyclophilin inhibitors COVID-19 and calcineurin inhibitors: should they get left out in the storm? |
| cord-284387-cjziykrz | Emergency medicine should play a fundamental role not only in the management but also in the rapid identification of and as an aid for surveillance and dissemination control of COVID-19. Human coronaviruses: what do they cause? |
| cord-280427-smqc23vr | Are other species such as mosquitoes, houseflies responsible for the transmission of virus to humans? |
| cord-280427-smqc23vr | Are there any precautions to be taken with live animals or animal products? |
| cord-280427-smqc23vr | Can companion animals become infected with Covid-19? |
| cord-280427-smqc23vr | Can your pet get COVID-19? |
| cord-280427-smqc23vr | How to protect pets if you are sick? |
| cord-280427-smqc23vr | The role of environmental factors to transmission of SARS- CoV-2( COVID-19) Is COVID-19 the first pandemic that evolves into a panzootic? |
| cord-282862-kve6fa49 | Overlapping Clinical Pictures in Two Gravid Patients Vaginal delivery in SARS- CoV-2-infected pregnant women in Northern Italy: a retrospective analysis Pre- labor anorectal swab for SARS- CoV-2 in COVID-19 pregnant patients: is it time to think about it? |
| cord-282862-kve6fa49 | Why are pregnant women susceptible to COVID-19? |
| cord-282862-kve6fa49 | pregnant women be included in phase IV clinical drug trials? |
| cord-285362-7dc2gox0 | 200 evaluation of the cobas SARS- CoV-2 test and a diagnostic platform switch during 48 hours in the 201 midst of the COVID-19 pandemic Xpress Flu/ RSV assay and commercial real- time PCR for the detection of influenza A and influenza B 204 in a prospective cohort from China Is Higher Viral Upper Respiratory Tract Associated With Severe Pneumonia? |
| cord-278839-uu2wlpmp | Respiratory viruses and sudden infant death Evaluation of maternal mortality under- reporting in the heights of Chiapas using the RAMOS and modified RAMOS strategies Maternal immunisation: what have been the gains? |
| cord-278839-uu2wlpmp | The expression and localization of the human placental prorenin/ renin- angiotensin system throughout pregnancy: roles in trophoblast invasion and angiogenesis? |
| cord-278839-uu2wlpmp | Viral infections and the neonatal brain Age- specific incidence of influenza A responds to change in virus subtype dominance Pulmonary susceptibility of neonates to respiratory syncytial virus infection: a problem of innate immunity? |
| cord-278839-uu2wlpmp | What does the future hold? |
| cord-278839-uu2wlpmp | Where are the gaps? |
| cord-278839-uu2wlpmp | role of glucocorticoids Hertz- Picciotto I. Is maternal influenza or fever during pregnancy associated with autism or developmental delays? |
| cord-278759-pykihnup | : What can we learn? |
| cord-278759-pykihnup | I'd like you to think back to when you first heard of them and tell me about your initial thoughts';'Tell me about your role in the recent H1N1 pandemic';'Tell me what you think the role of the government is towards healthcare professionals during a pandemic such as H1N1 and SARS';'Has the latest pandemic affected your work practices and scope of practice';'Did the H1N1 pandemic affect your ability to care? |
| cord-278759-pykihnup | The questions asked were:'Can you tell me what you know about emerging infectious respiratory diseases?';'In Singapore, we have been exposed to SARS and H1N1. |
| cord-278759-pykihnup | Was there a difference between the H1N1 and SARS? |
| cord-278759-pykihnup | What about during the SARS epidemic? |
| cord-278759-pykihnup | Why did outbreaks of severe acute respiratory syndrome occur in some hospital wards but not in others? |
| cord-285469-b61y9ezi | A Multinational Consensus Statement from the Fleischner Society Acute Stroke Care Is at Risk in the Era of COVID-19: Experience at a Comprehensive Stroke Center in Barcelona Has the aetiology of ischaemic stroke changed in the past decades? |
| cord-285203-ilxd0ih9 | f ? |
| cord-283372-c20i99qa | Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection? |
| cord-283372-c20i99qa | Does anti- inflammatory action of amiodarone explain the high efficacy in patients with heart failure? |
| cord-283372-c20i99qa | Thus, one question arises: can we use amiodarone to treat arrhythmias in COVID-19 patients? |
| cord-284449-z7r4n0w7 | Histological and hormonal testicular function in oligo/ azoospermic infertile men Acute Suppression of LH Secretion by Prolactin in Female Mice Is Mediated by Kisspeptin Neurons in the Arcuate Nucleus Clinical characteristics of 2019 novel coronavirus infection in China Recombinant B2L and Kisspeptin-54 DNA vaccine induces immunity against Orf virus and inhibits spermatogenesis in rats Does cortisol inhibit pulsatile luteinizing hormone secretion at the hypothalamic or pituitary level? |
| cord-284449-z7r4n0w7 | Viral threat to male fertility Testicular degeneration and infertility following arbovirus infection Do men with normal testosteroneoestradiol ratios benefit from letrozole for the treatment of male infertility? |
| cord-282384-qbcqbhk4 | : How much do we really know? |
| cord-282384-qbcqbhk4 | Can the Coronavirus Disease 2019( COVID-19) Affect the Eyes? |
| cord-282384-qbcqbhk4 | Detecting SARS- CoV-2 RNA in conjunctival secretions: Is it a valuable diagnostic method of COVID-19? |
| cord-282384-qbcqbhk4 | tomography angiography: Evolution or revolution? |
| cord-282964-dmc8mlxu | : Are we asking the right questions? |
| cord-282964-dmc8mlxu | : is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-282964-dmc8mlxu | An interactive web- based dashboard to track COVID-19 in real time Asymptomatic Transmission, the Achilles'Heel of Current Strategies to Control Covid-19 COVID-19 in Northern Italy: An integrative overview of factors possibly influencing the sharp increase of the outbreak COVID-19: Gastrointestinal Manifestations and Potential Fecal- Oral Transmission Survival of Coronaviruses in Water and Wastewater Air pollution aggravating COVID-19 lethality? |
| cord-282964-dmc8mlxu | Are faecal bioaerosols a route of transmission for SARS- CoV-2? |
| cord-274802-7ioiwsd8 | : what to expect for COVID-19? |
| cord-274802-7ioiwsd8 | COVID-19 Hyperinflammation: What about Neutrophils? |
| cord-274802-7ioiwsd8 | COVID-19 pandemic and the skin: what should dermatologists know? |
| cord-274802-7ioiwsd8 | Effects of chloroquine on viral infections: An old drug against today's diseases? |
| cord-274802-7ioiwsd8 | How far the lung surfactant system gets affected during severe symptoms? |
| cord-274802-7ioiwsd8 | Lessons from atypical haemolytic uraemic syndrome Complement- mediated endothelial cell damage in immune complex vasculitis of the skin: Ultrastructurallocalization of the membrane attack complex Mannose- Binding Lectin in Severe Acute Respiratory Syndrome Coronavirus Infection Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over- activation The complement system in COVID-19: friend and foe? |
| cord-274802-7ioiwsd8 | On the adaptive immune aspects, what variations exist within population in terms of the proportion of neutralising antibodies? |
| cord-274802-7ioiwsd8 | Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease SARS- CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study Why does COVID-19 disproportionately affect older people? |
| cord-274802-7ioiwsd8 | What are the genetic contributors to susceptibility and resistance to developing COVID-19? |
| cord-274802-7ioiwsd8 | What happens during the period of latency, i.e. between being infected and showing symptoms? |
| cord-274802-7ioiwsd8 | Where and What Is the Evidence? |
| cord-274802-7ioiwsd8 | Why there are a huge population that are asymptomatic carriers? |
| cord-274802-7ioiwsd8 | observational cohort study Loss of smell and taste as symptoms of COVID-19: what does the evidence say? |
| cord-284841-flhfagp3 | What Cost? |
| cord-284841-flhfagp3 | What can we do without SARS- CoV-2-IgG detection? 9%) |
| cord-285569-ei9w19i7 | World Health Organization website Transmission of 2019-nCoV infection from an asymptomatic contact in Germany Human- to- human transmission confirmed in China coronavirus Estimates of SARS death rates revised upward Interim laboratory biosafety guidelines for handling and processing specimens associated with 2019 novel coronavirus( COVID-19) CNHubei website Statistics of key performance indicators for China's civil aviation industry in Coronavirus: what airport measures are in place to detect sick passengers? |
| cord-283823-8n1cy0hj | What should additional clinical management of this patient include? |
| cord-283823-8n1cy0hj | Which of the following best describes potential reasons for false- negative molecular testing for SARS- CoV-2? |
| cord-283823-8n1cy0hj | Which of the following described processes would result in the best sampling of the nasopharynx for COVID-19 testing? |
| cord-284037-nj5jo1ev | Is it Worth Going the Extra Mile and Including the Chest to Screen for COVID-19 Infection? |
| cord-284037-nj5jo1ev | Thromboembolic findings in COVID-19 autopsies: pulmonary thrombosis or embolism? |
| cord-281508-zl2url8z | Does having diabetes or a high BMI, for example, involve a specific biological change( analogous to those observed for cancer and ALS) which is an intrinsic part of the process leading to Covid-19 mortality? |
| cord-281508-zl2url8z | If this is the case, are these conditions clearly- defined'steps'which can potentially be identified? |
| cord-281508-zl2url8z | If we can assume that the findings presented here are valid, given all the uncertainties of the data, what do they mean? |
| cord-281508-zl2url8z | On the other hand, are these conditions, like age, just markers of more general increases in immune- related susceptibility which accumulate across the life- course? |
| cord-281508-zl2url8z | The health of populations: general theories and particular realities Is social capital the key to inequalities in health? |
| cord-281508-zl2url8z | authors: Pearce, N.; Moirano, G.; Maule, M.; Kogevinas, M.; Rodo, X.; Lawlor, D.; Vandenbroucke, J.; Vandenbroucke- Grauls, C.; Polack, F. P.; Custovic, A. title: Is death from Covid-19 a multistep process? |
| cord-279406-wwdqh9qs | 2020, 8, 409 Exosomes and non- coding RNA, the healers of the heart? |
| cord-279406-wwdqh9qs | How are we going to discover new cancer biomarkers? |
| cord-279406-wwdqh9qs | The pathway through LC- MS method development: In- house or ready- to- use kit- based methods? |
| cord-279406-wwdqh9qs | The resurgence of controversy Milk A1 ß- casein and health related outcomes in humans: A systematic review biological properties and other potential effects on human health of ß- casomorphin 7: Current knowledge and concerns A method for identifying discriminative isoform- specific peptides for clinical proteomics application An isoform of AIF1 involved in breast cancer PTEN proteoforms in biology and disease How many human proteoforms are there? |
| cord-279406-wwdqh9qs | What is functional and what is junk? |
| cord-279406-wwdqh9qs | Where did it come from, what is it, and where is it going? |
| cord-284879-sjkni2uc | Can we contain the COVID-19 outbreak with the same measures as for SARS? |
| cord-284879-sjkni2uc | Will antibody tests for the coronavirus really change everything? |
| cord-284950-qqje5s04 | How can we reconcile these seemingly conflicting data? |
| cord-284950-qqje5s04 | Is there an ideal animal model for SARS? |
| cord-286038-a62k3lma | New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-285865-1gsy43a0 | For example, why have so many mutations been found in the human spike glycoproteins? |
| cord-285449-frft2h85 | Blood Groups and Anthropology HIV-1 incorporates ABO histo- blood group antigens that sensitize virions to complement- mediated inactivation Expression of ABO or related antigenic carbohydrates on viral envelopes leads to neutralization in the presence of serum containing specific natural antibodies and complement Evolution of the human ABO polymorphism by two complementary selective pressures Natural antibodies and complement are endogenous adjuvants for vaccine- induced CD8+ T- cell responses Human coronaviruses: What do they cause? |
| cord-285449-frft2h85 | I cross- presentation Blood group antigens: Molecules seeking a function? |
| cord-285254-8a1cia8s | But Some Are Also Planning for Large Numbers of Pets Being Returned, and Financial Peril Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Human- animal interactions and bat coronavirus spillover potential among rural residents in Southern China Wildlife as source of zoonotic infections Emerging Zoonoses: a One Health Challenge One Health Commission, What Is One Health? |
| cord-285254-8a1cia8s | What about the pets that have tested positive for SARS- CoV-2? |
| cord-285430-o086q2qa | Current trends recommendations for assisting in the prevention of perinatal transmission of human T lymphotropic virus type III/ lymphadenopathy- associated virus and acquired immunode!Ciency syndrome Free formula milk for infants of HIV- infected women: blessing or curse? |
| cord-285430-o086q2qa | The cost of not breastfeeding: global results from a new tool Does breastfeeding protect against substantiated child abuse and neglect? |
| cord-273918-knlc3bxh | How do individuals build optimal structures for a mentally healthy life that works for them in the wake of COVID-19 and social and physical distancing? |
| cord-273918-knlc3bxh | Interpretation training to target repetitive negative thinking in generalized anxiety disorder and depression Advancing social connection as a public health priority in the United States Addressing social isolation to improve the health of older adults: a rapid review What is the evidence on the role of the arts in improving health and well- being? |
| cord-273918-knlc3bxh | Key research questions include"What positive mechanistically based psychological interventions can be developed for mental wellbeing derived from theories of altruism and prosocial behaviour?" |
| cord-273918-knlc3bxh | Patients with mental health disorders in the COVID-19 epidemic Annual research review: secular trends in child and adolescent mental health Cross- cohort change in adolescent outcomes for children with mental health problems Mental health interventions in schools in high- income countries Preventing childhood anxiety disorders: is an applied game as effective as a cognitive behavioral therapy- based program? |
| cord-273918-knlc3bxh | Problem Management Plus( PM+): a WHO transdiagnostic psychological intervention for common mental health problems Social support interventions: do they work? |
| cord-273918-knlc3bxh | The relationship between encephalitis lethargica and influenza: a critical analysis Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? |
| cord-273918-knlc3bxh | These Longer- term strategic programmes What are the mental health consequences of the COVID-19 lockdown and social isolation for vulnerable groups, and how can these be mitigated under pandemic conditions? |
| cord-273918-knlc3bxh | WHO Regional Office for Europe Pocket psychiatry: mobile mental- health apps have exploded onto the market, but few have been thoroughly tested Media messages and perception of risk for Ebola virus infection, United States Systematic literature review on the spread of health- related misinformation on social media To fear or not to fear? |
| cord-273918-knlc3bxh | We need What is the effect of COVID-19 on risk of anxiety, depression, and other outcomes, such as self- harm and suicide? |
| cord-273918-knlc3bxh | What are the best methods for promoting successful adherence to behavioural advice about COVID-19 while enabling mental wellbeing and minimising distress? |
| cord-273918-knlc3bxh | What are the mental health consequences of the COVID-19 lockdown and social isolation for vulnerable groups, and how can these be mitigated under pandemic conditions? |
| cord-273918-knlc3bxh | What is the effect of repeated media consumption about COVID-19 in traditional and social media on mental health, and how can wellbeing be promoted? |
| cord-273918-knlc3bxh | What is the effect of repeated media consumption about COVID-19 through traditional media and social media on mental health, and how can wellbeing be promoted? |
| cord-273918-knlc3bxh | What is the optimal structure for a mentally healthy life in the wake of COVID-19 and social or physical distancing? |
| cord-273918-knlc3bxh | What's next for registered reports? |
| cord-273918-knlc3bxh | a systematic review and metaanalysis Component studies of psychological treatments of adult depression: a systematic review and meta- analysis Cognitive- behavioural therapy and personalized treatment: an introduction to the special issue Suicide prevention using self- guided digital interventions: a systematic review and meta- analysis of randomised controlled trials What works and what does n't work? |
| cord-273918-knlc3bxh | and"What can be learned from the large- scale roll- out of volunteer- based psychological interventions that will optimise the benefits to individuals and society?" |
| cord-285896-lb8toc1m | COVID-19 pneumonia: different respiratory treatments for different phenotypes? |
| cord-283440-8du0s33p | : should we worry? |
| cord-283440-8du0s33p | How useful is the lung ultrasound in cystic fibrosis? |
| cord-283440-8du0s33p | Why is COVID-19 so mild in children? |
| cord-285018-l26px1bc | The Allplex 2019-nCoV( Seegene) assay: which performances are for SARS- CoV-2 infection diagnosis? |
| cord-285018-l26px1bc | title: Comparison of the GeneFinder(TM) COVID-19 Plus RealAmp Kit on the sample- to- result Platform ELITe InGenius to the national reference method: an added value of N gene target detection? |
| cord-283486-ji0e8yoo | Copper enhanced nasal saline irrigations: a safe potential treatment and protective factor for COVID-19 infection? |
| cord-283486-ji0e8yoo | Should You Still Rinse Your Sinuses During The COVID-19 Outbreak? 2020. |
| cord-283486-ji0e8yoo | What Are the Potential Benefits of NL to COVID-19 Patients? |
| cord-283486-ji0e8yoo | What Are the Potential Benefits of NL to Personal Contacts/ Healthcare Workers Caring for COVID-19 Patients? |
| cord-285711-2utcn0hw | Might universal masking during this time of highest disease activity confer a survival advantage? |
| cord-285979-ha5nszxi | ( SARS- CoV-2) Infection: A Randomized Clinical Trial Convalescent plasma: new evidence for an old therapeutic tool? |
| cord-266738-8xx1xm2d | The paradox of highly effective sofosbuvir- based combination therapy despite slow viral decline: can we still rely on viral kinetics? |
| cord-266738-8xx1xm2d | The paradox of highly effective sofosbuvir- based combination therapy despite slow viral decline: can we still rely on viral kinetics? |
| cord-266738-8xx1xm2d | The paradox of highly effective sofosbuvir- based combination therapy despite slow viral decline: can we still rely on viral kinetics? |
| cord-286001-pu1fetq7 | In this study we set out to address an important basic and clinically relevant question: Is 255 the persistent viral RNA seen in COVID-19 patients'stool infectious and transmissible? |
| cord-283432-od5nnxvg | How can airborne transmission of COVID-19 indoors be minimised? |
| cord-283432-od5nnxvg | Is the coronavirus airborne? |
| cord-283432-od5nnxvg | Time to revisit infection control strategies? |
| cord-283432-od5nnxvg | What is an effective portable air cleaning device? |
| cord-285806-363ivs67 | What is there besides Tocilizumab? |
| cord-285806-363ivs67 | cord-285806- 363ivs67 authors: Magro, Giuseppe title: SARS- CoV-2 and COVID-19: is interleukin-6( IL-6) the'culprit lesion'of ARDS onset? |
| cord-286343-s8n1ldol | : What do we know? |
| cord-286365-fy0a8mb4 | what next? |
| cord-324559-p92y5er2 | The paradox of highly effective sofosbuvir- based combination therapy despite slow viral decline: can we still rely on viral kinetics? |
| cord-324559-p92y5er2 | The paradox of highly effective sofosbuvir- based combination therapy despite slow viral decline: can we still rely on viral kinetics? |
| cord-324559-p92y5er2 | The paradox of highly effective sofosbuvir- based combination therapy despite slow viral decline: can we still rely on viral kinetics? |
| cord-286301-7sjw5ci7 | A mechanism of virus- induced demyelination COPI in ER/ Golgi and intra- Golgi transport: do yeast COPI mutants point the way? |
| cord-286631-3fmg3scx | A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person- toperson transmission: a study of a family cluster Responding to Covid-19-A once- in- a- century pandemic? |
| cord-284376-plwyjhl8 | The paradox of highly effective sofosbuvir- based combination therapy despite slow viral decline: can we still rely on viral kinetics? |
| cord-284376-plwyjhl8 | The paradox of highly effective sofosbuvir- based combination therapy despite slow viral decline: can we still rely on viral kinetics? |
| cord-284376-plwyjhl8 | The paradox of highly effective sofosbuvir- based combination therapy despite slow viral decline: can we still rely on viral kinetics? |
| cord-286573-k4khwvt7 | NL63, France Can the Coronavirus Disease 2019( COVID-19) affect the eyes? |
| cord-286341-16tghl48 | Consensus- based Recommendations from Evidence- informed Experts Are Gastrointestinal Symptoms Specific for COVID-19 Infection? |
| cord-285486-99trkti1 | : what is our current state of knowledge? |
| cord-285486-99trkti1 | Pre- existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; the APCOLIS Study( APASL COVID-19 Chloroquine as chemoprophylaxis for COVID-19: will this work? |
| cord-286870-92eckkhk | Repositioning HIV protease inhibitors while developing more potent NO- hybridized derivatives? |
| cord-279861-gk8cow8k | Also, looking ahead, as participants in the Canadian workshop endeavored to do, what lessons from SARS might increase the utility of modeling the next time that a new infectious disease emerges? |
| cord-279861-gk8cow8k | But could we have convinced health authorities to allocate more resources to encouraging peopleespecially those who might have been exposed to someone subsequently diagnosedto seek medical care upon experiencing symptoms that might herald SARS, and to aiding clinicians in diagnosing, and infection control personnel in isolating patients? |
| cord-279861-gk8cow8k | But do health policymakers? |
| cord-279861-gk8cow8k | But do the apparently beneficial effects of historical school closures reliably translate into similar contemporary effects, given secular changes in family and workforce structure? |
| cord-279861-gk8cow8k | Could infected contacts have been identified more efficiently? |
| cord-279861-gk8cow8k | Could modelers have demonstrated that timely isolationnot quarantinewas the key to controlling SARS early enough to have influenced the public health response to this crisis( especially in light of the Amoy Gardens event, which may have biased responsible officials towards more aggressive interventions)? |
| cord-279861-gk8cow8k | If not by contact management, how was SARS controlled? |
| cord-279861-gk8cow8k | When is quarantine a useful control strategy for emerging infectious diseases? |
| cord-286854-0s7oq0uv | and the conservation of viral genome homology be explained? |
| cord-283367-azzy2t1a | A first case of meningitis/ encephalitis associated with SARS- Coronavirus-2 Acute transverse myelitis after COVID-19 pneumonia COVID-19-associated meningoencephalitis complicated with intracranial hemorrhage: a case report COVID-19 and intracerebral haemorrhage: causative or coincidental? |
| cord-283367-azzy2t1a | COVID-19-related Guillain- Barré syndrome different? |
| cord-283367-azzy2t1a | CT and MRI features Encephalopathy in patients with COVID-19:"causality or coincidence? |
| cord-283367-azzy2t1a | The neuroinvasive potential of SARS- CoV2 may play a role in the respiratory failure of COVID-19 patients Tocilizumab- associated multifocal cerebral thrombotic microangiopathy Tocilizumab and multiple sclerosis: a causal relationship? |
| cord-286895-i3g4ad4z | Lack of dyspnea in Covid-19 patients; another neurological conundrum? |
| cord-287372-ya5uvoki | Clinical features of patients infected 705 with 2019 novel coronavirus in Wuhan A role for CT in COVID-19? |
| cord-286072-kgpvdb42 | : What Do They All Do? |
| cord-286072-kgpvdb42 | How the SARS coronavirus causes disease: host or organism? |
| cord-286555-rz88g3ze | /Hel real- time reverse transcription- PCR assay validated in vitro and with clinical specimens Pooling of nasopharyngeal swab specimens for SARS- CoV-2 detection by RT- PCR Antibody responses to SARS- CoV-2 in patients with COVID-19 Diagnosis of the Coronavirus disease( COVID-19): rRT- PCR or CT? |
| cord-287205-k64svq6n | Will COVID-19 538 become the next neglected tropical disease? |
| cord-286472-pqtem19t | : what lessons can we learn? |
| cord-285787-xvi5miqw | : How are We Doing? |
| cord-285787-xvi5miqw | Learning From SARS: Renewal of Public Health in Canada Setting Limits Fairly: can we learn to share medical resources Oxford Fairness, accountability for reasonableness, and the views of priority setting decisionmakers Contested Decisions: Priority setting in the NHS London, UK: King's Fund Publishing Reasonable Rationing: International Experience of Priority Setting in Health Care Maidenhead Technology Acquisition in Canadian Hospitals: How is it done, and where is the information coming from? |
| cord-285787-xvi5miqw | To what extent should the need for containment over- ride other important needs? |
| cord-285787-xvi5miqw | To what extent should the need for quick decisions over- ride the need for legitimate and fair decision making? |
| cord-284038-93s3ffoy | A Potential New Neuropsychiatric Condition Triggered by Novel Coronavirus Infection and the Inflammatory Response? |
| cord-284038-93s3ffoy | COVID-19-White matter and globus pallidum lesions: Demyelination or small- vessel vasculitis? |
| cord-284038-93s3ffoy | COVID-19: What do we need to know about ICU delirium during the SARS- CoV-2 pandemic? |
| cord-284038-93s3ffoy | The New England journal of medicine Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? |
| cord-284038-93s3ffoy | Underestimated Opportunistic Pathogens of the Central Nervous System? |
| cord-284038-93s3ffoy | medRxiv Epidemiological, clinical characteristics of cases of SARS- CoV-2 infection with abnormal imaging findings Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-283439-hqdq2qrh | A novel coronavirus from patients with pneumonia in China Molecular evolution of human coronavirus genomes Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection Genome composition and divergence of the novel coronavirus( 2019-nCoV) originating in China Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Cryo- EM structure of the 2019-nCoV spike in the prefusion conformation Characterization of spike glycoprotein of SARS- CoV-2 on virus entry and its immune cross- reactivity with SARS- CoV Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques A crucial role of angiotensin converting enzyme 2( ACE2) in SARS coronavirus- induced lung injury Coronaviruses: an overview of their replication and pathogenesis Coronaviruses post- SARS: update on replication and pathogenesis Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-283439-hqdq2qrh | Can Zn Be a Critical Element in COVID-19 Treatment? |
| cord-283439-hqdq2qrh | How to reduce the likelihood of coronavirus-19( CoV-19 or SARS- CoV-2) infection and lung inflammation mediated by IL-1 Correspondence a real- time dashboard A trial of lopinavir- ritonavir in adults hospitalized with severe Covid-19 Favipiravir versus Arbidol for COVID-19: a randomized clinical trial Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an openlabel non- randomized clinical trial A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19 Personal view antiviral effects of chloroquine effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-283439-hqdq2qrh | beta coronavirus replication by a combination of interferon- alpha2b and ribavirin Coadministration of atazanavir- ritonavir and zinc sulfate: impact on hyperbilirubinemia and pharmacokinetics Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus( 2019-nCoV) in vitro The antiviral compound remdesivir potently inhibits RNAdependent RNA polymerase from Middle East respiratory syndrome coronavirus T-705( favipiravir) and related compounds: novel broad- spectrum inhibitors of RNA viral infections COVID-19 and chronological aging: senolytics and other anti- aging drugs for the treatment or prevention of corona virus infection? |
| cord-283439-hqdq2qrh | cord-283439-hqdq2qrh authors: Rahman, Mohammad Tariqur; Idid, Syed Zahir title: Can Zn Be a Critical Element in COVID-19 Treatment? |
| cord-286217-3uklf2u2 | ( 2) Are there any other viral proteins that could trigger significant antibody responses in at least some of the patients? |
| cord-286217-3uklf2u2 | ( 3) Is it possible to link the magnitude of the overall IgG and IgM response to the severity of the disease in patients? |
| cord-286217-3uklf2u2 | What is the variation among different patients, especially for antibodies against the nucleocapsid protein( N protein) and S protein? |
| cord-283380-l60yyr6l | Do we need to rethink our standards? |
| cord-283380-l60yyr6l | Do we need to rethink our standards? |
| cord-283380-l60yyr6l | Immunosuppression-a risk for severe forms of COVID-19 disease? |
| cord-283380-l60yyr6l | SARS- CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases? |
| cord-287497-93oiiqqi | Do checkpoint inhibitors compromise the cancer patients'immunity and increase the vulnerability to COVID-19 infection? |
| cord-287172-h8zoplkm | dysautonomia Guillain- Barre Syndrome Associated with SARS- CoV-2 Guillain- Barre syndrome associated with SARS- CoV-2 infection Guillain- Barre Syndrome associated with SARS- CoV-2 infection Guillain- Barre syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-282817-vtzpf2wr | A rapid point of care immunoswab assay for SARS- CoV detection Quantitative and sensitive detection of the SARS- CoV spike protein using bispecific monoclonal antibody- based enzyme- linked immunoassay Bispecific antibodies and ADCs: once and future kings? |
| cord-282817-vtzpf2wr | Camel single- domain antibodies as modular building units in bispecific and bivalent antibody constructs Engineered antibody fragments and the rise of single domains Bispecific antibodies for cancer therapy: the light at the end of the tunnel? |
| cord-282817-vtzpf2wr | Can bispecific antibody deliver superior, simplified diagnostics with application in low resource settings, through simplification of the assay capture and/or detection steps? |
| cord-282817-vtzpf2wr | Is the Triomab or BiTE or sdAb the way forward for human therapeutics? |
| cord-282817-vtzpf2wr | Will the multitude of bsAbs formats provide comparable preclinical information? |
| cord-282817-vtzpf2wr | Will the paucity of diagnostic bispecifics be improved by a single bispecific format coming to the fore in the therapeutic arena? |
| cord-287220-mpnuhqwg | Can SARS- CoV-2 Infection Be Acquired In Utero?: |
| cord-285557-my16g91c | A major outbreak of severe acute respiratory syndrome in Hong Kong Profile of specific antibodies to the SARS- associated coronavirus Clinical observation on 103 patients of severe acute respiratory syndrome treated by integrative traditional Chinese and Western Medicine Transmission dynamics and control of severe acute respiratory syndrome Medicinal herbs for hepatitis C virus infection Viral zoonoses- a threat under control? |
| cord-285557-my16g91c | Koch's postulates fulfilled for SARS virus Critically ill patients with severe acute respiratory syndrome SARS genome patent: symptom or disease? |
| cord-285557-my16g91c | Ribavirin in the treatment of SARS: a new trick for an old drug? |
| cord-285557-my16g91c | The big question now: will it be back? |
| cord-282839-3ii79g6j | A Review Possible Role of Mitochondrial DNA Mutations in Chronification of Inflammation: Focus on Atherosclerosis Is macrophages heterogeneity important in determining COVID-19 lethality? |
| cord-282839-3ii79g6j | A public health perspective of aging: do hyper- inflammatory syndromes such as COVID-19, SARS, ARDS, cytokine storm syndrome, and post- ICU syndrome accelerate short- and long- term inflammaging? |
| cord-282839-3ii79g6j | Calorie restriction as an intervention in ageing Is coenzyme Q a key factor in aging? |
| cord-282839-3ii79g6j | I IFNs in patients with life- threatening COVID-19 Resveratrol improves health and survival of mice on a high- calorie diet Resveratrol for patients with chronic obstructive pulmonary disease: hype or hope? |
| cord-282839-3ii79g6j | Molecular basis of disease 1863 Supplementation with the reduced form of Coenzyme Q10 decelerates phenotypic characteristics of senescence and induces a peroxisome proliferator- activated receptor- alpha gene expression signature in SAMP1 mice Effects of Acute and Chronic Exercise on Immunological Parameters in the Elderly Aged: Can Physical Activity Counteract the Effects of Aging? |
| cord-282839-3ii79g6j | Murine macrophage autophagy protects against alcohol- induced liver injury by degrading interferon regulatory factor 1( IRF1) and removing damaged mitochondria Autophagy in Chronic Kidney Diseases SS31 Ameliorates Sepsis- Induced Heart Injury by Inhibiting Oxidative Stress and Inflammation Essential role of mitochondrial dynamics in muscle physiology Mitochondrial activity and dynamics changes regarding metabolism in ageing and obesity Coenzyme Q in aging Bioavailability of coenzyme Q10 supplements depends on carrier lipids and solubilization Mitochondrial dysfunction in metabolism and ageing: shared mechanisms and outcomes? |
| cord-282839-3ii79g6j | The negative effect of lipid challenge on autophagy inhibits T cell responses Ageing and respiratory infections: the airway of ageing Calorie restriction enhances adult mouse lung stem cells function and reverses several ageing- induced changes Mitochondrial reactive oxygen species enable proinflammatory signaling through disulfide linkage of NEMO Coenzyme Q10 Supplementation in Aging and Disease Mitochondrial stress: a bridge between mitochondrial dysfunction and metabolic diseases? |
| cord-283850-kt8n6pg2 | Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? |
| cord-283850-kt8n6pg2 | Cureus 12 Neurologic manifestations of severe respiratory viral contagions Septic encephalopathy and septic encephalitis Incidence of thrombotic complications in critically ill ICU patients with COVID-19 Hypertension in patients with coronavirus disease 2019( COVID-19): a pooled analysis How do immune cells support and shape the brain in health, disease, and aging? |
| cord-283850-kt8n6pg2 | Outcome of delirium in critically ill patients: systematic review and meta- analysis Sepsis- associated encephalopathy: from delirium to dementia? |
| cord-283850-kt8n6pg2 | Past exposure to vaccines and subsequent risk of Alzheimer's disease COVID-19: gastrointestinal symptoms and potential sources of 2019-nCoV transmission Early- life adversity, systemic inflammation and comorbid physical and psychiatric illnesses of adult life Astrogliopathology: a central element of neuropsychiatric diseases? |
| cord-283850-kt8n6pg2 | Psychiatric comorbidities go untreated in patients with epilepsy: ignorance or denial? |
| cord-283850-kt8n6pg2 | Systematic review of proinflammatory cytokines in obsessive- compulsive disorder Blood levels of interleukin-1 beta, interleukin-6 and tumor necrosis factor- alpha and cognitive functions in patients with obsessive compulsive disorder Plasma cytokine abnormalities in drug- naïve, comorbidity- free obsessive- compulsive disorder Psychiatric comorbidities go unrecognized in patients with epilepsy Common psychiatric comorbidities in epilepsy: how big of a problem is it? |
| cord-287448-hwsr1804 | Clinical characteristics of coronavirus disease 2019 in China Neurologic manifestations of hospitalized patients with coronavirus disease Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-285748-us5do6c2 | 2 infection by detection of nucleocapsid protein Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China Single- cell RNA sequencing analysis of human kidney reveals the presence of ACE2 receptor: a potential pathway of COVID-19 infection Outbreak of chronic renal failure: will this be a delayed heritage of COVID-19? |
| cord-285748-us5do6c2 | Does the interaction between viral S1 protein and ACE2 has an impact on the systematic or renal local RAS system? |
| cord-285748-us5do6c2 | If yes, does the treatment of CKD patients need to be adjusted? |
| cord-285748-us5do6c2 | SARS- CoV-2 mainly distributes in proximal tubular epithelium and podocytes which triggered some interesting questions: Does the use of ACEIs/ ARBs lead to increased ACE2 expression and subsequently enhance viral entry? |
| cord-287091-a3nieh5p | Can the coronavirus disease 2019( COVID-19) affect the eyes? |
| cord-287091-a3nieh5p | What to expect for COVID-19? SARS- CoV-2 RNA dependent RNA polymerase( RdRp) targeting: |
| cord-287682-97fquq16 | key: cord-287682- 97fquq16 authors: Daubin, Cédric; Justet, Aurélien; Vabret, Astrid; Bergot, Emmanuel; Terzi, Nicolas title: Is a COPD patient protected against SARS- CoV-2 virus? |
| cord-288017-f9b3t0ts | Understanding immunopathological fallout of human coronavirus infections including COVID‐19: Will they cross the path of rheumatologists? |
| cord-288500-ko4eda9w | Does conflict between home and work explain the effect of multiple roles on mental health? |
| cord-287477-aios0h8s | How can CoV-2 divert them to its advantage? |
| cord-285111-qjclp51i | Gastroenterology, 1- 2 pii Practice- Advisory- Novel- Coronavirus2019? |
| cord-285111-qjclp51i | Severity and outcome associated with human coronavirus OC43 infections among children Can SARS- CoV-2 infections be acquired in utero? |
| cord-285111-qjclp51i | What are the risks of COVID-19 infection in pregnant women? |
| cord-285111-qjclp51i | What next? |
| cord-285111-qjclp51i | Why invest, and what it will take to improve breastfeeding practices? |
| cord-287447-5lzzobl3 | Glycyrrhizin, an active component of liquorice roots, and replication of SARS- associated coronavirus Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide HIV protease inhibitor nelfinavir inhibits replication of SARS- associated coronavirus Inhibition of SARS- coronavirus infection in vitro by S- nitroso- N- acetylpenicillamine, a nitric oxide donor compound Effects of chloroquine on viral infections: an old drug against todayÕs diseases? |
| cord-287447-5lzzobl3 | Summary of probable SARS cases with onset of illness from 1 Identification of a novel coronavirus in patients with severe acute respiratory syndrome SARS Working Group, A novel coronavirus associated with severe acute respiratory syndrome Coronavirus as a possible cause of severe acute respiratory syndrome Characterization of a novel coronavirus associated with severe acute respiratory syndrome Treatment of severe acute respiratory syndrome with lopinavir/ ritonavir: a multicentre retrospective matched cohort study Role of lopinavir/ ritonavir in the treatment of SARS: initial virological and clinical findings Role of interferons in the treatment of severe acute respiratory syndrome Antiviral treatment of SARS: can we draw any conclusions? |
| cord-284873-m1ehdydr | Acute renal impairment in coronavirus- associated severe acute respiratory syndrome Does COVID-19 affect male fertility? |
| cord-284873-m1ehdydr | COVID-19, SARS- CoV-1, MERS- CoV and lessons from the past Mineralocorticoid antagonists in ESRD: an overview of clinical trial evidence Non- genomic effects of spironolactone and eplerenone in cardiomyocytes of neonatal Wistar rats: do they evoke cardioprotective pathways? |
| cord-284873-m1ehdydr | Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension? |
| cord-284873-m1ehdydr | Clinical characteristics of coronavirus disease 2019 in China Obesity is associated with worse outcomes in COVID-19: analysis of Early data from New York City Association of obesity with disease severity among patients with coronavirus disease Severe obesity, increasing age and male sex are independently associated with worse in- hospital outcomes, and higher in- hospital mortality What does androgenetic alopecia have to do with COVID-19? |
| cord-284873-m1ehdydr | Does SARS- Cov-2 invade the brain? |
| cord-284873-m1ehdydr | Pneumonia in Wuhan, China Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-285960-1zuhilmu | COVID-19 Outbreak associated with air conditioning in restaurant Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-285960-1zuhilmu | The collision nebulizer: description, performance and application The airborne lifetime of small speech droplets and their potential importance in SARS- CoV-2 transmission Airborne transmission of SARS- CoV-2: the world should face the reality Airborne or droplet precautions for health workers treating COVID-19? |
| cord-285960-1zuhilmu | can we prevent the spread of infection? |
| cord-287247-vv0zc0gd | Malaria and Parasitic Neglected Tropical Diseases: Potential Syndemics with COVID-19? date: |
| cord-286638-bqxyb61p | Hypertension Dipeptidyl peptidase-4 inhibitors can inhibit angiotensin converting enzyme COVID-19 and Diabetes: can DPP4 inhibition play a role? |
| cord-286638-bqxyb61p | Virtually perfect? |
| cord-286638-bqxyb61p | a retrospective propensity- matched cohort study Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-286015-oonfpa0c | Can patents deter innovation? |
| cord-286015-oonfpa0c | HNPCC patent pool: a test for diagnostic testing? |
| cord-286015-oonfpa0c | The initial impetus for patenting an invention is to award original research and recuperate investment through revenue from the royalties due on the commercialization of the invention; however, will the creation of a patent pool still provide the patentee with such significant gains? |
| cord-286015-oonfpa0c | The tragedy of the anticommons: property in the transition from Marx to markets Models for facilitating access to patents on genetic inventions Patent pools: a solution to the problem of access in biotechnology patents? |
| cord-287043-53oy5w34 | CT and MRI Features Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-287043-53oy5w34 | This article is protected by copyright Guillain- Barré Syndrome associated with SARS CoV-2 infection COVID-19 may induce Guillain- Barré syndrome Guillain- Barré syndrome related to COVID-19 Guillain- Barré syndrome following COVID-19: new infection, old complication? |
| cord-288484-qy619tfg | A novel coronavirus from patients with pneumonia in China Multiple organ infection and the pathogenesis of SARS Neurologic alterations due to respiratory virus infections Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis Guillain- Barre syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-288051-wp8v2mc5 | COVID-19 ’s Patients? |
| cord-288051-wp8v2mc5 | Why tocilizumab could be an effective treatment for severe COVID-19? |
| cord-288558-rthnj6wd | what are the clinical distinctions from secondary infection? |
| cord-285467-uxfk6k3c | : What Does the Literature Say? |
| cord-285467-uxfk6k3c | A Double- Edged Sword Do All Opioid Drugs Share the Same Immunomodulatory Properties? |
| cord-285467-uxfk6k3c | Continuing Education in Anaesthesia Critical Care& Paracetamol: not as safe as we thought? |
| cord-285467-uxfk6k3c | Cytotoxic CD4 T Cells- Friend or Foe during Viral Infection? |
| cord-285467-uxfk6k3c | How do people with knee osteoarthritis use osteoarthritis pain medications and does this change over time? |
| cord-285467-uxfk6k3c | induces TNF- production and facilitates viral entry Up- regulation of IL-6 and TNF- α induced by SARS- coronavirus spike protein in murine macrophages via NF- κB pathway Imbalance of the renin- angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target? |
| cord-288271-p074ffpt | : Does immunosuppression alter the clinical presentation? |
| cord-282142-76jr4p7n | A novel coronavirus from patients with pneumonia in china Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding What are the risks of COVID-19 infection in pregnant women? |
| cord-282142-76jr4p7n | Antepartum pneumonia in pregnancy Risk factors associated with the increasing prevalence of pneumonia during pregnancy Pneumonia during pregnancy: has modern technology improved maternal and fetal outcome? |
| cord-282142-76jr4p7n | Can SARS- CoV-2 Infection Be Acquired In Utero? |
| cord-282142-76jr4p7n | Isolation of infectious SARS- CoV-2 from urine of a COVID-19 patient Enteric involvement of severe acute respiratory syndrome-Associated coronavirus infection Prevalence of gastrointestinal symptoms in patients with influenza, clinical significance, and pathophysiology of human influenza viruses in faecal samples: what do we know? |
| cord-282142-76jr4p7n | The SARS Epidemic in Hong Kong- what lessons have we learned? |
| cord-282142-76jr4p7n | what clinical recommendations to follow? |
| cord-289038-15yp9uqy | Where Does COVID-19 Stand? |
| cord-289079-m417oxpc | Therefore, soon two questions raised great concern: are IBD patients who receive immunotherapies more susceptible to SARS- CoV-2 infections than the general population and are infected patients exposed to a more severe course? |
| cord-284234-9cd2v6bt | ( Table 2) COVID-19, SARS and MERS: are they closely related? |
| cord-284234-9cd2v6bt | Fronts of Medicine ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism Imbalance of the renin- angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target? |
| cord-284234-9cd2v6bt | The facts the third epidemic Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation? |
| cord-284234-9cd2v6bt | is not a reason for concern Incidence of hepatitis B virus reactivation in patients with resolved infection on immunosuppressive therapy for rheumatic disease: a multicentre, prospective, observational study in Japan High viral load and respiratory failure in adults hospitalized for respiratory syncytial virus infections Immunosuppression for hyperinflammation in COVID-19: a double edged sword? |
| cord-284234-9cd2v6bt | p t Immunosuppressive drugs and severity of coronavirus infections: opportunity in the face of adversity? |
| cord-286168-019rcbpg | : What Is It? |
| cord-286168-019rcbpg | A longitudinal study on the mental health of general population during the COVID-19 epidemic in China Is returning to work during the COVID-19 pandemic stressful? |
| cord-286168-019rcbpg | Asadi- Pooya, A. A.& Simani, L. Central nervous system manifestations of COVID-19: A systematic review Neurologic complications of coronavirus infections Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? |
| cord-288758-onis9xmo | medRxiv How can airborne transmission of COVID-19 indoors be minimised? |
| cord-288403-m6qe57he | Similar to the concept of opportunity cost, what is the risk of SARS- CoV-2 infection to the healthcare staff engaged in alternative healthcare activities if not involved in immunisation activities? |
| cord-285848-37dmv4ep | How can psychological pressure on frontline medical personnel arising from the epidemic situation be mitigated or avoided? |
| cord-285848-37dmv4ep | These findings raise the following question: How long do the impacts of an epidemic endure among frontline medical staff? |
| cord-285848-37dmv4ep | What are the impacts of the considerable psychological pressure on frontline medical staff? |
| cord-285848-37dmv4ep | What kinds of psychological pressure are being experienced by frontline medical staff? |
| cord-289476-8wh3hn0n | respiratory syndrome coronavirus in travelers Middle East respiratory syndrome coronavirus: what does a radiologist need to know? |
| cord-289134-ne3tjt5g | Therefore, we sought to answer a straightforward yet important question: are there any natural polymorphisms in the furin cleavage site of the SARS- CoV-2 spike glycoprotein? |
| cord-287459-k9x3z2h1 | Covid-19: What do we know so far about a vaccine? |
| cord-287459-k9x3z2h1 | The regulation of hepatic fatty acid synthesis and partitioning: The effect of nutritional state Regulation of cholesterol and fatty acid synthesis Regulation of fatty acid and cholesterol synthesis: Co- operation or competition? |
| cord-288998-0by0bkgs | Why would this happen? |
| cord-288818-6uvb4qsk | COVID-19 and its implications for the Sendai framework Using"outbreak science"to strengthen the use of models during epidemics Ready and willing? |
| cord-287742-y1j9x5ne | A first step in understanding SARS pathogenesis Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome? |
| cord-287742-y1j9x5ne | Acute cerebral stroke with multiple infarctions and COVID-19 Macrothrombosis and stroke in patients with mild Covid-19 infection Acute ischemic stroke complicating common carotid artery thrombosis during a severe COVID-19 infection COVID-19 and intracerebral haemorrhage: causative or coincidental? |
| cord-287742-y1j9x5ne | a multicenter prospective cohort study New onset neurologic events in people with COVID-19 infection in three regions in China Characteristics of ischaemic stroke associated with COVID-19 COVID-19 presenting as stroke Coagulopathy and antiphospholipid antibodies in patients with Covid-19 Ischaemic stroke and SARS- CoV-2 infection: a causal or incidental association? |
| cord-289711-4ab3d00h | Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non- human Primates Molecular Mechanism for Antibody- Dependent Enhancement of Coronavirus Entry Is COVID-19 receiving ADE from other coronaviruses? |
| cord-288862-upcsvjuo | Can MM- PBSA calculations predict the specificities of protein kinase inhibitors? |
| cord-288153-2qsh2dlk | Clinical sequelae of the novel coronavirus: does COVID-19 infection predispose patients to cancer? |
| cord-288153-2qsh2dlk | From an understanding of the cancer- immunity cycle, are there are any elements of novel coronavirus infection that would make the cycle vulnerable to cancer at any point and prevent the generation of immunity to cancer? |
| cord-289407-8fje16z1 | ( SARS- CoV-2) from a symptomatic patient Environmental contamination by SARS CoV-2 in a designated hospital for coronavirus disease 2019 Environmental contamination of SARS- CoV-2 in healthcare premises Investigating SARS- CoV-2 surface and air contamination in an acute healthcare setting during the peak of the COVID-19 pandemic in London Are hygiene standards useful in assessing infection risk? |
| cord-288066-sh6n2c3n | Are anti- androgens a potential treatment for COVID-19? |
| cord-288066-sh6n2c3n | The majority of male patients with COVID-19 present low testosterone levels on admission to Intensive Care Low testosterone levels predict clinical adverse outcomes in SARS- CoV-2 pneumonia patients Testosterone deficiency in the aging male Commentary: who Is a Candidate for Testosterone Therapy? |
| cord-289574-engwi8h3 | Transplantation proceedings Cytopathology or immunopathology? |
| cord-284829-dge21g0g | Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? |
| cord-284829-dge21g0g | COVID-19: what if the brain had a role in causing the deaths? |
| cord-284829-dge21g0g | Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? |
| cord-284829-dge21g0g | Managing COVID-19 symptoms( including at the end of life) in the community: summary of NICE guidelines Delirium and sleep disturbances in COVID-19: a possible role for melatonin in hospitalized patients? |
| cord-284829-dge21g0g | Revue neurologique Guillain- Barre syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-284829-dge21g0g | The Lancet The COVID-19 pandemic, personal reflections on editorial responsibility Human coronaviruses: viral and cellular factors involved in neuroinvasiveness and neuropathogenesis Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? |
| cord-284829-dge21g0g | Viruses Does SARS- Cov-2 invade the brain? |
| cord-284829-dge21g0g | a retrospective case series study Olfactory and gustatory dysfunctions as a clinical presentation of mild- to- moderate forms of the coronavirus disease( COVID-19): a multicenter European study Miller Fisher Syndrome and polyneuritis cranialis in COVID-19 COVID-19 presenting with ophthalmoparesis from cranial nerve palsy Guillain- Barre syndrome following COVID-19: new infection, old complication? |
| cord-290429-0d34abdo | Would a rose by another name smell as sweet? |
| cord-288025-skkpkqw6 | Is Coronavirus a Food Safety Issue? |
| cord-288025-skkpkqw6 | medRxiv Does hand hygiene reduce SARS- CoV-2 transmission? |
| cord-288025-skkpkqw6 | what is its fate in urban water cycle and how can the water research community respond? |
| cord-290123-scd9u8ix | novel players in cardiovascular/ renal remodeling and hypertension COVID-19 pneumonia: ARDS or not? |
| cord-290209-gkx57lyq | A novel, validated risk score to predict surgical site infection after pancreaticoduodenectomy Impact of surgical site infection on healthcare costs and patient outcomes: a systematic review in six European countries Risk factors for superficial vs deep/ organ- space surgical site infections: implications for quality improvement initiatives Surgical site infections after colorectal surgery: do risk factors vary depending on the type of infection considered? |
| cord-286901-whvq8y1p | Could hypoxia increase the prevalence of thrombotic complications in polycythemia vera? |
| cord-286901-whvq8y1p | The science underlying COVID-19: implications for the cardiovascular system Review of D- dimer testing: good, bad, and ugly Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia Acute pulmonary embolism and COVID-19 pneumonia: a random association? |
| cord-286901-whvq8y1p | The stimulation of thrombosis by hypoxia Hypoxia and inflammation More than an anticoagulant: do heparins have direct anti- inflammatory effects? |
| cord-287054-zmxpuynv | Author's manuscript available at A brief review of monoclonal antibody technology and its representative applications in immunoassays Rapid detection of IgM antibodies against the SARS- CoV-2 virus via colloidal gold nanoparticle- based lateral- flow assay SARS- CoV-2 infection serology: A useful tool to overcome lockdown? |
| cord-287054-zmxpuynv | Is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-287054-zmxpuynv | The role of antibody testing for SARS- CoV-2: Is there one? |
| cord-290290-wyx9ib7s | gp120 Interactions with alpha4beta7 Structure, Function, and Antigenicity of the SARS- CoV-2 Spike Glycoprotein Testing for responses to the wrong SARS- CoV-2 antigen? |
| cord-287156-3plpi6i9 | A New Vasculitis at the time of COVID-19 A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China Corona Virus Disease 2019, a growing threat to children? |
| cord-287156-3plpi6i9 | Can Influence the Clinical Treatment of Pregnant Women With COVID-19 Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records Maternal and perinatal outcomes with COVID-19: A systematic review of 108 pregnancies Outcome of Coronavirus spectrum infections( SARS, MERS, COVID 1-19) during pregnancy: a systematic review and meta- analysis Perinatal Transmission of COVID-19 Associated SARS- CoV-2: Should We Worry? |
| cord-287156-3plpi6i9 | Wkly Rep Are children less susceptible to COVID-19? |
| cord-290254-m9l8ntur | The immunology of COVID-19: is immune modulation an option for treatment? |
| cord-289364-p31gt533 | Viral relapse, reinfection or inflammatory rebound? |
| cord-289364-p31gt533 | Viral relapse, reinfection or inflammatory rebound? |
| cord-289255-qwzg7prx | The large 386-nt deletion in SARS- associated coronavirus: evidence for quasispecies? |
| cord-289255-qwzg7prx | What is a quasispecies? |
| cord-288920-xkfcc2dx | Just another viral acronym? |
| cord-288920-xkfcc2dx | key: cord-288920-xkfcc2dx authors: Broxmeyer, L title: SARS: Just another viral acronym? |
| cord-285426-iyl12ber | First, whether IBD patients show mild or moderate signs and symptoms of COVID-19 compared to the others? |
| cord-285426-iyl12ber | Imbalance of the renin- angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target? |
| cord-285426-iyl12ber | Second, in the recent pandemic situation, could IBD patients be considered"silent carriers"and might they increase the disease spread rate? |
| cord-285426-iyl12ber | The pathophysiological roles of the renin- angiotensin system in the gastrointestinal tract Soluble angiotensin- converting enzyme 2: a potential approach for coronavirus infection therapy? |
| cord-285426-iyl12ber | True or False? |
| cord-285426-iyl12ber | disruption by hepatitis C virus NS3- 4A protease SARS coronavirus and innate immunity Cross- regulation of TNF and IFN- α in autoimmune diseases Are patients with inflammatory bowel disease at increased risk for Covid-19 infection? |
| cord-290277-ndfoppoq | cord-290277-ndfoppoq authors: Bahl, Prateek; Doolan, Con; de Silva, Charitha; Chughtai, Abrar Ahmad; Bourouiba, Lydia; MacIntyre, C Raina title: Airborne or droplet precautions for health workers treating COVID-19? |
| cord-289282-4oz6r7op | COVID-19 and Italy: what next? |
| cord-289282-4oz6r7op | The next big threat to global health? |
| cord-285574-i0dh1u5i | Disease- modifying drugs for multiple sclerosis and infection risk: a cohort study Risk of COVID-19 infection in MS and neuromyelitis optica spectrum disorders COVID-19 pandemic and the risk of infection in multiple sclerosis patients on disease modifying therapies:"what the bleep do we know? |
| cord-285574-i0dh1u5i | Do these drugs have a harmful or protective effect? |
| cord-285574-i0dh1u5i | Should we expect neurological symptoms in the SARS- CoV-2 Epidemic? |
| cord-285574-i0dh1u5i | The G8 dementia research summita starter for eight? |
| cord-285574-i0dh1u5i | What happened when two potential risk factors( age and dementia) are coexisting? |
| cord-285574-i0dh1u5i | key: cord-285574-i0dh1u5i authors: Ferini- Strambi, Luigi; Salsone, Maria title: COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable? |
| cord-285574-i0dh1u5i | new expectations for the future Is the brain a reservoir organ for SARS2-CoV2? |
| cord-287501-7it4kh0e | How can(-)-epigallocatechin gallate from green tea prevent HIV-1 infection? |
| cord-287501-7it4kh0e | The spike protein of SARS- CoV-a target for vaccine and therapeutic development Are drugs for SARS on the horizon? |
| cord-287501-7it4kh0e | genistein Effects of flavanoids on immune and inflammatory cell functions Metabolism of isoflavones in human subjects Flavonoids from carnation( Dianthus caryophyllus) and their antifungal activity Therapeutic potential of inhibition of the NF- κB pathway in the treatment of inflammation and cancer Antimicrobial activity of flavonoids Flavonoids: modulators of brain function? |
| cord-286923-o4fj8kx0 | Does Vitamin D Protect Against COVID-19? |
| cord-286923-o4fj8kx0 | How pregnancy can affect autoimmune diseases progression? |
| cord-286923-o4fj8kx0 | The Anti- Inflammatory Effects of Vitamin D in Tumorigenesis Low serum 25-hydroxyvitamin D level: An independent risk factor for tuberculosis? |
| cord-286923-o4fj8kx0 | What immunological and hormonal protective factors lower the risk of COVID-19 related deaths in pregnant women? |
| cord-286923-o4fj8kx0 | Why are pregnant women susceptible to COVID-19? |
| cord-290218-dvyeg5fk | Will There Be a Cure for Ebola? |
| cord-290796-x9xqqcj6 | medRxiv preprint Is recurrence possible in coronavirus disease 2019( COVID-19)? |
| cord-290257-2u228xe9 | Why did public health nurses lack confidence in implementing the anti- SARS program? |
| cord-289332-hvakv08t | Is traditional Chinese medicine useful in the treatment of SARS? |
| cord-289332-hvakv08t | key: cord-289332-hvakv08 t authors: Chen, Guoqian; Chen, Da- zhi; Li, Jianhua; Czura, Christopher J.; Tracey, Kevin J.; Sama, Andrew E.; Wang, Haichao title: Pathogenic role of HMGB1 in SARS? |
| cord-290195-8uaai9nv | What is the best drug to treat COVID-19? |
| cord-290414-8i8g0xdc | Do slit lamp shields and face masks protect ophthalmologists amidst COVID-19? |
| cord-289349-imkgpwn0 | Could an unrelated live attenuated vaccine serve as a preventive measure to dampen septic inflammation associated with covid-19 infection? |
| cord-289349-imkgpwn0 | The efficacy of bacillus calmette- guerin vaccinations for the prevention of acute upper respiratory tract infection in the elderly Trained immunity: A tool for reducing susceptibility to and the severity of sars- cov-2 infection Can existing live vaccines prevent covid-19? |
| cord-289349-imkgpwn0 | Why is covid-19 so mild in children? |
| cord-290001-603qy8ml | However, all these above- commented research results bring new questions and opportunities to deepen our understanding about disease and biochemistry: are alterations of cholesterol or other lipid biomarkers actually a feature solely of this condition or it is shared by other diseases?; does it provide us with information relatively to biochemical/ metabolic unbalance or about the activation of mechanisms to restore body homeostasis?. |
| cord-290001-603qy8ml | However, all these above- commented research results bring new questions and opportunities to deepen our understanding about disease and biochemistry: are alterations of cholesterol or other lipid biomarkers actually a feature solely of this condition or it is shared by other diseases?; does it provide us with information relatively to biochemical/ metabolic unbalance or about the activation of mechanisms to restore body homeostasis?. |
| cord-288733-c51lfwd6 | ( SARS- CoV-2) Hydroxychloroquine for treatment of SARS- CoV-2 infection? |
| cord-288733-c51lfwd6 | An old drug against today's diseases? |
| cord-290333-996tmrgo | What should gastroenterologists and patient know about COVID-19? |
| cord-288660-z0k2ui3y | Should rolls of tape be disposed between cases? |
| cord-288660-z0k2ui3y | What are the proper procedures to disinfect touch- screen monitors and equipment? |
| cord-288660-z0k2ui3y | What have we learned from the recent epidemics? |
| cord-288660-z0k2ui3y | What personal items, beepers, laptops, PDAs, pens, etc, are allowed in a contaminated OR? |
| cord-290677-3gdcyrrz | an observational cohort study Is a"cytokine storm"relevant to COVID-19? |
| cord-290845-bf1q4k6t | Do pregnant women have protective immunity against COVID‐19? date: 2020- 06- 24 journal: |
| cord-283824-c7y9zf7o | But how can one identify the risky body that shows no symptoms at all? |
| cord-283824-c7y9zf7o | But how does such topological territoriality challenge the national political territory as the basic unit of the modern international order? |
| cord-283824-c7y9zf7o | But what happens to the political qualities formerly associated with the act of Ortung? |
| cord-283824-c7y9zf7o | How do legal regulations discriminate between what is supposed to circulate and what not? |
| cord-283824-c7y9zf7o | If the continuity of the IHR with the basic presuppositions of liberal governmentality can be established easily, what about their specificity? |
| cord-283824-c7y9zf7o | In which way do they specify how circulations are to be monitored, channelled and held in check in order to be maintained? |
| cord-283824-c7y9zf7o | Only the second of the two viewpoints prompts empirical research to analyse how contemporary forms of global law are operative in developing governmental cartographies: How do legal textures configure movement- spaces? |
| cord-283824-c7y9zf7o | This raises the question of what has come to substitute the dual structure of the individual body and the population in public health: What is put at risk by epidemic disease? |
| cord-283824-c7y9zf7o | What is the'historic individuality'of the current attempt at dealing with pandemics as globally collective phenomena? |
| cord-290948-cuu78cvl | The non- structural protein nsp10 of mouse hepatitis virus binds zinc ions and nucleic acids Discovery of an RNA virus 3 → 5 exoribonuclease that is critically involved in coronavirus RNA synthesis Nidovirus transcription: how to make sense? |
| cord-289813-kq3ayyip | Always a burden? |
| cord-289813-kq3ayyip | Can SARS- CoV-2 infection be acquired in utero? |
| cord-289599-7vsynfgn | Are we rushing too much? |
| cord-289599-7vsynfgn | How much time is required? |
| cord-289599-7vsynfgn | Why are some animal experiments poor predictors of human outcomes and responses? |
| cord-291012-y0ufzx93 | We observed many ORs were significantly down regulated at 2 and 4 dpi, suggesting Pericytes: developmental, physiological, and 514 pathological perspectives, problems, and promises SARS- CoV-2 entry factors are highly expressed in nasal 603 epithelial cells together with innate immune genes STRING v11: protein- protein association networks with 606 increased coverage, supporting functional discovery in genome- wide experimental datasets Proinflammatory Cytokines in 610 the Olfactory Mucosa Result in COVID-19 Induced Anosmia Inflammatory obstruction of the olfactory clefts and olfactory loss in humans: a new syndrome? |
| cord-289612-4x5t4c5u | Can you put a price on COVID-19 options? |
| cord-289612-4x5t4c5u | Nurs A conceptual model for the coronavirus disease 2019( COVID-19) outbreak in Wuhan, China with individual reaction and governmental action Diagnosis of the Coronavirus disease( COVID-19): rRT- PCR or CT? |
| cord-289612-4x5t4c5u | necessity or potentiality? |
| cord-291028-ejidqmpm | Anestesia general frente a anestesia locorregional? |
| cord-284573-w0sk622m | ( COVID-19 Estimating Clinical Severity of COVID-19 from the Transmission Dynamics in Wuhan, China Is Barbarism with a Human Face Our Fate? |
| cord-284573-w0sk622m | How can it be that hospitals ran out of N95 masks in week one? |
| cord-284573-w0sk622m | How did we end up in a space of thinking, acting, and feeling that has normalized extremes and is based on the assumption that biological life is an absolute value separate from politics? |
| cord-284573-w0sk622m | How did we end up in this strange space of thinking, acting, and feeling that has normalized extremes and that is based on the assumption that biological life is an absolute value separate from politics? |
| cord-284573-w0sk622m | How was it possible for a virus to trigger such a massive response that continues to threaten society and the economy, with so little discussion about the costs and consequences of extreme measures? |
| cord-284573-w0sk622m | Was it the only possible way of managing the crisis? |
| cord-284573-w0sk622m | What could be more dangerous, more daring, more exciting than a walk on the wild side, an excursion to the other side of reason? |
| cord-284573-w0sk622m | Where did all the billions spent on preparedness go? |
| cord-284573-w0sk622m | Why has a crude version of China's approach become the dominant model? |
| cord-284573-w0sk622m | Why is there widespread agreement that aggressive interventions to"flatten the curve"were necessary and justified? |
| cord-284526-a5kgo4ct | A case series of Guillain- Barré syndrome following Covid-19 infection in New York Guillain- Barré syndrome related to SARS- CoV-2 infection Guillain- Barre syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-284526-a5kgo4ct | Demyelination or small- vessel vasculitis? |
| cord-284526-a5kgo4ct | Endothelial cell infection and endotheliitis in COVID-19 Do viral infections mimic bacterial sepsis? |
| cord-284526-a5kgo4ct | Osteonecrosis in patients after severe acute respiratory syndrome( SARS): possible role of anticardiolipin antibodies Lung pathology of fatal severe acute respiratory syndrome Analysis of deaths during the severe acute respiratory syndrome( SARS) epidemic in Singapore: challenges in determining a SARS diagnosis Complement as a target in COVID-19? |
| cord-284526-a5kgo4ct | The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS- CoV-2 receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade- long structural studies of SARS coronavirus Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2 Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host- virus interaction, and proposed neurotropic mechanisms Does SARS- Cov-2 invade the brain? |
| cord-284526-a5kgo4ct | The first European observational series on neurologic features of COVID-19 patients admitted to intensive care units Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? |
| cord-284526-a5kgo4ct | Two patients with acute meningoencephalitis concomitant to SARS- CoV-2 infection Generalized myoclonus in COVID-19 De novo status epilepticus in patients with COVID-19 New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: a retrospective multicenter study Frequent convulsive seizures in an adult patient with COVID-19: a case report Miller fisher syndrome and polyneuritis cranialis in COVID-19 Guillain- Barre syndrome related to COVID-19 infection Fatal Guillain- Barre syndrome after infection with SARS- CoV-2 Guillain- Barre syndrome following COVID-19: new infection, old complication? |
| cord-284526-a5kgo4ct | causative or coincidental? |
| cord-291523-4dtk1kyh | Could we use this clustering result( Fig. 7F) to infer that SARS- CoV-2 might not originate in bats or pangolins? |
| cord-291388-tt9eq7e0 | multi- country outbreak updated 34 Harrison's principles of internal medicine Gram- negative bacteremia Severe acute respiratory syndrome- Taiwan Induction of postinflammatory cytokines in human macrophages by influenza A( H5N1) virus: a mechanism for the unusual severity of human disease? |
| cord-289377-2vqqabum | But, could immunity after infection be virtually non- existing after all? |
| cord-289377-2vqqabum | What about an ongoing epidemic? |
| cord-289377-2vqqabum | en Does homologous reinfection drive multiple- wave influenza outbreaks? |
| cord-291513-vpehn6nx | Visualizations and statistical comparisons performed using PRISM 8.0 and the limit of detection determination were consistent with CDC recommendations whereby samples with a Ct value greater than Our experimental design sought to answer three primary questions: whether the e cacy of SARS- CoV-2 detection is in uenced by the following three variables: 1) does the swab storage solution( 95% EtOH vs 91% isopropanol) impact the sensitivity of detection; 2) which sample fraction, swab head or eluent, provides better detection delity; and 3) does the swab head material type matter? |
| cord-283352-0l1ggmhx | : Should we take the risk for our patients? |
| cord-283352-0l1ggmhx | A Marker of Psychological Distress? |
| cord-283352-0l1ggmhx | Did you say panic? |
| cord-283352-0l1ggmhx | How does the medical- scientific literature connect the current pandemic with the terminology of"panic"? |
| cord-283352-0l1ggmhx | Panic? |
| cord-283352-0l1ggmhx | The Interpretation of Dyspnea in the Patient with Asthma Do asthma patients with panic disorder really have worse asthma? |
| cord-283352-0l1ggmhx | Useful intervention or impediment? |
| cord-288255-p8uzrsbd | ( COVID-19) Infection in Wuhan, China Systematic review or meta- analysis? |
| cord-288255-p8uzrsbd | COVID-19 and Italy: what next? |
| cord-288255-p8uzrsbd | Can angiotensin receptor- blocking drugs perhaps be harmful in the COVID-19 pandemic? |
| cord-288255-p8uzrsbd | Circulation Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-288255-p8uzrsbd | Linking Obesity and Cardiovascular Disease across the Life- Course? |
| cord-288255-p8uzrsbd | The immunology of COVID-19: is immune modulation an option for treatment? |
| cord-291176-evb6yt0r | 2020 Characteristics of COVID-19 patients dying in Italy Report based on available data on Clinical Characteristics of Coronavirus Disease 2019 in China Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-291459-m56dy8us | A trial of Lopinavir- Ritonavir in adults hospitalized with severe Covid-19 Chloroquine is a potent inhibitor of SARS coronavirus infection and spread In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2( SARS- CoV-2) Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open- label non- randomized clinical trial Immunosuppression for hyperinflammation in COVID-19: a double- edged sword? |
| cord-289144-d6fgs8qg | COVID-19: what do we need to know about ICU delirium during the SARS- CoV-2 pandemic? |
| cord-289144-d6fgs8qg | Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition? |
| cord-289144-d6fgs8qg | depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor COVID and the renin- angiotensin system: are hypertension or its treatments deleterious? |
| cord-289144-d6fgs8qg | inhibitors/ angiotensin receptor blockers have a biphasic effect? |
| cord-289144-d6fgs8qg | rting Enzyme 2)-independent Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-291436-cu5o8ipw | What do we know about 767 parasites of wildlife in high biodiversity áreas with anthropogenic disturbance? |
| cord-291642-xfkdxnfb | : what are the roles for anticoagulation and long- term antibiotic therapy? |
| cord-291505-vt5vpp60 | Tocilizumab not associated with increased infection risk after CAR T-Implications for COVID-19? |
| cord-291738-nak5357h | SARS- CoV-2 RNA identification in nasopharyngeal swabs: issues in pre- analytics Diagnostic performances and thresholds: the key to harmonization in serological SARS- CoV-2 assays? |
| cord-289114-ifnk41oq | Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-289114-ifnk41oq | Will We Still Speak Ill of These Materials? |
| cord-289114-ifnk41oq | a first- in- class broad- spectrum antiviral agent Antiviral research Sick sinus syndrome induced by interferon and ribavirin therapy in a patient with chronic hepatitis Comparative analyses of SAR- CoV-2 genomes from different geographical locations and other coronavirus family genomes reveals unique features potentially consequential to host- virus interaction and pathogenesis Effects of chloroquineon viral infections: an old drug against today's diseases? |
| cord-289719-64ugdvfe | Patients with proxy respondents or who had died were excluded What is already known about this topic? |
| cord-289719-64ugdvfe | What are the implications for public health practice? |
| cord-289719-64ugdvfe | What is added by this report? |
| cord-289905-dvl2pud2 | COVID-19 pneumonia: ARDS or not? |
| cord-289905-dvl2pud2 | COVID-19 pneumonia: different respiratory treatments for different phenotypes? |
| cord-289905-dvl2pud2 | T Unger, UM Steckelings and RAS dos Santos Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-291577-nf80kih2 | A molecular docking study A Trial of Lopinavir- Ritonavir in Adults Hospitalized with Severe Covid-19 Could HIV infection alter the clinical course of SARS- CoV-2 infection? |
| cord-290687-kc7t1y5o | Did the 1918- 19 influenza pandemic originate in China? |
| cord-290687-kc7t1y5o | How India is going to response to this pandemic? |
| cord-290687-kc7t1y5o | What happened in China during the 1918 influenza pandemic? |
| cord-291809-b7sosrc7 | The Lancet ISHLT: Guidance for Cardiothoracic Transplant and Ventricular Assist Device Centers regarding the SARS 18 CoV-2 pandemic Case report of COVID-19 in a kidney transplant recipient: Does 21 immunosuppression alter the clinical presentation? |
| cord-291281-ygrh8ces | How can we deal with this problem? |
| cord-291281-ygrh8ces | To digress: Does it make sense to test people by PCR who do not( or no longer) have symptoms? |
| cord-291590-24psoaer | Qatar Drivers of MERS- CoV transmission: what do we know? |
| cord-291076-p350i54m | Neutrophil extracellular traps: is immunity the second function of chromatin? |
| cord-291076-p350i54m | The Middle East respiratory syndrome-- how worried should we be? |
| cord-285580-gq7400tq | : What should a clinician really know? |
| cord-285580-gq7400tq | Can nitric oxide overcome bacterial resistance to antibiotics? |
| cord-285580-gq7400tq | Coagulation and inflammation cross- talking Could nasal nitric oxide help to mitigate the severity of COVID-19? |
| cord-285580-gq7400tq | H1N1 Potential benefits of tryptophan metabolism to the efficacy of tocilizumab in COVID-19 Protocol for a randomized controlled trial testing inhaled nitric oxide therapy in spontaneously breathing patients with Nitric oxide- loaded chitosan nanoparticles as an innovative antileishmanial platform Pharmaceutical nanotechnology: which products are been designed against COVID-19? |
| cord-285580-gq7400tq | Inhalation of nitric oxide in the treatment of severe acute respiratory syndrome: A rescue trial in beijing To give or not to give? |
| cord-285580-gq7400tq | Inhaled nitric oxide treatment in spontaneously breathing COVID-19 patients Small molecules for great solutions: Can nitric oxide- releasing nanomaterials overcome drug resistance in chemotherapy? |
| cord-285580-gq7400tq | NL63 molecular epidemiology and evolutionary patterns in rural coastal Kenya Serum levels of nitric oxide as a predictor of survival in acute respiratory distress syndrome caused by H1N1 pneumonia? |
| cord-291014-cfnoxhtd | H3 stalk-a challenge for broad- spectrum vaccines? |
| cord-291014-cfnoxhtd | Immune response: protective or pathogenic? |
| cord-291965-9r9ll83m | What links bats to emerging infectious diseases? |
| cord-289852-4uxb70rh | A new approach in stem cell research- exosomes: their mechanism of action via cellular pathways CoviD-19: a conundrum to decipher Thromboembolic findings in COVID-19 autopsies: pulmonary thrombosis or embolism? |
| cord-289852-4uxb70rh | Ann Human mesenchymal stromal cells decrease the severity of acute lung injury induced by E. coli in the rat Extracellular vesicles: biology and emerging therapeutic opportunities Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell based therapies? |
| cord-289852-4uxb70rh | Mesenchymal stromal cell infusion modulates systemic immunological responses in stable COPD patients: a phase I pilot study Expanded umbilical cord mesenchymal stem cells( UC- MSCs) as a therapeutic strategy in managing critically ILL COVID-19 patients: the case for compassionate use Mesenchymal stem/ stromal cell secretome for lung regeneration: the long way through"pharmaceuticalization"for the best formulation Human Wharton's jelly mesenchymal stem cells show unique gene expression compared with bone marrow mesenchymal stem cells using single- cell RNA- sequencing Immunoinformatics- aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV Secretome of mesenchymal stromal cells prevents myofibroblasts differentiation by transferring fibrosis- associated microRNAs within extracellular vesicles Remdesivir for the treatment of covid-19-preliminary report Extracellular vesicles, exosomes and shedding vesicles in regenerative medicine-a new paradigm for tissue repair International society for extracellular vesicles and international society for cell and gene therapy statement on extracellular vesicles from mesenchymal stromal cells and other cells: considerations for potential therapeutic agents to suppress coronavirus disease-19 Pathogenic role of HMGB1 in SARS? |
| cord-289852-4uxb70rh | does ACE2 receptor matter? |
| cord-289588-n61gz7pi | COVID-19: what is next for public health? |
| cord-289588-n61gz7pi | Coronaviruses post- SARS: update on replication and 902 pathogenesis Risk 904 in vaccine research and development quantified Immunosuppression for hyperinflammation in 906 COVID-19: a double- edged sword? |
| cord-289588-n61gz7pi | How will 702 country- based mitigation measures influence the course of the COVID-19 epidemic? |
| cord-289588-n61gz7pi | What we know? |
| cord-286298-pn9nwl64 | : What is the role of radiologists? |
| cord-286298-pn9nwl64 | Are aerosol, saliva, feces, urine, and foodborne the only routes of transmission? |
| cord-286298-pn9nwl64 | Can Chinese medicine be used for prevention of corona virus disease 2019( COVID-19)? |
| cord-286298-pn9nwl64 | Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients? |
| cord-286298-pn9nwl64 | These unresolved questions include: What is the origin of SARS- CoV-2? |
| cord-286298-pn9nwl64 | What are the other unknown routes of transmission? |
| cord-286298-pn9nwl64 | What is the intermediate host that transmitted the virus from bats? |
| cord-286298-pn9nwl64 | Why does the virus cause severe disease and mortality in the elderly or those with co- morbidities, while it is milder in children? |
| cord-286298-pn9nwl64 | interferon signals in lung stromal cells protect from influenza virus infection Rescue fecal microbiota transplantation for antibiotic- associated diarrhea in critically ill patients Long- Term safety and efficacy of fecal microbiota transplant in active ulcerative colitis Microbiota and its role on viral evasion: Is it with us or against us? |
| cord-291687-kwu0otpi | The coronavirus is infecting and killing black Americans at an alarmingly high rate At the heart of the matter: unmasking and addressing COVID-19's toll on diverse populations Is racism a fundamental cause of inequalities in health? |
| cord-291687-kwu0otpi | [ Registry[ Full COVID-19 Registry Dashboard Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-291113-iizj932l | About It? |
| cord-291113-iizj932l | Some Factors Affecting the Survival of Airborne Viruses Do exposures to aerosols pose a risk to dental professionals? |
| cord-292386-hfbgigj6 | medRxiv Will coronavirus antibody tests really change everything? |
| cord-287100-xkp8a9b9 | : Is there a sensitive period, and is maternal exposure to infection during early pregnancy more harmful than later exposure? |
| cord-287100-xkp8a9b9 | Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? |
| cord-287100-xkp8a9b9 | Could this be the underlying cause of sex differences in the prevalence of mental disorders? |
| cord-287100-xkp8a9b9 | Does the effect of gestational exposure to infection differ among ethnic and cultural groups? |
| cord-287100-xkp8a9b9 | How does this genetic risk interact with maternal inflammation and other perinatal and postnatal contributors? |
| cord-287100-xkp8a9b9 | If so, what would be the role of health disparities on offspring neurodevelopmental abnormalities? |
| cord-287100-xkp8a9b9 | Is the male placenta( XY) more sensitive than the female placenta( XX) to the effects of the prenatal infection? |
| cord-287100-xkp8a9b9 | Is the risk of neurodevelopmental problems during maternal infection higher in those offspring with a family history of neuropsychiatric disorders? |
| cord-292462-zbjig3pt | A p r i l and Spain, chosen a stringent lockdown strategy in the fi rst place? |
| cord-291790-z5rwznmv | Which Genetic 594 Mutations Are Antigenically Important? |
| cord-291790-z5rwznmv | Why are RNA virus mutation rates so damn high? |
| cord-293059-2iwzieqm | In this special background, will inflammatory disorder and immune imbalance affect bone metabolism after COVID-19 infection? |
| cord-292650-i95upz10 | Are patients with inflammatory bowel disease at increased risk for Covid-19 infection? |
| cord-291420-40xsypzt | Can we gain valuable insights regarding RBD- ACE2 interface formation by analyzing these mutations? |
| cord-291420-40xsypzt | What are the mutations acquired on RBD during COVID-19 and what are the interfacial molecular rearrangements induced by these mutations? |
| cord-290148-6cxndab8 | Are there similarities between ACE-1, the target of ACEIs, and ACE-2, the target of SARS- CoV and SARS- CoV-2? |
| cord-290148-6cxndab8 | EMA Advises Continued Use of Medicines for Hypertension, Heart or Kidney Disease During COVID-19 Pandemic: EMA Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-290148-6cxndab8 | Enalapril attenuates downregulation of angiotensin- converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat Should COVID-19 concern nephrologists? |
| cord-290148-6cxndab8 | What is the role of ACE-1 and ACE-2 in infections caused by SARS- CoV and SARS- CoV-2? |
| cord-290148-6cxndab8 | why and to what extent? |
| cord-290472-w77cmljm | Autoallergy: a pathogenetic factor in atopic dermatitis? |
| cord-290472-w77cmljm | Is it possible that diseases such as multiple sclerosis and asthma actually are caused by the coordinating effect of genetic susceptibility and, say, viral infection? |
| cord-290472-w77cmljm | The evolving role of mass spectrometry in cancer biomarker discovery RNA- Seq: a revolutionary tool for transcriptomics Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinoma Asthma genetics: personalizing medicine Large- scale analysis of the yeast proteome by multidimensional protein identification technology Overcoming the dynamic range problem in mass spectrometry- based shotgun proteomics Autoantibodies as potential biomarkers for breast cancer Global analysis of protein activities using proteome chips Severe acute respiratory syndrome diagnostics using a coronavirus protein microarray ProCAT: a data analysis approach for protein microarrays Asthma and autoimmunity: is there a connection? |
| cord-290472-w77cmljm | Will we find that a disease associated with certain genetic markers also develops specific autoantibodies? |
| cord-290472-w77cmljm | mRNA? |
| cord-293315-kx4x2g24 | Report of four cases and review of the literature Screening and Severity of Coronavirus Disease 2019( COVID-19) in Children in Madrid Severe respiratory SARS- CoV2 infection: Does ACE2 receptor matter? |
| cord-292600-mgvrbfzd | When basic supplies are missing, what to do? |
| cord-292673-00s3wgem | over Ready to submit your research? |
| cord-293180-f1ulk9ce | Does it have a place in everyday practice? |
| cord-292657-gq3965se | The presence of SARS- CoV-2 RNA in feces of COVID-19 patients Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China Origin and evolution of pathogenic coronaviruses Phylogenetic network analysis of SARS- CoV-2 genomes Bat origin of human coronaviruses Influenza virus infectivity is retained in aerosols and droplets independent of relative humidity Effect of host species on the distribution of mutational fitness effects for an RNA virus Molecular evolution of MERS coronavirus: dromedaries as a recent intermediate host or longtime animal reservoir? |
| cord-293304-kakxmc14 | Hydroxychloroquine and Chloroquine for Treatment of SARS- CoV-2( COVID-19) New Insights on the Antiviral Effects of Chloroquine against Coronavirus: What to Expect for COVID-19? |
| cord-293517-8derad2p | When will NK- cells join the cellular immune cascade to fight SARS- CoV-2? |
| cord-286683-mettlmhz | : what decides the outcome? |
| cord-286683-mettlmhz | Could enhanced influenza and pneumococcal vaccination programs help limit the potential damage from SARS- CoV-2 to fragile health systems of southern hemisphere countries this winter? |
| cord-286683-mettlmhz | ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals Pediatric Patients With 2019 Coronavirus Disease in China Characteristics of pediatric SARS- CoV-2 infection and potential evidence for persistent fecal viral shedding Angiotensin- converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults Are children less susceptible to COVID-19? |
| cord-286683-mettlmhz | If clinically indicated:"Is it? |
| cord-286683-mettlmhz | Report of two cases& review of the literature Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records Clinical manifestations and outcome of SARS- CoV-2 infection during pregnancy Coronavirus in pregnancy and delivery: rapid review Coronavirus Disease 2019( COVID-19) and Pregnancy: What obstetricians need to know Guidelines for pregnant women with suspected SARS- CoV-2 infection Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province Novel corona virus disease( COVID-19) in pregnancy: What clinical recommendations to follow? |
| cord-286683-mettlmhz | The convalescent sera option for containing COVID-19 Drugmaker Takeda Is Working on Coronavirus Drug Breadth of concomitant immune responses prior to patient recovery: a case report of non- severe COVID-19 A Tale of Two Viruses: Does Heterologous Flavivirus Immunity Enhance Zika Disease? |
| cord-286683-mettlmhz | The role of ultrasound lung artifacts in the diagnosis of respiratory diseases Is there a role for lung ultrasound during the COVID-19 pandemic? |
| cord-292347-d7xq7x5g | Scalable, semi- automated fluorescence reduction neutralization assay 861 samples Diagnosis of Corona Virus Disease Announced the Development of a SARS-886 Analysis of serologic cross- reactivity between common human 889-2 using coronavirus antigen microarray Sensitive and specific monoclonal antibody- based capture enzyme 897 Diagnosis of Acute Respiratory Syndrome Coronavirus 2 903 Infection by Detection of Nucleocapsid Protein Chemiluminescent immunometric detection 906 of SARS- CoV in sera as an early marker for the diagnosis of SARS Standard coronavirus test, if available, works 910 well � but can new diagnostics help in this pandemic? |
| cord-292347-d7xq7x5g | What is CRISPR? |
| cord-291627-5dqwyd9r | : what is the evidence? |
| cord-291627-5dqwyd9r | Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus- EMC COVID-19 and Diabetes: Can DPP4 inhibition play a role? |
| cord-291397-look6ddt | : cord-291397-look6ddt authors: Roberto, Palumbo; Francesco, Londrino; Emanuela, Cordova; Giorgia, Gambardella; Pasquale, Niscola; Sara, Dominijanni title: Current treatment of COVID-19 in renal patients: hope or hype? |
| cord-291397-look6ddt | COVID-19 pneumonia: a random association? |
| cord-291397-look6ddt | Fact sheet for health care providers Emergency Use Authorization( EUA) of remdesivir( GS-5734 ™) Nucleosides for the treatment of respiratory RNA virus infections Mutagenesis in norovirus in response to Favipiravir treatment Laboratory findings, compassionate use of Favipiravir, and outcome in patients with Ebola virus disease, guinea, 2015-a retrospective observational study Drugs for influenza treatment: is there significant news? |
| cord-291397-look6ddt | The epidemiology, diagnosis and treatment of COVID-19 Chest X- ray features of SARS- CoV-2 in the emergency department: a multicenter experience from northern Italian hospitals New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-293301-7bmj8qsv | The risk of airborne influenza transmission in passenger cars Room ventilation and the risk of airborne infection 387 transmission in 3 health care settings within a large teaching hospital Droplet fate in indoor environments, or can we prevent the spread of infection? |
| cord-292152-gmru83ac | Different points from adults Viral RNA in Feces of Three Children during Recovery Period of COVID-19 Pneumonia Virological assessment of hospitalized patients with COVID-2019 Waugh's syndrome: a report of six patients Chronic Intussusception Associated with Malrotation in a Child: A Variation of Waugh's Syndrome? |
| cord-292152-gmru83ac | However, as the definition of suspected cases does not include presentations with gastrointestinal symptoms only, there is still no clear answer to the question"should we screen for SARS- CoV-2 infection in children who require admission to hospital with gastrointestinal symptoms?". |
| cord-293655-2ab7wdsk | From the 27 th of February until the 8 th of April, 2485 NF swabs( some of which repeated) were performed? |
| cord-292041-a65kfw80 | Has patient technique improved over time? |
| cord-292041-a65kfw80 | Phase I clinical trial of fenretinide( NSC374551) in advanced solid tumors Quis Custodiet Ipsos Custodes? |
| cord-292041-a65kfw80 | Sci Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19 SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS- Coronavirus infection Autophagy and viruses: Adversaries or allies? |
| cord-291954-wormplcu | : Does immunosuppression alter the clinical presentation? |
| cord-291954-wormplcu | COVID-19 pneumonia in kidney transplant recipients- where we are? |
| cord-293274-ysr1l557 | : Is Infection Along with Mycoplasma or other Bacteria Linked to Progression to a Lethal Outcome? |
| cord-293559-c78wcr8m | A Literature Review Is there a rationale for heparin use among severe COVID-19 patients? |
| cord-293389-3h9vsc1a | : Complement as a target in COVID-19? |
| cord-291624-fod0eyuj | As a potential treatment of COVID-19: Montelukast Recent advances in our understanding of mast cell activationor should it be mast cell mediator disorders? |
| cord-291624-fod0eyuj | Pathophysiologic and therapeutic considerations Kounis syndrome: an update on epidemiology, pathogenesis, diagnosis and therapeutic management Mast cell activation disorders presenting with cerebral vasospasm- related symptoms: a"Kounis- like"syndrome? |
| cord-291624-fod0eyuj | The mystery of the pandemic's'happy hypoxia Implications for forensic death investigations from rst Swiss post- mortem CT in a case of non- hospital treatment with COVID-19 Sudden and Complete Olfactory Loss Function as a Possible Symptom of COVID-19 The Early Natural History of SARS- CoV-2 Infection: Clinical Observations From an Urban, Ambulatory COVID-19 Clinic COVID-19 pneumonia: ARDS or not? |
| cord-291624-fod0eyuj | a review of the vascular barrier Therapeutic strategies targeting the endothelial glycocalyx: acute de cits, but great potential Increased levels of glycosaminoglycans during septic shock: relation to mortality and the antibacterial actions of plasma Thromboin ammation: challenges of therapeutically targeting coagulation and other host defense mechanisms Is Neuronal Histamine Signaling Involved in Cancer Cachexia? |
| cord-292836-1o2ynvy3 | Human coronavirus OC43 associated with fatal encephalitis Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis The role of human coronaviruses in children hospitalized for acute bronchiolitis, acute gastroenteritis, and febrile seizures: a 2-year prospective study Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? |
| cord-292836-1o2ynvy3 | What ’s New With the Old Coronaviruses? |
| cord-292416-3hhi4wps | The next outbreak? |
| cord-292416-3hhi4wps | what can they teach us about the severe acute respiratory syndrome? |
| cord-292972-p7ifetgw | Does SARS‐CoV‐2 has a longer incubation period than SARS and MERS? |
| cord-292972-p7ifetgw | medRxiv Does SARS- CoV-2 has a longer incubation period than SARS and MERS? |
| cord-293732-rxd1lyi7 | Will Coronavirus Pandemic Diminish by Summer? |
| cord-286006-t5gj0k54 | As an example, a health care provider described a decision- making process for obtaining sufficient infection- control masks: Someone said,'we're going to need 5,000 masks', and someone else asked,'how many masks?' |
| cord-286006-t5gj0k54 | Had we put our staff at risk? |
| cord-286006-t5gj0k54 | Had we put ourselves at risk? |
| cord-286006-t5gj0k54 | He looked to someone with him and asked,'how many do we have?' |
| cord-286006-t5gj0k54 | How are we going to get 5000?' |
| cord-286006-t5gj0k54 | Interviewer:"What do you think would have happened if you left your room?" |
| cord-286006-t5gj0k54 | The immediate psychological and occupational impact of the 2003 SARS outbreak in a teaching hospital Avian Flu fears: are we overdue for a pandemic? |
| cord-286006-t5gj0k54 | Who's going to educate the screeners?' |
| cord-290863-f0wpsaip | What are the implications for public health practice? |
| cord-290863-f0wpsaip | What is added by this report? |
| cord-290863-f0wpsaip | What is already known about this topic? |
| cord-290863-f0wpsaip | † Patients were asked the question"Would you say that you are feeling back to your usual health?" |
| cord-293167-3bd3adip | Associated with SARS- CoV-2 Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-293167-3bd3adip | Guillain- Barré syndrome following COVID-19: new infection, old complication? |
| cord-291719-1ku6cmwj | -Thymic involution or peripheral homeostatic proliferation? |
| cord-291719-1ku6cmwj | Is BCG vaccination affecting the spread and severity of COVID-19? |
| cord-291719-1ku6cmwj | [ Internet BCG vaccine protection from severe coronavirus disease 2019( COVID-19) Is global BCG vaccination- induced trained immunity relevant to the progression of SARS- CoV-2 pandemic? |
| cord-291719-1ku6cmwj | and what are the wider lessons? |
| cord-285822-b5itedu3 | According to Procedure Indication Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis Time to Endoscopy in Patients with Colorectal Cancer: Analysis of Wait- Times Symptom or faecal immunochemical test based referral criteria for colorectal cancer detection in symptomatic patients: a diagnostic tests study Diagnostic accuracy of one or two faecal haemoglobin and calprotectin measurements in patients with suspected colorectal cancer Canadian consensus on medically acceptable wait times for digestive health care Priority and appropriateness of upper endoscopy out- patient referrals: Two- period comparison in an open- access unit Identification of upper gastrointestinal malignancy in patients with uncomplicated dyspepsia referred under the two- week- wait cancer pathway: a single- centre, 10-year experience Improving the appropriateness of referrals and waiting times for endoscopic procedures Gastroenterology department operational reorganisation at the time of covid-19 outbreak: an Italian and Chinese experience Overview of guidance for endoscopy during the coronavirus disease COVID-19 in endoscopy: Time to do more? |
| cord-285822-b5itedu3 | COVID-19: How to select patients for endoscopy and how to reschedule the procedures? |
| cord-285822-b5itedu3 | Cómo debe realizarse la desinfección de dispositivos, material, superficies y salas de endoscopia? |
| cord-285822-b5itedu3 | Qué criterios se recomienda emplear para priorizar los procedimientos endoscópicos en nuestro medio? |
| cord-285822-b5itedu3 | Si no dispone de equipos de protección personal, se debe realizar la endoscopia? |
| cord-285822-b5itedu3 | Y la gestión de residuos? |
| cord-285822-b5itedu3 | a considerar en la fase de transicion European panel on the appropriateness of gastrointestinal endoscopy II guidelines help in selecting and prioritizing patients referred to colonoscopy-- a quality control study Colonoscopy appropriateness: Really needed or a waste of time? |
| cord-285822-b5itedu3 | especial durante la oxigenoterapia en la sedación? |
| cord-285822-b5itedu3 | o en una sala habilitada específicamente para tal uso? |
| cord-285822-b5itedu3 | previo al inicio de la reprogramación de actividad tras superar el pico de pandemia por SARS- CoV-2? |
| cord-285822-b5itedu3 | sanitario? |
| cord-285822-b5itedu3 | se discuta específicamente el método de trabajo? |
| cord-285822-b5itedu3 | ¿ es recomendable emplear métodos de barrera adicionales sobre el área nasobucal del paciente o sobre las válvulas del endoscopio? |
| cord-276209-5999g9gp | -Could a vaccine be provided through a revised definition of a compassionate use mechanism in the highest risk subjects after signing waivers of responsibility and enhanced informed- consent procedures? |
| cord-276209-5999g9gp | -Might one conceive of differential regulatory pathways for vaccine candidates using well- understood antigens, vaccine methodology, adjuvants, manufacture, and routes of administration( TBD) versus those using novel delivery technology and novel antigens or adjuvants? |
| cord-276209-5999g9gp | -What will be the endpoint for determining vaccine efficacyprevention of infection? |
| cord-276209-5999g9gp | -What, if any, animal models might be developed that allow the''animal rule"to be utilized in an effort to accelerate research and licensure? |
| cord-276209-5999g9gp | Could this be a viable strategy in accelerating licensure? |
| cord-276209-5999g9gp | For example, what level of risk are we willing to tolerate to immunize against an infection that may disappear in the next year or two? |
| cord-276209-5999g9gp | I and II trials are conducted earlier than normal procedure, could a phased initiation of studies from highest risk to lowest risk subjects be utilized? |
| cord-276209-5999g9gp | Might reasonable''accommodations"be made for such a scenario? |
| cord-276209-5999g9gp | Might that safety profile be somewhat different( to be defined) in an exceptionally high risk 80-yearold with multiple co- morbidities? |
| cord-276209-5999g9gp | Or that could diminish in severity in the short- to mid- term? |
| cord-276209-5999g9gp | Or to administer to young children whose risk of both serious illness or death is quantifiably very, very low? |
| cord-276209-5999g9gp | Other?-Will |
| cord-276209-5999g9gp | Prevention of severe disease? |
| cord-276209-5999g9gp | Prevention of viral shedding? |
| cord-276209-5999g9gp | Several seem worth immediate discussion:-Could a vaccine be provided through an EUA mechanism for mentally competent adults who meet certain risk guidelines, and in the context of study enrollment and data collection, and enhanced informed consent? |
| cord-276209-5999g9gp | What about for pregnant women or younger but immunocompromised persons? |
| cord-276209-5999g9gp | What does history teach us in regard to vaccine development? |
| cord-276209-5999g9gp | Who should be included- perhaps healthcare providers and first responders who share the highest risk of infection as a starting point? |
| cord-276209-5999g9gp | different vaccines and different regulatory pathways be feasible for different members of the population with differing risk: benefit ratios? |
| cord-294122-ou3wj4rz | Did the infection control measures and policies employed to control the SARS outbreak produce collateral damage to the delivery of health care to the population? |
| cord-293136-lfwqzf8m | High risk of severe forms? |
| cord-293136-lfwqzf8m | Pediatr Blood Cancer Will children reveal their secret? |
| cord-293991-x5zdo8t2 | Phenotype and kinetics of SARS- CoV-2-specific T cells 687 in COVID-19 patients with acute respiratory distress syndrome Selective and cross- reactive SARS- CoV-2 T cell epitopes in 690 unexposed humans Cutting edge: long- term B cell memory in humans after 692 smallpox vaccination Updates on immunologic correlates of vaccine- induced 695-28 Correlates of protection to influenza virus, where do we go from 697 here? |
| cord-294592-zwvr57a0 | A new key player in virus- host interactions? |
| cord-293765-xpc4yizb | the profile of humoral and cellular immunity and their importance in SARS; whether cytokines and chemokines play a role in pathogenesis of SARS; the status of immune memory function of lymphocytes in SARS? |
| cord-291264-akuvt5ig | Abstract Is the new coronavirus SARS- CoV-2 able to infect ocular tissue and thus poses a risk of infection through the tissue in addition to the risk of contact? |
| cord-291264-akuvt5ig | Frage ist, ab wann betrachtet man eine Expression als relevant? |
| cord-291264-akuvt5ig | Kann SARS- CoV-2 das Auge infizieren? |
| cord-291264-akuvt5ig | akuvt5ig Is the new coronavirus SARS- CoV‑2 able to infect ocular tissue and thus poses a risk of infection through the tissue in addition to the risk of contact? |
| cord-290443-naulq6q7 | 2 after myocardial infarction by blockade of angiotensin II receptors Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats Urinary angiotensin- converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker Renin- angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin- angiotensin system blockers Effects of spironolactone and eprosartan on cardiac remodeling and angiotensin- converting enzyme isoforms in rats with experimental heart failure COVID-19 and angiotensin- converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence? |
| cord-290443-naulq6q7 | Angiotensin converting enzyme 2-an ally or a Trojan horse? |
| cord-290443-naulq6q7 | Renin- angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension COVID-19 and the cardiovascular system COVID-19-is the ACE2 just a foe? |
| cord-290443-naulq6q7 | a retrospective cohort study Clinical characteristics of 140 patients infected with SARS- CoV-2 in Wuhan Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease? |
| cord-290443-naulq6q7 | key: cord-290443-naulq6q7 authors: Battistoni, Allegra; Volpe, Massimo title: Might renin – angiotensin system blockers play a role in the COVID-19 pandemic? |
| cord-294677-l1b4mw9d | towards prediction paradise? |
| cord-294136-e69ao8j0 | Since asymptomatic transmission is an established fact, how many individuals in the infected population are attributed to asymptomatic transmission? |
| cord-293988-f5gvwjyh | An important question remains unanswered: did the cat actually die due to SARS- CoV-2 infection? |
| cord-292580-caxb9ob9 | Are there more effective carriers than D5W for siRNA delivery? |
| cord-292580-caxb9ob9 | Will aerosol delivery of siRNAs be more effective than intranasal instillation? |
| cord-292580-caxb9ob9 | cord-292580-caxb9ob9 authors: Chang, Z; Hu, J title: RNAi therapeutics: Can siRNAs conquer SARS? |
| cord-294134-o9bx1gn7 | The role of antibody testing for SARS- CoV-2: is there one? |
| cord-292209-d1ty9etr | : Is There One? |
| cord-292209-d1ty9etr | : What can we learn from the 2010 National Demographic Census? |
| cord-292209-d1ty9etr | Due to the presence of widespread multiethnic population, the official Brazilian classification of ethnicity recognizes five groups, based on the question:"How do you classify yourself in terms of color or race?" |
| cord-292209-d1ty9etr | Society and the slow burn of inequality Risk factors for SARS- CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross- sectional study OpenSAFELY: factors associated with COVID-19 death in 17 million patients Prevalence of SARS- CoV-2 in Spain( ENE- COVID): a nationwide, population- based seroepidemiological study Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross- sectional observational study In the COVID-19 pandemic in Brazil, do brown lives matter? |
| cord-294427-6eiligyy | : Are We Doing Enough? |
| cord-294363-bv6xa8v8 | what lessons have we learned? |
| cord-292350-cmrtg91a | A Report of Thromboelastography Findings and other Parameters of Hemostasis Spontaneous echo contrast in venous ultrasound of severe COVID-19 patients COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow- up Type and dose of heparin in COVID-19 The old but new: Can unfractioned heparin and low molecular weight heparins inhibit proteolytic activation and cellular internalization of SARS- CoV2 by inhibition of host cell proteases? |
| cord-292350-cmrtg91a | Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities Catheter- directed thrombolysis in COVID-19 pneumonia with acute PE: Thinking beyond the guidelines Occurrence of pulmonary embolism in a patient with mild clinical expression of COVID-19 Acute Cerebral Stroke with Multiple Infarctions and COVID-19 Placental Pathology in Covid-19 Positive Mothers: Preliminary Findings Concomitant brain arterial and venous thrombosis in a COVID-19 patient Is there a correlation between inflammatory markers and coagulation parameters in women with advanced ovarian endometriosis? |
| cord-292350-cmrtg91a | Two Complications of COVID-19 Pneumonia? |
| cord-292350-cmrtg91a | an updated perspective of the European experience Delivering extracorporeal membrane oxygenation for patients with COVID-19: what, who, when and how? |
| cord-294571-qd0qjo3y | An evolving story in cardiovascular regulation ACE2 and diabetes: ACE of ACEs? |
| cord-290428-zrlqzbss | A recent perspective on alcohol, immunity, and host defense Health risks and benefits of alcohol consumption Vitamins, are they safe? |
| cord-290428-zrlqzbss | A review of micronutrients and the immune system- working in harmony to reduce the risk of infection Optimisation of vitamin D status for enhanced immuno- protection against Covid-19 Vitamin D status in the tropics: is sunlight exposure the main determinant? |
| cord-290428-zrlqzbss | Safety considerations and potential interactions of vitamins: should vitamins be considered drugs? |
| cord-290428-zrlqzbss | The effect on winter illness of large doses of vitamin C High- dose monthly vitamin D for prevention of acute respiratory infection in older long- term care residents: a randomized clinical trial Vitamin D for prevention of respiratory tract infections: a systematic review and meta- analysis Vitamin D and influenza- prevention or therapy? |
| cord-290428-zrlqzbss | The goal was to address one main question: What nutritional advice is being offered for individuals in quarantine during the COVID-19 pandemic? |
| cord-290428-zrlqzbss | The role of zinc in antiviral immunity Low zinc status: a new risk factor for pneumonia in the elderly? |
| cord-290428-zrlqzbss | Vitamin and mineral supplements: do we really need them? |
| cord-294372-pec1886j | Decreasing median age of COVID-19 cases in the United States — Changing epidemiology or changing surveillance? |
| cord-293831-28ddm9um | To capture possible over- reaction of the public, a supplementary question was asked"In the past week, have you ever purchased or tried to purchase goggles for the purpose of protection against infection with SARS- CoV-2?" |
| cord-293831-28ddm9um | why, how& when? |
| cord-294861-inlaz4od | The treatment and outcome of a lung cancer patient infected with SARS- CoV-2 Outcome of oncology patients infected with coronavirus Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study COVID-19 in a patient with chronic lymphocytic leukaemia Active and effective measures for the care of patients with cancer during the COVID-19 spread in China Case report of COVID-19 in a kidney transplant recipient: does immunosuppression alter the clinical presentation? |
| cord-284498-54j6ys8s | -A potential transmission route for SARS- CoV-2 to humans? |
| cord-284498-54j6ys8s | : what is its fate in urban water cycle and how can the water research community respond? |
| cord-284498-54j6ys8s | Any sustainable preventive measures to curtail the scourge in low- income countries? |
| cord-284498-54j6ys8s | COVID-19 faecal- oral transmission: Are we asking the right questions? |
| cord-284498-54j6ys8s | COVID-19: faecal- oral transmission? |
| cord-284498-54j6ys8s | How can materials science contribute to fighting against the new coronavirus? |
| cord-284498-54j6ys8s | RNA detection of hospital isolation wards hygiene monitoring during the Coronavirus Disease 2019 outbreak in a Chinese hospital Techno- economic analysis of single disinfection units and integrated disinfection systems for sewage effluent reclamation How much reduction of virus is needed for recycled water: A continuous changing need for assessment? |
| cord-284498-54j6ys8s | The SARS epidemic in Hong Kong: what lessons have we learned? |
| cord-284498-54j6ys8s | The role of wastewater treatment plants as tools for SARS- CoV-2 early detection and removal Fecal transmission in COVID-19: A potential shedding route SARS- CoV-2 from faeces to wastewater treatment: What do we know? |
| cord-284498-54j6ys8s | a Paper- Based Device Trace COVID-19 Sources with Wastewater- Based Epidemiology? |
| cord-284498-54j6ys8s | some serious consequences with urban and rural water cycle COVID-19 may transmit through aerosol Evidence for gastrointestinal infection of SARS- CoV-2 Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-294551-s3nsiano | The spectrum of severe acute respiratory syndrome- associated coronavirus infection Can routine laboratory tests discriminate between severe acute respiratory syndrome and other causes of community- acquired pneumonia? |
| cord-294349-ps3qlho2 | They are a large family of singlestranded RNA viruses(? ssRNA) that can be isolated from different animal species. |
| cord-288632-2aliqy8p | Can we use interleukin-6( IL-6) blockade for coronavirus disease 2019( COVID-19)-induced cytokine release syndrome( CRS)? |
| cord-288632-2aliqy8p | Does stress account for SES effects on health? |
| cord-288632-2aliqy8p | Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade- long structural studies of SARS coronavirus Molecular mechanism for antibody- dependent enhancement of coronavirus entry Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries( the INTERHEART study): case- control study Racial disparities in health: How much does stress really matter? |
| cord-288632-2aliqy8p | The ACE-2 in COVID-19: foe or friend? |
| cord-288632-2aliqy8p | The effect of novel polymorphisms in the interleukin-6( IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic- onset juvenile chronic arthritis Clinical significance of interleukin-6( IL-6) gene polymorphism and IL-6 serum level in pancreatic adenocarcinoma and chronic pancreatitis The− 174G/ C polymorphism of IL-6 is useful to screen old subjects at risk for atherosclerosis or to reach successful ageing Covid-19: known risk factors fail to explain the increased risk of death among people from ethnic minorities Genetic adaptation and neandertal admixture shaped the immune system of human populations Scarcity in digital health innovation for Medicaid populations: is help on the way? |
| cord-288632-2aliqy8p | The vasoprotective axes of the reninangiotensin system: physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-288632-2aliqy8p | decreases circulating inflammatory IL-6 and MCP-1 in mice Genetics of hypertension in African Americans and others of African descent Hospitalization rates and characteristics of patients hospitalized with laboratory- confirmed coronavirus disease 2019-COVID- NET, 14 states Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? |
| cord-294441-nehorqhi | What can natural infection of African monkeys with simian immunodeficiency virus tell us about the pathogenesis of AIDS? |
| cord-293415-u9onutny | SARS- coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum SARS- CoV-2 productively infects human gut enterocytes SARS coronavirus papain- like protease induces Egr-1-dependent up- regulation of TGF- beta1 via ROS/ p38 The Heart in COVID19: Primary Target or Secondary Bystander? |
| cord-293415-u9onutny | a more sensitive and accurate tool for SARS- CoV-2 detection in low viral load specimens Myocardial localization of coronavirus in COVID-19 cardiogenic shock SARS- CoV-2 receptor ACE2 expression in the human heart: cause of a post- pandemic wave of heart failure? |
| cord-293415-u9onutny | in a patient with SARS- CoV-2 respiratory infection Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS- CoV-2 in Covid-19: Key Therapeutic Targets? |
| cord-293736-nyvwv31m | : can we go from bench to bedside? |
| cord-293736-nyvwv31m | An update on immune dysregulation in obesity- related insulin resistance Adipokines and inflammation: is it a question of weight? |
| cord-293736-nyvwv31m | COVID-19 pneumonia: ARDS or not? |
| cord-291644-5y0ioety | : what's new to NO? |
| cord-291644-5y0ioety | How do red blood cells cause hypoxic vasodilation? |
| cord-291644-5y0ioety | How does spa treatment affect cardiovascular function and vascular endothelium in patients with generalized osteoarthritis? |
| cord-291644-5y0ioety | Repeated sauna therapy attenuates ventricular remodeling after myocardial infarction in rats by increasing coronary vascularity of noninfarcted myocardium Experimental investigation in rats to identify the cause of sudden death during bathing in Japan Small molecules for great solutions: Can nitric oxide- releasing nanomaterials overcome drug resistance in chemotherapy? |
| cord-291644-5y0ioety | Repeated sauna therapy increases arterial endothelial nitric oxide synthase expression and nitric oxide production in cardiomyopathic hamsters Can heat therapy help patients with heart failure? |
| cord-291595-8241pjpe | A report of five cases C5a negatively regulates tolllike receptor 4-induced immune responses Regulation of Toll- like receptor- mediated inflammatory response by complement in vivo Complement as a target in COVID-19? |
| cord-291595-8241pjpe | Angiotensin II- induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor- beta Angiotensin II sustains brain inflammation in mice via TGF- β Severe hypertension with renal thrombotic microangiopathy: what happened to the usual suspect? |
| cord-291595-8241pjpe | COVID-19: a case for inhibiting IL-17? |
| cord-291595-8241pjpe | Distinct immune response in two MERS- CoV- infected patients: can we go from bench to bedside? |
| cord-291595-8241pjpe | defined subsets, random expression, and external modulation IL-10 dampens TNF/ inducible nitric oxide synthaseproducing dendritic cell- mediated pathogenicity during parasitic infection Interleukin-10 and the regulation of mitogenactivated protein kinases: are these signalling modules targets for the anti- inflammatory action of this cytokine? |
| cord-291595-8241pjpe | to Prevent Lung Damage in SARSCoV2 Infection? |
| cord-294933-oc2glu4a | The SARS MERS and novel coronavirus( COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
| cord-295548-o877eog6 | ( 1) Can radiographic features seen early in the course of the disease predict clinical response and adverse outcome( intubation and intensive care unit support, death)? |
| cord-295075-cqbayzat | A new trick for an old drug Old drugs as lead compounds for a new disease? |
| cord-294789-07hto8qn | People will judge a COVID-19 vaccination campaign's integrity not simply on biomedical merits, but on matters of fairness and equity- that is, have people received their just portion of health services, and has disease prevention, ultimately, been fairly distributed? |
| cord-294789-07hto8qn | Will Ebola change the game? |
| cord-292387-2xv3wgaq | After the COVID-19 Crisis: Novel Resources to Sustain/ Improve Psychosis Outcome? |
| cord-292387-2xv3wgaq | Brief psychotic disorder triggered by fear of coronavirus? |
| cord-292387-2xv3wgaq | Perspectives from SARS to Ebola Elderly suicide and the 2003 SARS epidemic in Hong Kong Addressing the COVID-19 pandemic in populations with serious mental illness Mental health services in Italy during the COVID-19 outbreak What causes psychosis? |
| cord-292387-2xv3wgaq | the need for prevention and early intervention Is there a case for quarantine? |
| cord-294212-nlekz39f | Several immunological questions are critical:"Are the immunogenic profiles of SARS- CoV-2 and SARS- CoV as similar as the genetic relationship shown in the phylogenetic trees?";"Do the immunogenic properties of both viruses differ significantly from each other?"; and"Can the NAbs raised against SARS- CoV provide effective protection against the infection of SARS- CoV-2?". |
| cord-294212-nlekz39f | Several immunological questions are critical:"Are the immunogenic profiles of SARS- CoV-2 and SARS- CoV as similar as the genetic relationship shown in the phylogenetic trees?";"Do the immunogenic properties of both viruses differ significantly from each other?"; and"Can the NAbs raised against SARS- CoV provide effective protection against the infection of SARS- CoV-2?". |
| cord-294212-nlekz39f | Several immunological questions are critical:"Are the immunogenic profiles of SARS- CoV-2 and SARS- CoV as similar as the genetic relationship shown in the phylogenetic trees?";"Do the immunogenic properties of both viruses differ significantly from each other?"; and"Can the NAbs raised against SARS- CoV provide effective protection against the infection of SARS- CoV-2?". |
| cord-294910-gnc04ax1 | Primary Target or Secondary Bystander? |
| cord-294910-gnc04ax1 | vulnerability Acute kidney injury is associated with the mortality of coronavirus disease 2019 Determinants of blood pH in health and disease Is the kidney a target of SARS- CoV-2? |
| cord-294831-pem059zk | New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-294831-pem059zk | What caused lymphopenia in SARS and how reliable is the lymphokine status in glucocorticoid- treated patients? |
| cord-293946-4bquxdqa | : Do chickens pose the principal transmission threat? |
| cord-293946-4bquxdqa | A problem or solution for conservation? |
| cord-293946-4bquxdqa | The Distribution of Henipaviruses in Southeast Asia and Australasia: Is Wallace's Line a Barrier to Nipah Virus? |
| cord-293946-4bquxdqa | The National Academies Press Global Economic Effects of COVID-19 Global patterns in coronavirus diversity Rapid review Wet markets- a continuing source of severe acute respiratory syndrome and influenza? |
| cord-295375-nakxfhxk | Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus( MERS- CoV): a systematic review and meta- analysis Prevalence of diabetes in the 2009 influenza A( H1N1) and the Middle East respiratory syndrome coronavirus: a systematic review and meta- analysis A systematic, thematic review of social and occupational factors associated with psychological outcomes in healthcare employees during an infectious disease outbreak Effect of integrated traditional Chinese medicine and western medicine on the treatment of severe acute respiratory syndrome: a meta- analysis What have we learned about Middle East respiratory syndrome coronavirus emergence in humans? |
| cord-295257-iguhy1z8 | A.I.D.S Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-296147-yfcp0xf2 | COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions Diagnostic performances and thresholds: the key to harmonization in serological SARS- CoV-2 assays? |
| cord-294854-rvrgcugn | COVID-19) 2020 COVID-19, SARS and MERS: are they closely related? |
| cord-294854-rvrgcugn | The Journal of infection Hydroxychloroquine inhibits CD154 expression in CD4 T lymphocytes of systemic lupus erythematosus through NFAT, but not STAT5, signaling Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-296031-r6iqiy1n | The association of smoking status with SARS- CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review Smoking, vaping and hospitalization for COVID-19 Editorial: Nicotine and SARS- CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system How nicotine can inhibit cytokine storm in the lungs and prevent or lessen the severity of COVID-19 infection? |
| cord-294501-1nf98mpb | : Are they pieces of the same puzzle? |
| cord-294501-1nf98mpb | As Two Sides of the Same Coin: Friends or Foes? |
| cord-294501-1nf98mpb | a cytokine for gerontologists Current concepts in the diagnosis and management of cytokine release syndrome Sexual- dimorphism in human immune system aging Inflammaging as a major characteristic of old people: can it be prevented or cured? |
| cord-295800-w0dup04b | A major outbreak of severe acute respiratory syndrome in Hong Kong Case definitions for surveillance of severe acute respiratory syndrome( SARS) Induction of postinflammatory cytokines in human macrophages by influenza A( H5N1) viruses: a mechanism for the unusual severity of human disease? |
| cord-287304-h6wj7m8u | : what is acceptable in terms of use of space by various bodies in cities? |
| cord-287304-h6wj7m8u | Anomalous centrality, community structure, and cities'global roles Geographical aspects of the emergence of infectious diseases Policy without polity? |
| cord-287304-h6wj7m8u | Liberty and Security for the Post- September 11 United States Public resistance or cooperation? |
| cord-287304-h6wj7m8u | Policy recommendations on land use change and infectious disease emergence Too much fuss? |
| cord-287304-h6wj7m8u | Second, hospitals were sources of SARS infection in the community, breaking down the boundaries of medical care and community in threatening ways( leading to the question of how far do providers of healthcare have to go to provide safe spaces?). |
| cord-287304-h6wj7m8u | The event organizers are clear that they expect citizens to do their part when taking in exhibits under"the theme'What are your reasons for being prepared?' |
| cord-287304-h6wj7m8u | These paradoxes/ dilemmas were, first, that healthcare workers became sources of transmission and active sustainers of the SARS case matrix( leading to the dilemma to be forced to decide whose safety gets priority: patients or caregivers?). |
| cord-287304-h6wj7m8u | Thus, isolation and quarantine did appear effective in fighting the outbreak, but what more could be done to prepare such containment strategies in case of future outbreaks in the global city? |
| cord-287304-h6wj7m8u | Toronto inc.? |
| cord-296219-zzg9hds0 | The role of lung function in brain tissue oxygenation following traumatic brain injury Brain tissue oxygen response in severe traumatic brain injury Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual- energy CT COVID-19 patients with respiratory failure: what can we learn from aviation medicine? |
| cord-296187-nnv2e7gr | A small molecule- kinase interaction map for clinical kinase inhibitors Molecular therapeutics: is one promiscuous drug against multiple targets better than combinations of molecule- specific drugs? |
| cord-296362-9vi8xwu7 | Recently, the functions of several non- structural proteins( nsps) have been determined, including a non- canonical RdRp( nsp8), a single- stranded RNA- binding protein( nsp9), a RNA- dependent RNA polymerase( nsp12), a superfamily 1-like helicase( nsp13), a 3 0? |
| cord-294115-7t7kubf6 | Could we have done better with COVID-19 in nursing homes? |
| cord-294115-7t7kubf6 | For Ageing Is it wrong to prioritise younger patients with covid-19? |
| cord-294115-7t7kubf6 | What is'shielding'and who needs to do it? |
| cord-293852-r72c6584 | Could interferon- gamma be a therapeutic target for treating heart failure? |
| cord-293852-r72c6584 | Fatal Severe Acute Respiratory Syndrome is Associated with Multiorgan Involvement by Coronavirus Quantitative temporal- spatial distribution of severe acute respiratory syndromeassociated coronavirus( SARS- CoV) in post- mortem tissues SARS- coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS Preventing a Covid-19 Pandemic SARS- CoV2: should Inhibitors of the Renin- Angiotensin System be Withdrawn in Patients with COVID-19? |
| cord-293852-r72c6584 | Noncoding RNAs regulating inflammation and the cardiovascular system: are they playing a role in COVID-19? |
| cord-293852-r72c6584 | over Ready to submit your research? |
| cord-291916-5yqc3zcx | Are they closely related? |
| cord-291916-5yqc3zcx | New evidence for an old therapeutic tool? |
| cord-291916-5yqc3zcx | The Allplex 2019-nCoV( Seegene) assay: Which performances are for SARS- CoV-2 infection diagnosis? |
| cord-291916-5yqc3zcx | The epidemiology and pathogenesis of coronavirus disease( COVID-19) outbreak Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents Enteric involvement of coronaviruses: Is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-291916-5yqc3zcx | What we know? |
| cord-291916-5yqc3zcx | cyclin G- associated kinase regulate hepatitis C virus entry and are potential drug targets Effects of chloroquine on viral infections: An old drug against today's diseases? |
| cord-295523-5pv7kw6i | Still's disease and catastrophic antiphospholipid syndrome triggered by fulminant Chikungunya infection: A case report of two patients Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway Regulation of ferritin genes and protein Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/ sepsis/ multiple organ dysfunction syndrome/ macrophage activation syndrome: What is the treatment? |
| cord-295523-5pv7kw6i | The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: Systematic review and meta- analyses Long- term anti- TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry Long- term safety of abatacept in patients with rheumatoid arthritis Adverse effects of biologics: A network meta- analysis and Cochrane overview Influenza vaccination in systemic lupus erythematosus: Safe and protective? |
| cord-295742-d11ty5ed | SARS- CoV-2 and cancer: are they really partners in crime? |
| cord-295742-d11ty5ed | the results of the Assaad et al paper? |
| cord-294237-6hovffso | And, if it does, how should it be treated and can it be contained? |
| cord-294237-6hovffso | At the present time, there are two key questions that relate to SARS: Will the disease reoccur? |
| cord-294237-6hovffso | ␣ protects type 1 pneumocytes against SARS coronavirus infection in macaques Antiviral treatment of SARS: can we draw any conclusions? |
| cord-293259-o51fnvuw | : what is"immunosenescence Immunosenescence and inflamm- aging as two sides of the same coin: friends or foes? |
| cord-293259-o51fnvuw | COVID-19: the gendered impacts of the outbreak Will children reveal their secret? |
| cord-293259-o51fnvuw | Possible vertical transmission of SARS- CoV-2 from an infected mother to her newborn Antibodies in infants born to mothers with COVID-19 pneumonia Neonatal early- onset infection with SARS- CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan Is it Kawasaki shock syndrome, Kawasaki- like disease or pediatric inflammatory multisystem disease? |
| cord-293259-o51fnvuw | The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases( COVID-19)-China Coronavirus disease 2019( COVID-19) in Italy Clinical and epidemiological features of 36 children with coronavirus disease 2019( COVID-19) in Zhejiang, China: an observational cohort study Are children less susceptible to COVID-19? |
| cord-293259-o51fnvuw | Why some children experience more severe illness? |
| cord-296378-ki93iltt | what next? |
| cord-295830-1sbnewog | A Novel Synonymous Mutation of SARS- CoV-2: Is This Possible to Affect Their Antigenicity and Immunogenicity? |
| cord-295029-zki5ac2g | COVID-19: how do we protect health care personnel during neurosurgical operations in the midst of aerosol- generation from high- speed drills? |
| cord-295029-zki5ac2g | Is this just a lot of hot air? |
| cord-295864-kwdvais7 | A future for the world's children? |
| cord-295864-kwdvais7 | Has China faced only a herald wave of SARS- CoV-2? |
| cord-296390-jv86w4j9 | The epidemiologic characteristics of an outbreak of 2019 novel coronavirus diseases( COVID-19) in China Pathological findings of COVID-19 associated with acute respiratory distress syndrome COVID-19 Autopsies Pulmonary Manifestations of Acute Lung Injury: More Than Just Diffuse Alveolar Damage Surgical lung biopsy in adult respiratory distress syndrome: a meta- analysis Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study orticosteroids in sepsis: from bench to bedside? |
| cord-296128-kjoi54ea | Giulia title: Do we have serological evidences that chilblain‐like lesions are related to SARS‐CoV‐2? |
| cord-296128-kjoi54ea | No Antibody Response in Acral Cutaneous Manifestations Associated With COVID-19? |
| cord-296602-19noki6p | Different faces of regulatory DCs in homeostasis and immunity Is there an ideal animal model for SARS? |
| cord-296692-t5p09le8 | What next? |
| cord-296579-oa67njov | a call to action to identify and address racial and ethnic disparities Are clinicians contributing to excess African American COVID-19 deaths? |
| cord-294527-fct2y5vn | COVID-19 psychosis: a potential new neuropsychiatric condition triggered by novel coronavirus infection and the inflammatory response? |
| cord-294527-fct2y5vn | The spectrum of antecedent infections in Guillain- Barré syndrome: a case- control study Guillain- Barré syndrome associated with Zika virus infection Neurological complications during treatment of middle east respiratory syndrome Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-294527-fct2y5vn | based case- control study Anosmia and dysgeusia in the absence of other respiratory diseases: should COVID-19 infection be considered? |
| cord-294527-fct2y5vn | during the acute treatment phase: a series of 10 cases Factors associated with psychosis among patients with severe acute respiratory syndrome: a case- control study Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta- analysis with comparison to the COVID-19 pandemic Cytokines, oxidative stress and cellular markers of inflammation in schizophrenia Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? |
| cord-295794-glcg36si | But what happens when the initial critical phase of the COVID-19 outbreak has passed? |
| cord-289535-srrfr1es | CD8+ T- cell responses after rAd5 boost in a randomized clinical trial BCG- induced trained immunity: can it offer protection against COVID-19? |
| cord-289535-srrfr1es | Can existing live vaccines prevent COVID-19? |
| cord-289535-srrfr1es | Could an unrelated live attenuated vaccine serve as a preventive measure to dampen septic inflammation associated with COVID-19 infection? |
| cord-289535-srrfr1es | How immune T- cell augmentation can help prevent COVID-19: a possible nutritional solution using ketogenic lifestyle jri/ vol4without altering disease transmission work? |
| cord-289535-srrfr1es | How to achieve equitable global distribution? |
| cord-289535-srrfr1es | Is human challenge part of the pathway to a licensed product? |
| cord-289535-srrfr1es | Is there an ideal animal model for SARS? |
| cord-289535-srrfr1es | Mammalian microRNAs predominantly act to decrease target mRNA levels AU- rich elements and associated factors: are there unifying principles? |
| cord-289535-srrfr1es | Nonspecific protection of mice against influenza virus infection by local or systemic immunization with bacille Calmette- Guerin Is global BCG vaccination coverage relevant to the progression of SARS- CoV-2 pandemic? |
| cord-289535-srrfr1es | What is the risk of immunopathology? |
| cord-289535-srrfr1es | Why Norwood? |
| cord-296440-18vpg419 | enquête Do chronic respiratory diseases or their treatment affect the risk of SARS- CoV-2 infection? |
| cord-295051-upyar7en | COVID-19 concern nephrologists? |
| cord-295051-upyar7en | Why and to what extent? |
| cord-296426-upwsdgso | Identifying a Kidney Transplant Recipient COVID Phenotype to Aid Test Utilization in the Setting of Limited Testing Availability- Does One Exist? |
| cord-296426-upwsdgso | Should COVID-19 Infection Be Considered? |
| cord-296517-414grqif | Have Super- Spreaders Played a Role in Other Outbreaks? |
| cord-287758-da11ypiy | ( COVID-19) Clinically Significant Drug Interactions with Cyclosporin Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/ Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus( MERS- CoV), and Severe Acute Respiratory Syndrome Coronavirus( SARS- CoV) Discovery and development of safe- in- man broadspectrum antiviral agents Teicoplanin: an alternative drug for the treatment of COVID-19? |
| cord-287758-da11ypiy | : cord-287758-da11ypiy authors: Mônica Vitalino de Almeida, Sinara; Cleberson Santos Soares, José; Lima dos Santos, Keriolaine; Emanuel Ferreira Alves, Josival; Galdino Ribeiro, Amélia; Trindade Tenório Jacob, Íris; Juliane da Silva Ferreira, Cindy; Celerino dos Santos, Jéssica; Ferreira de Oliveira, Jamerson; Bezerra de Carvalho Junior, Luiz; do Carmo Alves de Lima, Maria title: COVID-19 therapy: what weapons do we bring into battle? |
| cord-287758-da11ypiy | A Review of Its Use in the Management of HIV-1 Infection Discovering drugs to treat coronavirus disease 2019( COVID-19) Therapeutic Options and Critical Care Strategies in COVID-19 Patients; Where Do We Stand in This Battle? |
| cord-287758-da11ypiy | A new trick for an old drug? |
| cord-287758-da11ypiy | Antiviral treatment of COVID-19 Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment? |
| cord-287758-da11ypiy | Clinical course and outcomes of critically ill patients with SARS- CoV-2 pneumonia in Wuhan, China: a single- centered, retrospective, observational study Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-287758-da11ypiy | Engineering an antiviral for COVID-19? |
| cord-287758-da11ypiy | How Far Are We? |
| cord-287758-da11ypiy | The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure? |
| cord-287758-da11ypiy | The possible mechanisms of action of 4-aminoquinolines( chloroquine/ hydroxychloroquine) against Sars- Cov-2 infection( COVID-19): A role for iron homeostasis? |
| cord-287758-da11ypiy | The world is facing a huge challenge in the coronavirus disease( COVID-19) pandemic: How to fight an enemy without weapons in terms of therapy? |
| cord-297197-klr208kp | But how will we know an individual's immune status in real- time? |
| cord-293860-6kz0iws6 | A real- time dashboard of clinical trials for COVID-19 Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury Immunosuppression for hyperinflammation in COVID-19: a double- edged sword? |
| cord-293860-6kz0iws6 | Can we use interleukin-6( IL-6) blockade for coronavirus disease 2019( COVID-19)-induced cytokine release syndrome( CRS)? |
| cord-293860-6kz0iws6 | Is ethnicity linked to incidence or outcomes of covid-19? |
| cord-293860-6kz0iws6 | WHO Clinical Characterisation Protocol Are more black, Asian and minority ethnic people dying with Covid-19 than might be expected? |
| cord-293860-6kz0iws6 | Why tocilizumab could be an effective treatment for severe COVID-19? |
| cord-296148-za3j19k5 | Does damage to hypothalamic paraventricular nucleus underlie symptoms of ultradian rhythm disorder and an increased anxiety in coronavirus disease 2019? |
| cord-296148-za3j19k5 | can you do about it? |
| cord-296657-mymndjvd | Why are RNA virus mutation rates so damn high? |
| cord-297326-n0fpu8s3 | -I: An analysis of factors underlying seasonal patterns Quantitative investigations of different vaccination policies for the control of congenital rubella syndrome( CRS) in the United Kingdom Age- related changes in the rate of disease transmission: implications for the design of vaccination programmes Who mixes with whom? |
| cord-296232-6zj99nuw | COVID-19: NAD+ deficiency may predispose the aged, obese and type2 diabetics to mortality through its effect on SIRT1 activity Coronavirus( Covid-19) sepsis: revisiting mitochondrial dysfunction in pathogenesis, aging, inflammation, and mortality Potential modulation of Sirtuins by oxidative stress Sirtuins: potential therapeutic targets for regulating acute inflammatory response? |
| cord-296232-6zj99nuw | Quis Custodiet Ipsos Custodes? |
| cord-297202-oup8ptya | How will country- based mitigation measures influence the course of the COVID-19 epidemic? |
| cord-297217-pe6mehjv | The biofilm eradication activity of acetic acid in the management of periprosthetic joint infection Antibacterial coating of implants: are we missing something? |
| cord-296556-fr8x8j3i | -do they occur beyond the indication of onchocerciasis? |
| cord-296556-fr8x8j3i | Ivermectin: panacea for resource- poor communities? |
| cord-297209-84gs67bn | An emerging target 1178 of JAK2 inhibitor Fedratinib Cell host response to infection with novel human coronavirus EMC 1180 predicts potential antivirals and important differences with SARS coronavirus Distinct immune response in two MERS- CoV- infected patients: can we go 1183 from bench to bedside? |
| cord-296250-7ln7p715 | An AlphaScreen ®-based assay for high- throughput screening for specific inhibitors of nuclear import Nuclear trafficking of proteins from RNA viruses: potential target for antivirals? |
| cord-296250-7ln7p715 | International Scientific and Technical Committee Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital Meta- analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? |
| cord-294812-nnlzwaf1 | The aetiology of tuberculosis( translation of Die Aetiologie der Tuberculose( 1882) Sequence- based identification of microbial pathogens: a reconsideration of Koch's postulates The environment and disease: association or causation? |
| cord-294812-nnlzwaf1 | Viral infections in immunocompromised patients: what's new with respiratory viruses? |
| cord-294812-nnlzwaf1 | Viruses associated with pneumonia in adults Emerging respiratory agents: new viruses for old diseases? |
| cord-297684-9q3oopaz | Lateral flow assays Enzyme- linked immunosorbent assay( ELISA) Chemiluminescent immunoassay technology: what does it change in autoantibody detection? |
| cord-296950-9dldbs6o | Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? |
| cord-296950-9dldbs6o | imaging features Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-295121-4xemmaqt | Can Zn be a critical element in COVID-19 treatment? |
| cord-295121-4xemmaqt | During the SARS- CoV2 Pandemic? |
| cord-295121-4xemmaqt | SARS- CoV-2, bacterial coinfections, and AMR: the deadly trio in COVID-19? |
| cord-297418-36j840wm | What's New With the Old Coronaviruses? |
| cord-279255-v861kk0i | ( COVID-19) outbreak: could pigs be vectors for human infections? |
| cord-279255-v861kk0i | 2019 novel coronavirus( 2019-nCoV): what advice can we give to travellers? |
| cord-279255-v861kk0i | : what have we learned? |
| cord-279255-v861kk0i | : what is the role of radiologists? |
| cord-279255-v861kk0i | COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression Increased incidence of gastrointestinal side effects in patients taking hydroxychloroquine: a brand- related issue? |
| cord-279255-v861kk0i | Can SARS- CoV-2 infection be acquired in utero? |
| cord-279255-v861kk0i | Can cats become infected with Covid-19? |
| cord-279255-v861kk0i | Can companion animals become infected with Covid-19? Leading veterinary diagnostic company |
| cord-279255-v861kk0i | Does SARS- CoV-2 has a longer incubation period than SARS and MERS? |
| cord-279255-v861kk0i | However, the real question is, how are we planning to counter the next zoonotic CoV epidemic that is likely to occur within the next 5 to 10 years or perhaps sooner? |
| cord-279255-v861kk0i | Influenza Other Respir Viruses Does hand hygiene reduce SARS- CoV-2 transmission? |
| cord-279255-v861kk0i | More definitive evidence is needed Wuhan virus: Chinese animal markets reopened with almost no precautions China must close down"wet markets Will they ever learn? |
| cord-279255-v861kk0i | Rational vaccine design in the time of COVID-19 Bacillus Calmette Guérin( BCG) vaccination use in the fight against COVID-19-what's old is new again? |
| cord-279255-v861kk0i | Reply to"Does hand hygiene reduce SARS- CoV-2 transmission? |
| cord-279255-v861kk0i | The establishment of reference sequence for SARS- CoV-2 and variation analysis Chloroquine and hydroxychloroquine as available weapons to fight COVID-19 A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19 New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-279255-v861kk0i | The next big threat to global health? |
| cord-279255-v861kk0i | What do we know about the SARS- CoV-2 coronavirus in the environment? |
| cord-279255-v861kk0i | What is the potential impact of the Amazon wildfires on vector- borne and zoonotic emerging diseases? |
| cord-279255-v861kk0i | and now the 2019-novel CoV: have we investigated enough about coronaviruses? |
| cord-279255-v861kk0i | e12591 Infection and rapid transmission of SARS- CoV-2 in ferrets Current therapeutic applications and pharmacokinetic modulations of ivermectin Hydroxychloroquine and ivermectin: a synergistic combination for COVID-19 chemoprophylaxis and/or treatment? |
| cord-279255-v861kk0i | is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-279255-v861kk0i | proactive infection control measures against the emerging Wuhan coronavirus pneumonia in China Emerging viruses without borders: the Wuhan coronavirus China coronavirus: what do we know so far? |
| cord-293127-c27qh5y7 | , it is necessary to think forwards towards a resumption of services and a number of questions need to be answered around the management of ART: Should we cancel all ART cycles at this moment? |
| cord-293127-c27qh5y7 | A novel coronavirus associated with severe acute respiratory syndrome Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus- Infected Pneumonia Novel corona virus disease( COVID-19) in pregnancy: What clinical recommendations to follow? |
| cord-293127-c27qh5y7 | Should we keep only embryo transfers for couple whose success of treatment can be impaired or those who desire transfer the embryos? |
| cord-293127-c27qh5y7 | Should we keep the treatments and postpone all embryo transfers? |
| cord-293127-c27qh5y7 | à Saúde A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person- to- person transmission: a study of a family cluster Early containment strategies and core measures for prevention and control of novel coronavirus pneumonia in China Pregnant women with new coronavirus infection: a clinical characteristics and placental pathological analysis of three cases Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus( COVID-19) infection Identification of a novel coronavirus in patients with severe acute respiratory syndrome Perinatal Transmission of COVID-19 Associated SARS- CoV-2: Should We Worry? |
| cord-297432-2edncbgn | COVID-19: consider cytokine storm syndromes and immunosuppression Cancer patients in SARS- CoV-2 infection: a nationwide analysis in China COVID-19 infection in kidney transplant recipients Immunosuppression for hyperinflammation in COVID-19: a double- edged sword? |
| cord-296483-x95lwwnm | Erhöhtes Risiko für Schwangere? |
| cord-296483-x95lwwnm | Should We Worry? |
| cord-296483-x95lwwnm | What clinical recommendations to follow? |
| cord-294700-pb5k21da | : First case report Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis Ruxolitinib for the treatment of lymphoma- associated hemophagocytic lymphohistiocytosis: A cautionary tale Ruxolitinib in treatment of severe coronavirus disease 2019( COVID-19): A multicenter, single- blind, randomized controlled trial Use of Baricitinib in Patients with Moderate and Severe COVID-19 Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study Herpes Zoster in Patients Receiving JAK Inhibitors For Ulcerative Colitis: Mechanism, Epidemiology, Management, and Prevention Baricitinib for COVID-19: a suitable treatment? |
| cord-294700-pb5k21da | : Implications for Paediatric Syndromes? |
| cord-294700-pb5k21da | WHICH IMMUNOMODULATORY AGENTS SHOULD BE CONSIDERED? |
| cord-294700-pb5k21da | What agents, if any, are preferred if immunomodulatory therapy is considered for children with COVID-19? |
| cord-294700-pb5k21da | What criteria define the pediatric population in whom immunomodulatory therapy may be considered? |
| cord-296986-8fuj072z | A major outbreak of severe acute respiratory syndrome in Hong Kong Molecular immune pathogenesis and diagnosis of COVID-19 Coronavirus disease 2019( COVID-19): role of chest CT in diagnosis and management Influenza seasonality: lifting the fog Research and development on therapeutic agents and vaccines for COVID-19 and Convalescent plasma: a valid option in the treatment of COVID-19? |
| cord-296986-8fuj072z | The species severe acute respiratory syndrome- related coronavirus: classifying 2019-nCoV and naming it SARS- CoV-2 Urbanization and humidity shape the intensity of influenza epidemics in US cities Middle east respiratory syndrome coronavirus: what does a radiologist need to know? |
| cord-297332-rzf0cw1x | : implications for SARS Is there an ideal animal model for SARS? |
| cord-294696-pm6pfeeb | : what next? |
| cord-294696-pm6pfeeb | COVID-19 concern Nephrologists? |
| cord-294696-pm6pfeeb | The presence of SARS- coV-2 RNA in feces of COVID-19 patients Comparison of retropubic, laparoscopic and robotic radical prostatectomy: who is the winner? |
| cord-294696-pm6pfeeb | Was sollte ein Urologe zu SARS- Cov-2 wissen? |
| cord-294696-pm6pfeeb | Why and to what extent? |
| cord-294696-pm6pfeeb | medRxiv Endothelial cell infection and endotheliitis in COVID-19 Urinalysis, but not blood biochemistry, detects the early renal- impairment in patients with COVID-19 Human papillomavirus DNA in LEEP plume Dissemination of melanoma cells within electrocautery plume Does exposure to laser plume place the surgeon at high risk for acquiringclinicalhumanpapillomavirusinfection? |
| cord-297178-moxhk2e0 | In sick adults, the Ang 1- 7 level is also high when compared to healthy subjects[ 68, 69], but the response intensity is much lower when compared to dogs and Covid-19 brings the world economy to its knees If the world fails to protect the economy, COVID-19 will damage health not just now but also in the future Developing a sustainable exit strategy for COVID-19: health, economic and public policy implications System Blockers and the Risk of Covid-19 Renin- Angiotensin- Aldosterone System Inhibitors in Patients with Covid-19 ACE2: The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel? |
| cord-297178-moxhk2e0 | Pulmonary Vascular Thrombosis, and Angiogenesis in Covid-19 Roles of RUNX in Hypoxia- Induced Responses and Angiogenesis Hypoxia Inducible Factor Pathway and Physiological Adaptation: A Cell Survival Pathway? |
| cord-297918-840thddt | 2019 SARS- CoV-2 can induce brain and spine demyelinating lesions COVID-19-associated acute disseminated encephalomyelitis: a case report Acute myelitis after SARS- CoV-2 infection: a case report Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Incidence of thrombotic complications in critically ill ICU patients with COVID-19 COVID-19 and stroke: casual or causal role? |
| cord-296676-2anl2agl | But, how would a respiratory virus, like SARS- CoV-2, get access to the central nervous system( CNS)? |
| cord-296676-2anl2agl | Complicated by acute pulmonary embolism Cerebral venous thrombosis associated with COVID-19 Atypical deep cerebral vein thrombosis with hemorrhagic venous infarction in a COVID-19-positive patient First case of Covid-19 presented with cerebral venous thrombosis: a rare and dreaded case Cerebral venous thrombosis: atypical presentation of COVID-19 in the young Cerebral venous thrombosis associated with COVID-19 infection: causality or coincidence? |
| cord-296676-2anl2agl | How does one explain this apparent association between AIS and COVID-19? |
| cord-297693-lqyc49t6 | Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts Guidance for decisions regarding cardiopulmonary resuscitation during the COVID19 pandemic? |
| cord-298216-iq7fenxm | An Evidence Based Perspective on mRNA- SARS- CoV-2 Can an effective SARS- CoV-2 vaccine be developed for the older 709 population? |
| cord-297599-y4lu8m4k | : over 100 M website views per year Ready to submit your research? |
| cord-297599-y4lu8m4k | Does SARS- Cov-2 invade the brain? |
| cord-298172-iyxyennq | Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients? |
| cord-289003-vov6o1jx | Also, is it the right strategy in that it banks more on cure than on anticipation? |
| cord-289003-vov6o1jx | Are there geographic areas in which these emerging infections are more frequently or widely observed today? |
| cord-289003-vov6o1jx | Are there more cases today? |
| cord-289003-vov6o1jx | Are we witnessing an increased frequency of EIDs appearance? |
| cord-289003-vov6o1jx | Based on this, is it possible to prevent the virus'transmission to humans? |
| cord-289003-vov6o1jx | Can we predict patterns, or rules, of emergence? |
| cord-289003-vov6o1jx | Do we possess the scientific ability to predict exactly where the next infectious epidemic will start? |
| cord-289003-vov6o1jx | How to provide care to patients in the case of new EIDs? |
| cord-289003-vov6o1jx | Is it possible to narrow the time gap between the beginning of an epidemic and its detection by the healthcare services? |
| cord-289003-vov6o1jx | What are governments doing faced with this type of threat when the demands on the part of the population are ever- increasing? |
| cord-289003-vov6o1jx | What are the major factors in the emergence of new infectious pathogens in humans? |
| cord-289003-vov6o1jx | What has been, or is, the extent of nosocomial infection's role in the transmission of SARS- CoV and MERS- CoV? |
| cord-298067-awo3smgp | medRxiv A new coronavirus associated with human respiratory disease in China Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS- CoV-2 infection Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-297451-p5rlquym | Rev Neurol( Paris) Guillain- Barré syndrome following COVID-19: new infection, old complication? |
| cord-297381-1upz6dsy | Are we now observing an increasing number of coinfections between SARS‐CoV‐2 and other respiratory pathogens? |
| cord-297381-1upz6dsy | COVID-19 antimicrobial prescribing Coinfections among patients with COVID-19: the need for combination therapy with non- anti- SARS- CoV-2 agents? |
| cord-293547-29i3u83s | A novel syndrome? |
| cord-293547-29i3u83s | Allergy Is BCG vaccination affecting the spread and severity of COVID-19? |
| cord-293547-29i3u83s | Distinct characteristics of COVID-19 patients with initial rRT- PCR- positive and rRT- PCR- negative results for SARS- CoV-2 Advanced forecasting of SARS- CoV-2-related deaths in Italy Is global BCG vaccination- induced trained immunity relevant to the progression of SARS- CoV-2 pandemic? |
| cord-293547-29i3u83s | EAACI Position Paper Is diet partly responsible for differences in COVID-19 death rates between and within countries? |
| cord-293547-29i3u83s | Germany( AWMF) Impact Of"eHealth"in Allergic Diseases and Allergic Patients Telemedicine for Allergy Services to Rural Communities Is there a role for telemedicine in adult allergy services? |
| cord-293547-29i3u83s | The journal of allergy and clinical immunology ERS/ EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions Infection- related asthma Do chronic respiratory diseases or their treatment affect the risk of SARS- CoV-2 infection? |
| cord-298482-r7lallv0 | suggest gated access of Crb to the 329 PDZ peptide- binding groove Understanding the nature of variations in structural sequences coding for 331 coronavirus spike, envelope, membrane and nucleocapsid proteins of SARS- CoV-2 Genome composition and divergence 334 of the novel coronavirus( 2019-nCoV) originating in China Epithelial barrier function: at the front line of asthma immunology and 337 allergic airway inflammation Epithelial- mesenchymal transition 339 in lung development and disease: Does it exist and is it important? |
| cord-298894-t5hyfum3 | Guillain- Barré syndrome associated with SARS- CoV-2 Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-298321-8871aifz | Could the D614 G substitution in the SARS- CoV-2 spike( S) protein be associated with higher COVID-19 mortality? |
| cord-296388-ayfdsn07 | Isolation, quarantine, social distancing and community containment: pivotal role for old- style public health measures in the novel coronavirus( 2019-nCoV) outbreak Is the coronavirus airborne? |
| cord-296388-ayfdsn07 | The integration of social, behavioral, and biological mechanisms in models of pathogenesis Idealization and abstraction in scientific modeling Identifying and interrupting Superspreading events- implications for control of severe acute respiratory syndrome coronavirus 2 Superspreading and the effect of individual variation on disease emergence the role of super- spreaders in infectious disease Seroprevalence and ethnic differences in helicobacter pylori infection among adults in the United States Single nucleotide polymorphisms in innate immunity genes: abundant variation and potential role in complex human disease Ethnic- specific genetic associations with pulmonary tuberculosis Increase in Clostridium difficilerelated mortality rates, United States FcγRIIB in autoimmunity and infection: evolutionary and therapeutic implications SARS- CoV-2 viral load in upper respiratory specimens of infected patients Mechanisms: what are they evidence for in evidencebased medicine? |
| cord-296388-ayfdsn07 | What is a mechanism? |
| cord-298490-p1msabl5 | Human intestine luminal ACE2 and amino acid transporter expression increased by ACE- inhibitors Imbalance of the renin- angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target? |
| cord-298075-lzuxlzb0 | a Paper- Based Device Trace COVID-19 Sources with Wastewater- Based Epidemiology? |
| cord-294999-a5x8bmfr | Are antibodies to the virus protective or enhancing? |
| cord-294999-a5x8bmfr | Can large amounts of a vaccine be made before next winter, assuming that SARS- CoV-2 becomes a seasonal threat? |
| cord-294999-a5x8bmfr | Do antibodies to SARS or MERS protect against SARS- CoV-2? |
| cord-294999-a5x8bmfr | How to grow the virus? |
| cord-294999-a5x8bmfr | What animal models can be used to study the virus? |
| cord-294999-a5x8bmfr | What is the best vaccine antigen: whole virus, spike protein, or receptor- binding domain of the spike protein? 6. |
| cord-298722-rmibv5z7 | key: cord-298722-rmibv5z7 authors: Abdel- latif, Rania G; Mohammed, Shaban; Elgendy, Islam Y title: Statin therapy and SAR- COV-2: an available and potential therapy? |
| cord-296227-dm1wkpnv | And for how many times? |
| cord-296227-dm1wkpnv | Do N95 respirators provide 95% protection level against airborne viruses, and how adequate are surgical masks? |
| cord-296227-dm1wkpnv | Liao, L.; Xiao, W.; Zhao, M.; Yu, X.; Wang, H.; Wang, Q.; Chu, S.; Cui, Y. title: Can N95 respirators be reused after disinfection? |
| cord-296227-dm1wkpnv | questions for impact assessment Functional assessment of cell entry and receptor usage for SARS- CoV-2 and other lineage B betacoronaviruses Structural basis for the recognition of the SARS- CoV-2 by full- length human ACE2 Clinical Characteristics of Coronavirus Disease 2019 in China First case of 2019 novel coronavirus in the United States What to do next to control the 2019-nCoV epidemic? |
| cord-298850-tgxfki7n | Why tocilizumab could be an effective treatment for severe COVID-19? FDA approval summary: tocilizumab for treatment of chimeric antigen receptor T cell- induced severe of life- threatening cytokine release syndrome |
| cord-299024-jkqdzt87 | Mangner, Norman; Sveric, Krunoslav; Gerber, Johannes C.; Svitil, Jan; Linke, Axel; Jellinghaus, Stefanie title: Paraneoplastic syndrome and SARS- CoV-2 – incremental effect of two thrombogenic conditions? |
| cord-298920-1lc2xf7u | Bafilomycin a1 Block the Fusion of Autophagosomes with Lysosomes? |
| cord-295144-tyyc81uc | A cross- sectional study on 916 atients Are patients with systemic lupus erythematosus at increased risk for COVID-19? |
| cord-295144-tyyc81uc | COVID-19 patients with psoriasis and psoriatic arthritis on biologic immunosuppressant therapy versus apremilast in North Spain COVID-19 with rheumatic diseases: a report of 5 cases Incidence of COVID-19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data? |
| cord-295144-tyyc81uc | a multicenter prospective cohort study Prevalence, specificity, and clinical association of anti- phospholipid antibodies in COVID-19 patients: are the antibodies really guilty? |
| cord-295144-tyyc81uc | the risk of a complicated course of CTD/ vasculitis patients heightened? |
| cord-297671-3d3gcn6k | How fast does oral dexamethasone work in mild to moderately severe croup? |
| cord-297671-3d3gcn6k | One or Two Doses of Dexamethasone for the Treatment of Croup? |
| cord-296881-2g81sjnl | A retrospective cohort study Regulation of interferon production as a potential strategy for COVID-19 treatment New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-296881-2g81sjnl | Ahmed Doubtful precipitation of hemolysis by hydroxychloroquine in glucose-6-phosphate dehydrogenase- deficient patient with COVID-19 infection Psychosis consequent to antimalarial drug use in a young child Teicoplanin: an alternative drug for the treatment of COVID-19? |
| cord-296881-2g81sjnl | Lopinavir/ ritonavir use in Covid-19 infection: Is it completely non- beneficial? |
| cord-296881-2g81sjnl | Modeling the potential for face mask use by the general public to curtail the COVID-19 pandemic Hydroxychloroquine- induced hypoglycaemia in non- diabetic renal patient on peritoneal dialysis Anti- HCV, nucleotide inhibitors, repurposing against COVID-19 Which countries do best in beating COVID-19? |
| cord-298716-pubhq564 | bioRxiv CNS infection and immune privilege Olfactory epithelium changes in germfree mice Is the Collapse of the Respiratory Center in the Brain Responsible for Respiratory Breakdown in COVID-19 Patients? |
| cord-295433-olmein3q | A comparison of bats and rodents as reservoirs of zoonotic viruses: Are bats special? |
| cord-295433-olmein3q | Bats and zoonotic viruses: Can we confidently link bats with emerging deadly viruses? |
| cord-295433-olmein3q | Further Evidence for Bats as the Evolutionary Source of Middle East Respiratory Syndrome Coronavirus Middle East respiratory syndrome( MERS): Bats or dromedary, which of them is responsible? |
| cord-295433-olmein3q | How do these viruses modulate the numerous host responses in bats and how does that affect virus replication? |
| cord-299432-lbv69du4 | Prolonged presence of SARS- CoV-2 viral RNA in faecal samples Evidence for Gastrointestinal Infection of SARS- CoV-2 Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-297132-lhfa9fl5 | Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-297132-lhfa9fl5 | Is COVID-19 an endothelial disease? |
| cord-297132-lhfa9fl5 | a retrospective cohort study COVID-19 and its implications for thrombosis and anticoagulation Acute cerebrovascular disease following COVID-19: a single center Coagulopathy and antiphospholipid antibodies in patients with Covid-19 Large- vessel stroke as a presenting feature of Covid-19 in the young Emergency room neurology in times of COVID-19: malignant ischemic stroke and SARS- COV2 infection Lupus anticoagulant is frequent in patients with Covid-19 Is endothelial dysfunction the concealed cornerstone of COVID-19? |
| cord-297132-lhfa9fl5 | related coagulopathy: a distinct entity? |
| cord-298669-g2up0cfi | Why is CpG suppressed in the genomes of virtually all small eukaryotic viruses but not in those of large eukaryotic viruses? |
| cord-291588-tp89j1kk | A novel syndrome? |
| cord-291588-tp89j1kk | Acute Symptomatic Seizures in Critically Ill Patients with COVID-19: Is There an Association? |
| cord-291588-tp89j1kk | Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? |
| cord-291588-tp89j1kk | COVID-19 and herpes zoster co- infection presenting with trigeminal neuropathy Pearls and Oy- sters: Facial nerve palsy as a neurological manifestation of Covid-19 infection Guillain Barre syndrome associated with COVID-19 infection: A case report Early Guillain- Barré syndrome in coronavirus disease 2019( COVID-19): a case report from an Italian COVID- hospital COVID-19 may induce Guillain- Barré syndrome Guillain- Barré syndrome related to COVID-19 infection Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-291588-tp89j1kk | COVID-19-White matter and globus pallidum lesions: Demyelination or small- vessel vasculitis? |
| cord-291588-tp89j1kk | Case Report Guillain- Barré syndrome in the COVID-19 era: just an occasional cluster? |
| cord-291588-tp89j1kk | Cause or Coincidence? |
| cord-291588-tp89j1kk | Guillain- Barré syndrome following COVID-19: new infection, old complication? |
| cord-291588-tp89j1kk | Severe COVID-19 Infection: Sequela of Hypoxemia? |
| cord-291588-tp89j1kk | Version 2 Delirium as a presenting feature in COVID-19: Neuroinvasive infection or autoimmune encephalopathy? |
| cord-299520-2khjhows | how much can telemedicine be useful during and after the COVID-19 pandemic? |
| cord-298734-h286m32c | Conditionally reprogrammed cells represent a stem- like state of adult epithelial cells Primitive cancer cell states: a target for drug screening? |
| cord-299491-8rfm0jxh | Alert, verification and public health management of SARS in the post- outbreak period Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection Where Has SARS Gone? |
| cord-298693-x25r0gtt | Are we forgetting the “ universal ” in universal masking? |
| cord-298693-x25r0gtt | Universal masking in hospitals in the COVID-19 era: Is it time to consider shielding? |
| cord-299449-226dd23u | Glioblastoma Multiforme Are three weeks hypofractionated radiation therapy( HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? |
| cord-298773-vnmc6nqd | : cord-298773-vnmc6nqd authors: Pfeiffer, Julie K. title: Is the Debate and “ Pause ” on Experiments That Alter Pathogens with Pandemic Potential Influencing Future Plans of Graduate Students and Postdoctoral Fellows? |
| cord-298773-vnmc6nqd | For example, factoring in retirement rates and potential loss of future investigators, what will the influenza/ MERS/ SARS virus fields look like in 2030, 2040, or 2050? |
| cord-298991-5qae0ege | Can the Coronavirus Disease 2019( COVID-19) affect the eyes? |
| cord-298991-5qae0ege | Novel coronavirus( COVID-19) situation Angiotensin- converting enzyme 2 is a functional receptor for the SARS coronavirus Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-299552-rgrm8dil | Structural Differences Linked to Virus Characteristics? |
| cord-298281-wkje5jyt | : Importance of the awareness of the clinical syndrome by urologists Structure analysis of the receptor binding of 2019-nCoV ACE2 Expression in kidney and testis may cause kidney and testis damage after 2019-nCoV infection Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses Single- cell RNA- seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single- cell transcriptome analysis Case report of COVID-19 in a kidney transplant recipient: does immunosuppression alter the clinical presentation? |
| cord-298281-wkje5jyt | China Identification of kidney transplant recipients with coronavirus disease 2019 COVID-19 in a kidney transplant patient Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-297423-iefq0fh0 | What are the implications for public health practice? |
| cord-297423-iefq0fh0 | What is added by this report? |
| cord-297423-iefq0fh0 | What is already known about this topic? |
| cord-297323-l3f12hg4 | A Multibasic Cleavage Site in the Spike Protein of SARS- CoV-2 Is Essential for Infection of Human Lung Cells Clinical and immunologic features in severe and moderate Coronavirus Disease Asymptomatic carriage and transmission of SARS- CoV-2: What do we know? |
| cord-297323-l3f12hg4 | Reduced dynamic range of antiviral innate immune responses in aging Oxidative stress, inflamm- aging and immunosenescence Genomewide Association Study of Severe Covid-19 with Respiratory Failure Metabolic Alterations in Aging Macrophages: Ingredients for Inflammaging? |
| cord-297323-l3f12hg4 | Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection COVID-19 as a STING disorder with delayed over- secretion of interferon- beta Activated STING in a Vascular and Pulmonary Syndrome Dampened STING- Dependent Interferon Activation in Bats Pathogenic role of HMGB1 in SARS? |
| cord-298899-lkrmg5qr | , it seems that Fuyang patients are not infectious What is Kawasaki disease and its possible link with COVID-19 in children? |
| cord-298899-lkrmg5qr | Novel coronavirus pneumonia prevention and control program Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-292274-upwn9o2m | A useful complement to nucleic acid testing Performance Characteristics of the Abbott Architect SARS- CoV-2 IgG Assay and Seroprevalence in Waiting for Certainty on Covid-19 Antibody Tests- At What Cost? |
| cord-292274-upwn9o2m | Are individuals susceptible to reinfection with SARS- CoV-2? |
| cord-292274-upwn9o2m | Coordinated research efforts are urgently needed to investigate some of the key gaps in our knowledge, including: Which serological tests can identify SARS- CoV-2-neutralizing antibodies? |
| cord-292274-upwn9o2m | How Well Do They Actually Perform? |
| cord-292274-upwn9o2m | How long does protective immunity last in recovered patients? |
| cord-292274-upwn9o2m | Is humoral antibody response the best indicator for protective immunity, or are there other immune- cell- based mechanisms? |
| cord-292274-upwn9o2m | Is there cross- reactivity between neutralizing antibodies and other coronaviruses? |
| cord-292274-upwn9o2m | What is the correlation between SARS- CoV-2-specific antibodies and protective immunity status? |
| cord-292274-upwn9o2m | Which SARS- CoV-2 antigens are optimal for the detection of neutralizing antibodies? |
| cord-295041-5vpawtef | ( SARS- CoV-2) Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host- virus interaction, and proposed neurotropic mechanisms Can the enteric nervous system be an alternative entrance door in SARS- CoV2 neuroinvasion? |
| cord-295041-5vpawtef | A mechanism of virus- induced demyelination Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? |
| cord-295041-5vpawtef | COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role? |
| cord-295041-5vpawtef | How Covid-19 can damage the brain Neurological manifestations in severe acute respiratory syndrome Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-295041-5vpawtef | More Prevalent Than Acknowledged? |
| cord-295041-5vpawtef | causative or coincidental? |
| cord-299635-bxdf27sv | what next? |
| cord-299308-gza1pwx6 | : Is Gradual and Controlled Approach to Herd Protection a Valid Strategy to Curb the COVID-19 Pandemic? |
| cord-299308-gza1pwx6 | nan Curb the COVID-19 Pandemic? |
| cord-297256-i9468t8v | Are we redundant? |
| cord-297256-i9468t8v | How is the life of a geriatrician in such an apocalyptic scenario? |
| cord-297256-i9468t8v | Is this the way things should go? |
| cord-297256-i9468t8v | What will remain after the SARS- CoV-2 will be defeated? |
| cord-297256-i9468t8v | … Is this right? |
| cord-300272-95o8yd7h | ( bioRxiv) Is innate immunity our best weapon for flattening the curve? |
| cord-299116-1agfnjvq | Distinct early serological signatures track with SARS- CoV-2 survival Natural history and management of hepatitis C: does sex play a role? |
| cord-299116-1agfnjvq | and COVID-19: Serendipity or Opportunity for Intervention? |
| cord-299999-jra1yu6a | What can BDJ readers do to help? |
| cord-299499-66qh3r75 | : a metaanalysis Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? |
| cord-298505-r7ihqb96 | Bacterial viruses against viruses pathogenic for man? |
| cord-298505-r7ihqb96 | It was first detected in Wuhan, China, which suggests the existence of an intermediary( pangolin?) |
| cord-298505-r7ihqb96 | Virus Res T4 bacteriophagemediated inhibition of adsorption and replication of human adenovirus in vitro Bacteriophage uptake by eukaryotic cell layers represents a major sink for phagesduring therapy Inhibitory effects of bacteriophage preparations on adenoviral replication Phages in the fight against COVID-19? |
| cord-299679-6z9e5gi6 | COVID-19 pneumonia different respiratory treatment for different phenotypes? |
| cord-298967-vjyh1xvh | China Barriers and facilitators to healthcare workers'adherence with infection prevention and control( IPC) guidelines for respiratory infectious diseases: a rapid qualitative evidence synthesis What are we doing in the dermatology outpatient department amidst the raging of the 2019 novel coronavirus? |
| cord-298967-vjyh1xvh | How do we leave lockdown? |
| cord-300018-3uzau7if | Decade- Long Structural Studies of SARS Coronavirus Structure, Function, and Antigenicity of the SARS- CoV-2 Spike Glycoprotein Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission Cryo- EM structure of the 2019-nCoV spike in the prefusion conformation Could the D614 G substitution in the SARS- CoV-2 spike( S) protein be associated with higher COVID-19 mortality? |
| cord-300423-q2i328sz | iScience Could an endo- lysosomal ion channel be the Achilles heel of SARS- CoV2? |
| cord-294800-akr4f5p8 | : what's next? |
| cord-294800-akr4f5p8 | Can Chinese medicine be used for prevention of corona virus disease 2019( COVID-19)? |
| cord-294800-akr4f5p8 | Teicoplanin: an alternative drug for the treatment of COVID-19? |
| cord-294800-akr4f5p8 | The FDA- approved drug ivermectin inhibits the replication of SARS- CoV-2 in vitro Nuclear trafficking of proteins from RNA viruses: potential target for antivirals? |
| cord-294800-akr4f5p8 | The mercurial nature of neutrophils: still an enigma in ARDS? |
| cord-294800-akr4f5p8 | a retrospective cohort study Characterization of SARS- CoV- specific memory T cells from recovered individuals 4 years after infection Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-294800-akr4f5p8 | emergence and implications for emergency care Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-300041-1d9xu4ts | The impact of viral transport media on PCR assay results for the detection of nucleic acid from SARS- CoV-2 Contamination of SARS- CoV-2 RT- PCR probes at the oligonucleotide manufacturer Histopathology of cutaneous COVID-19 lesion: possible SARS- CoV-2 cytopathogenic effect Is prostate infarction and acute urinary retention a possible complication of severe COVID-19 infection? |
| cord-300625-fvirvpyl | Can it be facilitated? |
| cord-300399-21xozruq | Eurosurveillance Comparative performance of SARS- CoV-2 detection assays using seven different primer- probe sets and one assay kit How to choose the right real- time RT- PCR primer sets for the SARS- CoV-2 genome detection? |
| cord-299082-s8bm40vy | An example of reversible electrical storm Incessant monomorphic ventricular tachycardia during febrile illness in a patient with Brugada syndrome: fatal electrical storm Fhf2 gene deletion causes temperature- sensitive cardiac conduction failure Fever increases the risk for cardiac arrest in the Brugada syndrome Hyperthermia influences the effects of sodium channel blocking drugs in human- induced pluripotent stem cell- derived cardiomyocytes Controversies of renin- angiotensin system inhibition during the COVID-19 pandemic Antihypertensive treatment with ACEI/ ARB of patients with COVID-19 complicated by hypertension Angiotensin II and angiotensin 1- 7: which is their role in atrial fibrillation? |
| cord-299082-s8bm40vy | COVID-19: risk for cytokine targeting in chronic inflammatory diseases? |
| cord-300608-eju7wnb9 | medRxiv Identifying medical diagnoses and treatable diseases by image- based deep learning Outbreak of novel coronavirus( COVID-19): What is the role of radiologists? |
| cord-300604-xx2d1s41 | a descriptive study Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-300466-sk9iilum | The consistency rate between results of antibody test and NAT was 48.86%[( 39? 4)/88]. |
| cord-300191-vpc7p0d6 | Have We Learned? |
| cord-299346-f13xly6q | 7 Face masks and Respirators; Which to Use? |
| cord-299346-f13xly6q | A randomized controlled trial Telemedicine in the time of coronavirus Personal protective equipment doffing practices of healthcare workers Are health care personnel trained in correct use of personal protective equipment? |
| cord-299346-f13xly6q | Air Filtration Reduce COVID-19 Severity and Spread? |
| cord-297127-nhgm09db | As in the general population, patients with IRD having comorbidities are at higher risk to develop a more severe course of How might this impact on clinical practice? ► |
| cord-297127-nhgm09db | Does a specific immunomodulatory treatment ameliorate or deteriorate the course of COVID-19? ► |
| cord-297127-nhgm09db | Does geographical location/ different access to healthcare within Germany affect the course? ► |
| cord-297127-nhgm09db | What does this study add? ► |
| cord-297127-nhgm09db | What is the course of COVID-19 in patients with IRD? ► |
| cord-297127-nhgm09db | Which other factors are associated with a poor outcome of COVID-19 in patients with IRD? |
| cord-300319-9k8zseao | Enterocyte- like differentiation and polarisation of the human colon carcinoma cell line Caco-2 in culture Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus: a first step in understanding SARS pathogenesis Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia- induced sepsis Total parenteral nutrition- induced apoptosis in mouse intestinal epithelium: modulation by keratinocyte growth factor Human intestinal epithelial cell survival: differentiation state- specific control mechanisms Failure to regulate TNF- induced NF- kappaB and cell death responses in A20-deficient mice Apoptosis- programmed cell death and its relevance to gastrointestinal epithelium: survival signal from the matrix Hierarchical cleavage of focal adhesion kinase by caspases alters signal transduction during apoptosis of intestinal epithelial cells Programmed cell death protein 4( pdcd4): a novel target for antineoplastic therapy? |
| cord-300319-9k8zseao | interferon type I- independent? |
| cord-289064-435bp4rt | : the CORONADO study Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-289064-435bp4rt | A pneumonia outbreak associated with a new coronavirus of probable bat origin Physiological and pathological regulation of ACE2, the SARS- CoV-2 receptor Obesity and impaired metabolic health in patients with COVID-19 Could anti- hypertensive drug therapy affect the clinical prognosis of hypertensive patients with COVID-19 infection? |
| cord-289064-435bp4rt | Be the New Target in Treating COVID-19-Related Systemic Thrombosis? |
| cord-289064-435bp4rt | Can We Do More on Glycemic Control? |
| cord-289064-435bp4rt | Can pioglitazone be potentially useful therapeutically in treating patients with COVID-19? |
| cord-289064-435bp4rt | Could ACE2 present on beta cells represent a direct target for virus entry, potentially leading to the dysregulation or destruction of these cells, promoting a( potentially irreversible) loss of insulin production? |
| cord-289064-435bp4rt | Could this affect islet or kidney function? |
| cord-289064-435bp4rt | Data from centers of southern Italy ACE2 and Diabetes: ACE of ACEs? |
| cord-289064-435bp4rt | Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti- inflammatory effect? |
| cord-289064-435bp4rt | Is Blocked by a Clinically Proven Protease Inhibitor How does coronavirus kill? |
| cord-289064-435bp4rt | Might elevated levels of ACE2, facilitating viral entry, contribute to increased disease risk and mortality in metabolic disease? |
| cord-289064-435bp4rt | The immunology of COVID-19: is immune modulation an option for treatment? |
| cord-289064-435bp4rt | The most question remains: are the effects of the virus on glycemic control purely the result of an over- active immune system, with immune cells and inflammatory cytokines acting on multiple tissues( which)?, or are there direct actions of the virus on tissues and organs relevant to metabolic homoeostasis( beta cells, other islet hormone- secreting cells, liver, fat, muscle, brain, kidney etc.)? |
| cord-289064-435bp4rt | The most question remains: are the effects of the virus on glycemic control purely the result of an over- active immune system, with immune cells and inflammatory cytokines acting on multiple tissues( which)?, or are there direct actions of the virus on tissues and organs relevant to metabolic homoeostasis( beta cells, other islet hormone- secreting cells, liver, fat, muscle, brain, kidney etc.)? |
| cord-289064-435bp4rt | new insights Is it relevant to wound healing in diabetic foot disease? |
| cord-300627-7x4me5lx | A thrombophilic connection between pregnancy complications and neonatal thrombosis? |
| cord-300194-nsp53lv6 | An overview of viral structure and host response Structure, Function, and Evolution of Coronavirus Spike Proteins Structure, Function, and Antigenicity of the SARS- CoV-2 Spike Glycoprotein Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites Structural and Functional Basis of SARS- CoV-2 Entry by Using Human ACE2 Cryo- EM structures of MERS- CoV and SARS- CoV spike glycoproteins reveal the dynamic receptor binding domains Structure of the SARS- CoV-2 spike receptor- binding domain bound to the ACE2 receptor Thermal Stability of Globins: Implications of Flexibility and Heme Coordination Studied by Molecular Dynamics Simulations Structural flexibility and protein adaptation to temperature: Molecular dynamics analysis of malate dehydrogenases of marine molluscs Effects of temperature and humidity on the daily new cases and new deaths of COVID-19 in 166 countries Will coronavirus pandemic diminish by summer? |
| cord-300194-nsp53lv6 | How significant is a protein structure similarity with TM- score= 0.5? |
| cord-299911-v95pf3eg | Pregnane X receptor is required for interleukin-6-mediated down- regulation of cytochrome P450 3A4 in human hepatocytes Is nuclear factor kappa- B the missing link between inflammation, cancer and alteration in hepatic drug metabolism in patients with cancer? |
| cord-299911-v95pf3eg | anti- inflammatory strategies COVID-19: combining antiviral and antiinflammatory treatments Immunosuppression for hyperinflammation in COVID-19: a double- edged sword? |
| cord-299911-v95pf3eg | why and how? |
| cord-300978-busx8w6s | a systematic review and meta- analysis Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-300968-dtaasxk1 | Inhibiting severe acute respiratory syndrome- associated coronavirus by small interfering RNA Old drugs as lead compounds for a new disease? |
| cord-298866-dzatps7b | 11, 12 Is asthma a chronic medical condition that is associated with a higher risk of severe illness or death from COVID 19? |
| cord-298866-dzatps7b | 17, 18 Should asthma patients change treatment during the COVID-19 pandemic? |
| cord-298866-dzatps7b | 6, 7, 8 Are patients with asthma at risk of having an exacerbation triggered by SARS- CoV-2( COVID 19)? |
| cord-298866-dzatps7b | Diagnosis and management of asthma in preschoolers, children and adults Diagnosis and Management of Asthma in Preschoolers: A Canadian Thoracic Society and Canadian Pediatric Society position paper Do chronic respiratory diseases or their treatment affect the risk of SARS- CoV-2 infection? |
| cord-300899-yi2mx91a | A boon or inutile SARS- CoV-2 pandemic in India: What might we expect? |
| cord-295792-hajvtzj9 | Are all children well protected from acquiring the infection or only from the risk of becoming ill after being infected? |
| cord-295792-hajvtzj9 | Assuming that children as secondary cases become infected in second, third or even fourth order after the initial case, would their clinical manifestations be more attenuated? |
| cord-295792-hajvtzj9 | COVID-19 infection: the perspectives on immune responses Are children less susceptible to COVID19? |
| cord-295792-hajvtzj9 | Can melatonin reduce the severity of COVID-19 pandemic? |
| cord-295792-hajvtzj9 | Considering this state of cell differentiation in childhood and that the distribution of ACE2 receptors is uneven in different organs and populations, are there differences in the extent and function of ACE2 in the alveolar tissue of children and adults? |
| cord-295792-hajvtzj9 | So what is the chance of transmission of active virus from the respiratory tract of the child? |
| cord-295792-hajvtzj9 | The impact of pneumococcal vaccination on bacterial and viral Pneumonia in western australian children: Record Linkage Cohort Study of 469589 Births Does pneumococcal vaccine reduce influenza morbidity in humans? |
| cord-300078-svu06v9c | Can new tools keep them afloat? |
| cord-300078-svu06v9c | Mapping the science behind ebola Estimation of covid-19 dynamics"on a back- of- envelope": Does the simplest sir model provide quantitative parameters and predictions? |
| cord-300300-jqi4ylrx | How does TraceTogether work? |
| cord-300300-jqi4ylrx | Situation report-27 Circuit breaker to minimise further spread of COVID-19 Containing COVID-19 spread at foreign worker dormitories Tackling transmissions in migrant worker clusters 22 Testing for SARS- CoV-2: can we stop at two? |
| cord-298886-xidaim04 | Do patients with rheumatic diseases have a higher risk of being infected with SARS- CoV-2 virus and developing COVID-19 disease? |
| cord-298886-xidaim04 | Does coronavirus, which turned out to be the greatest celebrity of the modern world, have any connection with the field of rheumatology? |
| cord-298886-xidaim04 | Does the standard treatment of synthetic and biological drugs that modifies autoimmune multiorgan inflammation have such a negative impact on the immune system that it could be a threat to rheumatological patients? |
| cord-298886-xidaim04 | Effects of Chloroquine on Viral Infections: An Old Drug Against Today's Diseases? |
| cord-301026-spgidqh3 | Once- in- a- Century Pandemic? |
| cord-298679-w0yp4u19 | Beyond smoking cessation: Investigating medicinal nicotine to prevent and treat COVID-19 Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population? |
| cord-298679-w0yp4u19 | How will country- based mitigation measures influence the course of the COVID-19 epidemic? |
| cord-298679-w0yp4u19 | May old anti- diabetic agents become the new philosopher's stone? |
| cord-298679-w0yp4u19 | Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? |
| cord-298679-w0yp4u19 | what next? |
| cord-300866-cso6l6ze | Is the occurrence of cerebral hemorrhage in patients related to the consumption of ACE2 by SARS- CoV-2? |
| cord-300866-cso6l6ze | Nevertheless, are patients with type A more likely to develop cerebrovascular accidents after SARS- CoV-2 infection? |
| cord-301638-2f8r37ns | Cause, consequence or epiphenomenon? |
| cord-298461-tyhtdawb | A survey of wind speeds in indoor workplaces Physico- chemical characteristics of evaporating respiratory fluid droplets Airborne or droplet precautions for health workers treating COVID-19? |
| cord-298461-tyhtdawb | Can N95 Respirators Be Reused after Disinfection? |
| cord-298461-tyhtdawb | Under certain weather conditions, how far can the virus carriers travel on average? |
| cord-298461-tyhtdawb | What fraction of droplets will turn into aerosol particles? |
| cord-298461-tyhtdawb | What role do the HVAC and air conditioning systems play in virus propagation? |
| cord-298350-pq1dcz3a | A coincidence? |
| cord-298350-pq1dcz3a | Could it have been due to an intentional act? |
| cord-298350-pq1dcz3a | Is this indicative of how all new emerging disease threats will be handled? |
| cord-298350-pq1dcz3a | • Is coronavirus just a relic? |
| cord-302111-kg0dmgq0 | cause recurrent wheeze of early childhood and asthma? |
| cord-301590-70qmpccs | Should viral RNA detection by RT- PCR testing be asked for all asymptomatic patients undergoing topical anesthetic procedures, such as phacoemulsification or intra- vitreal injections? |
| cord-299156-1dwsm3ie | 3 in the left eye only with follicular reaction, associated with discharge graded? |
| cord-299156-1dwsm3ie | Can the coronavirus disease 2019( COVID-19) affect the eyes? |
| cord-299156-1dwsm3ie | On exam there was active conjunctival injection graded? |
| cord-299156-1dwsm3ie | On exam there was active conjunctival injection graded? |
| cord-299156-1dwsm3ie | On exam there was active conjunctival injection graded? |
| cord-302075-ctd9sutv | Is COVID-19 receiving ADE from other coronaviruses? |
| cord-301626-7ow1jja4 | The papain- like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme Deubiquitination, a new function of the severe acute respiratory syndrome coronavirus papain- like protease? |
| cord-300963-1n1f8mf2 | Could patients with inflammatory bowel disease treated with immunomodulators or biologics be at lower risk for severe forms of covid-19? |
| cord-300963-1n1f8mf2 | recent insights into emerging coronaviruses Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology A pneumonia outbreak associated with a new coronavirus of probable bat origin Profile of specific antibodies to the SARSassociated coronavirus Pathological findings of COVID-19 associated with acute respiratory distress syndrome Are patients with inflammatory bowel disease at increased risk for Covid-19 infection? |
| cord-298696-rsifxvtj | But if the technology for picking out passengers capable of transmitting deadly pathogens and setting off killer epidemics does not exist today, should we not be pursuing it as energetically as we do, the technology for stopping terrorists from boarding a plane? |
| cord-298696-rsifxvtj | But that may be just the problem: What is the evidential base for effective public health interventions in the aviation industry, and how rigorously have the relevant aviation policy options been evaluated in the intervening years since the SARS episode[ 7]? |
| cord-298696-rsifxvtj | Given that international air travel is the one feature that most differentiates present day transmission scenarios from those in 1918, it is surely relevant to ask, just how flu- ready are the airlines and airports of the world? |
| cord-298696-rsifxvtj | Granted, if a substantial portion of transmission occurs during the incubation or asymptomatic phase of disease, entry screening is unlikely to be effective in preventing or delay- ing an epidemic resulting from the importation of influenza[ 17]; and granted, the short time lag for scrambling upon discovery of a sentinel case will pose serious challenges to effective quarantine and contact tracing measures; but are we acquiescing on this critical front too readily? |
| cord-298696-rsifxvtj | Surely any global battle plan against pandemic flu should entertain the notion of stopping the enemy at the gates, or along the corridors of its advance, before it reaches our homes, hospitals and clinics? |
| cord-298696-rsifxvtj | These efforts are necessary and laudable, but might they not also reflect the"medical"bias of existing paradigms? |
| cord-301454-ayf42grs | Could a Diabetes Medication Affect COVID-19 Outcomes? |
| cord-301454-ayf42grs | it mandatory? |
| cord-301876-d2j9wpqk | The SARS- CoV-2 vaccine pipeline: an overview SARS vaccines: where are we? |
| cord-300445-qzu4gz2d | COVID-19 treatment: close to a cure? |
| cord-300445-qzu4gz2d | COVID-19: are we dealing with a multisystem vasculopathy in disguise of a viral infection? |
| cord-300445-qzu4gz2d | Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury COVID-19 and decompressive hemicraniectomy for acute ischemic stroke Cerebrovascular disease in patients with COVID-19: a review of the literature and case series COVID-19 and stroke: casual or causal role? |
| cord-300046-orlga9qf | Annual Report Data From 182 Countries Does hand hygiene reduce SARS- CoV-2 transmission? |
| cord-300046-orlga9qf | Covid-19 How will country- based mitigation measures influence the course of the COVID-19 epidemic? |
| cord-300046-orlga9qf | How Often Do You Wash Your Hands? |
| cord-300046-orlga9qf | How to apply and remove medical gloves Face Masks Against COVID-19: An Evidence Review Face masks for the public during the covid-19 crisis Will COVID-19 generate global preparedness? |
| cord-302414-g5onwhg1 | The SARS- CoV-2 vaccine pipeline: an overview SARS vaccines: where are we? |
| cord-300640-9pvhaz8q | Can Bioactive Lipids Inactivate Coronavirus( COVID-19)? |
| cord-300640-9pvhaz8q | Fighting on the Front Lines or Fanning the Flames of COVID-19? |
| cord-300640-9pvhaz8q | What about COVID-19 and arachidonic acid pathway? |
| cord-302163-0jav84zw | an ACE2 and TMPRSS2 polymorphism analysis TMPRSS2 and COVID-19: serendipity or opportunity for intervention? |
| cord-299333-qu0bmov5 | Acute pulmonary embolism and COVID-19 pneumonia: a random association? |
| cord-299333-qu0bmov5 | Can COVID-19 present unusual GI symptoms? |
| cord-299333-qu0bmov5 | Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? |
| cord-299333-qu0bmov5 | What will be the economic impact of COVID-19 in the US? |
| cord-301744-rx7ywew5 | COVID-19 unexplained mortality in the young adults: could it be due to ACE2 polymorphisms? |
| cord-292988-q1yz9y8k | Creating repository of samples obtained during MSC trials eg blood samples( or BAL) for unbiased gene expression analysis, proteomics and molecular analysis of T- cell responses, e.g defined by deep TCR sequencing to gauge for MSC effects, different reactivity and biology of neutrophils, macrophages and dendritic cells from patients with COVID-19 as compared to non- Covid-19 patients? |
| cord-292988-q1yz9y8k | Dawn of the Therapeutic Era? |
| cord-292988-q1yz9y8k | Differences associated with MSC products( viable, MSC-apoptotic bodies, exosomes),( COVID-19), disease status or the patients phenotype( e.g. high IL-6 or IL-17 levels)? |
| cord-292988-q1yz9y8k | Differences in gene expression/ proteomics in freshly prepared versus cryopreserved and subsequently thawed MSC? |
| cord-292988-q1yz9y8k | Gauging the most suitable and safest MSC profile for COVID-19 treatment Smart clinical studies to address different modes of MSC delivery, e.g. single or repeated doses, escalating dosing? |
| cord-292988-q1yz9y8k | Improved clinical efficacy by repeated infusions? |
| cord-292988-q1yz9y8k | Increased efficacy and safety if MSCs are used from different donors in the case of repeated infusions? |
| cord-292988-q1yz9y8k | Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS- CoV-2 infected patients Anti- donor immune responses elicited by allogeneic mesenchymal stem cells and their extracellular vesicles: are we still learning? |
| cord-292988-q1yz9y8k | Role of identical MSC donor in repeated dosing? |
| cord-292988-q1yz9y8k | Role of lymphopenia in response to MSCs? |
| cord-292988-q1yz9y8k | e.g. decreasing damaging inflammation Which patients benefit most from MSC treatment? |
| cord-299565-shlhreve | A review of treatment modalities for Middle East Respiratory Syndrome Middle east respiratory syndrome coronavirus( MERS- CoV) origin and animal reservoir Challenges presented by MERS corona virus, and SARS corona virus to global health Middle East respiratory syndrome and severe acute respiratory syndrome Molecular epidemiology and phylogeny of nipah virus infection: a mini review Animal models of disease shed light on Nipah virus pathogenesis and transmission Pathogenesis of Hendra and Nipah virus infection in humans Bats as reservoirs of severe emerging infectious diseases Has Rift Valley fever virus evolved with increasing severity in human populations in East Africa? |
| cord-299565-shlhreve | Bibliometric analysis of publications in infectious diseases and clinical microbiology areas: Which coutries led in 1996- 2011 and 2011 periods? |
| cord-299565-shlhreve | The economic impact of SARS: how does the reality match the predictions? |
| cord-299565-shlhreve | Transboundary and emerging diseases Will increased funding for neglected tropical diseases really make poverty history? |
| cord-299565-shlhreve | respiratory syndrome coronavirus( MERS- CoV) in Oman MERS coronavirus: data gaps for laboratory preparedness Understanding bat SARS- like coronaviruses for the preparation of future coronavirus outbreaks-Implications for coronavirus vaccine development Will escalating spending on HIV treatment displace funding for treatment of other diseases? |
| cord-301730-flv5lnv8 | However, was COVID-19 an unexpected viral pandemic? |
| cord-301730-flv5lnv8 | What Does Plant- Based Vaccine Technology Offer to the Fight against COVID-19? |
| cord-302393-hrz3bypr | requiring invasive mechanical ventilation Epidemic obesity and type 2 diabetes in Asia Deaths from COVID-19 in healthcare workers in Italy- what can we learn? |
| cord-303384-bgvagdft | THE SAME COIN? |
| cord-302912-aqutzlx4 | Did the hesitancy in declaring COVID-19 a pandemic reflect a need to redefine the term? |
| cord-302786-ibt7mupq | How should I manage immunosuppression in a kidney transplant patient with COVID-19? |
| cord-289520-i6pv90s9 | What are risk factors for death or severe illness? |
| cord-289520-i6pv90s9 | What are the risk factors for death or severe illness? |
| cord-289520-i6pv90s9 | What are the risk factors for death or severe illness? |
| cord-289520-i6pv90s9 | What are the risk factors for infection( in patient population)? |
| cord-289520-i6pv90s9 | What characteristics define a"case"? |
| cord-289520-i6pv90s9 | What is the causative agent of disease? |
| cord-289520-i6pv90s9 | What is the causative agent of disease? |
| cord-289520-i6pv90s9 | What is the causative agent of disease? |
| cord-289520-i6pv90s9 | What is the clinical presentation and spectrum of disease? |
| cord-289520-i6pv90s9 | What is the duration of viral shedding? |
| cord-289520-i6pv90s9 | What is the optimal diagnostic test for detecting the virus? |
| cord-289520-i6pv90s9 | What is the optimal diagnostic test? |
| cord-289520-i6pv90s9 | What is the role of antivirals in treatment? |
| cord-289520-i6pv90s9 | What is the role of steroids in treatment? |
| cord-289520-i6pv90s9 | What risk factors pre- dispose health care workers to infection or transmission? |
| cord-289520-i6pv90s9 | What treatments are effective? |
| cord-303017-4zx94rm6 | Individuals Beta- blockers: Friend or foe in asthma? |
| cord-301771-43fl2gwp | 2019 novel coronavirus( 2019-nCoV): what advice can we give to travellers? |
| cord-301771-43fl2gwp | The next big threat to global health? |
| cord-303143-4sksz6xz | A prediction rule for clinical diagnosis of severe acute respiratory syndrome Severe acute respiratory syndrome: relationship between radiologic and clinical parameters Serologic and molecular biologic methods for SARS- associated coronavirus infection Surfactant protein D( SP- D) serum levels in patients with community- acquired pneumonia Can routine laboratory tests discriminate between severe acute respiratory syndrome and other causes of community- acquired pneumonia? |
| cord-303022-9hqoq7tf | Oral cancer and periodontal disease increase the risk of COVID 19? |
| cord-302735-zal2gr28 | medRxiv Aerosol transmission of SARS- CoV-2? |
| cord-300458-jeuwaj50 | Is it only that patients do not dare to go to the cath lab because they fear the virus? |
| cord-300458-jeuwaj50 | Is reading and remembering so difficult? |
| cord-300458-jeuwaj50 | could it still be the virus? |
| cord-303407-n7j56sci | Neonatal Early- Onset Infection With SARS- CoV-2 in 33 Neonates Born to Mothers With COVID-19 in Wuhan, China Novel coronavirus in a 15-day- old neonate with clinical signs of sepsis, a case report Should Infants Be Separated from Mothers with COVID-19? |
| cord-297327-19dfgfz6 | A molecular platform triggering activation of inflammatory caspases and processing of proil- beta Acute neurodegeneration and the inflammasome: Central processor for danger signals and the inflammatory response? |
| cord-297327-19dfgfz6 | COVID-19 and treatment with NSAIDs and corticosteroids: Should we be limiting their use in the clinical setting? |
| cord-297327-19dfgfz6 | Does analgesia and condition influence immunity after surgery? |
| cord-297327-19dfgfz6 | Similar or different? |
| cord-297327-19dfgfz6 | The X- ray crystal structure of the membrane protein prostaglandin H2 synthase-1 Cyclo- Oxygenase( COX) inhibitors and cardiovascular risk: Are non- steroidal anti- inflammatory drugs really anti- inflammatory? |
| cord-297327-19dfgfz6 | What do we need to know about ICU delirium during SARS- CoV-2 pandemic? |
| cord-297327-19dfgfz6 | What is the risk? |
| cord-300763-3ateeei3 | What Is COVID-19? |
| cord-300763-3ateeei3 | What happened? |
| cord-300763-3ateeei3 | medRxiv Responding to community spread of COVID-19 interim guidance Coronavirus: when will a COVID-19 vaccine be ready? |
| cord-300763-3ateeei3 | what next? |
| cord-301947-b6nwaost | COVID-19 New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-301947-b6nwaost | COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression Increased incidence of gastrointestinal side effects in patients taking hydroxychloroquine: a brand- related issue? |
| cord-303216-1pbuywz6 | Does COVID19 infect the brain? |
| cord-300793-tuq8z6gm | The challenge of emerging and re- emerging infectious diseases Environmental and social influences on emerging infectious diseases: past, present and future Mortality trends and setbacks: global convergence or divergence? |
| cord-300793-tuq8z6gm | The injection century: massive unsterile injections and the emergence of human pathogens Mortality before and after HIV infection in the complete UK population of haemophiliacs Transmission of West Nile virus through blood transfusion in the United States in 2002 Transmission of West Nile virus from an organ donor to four transplant recipients Cell and molecular biology of simian virus 40: implications for human infections and disease SV40 in human cancers- an endless tale? |
| cord-300793-tuq8z6gm | What have we learnt from SARS? |
| cord-301921-i1o18nmw | How can dermatologists contribute to health surveillance during the coronavirus outbreak? |
| cord-301921-i1o18nmw | The SARS, MERS and novel coronavirus( COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
| cord-303745-wx3udkee | Do salivary antibodies reliably reflect both mucosal and systemic 486 immunity? |
| cord-303880-zv4nbz9p | Artificial intelligence vs COVID-19: limitations, constraints and pitfalls Apple and Google's covid- tracing tech has been released to 23 countries Can mathematical modelling solve the current Covid-19 crisis? |
| cord-303585-8py6joh6 | Can we contain the COVID-19 outbreak with the same measures as for SARS? |
| cord-300848-0igfcixy | COVID-19 concern nephrologists? |
| cord-300848-0igfcixy | Is haematuria a marker of more severe COVID-19( and need of urinary catheter insertion), or does this indicate a subgroup of patients in which kidney tropism, resulting in COVAN, contributes to worse outcome? |
| cord-300848-0igfcixy | Why and to what extent? |
| cord-300848-0igfcixy | Will kidney tropism of SARS- CoV-2 result in an increased risk for progressive CKD? |
| cord-303661-etb19d6y | Nebulized heparin is associated with fewer days of mechanical ventilation in critically ill patients: a randomized controlled trial Inhibition of feline( FIPV) and human( SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics Teicoplanin: an alternative drug for the treatment of COVID-19? |
| cord-303959-e1654g5j | : what do we know? |
| cord-302238-l8j1vy0y | ( COVID-19) in Inpatient Obstetric Healthcare Settings US Department of Health and Human Services Novel corona virus disease( COVID-19) in pregnancy: what clinical recommendations to follow? |
| cord-302238-l8j1vy0y | Epub An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal- fetal transmission of SARS- CoV-2: maternal coronavirus infections and pregnancy outcomes Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records Can SARS- CoV-2 infection be acquired in utero? |
| cord-302238-l8j1vy0y | When does mother to child transmission of hepatitis C virus occur? |
| cord-295431-p9iy7uaf | : Can they have sides effects? |
| cord-295431-p9iy7uaf | A Novel Coronavirus outbreak of global health concerned Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Respiratory Protection Against Airborne Infectious Agents for Health Care Workers: Do surgical masks protect workers? |
| cord-295431-p9iy7uaf | Can this therefore be associated to fainting? |
| cord-295431-p9iy7uaf | Could a winding beach be a place of high COVID spread? |
| cord-295431-p9iy7uaf | Did the wind contributed in spreading COVID-19 around the globe? |
| cord-295431-p9iy7uaf | Did we observe hot spot of COVID-19 infections in winding places around the globe? |
| cord-295431-p9iy7uaf | Facemasks shortage? |
| cord-295431-p9iy7uaf | The COVID-19 infected people are already suffering from symptoms such as fatigue, headache or shortness of breath; how much more does the inhaling of CO 2 can influence the health of the general public? |
| cord-295431-p9iy7uaf | Therefore, one could ask if it is possible that wearing an appropriate facemask for a long period while exercising social distancing can cause one to inhale so much CO 2 than oxygen? |
| cord-298156-d0pb1kik | Air Pollution Influence COVID-19 Outbreaks? |
| cord-298156-d0pb1kik | Atmosphere 2020 Is the coronavirus airborne? |
| cord-298156-d0pb1kik | Can you put a price on COVID-19 options? |
| cord-298156-d0pb1kik | Does global change increase the success of biological invaders? |
| cord-298156-d0pb1kik | Health Perspect Climate affects global patterns of COVID-19 early outbreak dynamics High temperature and high humidity reduce the transmission of COVID-19 Will Coronavirus Pandemic Diminish by Summer? |
| cord-298156-d0pb1kik | Is the future here? |
| cord-298156-d0pb1kik | What do we know about the SARS- CoV-2 coronavirus in the environment? |
| cord-298156-d0pb1kik | atmosferico e COVID-19 Mascherine per tutti? |
| cord-304232-c0cpx2q3 | ( COVID-19) outbreak: could pigs be vectors for human infections? |
| cord-304340-9mrtic2k | What does this mean for re- emergence? |
| cord-301603-gdxvbspx | The SARS, MERS and novel coronavirus( COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
| cord-301603-gdxvbspx | and 62784?, respectively. |
| cord-301603-gdxvbspx | int/ emergencies/ diseases/ novel- coronavirus-2019/ situationreports), the numbers of laboratory- confirmed cases and mortalities were 1133758? |
| cord-302166-tah3jdw0 | COVID-19? |
| cord-302166-tah3jdw0 | Severe COVID-19 in the young and healthy: monogenic inborn errors of immunity? |
| cord-302166-tah3jdw0 | The human genetic determinism of life- threatening infectious diseases: genetic heterogeneity and physiological homogeneity? |
| cord-302166-tah3jdw0 | title: Severe COVID-19 in the young and healthy: monogenic inborn errors of immunity? |
| cord-302821-b9ikg0xy | A sporadic occurrence? |
| cord-302821-b9ikg0xy | the Framingham Heart Study Is epicardial fat tissue associated with atrial fibrillation recurrence after ablation? |
| cord-304073-f3iwclkm | Is there an ideal animal model for SARS? |
| cord-304073-f3iwclkm | What is the predictive value of animal models for vaccine efficacy in humans? |
| cord-303506-rqerh2u3 | How and why scholars cite on Twitter Can alternative indicators overcome language biases in citation counts? |
| cord-303506-rqerh2u3 | understanding community annotation of uncollected sources Are papers addressing certain diseases perceived where these diseases are prevalent? |
| cord-304388-pth2d40p | Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak e United States Controlling Middle East respiratory syndrome: lessons learned from severe acute respiratory syndrome Are children less susceptible to COVID-19? |
| cord-302381-oujsmf8d | One nurse reported that no matter where she was, both friends and families would ask,''Should you be here? |
| cord-302381-oujsmf8d | The goal is to determine whether the SARS outbreak was a unique experience for nurses or whether similar experiences were shared by nurses in the past? |
| cord-302381-oujsmf8d | This search began shortly after the conclusion of the SARS crisis with a deceptively simple question: how did nurses in the past cope with workplace and personal stress during epidemics? |
| cord-301025-cf2jcw6x | Is the number of those people large enough to allow for sound statistical inference? |
| cord-301025-cf2jcw6x | Is there a large enough number of identifiable people who have been chronically taking HCQ medication since before the outbreak of SARS- CoV-2 as a treatment for other diseases? |
| cord-301025-cf2jcw6x | The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study Is the incidence of rheumatoid arthritis rising? |
| cord-301025-cf2jcw6x | What happens if FNR and FPR have the exact same( nonzero) value? |
| cord-301025-cf2jcw6x | What results found in them would be suggestive of a prophylactic effect of HCQ against COVID- 19? |
| cord-304088-xkg0ylz8 | Effective treatment of severe COVID-19 patients with Tocilizumab Elevated fibroblast growth factor-2 increases tumor necrosis factor- α induced endothelial cell death in high glucose SDF-1 induces TNF- mediated apoptosis in cardiac myocytes Are children less susceptible to COVID-19? |
| cord-304088-xkg0ylz8 | Is there an ideal animal model for SARS? |
| cord-302442-jhio7mrl | COVID-19 pneumonia: different respiratory treatments for different phenotypes? |
| cord-302442-jhio7mrl | Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? |
| cord-302442-jhio7mrl | Why tocilizumab could be an effective treatment for severe COVID-19? |
| cord-303960-86mukxg1 | ( COVID-19) Situation Report-51 COVID-19: what is next for public health? |
| cord-303960-86mukxg1 | Nil Coronavirus: Revenge of the pangolins?: |
| cord-302195-25gjbyi1 | : what is its fate in urban water cycle and how can the water research community respond? |
| cord-302195-25gjbyi1 | First? |
| cord-302195-25gjbyi1 | Regressing SARS- CoV-2 sewage measurements onto COVID-19 burden in the population: a proof- of- concept for quantitative environmental surveillance Higher virulence of COVID-19 in the air- polluted regions of eight severely affected countries Clinical progression and viral load in a community outbreak of coronavirus- associated SARS pneumonia: a prospective study Editorial Perspectives: will SARS- CoV-2 reset public health requirements in the water industry? |
| cord-303787-dx1n8jap | All rights reserved Neurological Complications during Treatment of Middle East Respiratory Syndrome Guillain- Barre syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-303787-dx1n8jap | Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19 Neurological manifestations in severe acute respiratory syndrome Environmental Triggers of Autoreactive Responses: Induction of Antiphospholipid Antibody Formation Human coronaviruses and other respiratory viruses: Underestimated opportunistic pathogens of the central nervous system? |
| cord-303135-rx21ajiw | How is this receptor and the protease regulated in the nasal cavity, and how does that change with age, sex, or disease status, 1 and would that possibly explain some of the questions posed above? |
| cord-303135-rx21ajiw | What do we know about upper airway conditions such as chronic rhinosinusitis( CRS) with or without polyps, or allergic rhinitis; would these diseases increase the risk of infection? |
| cord-298227-av1ev8ta | Does Risk Compensation Undo the Protection of Ski Helmet Use? |
| cord-298227-av1ev8ta | During the lockdown, the distance rules can usually be adhered to, but what happens when the actual lockdown is over and the people meet again in a confined space? |
| cord-298227-av1ev8ta | Lo et al., 2005 and Seto et al., 2003? |
| cord-298227-av1ev8ta | The Lancet Testing the efficacy of homemade masks: Would they protect in an influenza pandemic? |
| cord-298227-av1ev8ta | The Lessons of the Pandemic Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? |
| cord-298227-av1ev8ta | Why do some COVID-19 patients infect many others, whereas most do n't spread the virus at all? |
| cord-298227-av1ev8ta | Why should the people of Western societies not be able to protect themselves as many people in East Asian countries have long been doing? |
| cord-304306-rxjahqwh | Structural Differences Linked to Virus Characteristics? |
| cord-304617-5ozf18lg | What lessons have we learned? |
| cord-304058-i8cywew0 | The large 386-nt deletion in SARS- associated coronavirus: evidence for quasispecies? |
| cord-304058-i8cywew0 | what can they teach us about the severe acute respiratory syndrome? |
| cord-301547-d4wt9dqp | , Saudi Arabia Are Saudi medical students aware of middle east respiratory syndrome coronavirus during an outbreak? |
| cord-301547-d4wt9dqp | Among Korean Adults: Do Women Have a Higher Level of Health Literacy Than Men? |
| cord-301547-d4wt9dqp | Is the Saudi public aware of Middle East respiratory syndrome? |
| cord-301547-d4wt9dqp | Won S- y, Pascall G. A Confucian War over Childcare? |
| cord-304734-r0k1rfmt | The epidemiological characteristics of an of 2019 Novel Coronavirus Diseases( COVID-19) COVID-19 How many Healthcare workers are infected? |
| cord-304792-8sdxqmkb | Hypoxia activates 15- 687 PGDH and its metabolite 15-KETE to promote pulmonary artery endothelial cells 688 proliferation via ERK1/2 signalling The protective and pathogenic 691 roles of IL-17 in viral infections: friend or foe? |
| cord-296494-6kn4mr04 | A Missing Link? |
| cord-296494-6kn4mr04 | A Nationwide Analysis Immunology in the clinic review series; focus on type 1 diabetes and viruses: the enterovirus link to type 1 diabetes: critical review of human studies Autoantibody negative new onset type 1 diabetic patients lacking high risk HLA alleles in a caucasian population: are these type 1b diabetes cases? |
| cord-296494-6kn4mr04 | Advances in the physiology in the last decade consider atherothrombosis and aging as an inflammatory disorder( 81) but, which molecular aspects are common to both conditions?. |
| cord-296494-6kn4mr04 | Do we give the value it really has?. |
| cord-296494-6kn4mr04 | How to Oppose Aging Strategically? |
| cord-296494-6kn4mr04 | In accordance with the above, could the immunosenescence be related to the special aggressiveness of COVID-19 in the elderly?. |
| cord-296494-6kn4mr04 | In aged COVID-19 patients or with history of coronary artery disease( CAD) an acute coronary syndrome( ACS) can also be seen for plaque vulnerability in the presence of a pro- inflammatory state with cytokine release( 71) but from the experience in animals, could it be plausible that any of them could be due to arteritis? |
| cord-296494-6kn4mr04 | In patients of COVID-19, what are the symptoms and clinical features of mild and moderate cases? |
| cord-296494-6kn4mr04 | In this sense, are we really optimizing the main targets during the hospitalisation? |
| cord-296494-6kn4mr04 | Our questions are, why?, and beyond, would it be useful?. |
| cord-296494-6kn4mr04 | Our questions are, why?, and beyond, would it be useful?. |
| cord-296494-6kn4mr04 | The question now is, what can we do pro- actively, in the meantime? |
| cord-304742-ytf2ilw4 | The SARS- CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE- inhibitor- and angiotensin II receptor blocker- based cardiovascular therapies ACE 2 coding variants: a potential X- linked risk factor for COVID-19 disease Host cell proteases: critical determinants of coronavirus tropism and pathogenesis Down syndrome and COVID-19: a perfect storm? |
| cord-299927-ixuvy2g4 | China Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis Guillain- Barre syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-299927-ixuvy2g4 | Guillain Barre syndrome associated with COVID-19 infection: a case report COVID-19 may induce Guillain- Barre syndrome Guillain- Barre syndrome associated with SARS- CoV-2 infection Guillain- Barre syndrome related to COVID-19 infection Guillain- Barre syndrome following COVID-19: new infection, old complication? |
| cord-299927-ixuvy2g4 | Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? |
| cord-299927-ixuvy2g4 | The environment and disease: association or causation? |
| cord-299927-ixuvy2g4 | Time to re- examine the problem Encephalitis lethargica: could this disease be recognised if the epidemic recurred? |
| cord-299927-ixuvy2g4 | a post- influenzal or some other phenomenon? |
| cord-304626-ffao7vka | Fibronectin binds to the C1q component of complement New functional ligands for ficolin-3 among lipopolysaccharides of Hafnia alvei Heteromeric Complexes of native collectin kidney 1 and collectin liver 1 are found in the circulation with MASPs and activate the complement system Proteolytic activities of two types of mannose- binding lectin- associated serine protease Natural substrates and inhibitors of mannan- binding lectin- associated serine protease-1 and−2: a study on recombinant catalytic fragments MASP-3 and its association with distinct complexes of the mannanbinding lectin complement activation pathway C3 adsorbed to a polymer surface can form an initiating alternative pathway convertase The tick- over theory revisited: is C3 a contactactivated protein? |
| cord-304550-6j1pb1pu | How specific is too specific? |
| cord-305139-851v2qr3 | massive hemoptysis Observational, multicentre study on the epidemiology of haemoptysis Is EVALI the new scapegoat for every abnormal chest imaging? |
| cord-305054-4d84b2g6 | the intermediate host of the 2019 novel coronavirus( SARS- CoV-2)? |
| cord-304899-vruq4r7z | digestifs que les anti- inflammatoires non stéroïdiens classiques? |
| cord-304724-luql6159 | Chest CT findings in cases from the cruise ship"Diamond Princess A role for CT in COVID-19? |
| cord-304815-3datxv8j | Who controls the samples? |
| cord-305263-fgwf6wy3 | alpha-2a with or without ribavirin for HBeAg- negative chronic hepatitis B Increasing proportion of herpes simplex virus type I as a cause of genital herpes infection in college students Herpes simplex virus encephalitis: new infection or reactivation? |
| cord-304943-thg4fqi2 | How will country- based mitigation measures influence the course of the COVID-19 epidemic? |
| cord-303363-uu9hb1c9 | A contribution of Thalassaemia International Federation to its global patients'community Role of iron in inducing oxidative stress in thalassemia: Can it be prevented by inhibition of absorption and by antioxidants? |
| cord-303363-uu9hb1c9 | Oxidative stress and inflammation in iron- overloaded patients with betathalassaemia or sickle cell disease Oxidative stress and age- related changes in T cells: is thalassemia a model of accelerated immune system aging? |
| cord-303363-uu9hb1c9 | Very few cases in thalassemia have so far been reported; is this due to lack of testing or a true lack of infection/ susceptibility? |
| cord-303363-uu9hb1c9 | key: cord-303363-uu9hb1c9 authors: Karimi, Mehran; De Sanctis, Vincenzo title: Implications of SARSr- CoV 2 infection in thalassemias: Do patients fall into the “ high clinical risk ” category? |
| cord-304418-k9owyolj | -A systematic review of the literature, case series, and recommendations for clinical assessment and management Epidemiologie und therapie in Deutschland, Österreich und der Schweiz Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease COVID-19 and anosmia: A review based on up- to- date knowledge Self- reported olfactory and taste disorders in SARS- CoV-2 patients: a cross- sectional study Neurologic features in severe SARS- COV-2 infection Neurological manifestations and complications of COVID-19: A literature review A first Case of Meningitis/ Encephalitis associated with SARS- Coronavirus-2 Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-304418-k9owyolj | What Is a Pandemic? |
| cord-304574-03s404s5 | : Does SARS- CoV-2 Cause Viral Cystitis? |
| cord-304574-03s404s5 | Urinary frequency as a possible overlooked symptom in COVID-19 patients: does SARS- CoV-2 cause viral cystitis? |
| cord-299093-zp07aqpm | Do the SARS- CoV-2 proteins with more potent antagonistic immune functions increase virulence in humans compared to other HCoVs? |
| cord-299093-zp07aqpm | Question mark symbol(?) denotes |
| cord-299093-zp07aqpm | SARS- CoV-2 proteins with* denotes functional conservation with SARS- CoV Which animal(s) serves as the natural reservoir of SARS- CoV-2? |
| cord-299093-zp07aqpm | What are the correlates of immune protection for SARS- CoV2 and will they provide sterilizing immunity? |
| cord-299093-zp07aqpm | What are the underlying mechanisms contributing to an inadequate IFN response to SARS- CoV-2? |
| cord-299093-zp07aqpm | Which SARS- CoV-2 proteins antagonize innate and adaptive immune responses? |
| cord-299093-zp07aqpm | Why do some recovered patients fail to develop neutralizing antibodies? |
| cord-299093-zp07aqpm | Does active replication of SARS- CoV-2 in the upper respiratory tract contribute to enhanced transmissibility in humans? |
| cord-299093-zp07aqpm | Is intestinal SARS- CoV-2 infection a source of virus transmission? |
| cord-305223-go75cs6r | Emerg Microbes Infect Viral pneumonia in severe respiratory failure Clinical management of severe acute respiratory infection when novel coronavirus( nCoV)infection is suspected: interim guidance Hypoalbuminemia in acute illness: is there a rationale for intervention? |
| cord-305610-v1hn934x | testosterone metabolite 19-hydroxyandrostenedione induces neuroendocrine trans- differentiation of prostate cancer cells via an ectopic olfactory receptor Androgen sensitivity gateway to cOVId-19 disease severity TMPRSS2 and cOVId-19: Serendipity or opportunity for intervention? |
| cord-305742-wf6qxplf | What is Life? |
| cord-305091-tfn2pyc6 | A matter of concern Pharmacodynamics of teicoplanin against MRSA Teicoplanin: an alternative drug for the treatment of COVID-19? |
| cord-305091-tfn2pyc6 | Is teicoplanin a complementary treatment option for COVID-19? |
| cord-303054-s1clwunc | Can the Coronavirus Disease 2019( COVID-19) Affect the Eyes? |
| cord-303054-s1clwunc | Covid-19 Outbreak: Is There Still a Place for Scheduled Surgery?" |
| cord-303054-s1clwunc | How to risk- stratify elective surgery during the COVID-19 pandemic? |
| cord-305582-3hmsknon | Yu Ping Feng San, an ancient Chinese herbal decoction, induces gene expression of anti- viral proteins and inhibits neuraminidase activity Oseltamivir compared with the Chinese traditional therapy maxingshigan- yinqiaosan in the treatment of H1N1 influenza: a randomized trial Convalescent plasma: new evidence for an old therapeutic tool? |
| cord-305755-6jup93v4 | The human nasal microbiota and Staphylococcus aureus carriage Evaluation of Sample Preparation Methods for Fast Proteotyping of Microorganisms by Tandem Mass Spectrometry Mass spectrometry: a revolution in clinical microbiology? |
| cord-305704-grzrkff9 | -What should dermatologists know? |
| cord-305564-dj3vj4tk | The severe acute respiratory syndrome coronavirus 3a is a novel structural protein SARS- CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium Unique and conserved features of genome and proteome of SARS- coronavirus, an early split- off from the coronavirus group 2 lineage A doubleinactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses Is there an ideal animal model for SARS? |
| cord-305788-z75yv88e | Should we group SARS- CoV-2 samples from households? |
| cord-295455-km0qcmlh | Are targets mono- or poly- ADP- ribosylated? |
| cord-295455-km0qcmlh | Can a macrodomain from one virus family substitute for a different one? |
| cord-295455-km0qcmlh | Could viruses escape these inhibitors? |
| cord-295455-km0qcmlh | Do all viruses require macrodomain enzymatic activity or is MAR/ PAR binding sufficient to promote virus fitness/ virulence? |
| cord-295455-km0qcmlh | Do invertebrates have antiviral PARP activity that is counteracted by macrodomains? |
| cord-295455-km0qcmlh | Do regions outside of the ADP- ribose binding pocket contribute to interactions with targets? |
| cord-295455-km0qcmlh | Do viral macrodomains counteract antiviral ADP- ribosylation? |
| cord-295455-km0qcmlh | How do viral macrodomains acquire specificity? |
| cord-295455-km0qcmlh | How does ADP- ribosylation impact these targets? |
| cord-295455-km0qcmlh | Is the development of small- molecule inhibitors specific for viral macrodomains to repress viral pathogenesis feasible? |
| cord-295455-km0qcmlh | What are the ADP- ribosylated protein targets of viral macrodomains? |
| cord-295455-km0qcmlh | What are the determinants of mono- versus poly- ADPribose binding/ removal? |
| cord-295455-km0qcmlh | What effects do mutations in viral macrodomains have on de- ADP- ribosylation kinetics? |
| cord-295455-km0qcmlh | Which PARP(s) is responsible for antiviral ADP- ribosylation? |
| cord-295455-km0qcmlh | Would these inhibitors also affect mammalian enzymes, leading to significant side effects? |
| cord-302806-1e99cygs | Can the Coronavirus Disease 2019( COVID-19) Affect the Eyes? |
| cord-302806-1e99cygs | Is There Ophthalmological Concern? |
| cord-302806-1e99cygs | New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-298372-4pw1y404 | Biothreat Detection, Forensics, and the Clinic Recalibration of the Grunow- Finke Assessment Tool to Improve Performance in Detecting Unnatural Epidemics People intentionally spreading coronavirus could be charged with terrorism, DOJ says Risks to emergency medical responders at terrorist incidents: a narrative review of the medical literature Diagnostic preparedness for infectious disease outbreaks Epidemic preparedness: why is there a need to accelerate the development of diagnostics? |
| cord-298372-4pw1y404 | How to deal with the two sides of the same coin? |
| cord-298372-4pw1y404 | How to deal with the two sides of the same coin? |
| cord-298372-4pw1y404 | Is SARS- CoV-2 originated from laboratory? |
| cord-298372-4pw1y404 | Is there any interest to identify one from the other? |
| cord-298372-4pw1y404 | The CRISPR tool kit for genome editing and beyond Agricultural research, or a new bioweapon system? |
| cord-298372-4pw1y404 | The SARS wake- up call What Factors Might Have Led to the Emergence of Ebola in West Africa? |
| cord-298372-4pw1y404 | The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable? |
| cord-298372-4pw1y404 | To what extent does evidence support decision making during infectious disease outbreaks? |
| cord-298372-4pw1y404 | Using connected objects in clinical research Constructing a Data- Driven Society: China's Social Credit System as a State Surveillance Infrastructure Prospective Hot- SpottingThe Future of Crime Mapping? |
| cord-304013-nzigx0k0 | : Can we stay safe as lockdown eases? |
| cord-304013-nzigx0k0 | Covid-19? |
| cord-304013-nzigx0k0 | Does COVID-19 transmit via expiratory particles? |
| cord-304013-nzigx0k0 | The ventilation problem in schools: literature review, Indoor Air Association of classroom ventilation with reduced illness absence: A prospective study in California elementary schools Role of ventilation in airborne transmission of infectious agents in the built environment? |
| cord-303917-2tu707ng | Chloroquine is a potent inhibitor of SARS coronavirus infection and spread Membrane- related effects underlying the biological activity of the anthraquinones emodin and barbaloin Emodin blocks the SARS coronavirus spike protein and angiotensin- converting enzyme 2 interaction Old drugs as lead compounds for a new disease? |
| cord-303917-2tu707ng | Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? |
| cord-303917-2tu707ng | Potent neutralization of severe acute respiratory syndrome( SARS) coronavirus by a human mAb to S1 protein that blocks receptor association Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-303917-2tu707ng | induce robust and multifunctional T cell responses against both viruses in an appropriate mouse model Measles- derived vaccines to prevent emerging viral diseases Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets Convalescent plasma: new evidence for an old therapeutic tool? |
| cord-306390-pzzev8hd | A comparative- descriptive analysis of clinical characteristics in 2019-coronavirus- infected children and adults Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces( autonomous region) of northern China Infection fatality rate of SARS- CoV-2 infection in a German community with a super- spreading event Comparison of four new commercial serologic assays for determination of SARS- CoV-2 IgG Immunoglobulins or convalescent plasma to tackle COVID-19: buying time to save lives-current situation and perspectives Virological assessment of hospitalized patients with COVID-19 Inactivation and safety testing of Middle East Respiratory Syndrome Coronavirus Reverse ELISA for IgG and IgM antibodies to detect Lassa virus infections in Africa Lexikon der Medizinischen Laboratoriumsdiagnostik Impact assessment of non- pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study An Analysis of SARS- CoV-2 viral load by patient age Symptomatic Infants have Higher Nasopharyngeal SARS- CoV-2 Viral Loads but Less Severe Disease than Older Children Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children SARS- CoV-2( COVID-19): What do we know about children? |
| cord-302115-r39ser2c | Exercise, upper respiratory tract infection, and the immune system Favorable outcome of COVID19 in two patients with X- linked agammaglobulinemia A possible role for B cells in COVID-19?: |
| cord-302115-r39ser2c | How does COVID-19 kill? |
| cord-302115-r39ser2c | The species and its viruses- A statement of the Coronavirus Study Group COVID-19: what is next for public health? |
| cord-302115-r39ser2c | What makes COVID-19 pneumonia a life- threatening disease? |
| cord-302115-r39ser2c | What makes the difference? |
| cord-302115-r39ser2c | What prevents the virus from rapidly reaching the lungs and then causing severe pneumonia? |
| cord-304263-5kddk5fa | Compared to the Single X- Chromosome in Males? |
| cord-304263-5kddk5fa | Internal and emergency medicine COVID-19 and smoking: A systematic review of the evidence How nicotine can inhibit cytokine storm in the lungs and prevent or lessen the severity of COVID-19 infection? |
| cord-304263-5kddk5fa | Is Nicotine the Hidden Link? |
| cord-304263-5kddk5fa | Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? |
| cord-301946-erzh30mt | American journal of physiology Could intravenous immunoglobulin collected from recovered coronavirus patients protect against covid-19 and strengthen the immune system of new patients? |
| cord-301946-erzh30mt | Archives of gynecology and obstetrics Lymphocyte immunotherapy for recurrent miscarriages: Predictors of therapeutic success Information for clinicians on therapeutic options for covid-19 patients Clinical and immunologic features in severe and moderate coronavirus disease 2019 Tumor necrosis factor Chloroquine and hydroxychloroquine as available weapons to fight covid-19 A systematic review on the efficacy and safety of chloroquine for the treatment of covid-19 Does immunotherapy for treatment of reproductive failure enhance live births? |
| cord-301946-erzh30mt | Intravenous immunoglobulin therapy: How does igg modulate the immune system? |
| cord-301946-erzh30mt | What to expect for covid-19? |
| cord-301946-erzh30mt | a th2 phenomenon? |
| cord-301946-erzh30mt | china Hfea coronavirus( covid-19) guidancecurrent status as of Covid-19 and vitamin d- is there a link and an opportunity for intervention? |
| cord-306733-df36w6l7 | What Does Plant- Based Vaccine Technology Offer to the Fight against COVID-19? |
| cord-306308-zjq6cscm | what we know so far COVID-19, SARS and MERS: are they closely related? |
| cord-306749-qetf3uur | Improved outcome for pre- hospital cardiopulmonary collapse with resuscitation by bystanders Pre- hospital cardiopulmonary resuscitation: is it effective? |
| cord-305763-160heazx | In vitro diagnostics of coronavirus disease 2019: Technologies and application Extra- respiratory manifestations of COVID-19 Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2( SARS- CoV-2): Facts and myths Coronavirus disease 2019( COVID-2019) infection among health care workers and implications for prevention measures in a tertiary hospital in Wuhan, China Bonuses and pitfalls of a paperless drivethrough screening and COVID-19: A field report Are children less susceptible to COVID-19? |
| cord-270348-5804ffwx | Does the system have a plan for admitting SARS- CoV-2 negative patients to a different facility, or a different unit within the same facility? |
| cord-270348-5804ffwx | Does the unit have adequate wifi for video conferences as required? |
| cord-270348-5804ffwx | How do staff access higher levels of evaluation or treatment if necessary? |
| cord-270348-5804ffwx | How does the system process SARS- CoV-2 testing for admitted patients? |
| cord-270348-5804ffwx | How many assistant staff will be required for donning/ doffing PPE? |
| cord-270348-5804ffwx | How many beds? |
| cord-270348-5804ffwx | How many nursing staff per patient? |
| cord-270348-5804ffwx | How will SARS- CoV-2 positive patients be admitted? |
| cord-270348-5804ffwx | How will SARS- CoV-2 positive patients be transported to their discharge site? |
| cord-270348-5804ffwx | How will aftercare be arranged? |
| cord-270348-5804ffwx | How will legal conferences and hearings be handled? |
| cord-270348-5804ffwx | How will repeat SARS- CoV-2 testing be done to determine negativity, if required? |
| cord-270348-5804ffwx | How will staff be trained in use of PPE? |
| cord-270348-5804ffwx | How will the unit handle seclusion/ restraint events? |
| cord-270348-5804ffwx | How will the unit handle visitors? |
| cord-270348-5804ffwx | If patients are in their rooms with doors closed for negative pressure, how will they be monitored? |
| cord-270348-5804ffwx | Is there a consultation- liaison psychiatrist or other psychiatrist with knowledge of COVID-19 illness and comfortable with managing minor disease? |
| cord-270348-5804ffwx | Single or double rooms? |
| cord-270348-5804ffwx | What PPE is available for your unit? |
| cord-270348-5804ffwx | What activities will be available for recreation? |
| cord-270348-5804ffwx | What is the best location for a SARS- CoV-2 positive asymptomatic psychiatry unit in the system? |
| cord-270348-5804ffwx | What is the transfer process? |
| cord-270348-5804ffwx | What processes are in place for rapid intervention for patients developing illness? |
| cord-270348-5804ffwx | What resources are in place to help staff deal with stress? |
| cord-270348-5804ffwx | What systems are in place to monitor staff for symptoms of stress? |
| cord-270348-5804ffwx | What therapies will be offered and how? |
| cord-270348-5804ffwx | Where will be the clean zones for donning/ doffing PPE? III. |
| cord-270348-5804ffwx | Who will be responsible for vital signs and pulse oximetry and how often? |
| cord-270348-5804ffwx | Will patients eat in their rooms? |
| cord-270348-5804ffwx | Will providers see patients face to face or via telepsychiatry? |
| cord-270348-5804ffwx | Will staff be required to wear PPE for extended periods or only while interacting with patients in their rooms? |
| cord-270348-5804ffwx | Will the unit accept involuntary patients? |
| cord-270348-5804ffwx | Will there be communal spaces for treatment/ activity? |
| cord-270348-5804ffwx | b. Are medicines available for patients being discharged into quarantine? |
| cord-270348-5804ffwx | i. 1 test, 2 tests separated by 24 hours, rapid tests or regular- time tests, etc.? |
| cord-306826-vbfdxoc2 | like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes Anti- inflammatory effects of GLP-1-based therapies beyond glucose control Dose rectification of an imbalance between DPP4 and GLP-1 ameliorates chronic stress- related vascular aging and atherosclerosis? |
| cord-300716-urmogf97 | : what is the evidence? |
| cord-300716-urmogf97 | Does COVID19 infect the brain? |
| cord-300716-urmogf97 | Is it possible that the coronavirus was so virulent that it entered the central nervous system directly without passing through the airways? |
| cord-300716-urmogf97 | The gutmicroglia connection: implications for central nervous system diseases Nervous system damage after COVID-19 infection: presence or absence? |
| cord-300716-urmogf97 | The olfactory vector hypothesis of neurodegenerative disease: is it viable? |
| cord-300716-urmogf97 | The pathogenesis of thromboembolic disease in COVID-19 patients: could be a catastrophic antiphospholipid syndrome? |
| cord-300716-urmogf97 | potential reservoirs for COVID-19 asymptomatic infection Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis Olfactory mucosal findings and clinical course in patients with olfactory disorders following upper respiratory viral infection Encephalitis as a clinical manifestation of COVID-19 Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-305616-2obemy16 | : can we improve the future? |
| cord-305616-2obemy16 | Front Pediatr, 8, 74 Coronavirus disease( COVID-19) and neonate: What neonatologist need to know Chinese Pediatric Novel Coronavirus Study SARS- CoV-2 Infection in Children Perinatal aspects on the covid-19 pandemic: a practical resource for perinatal- neonatal specialists Effectiveness of Family Integrated Care in neonatal intensive care units on infant and parent outcomes: a multicentre, multinational, cluster- randomised controlled trial Always a burden? |
| cord-302616-1uwrcvjx | : at present there is no evidence to abandon Renin- Angiotensin System blockers COVID-19 and angiotensin- converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence? |
| cord-302616-1uwrcvjx | Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-302616-1uwrcvjx | how, why, and so what? |
| cord-302616-1uwrcvjx | in vitro MicroRNome analysis unravels the molecular basis of SARS infection in bronchoalveolar stem cells Stress- inducible- stem cells: a new view on endocrine, metabolic and mental disease? |
| cord-302616-1uwrcvjx | what next? |
| cord-307109-nz8qvuw6 | convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? |
| cord-301943-qdtfjdxr | : Should we take the risk for our patients? |
| cord-301943-qdtfjdxr | A Marker of Psychological Distress? |
| cord-301943-qdtfjdxr | COVID-19 et trouble panique respiratoire: quels liens éventuels, quelles anticipations possibles? |
| cord-301943-qdtfjdxr | Panique? |
| cord-301943-qdtfjdxr | The Interpretation of Dyspnea in the Patient with Asthma Do asthma patients with panic disorder really have worse asthma? |
| cord-301943-qdtfjdxr | Useful intervention or impediment? |
| cord-301943-qdtfjdxr | Vous avez dit panique? |
| cord-306177-5wefp31y | A"rule of three"for fragment- based lead discovery? |
| cord-306819-otabtxin | Causal or confounded? |
| cord-304280-2a84u4tm | : what is the evidence? |
| cord-304280-2a84u4tm | An update of its mode of action, pharmacological properties and medical applications SARS- CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor Pharmacology of the renin- angiotensin system Where are we now with COVID-19? |
| cord-304280-2a84u4tm | The Nrf2 Activator( DMF) and Covid-19: Is there a Possible Role? |
| cord-303297-fiievwy7 | COVID-19 patients after successful treatment or recovery again become severely infected with other strains of this virus? |
| cord-303297-fiievwy7 | Even though the exact origin of the virus remains unclear, it is possible to infect a Chinese horseshoe bat or a pangolin with the SARS- CoV-2 and evaluate the success of the infection to determine the origin of the new virus responsible for the pandemic: did it come from animals or from a laboratory? |
| cord-303297-fiievwy7 | However, is it in our power to do so when the official number of diagnosed cases has already exceeded 1 million people worldwide? |
| cord-303297-fiievwy7 | Is it important today to stop the spread of infection as quickly as possible? |
| cord-303297-fiievwy7 | What about reinfection with other possible strains of people who recovered from initial infection with one strain? |
| cord-303297-fiievwy7 | What about reinfection? |
| cord-302382-eifh95zm | Immunosuppression for hyperinflammation in COVID-19: a doubleedged sword? |
| cord-302382-eifh95zm | The use of anti- inflammatory drugs in the treatment of people with severe coronavirus disease 2019( COVID-19): The experience of clinical immunologists from China Immunosuppression for hyperinflammation in COVID-19: a doubleedged sword? |
| cord-302382-eifh95zm | Virus Research A Role for Metal- Based Drugs in Fighting Covid-19 Infection? |
| cord-302382-eifh95zm | Where Do We Stand Now? |
| cord-302382-eifh95zm | interferon responses in COVID-19 Integrated analyses of single- cell atlases reveal age, gender, and smoking status associations with cell type- specific expression of mediators of SARS- CoV-2 viral entry and highlights inflammatory programs in putative target cells DPP4 inhibition: Preventing SARS- CoV-2 infection and/or progression of COVID-19? |
| cord-305632-xbji6g5x | COVID-19 pneumonia: ARDS or not? |
| cord-305632-xbji6g5x | Is Bariatric Surgery Protective? |
| cord-305632-xbji6g5x | Time to use the p- word? |
| cord-306760-05my504t | What should gastroenterologists and patients know about COVID-19? |
| cord-305591-ir3wz6nr | Quadruplex DNA: sequence, topology and structure G- quadruplexes and their regulatory roles in biology G- quadruplexes in pathogens: a common route to virulence control? |
| cord-305591-ir3wz6nr | The folding of 5'-UTR human G- quadruplexes possessing a long central loop How long is too long? |
| cord-307504-cogk5kig | COVID-19? |
| cord-305858-gp1u4kh7 | ( COVID-19): A Review Should chloroquine and hydroxychloroquine be used to treat COVID-19? |
| cord-305858-gp1u4kh7 | Is Blocked by a Clinically Proven Protease Inhibitor SARS- CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes Organ distribution of severe acute respiratory syndrome( SARS) associated coronavirus( SARS- CoV) in SARS patients: implications for pathogenesis and virus transmission pathways Single- cell landscape of bronchoalveolar immune cells in patients with COVID-19 The Lung Macrophage in SARS- CoV-2 Infection: A Friend or a Foe? |
| cord-302983-3v5bc80z | A Cross- sectional Survey on COVID-19 Is Pakistan prepared for the COVID-19 epidemic? |
| cord-302983-3v5bc80z | Can we contain the COVID-19 outbreak with the same measures as for SARS? |
| cord-302983-3v5bc80z | The effects of social determinants on public health emergency preparedness mediated by health communication: The 2015 mers outbreak in south korea Preventive behaviors by the level of perceived infection sensitivity during the Korea outbreak of Middle East Respiratory Syndrome in 2015 Tuning in and catching on? |
| cord-302983-3v5bc80z | The epidemic and the challenges COVID-19 and Italy: what next? |
| cord-302983-3v5bc80z | The prevalence of limited health literacy Health literacy and infectious diseases: why does it matter? |
| cord-302983-3v5bc80z | To what extent are Arab pilgrims to Makkah aware of the middle east respiratory syndrome coronavirus and the precautions against it? |
| cord-302983-3v5bc80z | To what extent are Arab pilgrims to Makkah aware of the middle east respiratory syndrome coronavirus and the precautions against it? |
| cord-305856-xt3zxajf | A cluster of cases of severe acute respiratory syndrome in Hong Kong Identification of severe acute respiratory syndrome in Canada Coronavirus in the United States Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records How can airborne transmission of COVID-19 indoors be minimised? |
| cord-305856-xt3zxajf | Does SARS- CoV-2 has a longer incubation period than SARS and MERS? |
| cord-303741-1ou0cy5k | Does SARS- Cov-2 invade the brain? |
| cord-303741-1ou0cy5k | Why do children seem to be more protected against COVID-19? |
| cord-303741-1ou0cy5k | causes disease?). |
| cord-303741-1ou0cy5k | once there( e.g., infects neural cells? |
| cord-307070-tqxvu3pu | Covid-19: WHO halts hydroxychloroquine trial to review links with increased mortality risk Does lopinavir really inhibit SARS- CoV-2? |
| cord-307070-tqxvu3pu | Polymerase Chain Reaction Negative COVID-19 Patients? |
| cord-307227-x6xketcn | New treatments for Zika virus infection? |
| cord-303517-8971aq02 | -The Editors Speak Out Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19? |
| cord-303517-8971aq02 | A Trial of Lopinavir- Ritonavir in Adults Hospitalized with Severe Covid-19 Centro Nacional de Información de Ciencias Médicas Incidence and Severity of COVID-19 in HIV- Positive Persons Receiving Antiretroviral Therapy Could HIV infection alter the clinical course of SARS- CoV-2 infection? |
| cord-303517-8971aq02 | Mult Scler Houndmills Basingstoke Engl COVIDa MS patient treated with ocrelizumab: does immunosuppression have a protective role? |
| cord-303517-8971aq02 | Should cyclosporine be useful in renal transplant recipients affected by SARS- CoV-2? |
| cord-303517-8971aq02 | When less is better Maintaining HIV care during the COVID-19 pandemic Biomarkers of immunosuppression Immunosuppression for the non- transplant physician: what should you know? |
| cord-303517-8971aq02 | a narrative review Attenuated early inflammatory response in solid organ recipients with COVID-19 Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation? |
| cord-304139-ya3d7u9b | Increased alternative complement pathway function and improved survival during critical illness Role of C3, C5 and anaphylatoxin receptors in acute lung injury and in sepsis Complement as a target in COVID-19? |
| cord-304139-ya3d7u9b | So, what disease mechanisms could explain the described correlation between higher AH50 and better survival of critical illness? |
| cord-304139-ya3d7u9b | Will complement inhibition be the new target in treating COVID-19 related systemic thrombosis? |
| cord-304139-ya3d7u9b | Yet? |
| cord-306901-uuwgpuhw | Assays Optimized pseudotyping conditions for the SARS COV-2 Spike glycoprotein Extracellular vesicles and viruses: Are 556 they close relatives? |
| cord-306901-uuwgpuhw | Vaccines: Status Report Development of SARS- CoV-2 411 vaccines: should we focus on mucosal immunity? |
| cord-307436-qcdlcxyb | The Lancet Infectious Diseases Practical Bayesian model evaluation using leaveone- out cross- validation and WAIC RStan: the R interface to Stan R: A Language and Environment for Statistical Computing Incubation period of 2019 novel coronavirus( 2019-nCoV) infections among travellers from Wuhan, China Does SARS- CoV-2 has a longer incubation period than SARS and MERS? |
| cord-303609-9217t0ui | Cuál es la calidad de la evidencia publicada? |
| cord-303609-9217t0ui | Existen hallazgos analíticos comunes en los pacientes con COVID-19? ¿ |
| cord-303609-9217t0ui | Existen síntomas similares entre los pacientes? |
| cord-303609-9217t0ui | Qué pruebas radiológicas han sido empleadas para el diagnóstico de las complicaciones trombóticas? |
| cord-303609-9217t0ui | trombótica causada por el SARS- CoV-2? |
| cord-304479-uxp1kg86 | A Periodic Systematic Review and Meta- Analysis Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open- label non- randomized clinical trial Is Hydroxychloroquine Safe During Pregnancy? |
| cord-304479-uxp1kg86 | A first step in understanding SARS pathogenesis Cryo- EM structure of the 2019-nCoV spike in the prefusion conformation Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade- long structural studies of SARS coronavirus Prosper, Inhibition of SARS- CoV-2 infections in engineered human tissues using clinical- grade soluble human Soluble angiotensin- converting enzyme 2: a potential approach for coronavirus infection therapy? |
| cord-304479-uxp1kg86 | Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-304479-uxp1kg86 | Can cell therapies halt cytokine storm in severe COVID-19 patients? |
| cord-307942-t8165mdx | What is already known about this topic? |
| cord-306034-1u29o2id | The Impact of COVID-19 on Italy: A Lesson for the Future Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? |
| cord-306034-1u29o2id | a study of 750 patients from the University of Pennsylvania Smell and Taste Center Multimodal chemosensory interactions and perception of flavor Axonal transport enables neuron- to- neuron propagation of human coronavirus OC43 Virus infections in the nervous system Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? |
| cord-305534-936peb1n | A 55-day- old female infant infected with COVID 19: presenting with pneumonia, liver injury, and heart damage Anosmia and dysgeusia in the absence of other respiratory diseases: should COVID-19 infection be considered? |
| cord-305534-936peb1n | Single- cell RNA- seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease SARS- coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS Acute renal impairment in coronavirus- associated severe acute respiratory syndrome Should COVID-19 Concern Nephrologists? |
| cord-305534-936peb1n | Why and to what extent? |
| cord-305534-936peb1n | is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-307596-0bbxyyea | -what is the evidence? |
| cord-307596-0bbxyyea | Comparison of 5% povidone- iodine solution against 1% povidone- iodine solution in preoperative cataract surgery antisepsis: a prospective randomised double blind study Skin preparation for the prevention of surgical site infection: which agent is best? |
| cord-308356-ojx3tasi | Schulen und Kitas sollen wieder geöffnet werden Are children less susceptible to COVID-19? |
| cord-307229-wjx90xki | ( ACE2) is a key modulator of the renin angiotensin system in health and disease Expression of the SARS- CoV-2 cell receptor gene ACE2 in a wide variety of human tissues COVID-19 and chronological aging: senolytics and other anti- aging drugs for the treatment or prevention of corona virus infection? |
| cord-307229-wjx90xki | The ACE-2 in COVID-19: foe or Friend? |
| cord-304282-om2xc4bs | If that is not the case, why the European or the American type of cases flooding into hospitals and overwhelming deaths are not yet observed in Africa, in particular, and other countries in the tropics? |
| cord-304282-om2xc4bs | Pathogens Are we prepared for the next pandemic? |
| cord-304282-om2xc4bs | What can we learn from history to upkeep the above argument? |
| cord-304282-om2xc4bs | What is likely to happen next? |
| cord-304282-om2xc4bs | authors: Berhan, Yifru title: Will Africa be Devastated by Covid-19 as Many Predicted? |
| cord-308576-iw8oobbe | It also interacts with the N protein presumably to assemble the nucleocapsid at the surface of the mature virion ET?. |
| cord-308358-2bap7iih | Clinical course and outcomes of critically ill patients with SARS- CoV-2 pneumonia in Wuhan, China: a single- centered, retrospective, observational study Immune response, inflammation, and the clinical spectrum of COVID-19 The innate immune system: fighting on the frontlines or fanning the flames of COVID-19? |
| cord-300991-ipy24zxp | 2020, 9, x FOR PEER REVIEW 4 of 12 buds or nasal mucosal epithelia? |
| cord-300991-ipy24zxp | A Sixth Taste Modality? |
| cord-300991-ipy24zxp | COVID-19 patients not exhibit a change in ONS perception? |
| cord-300991-ipy24zxp | Can the strategies to alter the intestinal microbiota decrease the severity of SARS- CoV-2 infection? |
| cord-300991-ipy24zxp | Does SARS- CoV-2 infect taste buds or nasal mucosal epithelia? |
| cord-300991-ipy24zxp | Does this viral infection promote a particular microbiome in the gut and ONS epithelia? |
| cord-300991-ipy24zxp | Is there any genetic or epigenetic predisposition? |
| cord-300991-ipy24zxp | all the COVID-19 subjects not complain of the loss of smell? |
| cord-305266-fuaq4ujb | COVID-19: what is next for public health? |
| cord-305266-fuaq4ujb | Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-305266-fuaq4ujb | First respiratory transmitted food borne outbreak? |
| cord-305266-fuaq4ujb | What clinical recommendations to follow? |
| cord-305266-fuaq4ujb | a global emergency that needs new approaches? |
| cord-308110-cco3aq4n | A review of the safety of favipiravir-a potential treatment in the COVID-19 pandemic? |
| cord-307605-8zgyar7e | -a consensus statement Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19 EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity Auslöser von Arzneiexanthemen: Absetzen, durchbehandeln oder desensibilisieren? |
| cord-307605-8zgyar7e | Is There a Connection or Interaction? |
| cord-305262-23qylbmg | -Quo Vadis? |
| cord-305262-23qylbmg | Can N95 Respirators Be Reused after Disinfection? |
| cord-305262-23qylbmg | How Many Times? |
| cord-305262-23qylbmg | Which type of personal protective equipment( PPE) and which method of donning or doffing PPE carries the least risk of infection for healthcare workers? |
| cord-305262-23qylbmg | hospital- acquired infection? |
| cord-307160-1vz0gw1w | Do chronic respiratory diseases or their treatment affect the risk of SARS- CoV-2 infection? |
| cord-307160-1vz0gw1w | Thus, the question remains in our clinical practice, biologic treatment for whom and when? |
| cord-301823-fbeb1nw1 | If any results are presented, are all the source data underlying the results available to ensure full reproducibility? |
| cord-301823-fbeb1nw1 | Is the description of the method technically sound? |
| cord-301823-fbeb1nw1 | Is the description of the method technically sound? |
| cord-301823-fbeb1nw1 | What are the key recommendations that would help minimise the QuantStudio contamination? |
| cord-301823-fbeb1nw1 | Yes If any results are presented, are all the source data underlying the results available to ensure full reproducibility? |
| cord-301823-fbeb1nw1 | the conclusions about the method and its performance adequately supported by the findings presented in the article? |
| cord-301823-fbeb1nw1 | the conclusions about the method and its performance adequately supported by the findings presented in the article? |
| cord-308302-5yns1hg9 | Which are most important for predicting outcome? |
| cord-307815-reg04lpt | Sars- COV-2 Infection SARS- CoV-2: a potential trigger for subacute thyroiditis? |
| cord-307815-reg04lpt | key: cord-307815-reg04lpt authors: Brancatella, Alessandro; Ricci, Debora; Cappellani, Daniele; Viola, Nicola; Sgrò, Daniele; Santini, Ferruccio; Latrofa, Francesco title: Is subacute thyroiditis an underestimated manifestation of SARS- CoV-2 infection? |
| cord-308800-b8gtwdxc | Why did outbreaks of severe acute respiratory syndrome occur in some hospital wards but not in others? |
| cord-304791-wv4qu9xm | COVID-19 Endothelial cell infection and endotheliitis in COVID-19 New therapeutic implications of endothelial nitric oxide synthase( eNOS) function/ dysfunction in cardiovascular disease Pulmonary embolism or pulmonary thrombosis in COVID-19? |
| cord-304791-wv4qu9xm | Is the recommendation to use high- dose heparin for thromboprophylaxis justified? |
| cord-304791-wv4qu9xm | Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus( SARS- CoV-2) Outcomes in patients with hyperglycemia affected by COVID-19: can we do more on glycemic control? |
| cord-304791-wv4qu9xm | Will complement inhibition be the new target in treating COVID-19 related systemic thrombosis? |
| cord-308615-4fobikeh | : what lessons have we learned? |
| cord-308499-xqmguqyi | the dark horse for COVID-19? |
| cord-308667-6jr3z9wx | Emergence of novel coronavirus and COVID-19: whether to stay or die out? |
| cord-303941-3lg1bzsi | How long can bats harbor these viruses? |
| cord-303941-3lg1bzsi | How long can viruses excreted by bats survive in the environment? |
| cord-303941-3lg1bzsi | There are many questions that remain to be answered about the ecology of bat- borne infections:( 1) Are bats the natural reservoirs or just transient carriers of these novel viruses? |
| cord-303941-3lg1bzsi | What are the routes of virus shedding? |
| cord-303941-3lg1bzsi | What links bats to emerging infectious diseases? |
| cord-303941-3lg1bzsi | and What are the risk factors leading to infection of humans or intermediate animals exposed to bat- borne viruses? |
| cord-306748-i9ndb71n | Are Africa's diagnostic challenges blunting response effectiveness? |
| cord-306748-i9ndb71n | COVID-19: Are Africa ’s diagnostic challenges blunting response effectiveness? |
| cord-306748-i9ndb71n | It would be nice to challenges blunting response effectiveness? |
| cord-308100-tvk47fd7 | ; 2020 Hot air? |
| cord-308100-tvk47fd7 | Is endoscopy an aerosol- generating procedure? |
| cord-276758-k2imddzr | : National Committee for Clinical Laboratory Standards Reality of developing a community- wide antibiogram Are United States hospitals following national guidelines for the analysis and presentation of cumulative antimicrobial susceptibility data? |
| cord-276758-k2imddzr | : do they pose a risk to the safety of transfused blood and blood products? |
| cord-276758-k2imddzr | : is it really necessary? |
| cord-276758-k2imddzr | : what is the evidence? |
| cord-276758-k2imddzr | A comparison of hand- washing techniques to remove Escherichia coli and caliciviruses under natural or artificial fingernails Impact of a 5-minute scrub on the microbial flora found on artificial, polished, or natural fingernails of operating room personnel Bacterial carriage by artificial versus natural nails Pathogenic organisms associated with artificial fingernails worn by healthcare workers Postoperative Serratia marcescens wound infections traced to an out- of- hospital source A prolonged outbreak of Pseudomonas aeruginosa in a neonatal intensive care unit: did staff fingernails play a role in disease transmission? |
| cord-276758-k2imddzr | A training program in universal precautions for second- year medical students Control of vancomycinresistant enterococcus in health care facilities in a region Risk factors for ventilator- associated pneumonia: from epidemiology to patient management SARS transmission among hospital workers in Hong Kong Influenza vaccination of healthcare workers and vaccine allocation for healthcare workers during vaccine shortages Influenza immunization: improving compliance of healthcare workers Improving influenza immunization rates among healthcare workers caring for high- risk pediatric patients Correlation between healthcare workers'knowledge of influenza vaccine and vaccine receipt Learning styles and teaching/ learning strategy preferences: implications for educating nurses in critical care, the operating room, and infection control Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes? |
| cord-276758-k2imddzr | An outbreak of Burkholderia( formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy Home- use nebulizers: a potential primary source of Burkholderia cepacia and other colistin- resistant, Gram- negative bacteria in patients with cystic fibrosis Low bacterial contamination of nebulizers in home treatment of cystic fibrosis patients Cleaning home nebulizers used by patients with cystic fibrosis: is rinsing with tap water enough? |
| cord-276758-k2imddzr | Available from Tracking perinatal infection: is it safe to launder your scrubs at home? |
| cord-276758-k2imddzr | Barrier precautions in trauma: is knowledge enough? |
| cord-276758-k2imddzr | Do physicians examine patients in contact isolation less frequently? |
| cord-276758-k2imddzr | Evidence- based medicine meets patient safety Infection control: a problem for patient safety Managing infection in the critical care unit: how can infection control make the ICU safe? |
| cord-276758-k2imddzr | Failure of bland soap handwash to prevent hand transfer of patient bacteria to urethral catheters Skin tolerance and effectiveness of two hand decontamination procedures in everyday hospital use Replace hand washing with use of a waterless alcohol hand rub? |
| cord-276758-k2imddzr | How can clinicians measure safety and quality in acute care? |
| cord-276758-k2imddzr | Is Burkholderia( Pseudomonas) cepacia disseminated from cystic fibrosis patients during physiotherapy? |
| cord-276758-k2imddzr | Learning associated with participation in journal- based continuing medical education Blood and body fluid exposures during clinical training: relation to knowledge of universal precautions Universal precautions training of preclinical students: impact on knowledge, attitudes, and compliance An educational intervention to prevent catheter- associated bloodstream infections in a nonteaching, community medical center Increasing ICU staff handwashing: effects of education and group feedback Handwashing practices in a tertiary- care, pediatric hospital and the effect on an educational program Knowledge of the transmission of tuberculosis and infection control measures for tuberculosis among healthcare workers Senior medical students'knowledge of universal precautions An educational intervention to reduce ventilator- associated pneumonia in an integrated health system: a comparison of effects Evaluation of a patient education model for increasing hand hygiene compliance in an inpatient rehabilitation unit Patient- education handbook Learning styles and teaching strategies: enhancing the patient education experience Handwashing: the Semmelweis lesson forgotten? |
| cord-276758-k2imddzr | Molecular heterogeneity of Acinetobacter baumanii isolates during seasonal increase in prevalence How contagious are common respiratory tract infections? |
| cord-276758-k2imddzr | Nosocomial outbreak of tuberculosis in an outpatient HIV treatment room Mycobacterium tuberculosis transmission in a health clinic Mycobacterium tuberculosis transmission in a health clinic Measles spread in medical settings: an important focus of disease transmission? |
| cord-276758-k2imddzr | Nosocomial rotavirus in a pediatric hospital Toys in a pediatric hospital: are they a bacterial source? |
| cord-276758-k2imddzr | Nursing research in home health care: endangered species? |
| cord-276758-k2imddzr | Persistent Acinetobacter baumannii? |
| cord-276758-k2imddzr | Results of a survey of work duties of 56 infection control professionals( ICPs): are new guidelines needed for the staffing of infection control( IC) programs? |
| cord-276758-k2imddzr | The burden of infection in long- term care Healthcare industry market update Nosocomial infection and antibiotic utilization in geriatric patients: a pilot prospective surveillance program in skilled nursing facilities Regional data set of infection rates for long- term care facilities: description of a valuable benchmarking tool Intensive surveillance for infections in a three- year study of nursing home patients Two years of infection surveillance in a geriatric long- term care facility Nosocomial infection rates during a one- year period in a nursing home care unit of a Veterans Administration hospital Infection surveillance and control programs in the Department of Veterans Affairs nursing home care units: a preliminary assessment Everyday matters in the lives of nursing home residents: wish for and perception of choice and control Care of the nursing home patient Higher respiratory infection rates on an Alzheimer's special care unit and successful intervention Issues in the management of resistant bacteria in longterm- care facilities Vancomycin- resistant enterococci in long- term- care facilities Antimicrobial resistance in long- term- care facilities Infections in Long- Term- Care Facilities: Screen or Clean? |
| cord-276758-k2imddzr | The case for face masks: zorro or zero? |
| cord-276758-k2imddzr | The experience of infectious patients in isolation Contact isolation in surgical patients: a barrier to care? |
| cord-276758-k2imddzr | The infection control nurse in US hospitals, 1976- 1977: characteristics of the position and its occupant Are there regional variations in the diagnosis, surveillance, and control of methicillin- resistant Staphylococcus aureus? |
| cord-276758-k2imddzr | The use and interpretation of quasi- experimental studies in infectious diseases Effect of regression to the mean on decision making in health care Randomized trials or observational tribulations? |
| cord-276758-k2imddzr | To err is human: building a safer health system Hospital- onset infections: a patient safety issue What practices will most improve safety? |
| cord-276758-k2imddzr | What is the evidence for a causal link between hygiene and infections? |
| cord-276758-k2imddzr | Working Group Vancomycin resistance in staphylococci Risk factors for increasing multidrug resistance among extended- spectrum ß- lactamase- producing Escheria coli and Klebsiella species Streptococcus pneumoniae serotype 4 outbreak in a home for the aged: report and review of recent outbreaks Persistence of fluoroquinolone- resistant, multidrug- resistant Streptococcus pneumoniae in a long- term- care facility: efforts to reduce intrafacility transmission Failure to control an outbreak of multidrug- resistant Streptococcus pneumoniae in a longterm- care facility: emergence and ongoing transmission of a fluoroquinolone- resistant strain Role of healthcare workers in outbreaks of methicillin- resistant Staphylococcus aureus: a 10-year evaluation from a Dutch university hospital SHEA guideline for preventing nosocomial transmission of multidrug- resistant strains of Staphylococcus aureus and enterococcus Nasal and hand carriage of Staphylococcus aureus in staff at a Department for Thoracic and Cardiovascular Surgery: endogenous or exogenous source? |
| cord-276758-k2imddzr | a prospective four- year study based on knowledge of the carrier state Are most ICU infections really nosocomial? |
| cord-276758-k2imddzr | how do infection control and quality assurance personnel compare? |
| cord-276758-k2imddzr | interruption by infection- control measures How contagious is necrotizing enterocolitis? |
| cord-276758-k2imddzr | medical and public health management Notice to readers update: management of patients with suspected viral hemorrhagic fever, United States Hemorrhagic fever viruses as biological weapons: medical and public health management Contact vaccinia: transmission of vaccinia from smallpox vaccination How contagious is vaccinia? |
| cord-276758-k2imddzr | practical recommendations for the hospital, clinic, and social settings Probable secondary infections in households of SARS patients in Hong Kong Contamination, disinfection, and cross- colonization: are hospital surfaces reservoirs for nosocomial infection? |
| cord-276758-k2imddzr | terminals a surrogate marker for nosocomial MRSA transmission and handwashing compliance? |
| cord-276758-k2imddzr | three cases and review Streptococcal meningitis after myelography Iatrogenic meningitis: an increasing role for resistant viridans streptococci? |
| cord-306770-hjzlj8k3 | A Systematic Review Which preventive measures might protect health care workers from SARS? |
| cord-306770-hjzlj8k3 | Part 1: aerosol- generating otolaryngology procedures Is COVID-19 transmitted via aerosols? |
| cord-309319-si5c14e8 | A simple approximate mathematical model to predict the number of severe acute respiratory syndrome cases and deaths On the physical geometry concept at the basis of space/ time geostatistical hydrology Bayesian maximum entropy analysis and mapping: a farewell to kriging estimators? |
| cord-307285-bxy0zsc7 | An old drug against today's diseases? |
| cord-307285-bxy0zsc7 | Are we different, like Antihypertensive drugs and risk of COVID-19? |
| cord-307285-bxy0zsc7 | Quinoline- based antimalarial drugs: A novel class of autophagy inhibitors Hydroxychloroquine in systemic lupus erythematosus( SLE) Chloroquine- induced oral mucosal hyperpigmentation and nail dyschromia Pigmented lichenoid drug eruption secondary to chloroquine therapy: An unusual presentation in lower lip Safety of ibuprofen in patients with COVID-19; causal or confounded? |
| cord-309370-g8d3w7it | Can the coronavirus disease 2019( COVID-19) affect the eyes? |
| cord-307811-6e3j0pn7 | Tissue specific distribution of sulfated mucopolysaccharides in mammals Bio- specific sequences and domains in heparan sulphate and the regulation of cell growth and adhesion Heparan sulfates and heparins: similar compounds performing the same functions in vertebrates and invertebrates? |
| cord-307811-6e3j0pn7 | Would a rose by another name smell as sweet? |
| cord-300324-95fty9yi | Do you have diabetes? |
| cord-300324-95fty9yi | Do you have heart disease? |
| cord-300324-95fty9yi | Do you have kidney disease? |
| cord-300324-95fty9yi | Do you have lung disease or asthma? |
| cord-300324-95fty9yi | Do you smoke? |
| cord-300324-95fty9yi | Notably, the COVID Symptom Tracker App asked participants:"Do you have lung disease or asthma?", and we believe that the group answering yes to this question likely includes a large proportion of individuals who self- reported mild asthma( or a previous history of mild asthma). |
| cord-300324-95fty9yi | What is your height? |
| cord-300324-95fty9yi | What is your weight? |
| cord-300324-95fty9yi | What sex were you assigned at birth? |
| cord-300324-95fty9yi | What treatment are you receiving right now? |
| cord-300324-95fty9yi | asthma exacerbations Do chronic respiratory diseases or their treatment affect the risk of SARS- CoV-2 infection? |
| cord-309206-kq77whdx | Where Next? |
| cord-306465-7kevsl1z | An Appraisal How did New Zealand become Covid-19 free? |
| cord-306465-7kevsl1z | But How Does It Compare To Other Countries? |
| cord-306465-7kevsl1z | What are the tests and testing procedures being carried out in India? |
| cord-306465-7kevsl1z | are they closely related? |
| cord-306465-7kevsl1z | what lessons have we learned? |
| cord-309513-dleo9rpl | Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterest Forms.do? |
| cord-308760-xonuu04p | a systematic review Is ITP a thrombophilic disorder? |
| cord-308424-crvnzr44 | ( SARS- CoV-2) confirmed patient Maternal deaths with Covid-19: a different outcome from mid to low resource countries? |
| cord-308424-crvnzr44 | COVID-19) pneumonia: a preliminary analysis Novel corona virus disease( COVID-19) in pregnancy: what clinical recommendations to follow? |
| cord-308075-1ftswsm8 | But when? |
| cord-308075-1ftswsm8 | How to resume endoscopic activity following the cessation of the current outbreak? |
| cord-308075-1ftswsm8 | What do we know now? |
| cord-307860-iqk1yiw4 | Emergence of novel coronavirus and COVID-19: whether to stay or die out? |
| cord-307860-iqk1yiw4 | Why is COVID-19 so mild in children? |
| cord-309302-n6cd2fc3 | Chloroquine is a potent inhibitor of SARS coronavirus infection and spread Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus( 2019-nCoV) in vitro Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial Convalescent plasma: new evidence for an old therapeutic tool? |
| cord-307885-butuv3n1 | -outmaneuvering antigenic shift and drift The role of evolution in the emergence of infectious diseases Infectious disease dynamics: what characterizes a successful invader? |
| cord-307885-butuv3n1 | What Have We Learned from SARS? |
| cord-309323-yflng8m3 | Can we use interleukin-6( IL-6) blockade for coronavirus disease 2019( COVID-19)-induced cytokine release syndrome( CRS)? |
| cord-306414-2dv3qced | CoV-2-specific TCR repertoire and, potentially, the immune response? |
| cord-306414-2dv3qced | How and which characteristics of the TCR repertoire may explain the disproportional risk of COVID-19 in older population? |
| cord-306414-2dv3qced | How might factors such as comorbidities influence the TCR repertoire in COVID-19 patients? |
| cord-306414-2dv3qced | Indeed, a recent study has applied a single- cell immune profiling approach that combines single- cell transcriptomic analysis with single- cell TCR and B cell receptor( BCR) sequencing technologies to examine the cellular context of the adaptive immune response and immune repertoires of T and B cells in blood samples of How does SARS- CoV-2 influence the TCR repertoire? |
| cord-306414-2dv3qced | What impact does the lymphocytopenia in COVID-19 have on the TCR repertoire architecture, diversity, and composition? |
| cord-308996-tf0v2ojk | I have been through a roller coaster of ill health, extreme emotions, and utter exhaustion Sex bias in referral of women to outpatient cardiac rehabilitation? |
| cord-309794-scqkyr5g | key: cord-309794-scqkyr5 g authors: Sharif‐Askari, Fatemeh Saheb; Sharif‐Askari, Narjes Saheb; Goel, Swati; Fakhri, Samer; Al‐Muhsen, Saleh; Hamid, Qutayba; Halwani, Rabih title: Are patients with chronic rhinosinusitis with nasal polyps at a decreased risk of COVID‐19 infection? |
| cord-309289-vm0k7hfx | Flavivirus Replication and Assembly Complexes COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? |
| cord-309554-ctc84tfy | ( C), summary of the MS/ MS matching Coronavirus genomic- sequence variations and the epidemiology of the severe acute respiratory syndrome Clinical progression and viral load in a community outbreak of coronavirus- associated SARS pneumonia: a prospective study Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome Protein chip array profiling analysis in patients with severe acute respiratory syndrome identified serum amyloid a protein as a biomarker potentially useful in monitoring the extent of pneumonia Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes Diagnosis of intra- amniotic infection by proteomic profiling and identification of novel biomarkers Serial analysis of plasma proteomic signatures in pediatric patients with severe acute respiratory syndrome and correlation with viral load Proteomic fingerprints for potential application to early diagnosis of severe acute respiratory syndrome Proteomics and severe acute respiratory syndrome( SARS): emerging technology meets emerging pathogen Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: a pilot study Cluster analysis and display of genome- wide expression patterns Comparison of protein expression patterns between hepatocellular carcinoma cell lines and a hepatoblastoma cell line Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics? |
| cord-307463-bheq9p5w | : what is the evidence? |
| cord-307463-bheq9p5w | How radiotherapy was historically used to treat pneumonia: could it be useful today? |
| cord-307463-bheq9p5w | Induction and repair of clustered DNA lesions: what do we know so far? |
| cord-307463-bheq9p5w | Remarkably, in 2013, Calabrese and Dhavan published a report on"How radiotherapy was historically used to treat pneumonia: Could it be useful today?", which may serve as a basis for current considerations[ 5]. |
| cord-309633-1cd74xdl | Participants with ARI symptoms also had symptom duration data collected in response to the question,"When did the symptoms you mentioned in the beginning of this survey become new or worsening?" |
| cord-308740-06jr58kz | From a Symptomatic Patient Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-308740-06jr58kz | The Heart in COVID19: Primary Target or Secondary Bystander? |
| cord-307406-59yh48tt | Insulin treatment attenuates renal ADAM17 and ACE2 shedding in diabetic Akita mice Cell pyroptosis, a potential pathogenic mechanism of 2019-nCoV Infection by Ming Yang:: SSRN Air pollution and the novel Covid-19 disease: a putative disease risk factor Can atmospheric pollution be considered a co- factor in extremely high level of SARS- CoV-2 lethality in northern Italy? |
| cord-307406-59yh48tt | Might the double X- chromosome in females be protective against SARS- CoV-2 compared to the single X- chromosome in males? |
| cord-307406-59yh48tt | casual or causal? |
| cord-307406-59yh48tt | gene mutations in Egyptian cases with HCV liver cirrhosis A1AT polymorphisms may be associated with clinical characteristics of retrovirus infections in a mixed ethnic population from the Brazilian Amazon region Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-306351-ka6asw3m | ( COVID-19): A Review A brief review of antiviral drugs evaluated in registered clinical trials for COVID-19 Arbidol combined with LPV/ r versus LPV/ r alone against Corona Virus Disease 2019: A retrospective cohort study Baricitinib for COVID-19: a suitable treatment? |
| cord-306351-ka6asw3m | How will country- based mitigation measures influence the course of the COVID-19 epidemic? |
| cord-306351-ka6asw3m | Hydroxychloroquine in Covid-19: Does the end justify the means? |
| cord-306351-ka6asw3m | Is Blocked by a Clinically Proven Protease Inhibitor Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-309120-05bg7rfa | medRxiv Mechanistic insights into the effect 861 of humidity on airborne influenza virus survival, transmission and incidence Environmental sampling for respiratory pathogens in Jeddah airport during the 2013 Hajj 865 season Deviations in influenza seasonality: odd coincidence or 868 obscure consequence? |
| cord-306835-juitltpi | A pair of aces for pulmonary arterial hypertension treatment? |
| cord-306835-juitltpi | Curcumin an effective intervention? |
| cord-306835-juitltpi | Novel coronavirus in a 15-day- old neonate with clinical signs of sepsis, a case report Plant polyphenols as inhibitors of NF- κB induced cytokine production- a potential anti- inflammatory treatment for Alzheimer's disease? |
| cord-306835-juitltpi | apoptosis Critical review on curcumin as a therapeutic agent: From traditional herbal medicine to an ideal therapeutic agent Curcumin and muscle wasting: A new role for an old drug? |
| cord-309650-6xz9gjq0 | can we learn? |
| cord-309556-xv3413k1 | The GTEx Project Cryo- EM structure of the 2019-nCoV spike in the prefusion conformation Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade- Long Structural Studies of SARS Coronavirus SARS- CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Structure, Function, and Antigenicity of the SARS- CoV-2 Spike Glycoprotein COVID-19 and Italy: what next? |
| cord-309411-2dfiwo65 | What are the implications of this transition state found in CoV1 but not in CoV2 at neutral pH? |
| cord-307287-zpq6byml | Case Reports and Review of Treatment Options Identification of Kidney Transplant Recipients with Coronavirus Disease Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation? |
| cord-307287-zpq6byml | Should cyclosporine be useful in renal transplant recipients affected by SARS- CoV-2? |
| cord-307287-zpq6byml | key: cord-307287-zpq6byml authors: Poulsen, Nadia Nicholine; von Brunn, Albrecht; Hornum, Mads; Blomberg Jensen, Martin title: Cyclosporine and COVID‐19: Risk or Favorable? |
| cord-307287-zpq6byml | medRxiv Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-305770-xygg4lxu | Are There Any Common Features? |
| cord-305770-xygg4lxu | Can Neutrophil- to- Lymphocyte ratio predict the response to BCG in high- risk non muscle invasive bladder cancer? |
| cord-305770-xygg4lxu | Science COVID-19 and Bacillus Calmette- Guérin: what is the Link? |
| cord-305770-xygg4lxu | predicts flattened curves for the spread of Can a century- old TB vaccine steel the immune system against the new coronavirus? |
| cord-309915-isw1arrp | Immune defects and cardiovascular risk in X chromosome monosomy mosaicism mediated by loss of chromosome Y. A risk factor for SARS- CoV-2 vulnerability in elderly men? |
| cord-309869-gk0svt2f | : how likely are they? |
| cord-309582-ihrj84hr | Performance of different clinical trial designs to evaluate treatments during an epidemic Ethical Rationale for the Ebola"Ring Vaccination"Trial Design Designing cell lines for viral vaccine production: Where do we stand? |
| cord-309582-ihrj84hr | The n- of-1 clinical trial: the ultimate strategy for individualizing medicine? |
| cord-309914-1lpl26eo | In particular, is there an increased risk of acquiring the infection or 38 experiencing a worse outcome from SARS- CoV-2? |
| cord-309728-7vfotgrr | Interim infection prevention and control recommendations for patients with suspected or confirmed coronavirus disease 2019( COVID-19) in healthcare settings Case report of COVID-19 in a kidney transplant recipient: does immunosuppression alter the clinical presentation? |
| cord-301677-b6mnn27h | A systematic approach to virus- virus interactions NK cells: tuned by peptide? |
| cord-301677-b6mnn27h | Can we use interleukin-6( IL-6) blockade for coronavirus disease 2019( COVID-19)-induced cytokine release syndrome( CRS)? |
| cord-301677-b6mnn27h | Is disease progression in HCMV- seropositive patients involved with SARS- CoV-2 infection compared with HCMV- seronegative ones can be different? |
| cord-301677-b6mnn27h | Is it possible to have a cross- reactivity of HCMV- specific NK cells( Figure 1) with a protective role against new viruses( such as SARS- Cov2), even unrelated ones? |
| cord-301677-b6mnn27h | The COVID-19 epidemic Innate or adaptive immunity? |
| cord-301677-b6mnn27h | The ancient and the new": is there an interaction between cytomegalovirus and SARS- CoV-2 infection? |
| cord-301677-b6mnn27h | The innate immune system: fighting on the front lines or fanning the flames of COVID-19? |
| cord-301677-b6mnn27h | The involvement of natural killer cells in the pathogenesis of severe acute respiratory syndrome Lung pathology of fatal severe acute respiratory syndrome Human natural killer cells mediate adaptive immunity to viral antigens Natural killer cell education and tolerance Fatal COVID-19 infections: Is NK cell dysfunction a link with autoimmune HLH? |
| cord-301677-b6mnn27h | Why tocilizumab could be an effective treatment for severe COVID-19? |
| cord-301677-b6mnn27h | i. Can SARS- CoV-2 infection specifically drive the expansion of adaptive- like trNK cells? |
| cord-309876-l0xginsa | How Well Do They Actually Perform? |
| cord-310061-nro623aa | Toward the emergence of novel infectious diseases? |
| cord-310051-bl8l4bgo | Where did SARS- CoV-2 come from? |
| cord-309588-kw4d32dt | Are corticosteroids salvage therapy for refractory acute respiratory distress syndrome? |
| cord-310195-am3u7z76 | The Lancet Understanding sensitivity and specificity with the right side of the brain Numbers or words? |
| cord-305134-s7h6bpof | : retrospective analysis Is MERS another SARS? |
| cord-305134-s7h6bpof | Complement as a target in COVID-19? |
| cord-305134-s7h6bpof | The intrinsic pathway of coagulation: a target for treating thromboembolic disease? |
| cord-305134-s7h6bpof | Using Clinical- Grade Soluble Human ACE2 Endothelial cell infection and endotheliitis in COVID-19 Overcoming barriers: the endothelium as a linchpin of coronavirus disease 2019 pathogenesis? |
| cord-305134-s7h6bpof | Will complement inhibition be the new target in treating COVID-19-related systemic thrombosis? |
| cord-305134-s7h6bpof | a multicenter prospective cohort study Incidence of venous thromboembolism in hospitalized patients with COVID-19 COVID and coagulation: bleeding and thrombotic manifestations of SARS- CoV2 infection Pulmonary embolism or pulmonary thrombosis in COVID-19? |
| cord-305134-s7h6bpof | is the recommendation to use high- dose heparin for thromboprophylaxis justified? |
| cord-310333-70ldbw3r | What is the interest of this infection for parasitology? |
| cord-306424-gf0bglm0 | IFN- lambda( IFN-??) is expressed in a tissue- dependent fashion and primarily acts on epithelial cells in vivo Severe acute respiratory syndrome- related coronavirus is inhibited by interferon- alpha Interferon- beta and interferongamma synergistically inhibit the replication of severe acute respiratory syndrome- associated coronavirus( SARS- CoV) Evaluation of immunomodulators, interferons and known in vitro SARS- CoV inhibitors for inhibition of SARS- CoV replication in BALB/ c mice Single- dose intranasal administration with mDEF201 |
| cord-306424-gf0bglm0 | IFN- lambda( IFN-??) is expressed in a tissue- dependent fashion and primarily acts on epithelial cells in vivo Severe acute respiratory syndrome- related coronavirus is inhibited by interferon- alpha Interferon- beta and interferongamma synergistically inhibit the replication of severe acute respiratory syndrome- associated coronavirus( SARS- CoV) Evaluation of immunomodulators, interferons and known in vitro SARS- CoV inhibitors for inhibition of SARS- CoV replication in BALB/ c mice Single- dose intranasal administration with mDEF201 |
| cord-306424-gf0bglm0 | Membranous replication factories induced by plus- strand RNA viruses Does form meet function in the coronavirus replicative organelle? |
| cord-306424-gf0bglm0 | interferon induction Cardif is an adaptor protein in the RIG- I antiviral pathway and is targeted by hepatitis C virus Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF VISA is an adapter protein required for virus- triggered IFN-?.?. |
| cord-306424-gf0bglm0 | interferon induction Cardif is an adaptor protein in the RIG- I antiviral pathway and is targeted by hepatitis C virus Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF VISA is an adapter protein required for virus- triggered IFN-?.?. |
| cord-306424-gf0bglm0 | what and how? |
| cord-310124-3bc8zeww | A novel method for isolation of pluripotent stem cells from human umbilical cord blood Dynamics of bone marrow VSELs and HSCs in response to treatment with gonadotropin and steroid hormones, during pregnancy and evidence to support their asymmetric/ symmetric cell divisions Molecular and phenotypic characterization of CD133 and SSEA4 enriched very small embryonic- like stem cells in human cord blood Functional testing of primitive oocyte- like cells developed in ovarian surface epithelium cell culture from small VSEL- like stem cells: Can they be fertilized one day? |
| cord-308071-1bk3xuwf | Extracorporeal life support as a bridge to lung transplantation- experience of a high- volume transplant center Temporal dynamics in viral shedding and transmissibility of COVID-19 Predicting infectious SARS- CoV-2 from diagnostic samples Bilateral lung transplantation on intraoperative extracorporeal membrane oxygenator: an observational study Lung transplantation as therapeutic option in acute respiratory distress syndrome for coronavirus disease 2019-related pulmonary fibrosis Lung transplantation for elderly patients with end- stage COVID-19 pneumonia Covid-19: why test? |
| cord-308071-1bk3xuwf | How to test? |
| cord-308071-1bk3xuwf | Virological assessment of hospitalized patients with COVID-2019 Extracorporeal membrane oxygenation for critically ill patients with COVID-19-related acute respiratory distress syndrome: worth the effort? |
| cord-308071-1bk3xuwf | Who to test? |
| cord-308071-1bk3xuwf | what next? |
| cord-310753-sv88b0dt | What settings have been linked to SARS-298 CoV-2 transmission clusters? |
| cord-309074-pys4aa60 | What to know Virtually Perfect? |
| cord-309074-pys4aa60 | Where does telemedicine fit into otolaryngology? |
| cord-307671-f9l2l8fi | Are HIV/ AIDS conspiracy beliefs a barrier to HIV prevention among African Americans? |
| cord-307671-f9l2l8fi | COVID-19 conspiracy theory beliefs form a monological belief system? |
| cord-307671-f9l2l8fi | Is there a need for a different approach during patient counseling? |
| cord-307671-f9l2l8fi | Should the patient consent be modified in the era of the COVID-19 pandemic? |
| cord-307671-f9l2l8fi | What drives people to believe in Zika conspiracy theories? |
| cord-307653-nyr6mtj1 | : Why is SARS- CoV-2 infection milder among children? |
| cord-307653-nyr6mtj1 | In contrast, could the relative resistance of children be due to an immature immune system? |
| cord-307653-nyr6mtj1 | Preventing a COVID-19 pandemic: ACE inhibitors as a potential risk factor for fatal COVID-19 Can angiotensin receptor- blocking drugs perhaps be harmful in the COVID-19 pandemic? |
| cord-307653-nyr6mtj1 | bioRxiv Angiotensin- converting enzyme 2( ACE2) in disease pathogenesis SARS- CoV-2 infects T lymphocytes through its spike protein- mediated membrane fusion Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-307653-nyr6mtj1 | the renin- angiotensin system to gut microbiota and malnutrition ACE2: more of Ang-(1- 7) or less Ang II? |
| cord-310624-3kojrkz7 | Identifying SARS- CoV-2 related coronaviruses in Malayan pangolins Are pangolins the intermediate host of the 2019 novel coronavirus( SARS- CoV-2)? |
| cord-309970-jkmjiika | Epidemiology and cause of severe acute respiratory syndrome( SARS) in Guangdong, People's Republic of China Clinical features of patients infected with 2019 novel coronavirus in Wuhan Labs scramble to produce new coronavirus diagnostics COVID-19, SARS and MERS: are they closely related? |
| cord-309970-jkmjiika | From SARS to COVID-19: What lessons have we learned? |
| cord-307148-k1uo3fxm | Catalase immunocytochemistry allows automatic detection of lung type II alveolar cells Mouse extracellular superoxide dismutase: primary structure, tissue- specific gene expression, chromosomal localization, and lung in situ hybridization Plasma catalase activity and malondialdehyde level in patients with cataract Human alveolar macrophages and granulocytemacrophage colony- stimulating factor- induced monocytederived macrophages are resistant to H 2 O 2 via their high basal and inducible levels of catalase activity Nonclassical secretion of human catalase on the surface of CHO cells is more efficient than classical secretion Epidemiological characteristics of coronavirus disease 2019( COVID-19) patients in IRAN: a single center study Is low alveolar type II cell SOD3 in the lungs of elderly linked to the observed severity of COVID-19? |
| cord-307148-k1uo3fxm | Does CO 2 modulate peroxynitrite specificity? |
| cord-307148-k1uo3fxm | Should we stimulate or suppress immune responses in COVID-19? |
| cord-307148-k1uo3fxm | So, how may glucose gavage of mice during viral- induced anorexia decrease mortality from IAV infection? |
| cord-307148-k1uo3fxm | Why does lactic acidosis occur in acute lung injury? |
| cord-308252-qwoo7b1l | COVID-19: risk for cytokine targeting in chronic inflammatory diseases? |
| cord-308252-qwoo7b1l | COVID-19: what has been learned and to be learned about the novel coronavirus disease Complement as a target in COVID-19? |
| cord-308252-qwoo7b1l | Intestinal permeability-- a new target for disease prevention and therapy Novel coronavirus infection and gastrointestinal tract Are patients with inflammatory bowel disease at increased risk for Covid-19 infection? |
| cord-308252-qwoo7b1l | Why tocilizumab could be an effective treatment for severe COVID-19? Cytokine release syndrome. |
| cord-310477-vniokol0 | The SARS epidemic in Hong Kong: what lessons have we learned? |
| cord-309931-cpzp33b3 | The rate of underascertainment of novel coronavirus( 2019-nCoV) infection: estimation using Japanese passengers data on evacuation flights A mathematical model for simulating the phase- based transmissibility of a novel coronavirus How will country- based mitigation measures influence the course of the COVID-19 epidemic? |
| cord-309931-cpzp33b3 | medRxiv Is global BCG vaccination- induced trained immunity relevant to the progression of SARS- CoV-2 pandemic? |
| cord-309138-44qpk2vf | : what's next? |
| cord-309138-44qpk2vf | Complementary Altern COVID-19)? |
| cord-309138-44qpk2vf | Myth or Science? |
| cord-310331-29srzbuk | 2019 novel Coronavirus outbreak: a quiz or final exam? |
| cord-310790-3ikgmiof | Which show better biological significance? |
| cord-309898-sju15hev | Recent insights into emerging coronaviruses Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia MERS in South Korea and China: A potential outbreak threat? |
| cord-309898-sju15hev | SARS- CoV-2 Have Arisen via Serial Passage through an Animal Host or Cell Culture?: |
| cord-310299-isdsestc | A first case of meningitis/ encephalitis associated with SARS- Coronavirus-2 Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host- virus interaction, and proposed neurotropic mechanisms Central Nervous System Involvement by Severe Acute Respiratory Syndrome Coronavirus-2( SARS- CoV-2) Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? |
| cord-310299-isdsestc | cord-310299-isdsestc authors: Hosseini, Akram A.; Shetty, Ashit K.; Sprigg, Nikola; Auer, Dorothee P.; Constantinescu, Cris S. title: Delirium as a presenting feature in COVID-19: neuroinvasive infection or autoimmune encephalopathy? |
| cord-310230-9wfb43gt | Enhanced Receptor Binding of SARS- CoV-2 through Networks of Hydrogen- Bonding and Hydrophobic Interactions Is the Rigidity of SARS- CoV-2 Spike Receptor- Binding Motif the Hallmark for Its Enhanced Infectivity? |
| cord-310230-9wfb43gt | Insights from All- Atom Simulations Characterization of the Receptor- Binding Domain( RBD) of 2019 Novel Coronavirus: Implication for Development of RBD Protein as a Viral Attachment Inhibitor and Vaccine Structural and Functional Basis of SARS- CoV-2 Entry by Using Human ACE2 Phylogenetic Network Analysis of SARS- CoV-2 Genomes Is the Rigidity of SARS- CoV-2 Spike Receptor- Binding Motif the Hallmark for Its Enhanced Infectivity? |
| cord-309360-cpis1l4u | Ischaemic stroke and SARS- CoV-2 infection: a causal or incidental association? |
| cord-309360-cpis1l4u | authors: Barrios- López, J. M.; Rego- García, I.; Muñoz Martínez, C.; Romero- Fábrega, J. C.; Rivero Rodríguez, M.; Ruiz Giménez, J. A.; Escamilla- Sevilla, F.; Mínguez- Castellanos, A.; Fernández Pérez, M. D. title: Ischaemic stroke and SARS- CoV-2 infection: A causal or incidental association? |
| cord-309360-cpis1l4u | por SARS- CoV-2? |
| cord-309360-cpis1l4u | ¿ Una pandemia demorada? |
| cord-311377-ffkwis40 | anti- IL-6 Should we stimulate or suppress immune responses in COVID-19? |
| cord-311216-mfqlv3nh | The ACE2 expression in human heart indicates New potential mechanism of heart injury among patients infected with SARS- CoV-2 Counter- regulatory reninangiotensin system in cardiovascular disease Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-311207-qkkn0297 | Time to use the p- word? |
| cord-309147-c3ikb81g | Can Chinese medicine be used for prevention of Corona virus disease 2019( COVID-19)? |
| cord-309147-c3ikb81g | Does SARS- CoV-2 has a longer incubation period than SARS and MERS? |
| cord-309147-c3ikb81g | Is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-309147-c3ikb81g | hygiene reduce SARS- CoV-2 transmission? |
| cord-311358-nrj4aysh | ( COVID‐19) transmitted through conjunctiva? |
| cord-311144-tumtzad8 | : Is This Possible to Affect Their Antigenicity and Immunogenicity? |
| cord-310027-846vp7ii | : what are they and which is better? |
| cord-310027-846vp7ii | Is it Really Needed? |
| cord-311585-h4holhit | An Invited Commentary on"World Health Organization declares global emergency: A review of the 2019 novel Coronavirus( COVID-19)": Emergency or new reality? |
| cord-310184-qth1y88o | Emergent high fatality lung disease in systemic juvenile arthritis New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity Ferritin to erythrocyte sedimentation rate ratio: simple measure to identify macrophage activation syndrome in systemic juvenile idiopathic arthritis COVID-19 infection in children Kawasaki disease: the role of immune complexes revisited Macrophage activation syndrome in Kawasaki disease: more common than we thought? |
| cord-310184-qth1y88o | To cite: Alunno A, Carubbi F, Rodríguez- Carrio J. Storm, typhoon, cyclone or hurricane in patients with COVID-19? |
| cord-310184-qth1y88o | key: cord-310184-qth1y88o authors: Alunno, Alessia; Carubbi, Francesco; Rodríguez- Carrio, Javier title: Storm, typhoon, cyclone or hurricane in patients with COVID-19? |
| cord-305745-9lngdjow | A review on the phytochemistry, pharmacology, and pharmacokinetics of amentoflavone Flavonoids: promising natural compounds against viral infections Old drugs as lead compounds for a new disease? |
| cord-305745-9lngdjow | Baicalin is also a known inhibitor of HIV-1 reverse transcriptase( Li et al. 2000), and was shown to possess inhibitory potential against influenza in vitro and in vivo by acting as immune modulator promoting IFN- c production in mice and human CD4? |
| cord-305745-9lngdjow | Coronaviruses( CoVs) are highly diverse, enveloped, positive- sense, single- stranded RNA viruses(? ssRNA) |
| cord-305745-9lngdjow | Insights from structures of protease and inhibitors Immunomodulatory effects of flavonoids: possible induction of T CD4? |
| cord-305745-9lngdjow | Isolation of specific cranberry flavonoids for biological activity assessment Š mejkal K Flavonoids as novel efflux pump inhibitors and antimicrobials against both environmental and pathogenic intracellular mycobacterial species Structurally modified'dietary flavonoids': are these viable drug candidates for chemoprevention? |
| cord-305745-9lngdjow | an overview Plant polyphenols as dietary antioxidants in human health and disease Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS- CoV Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors Synthesis and antiviral evaluation of 7-O- arylmethylquercetin derivatives against SARS- associated coronavirus( SCV) and hepatitis C virus( HCV) Rhodiosin and herbacetin in Rhodiola rosea preparations: additional markers for quality control? |
| cord-305745-9lngdjow | and CD8? |
| cord-305745-9lngdjow | title: Flavonoids: A complementary approach to conventional therapy of COVID-19? |
| cord-305745-9lngdjow | what we know? |
| cord-311332-n8tvglif | What is potential discovery? |
| cord-304498-ty41xob0 | Does the ExoN mutator phenotype result in more rapid adaptation or attenuation associated with lethal mutational load and rapid extinction during infection in vivo? |
| cord-304498-ty41xob0 | Does the mutator phenotype increase susceptibility to mutagens for lethal mutagenesis? |
| cord-304498-ty41xob0 | How do CoVs maintain a large and complex genome over time while allowing sufficient mutation rates for adaptation and trans- species movement? |
| cord-304498-ty41xob0 | In this case the central unanswered research question remains: by what mechanism does nsp14 increase fidelity? |
| cord-304498-ty41xob0 | Is the fidelity of wt CoV replication fixed by highly selected interactions between the RdRp, ExoN and possibly other viral and cellular proteins or is it flexible in response to altered environmental conditions as has been shown for bacteria such as E. coli? |
| cord-304498-ty41xob0 | What are the limitations to CoV genome diversity in vitro and in vivo? |
| cord-304498-ty41xob0 | clues that the last universal common ancestor possessed an RNA genome? |
| cord-304498-ty41xob0 | subgenomic mouse hepatitis virus replicative intermediates function in RNA synthesis Nidovirus transcription: how to make sense …? |
| cord-311566-x8n1bbwn | When is complexity justified? |
| cord-309619-glb2y82u | The antithrombotic effect of angiotensin-(1- 7) involves mas- mediated NO release from platelets High frequency of antiphospholipid antibodies in critically- ill COVID-19 patients: a link with hypercoagulability? |
| cord-309619-glb2y82u | risk factors in medical- surgical critically ill patients* multicenter study; randomized controlled trial Pulmonary thrombosis: a clinical pathological entity distinct from pulmonary embolism? |
| cord-309619-glb2y82u | rs12252-C is associated with disease severity in COVID-19 Genomewide Association study of severe Covid-19 with respiratory failure Use of reninÀangiotensinÀaldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case- population study Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS- CoV-2 compared to SARS- CoV Soluble angiotensin- converting enzyme 2: a potential approach for coronavirus infection therapy? |
| cord-311926-n7co0jtu | Closer Look at the Chinese Hospitals Built to Control the COVID-19 Pandemic Systematic review of COVID-19 in children show milder cases and a better prognosis than adults Is returning to work during the COVID-19 pandemic stressful? |
| cord-308857-otsrexqu | A major question remains open to date,"how can the symptoms of COVID-19 be detected in their early stages? |
| cord-308857-otsrexqu | A more specific question is whether ultra- violet( UV) light can kill coronavirus? |
| cord-308857-otsrexqu | COVID-19: A new digital dawn? |
| cord-308857-otsrexqu | Will 10 million people die a year due to antimicrobial resistance by 2050? |
| cord-308857-otsrexqu | [ 104] asked"Will 10 million people die a year due to AMR by 2050? |
| cord-311848-8n9ee57a | 71 factors associated with COVID-19 death in 17 million patients Clinical characteristics of COVID-19- 73 infected cancer patients: a retrospective case study in three hospitals within Wuhan Clinical characteristics and outcomes of cancer 19 CoV-2 infection in cancer patients undergoing active treatment: analysis of clinical features and 81 predictive factors for severe respiratory failure and death Granulocyte-83 colony stimulating factor in COVID-19: Is it stimulating more than just the bone marrow? |
| cord-311446-afhw0450 | Right Now? |
| cord-311446-afhw0450 | What Cost? CDC. |
| cord-310239-mmvuij3k | COVID-19) outbreak Diabetes is a risk factor for the progression and prognosis of COVID-19 A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus( 2019-nCoV) infected pneumonia( standard version) Low zinc status: a new risk factor for pneumonia in the elderly? |
| cord-310239-mmvuij3k | Does Zinc Supplementation Enhance the Clinical Efficacy of Chloroquine/ Hydroxychloroquine to Win Todays Battle Against COVID-19? |
| cord-310239-mmvuij3k | The nutrition CRSP: what is marginal malnutrition, and does it affect human function? |
| cord-311535-ppkwd1kp | Oxidative stress and vascular disease in diabetes: is the dichotomization of insulin signaling still valid? |
| cord-311730-189vax2m | What does it offer? |
| cord-311730-189vax2m | and why might it be effective in the treatment of COVID-19? |
| cord-312170-p2yrbosz | 89-What happens if SARS returns? |
| cord-312561-9o2fhi6e | A cluster of cases of severe acute respiratory syndrome in Hong Kong Temporal patterns of hepatic dysfunction and disease severity in patients with SARS Viral replication in the nasopharynx is associated with diarrhea in patients with SARS Detection of SARS coronavirus in plasma by real- time RT- PCR Lung pathology of fatal severe acute respiratory syndrome Enteric involvement of severe acute respiratory syndrome- associated coronavirus infection High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem- cell transplantation Detection of respiratory syncytial virus RNA in blood of neonates by polymerase chain reaction Rotavirus antigenaemia and viraemia: a common event? |
| cord-283485-xit6najq | 36 84 What is the role of children in transmission? |
| cord-283485-xit6najq | Acquired immunity is not very strong; hence, what is the consequence regarding herd immunity? ► |
| cord-283485-xit6najq | After how many doses? ► How protective will it be against infection? |
| cord-283485-xit6najq | After how many doses? ► How protective will it be against infection? |
| cord-283485-xit6najq | And hence: how often will the vaccine have to be administered? |
| cord-283485-xit6najq | COVID-19: What proportion are asymptomatic?: |
| cord-283485-xit6najq | Continuous tides, with ups and downs? |
| cord-283485-xit6najq | For how long will vaccine- acquired immunity last? |
| cord-283485-xit6najq | Furthermore, benefits and costs are also related to the positionality from which they are analysed: benefits for whom and costs borne by whom? |
| cord-283485-xit6najq | How expensive will the vaccine be? |
| cord-283485-xit6najq | How long will it take to effectively vaccinate the critical population? |
| cord-283485-xit6najq | How significant are asymptomatic carriers in transmission? |
| cord-283485-xit6najq | How stable is the virus( mutation) and do the different clades seen worldwide have any effect on the transmission potential/ severity of the disease? |
| cord-283485-xit6najq | If a vaccine is developed? |
| cord-283485-xit6najq | Only once? |
| cord-283485-xit6najq | Or will vaccine hesitancy reduce uptake? |
| cord-283485-xit6najq | Or yearly? |
| cord-283485-xit6najq | Quasi- absence of disease in children: why? |
| cord-283485-xit6najq | Seasonal transmission in temperate climate? ► |
| cord-283485-xit6najq | Some critical unknowns in SARS- CoV-2 transmission Which transmission patterns will occur and will human- to- human transmission continue permanently? |
| cord-283485-xit6najq | The role of antibody testing for SARS- CoV-2: is there one? |
| cord-283485-xit6najq | This will strongly depend on: How strong will the acquired immunity after a first infection with SARS- CoV-2 be and how long will it last? |
| cord-283485-xit6najq | To achieve herd immunity, how efficient will the vaccine need to be? |
| cord-283485-xit6najq | What are the socioeconomic implications? ► |
| cord-283485-xit6najq | What can we learn from them? |
| cord-283485-xit6najq | What determines that an infection remains asymptomatic? ► |
| cord-283485-xit6najq | What proportion of the population( critical population) will need to be vaccinated? |
| cord-283485-xit6najq | What settings have been linked to SARS- CoV-2 transmission clusters? |
| cord-283485-xit6najq | What type of vaccine will it be( live/ non- live, classic killed, DNA, or recombinant)? |
| cord-283485-xit6najq | Which countries will get the vaccine first( implications for LICs/ LMICs)? |
| cord-283485-xit6najq | Why do some COVID-19 patients infect many others, whereas most do n't spread the virus at all? |
| cord-283485-xit6najq | Will it need special manufacture and transport conditions( such as cold chain)? |
| cord-283485-xit6najq | Will there be any adverse effects? |
| cord-283485-xit6najq | Will vaccination be acceptable in the population? |
| cord-283485-xit6najq | Will vaccination be made mandatory, especially for international travel? |
| cord-283485-xit6najq | a population- based cohort study Covid-19 and Italy's Case Fatality Rate: What's the Catch? |
| cord-283485-xit6najq | how and why? |
| cord-283485-xit6najq | to Vaccinate? |
| cord-283485-xit6najq | ► How robust will be vaccine- acquired immunity? |
| cord-312350-klxw65qa | WHO, adapted from WHO welcomes preliminary results about dexamethasone diseases: official publication of the European Society of Clinical Microbiology Rapid antigen- based testing for respiratory syncytial virus: 776 moving diagnostics from bench to bedside? |
| cord-310857-i9v9antx | Testing and quarantine before staff member and camper arrival was essential to identifying SARS- CoV-2 infection and preventing introduction of virus into these congregate settings of younger adults who might be only mildly symptomatic or What is already known about this topic? |
| cord-310857-i9v9antx | What are the implications for public health practice? |
| cord-310857-i9v9antx | What is added by this report? |
| cord-312619-7jpf81yz | : the possible role of dry surface contamination Is the fit of N95 facial masks effected by disinfection? |
| cord-312633-cks6aij2 | Full genomes from 2 epidemiologically unlinked novel CoV infections separated in time by> 2 months were analyzed to gain clues to 2 major questions: what are the precursors of the virus, and how long has the virus been circulating in its current form? |
| cord-312652-zhccmfgw | A novel coronavirus outbreak of global health concern A Novel Coronavirus from Patients with Pneumonia in China World Health Organization Detection of 2019 novel coronavirus( 2019-nCoV) by real- time RT- PCR Development and Clinical Application of A Rapid IgM- IgG Combined Antibody Test for SARS- CoV-2 Infection Diagnosis IgM in microbial infections: taken for granted? |
| cord-311758-wof4yi39 | Global covid-19 case fatality rates Long- term quality of life after surgical intensive care admission Etiology and pathophysiology of fibromyalgia syndrome: updated guidelines 2017, overview of systematic review articles and overview of studies on small fiber neuropathy in FMS subgroups Fibromyalgia: a stress disorder? |
| cord-311758-wof4yi39 | Was SARS a mental health catastrophe? |
| cord-310623-zbjgr9jk | What are the implications for public health practice? |
| cord-310623-zbjgr9jk | What is added by this report? |
| cord-310623-zbjgr9jk | What is already known about this topic? |
| cord-311847-2czqs84q | Common Findings in COVID-19 Patients First case of 2019 novel coronavirus disease with Encephalitis Guillain- Barré syndrome associated with SARS- CoV-2 infection: Causality or coincidence? |
| cord-311847-2czqs84q | Underestimated Opportunistic Pathogens of the Central Nervous System? |
| cord-312955-gs65c3fy | This raises the question of why the innate immune system fails to combat SARS- CoV-2? |
| cord-311383-1aqt65cc | Molecular dynamics simulations and multiple X- ray structure analyses Deubiquitination, a new function of the severe acute respiratory syndrome coronavirus papain- like protease? |
| cord-311383-1aqt65cc | What are the functions of these modules? |
| cord-312677-rwznqiib | COVID-19 pneumonia: an increased risk for candidemia? |
| cord-313028-0nhgxoim | a descriptive study Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome MERS- CoV infection in humans is associated with a pro- inflammatory Th1 and Th17 cytokine profile Expression of elevated levels of pro- inflammatory cytokines in SARS- CoV- infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS Distinct immune response in two MERS- CoV- infected patients: can we go from bench to bedside? |
| cord-311029-x0lk4110 | The importance of frailty in the assessment of influenza vaccine effectiveness against influenza- related hospitalization in elderly people Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging Innovation partnership for a roadmap on vaccines in Europe( IPROVE): a vision for the vaccines of tomorrow Insight into 2019 novel coronavirus-an updated interim review and lessons from SARS- CoV and MERS- CoV COVID-19, SARS and MERS: are they closely related? |
| cord-311029-x0lk4110 | Why are older adults and individuals with underlying chronic diseases in Germany not vaccinated against flu? |
| cord-312444-c1dz5o85 | What about treating pregnant patients? |
| cord-312444-c1dz5o85 | Y title: How should we treat pregnant women infected with SARS‐CoV‐2? |
| cord-312697-ffxcze6c | New coronavirus threat galvanizes scientists Perspectives of immune therapy in coronavirus disease 2019 Treatment of SARS- CoV-2: how far have we reached? |
| cord-312743-9e4yufo5 | Evolution of carbohydrate antigens- microbial forces shaping host glycomes? |
| cord-312708-9ywu6r2t | preliminary evidencebased review Coronaviruses: an overview of their replication and pathogenesis Airborne or droplet precautions for health workers treating COVID-19? |
| cord-312736-bm6t2bxz | Will it have lasting impact on the rules? |
| cord-312702-fruzsn26 | the how and 846 why of misses and misinterpretations Error and discrepancy in radiology: inevitable or avoidable? |
| cord-312730-4ejjmab4 | When will it be over?": an introduction to viral reproduction numbers, R 0 and R e. |
| cord-311610-uniz8tuc | A Population Study Association between level of delivery hospital and neonatal outcomes among South Carolina Medicaid recipients Changing patterns in regionalization of perinatal care and the impact on neonatal mortality Is obstetrics safe in small hospitals? |
| cord-311610-uniz8tuc | Hospital setting and fetal death during labor among women at low risk Relation between size of delivery unit and neonatal death in low risk deliveries: population based study Are we regionalized enough? |
| cord-311610-uniz8tuc | The relationship between neonatal mortality and hospital level Perinatal mortality rates in isolated general practitioner maternity units Neonatal mortality in normal birth weight babies: does the level of hospital care make a difference? |
| cord-311026-mpr3xb2a | Can China return to normalcy while keeping the coronavirus in check? |
| cord-311026-mpr3xb2a | What happened? |
| cord-311026-mpr3xb2a | What is the"post peak period"? |
| cord-311026-mpr3xb2a | lessons from containment efforts in Singapore Are high- performing health systems resilient against the COVID-19 epidemic? |
| cord-305422-t8azymo7 | After 2019-nCoV Infection Applications of acute phase reactants in infectious diseases Aspartate aminotransferase: bridging carbohydrate and energy metabolism in Plasmodium falciparum Lactate dehydrogenase in sickle cell disease Induction of proinflammatory cytokines in human macrophages by influenza A( H5N1) viruses: a mechanism for the unusual severity of human disease? |
| cord-305422-t8azymo7 | Although molecular modeling and biochemical assays have demonstrated that SARS- CoV-2 binds to ACE2, how exactly does the virus enter the airway cells and cause subsequent pathological changes? |
| cord-305422-t8azymo7 | Do N95 respirators provide 95% protection level against airborne viruses, and how adequate are surgical masks? |
| cord-305422-t8azymo7 | Does the virus also bind ACE2-expressing cells in other organs[ 121]? |
| cord-305422-t8azymo7 | How is the virus genetically evolving during transmission among humans? |
| cord-305422-t8azymo7 | How long will the epidemic last? |
| cord-305422-t8azymo7 | Should the quarantine time be extended to 24 days? |
| cord-305422-t8azymo7 | The spike protein of SARS- CoV-- a target for vaccine and therapeutic development SARS vaccines: where are we? |
| cord-305422-t8azymo7 | What animal was the intermediate species to transmit the virus from the original host, say bats, to humans? |
| cord-305422-t8azymo7 | Will it become a pandemic worldwide, die down like SARS or relapse periodically like the flu? |
| cord-305422-t8azymo7 | • Where did SARS- CoV-2 come from? |
| cord-312999-3erodkv9 | The architecture of sars- cov-2 transcriptome Are pangolins the intermediate host of the 2019 novel coronavirus( sars- cov-2)? |
| cord-312984-rzryn3on | Detecting SARS- CoV-2 RNA in conjunctival secretions: is it a valuable diagnostic method of COVID-19? |
| cord-311673-z4hkw17g | : Why is SARS- CoV-2 infection more severe in obese men? |
| cord-311673-z4hkw17g | COVID-19 pneumonia: different respiratory treatments for different phenotypes? |
| cord-309200-t2xugb8l | But if pre- or asymptomatic infected individuals do not sneeze or cough, how do they generate aerosols? |
| cord-309200-t2xugb8l | Do infected but asymptomatic individuals emit more expiratory aerosols than the healthy individuals tested to date? |
| cord-309200-t2xugb8l | Do these expiratory aerosols contain virions and how do the viral titers in these aerosols change with time post- infection and post- emission? |
| cord-309200-t2xugb8l | Does COVID-19 transmit via expiratory particles? |
| cord-309200-t2xugb8l | How do ambient environmental conditions, such as temperature and humidity, affect airborne virus viability? |
| cord-309200-t2xugb8l | What animal models are best for simulating airborne human transmission of COVID-19? |
| cord-309200-t2xugb8l | and how do we assess their virulence? |
| cord-312367-24huwt3y | Can Unconventional Immunomodulatory Agents Help Alleviate COVID-19 Symptoms and Severity? |
| cord-312367-24huwt3y | Tannic acid and proteolytic enzymes: Enzyme inhibition or substrate deprivation? |
| cord-313371-fdyfg0kf | Olmsted County, Minnesota, study Prednisolone dosing regimen for treatment of subacute thyroiditis Clinical characteristics of subacute thyroiditis classified according to human leukocyte antigen typing Sporadic painless, painful subacute and acute infectious thyroiditis Subacute thyroiditis: observations on 98 cases for the last 14 years High prevalence of subacute thyroiditis during summer season in Italy Expanded dengue syndrome: subacute thyroiditis and intracerebral hemorrhage A case of subacute thyroiditis associated with primary HIV infection Acute hepatitis E virus infection and association with a subacute thyroiditis Pathology of the thyroid in severe acute respiratory syndrome COVID-19 and Italy: what next? |
| cord-313316-l147b7jk | UK Covid-19 testing expanded to police, fire service and judiciary Laboratory testing for coronavirus disease( COVID-19) in suspected human cases Diagnosis of the Coronavirus disease( COVID-19): rRT- PCR or CT? |
| cord-310507-5h6egve4 | COVID-19 Pneumonia with Favipiravir and Tocilizumab in Post- kidney Transplant Recipient Are They Just Two Children COVID-19 Cases Confused With Flu? |
| cord-310507-5h6egve4 | The presence of SARS- CoV-2 RNA in the feces of COVID-19 patients CHILDREN: IS IT TIME TO CHANGE OUR APPROACH? |
| cord-310507-5h6egve4 | a case series Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes SARS- CoV-2-Positive Sputum and Feces After Conversion of Pharyngeal Samples in Patients With COVID-19 Do children need a longer time to shed SARS- CoV-2 in stool than adults? |
| cord-312971-r9sggqh8 | in clinical specimens using a single- tube multiplex real- time PCR assay COVID-19 in children: the link in the transmission chain Will children reveal their secret? |
| cord-313379-6sa6oc6u | an observational cohort study Validation of a 353 chemiluminescent assay for specific SARS- CoV-2 antibody Diagnostic performances and 356 thresholds: the key to harmonization in serological SARS- CoV-2 assays? |
| cord-311965-3x3tjzhi | -Could ready meals be part of the solution? |
| cord-311965-3x3tjzhi | : What have we learned? |
| cord-311965-3x3tjzhi | An essential interrelation Zinc deficiency Low zinc status: A new risk factor for pneumonia in the elderly? |
| cord-309089-ex9nh1yi | The mercurial nature of neutrophils: still an enigma in ARDS? |
| cord-309089-ex9nh1yi | What does the peripheral blood tell you in SARS? |
| cord-309089-ex9nh1yi | a meta- analysis Interleukin-6 as a potential biomarker of COVID-19 progression Inhibition of NF- κB- mediated inflammation in severe acute respiratory syndrome coronavirus- infected mice increases survival Role of chemokines in thyroid cancermicroenvironment: is CXCL8 the main player? |
| cord-309089-ex9nh1yi | antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/ Golgi membrane Severe acute respiratory syndrome coronavirus open reading frame( ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists One nucleotide in a kappaB site can determine cofactor specificity for NF- kappaB dimers Infection of cultured intestinal epithelial cells with severe acute respiratory syndrome coronavirus SARS coronavirus and innate immunity Inhibition of cytokine gene expression and induction of chemokine genes in nonlymphatic cells infected with SARS coronavirus Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein Clinical Progression and Cytokine Profiles of Middle East Respiratory Syndrome Coronavirus Infection Distinct immune response in two MERS- CoVinfected patients: can we go from bench to bedside? |
| cord-309089-ex9nh1yi | do you draw the line? |
| cord-313571-umcbulcw | Evolutionary history, potential 360 intermediate animal host, and cross- species analyses of SARS- CoV-2 Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus 366 origins and receptor binding A pneumonia 370 outbreak associated with a new coronavirus of probable bat origin Real- time PCR in virology Identification of a Novel Coronavirus in Patients with 377 nat-inst-health-t.pdf? |
| cord-312065-nqy7m38f | For example: should the pager be clipped on the OR uniform inside the OR? |
| cord-312065-nqy7m38f | Should we use tape from the roll to secure the endotracheal tube or should the tape be precut? |
| cord-312065-nqy7m38f | severe acute respiratory syndrome Updated 47-Studies of SARS virus survival, situation in China but fast enough? |
| cord-312684-3i2r2ahr | All rights reserved Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia COVID-19 complicated by acute pulmonary embolism Acute pulmonary embolism and COVID-19 pneumonia: a random association? |
| cord-312684-3i2r2ahr | Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease Viral hemorrhagic fever-- a vascular disease? |
| cord-311477-gm0vg53l | 50 years later Can Zn be a critical element in COVID-19 treatment? |
| cord-311477-gm0vg53l | RdRp, RNA- dependent- RNA- polymearse; PL pro, papain- like protease; SARS- CoV-2, severe acute respiratory syndrome- related coronavirus 2 Zinc finger domains as therapeutic targets for metal- based compounds-an update Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta THE CONCISE GUIDE TO PHARMACOLOGY Biological activity of synthetic ionophores: ion transporters as prospective drugs? |
| cord-311477-gm0vg53l | recent insights into emerging coronaviruses Does zinc supplementation enhance the clinical efficacy of chloroquine/ hydroxychloroquine to win today's battle against COVID-19? |
| cord-311477-gm0vg53l | what to expect for COVID-19? |
| cord-313458-ka02rsla | The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS- CoV-2 Dynamic interplay between pericytes and endothelial cells during sprouting angiogenesis Severe COVID-19 infection associated with endothelial activation Mapping the mouse cell atlas by microwell- seq Fibroblasts in the infarcted, remodeling, and failing heart Incidence of thrombotic complications in critically ill ICU patients with COVID-19 Left ventricular performance in patients with severe acute respiratory syndrome A role for pericytes in coronary noreflow Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? |
| cord-312533-4u3bmb0e | 2009 H1N1 strain Should remaining stockpiles of smallpox virus( variola) be destroyed? |
| cord-312533-4u3bmb0e | Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? |
| cord-313684-61hkogdh | Why Children Fare Better than Adults? |
| cord-313756-2pqpk3v7 | ‘ Is SARS- CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19? ’ date: 2020- 06- 27 journal: |
| cord-312434-yx24golq | : what can they teach us about the severe acute respiratory syndrome? |
| cord-312434-yx24golq | and now the 2019-novel CoV: have we investigated enough about coronaviruses? |
| cord-312434-yx24golq | what lessons have we learned? |
| cord-313957-hviv5zar | The papain- like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme Biomolecules 2020 Deubiquitination, a new function of the severe acute respiratory syndrome coronavirus papain- like protease? |
| cord-311044-kjx0z1hc | Are the facilities satisfactory to operate safely? |
| cord-311044-kjx0z1hc | British society of Thoracic Imaging statement Thailand joins the WHO"Solidarity Trial": global testing of effective treatments of COVID-19 across 8 countries-an aggressive effort to save lives from the pandemic( press release) Could chloroquine/hydroxychloroquine be harmful in Coronavirus Disease 2019( COVID-19) treatment? |
| cord-311044-kjx0z1hc | COVID-19 status: does the patient present a concomitant viral infection in addition to the surgical disease? |
| cord-311044-kjx0z1hc | sufficient protective material( personal protective equipment[ PPE])? |
| cord-311044-kjx0z1hc | there any alternative treatments other than surgery that would be safe for the patient? |
| cord-310304-f28tjmi8 | /NYSDOHCOVID-19Tracker- Fatalities? |
| cord-310304-f28tjmi8 | A potential approach for coronavirus infection therapy? |
| cord-310304-f28tjmi8 | Dexamethasone in Hospitalized Patients with Covid-19-Preliminary Report Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-310304-f28tjmi8 | Not Associated? |
| cord-312278-rin733w4 | COVID-19: what is next for public health? |
| cord-312278-rin733w4 | The SARS, MERS and novel coronavirus( COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
| cord-312278-rin733w4 | are they closely related? |
| cord-308231-1t70vkxm | Could something so simple be the explanation? |
| cord-308231-1t70vkxm | How does one explain this conundrum? |
| cord-308231-1t70vkxm | However, could all of this have driven the 1.69 down as far as 1.08, the r 0-value necessary for the 99.3% perception? |
| cord-308231-1t70vkxm | Peak? date: 2020- 09- 02 journal: |
| cord-308231-1t70vkxm | Perhaps, by the 13th of July, the population's assymptotic compliance had reached the necessary level? |
| cord-308231-1t70vkxm | Perhaps, too, the intrahousehold infections that obviously took place early on in the lockdowns, had also run their course? |
| cord-308231-1t70vkxm | Perhaps, when the prohibition was reimposed, the seemingly- endless supply of liquor, that had understandably leaked from the stricken hospitality industry, had finally dried up? |
| cord-314013-g091lv0s | Where they come from? |
| cord-311125-v9ddes3c | GMS Current Topics in Otorhinolaryngology, Head and Neck Surgery 4 Olfactory disorders following upper respiratory tract infections Olfactory Dysfunction in COVID-19: Diagnosis and Management Is chronic rhinosinusitis caused by persistent respiratory virus infection? |
| cord-311125-v9ddes3c | What mechanistic hypotheses can explain the specific impact of SARS- CoV-2 on taste function, and which cell populations may be targeted by the virus such that their loss would lead to distorted taste? |
| cord-311125-v9ddes3c | Who should we test for COVID-19? |
| cord-311125-v9ddes3c | and TMPRSS4 promote SARS- CoV-2 infection of human small intestinal enterocytes Sour Sensing from the Tongue to the Brain Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19 Conductive olfactory losses in chronic rhinosinusitis? |
| cord-311125-v9ddes3c | smell reported in COVID-19( Figure 3)? |
| cord-313415-5qrpucr4 | COVID-19: too little, too late? |
| cord-313754-f4sq45gy | What might we have done better? |
| cord-314102-8jf3fnqe | In addition to the factors that connect the respiratory system with the external environment, is there any receptor other than ACE2 that mediates the invasion of 2019-nCoV into the host? |
| cord-311545-3rll9mca | Gillian R Bentley https://orcid.org/0000-0002-2009-5540 COVID-19 crisis-Business as usual for Gaza? |
| cord-311545-3rll9mca | Here to stay? |
| cord-311545-3rll9mca | Nevertheless, are there potentially any underlying biological realities that could also render some groups more vulnerable to poorer outcomes after contracting the disease? |
| cord-311545-3rll9mca | The COVID-19 response for vulnerable people in places affected by conflict and humanitarian crises Coronavirus( COVID-19) related deaths by ethnic group Could BCG be used to protect against COVID-19? |
| cord-311545-3rll9mca | The lurking threat of COVID-19 in Syrian war refugee camps Is ethnicity linked to incidence or outcomes of COVID-19? |
| cord-314311-xbpb9nfi | What to do next to control the 2019-nCoV epidemic? |
| cord-313268-j51zyodw | Indomethacin has a potent antiviral activity against SARS coronavirus as adjuvant treatment for coronavirus disease 2019 pneumonia patients requiring hospitalization( MAC-19 PRO): a case series Beneficial actions of melatonin in the management of viral infections: a new use for this ″molecular handyman″? |
| cord-313268-j51zyodw | Phase II study Prostate cancer and prostatic intraepithelial neoplasia: true, true, and unrelated? |
| cord-312115-foy3dsq4 | CD8+ T cells with a naive- like profile upon yellow fever vaccination Targets of T Cell Responses to SARS- CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals Clinical Characteristics of Coronavirus Disease 2019 in China Has Sweden's controversial covid-19 strategy been successful? |
| cord-312115-foy3dsq4 | The key to harmonization in serological SARS- CoV-2 assays? |
| cord-312115-foy3dsq4 | Will antibody tests for the coronavirus really change everything? |
| cord-311523-erntrh3p | All rights reserved 20 Guidance on the use of biologic agents during COVID-19 outbreak COVID-19 and psoriasis: is it time to limit treatment with immunosuppressants? |
| cord-311523-erntrh3p | Framing questions for pandemic prevention On the front lines of coronavirus: the Italian response to covid-19 Virtually Perfect? |
| cord-311523-erntrh3p | Lancet Potential impact of seasonal forcing on a SARS- CoV-2 pandemic Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts COVID-19 cacophony: is there any orchestra conductor? |
| cord-311523-erntrh3p | Time to use the p- word? |
| cord-311523-erntrh3p | what next? |
| cord-314333-hkyiy1gm | Aged BALB/ c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans Is ageing associated with a shift in the balance between type 1 and type 2 cytokines in humans? |
| cord-313227-6zwkfzab | An overview on medicinal perspective of thiazolidine-2,4-dione: a remarkable scaffold in the treatment of type 2 diabetes TNF- alpha and inflammatory cytokines and risk of type 2 diabetes: a systematic review and meta- analysis Selective insulin resistance and the development of cardiovascular diseases in diabetes: the 2015 edwin bierman award lecture Can pioglitazone be potentially useful therapeutically in treating patients with COVID-19? |
| cord-313227-6zwkfzab | are we already that far? |
| cord-311905-4yu29b49 | : can we optimize the dose? |
| cord-311905-4yu29b49 | What about antenatal corticosteroids? |
| cord-311905-4yu29b49 | What about antenatal corticosteroids? |
| cord-311905-4yu29b49 | What clinical recommendations to follow? |
| cord-314107-x6e1jhcd | Coincident or Causal? date: 2020- 07- 29 journal: |
| cord-313728-08kwkbmd | por coronavirus SARS- CoV-2( Covid-19) en pacientes con transplante renal Safety of mTOR inhibitors in adult solid organ transplantation Case report of COVID-19 in a kidney transplant recipient: does immunosuppression alter the clinical presentation? |
| cord-314833-6fue84x6 | } Are weak protein- protein interactions the general rule in capsid assembly? |
| cord-313910-bwe2f7xf | Back to the future? |
| cord-313910-bwe2f7xf | How does SARS- CoV-2 cause COVID-19? |
| cord-312178-tojgojjf | ( COVID-19) in Inpatient Obstetric Healthcare Settings COVID-19: faecal- oral transmission? |
| cord-312178-tojgojjf | Lactation A Trial of Lopinavir- Ritonavir in Adults Hospitalized with Severe Covid-19 Treating COVID-19-Off- Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics Recommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-312178-tojgojjf | Should We Worry? |
| cord-312178-tojgojjf | What Is Known? |
| cord-314024-n6l2804j | A Trial of Lopinavir- Ritonavir in Adults Hospitalized 206 with Severe Covid-19 Acute bacterial or viral infection- What's the difference? |
| cord-314663-8cf0jci9 | Current evidence and implications for public health Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-312559-ygh507x2 | Are my patients with rheumatic diseases at higher risk of COVID-607 19? |
| cord-312559-ygh507x2 | Preparación y control de la enfermedad 772 por coronavirus 2019( COVID-19) en América Latina Clinical trials on drug repositioning for COVID-19 treatment Will plant- made biopharmaceuticals play a role in the fight against 778 COVID-19? |
| cord-312559-ygh507x2 | Should the Holy Week 2020 be 766 cancelled in Latin America due to the COVID-19 pandemic? |
| cord-312559-ygh507x2 | de abril de 2020 Is the ACE2 Overexpression a Risk Factor for COVID-19 Infection? |
| cord-314445-4cb4a9r5 | The species 522 Severe acute respiratory syndrome- related coronavirus: classifying 2019-nCoV and naming it SARS-523 Could the D614 G substitution in the 525 SARS- CoV-2 spike( S) protein be associated with higher COVID-19 mortality? |
| cord-312488-uzhj4i1q | Italia COVID-19, SARS and MERS: are they closely related? |
| cord-312488-uzhj4i1q | The razor of Ockham( 1285- 1347)? |
| cord-312488-uzhj4i1q | What causes this change of course of the epidemic? |
| cord-312488-uzhj4i1q | Where are we now? |
| cord-312741-0au4nctt | A decade after SARS: strategies for controlling emerging coronaviruses SARS vaccines: where are we? |
| cord-312741-0au4nctt | In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine Inhibition of human coronavirus 229E infection in human epithelial lung cells( L132) by chloroquine: involvement of p38 MAPK and ERK A systematic screen of FDA- approved drugs for inhibitors of biological threat agents Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-312741-0au4nctt | The mercurial nature of neutrophils: still an enigma in ARDS? |
| cord-312741-0au4nctt | the beginning of another SARS- like pandemic? |
| cord-314451-mqnqjn0c | Summary of a technical meeting 25- 26 Is there an ideal animal model for SARS? |
| cord-312918-iof45k1r | : over 100 M website views per year Ready to submit your research? |
| cord-312918-iof45k1r | After these four large RCTs, it is legitimate to ask ourselves:"Who won and who lost?". |
| cord-312918-iof45k1r | cord-312918-iof45k1r authors: Ortolani, Claudio; Pastorello, Elide A. title: Hydroxychloroquine and dexamethasone in COVID-19: who won and who lost? |
| cord-312740-2ro2p77q | : What lessons have we learned? |
| cord-312740-2ro2p77q | An in silico study Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-312740-2ro2p77q | COVID-19: What is next for public health? |
| cord-312740-2ro2p77q | The classification of viruses infecting the respiratory tract Nucleoside/ nucleotide analog inhibitors of hepatitis B virus polymerase: Mechanism of action and resistance Drug repurposing for viral infectious diseases: How far are we? |
| cord-315129-p31vm79o | a 2 IIA to inflammation and eicosanoid production in arthritis Phospholipase A2 is an inflammatory predictor in cardiovascular diseases: is there any spacious room to prove the causation? |
| cord-307303-9mzs5dl4 | How would local, state, and federal public health and partner emergency response agencies work together in this scenario? |
| cord-307303-9mzs5dl4 | What approaches could a local public health department use to deliver comprehensive public health prevention, intervention, and risk communication measures before, during, and after such an outbreak? |
| cord-307303-9mzs5dl4 | What are the hospital infection control issues associated with a SARS outbreak, and what are the most effective approaches to address these issues? |
| cord-307303-9mzs5dl4 | What are the potential environmental impacts of a dirty bomb? |
| cord-307303-9mzs5dl4 | What can be done to prepare for and respond to such impacts? |
| cord-307303-9mzs5dl4 | What steps would be taken to distinguish a dirty bomb vs. from another type of explosion? |
| cord-307303-9mzs5dl4 | What steps would be taken to evacuate, contain, and decontaminate the affected area? |
| cord-307303-9mzs5dl4 | What steps, if any, could have prevented this attack from occurring or could have reduced the number of deaths and injuries? |
| cord-307303-9mzs5dl4 | What would the crisis- and consequence- phase mental health service responses be to an attack on Anytown by a"dirty bomb"? |
| cord-307303-9mzs5dl4 | Who would take the lead in communicating timely, accurate information to the public on radiation terror before, during, and after this event? |
| cord-307303-9mzs5dl4 | Would evacuation involve all of Anywhere County? |
| cord-307303-9mzs5dl4 | of advance planning strategy could a local public health department use to identify the contributing factors to this public health emergency? |
| cord-313537-920tgv1j | Hacia dónde vamos? |
| cord-313537-920tgv1j | a retrospective cohort study COVID-19 y enfermedad cardiovascular y renal:¿Dónde estamos? |
| cord-314369-o4nis91y | Should We Put Our Money Where Our Mouth Is? |
| cord-314489-e5r5s5ee | Quo vadis? |
| cord-314489-e5r5s5ee | What did we learn over the last 20 years? |
| cord-315058-t7bq4yqw | COVID-19 control in low- income settings and displaced populations: what can realistically be done? |
| cord-315064-2mgv9j6n | The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS- CoV-2 Endothelial cell infection and endotheliitis in COVID-19 What is a pericyte? |
| cord-314960-f4hj35dr | The Lancet Transcript for the CDC Telebriefing Update on COVID-19 The antigenic evolution of influenza: drift or thrift? |
| cord-315289-4x229n8n | ) TMPRSS2 and COVID-19: serendipity or opportunity for intervention? |
| cord-315328-8g40ukml | The interferon beta therapies for treatment of relapsing- remitting multiple sclerosis: are they equally efficacious? |
| cord-314070-8qz23nn4 | : do we understand it yet? |
| cord-314070-8qz23nn4 | Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual- energy CT Management of COVID-19 respiratory distress COVID-19 pneumonia: ARDS or not? |
| cord-314070-8qz23nn4 | factors associated with COVID-19 death in 17 million patients Clinical characteristics of patients who died of coronavirus disease 2019 in China Immune response, inflammation, and the clinical spectrum of COVID-19 COVID-19 pneumonia: different respiratory treatments for different phenotypes? |
| cord-315046-ltmuw6f8 | infection‐induced immune responses: friends or foes? |
| cord-314734-ai0hz4uq | Can we contain the COVID-19 outbreak with the same measures as for SARS? |
| cord-314734-ai0hz4uq | How old is the average cruise passenger? |
| cord-315198-v4ay9kwg | Given that SARS- CoV-2 also uses the nose as a portal of entry and the fact that it has been detected in human wastewater, can there be fecal−nasal transmission as observed with the brain- eating amoebae? |
| cord-312486-rumqopg0 | Management of patients with Crohn's Disease and Ulcerative Colitis during the coronavirus disease-2019 pandemic: results of an international meeting Factors associated with COVID-19-related death using OpenSAFELY Epigenetic dysregulation of ACE2 and interferon- regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients On the alert for cytokine storm: immunopathology in COVID-19 COVID-19-induced acute respiratory failure- an exacerbation of organ- specific autoimmunity? |
| cord-312486-rumqopg0 | What has SARS- CoV-2 revealed? |
| cord-312486-rumqopg0 | an overview The Complement System in COVID-19: Friend and Foe? |
| cord-312486-rumqopg0 | medRxiv Serum IgA, IgM, and IgG responses in COVID-19 Anti- SARS- CoV IgG response in relation to disease severity of severe acute respiratory syndrome Anti- spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS- CoV infection Antibodydependent infection of human macrophages by severe acute respiratory syndrome coronavirus Molecular mechanism for antibodydependent enhancement of coronavirus entry Clinical efficiency of intravenous immunoglobulin therapy in critical patients with COVID-19: a multicenter retrospective cohort study The potential danger of suboptimal antibody responses in COVID-19 Frequency of infection in patients with Rheumatoid Arthritis compared with controls: a population study Risk of severe herpes simplex virus infection in SLE: analysis of epidemiology and risk factors analysis in Taiwan Incidence of COVID-19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data? |
| cord-314948-7tnrfk24 | Does COVID-19 affect male fertility? |
| cord-314948-7tnrfk24 | Prior and Novel Coronaviruses, COVID-19, and Human Reproduction: What Is Known? |
| cord-313489-i969aqn9 | : cord-313489-i969aqn9 authors: Galbadage, Thushara; Peterson, Brent M.; Gunasekera, Richard S. title: Does COVID-19 Spread Through Droplets Alone? |
| cord-313489-i969aqn9 | How COVID-19 Spreads How Does COVID-19 Spread? |
| cord-313489-i969aqn9 | This brings us to the fundamental question: Does COVID-19 Spread through Droplets Alone? |
| cord-315278-iv2zj67t | Why Children Fare Better than Adults? |
| cord-315611-xbj41ekc | What We Know? |
| cord-314171-431buxxr | Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury Soluble angiotensin- converting enzyme 2: a potential approach for coronavirus infection therapy? |
| cord-314171-431buxxr | what to expect for COVID-19? |
| cord-314932-edf9xjwr | A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person- to- person transmission: a study of a family cluster Early transmission dynamics in Wuhan, China, of novel coronavirusinfected pneumonia China coronavirus: what do we know so far? |
| cord-314932-edf9xjwr | Covid-19: FDA approves use of convalescent plasma to treat critically ill patients Passive immunotherapy: assessment of convalescent serum against Ebola virus Makona infection in nonhuman primates Evaluation of convalescent plasma for Ebola virus disease in Guinea Convalescent plasma: new evidence for an old therapeutic tool? |
| cord-316330-55nd3pwe | is a receptor for severe acute respiratory syndrome 7 pH- dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC- SIGN ACE2 gene polymorphisms do not affect outcome of severe acute respiratory syndrome Identification of an alternative 5'-untranslated exon and new polymorphisms of angiotensin- converting enzyme 2 gene: lack of association with SARS in the Vietnamese population Immunity to viruses Role of early cytokines, including alpha and beta interferons( IFN- alpha/ beta), in innate and adaptive immune responses to viral infections Immunogenetics of viral infections HLA and infectious diseases Genetic susceptibility to infectious diseases: big is beautiful, but will bigger be even better? |
| cord-313984-7wvfnag1 | The use of anti- inflammatory drugs in the treatment of people with severe coronavirus disease 2019( COVID-19): the perspectives of clinical immunologists from China Immunosuppression for hyperinflammation in COVID-19: a double- edged sword? |
| cord-313984-7wvfnag1 | What else needs to be considered? |
| cord-313984-7wvfnag1 | What has treating patients with sepsis taught us about treatment approaches for patients with COVID-19? |
| cord-313984-7wvfnag1 | What is the most rational approach to supporting host protective immunity? |
| cord-314135-udce22id | A sexually transmitted infection? |
| cord-314135-udce22id | Cancer Patients Have a Higher Risk Regarding COVID-19–and Vice Versa? |
| cord-314135-udce22id | Persistent infection of SARS coronavirus in colonic cells in vitro Severe acute respiratory syndrome coronavirus persistence in Vero cells Persistent Replication of Severe Acute Respiratory Syndrome Coronavirus in Human Tubular Kidney Cells Selects for Adaptive Mutations in the Membrane Protein Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients Human Genital Cancer: Synergism Between Two Virus Infections or Synergism Between a Virus Infection and Initiating Events? |
| cord-314135-udce22id | Why do viruses cause cancer? |
| cord-314662-nem6dw34 | An increased risk for candidemia? |
| cord-314662-nem6dw34 | Temporally Associated with COVID-19 Interim Case Definition in New York State COVID-19 in newborns and infants- low risk of severe disease: Silver lining or dark cloud? |
| cord-315388-8sv00zqz | A Hope or Hype? |
| cord-315388-8sv00zqz | A hope or hype? |
| cord-316498-f43apjul | key: cord-316498-f43apjul authors: Karlsson, Jan Olof G; Jynge, Per; Ignarro, Louis J title: May Mangafodipir or Other SOD Mimetics Contribute to Better Care in COVID-19 Patients? |
| cord-316129-mjg3un0l | Do intact viral particles survive excimer laser ablation? |
| cord-315585-bjij8ds7 | On a knife's edge of a COVID-19 pandemic: is containment still possible? |
| cord-315585-bjij8ds7 | Prognostic factors for mortality due to pneumonia among adults from different age groups in Singapore and mortality predictions based on PSI and CURB-65 Containing COVID-19 in the emergency room: the role of improved case detection and segregation of suspect cases Minimising intrahospital transmission of COVID-19: the role of social distancing De- isolating COVID-19 suspect cases: a continuing challenge Testing for SARS- CoV-2: can we stop at two? |
| cord-316374-mzomj1ab | apoA- I, and BTN3A1: a Legitimate Ménage à Trois in Dendritic Cells SARS- coronavirus replication in human peripheral monocytes/ macrophages Antigen processing and remodeling of the endosomal pathway: requirements for antigen cross- presentation Golgi pH, ion and redox homeostasis: how much do they really matter? |
| cord-315440-he7sm7nj | Does SARS- CoV-2 has a longer incubation period than SARS and MERS? |
| cord-315440-he7sm7nj | Emerging themes in epidemiology Does SARS- CoV-2 has a longer incubation period than SARS and MERS? |
| cord-316670-x9x54fxw | antibody kinetics, correlates of protection, and association Kohmer N Microcrystalline chitosan is ineffective to decrease plasma lipids in both apolipoprotein E epsilon 4 carriers and non- carriers: a long- term placebocontrolled trial in hypercholesterolaemic volunteers Evaluation of Nucleocapsid and Spike Protein- Based Enzyme- Linked Immunosorbent Assays for Detecting Antibodies against SARS- CoV-2 Antibody responses to SARS- CoV-2 in patients with COVID-19 Head- to- Head Comparison of Two SARS- CoV-2 Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti- SARS- CoV-2 antibodies Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Diagnostic performances and thresholds: the key to harmonization in serological SARS- CoV-2 assays? |
| cord-315283-xwan2t1u | Do we really need cadavers anymore to learn anatomy in undergraduate medicine? |
| cord-315283-xwan2t1u | What does this mean for medical students at schools who traditionally teach anatomy through cadaveric dissections? |
| cord-315685-ute3dxwu | COVID-19 cases Is there an ideal animal model for SARS? |
| cord-315685-ute3dxwu | SARS- CoV-2 receptor ACE2 is an interferon- stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues Asymptomatic and human- to- human transmission of SARS- CoV-2 in a 2-family cluster Transmission of 2019-nCoV infection from an asymptomatic contact in Germany Histopathology and ultrastructural findings of fatal COVID-19 infections Autopsy findings and venous thromboembolism in patients with COVID-19 Offline: a global health crisis? |
| cord-316255-93srx4s7 | Can climatic factors explain the differences in COVID-19 incidence and severity across the Spanish regions?: |
| cord-315637-7td617dm | : the PRISMA statement Cochrane Handbook for Systematic Reviews of Interventions Farmer 286 Field Schools for Improving Farming Practices and Farmer Outcomes in Low- and Middle-287 Income Countries Dry Heat 289 as a Decontamination Method for N95 Respirator Reuse Disinfection effect of pulsed xenon ultraviolet irradiation on SARS- CoV-2 and implications for 293 environmental risk of COVID-19 transmission Multicycle Autoclave Decontamination of N95 Filtering Facepiece Respirators Effect of various decontamination procedures on disposable N95 mask integrity and 300 SARS- CoV-2 infectivity Applying Heat and 353 Humidity using Stove Boiled Water for Decontamination of N95 Respirators in Low Resource 354 Settings Decontamination of surgical face masks and N95 respirators by dry 356 heat pasteurization for one hour at 70 ° C Effect of Dry Heat and Autoclave Decontamination Cycles on N95 FFRs Is the fit of N95 facial masks effected by disinfection? |
| cord-315637-7td617dm | Can Masks Be Reused After Hot Water 434 Decontamination During the COVID-19 Pandemic? |
| cord-316186-254z62e4 | how will COVID-19 and global trends in physical inactivity and sedentary behavior affect one another? |
| cord-316186-254z62e4 | should inhibitors of the renin- angiotensin system be withdrawn in patients with COVID-19? |
| cord-308597-ieju8gd8 | As for ART, should we test all men for COVID-19 just as we do for HIV, hepatitis B and C, syphilis, HTLV I/ II, and Zika before the procedure? |
| cord-308597-ieju8gd8 | Can this viral infection lead to loss of gonadal function or changes in male fertility potential? |
| cord-308597-ieju8gd8 | If the presence of SARS- Cov-2 in semen is confirmed, the methods of assisted human reproduction conduct should be modified, ensuring the timely safety of couples; however, current information about the virus raises other issues, such as: if seminal transmission exists, should a couple avoid sexual intercourse or use a barrier method if the male partner is known to be positive for the coronavirus disease 2019( COVID-19)? |
| cord-308597-ieju8gd8 | If there is SARS- Cov-2 in an infected male's semen, is double sperm washing effective in isolating the virus as it is for HIV and hepatitis C? |
| cord-308597-ieju8gd8 | If this loss or change is proven, is it a reversible or permanent? |
| cord-308597-ieju8gd8 | In relation to assisted reproduction techniques( ART), will future conduct in this area need to be reprogrammed? |
| cord-308597-ieju8gd8 | Is the seminal sample a means of transmission for this virus? |
| cord-308597-ieju8gd8 | Should we take special care when cryopreserving semen from COVID-19 positive men? |
| cord-308597-ieju8gd8 | Taking into account all this information, several issues around the Coronavirus to semen and male fertility relationships are being raised, including: Can SARS- Cov-2 be found in semen? |
| cord-314111-bqmfmcfm | Mounting lab accidents raise SARS fears Severe acute respiratory syndrome( SARS) in Singapore: clinical features of index patient and initial contacts Clinical features and short- term outcomes of 144 patients with SARS in the greater Toronto area SARS treatment: who will lead the way forward? |
| cord-314111-bqmfmcfm | la fusion du SARS- CoV avec la membrane cytoplasmique des cellules cibles? |
| cord-314111-bqmfmcfm | ont- ils une place dans le traitement du syndrome respiratoire aigu sévère? |
| cord-314111-bqmfmcfm | une place dans le traitement du syndrome respiratoire aigu sévère? |
| cord-316970-n2dly3oa | Why does Japan have so few cases of COVID-19? EMBO |
| cord-313356-ninzeazy | Is COVID-19 Receiving ADE From Other Coronaviruses? |
| cord-313356-ninzeazy | What is the mean persistence of coronaviruses compared to SARS- CoV-2? |
| cord-313356-ninzeazy | What is the persistence of SARS- CoV-2 on surfaces? |
| cord-313356-ninzeazy | What lessons have we learned? |
| cord-313356-ninzeazy | What should we know and what could we do? |
| cord-315641-bzfrd7xj | COVID-19 and Italy: what next? |
| cord-315641-bzfrd7xj | Can we contain the COVID-19 outbreak with the same measures as for SARS? |
| cord-316525-uadfehr6 | What is the molecular basis of recombination in SARS- CoV? |
| cord-316712-1ngcwdln | Hindustan Times Statewise estimates of current hospital beds, intensive care unit( ICU) beds and ventilators in India: are we prepared for a surge in COVID-19 hospitalizations? |
| cord-316712-1ngcwdln | How did India respond and how has it fared? |
| cord-317355-z5tk3v3b | o o f Particulate matter pollution and the COVID-19 outbreak: results from Italian regions and provinces Symptoms and immunoglobulin development in hospital staff exposed to a SARS- CoV-2 outbreak Can atmospheric pollution be considered a co- factor in extremely high level of SARS- CoV-2 lethality in Northern Italy? |
| cord-315556-84rgd2s9 | Can China's COVID-19 strategy work elsewhere? |
| cord-315556-84rgd2s9 | Underestimated Opportunistic Pathogens of the Central Nervous System? |
| cord-315556-84rgd2s9 | or not? |
| cord-317233-k3wuqwyu | Emerging SARS- CoV-2 mutation hot spots include a novel RNA- dependent- RNA polymerase variant Understanding COVID-19: what does viral RNA load really mean? |
| cord-315453-mbv8vb2r | COVID-19? |
| cord-315453-mbv8vb2r | Characteristics of and important lessons from the coronavirus disease 2019( COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention Are children less susceptible to COVID-19? |
| cord-315453-mbv8vb2r | Issuing an important finding, validated by US FDA, about the in vitro efficacy of ivermectin on reducing SARS- CoV-2 loading Nuclear trafficking of proteins from RNA viruses: potential target for antivirals? |
| cord-315453-mbv8vb2r | Serious neurological adverse events after ivermectin- Do they occur beyond the Indication of onchocerciasis? |
| cord-315656-asvf4roo | : at the crossroad between aging and neurodegeneration Impact of SARS- CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? |
| cord-315656-asvf4roo | a review Neurological associations of COVID-19 Does SARS- CoV-2 infection cause chronic neurological complications? |
| cord-315656-asvf4roo | bioRxiv Effects of COVID-19 on the nervous system Neurologic Alterations Due to Respiratory Virus Infections Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? |
| cord-317563-mu47vvma | medRxiv Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-313082-n3bo9jw1 | A more challenging question for health systems is,''Is the test accurate enough to alter patient management and infection control precautions based on its results?'' |
| cord-313082-n3bo9jw1 | How many patients harbouring SARS- CoV-2 should be admitted to our hospitals for elective surgery? |
| cord-313082-n3bo9jw1 | Why, then, would preoperative testing for SARS- CoV-2 be any different? |
| cord-313082-n3bo9jw1 | atteints de SARS- CoV-2 devrions- nous admettre dans nos hôpitaux pour des chirurgies non urgentes? |
| cord-313082-n3bo9jw1 | du SARS- CoV-2 serait- il donc différent? |
| cord-313082-n3bo9jw1 | risque d'exposition et symptômes)? |
| cord-316345-a1cirnya | However, a gender vision of health begs the question: Why are pregnant women not considered a risk group for COVID-19? |
| cord-316345-a1cirnya | However, a gender vision of health begs the question: Why are pregnant women not considered a risk group for COVID‐19? |
| cord-303651-fkdep6cp | ( a) How much resolution is needed when modelling human heterogeneities? |
| cord-303651-fkdep6cp | ( b) What are the roles of networks and households in SARS- CoV-2 transmission? |
| cord-303651-fkdep6cp | ( b) What is the herd immunity threshold and when might we reach it? |
| cord-303651-fkdep6cp | ( b) Which data should be collected as countries emerge from lockdown, and why? |
| cord-303651-fkdep6cp | ( c) How should model and parameter uncertainty be communicated? |
| cord-303651-fkdep6cp | ( d) Is global eradication of SARS- CoV-2 a realistic possibility? |
| cord-303651-fkdep6cp | How can viral transmissibility be assessed more accurately? |
| cord-303651-fkdep6cp | How will country- based mitigation measures influence the course of the COVID-19 epidemic? |
| cord-303651-fkdep6cp | In particular, do sustained infection chains within households lead to amplification of infection rates between households despite lockdowns aimed at minimizing between- household transmission? |
| cord-303651-fkdep6cp | Is it safe to lift COVID-19 travel bans? |
| cord-303651-fkdep6cp | Linking the risk from invading pathogens to practical definitions of a major epidemic Stochastic epidemic models and their statistical analysis Novel coronavirus outbreak in Wuhan, China, 2020: intense surveillance is vital for preventing sustained transmission in new locations Estimating the probability of a major outbreak from the timing of early cases: an indeterminate problem? |
| cord-303651-fkdep6cp | The effects of local spatial structure on epidemiological invasions Pair approximations for spatial structures? |
| cord-303651-fkdep6cp | The pandemic is social: how can we model that? |
| cord-303651-fkdep6cp | This brings new issues: for example, are observed networks missing key transmission routes, such as indirect contact via contaminated surfaces, or including contacts that are low risk[ 87]? |
| cord-303651-fkdep6cp | To what extent does heterogeneous vulnerability at an individual level affect the impact of exit strategies beyond the reporting of potential outcomes? |
| cord-303651-fkdep6cp | What are the additional challenges of data- limited settings? |
| cord-303651-fkdep6cp | Where host vulnerability is an issue, is it necessary to account for considerations other than reported risk factors, as these may be proxies for underlying causes? |
| cord-303651-fkdep6cp | Where models have been developed for similar purposes, formal methods of comparison can be applied, but in epidemiological modelling, models often have been developed to address different questions, possibly involving'what- if?'scenarios, in which case only qualitative comparisons can be made. |
| cord-303651-fkdep6cp | medRxiv When does a minor outbreak become a major epidemic? |
| cord-303651-fkdep6cp | smart: when should invading pathogens be controlled? |
| cord-314933-wq1xo0z0 | ACE inhibitors as a potential risk factor for fatal Covid-19 Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-314933-wq1xo0z0 | Deleterious? |
| cord-314933-wq1xo0z0 | If the reduction of membranous ACE2 observed in hypertension and obesity plays an important role in the pathophysiology of severe COVID-19, can it be hypothesized that non- ACEi/ BRA drugs( beta- blockers, calcium channel blockers, diuretics) are more likely to increase the risk of deleterious outcomes than ACEi/ BRA drugs that increase ACE2 and provide theoretical protection? |
| cord-314933-wq1xo0z0 | Severe infections are a known precipitant factor for acute venous thrombo- embolism because of epithelial damage and platelet and endothelial cell dysfunction, but does it by itself explain the observed high prevalence of pulmonary embolism in these patients? |
| cord-314933-wq1xo0z0 | and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein Angiotensin- converting enzyme 2 and new insights into the renin- angiotensin system Soluble angiotensin- converting enzyme 2: a potential approach for coronavirus infection therapy? |
| cord-317820-od9l7p1r | Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome( ARDS)? |
| cord-317468-pnxni1x5 | How to risk- stratify elective surgery during the COVID-19 pandemic? |
| cord-315970-m5o962yw | COVID-19) fatality rate Can atmospheric pollution be considered a co- factor in extremely high level of SARS- CoV-2 lethality in Northern Italy? |
| cord-315970-m5o962yw | what next? |
| cord-317693-l08q2lhp | A lesson from animal coronaviruses 2019-nCoV in context: lessons learned? |
| cord-316658-zwxtbena | -CoV-659 2 vaccines: should we focus on mucosal immunity? |
| cord-316658-zwxtbena | Intravascular and mucosal immunoglobulin A: two 574 separate but related systems of immune defense? |
| cord-316658-zwxtbena | Is COVID-19 receiving ADE from other coronaviruses? |
| cord-315754-dq2empne | : Revision of screening strategies urgently needed Teicoplanin: An alternative drug for the treatment of coronavirus COVID-19? |
| cord-315754-dq2empne | A key target for antivirals Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-315754-dq2empne | COVID-19: What is next for public health? |
| cord-315754-dq2empne | Critical determinants of coronavirus tropism and pathogenesis Promising approaches for the treatment and prevention of viral respiratory illnesses The SARS, MERS and novel coronavirus( COVID-19) epidemics, the newest and biggest global health threats: What lessons have we learned? |
| cord-318253-vp22xd8p | Does the protein corona take over the selectivity of molecularly imprinted nanoparticles? |
| cord-315696-43wmazxa | : A case report A familial cluster, including a kidney transplant recipient Coronavirus disease 2019 in renal transplant recipients: Report of two cases COVID-19) in a Renal Transplant Patient Fatal SARS- CoV-2 infection in a renal transplant recipient COVID-19 pneumonia in a kidney transplant recipient successfully treated with tocilizumab and hydroxychloroquine COVID-19 in kidney transplant recipients Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation? |
| cord-315696-43wmazxa | Do They Pose a Risk to Other Recipients? |
| cord-315696-43wmazxa | Should cyclosporine be useful in renal transplant recipients affected by SARS- CoV-2? |
| cord-315696-43wmazxa | The interplay between immunosuppression and novel therapy including tocilizumab COVID-19 pneumonia in kidney transplant recipients- Where we are? |
| cord-317435-4yuw7jo3 | Putting the patient back together- social medicine, network medicine, and the limits of reductionism The$ 2.6 billion pill- methodologic and policy considerations silico oncology drug repositioning and polypharmacology Individualized network- based drug repositioning infrastructure for precision oncology in the panomics era Drug repurposing: new treatments for Zika virus infection? |
| cord-317435-4yuw7jo3 | its possible role in the management of viral infections- a brief review Melatonin in bacterial and viral infections with focus on sepsis: a review Ebola virus disease: potential use of melatonin as a treatment One molecule, many derivatives: a never- ending interaction of melatonin with reactive oxygen and nitrogen species? |
| cord-316617-8cqxz3wi | A key gap in our knowledge of SARS- CoV-2 transmission is the role of animals, and despite a consensus that this virus arose from an animal reservoir, a fundamental and intriguing question is which species? |
| cord-316617-8cqxz3wi | High COVID-19 virus replication rates, the creation of antigen- antibody immune complexes, and indirect hemagglutination resulting in thrombosis One health surveillance: More than a buzz word? |
| cord-316617-8cqxz3wi | key: cord-316617- 8cqxz3wi authors: Ward, Michael P. title: SARS‐CoV‐2, where to now? |
| cord-318499-uihof6k6 | Possible increase in infectivity associated to integrin motif expression Covid-19 in a patient with multiple sclerosis treated with natalizumab: May the blockade of integrins have a protective role? |
| cord-317628-1inxq7t5 | What Are We Talking About? |
| cord-318316-9unfl966 | A Multibasic Cleavage Site in the Spike Protein of SARS- CoV-2 Is Essential for Infection of Human Lung Cells New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-308912-2pd801t1 | A global problem Book reopened on infectious diseases Diminishing returns? |
| cord-308912-2pd801t1 | A qualitative study of Toronto health care workers On pandemics and the duty to care: Whose duty? |
| cord-308912-2pd801t1 | Another regulator wondered,''How can you oblige someone to report to work when their duty first and foremost is to their family?'' |
| cord-308912-2pd801t1 | Do I want this?' |
| cord-308912-2pd801t1 | Do physicians have an ethical obligation to care for patients with AIDS? |
| cord-308912-2pd801t1 | Education is not just an article in the newspaper, it's actually organizing forums with HCPs to get their input and ask them: how would you like to see a hospital run during a pandemic, or a private clinic or an emergency ward? |
| cord-308912-2pd801t1 | Lessons from Toronto Codes of medical ethics: Traditional foundations and contemporary practice Virulent epidemics and scope of healthcare workers'duty of care Basics of qualitative research: Grounded theory procedures and technique SARS and the duty to treat: Remember AIDS? |
| cord-308912-2pd801t1 | Ready and willing? |
| cord-308912-2pd801t1 | The history of responses to epidemic disease in the United States since the 18th century Health professions, codes, and the right to refuse HIV- infectious patients On the obligation of physicians to treat AIDS: Is there a historical basis? |
| cord-308912-2pd801t1 | Who cares? |
| cord-308912-2pd801t1 | [ nurses] really need to think more carefully about what we are choosing and ask,'am I willing to put myself at risk? |
| cord-314942-eym2rh8v | 1157 Reflection on lower rates of COVID-19 in children: does childhood 1160 immunizations offer unexpected protection? |
| cord-314942-eym2rh8v | Simvastatin increases the infection: is it completely non- beneficial? |
| cord-314942-eym2rh8v | Why are pregnant women susceptible to COVID-19? |
| cord-314942-eym2rh8v | what it comes down to? |
| cord-313084-l7odplqg | Can oral bacteria affect the microbiome of the gut? |
| cord-313084-l7odplqg | Coronavirus disease 2019( COVID-19) pandemic: increased transmission in the EU/ EEA and the UKseventh update Is SARS just ARDS? |
| cord-313084-l7odplqg | Could there be a link between oral hygiene and the severity of SARS- CoV-2 infections? |
| cord-313084-l7odplqg | Subgingival microflora and antibody responses against periodontal bacteria of young Japanese patients with type 1 diabetes mellitus Dental disease and the risk of coronary heart disease and mortality Is There an Association between Periodontitis and Hypertension? |
| cord-313084-l7odplqg | The Trinity of COVID-19: Immunity, Inflammation and Intervention COVID-19 cytokine storm: the interplay between inflammation and coagulation Should COVID-19 Concern Nephrologists? |
| cord-313084-l7odplqg | Why and to What Extent? |
| cord-314822-lmoc0xwi | Inhibition of the interaction between the SARS- CoV spike protein and its cellular receptor by anti- histoblood group antibodies Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme ABO blood group and susceptibility to severe acute respiratory syndrome SARS- CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission Coronavirus disease 2019: coronaviruses and blood safety Is SARS- CoV-2 transfusion transmitted? |
| cord-314822-lmoc0xwi | Which comorbidities are predisposing to blood transfusion and severity of viral disease? |
| cord-314822-lmoc0xwi | Why then should studying transfusion requirements be worthwhile in patient with CoVID-19? |
| cord-314822-lmoc0xwi | another viewpoint Can anti- A1 cause hemolysis? |
| cord-315652-hct9yh3n | Can angiotensin receptor- blocking drugs perhaps be harmful in the COVID-19 pandemic? |
| cord-315652-hct9yh3n | Cardiac involvement in a patient with coronavirus disease 2019( COVID-19) Aldosterone receptor antagonists and cardiovascular disease: Do we need a change of the guard? |
| cord-315652-hct9yh3n | Phosphorylation of p38 MAPK and its downstream targets in SARS coronavirus- infected cells JNK and PI3k/ Akt signaling pathways are required for establishing persistent SARS- CoV infection in Vero E6 cells Cytokines in HIV- associated cardiomyopathy Inhibition of SARS- CoV-2 Infections in Engineered Human Tissues Using Clinical- Grade Soluble Human ACE2 MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets Cardioprotective mechanisms of lifestyle modifications and pharmacotherapies on cardiac remodeling and dysfunction in hypertensive heart disease: an overview Cellular distribution and interaction between extended renin- angiotensin- aldosterone system pathways in atheroma Efficiency and specificity of RAAS inhibitors in cardiovascular diseases: how to achieve better end- organ protection? |
| cord-315652-hct9yh3n | The relevance of coagulation in cardiovascular disease: what do the biomarkers tell us? |
| cord-317379-ljdaj80d | Can SARS- CoV-2 Infection Be Acquired In Utero?: |
| cord-317379-ljdaj80d | SARS- CoV-2 Is Not Detectable in the Vaginal Fluid of Women With Severe COVID-19 Infection Detection of SARS- COV-2 in Placental and Fetal Membrane Samples 2019-nCoV epidemic: what about pregnancies? |
| cord-316702-dj2fo8sn | Do superspreaders generate new superspreaders? |
| cord-316702-dj2fo8sn | The Problem of Herd- Immunity Herd immunity: history, theory, practice Herd immunity": a rough guide Vaccination and herd immunity: what more do we know? |
| cord-316702-dj2fo8sn | cord-316702-dj2fo8sn authors: Vignesh, Ramachandran; Shankar, Esaki M.; Velu, Vijayakumar; Thyagarajan, Sadras Panchatcharam title: Is Herd Immunity Against SARS- CoV-2 a Silver Lining? |
| cord-318492-uu1p1rgi | Late histological findings in symptomatic COVID-19 patients A case report Can COVID 2019 disease induce a specific cardiovascular damage or it exacerbates pre- existing cardiovascular diseases? |
| cord-317795-689at1qx | COVID-19 and Italy: what next? |
| cord-316616-j82q99in | Has China faced only a herald wave of SARS- CoV-2? |
| cord-316616-j82q99in | Influenza vaccination: a one- shot deal to reduce cardiovascular events Initial precipitants and recurrence of atrial fibrillation Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia Cardiac involvement in a patient with coronavirus disease 2019( COVID-19) Pathological findings of COVID-19 associated with acute respiratory distress syndrome Myocardial localization of coronavirus in COVID-19 cardiogenic shock Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus( 2019-nCoV) in vitro Compassionate use of remdesivir for patients with severe COVID-19 A trial of lopinavirritonavir in adults hospitalized with severe COVID-19 Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus- infected pneumonia in Wuhan, China Discovering drugs to treat coronavirus disease 2019( COVID-19) Experimental treatment with favipiravir for COVID-19: an open- label control study Favipiravir versus arbidol for COVID-19: a randomized clinical trial Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-316616-j82q99in | a case series Catheterization laboratory considerations during the coronavirus( COVID-19) pandemic: from the ACC's Interventional Council and SCAI COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow- up Of birds and men: cardiologists'role in influenza pandemics Influenza and cardiovascular disease: is there a causal relationship? |
| cord-311762-f6muhf3d | And how are different results assembled? |
| cord-311762-f6muhf3d | Are all the source data underlying the results available to ensure full reproducibility? |
| cord-311762-f6muhf3d | Could the authors explain? |
| cord-311762-f6muhf3d | How is the hits( reported in Table 3) used? |
| cord-311762-f6muhf3d | How is this considered in the virtual screening? |
| cord-311762-f6muhf3d | If applicable, is the statistical analysis and its interpretation appropriate? |
| cord-311762-f6muhf3d | What are the difference? |
| cord-311762-f6muhf3d | What does the"( B Top scorers)"mean? |
| cord-311762-f6muhf3d | What's the binding energy cutoff used? |
| cord-311762-f6muhf3d | What's the binding energy cutoff used? |
| cord-317928-doj39520 | A first step in understanding SARS pathogenesis Effect of angiotensin- converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin- converting enzyme 2 Cell type- specific expression of the putative SARS- CoV-2 receptor ACE2 in human hearts SARS- CoV2: should inhibitors of the renin- angiotensin system be withdrawn in patients with COVID-19? |
| cord-317928-doj39520 | authors: Thum, Thomas title: SARS- CoV-2 receptor ACE2 expression in the human heart: cause of a post- pandemic wave of heart failure? |
| cord-317359-7yuygcew | Although the modification of the original Human coronaviruses associated with upper respiratory tract infections in three rural areas of Ghana Human coronaviruses: what do they cause? |
| cord-317359-7yuygcew | What are the priorities of pathologists'activities during COVID-19 emergency? |
| cord-316647-jj8anf5g | Does pulse pressure variation predict fluid responsiveness in critically ill patients? |
| cord-316647-jj8anf5g | The convalescent sera option for containing COVID-19 Meta- analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? |
| cord-316647-jj8anf5g | Use of convalescent plasma therapy in SARS patients in Hong Kong Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A( H1N1) 2009 virus infection Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience Treatment of 5 critically ill patients with COVID-19 with convalescent plasma Effectiveness of convalescent plasma therapy in severe COVID-19 patients Convalescent plasma: new evidence for an old therapeutic tool? |
| cord-316647-jj8anf5g | a study on coronary artery bypass graft surgery patients Monitoring sound and light continuously in an intensive care unit patient room: a pilot study The efficacy of earplugs as a sleep hygiene strategy for reducing delirium in the ICU: a systematic review and meta- analysis Effect of dexmedetomidine added to standard care on ventilatorfree time in patients with agitated delirium: a randomized clinical trial Melatonin decreases delirium in elderly patients: a randomized, placebo- controlled trial Preventive effects of ramelteon on delirium: a randomized placebo- controlled trial Melatonin, ramelteon, suvorexant, and dexmedetomidine to promote sleep and prevent delirium in critically ill patients: a narrative review with practical applications Interpreting and implementing the 2018 pain, agitation/ sedation, delirium, immobility, and sleep disruption clinical practice guideline Sedation with sufentanil in patients receiving pressure support ventilation has no effects on respiration: a pilot study Could remifentanil reduce duration of mechanical ventilation in comparison with other opioids for mechanically ventilated patients? |
| cord-319194-ukuia48s | Can phylogeneticists and bioinformaticians help virologists to tackle SARS- CoV( severe acute respiratory syndrome coronavirus)? |
| cord-318235-2e5er0x0 | Evidence for a common antecedent? |
| cord-314381-ltil9hwl | , psychologist says To be paranoid is the standard? |
| cord-314381-ltil9hwl | Because SARS affected a number of regions, including people from both Asian and Western cultures, did individuals from different cultures perceive and cope with the crisis in distinct manners? |
| cord-314381-ltil9hwl | Could the current knowledge yielded from coping research help in the understanding of people's attempts to handle the SARS outbreak? |
| cord-314381-ltil9hwl | Did people attempt to handle the SARS epidemic in ways that were similar to those with which they attempt to handle stressful daily events? |
| cord-314381-ltil9hwl | Is global panic justified? |
| cord-314381-ltil9hwl | To cope with the outbreak, why did some people engage in preventive health behavior while others ignore the use of preventive measures? |
| cord-319013-oytqcifa | Is it time to rethink UK restrictions on blood donation? |
| cord-318909-h5b7mncf | Underestimated Opportunistic Pathogens of the Central Nervous System? |
| cord-317037-1qydcc5e | : Are they close relatives? |
| cord-317037-1qydcc5e | A novel mechanism of generating extracellular vesicles during apoptosis via a beads- on- a- string membrane structure Plasma Membrane Lipid Domains as Platforms for Vesicle Biogenesis and Shedding? |
| cord-317037-1qydcc5e | Premises for the Therapeutic Use Mesenchymal stromal cells and their secreted extracellular vesicles as therapeutic tools for COVID-19 pneumonia? |
| cord-317037-1qydcc5e | The chicken or the egg? |
| cord-318339-j35w1vsw | What Did the Researchers Do and Find? |
| cord-318339-j35w1vsw | What Do These Findings Mean? |
| cord-316845-k9zvsfvj | Hyperkinetic Movement Disorders PubMed Abstract Publisher Full Text Is the topic of the opinion article discussed accurately in the context of the current literature? |
| cord-316845-k9zvsfvj | Publisher Full Text Is the topic of the opinion article discussed accurately in the context of the current literature? |
| cord-316845-k9zvsfvj | Yes Are all factual statements correct and adequately supported by citations? |
| cord-316845-k9zvsfvj | Yes Are all factual statements correct and adequately supported by citations? |
| cord-315617-mhm9wh9q | But will such individuals be available? |
| cord-315617-mhm9wh9q | Genetic analysis of West Nile New York 1999 encephalitis virus Mixing bugs and bombs Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States Viral zoonoses- a threat under control? |
| cord-315617-mhm9wh9q | How likely is a bioweapon attack and, more tightly focused, how real is the chance of such an attack by a terrorist group? |
| cord-315617-mhm9wh9q | The detection of monkeypox in humans in the Western hemisphere Buying biosafety- is the price right? |
| cord-315617-mhm9wh9q | key: cord-315617-mhm9wh9q authors: Gottschalk, René; Preiser, Wolfgang title: Bioterrorism: is it a real threat? |
| cord-318938-7d731q65 | Baseline characteristics and outcomes of 1591 patients infected with SARS- CoV-2badmitted to ICUs of the Lombardy Region Spread of SARS- CoV-2 in the Icelandic population COVID-19 and chronological aging: senolytics and other anti- aging drugs for the treatment or prevention of corona virus infection? |
| cord-317240-d7ioosi6 | A possible treatment for coronavirus? |
| cord-317240-d7ioosi6 | Could you donate plasma to help treat coronavirus( COVID-19) patients? |
| cord-317240-d7ioosi6 | Plasma therapy: Do we finally have treatment for coronavirus disease? |
| cord-319540-kivk3h1k | A SARS- Cov2-negative corona victim COVID-19 sends STEMI to quarantine!? |
| cord-319333-jwbgytwd | Novel coronavirus infection( COVID-19) in humans: a scoping review and meta- analysis Clinical features of patients infected with 2019 novel coronavirus in Wuhan Neurologic alterations due to respiratory virus infections Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study Neurologic features in severe SARS- CoV-2 infection Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Incidence of thrombotic complications in critically ill ICU patients with COVID-19 Macrothrombosis and stroke in patients with mild Covid-19 infection Large- vessel stroke as a presenting feature of Covid-19 in the young Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan COVID-19: ICU delirium management during SARS- CoV-2 pandemic Pathological findings of COVID-19 associated with acute respiratory distress syndrome Epidemiology of acute symptomatic seizures among adult medical admissions Seizures associated with coronavirus infections Acute ischaemic stroke and infection: recent and emerging concepts Why now? |
| cord-318625-hf7fgtnp | Progress and Challenges Peptide Based Viral Detection Systems for Effective Diagnosis of Common Viral Infections in India Peptide based diagnostics: are random-se quence peptides more useful than tiling proteome sequences? |
| cord-308066-lrbi5198 | : is there a host restricted circulation of influenza viruses in sympatric ducks and coots? |
| cord-308066-lrbi5198 | Can we continue to prepare and respond to such pathogens by strictly defensive measures aimed at the human H S? |
| cord-308066-lrbi5198 | China culls wild animals to prevent new SARS threat Venezuelan equine encephalitis Characterization of H5N1 influenza viruses that continue to circulate in geese in southeastern China Occurrence of rabies in a wolf population in northeastern Alaska Rabies virus in the decomposed brain of an Ethiopian wolf detected by nested reverse transcription- polymerase chain reaction Factors influencing the incidence and scale of bovine tuberculosis in cattle in southwest England Transmissible spongiform encephalopathies in nondomestic animals: origin, transmission and risk factors Emergence of raccoon rabies in Connecticut, 1991- 1994: spatial and temporal characteristics of animal infection and human contact Experimental rabies infection in wild rodents Disease management strategies for wildlife Naturally acquired simian retrovirus infections in central African hunters Foot- and- mouth disease in the UK: what should we do next time? |
| cord-308066-lrbi5198 | How are we surveilling and preparing for the next pandemic of influenza? |
| cord-308066-lrbi5198 | Koch's postulates fulfilled Are predators good for your health? |
| cord-308066-lrbi5198 | So given the proven record of achievement of a medical or technological approach to defending humans from invasion by infectious organisms, is there much to be gained by examining processes, antecedent to human spillover, for potential vulnerabilities and as intervention targets, as a complement to ongoing efforts to improve human- based disease prevention activities? |
| cord-308066-lrbi5198 | The evolution of H5N1 influenza viruses in ducks in southern China Risk factors for Nipah virus infection among abattoir workers in Singapore Zoonotic viruses of wildlife: hither from yon Passive surveillance as an instrument to identify risk factors for fatal Rocky Mountain spotted fever: is there more to learn? |
| cord-308066-lrbi5198 | The impact of badger removal on the control of tuberculosis in cattle herds in Ireland Molecular characterization of H9N2 influenza viruses: were they the donors of the"internal"genes of H5N1 viruses in Hong Kong? |
| cord-308066-lrbi5198 | What Are the Tools? |
| cord-308066-lrbi5198 | Whose problem is it? |
| cord-308066-lrbi5198 | Would there be a payoff from large investments to improve surveillance and knowledge of known or potential zoonotic pathogens circulating among wildlife H R populations? |
| cord-308066-lrbi5198 | infected non- human primates( NHP) in Africa Preventing the westward spread of rabies Costs and benefits of rabies control in wildlife in France Occurrence of rabies in wolves of Alaska California state mosquito- borne virus surveillance and response plan: a retrospective evaluation using conditional simulations Animal origins of SARS coronavirus: possible links with the international trade in small carnivores Implications of BSE policy for livestock production and veterinary services in the United Kingdom Principles and practice of public health surveillance Molecular strategies for interrupting arthropodborne virus transmission by mosquitoes Mammals, small and large: the ecological implications of size Bovine spongiform encephalopathy( BSE): the end of the beginning or the beginning of the end? |
| cord-308066-lrbi5198 | would such a vaccine immunize sufficient numbers of waterfowl to reduce the susceptible population if widely dispersed among migratory staging areas? |
| cord-313829-pjscmen8 | ( D&CVD) Issues of cardiovascular risk management in people with diabetes in the COVID-19 era COVID-19 and diabetes management: What should be considered? |
| cord-313829-pjscmen8 | 30 What will be the scenario for COVID-19 related mortality and hospitalization in the next 24 months? |
| cord-313829-pjscmen8 | Is ethnicity linked to incidence or outcomes of COVID-19? |
| cord-313829-pjscmen8 | Practical recommendations for the management of diabetes in patients with COVID-19 Pragmatic Approach to Inpatient Diabetes Management during the COVID-19 Pandemic Metformin Treatment was Associated with with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-313829-pjscmen8 | Why is hyperglycemia worsening COVID-19 and its prognosis? |
| cord-313829-pjscmen8 | can we do more on glycemic control? |
| cord-318048-6nvi63rq | All rights reserved What is the current knowledge on the topic? |
| cord-318048-6nvi63rq | What question did this study address? |
| cord-317761-tkqmu1va | Avian influenza and sialic acid receptors: more than meets the eye? |
| cord-317761-tkqmu1va | New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-317761-tkqmu1va | The use of chloroquine and hydroxychloroquine for non- infectious conditions other than rheumatoid arthritis or lupus: a critical review Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-319555-pccqo36g | How can airborne transmission of COVID-19 indoors be minimised? |
| cord-319706-2e9jrv0s | Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? |
| cord-315730-fzgxuak7 | Gilead Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-315730-fzgxuak7 | Lessons from Other Coronavirus Strains Low incidence of severe liver events in HIV patients with and without hepatitis C or B coinfection receiving lopinavir/ ritonavir Saunders Handbook of Veterinary Drugs Interaction between antihypertensives and NSAIDs in primary care: a controlled trial Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study Review of safety and minimum pricing of nitazoxanide for potential treatment of COVID-19 A review of the safety of favipiravir-a potential treatment in the COVID-19 pandemic? |
| cord-315730-fzgxuak7 | PHOSPHATE Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-315730-fzgxuak7 | The Lancet Fifteen years of losartan: what have we learned about losartan that can benefit chronic kidney disease patients? |
| cord-315730-fzgxuak7 | What if I take an extra contraceptive pill by accident? |
| cord-315730-fzgxuak7 | Why your health may never be the same after Covid-19. Retrieved from Swedish Orphan Biovitrum Ltd Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo- controlled phase III trial in Japan Hydroxychloroquine in patients with COVID-19: an open- label, randomized Cardiovascular Safety During Treatment With Baricitinib in Rheumatoid Arthritis Mechanism of Inhibition of Ebola Virus RNA- Dependent RNA Polymerase by Remdesivir Interferon and cytokine responses to SARS- coronavirus infection Antihypertensive drugs and risk of COVID-19? |
| cord-319184-voc0eqb9 | is faecal- oral 370 transmission of SARS- CoV-2 possible? |
| cord-318262-w8oixzdg | Novel Coronavirus Pneumonia Emergency Response Epidemiology Team Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? |
| cord-318262-w8oixzdg | The psychological impact of the SARS epidemic on hospital employees in China: exposure, risk perception, and altruistic acceptance of risk Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed What about telepsychiatry? |
| cord-318262-w8oixzdg | la mise en question du modèle asilaire? |
| cord-319749-je0l22l5 | However, when the pandemic is over, what will the consequences be to the health of survivors? |
| cord-315339-dcui85lw | : is it infectious? |
| cord-315339-dcui85lw | In vitro comparison of the biologic activities of monoclonal monomeric IgA, polymeric IgA, and secretory IgA Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract Cytotoxic T lymphocyte memory: role in cross- protective immunity against influenza? |
| cord-315339-dcui85lw | N- trimethyl chitosan( TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model Incidence of acute respiratory illnesses among enlisted service members during their first year of military service: did the 2011 resumption of adenovirus vaccination of basic trainees have an effect? |
| cord-315339-dcui85lw | The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines Orthomyxoviruses M cell- targeted DNA vaccination Pathogen recognition and development of particulate vaccines: does size matter? |
| cord-315339-dcui85lw | modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region Seasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine Induction of proinflammatory cytokines in human macrophages by influenza A( H5N1) viruses: a mechanism for the unusual severity of human disease? |
| cord-315576-bgcqkz0p | HIV resistance allele Use of chemokine receptors by poxviruses Sickle cell disease and malaria morbidity: a tale with two tails Blood Type Biochemistry and Human Disease Epidemiological evidence of an infectious basis for childhood leukaemia Origins of chromosome translocations in childhood leukaemias Virus target cell conditioning model to explain some epidemiologic characteristics of childhood leukemias and lymphomas Cross- protection induced by encephalitis vaccines against COVID-19 might be a reason for relatively lower mortality rate in some countries Is BCG vaccination causally related to reduced COVID-19 mortality? |
| cord-315576-bgcqkz0p | Is corona's low pathogenicity for East Asians not related to the situation of Asia being less- hygienic than in Europe? |
| cord-315576-bgcqkz0p | Might the double X- chromosome in females be protective against SARS- CoV-2 compared to the single X- chromosome in male? |
| cord-315576-bgcqkz0p | Naming the coronavirus disease( COVID-19) and the virus that causes it COVID-19: What is Next for Public Health? |
| cord-315576-bgcqkz0p | Or is the new coronavirus indeed the first case to show such ethnic differences in terms of pathogenicity? |
| cord-319590-f9qcabcx | : What Are the Next Steps? |
| cord-319930-ymqnb54a | : viral and cellular factors involved in neuroinvasiveness and neuropathogenesis Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? |
| cord-319900-16osnnga | COVID-19: what is next for public health? |
| cord-316705-3wzurnfp | Is information gathering lessened? |
| cord-316705-3wzurnfp | Is the attempt clear or translucent? |
| cord-316705-3wzurnfp | Will collected information be demolished as declared?,"Is the data safe with the host"and"Are there any restrictions or control on utilizing the information?". |
| cord-316705-3wzurnfp | Will collected information be demolished as declared?,"Is the data safe with the host"and"Are there any restrictions or control on utilizing the information?". |
| cord-316705-3wzurnfp | :"Is it mandatory or voluntary?" |
| cord-319876-psilbis0 | Technical guide for prevention and control of novel coronavirus infection in medical institutions Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus- infected pneumonia in Wuhan Early transmission dynamics in Wuhan, China, of novel coronavirus- infected pneumonia Discovery of a rich gene pool of bat SARS- related coronaviruses provides new insights into the origin of SARS coronavirus Clinical features of patients infected with 2019 novel coronavirus in Wuhan The SARS, MERS and novel coronavirus( COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
| cord-320063-n9qzbnup | The spectrum of opportunistic diseases complicating sarcoidosis New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-319799-h9kot3og | : What is functional and what is junk? |
| cord-316126-j51dik7f | Aerodynamic analysis of SARS- CoV-2 in two Wuhan hospitals Is the coronavirus airborne? |
| cord-316126-j51dik7f | Can a toilet promote virus transmission? |
| cord-316126-j51dik7f | How can airborne transmission of COVID-19 indoors be minimised? |
| cord-316126-j51dik7f | This review attempts to summarize current cumulative data on SARS- CoV-2's modes of transmission and identify gaps in research while offering preliminary answers to the question on everyone's mind: is the airborne route significant and should we modify our COVID-19 PPE recommendations for frontline workers in low- risk settings? |
| cord-316126-j51dik7f | What face mask for what use in the context of COVID-19 pandemic? |
| cord-319022-1twsxzcd | : What Is the Evidence? |
| cord-319022-1twsxzcd | The angiotensin II type 2 receptor: what is its clinical significance? |
| cord-315181-emf4i6ir | Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium Delirium and dementia with Lewy bodies: distinct diagnoses or part of the same spectrum? |
| cord-315181-emf4i6ir | Does the combination use of two pain assessment tools have a synergistic effect? |
| cord-315181-emf4i6ir | How is COVID-19 affecting South Korea? |
| cord-315181-emf4i6ir | Hypersensitivity to atypical antipsychotics in dementia with Lewy bodies: is it common or rare? |
| cord-315181-emf4i6ir | Supporting the health care workforce during the COVID-19 global epidemic Infection prevention and control guidance for long- term care facilities in the context of COVID-19: interim guidance? |
| cord-315181-emf4i6ir | The effects of confinement on neuropsychiatric symptoms in Alzheimer's disease during the COVID-19 crisis Is mild cognitive impairment prodromal for vascular dementia like Alzheimer's disease? |
| cord-315181-emf4i6ir | The spectrum of neurologic disease in the severe acute respiratory syndrome coronavirus 2 pandemic infection How to detect and track chronic neurologic sequelae of COVID-19? Use of auditory brainstem responses and neuroimaging for long- term patient follow- up Neurobiology of COVID-19 Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China A first case of meningitis/ encephalitis associated with SARS- coronavirus-2 Expression of the SARS- CoV-2 cell receptor gene ACE2 in a wide variety of human tissues Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Large- vessel stroke as a presenting feature of COVID-19 in the young A case of coronavirus disease 2019 with concomitant acute cerebral infarction and deep vein thrombosis Intermittent hypoxia and cognitive function: implications from chronic animal models |
| cord-315181-emf4i6ir | where are we and where are we going? |
| cord-320054-wqpr8v3p | higher case 511 fatality rate spike( S) protein be associated with higher COVID-19 mortality? |
| cord-319501-a2x1hvkk | The action points at which viral proteins function marked with a question mark(?) represent controversial and inconclusive findings in the field or molecular mechanisms not well studied. |
| cord-319501-a2x1hvkk | announcement of the coronavirus study group Middle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak control Inhibition of novel β coronavirus replication by a combination of interferon- α2b and ribavirin Distinct immune response in two MERS- CoV- infected patients: Can we go from bench to bedside? |
| cord-319241-div9rzax | : Should We Worry? |
| cord-319241-div9rzax | Is it the newest spark in the TORCH? |
| cord-319241-div9rzax | What are the risks of COVID-19 infection in pregnant women? |
| cord-319469-fkuqs3ie | Could BCG be used to protect against COVID-19? |
| cord-319469-fkuqs3ie | WHO Director- General's opening remarks at the media briefing on COVID-19-20 Seroprevalence of immunoglobulin M and G antibodies against SARS- CoV-2 in China Coronavirus herd immunity? |
| cord-319236-gxcs77pl | Can we migrate COVID-19 spreading risk? |
| cord-319236-gxcs77pl | Can we migrate COVID-19 spreading risk? |
| cord-319236-gxcs77pl | Potential implications for reducing transmission of COVID-19 System Performance Evaluation and Design Guidelines for Displacement Ventilation Risk assessment for airborne infectious diseases in aircraft cabins Is the coronavirus airborne? |
| cord-320333-audnwp8t | We used 3 different databases( https://www.ncbi.nlm.nih.gov/gene/? |
| cord-319519-mb9ofh12 | Neutrophil extracellular traps( NETs) exacerbate severity of infant sepsis Association of Blood Glucose Control and Outcomes in Patients with COVID-780 19 and Pre- existing Type 2 Diabetes Dementia care during COVID-19 Epidemiology of Covid-19 in a Long- Term Care Facility in King 784 Storm, typhoon, cyclone or hurricane in 786 patients with COVID-19? |
| cord-319519-mb9ofh12 | The DisGeNET knowledge platform for disease genomics Which White Blood Cell Subtypes Predict Increased Cardiovascular 756 Risk? |
| cord-320127-55h4hhm3 | a prospective cohort study Infants born to mothers with a new coronavirus( COVID-19) Perinatal Transmission of COVID-19 Associated SARS- CoV-2: Should We Worry? |
| cord-315411-11mq8wll | An insight into the sex differences in COVID-19 patients: what are the possible causes? |
| cord-315411-11mq8wll | Does COVID19 infect the brain? |
| cord-315411-11mq8wll | The cholinergic system in the pathophysiology and treatment of Alzheimer's disease Potential novel role of COVID-19 in Alzheimer's disease and preventative mitigation strategies Smell dysfunction: a biomarker for COVID-19 Might olfactory dysfunction be a marker of early Alzheimer's disease? |
| cord-315411-11mq8wll | To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? |
| cord-315411-11mq8wll | Why are women better protected from COVID-19: clues for men? |
| cord-315411-11mq8wll | it matter? |
| cord-320149-3q4q98a6 | the Cardiovascular Health Study Guillain- Barré syndrome associated with SARS- CoV-2 Early Guillain- Barré syndrome in coronavirus disease 2019( COVID-19): a case report from an Italian COVID- hospital Miller Fisher syndrome and polyneuritis cranialis in COVID-19 Guillain Barre syndrome associated with COVID-19 infection: a case report Acute symptomatic seizures in critically Ill patients with COVID-19: is there an association? |
| cord-319273-ok2p1h9f | A randomized, controlled trial of Ebola virus disease therapeutics Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies Chloroquine and hydroxychloroquine in covid-19 Mefloquine for preventing malaria in pregnant women Chloroquine as weekly chemoprophylaxis or intermittent treatment to prevent malaria in pregnancy in Malawi: a randomised controlled trial Back to chloroquine for malaria prophylaxis in pregnancy? |
| cord-319273-ok2p1h9f | The outbreak of COVID-19: An overview The looming pandemic of COVID-19: What therapeutic options do we have now? |
| cord-320417-01l27d99 | How does recombination affect phylogeny estimation? |
| cord-320619-r466dc5t | COVID-19: immunopathology and its implications for therapy In- silico discovery of candidate drugs against Covid-19 Coronavirus- induced membrane fusion requires the cysteine- rich domain in the spike protein Structure analysis of the receptor binding of 2019-nCoV Chloroquine and hydroxychloroquine as available weapons to fight COVID-2019 New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-315756-g6g34uvh | Among these questions, prominent ones are: Why are the mortality patterns so skewed toward higher ages? |
| cord-315756-g6g34uvh | G. title: Immunity after COVID-19: protection or sensitization? |
| cord-315756-g6g34uvh | The trinity of COVID-19: immunity, inflammation and intervention Is COVID-19 receiving ADE from other coronaviruses? |
| cord-315756-g6g34uvh | What is the common denominator of the observed comorbidities that affect in a non- negligible way the outcome of the disease? |
| cord-315756-g6g34uvh | What is the size of the asymptomatic cohorts? |
| cord-315756-g6g34uvh | asymptomatic( or paucisymptomatic) cases a barrier or an accelerator of the disease propagation? |
| cord-319754-5isw53wl | An Essential"Receptor"or an"Accessory Attachment Factor"for Hepatitis A Virus? PIP5K- driven PtdIns(4,5)P2 synthesis: Regulation and cellular functions Function and dysfunction of the PI system in membrane trafficking PIP2: Choreographer of actin- adaptor proteins in the HIV-1 dance Synchronized HIV assembly by tunable PIP2 changes reveals PIP2 requirement for stable Gag anchoring Quantification of phosphoinositides reveals strong enrichment of PIP2 in HIV-1 compared to producer cell membranes Investigation of the Lipid Binding Properties of the Marburg Virus Matrix Protein VP40 Type I phosphatidylinositol-4-phosphate |
| cord-319754-5isw53wl | Signaling Multifaceted roles for lipids in viral infection Ultrastructure of the replication sites of positive- strand RNA viruses Does form meet function in the coronavirus replicative organelle? |
| cord-320490-3jmo35jc | Do salt bridges stabilize proteins? |
| cord-319728-d0kf9gme | Multiple sclerosis and related disorders Comparison of four new commercial serologic assays for determination of SARS- CoV-2 IgG Duration of serum neutralizing antibodies for SARS- CoV-2: Lessons from SARS- CoV infection Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti- SARS- CoV-2 antibodies Initial Serological Response after Prime- boost Pneumococcal Vaccination in Rheumatoid Arthritis Patients: Results of a Randomized Controlled Trial COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role? |
| cord-319728-d0kf9gme | key: cord-319728-d0kf9gme authors: Lucchini, Matteo; Bianco, Assunta; Giacomo, Paola Del; De Fino, Chiara; Nociti, Viviana; Mirabella, Massimiliano title: Is serological response to SARS- CoV-2 preserved in MS patients on ocrelizumab treatment? |
| cord-317151-cxx5pcln | Before access to the infusion clinic all patients should have body temperature measured and they should complete a history questionnaire( symptoms compatible with COVID-19? |
| cord-317151-cxx5pcln | Contact with individuals with SARS- CoV-2 infection?). |
| cord-317151-cxx5pcln | Epub ahead of print 18 Proposal for the return to routine endoscopy during the COVID-19 pandemic Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans COVID-19: elective case triage guidelines for surgical care Coronavirus pandemic and colorectal surgery: practical advice based on the Italian experience Laparoscopy at all costs? |
| cord-317151-cxx5pcln | The current question is: how has the pandemic changed the landscape of the management of IBD patients? |
| cord-320455-doup2bqq | 2020, in press Ultrastructural Evidence for Direct Renal Infection with SARS- CoV-2 Am I a Coronavirus? |
| cord-320455-doup2bqq | The Novel Coronavirus 2019 epidemic and kidneys Kidney disease is associated with in- hospital death of patients with COVID-19 Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia Caution on Kidney Dysfunctions of COVID-19-associated nephritis: early warning for disease severity and complications? |
| cord-320087-iu4ulxtu | Could intravenous immunoglobulin collected from recovered coronavirus patients protect against COVID-19 and strengthen the immune system of new patients? |
| cord-320087-iu4ulxtu | Neuroinvasive, neurotropic and potentially neurovirulent pathogens Clinical features, pathogenesis, and treatment of Guillain- Barre syndrome Guillain- Barre syndrome associated with SARS- CoV-2 Guillain- Barre syndrome associated with SARS- CoV-2 infection: Causality or coincidence? |
| cord-319855-78xmxymu | Are sufficient details of methods and analysis provided to allow replication by others? |
| cord-319855-78xmxymu | Yes Are all the source data underlying the results available to ensure full reproducibility? |
| cord-319408-841c0g1c | 2019-nCoV epidemic: what about pregnancies? |
| cord-319408-841c0g1c | A novel coronavirus from patients with pneumonia in China Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records What are the risks of COVID-19 infection in pregnant women? |
| cord-319408-841c0g1c | Can SARS- CoV-2 infection be acquired in utero? |
| cord-319707-j8y9gt2o | Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-319707-j8y9gt2o | What does this mean in the clinical setting? |
| cord-319707-j8y9gt2o | What it comes down to? |
| cord-320308-pzex799x | Does your manuscript have a reference number? |
| cord-320308-pzex799x | If yes, enter number here: Does your manuscript have a handling editor? |
| cord-319920-vn5si7xm | ( ISNCSCI)-what's new? |
| cord-319920-vn5si7xm | Why tocilizumab could be an effective treatment for severe COVID-19? |
| cord-320681-b3ui95vx | Acute hypoxemia in humans enhances the neutrophil inflammatory response Oxidants and redox signaling in acute lung injury Correlation among cytokines, bronchopulmonary dysplasia and modality of ventilation in preterm newborns: improvement with melatonin treatment Oxidative and inflammatory parameters in respiratory distress syndrome of preterm newborns: beneficial effects of melatonin Quis Custodiet Ipsos Custodes? |
| cord-321315-bzmokdzk | Thus, researchers are trying to answer two questions:''Should we approach each patient as COVID-19 positive or should we screen every pregnant patient admitted to the hospital?''. |
| cord-319833-u9uuuu38 | Can N95 Respirators Be Reused after Disinfection? |
| cord-319833-u9uuuu38 | Evaluating UVGI- Treated FFR Odor A method to determine the available UV- C dose for the decontamination of filtering facepiece respirators What are the effective methods of decontaminating N95 mask for reuse? |
| cord-319833-u9uuuu38 | How Many Times? |
| cord-316432-xemz7zn9 | : cord-316432-xemz7zn9 authors: Talaie, Haleh; Hosseini, Sayed Masoud; Nazari, Maryam; Fakhri, Yadollah; Mousavizadeh, Atieh; Vatanpour, Hossein; Firoozfar, Ali title: Is there any potential management against COVID-19? |
| cord-316432-xemz7zn9 | A commentary on World Health Organization declares global emergency: A review of the 2019 novel Coronavirus( COVID-19) Outbreak of COVID-19-an urgent need for good science to silence our fears? |
| cord-316432-xemz7zn9 | Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: |
| cord-316432-xemz7zn9 | Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis Lack of Efficacy of Hydroxychloroquine or Azithromycin on COVID-19 Clinical Course Coronavirus disease 2019( COVID-19): a clinical updateThe epidemiology of norovirus gastroenteritis in China: disease burden and distribution of genotypes Antiviral activity of arbidol and its derivatives against the pathogen of severe acute respiratory syndrome in the cell cultures Favipiravir, an antiviral for COVID-19? |
| cord-316432-xemz7zn9 | Should chloroquine and hydroxychloroquine be used to treat COVID-19? |
| cord-316432-xemz7zn9 | what we know so far Baricitinib for COVID-19: a suitable treatment? |
| cord-320882-cr0ccsnp | Smoking and SARS- CoV-2 Disease( COVID-19): Dangerous Liaisons or Confusing Relationships? |
| cord-320158-6dh9e5rg | In practice, several specialists may provide expert opinion on COVID-19 management, including intensivists, respiratory How might it impact on clinical practice in the foreseeable future? |
| cord-320158-6dh9e5rg | what do we know about the risks and treatment? |
| cord-320331-wtxja5i9 | Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-320331-wtxja5i9 | Can we contain the COVID-19 outbreak with the same measures as for SARS? |
| cord-319704-xzhoa03d | Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? |
| cord-319704-xzhoa03d | Evidence Base and Barriers to Expanded Access in Practice Psychosocial effects of an Ebola outbreak at individual, community and international levels Post- SARS psychological morbidity and stigma among general practitioners and traditional Chinese medicine practitioners in Singapore Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease( COVID-19) Epidemic among the General Population in China Social isolation in mental health: a conceptual and methodological review Study on the public psychological states and its related factors during the outbreak of coronavirus disease 2019( COVID-19) in some regions of China Is quarantine related to immediate negative psychological consequences during the 2009 H1N1 epidemic? |
| cord-319704-xzhoa03d | The Importance of Supervisor Support Mental health care during the Ebola virus disease outbreak in Sierra Leone Do online mental health services improve help- seeking for young people? |
| cord-321549-r7bmtloy | Trained dogs identify people with malaria parasites by their odour Using dog scent detection as a point- of- care tool to identify toxigenic clostridium difficile in stool Canine detection of the volatilome: a review of implications for pathogen and disease detection Realtime detection of a virus using detection dogs Biomedical scent detection dogs: would they pass as a health technology? |
| cord-320466-l7017jis | The opsonizing ligand on Salmonella typhimurium influences incorporation of specific, but not azurophil, granule constituents into neutrophil phagosomes Neutrophil in viral infections, friend or foe? |
| cord-320466-l7017jis | friend and foe Myeloperoxidase mediates neutrophil activation by association with CD11b/ CD18 integrins Inflammation resolution: a dual- pronged approach to averting cytokine storms in COVID-19? |
| cord-320860-qt84oicg | What Should Gastroenterologists and Patients Know About COVID-19? |
| cord-321013-8pkrg0mx | A clinically important virus? |
| cord-321013-8pkrg0mx | If indeed so, could this then indicate a probable basis for the increased pathogenicity of SARS- CoV compared to HCoV- NL63? |
| cord-320560-yn3bbkdh | The airborne lifetime of small speech droplets and their potential importance in SARS- CoV-2 transmission Aerosol emission and superemission during human speech increase with voice loudness Modality of human expired aerosol size distributions Singing and the dissemination of tuberculosis Which procedures are considered aerosol generating procedures in healthcare settings? |
| cord-320560-yn3bbkdh | What is an effective portable air cleaning device? |
| cord-321552-lsz1onrj | Miller Fisher syndrome and polyneuritis cranialis in COVID-19 Guillain- Barré syndrome associated with SARS- CoV-2 infection: Causality or coincidence? |
| cord-320632-369kax2m | Close to a Cure? – |
| cord-320401-itltvh3f | Angiogenesis A perspective on the modulation of plant and animal two pore channels( TPCs) by the flavonoid naringenin Could an endo- lysosomal ion channel be the Achilles heel of SARS- CoV2? |
| cord-320401-itltvh3f | the Inhibition of Endo- Lysosomal Two- Pore Channels( TPCs) by the Natural Flavonoid Naringenin Represent an Option to Fight SARS- CoV-2 Infection? |
| cord-320704-rrq6x25k | : What is the evidence? |
| cord-320704-rrq6x25k | Molecular mechanisms and potential therapeutic target Effect of angiotensinconverting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin- converting enzyme 2 Role of the ACE2/ angiotensin 1- 7 axis of the renin- angiotensin system in heart failure Reninangiotensin system at the heart of COVID-19 pandemic Comparative genetic analysis of the novel coronavirus( 2019-nCoV/ SARS- CoV-2) receptor ACE2 in different populations Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-321580-3ru92tra | key: cord-321580- 3ru92tra authors: Hadler, James L title: Will SARS- CoV-2 prevention efforts affect the coming influenza season in the United States and northern hemisphere? |
| cord-320535-fo4lzcav | Art Thou? |
| cord-320535-fo4lzcav | What accounts for the discrepancy between these two related viruses in terms of neurologic involvement? |
| cord-320535-fo4lzcav | What might account for the dearth of expected movement disorders in COVID-19 patients? |
| cord-317092-5qba9jiq | Can children respond most effectively to this vaccine, and will infancy be the optimal timing to achieve lifelong protection? |
| cord-317092-5qba9jiq | Can we leverage understanding of protective pediatric immunity and pathophysiology to guide design of therapeutic targets and vaccines? |
| cord-317092-5qba9jiq | How soon can we include vulnerable populations including pregnant women, neonates, and children in the vaccine development process to optimally tailor vaccine design to these populations? |
| cord-317092-5qba9jiq | In which target population will the vaccine be most effective and durable? |
| cord-317092-5qba9jiq | True or false? |
| cord-317092-5qba9jiq | What will be the effect of pre- existing immunity and maternal antibody on the vaccine? |
| cord-317092-5qba9jiq | Will antivirals suppress viral load in vivo as well as lower clinical pathology? |
| cord-321784-nubu5fuz | A novel coronavirus outbreak of global health concern Isolation and rapid sharing of the 2019 novel coronavirus( SARS- CoV-2) from the first patient diagnosed with COVID-19 in Australia Linear Regression Analysis to predict the number of deaths in India due to SARS- CoV-2 at 6 weeks from day 0( 100 cases Spread of SARS- CoV-2 in the Icelandic Population Preliminary case report on the SARS- CoV-2 cluster in the UK Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19 Meta- analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? |
| cord-320815-p9oh54nt | How is it possible? |
| cord-320815-p9oh54nt | based on the administration of AD- MSCs in COVID-19 patients and of these three are authorized, as followed reported:-Clinical study for the prophylactic efficacy of AD- MSCs against COVID-19( Trial ID NCT04428801 https://clinicaltrials.gov/ct2/show/record/NCT04428801? |
| cord-320964-1gg33gdn | SARS- CoV-2-infected women breastfeed after viral clearance? |
| cord-320964-1gg33gdn | what obstetricians need to know SARS and pregnancy: a case report SARS during pregnancy, United States SARS- CoV-2 and human milk: what is the evidence? |
| cord-320587-936cavob | The Allplex 2019-nCoV( Seegene) assay: which performances are for SARS- CoV-2 infection diagnosis? |
| cord-320587-936cavob | The value of serology testing to manage SARS- CoV-2 infections SARS- CoV-2 serosurvey in health care workers of the Veneto Region Implications of test characteristics and population seroprevalence on'immune passport'strategies Diagnostic performances and thresholds: The key to harmonization in serological SARS- CoV-2 assays? |
| cord-321855-7b1c2xdh | A novel syndrome? |
| cord-317246-8c7d5ynz | 30 Sixteen years later, this'treatment philosophy'is still struggling to take off; given today's unique circumstances, we can not help wondering:'Will SARS- CoV-2 be able to change the way of thinking and acting in paediatric dentistry?'. |
| cord-317246-8c7d5ynz | : Does this make you ill? |
| cord-317246-8c7d5ynz | A systematic review and meta- analysis Survival percentages of atraumatic restorative treatment( ART) restorations and sealants in posterior teeth: an updated systematic review and meta- analysis High- viscosity glass- ionomer vs. composite resin restorations in persons with disability: Five- year follow- up of clinical trial Leal SC Glass hybrid restorations as an alternative for restoring hypomineralized molars in the ART model When to intervene in the caries process? |
| cord-317246-8c7d5ynz | In 2004, Nigel Pitts wondered:'Are we ready to move from operative to non- operative/ preventive treatment of dental caries in clinical practice?'. |
| cord-317246-8c7d5ynz | Is Atraumatic restorative treatment an option for restoring occlusoproximal caries lesions in primary teeth? |
| cord-317246-8c7d5ynz | The effect of rubber dam on atmospheric bacterial aerosols during restorative dentistry Are we ready to move from operative to non- operative/ preventive treatment of dental caries in clinical practice? |
| cord-317246-8c7d5ynz | key: cord-317246- 8c7d5ynz authors: Cagetti, Maria Grazia; Angelino, Eleonora title: Could SARS‐CoV‐2 burst the use of Non‐Invasive and Minimally Invasive treatments in paediatric dentistry? |
| cord-317246-8c7d5ynz | should this be the treatment of choice? |
| cord-321358-plxz5mkg | Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-321146-dd8z5c6d | A first step in understanding SARS pathogenesis Is the Collapse of the Respiratory Center in the Brain Responsible for Respiratory Breakdown in COVID-19 Patients? |
| cord-321146-dd8z5c6d | Does SARS- Cov-2 invade the brain? |
| cord-317622-o10ntfi8 | Considering the above, could paricalcitol be repurposed to help patients with severe COVID-19 avoid mechanical ventilation or have a better response and thus increased hope of safely getting off the respirator? |
| cord-317622-o10ntfi8 | If so, what would be the appropriate dose and what might be the potential complications? |
| cord-317622-o10ntfi8 | Might study of vitamin D, discovered 100 years ago, provide a clue? |
| cord-317622-o10ntfi8 | So what can we do now? |
| cord-317622-o10ntfi8 | Vitamin D increases the antiviral activity of bronchial epithelial cells in vitro Chronology of histological lesions in acute respiratory distress syndrome with diffuse alveolar damage: a prospective cohort study of clinical autopsies Estriol reduces pulmonary immune cell recruitment and inflammation to protect female mice from severe influenza Sars- CoV-2 and black population: ACE2 as shield or blade? |
| cord-317622-o10ntfi8 | suppresses inflammatory response to influenza A( H1N1) infection in human lung A549 epithelial cells Avoidance of vitamin D deficiency to slow the COVID-19 pandemic VDR attenuates acute lung injury by blocking Ang-2-Tie-2 pathway and renin- angiotensin system Research in the context of a pandemic Vitamin D insufficiency is prevalent in severe COVID-19 Vitamin D: a negative endocrine regulator of the renin- angiotensin system and blood pressure ACE2 expression in pancreas may cause pancreatic damage after SARS- CoV-2 infection Potential role of ACE2 in coronavirus disease 2019( COVID-19) prevention and management Preventing mortality in COVID-19 patients: which cytokine to target in a raging storm? |
| cord-321819-lqyo9px1 | Early dynamics of transmission and control of COVID-19: a mathematical modelling study Secondary attack rate and superspreading events for SARS- CoV-2 Tracking social contact networks with online respondentdriven detection: who recruits whom? |
| cord-322129-uyswj4ow | beringei tracking: how close do tourists get? |
| cord-318944-13zk6cco | : The world should face the reality The Size Distribution of Droplets in the Exhaled Breath of Healthy Human Subjects Infectivity of respiratory syncytial virus by various routes of inoculation Characterization of infectious aerosols in health care facilities: An aid to effective engineering controls and preventive strategies How far droplets can move in indoor environments? |
| cord-318944-13zk6cco | Is IL-6 the right target? |
| cord-318944-13zk6cco | Results of a retrospective chart review Tuberculosis infection control: A reasonable approach for dentistry Dentistry and tuberculosis in the 1900s Tuberculosis in the 1990s: Current implications for dentistry Tuberculosis: A Growing Concern for Dentistry? |
| cord-318944-13zk6cco | What Changes for Dentists and Oral Medicine Experts? |
| cord-318944-13zk6cco | as Compared with SARS- CoV-1 Airborne or droplet precautions for health workers treating COVID-19? |
| cord-318164-6rqi17oz | ( 3) Would the use of infected cryopreserved semen affect the fertilization process[ 18, 19]? |
| cord-318164-6rqi17oz | However, apart from safety issues for the sperm bank personnel, this novel pandemic forced us to consider three major issues:( 1) does the SARS- CoV-2 virus reach the testis and the seminal fluid? |
| cord-318164-6rqi17oz | If it does,( 2) are there any long- lasting consequences of viral testicular infection? |
| cord-318164-6rqi17oz | In any case, how might SARS- CoV-2 reach the testis? |
| cord-318164-6rqi17oz | The COVID-19 pandemics: Shall we expect andrological consequences? |
| cord-318164-6rqi17oz | The novel angiotensin- converting enzyme( ACE) homolog, ACE2, is selectively expressed by adult Leydig cells of the testis Evaluating risk, safety and efficacy of novel reproductive techniques and therapies through the EuroGTP II risk assessment tool SARS- CoV-2 pandemic and repercussions for male infertility patients: a proposal for the individualized provision of andrological services COVID-19: should we continue to cryopreserve sperm during the pandemic? |
| cord-321155-dty18esg | A Problem or a Necessity? |
| cord-321155-dty18esg | Targeting G- quadruplexes in gene promoters: a novel anticancer strategy? |
| cord-321155-dty18esg | rG4-seq reveals widespread formation of G- quadruplex structures in the human transcriptome UTR G- quadruplex structures acting as translational repressors Integrative analysis reveals RNA G- quadruplexes in UTRs are selectively constrained and enriched for functional associations G- quadruplex DNA: a potential target for anti- cancer drug design Quadruplex nucleic acids as targets for anticancer therapeutics G- quadruplexes: selective DNA targeting for cancer therapeutics? |
| cord-321673-v5o49ees | A lipidic pore stabilized by lipopeptide? |
| cord-321673-v5o49ees | How can viral IC activity stimulate this exacerbated inflammatory response leading to pathology and disease? |
| cord-322102-4fi0y96f | A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person- to- person transmission: a study of a family cluster Practical aspects of otolaryngologic clinical services during the 2019 novel coronavirus epidemic: an experience in Hong Kong Possible SARS coronavirus transmission during cardiopulmonary resuscitation Personal protective equipment for preventing respiratory infections: what have we really learned? |
| cord-322009-0cwljo0c | Why is coinfection with influenza virus and bacteria so difficult to control Co- circulation of human metapneumovirus and SARS- associated coronavirus during a major nosocomial SARS outbreak in Hong Kong Are SARS superspreaders cloud adults? |
| cord-322789-9elfpx0e | The FDA- approved drug sofosbuvir inhibits Zika virus infection Sofosbuvir as treatment against dengue? |
| cord-321308-rwxhdg8r | Did SARS- CoV-2 evolve to become better adapted to humans? |
| cord-321308-rwxhdg8r | More deadly? |
| cord-321308-rwxhdg8r | More infectious or transmissible? |
| cord-322885-ob5euspo | Gold mine or just a bigger haystack? |
| cord-316260-1t3ifsfi | ( COVID-19) in the US Projecting the impact of the coronavirus disease-19 pandemic on childhood obesity in the United States: a microsimulation model Effects of COVID-19 lockdown on lifestyle behaviors in children with obesity living in Verona, Italy: a longitudinal study Can exercise affect immune function to increase susceptibility to infection? |
| cord-316260-1t3ifsfi | A pilot study of cardiorespiratory fitness, adiposity, and cardiometabolic health in youth with overweight and obesity Should patients with obesity be more afraid of COVID-19? Association of pediatric obesity and asthma, pulmonary physiology, metabolic dysregulation and the role of weight management Obesity phenotype is a predictor of COVID-19 disease susceptibility Obesity and childhood asthma in male schoolchildren in Saudi Arabia: is there a role for leptin, interleukin-4, interleukin-5, and interleukin-21? |
| cord-316260-1t3ifsfi | A pilot study of cardiorespiratory fitness, adiposity, and cardiometabolic health in youth with overweight and obesity Should patients with obesity be more afraid of COVID-19? Association of pediatric obesity and asthma, pulmonary physiology, metabolic dysregulation and the role of weight management Obesity phenotype is a predictor of COVID-19 disease susceptibility Obesity and childhood asthma in male schoolchildren in Saudi Arabia: is there a role for leptin, interleukin-4, interleukin-5, and interleukin-21? |
| cord-316260-1t3ifsfi | COVID-19 and obesity: links and risks Obesity- related glomerulopathy: clinical and pathologic characteristics and pathogenesis Nephrolithiasis in the obese patient Lipid accumulation and chronic kidney disease Obesity- related glomerulopathy: a latent change in obesity requiring more attention Renoprotective effects of ET(A) receptor antagonists therapy in experimental non- diabetic chronic kidney disease: is there still hope for the future? |
| cord-316260-1t3ifsfi | Higher body mass index is associated with iron deficiency in children 1 to 3 years of age Relationship between obesity and iron deficiency anemia: is there a role of hepcidin? |
| cord-316260-1t3ifsfi | Renin- angiotensin- aldosterone system and COVID-19 infection Is the kidney a target of SARS- CoV-2? |
| cord-316260-1t3ifsfi | The impact of childhood and adolescent obesity on cardiovascular risk in adulthood: a systematic review Ultrasonographic evaluation of the common carotid intima- media complex in healthy and overweight/ obese children Markers of subclinical atherosclerosis in schoolchildren with obesity and metabolic syndrome Endothelial cell infection and endotheliitis in COVID-19 Potential pathophysiological mechanisms leading to increased COVID-19 susceptibility and severity in obesity Insight into the relationship between obesity- induced low- level chronic inflammation and COVID-19 infection Metabolic inflammation and insulin resistance in obesity Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic COVID-19 related coagulopathy: a distinct entity? |
| cord-316260-1t3ifsfi | The obese child in the intensive care unit What evidence informs the nursing care of people with class iii obesity in an acute care setting? |
| cord-316260-1t3ifsfi | longitudinal associations between exclusive breastfeeding duration, child growth and obesity among WIC- participating children Coronavirus disease 2019 and children: what pediatric health care clinicians need to know The immune system and COVID-19: Friend or foe? |
| cord-316260-1t3ifsfi | why children fare better than adults? |
| cord-319933-yp9ofhi8 | * Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome SARS vaccines: where are we? |
| cord-319933-yp9ofhi8 | An unusual hantavirus outbreak in southern Argentina: person- to- person transmission? |
| cord-319933-yp9ofhi8 | Efficacy assessment of a cell- mediated immunity HIV-1 vaccine( the step study): a double- blind, randomised, placebo- controlled, test- of- concept trial Human papillomavirus in cervical cancer Human papillomavirus research: do we still need animal models? |
| cord-319933-yp9ofhi8 | Phenotypic changes in Langerhans'cells after infection with arboviruses: a role in the immune response to epidermally acquired viral infection? |
| cord-322811-6lebh7ca | 11 323 deaths later, how far have we come? |
| cord-321664-3qlfsei6 | Experts ca n't agree Does that face mask really protect you? |
| cord-321664-3qlfsei6 | Is the coronavirus airborne? |
| cord-322660-bis2arbu | away from others( social distancing) Understanding distress in people with severe communication difficulties: Developing and assessing the Disability Distress Assessment Tool( DisDAT) Emotional disturbance and mental retardation: Diagnostic overshadowing COVID-19 and Italy: What next? |
| cord-322913-sq9mq6f1 | Immunosenescence and inflamm- aging as two sides of the same coin: friends or foes? |
| cord-319877-izn315hb | Distinct immune response in two MERS- CoV- infected patients: can we go from bench to bedside? |
| cord-319877-izn315hb | Nidovirus transcription: how to make sense …? |
| cord-319877-izn315hb | The mercurial nature of neutrophils: still an enigma in ARDS? |
| cord-319877-izn315hb | The role of C5a in acute lung injury induced by highly pathogenic viral infections Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus A decade after SARS: strategies for controlling emerging coronaviruses SARS vaccines: where are we? |
| cord-323449-r1gyjxei | Interim infection prevention and control recommendations for patients with suspected or confirmed coronavirus disease 2019( COVID-19) in healthcare settings Detection of air and surface contamination by SARS- CoV-2 in hospital rooms of infected patients Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards Aerosol and surface stability of SARS- CoV-2 as compared with SARS- CoV-1 Aerodynamic analysis of SARS- CoV-2 in two Wuhan hospitals Airborne or droplet precautions for health workers treating COVID-19? |
| cord-320935-3n157yl4 | : what is its fate in urban water cycle and how can the water research community respond? |
| cord-320935-3n157yl4 | COVID-19: gastrointestinal manifestations and potential fecal- oral transmission Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-320935-3n157yl4 | Put a lid on it: are faecal bio- aerosols a route of transmission for SARS- CoV-2? |
| cord-320909-p93gxjm2 | : cord-320909-p93gxjm2 authors: Natoli, S.; Oliveira, V.; Calabresi, P.; Maia, L. F.; Pisani, A. title: Does SARS‐Cov‐2 invade the brain? |
| cord-320909-p93gxjm2 | Prophylactic and therapeutic remdesivir( GS-5734) treatment in the rhesus macaque model of MERS- CoV infection Guillain- Barr e syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-320909-p93gxjm2 | Viral and cellular factors involved in neuroinvasiveness and neuropathogenesis Multiple organ infection and the pathogenesis of SARS Interaction of severe acute respiratory syndrome- associated coronavirus with dendritic cells Is there an ideal animal model for SARS? |
| cord-323394-osx7llte | A systematic review of the clinical utility of cycle threshold values in the context of COVID-19 Will the COVID-19 pandemic slow down in the Northern hemisphere by the onset of summer? |
| cord-322087-gj5mfzxz | Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease? |
| cord-322087-gj5mfzxz | recommendations of the Advisory Committee on Immunization Practices- United States, 2019- 20 influenza season Are We Ready for Coronavirus Disease 2019 Arriving at Schools? |
| cord-321670-f2d4bykp | : Is it the newest spark in the TORCH? |
| cord-321670-f2d4bykp | : Should We Worry? |
| cord-321670-f2d4bykp | Born to Mothers With COVID-19 Pneumonia Virus Disease 2019, a growing threat to children? |
| cord-323327-08p122lw | Bacterial pathogens and death during the 1918 influenza pandemic Is SARS just ARDS? |
| cord-322957-clf8f90t | what next? |
| cord-323061-0i5w7vm9 | Can the coronavirus disease 2019( COVID-19) affect the eyes? |
| cord-323424-86wh4u6l | The Lancet( 2020) COVID-19 in Brazil:'so what?'. |
| cord-320970-ru2iw0py | Can serology tests be used for discharging recovered patients when molecular testing is not available? |
| cord-320970-ru2iw0py | On recovery, should a serology test be used to decide when they can safely return to work? |
| cord-320970-ru2iw0py | What diagnostic alternatives are available to support decentralised testing that would allow countries to mount an adequate response to the pandemic? |
| cord-320970-ru2iw0py | When is serology testing recommended? |
| cord-320970-ru2iw0py | Why are diagnostics important? |
| cord-322641-mz0b91xr | True or False? |
| cord-322641-mz0b91xr | What could be the reason for these false positive results? |
| cord-322955-7dw32xby | Evaluation of COVID-19 RT- qPCR test in multi- sample pools Role of Chest CT in Diagnosis and Management COVID-19)? |
| cord-320270-lduhhdld | Does time from diagnosis to treatment of high- or very- highrisk prostate cancer affect outcome? |
| cord-320270-lduhhdld | How will country- based mitigation measures influence the course of the COVID-19 epidemic? |
| cord-320270-lduhhdld | radical prostatectomy is not associated with adverse oncological outcomes: implications for men experiencing surgical delay due to the COVID-19 pandemic Evaluating the effect of time from prostate cancer diagnosis to radical prostatectomy on cancer control: can surgery be postponed safely? |
| cord-320270-lduhhdld | review of research activities and practical guidance Is surgical smoke harmful to theater staff? |
| cord-323666-t7cshj05 | r o o f COVID-19: what is next for public health? |
| cord-323871-2hx4fuk2 | How Are Close Residues of Protein Structures Distributed in Primary Sequence? |
| cord-323737-6ajqy0ch | a heat shock- induced methyltransferase Is hesperidin essential for prophylaxis and treatment of COVID-19 Infection? |
| cord-321918-9jwma2y6 | Human monoclonal antibodies block the binding of SARS- CoV-2 spike protein to angiotensin converting enzyme 2 receptor A human monoclonal antibody blocking SARS- CoV-2 infection Rapid selection of a human monoclonal antibody that potently neutralizes SARS- CoV-2 in two animal models Therapeutic potential of small molecules and engineered proteins What are the drugs of the future? |
| cord-321918-9jwma2y6 | Prim Care Meta- analysis: convalescent blood products for spanish influenza pneumonia: a future h5n1 treatment? |
| cord-321918-9jwma2y6 | Targeting membrane- bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the Middle East respiratory syndrome virus Angiotensin- converting enzyme 2: cardioprotective player in the renin- angiotensin system? |
| cord-323943-9916y6x0 | Will Children Reveal Their Secret? |
| cord-322650-q8inhgtr | A real- time PCR for SARS- coronavirus incorporatingtarget gene pre- amplification Boosting the sensitivity of real- time PCR SARS detection by simultaneous reverse transcription and target gene pre- amplification Severe acute respiratory syndrome: relapse? |
| cord-322650-q8inhgtr | Hospital infection? |
| cord-317952-4oa9hfb4 | All rights reserved Quantitative proteomic analysis reveals the deregulation of nicotinamide adenine dinucleotide metabolism and CD38 in inflammatory bowel disease Upregulation of circulating components of the alternative renin- angiotensin system in inflammatory bowel disease: A pilot study Imbalance of the renin- angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target? |
| cord-317952-4oa9hfb4 | COVID-19 concern nephrologists? |
| cord-317952-4oa9hfb4 | Covid-19: risk factors for severe disease and death Cyclosporin A inhibits the replication of diverse coronaviruses COVID-19: risk for cytokine targeting in chronic inflammatory diseases? |
| cord-317952-4oa9hfb4 | Preventing a covid-19 pandemic Can angiotensin receptor- blocking drugs perhaps be harmful in the COVID-19 pandemic? |
| cord-317952-4oa9hfb4 | Renin- angiotensin- aldosterone system inhibitors in patients with Covid-19 Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-317952-4oa9hfb4 | Why and to what extent? |
| cord-317952-4oa9hfb4 | causative or coincidental? |
| cord-317952-4oa9hfb4 | induced pneumonia and macrophage activation syndrome- like disease A combined set of four serum inflammatory biomarkers reliably predicts endoscopic disease activity in inflammatory bowel disease Tocilizumab treatment in COVID-19: A single center experience Favorable changes of CT findings in a patient with COVID-19 pneumonia after treatment with tocilizumab Rapid and severe Covid-19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab Off- label use of tocilizumab in patients with SARS- CoV-2 infection Preventing COVID-19-induced pneumonia with anticytokine therapy Baricitinib for COVID-19: a suitable teatment? |
| cord-322385-sc2vxxnn | Apprehensions, opportunities, and the path forward Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency SARS- CoV-2 infection serology: a useful tool to overcome lockdown? |
| cord-322385-sc2vxxnn | Covid-19 Pandemic: What's Our Role? |
| cord-322385-sc2vxxnn | Will antibody tests for the coronavirus really change everything? |
| cord-322908-e3gok0ot | A flavonol with multifaceted therapeutic applications? |
| cord-322908-e3gok0ot | invades host cells via a novel route: CD147-spike protein SARS- coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum Coronaviruses: an overview of their replication and pathogenesis SARS- CoV-2 infects T lymphocytes through its spike protein- mediated membrane fusion Cytokine release syndrome Breadth of concomitant immune responses prior to patient recovery: a case report of non- severe COVID-19 Neutrophil extracellular traps( NETs) as markers of disease severity in COVID-19 COVID-19: immunopathology and its implications for therapy COVID-19: risk for cytokine targeting in chronic inflammatory diseases? |
| cord-324102-75v4ebag | Maria del Carmen title: SARS- COV-2 infection during pregnancy, a risk factor for eclampsia or neurological manifestations of COVID-19? |
| cord-321231-zlpa3x2x | : Should we worry? |
| cord-321231-zlpa3x2x | COVID-19 surveillance for all newborns at the NICU; conditio sine qua non? |
| cord-321231-zlpa3x2x | Should infants be separated from mothers with COVID-19? |
| cord-321231-zlpa3x2x | States Are clinical outcomes worse for pregnant women ≥ 20 weeks'gestation infected with COVID-19? |
| cord-323685-gjocoa60 | Trial of a SARS- CoV-2 Recombinant Spike Protein Nanoparticle Vaccine Tracking Changes in SARS- CoV-2 Spike: Evidence that D614 G Increases Infectivity of the COVID-19 Virus Extracellular vesicles carry microRNA-195 to intrahepatic cholangiocarcinoma and improve survival in a rat model Expression of the SARS- CoV-2 cell receptor gene ACE2 in a wide variety of human tissues Thoughts on the alveolar phase of COVID-19 How does SARS- CoV-2 cause COVID-19? |
| cord-322417-9e95m4kz | Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? |
| cord-322417-9e95m4kz | Why are children overwhelmingly spared? |
| cord-322417-9e95m4kz | o f Does the pathogenesis of SARS- CoV-2 virus decrease at highaltitude? |
| cord-320912-jfeu4tho | How could the policymaker design the mitigation policies effectively if the distribution of infection rates is fat- tailed? |
| cord-320912-jfeu4tho | How could the policymakers plan their efforts do given such large uncertainty in R 0? |
| cord-320912-jfeu4tho | Settings Have Been Linked to SARS- CoV-2 Transmission Clusters? |
| cord-320912-jfeu4tho | What methods could address the concerns that the sample mean may be empirically unstable? |
| cord-320912-jfeu4tho | Why could such effects emerge? |
| cord-320912-jfeu4tho | i valid? |
| cord-318204-t024w7h6 | : Is there one? |
| cord-318204-t024w7h6 | A c c e p t e d M a n u s c r i p t 12 Is there a correlation between age and antibody titer? |
| cord-318204-t024w7h6 | Are quantitative serologies helpful? |
| cord-318204-t024w7h6 | Are serologic tests useful to diagnose acute COVID-19? |
| cord-318204-t024w7h6 | Does a positive antibody test mean that a patient is immune? |
| cord-318204-t024w7h6 | Does a positive specimen mean that a patient is infectious? |
| cord-318204-t024w7h6 | Is it worth repeating a test after a patient has tested negative? |
| cord-318204-t024w7h6 | Is point- of- care testing available? |
| cord-318204-t024w7h6 | negative? |
| cord-318204-t024w7h6 | useful? |
| cord-322348-8opy5z9h | An example item is"During last month how do you usually feel nervous and stressed?" |
| cord-322348-8opy5z9h | The scale was modified asking parents to think about the quarantine period related to COVID-19 health emergency, and the following item was added to the scale"How do you feel able to manage the anxiety caused by hearing the news about coronavirus that is given on TV or that you read on the internet?" |
| cord-322348-8opy5z9h | is parents'sexual orientation associated with child health outcomes and parental dimensions? |
| cord-322473-fmob6k0q | Dig Liver Dis Treatment with proton pump inhibitors increases the risk of secondary infections and ARDS in hospitalized patients with COVID-19: coincidence or underestimated risk factor? |
| cord-322473-fmob6k0q | Is it possible to use proton pump inhibitors in COVID-19 treatment and prophylaxis? |
| cord-322473-fmob6k0q | Proton Pump Inhibitors are Risk Factors for Viral Infections: Even for COVID-19? |
| cord-323643-lu3ngt6r | How did general practitioners protect themselves, their family and staff during the SARS epidemic in Hong Kong? |
| cord-324328-olnwynfu | Rule- Out Outbreak: 24-Hour Metagenomic Next- Generation Sequencing for Characterizing Respiratory Virus Source for Infection Prevention Rapid Metagenomic Next- Generation Sequencing during an Investigation of Hospital- Acquired Human Parainfluenza Virus 3 Infections Choosing among generalized linear models applied to medical data AUC- RF: a new strategy for genomic profiling with random forest Overview of LASSO- related penalized regression methods for quantitative trait mapping and genomic selection Multiple imputation using chained equations: Issues and guidance for practice How many imputations are really needed? |
| cord-323489-ro7kbnu3 | COVID-19 destinadas a consejeros de sanidad de comunidades autónomas Presumed Asymptomatic Carrier Transmission of COVID-19 How Should U.S. Hospitals Prepare for Coronavirus Disease 2019( COVID-19)? |
| cord-323489-ro7kbnu3 | and What Should We Do? |
| cord-324288-qgxswltx | An investigation of vitamin D status in alopecia areata Is there A Need to Reasses Reference Levels of Vitamin D for India? |
| cord-321259-wio2b49i | Altogether, further clinical work must clarify if chloroquine and hydroxychloroquine have major effects on COVID-19 and at which( early?) |
| cord-321259-wio2b49i | Associated with the Severe Acute Respiratory Syndrome Coronavirus Replication Complex Rapamycin- induced autophagy restricts porcine epidemic diarrhea virus infectivity in porcine intestinal epithelial cells Autophagy and viruses: adversaries or allies? |
| cord-321259-wio2b49i | Can autophagy induction reduce cellular infection, and does the virus actively inhibit autophagy( suggesting antiviral effects for autophagy)? |
| cord-321259-wio2b49i | Chloroquine is a potent inhibitor of SARS coronavirus infection and spread Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open- label non- randomized clinical trial Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus( 2019-nCoV) in vitro Regulators split on antimalarials for COVID-19 Chloroquine and hydroxychloroquine in covid-19 Should chloroquine and hydroxychloroquine be used to treat COVID-19? |
| cord-321259-wio2b49i | Nevertheless, the diverse putative roles of autophagy during viral infection[ 38] require that two opposite aspects be covered by this overview:( i) Is there evidence for autophagy being used for the survival or replication of CoVs( proviral effects)? |
| cord-319781-6thdg2up | No evidence of SARS- CoV-2 in semen of males recovering from COVID-19 Absence of 2019 novel coronavirus in semen and testes of COVID-19 patients Study of SARS- CoV-2 in semen and urine samples of a volunteer with positive nasopharyngeal swab Clinical characteristics and results of semen tests among men with coronavirus disease 2019 SARS- CoV-2 Presence in seminal fluid: myth or reality COVID-19, or the triumph of monogamy? |
| cord-319781-6thdg2up | The Fundamental Reasons Why laptop Computers should not be used on Your Lap High risk of temporary alteration of semen parameters after recent acute febrile illness Sperm chromatin structure assay is useful for fertility assessment Cytogenetic effects of influenza virus infection on male germ cells of mice Dominant lethality in mice- a test for mutagenicity of influenza X-31 virus 139 Viral epididymitis and orchitis e myth or reality? |
| cord-319781-6thdg2up | The Threat of pandemic influenza: are We Ready? |
| cord-319781-6thdg2up | The X chromosome in immune functions: when a chromosome makes the difference X- chromosome- located microRNAs in immunity: might they explain male/ female differences? |
| cord-319781-6thdg2up | The dual role of the immune response in reproductive organs during Zika virus infection Zika virus causes testicular atrophy Zika virus infection damages the testes in mice Zika virus in semen: a prospective cohort study of symptomatic travellers returning to Belgium Potential effect of Zika virus infection on human male fertility? |
| cord-319781-6thdg2up | what lessons have we learned? |
| cord-324480-7u5lh4jx | Toward understanding the risk of secondary airborne infection: emission of respirable pathogens Droplet fate in indoor environments, or can we prevent the spread of infection? |
| cord-321742-cstub5zz | Bone Marrow Transplant Mesenchymal stem cells are resistant to carbon ion radiotherapy TRAIL- expressing mesenchymal stem cells kill the putative cancer stem cell population Stem cells as vectors for antitumour therapy Mesenchymal stem cells- A new hope for radiotherapy- induced tissue damage? |
| cord-321742-cstub5zz | Radiotherapy and the potential exploitation of bystander effects Systemic effects of local radiotherapy Enhancing the Bystander and Abscopal Effects to Improve Radiotherapy Outcomes Calcium, oxidative stress and connexin channels, a harmonious orchestra directing the response to radiotherapy treatment? |
| cord-321742-cstub5zz | Single and multiple dose MultiStem( multipotent adult progenitor cell) therapy prophylaxis of acute graft- versus- host disease in myeloablative allogeneic hematopoietic cell transplantation: A phase 1 trial Therapy with Multipotent Mesenchymal Stromal Cells Protects Lungs from Radiation- Induced Injury and Reduces the Risk of Lung Metastasis Mesenchymal stromal cells: A novel and effective strategy for facilitating engraftment and accelerating hematopoietic recovery after transplantation? |
| cord-321742-cstub5zz | Towards federated databases and anonymised public datasets Mesenchymal stem cells: Environmentally responsive therapeutics for regenerative medicine Preactivation of human MSCs with TNF- alpha enhances tumor- suppressive activity Unbiased analysis of senescence associated secretory phenotype( SASP) to identify common components following different genotoxic stresses Mesenchymal stromal cells( MSCs) and colorectal cancer: A troublesome twosome for the anti- tumour immune response? |
| cord-323241-1twnqr4k | A new possible route of infection? |
| cord-323241-1twnqr4k | Therefore, if saliva and feces are both capable of carrying the virus and ACE2 is expressed both in the glandular cells of rectal epithelia and oral mucosa, how can we be sure that sexual intercourse does not represent another way of contagion? |
| cord-323241-1twnqr4k | Transmission routes of 2019-nCoV and controls in dental practice COVID-19: faecal- oral transmission? |
| cord-324651-8teb5jrn | Could the Inhibition of Endo- Lysosomal Two- Pore Channels( TPCs) by the Natural Flavonoid Naringenin Represent an Option to Fight SARS- CoV-2 Infection? |
| cord-323596-dh7oh54z | ? |
| cord-323596-dh7oh54z | Published Conserving supply of personal protective equipment- a call for ideas Challenges and solutions for addressing critical shortage of supply chain for personal and protective equipment( PPE) arising from Coronavirus disease( COVID19) pandemic- case study from the Republic of Ireland Interim infection prevention and control recommendations for patients with suspected or confirmed coronavirus disease 2019( COVID-19) in healthcare settings Duke Infection Control Outreach Network website Policies and practices of SHEA research network hospitals during the COVID-19 pandemic A survey of COVID-19 preparedness among hospitals in Idaho Universal masking in hospitals in the COVID-19 era: is it time to consider shielding? |
| cord-323940-ubazgvov | The trinity of COVID-19: immunity, inflammation and intervention The pathogenesis and treatment of the` Cytokine Storm'in COVID-19 The eye as the discrete but defensible portal of coronavirus infection Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-323940-ubazgvov | what to expect for COVID-19? |
| cord-324557-4u8dja0n | Electron microscopy of SARS- CoV-2: a challenging task Detection of viral SARS- CoV-2 genomes and histopathological changes in endomyocardial biopsies Isolation, Sequence, infectivity, and replication kinetics of severe acute respiratory syndrome coronavirus 2 Is SARS- CoV-2 transfusion transmitted? |
| cord-323468-xn7anxj6 | -United States Do chronic respiratory diseases or their treatment affect the risk of SARS- CoV-2 infection? |
| cord-323468-xn7anxj6 | Active smoking is not associated with severity of coronavirus disease 2019( COVID-19 A Novel Coronavirus from Patients with Pneumonia in China Evaluation and Treatment Coronavirus( COVID-19) WHO Declares COVID-19 a Pandemic Potential interventions for novel coronavirus in China: A systematic review COVID-19 and the cardiovascular system Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-323468-xn7anxj6 | Viral, bacterial or both? |
| cord-322456-5at1euqm | Can the Coronavirus disease 2019( COVID-19) affect the eyes? |
| cord-322456-5at1euqm | JiaZF(2020)2019-nCoVtransmission through the ocular surface must not be ignored The Covid-19 pandemic and otolaryngology: what it comes down to? |
| cord-322456-5at1euqm | Li Wenliang Isnovelcoronavirusdisease( COVID-19) transmitted through conjunctiva? |
| cord-324295-9c1zxjng | The next big threat to global health? |
| cord-324295-9c1zxjng | What is the potential impact of the Amazon wildfires on vector- borne and zoonotic emerging diseases? |
| cord-323695-jkik03lb | Last accessed on Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG- IBD study Should we stimulate or suppress immune responses in COVID-19? |
| cord-323695-jkik03lb | The epidemiology and pathogenesis of coronavirus disease( COVID-19) outbreak Should biologics for psoriasis be interrupted in the era of COVID-19? |
| cord-323882-127c5bve | But our observations leave one important question: why are ancestral haplotypes, like H13 and H38, less frequent than H1? |
| cord-323882-127c5bve | Did pangolins spread the China coronavirus to people? |
| cord-323980-rcyjthze | -Gesundheit: Statistisches Bundesamt( DeStatis) Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany- a nationwide population- based study in children and adults Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies Definition of refractory epilepsy: defining the indefinable? |
| cord-323980-rcyjthze | Lancet Neurol Revised version of quality guidelines for presurgical epilepsy evaluation and surgical epilepsy therapy issued by the Austrian, German, and Swiss working group on presurgical epilepsy diagnosis and operative epilepsy treatment Association of levels of specialized care with risk of premature mortality in patients with epilepsy Incidence and case fatality rate of COVID-19 in patients with active epilepsy Global telemedicine implementation and integration within health systems to fight the COVID-19 pandemic: a call to action Virtually perfect? |
| cord-323832-w19ump0o | : Have You Tried the Sewage? |
| cord-323832-w19ump0o | Bacterial viruses against viruses pathogenic for man? |
| cord-325293-nwxtyrpl | : should we worry? |
| cord-321568-okvt1fg3 | Could an endo- lysosomal ion channel be the Achilles heel of SARS- CoV2? |
| cord-321568-okvt1fg3 | The fate of naringin in humans: a key to grapefruit juice- drug interactions? |
| cord-321568-okvt1fg3 | What is COVID-19? |
| cord-321568-okvt1fg3 | medRxiv Protective effects of naringenin in a rat model of sepsis- triggered acute kidney injury via activation of antioxidant enzymes and reduction in urinary angiotensinogen Does consumption of red grapefruit juice alter naringenin concentrations in milk produced by breastfeeding mothers? |
| cord-324324-8ybfiz8f | Could have the current COVID-19 outbreak been avoided? |
| cord-324324-8ybfiz8f | What should we expect from the current pandemic? |
| cord-325420-e9fjo7tl | Could chloroquine/hydroxychloroquine be 318 harmful in Coronavirus Disease 2019( COVID-19) treatment? |
| cord-322051-89wgv100 | - what is known? |
| cord-322051-89wgv100 | A new syndrome? |
| cord-322051-89wgv100 | Does COVID19 infect the brain? |
| cord-322051-89wgv100 | Would a rose by another name smell as sweet? |
| cord-323618-d09b65gd | S'agit- il seulement d'une excrétion digestive ou de la détection d'un agent responsable des symptômes entériques? |
| cord-323618-d09b65gd | The Coronavirus Hemagglutinin- esterase Glycoprotein Expression of hemagglutinin esterase protein from recombinant mouse hepatitis virus enhances neurovirulence Structure and expression of the bovine coronavirus hemagglutinin protein Luxury at a cost? |
| cord-323618-d09b65gd | localisé dans différentes régions de la protéine selon l'espèce de coronavirus, le clivage de S en ses deux sous- unités S1 et S2 est variable selon le coronavirus et le type cellulaire, le rôle de la liaison aux acides sialiques n'est pas déterminé( corécepteur?) |
| cord-325863-3t73v4ng | Why tocilizumab could be an effective treatment for severe COVID-19? |
| cord-324166-6ydn2bvy | A synergistic combination for COVID-19 chemoprophylaxis and treatment? |
| cord-324166-6ydn2bvy | Individualized networkbased drug repositioning infrastructure for precision oncology in the panomics era Drug repurposing: New treatments for zika virus infection? |
| cord-322980-rembksdr | Articles on homeopathy Homeopathy in Influenza- a chorus of fifty in harmony Homeopathic approach to COVID-19: a review Research review of genus Epidemicus Genus Epidemicus: are notions of entanglement relevant to the homeopathic understanding of epidemic disease? |
| cord-322980-rembksdr | COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-322980-rembksdr | Systematic review of treatment effects Clinical outcomes of current medical approaches for Middle East respiratory syndrome: a systematic review and metaanalysis Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-322980-rembksdr | meta- analysis, and meta- regression: diabetes and COVID-19 Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: a systematic review, meta- analysis and meta- regression Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-19 Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19-systematic review, meta- analysis, and meta- regression Potential role of telemedicine in solving ST- segment elevation dilemmas in remote areas during the COVID-19 pandemic Lymphopenia in severe coronavirus disease-2019( COVID-19): systematic review and meta- analysis Dexamethasone for COVID-19? |
| cord-325038-q7gxw1go | As an example, to determine changes in in- person clinical volume, respondents were asked the following question:"Since the pandemic has begun, what percentage of patients are you now seeing IN PERSON compared to your typical practice? |
| cord-325038-q7gxw1go | The behavior of maximum likelihood estimates under nonstandard conditions need- extra- precautions/ people- at- higher- risk.html? |
| cord-325261-bdumhy5b | The papain- like protease of avian infectious bronchitis virus has deubiquitinating activity Deubiquitination, a New Function of the Severe Acute Respiratory Syndrome Coronavirus Papain- Like Protease? |
| cord-325261-bdumhy5b | Thiopurine Analogue Inhibitors of Severe Acute Respiratory Syndrome- Coronavirus Papain- Like Protease, a Deubiquitinating and deISGylating Enzyme Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection? |
| cord-323092-j2u0ny2u | New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-323092-j2u0ny2u | Pre- publication date Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade- long structural studies of SARS Are Patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-323092-j2u0ny2u | You Saw on Facebook? |
| cord-325657-s2vdazq0 | ( Diptera: Muscidae) to transmit Rift Valley fever virus Nonviremic transmission of West Nile virus Nonviremic transmission of West Nile virus: evaluation of the effects of space, time, and mosquito species Is nonviremic transmission of West Nile virus by Culex mosquitoes( Diptera: Culicidae) nonviremic? |
| cord-316232-7w1vrx96 | : what are the mental health implications? |
| cord-316232-7w1vrx96 | Anesth Analg The COVID-19 pandemic in the USA: what might we expect? |
| cord-316232-7w1vrx96 | How high is the risk of infection for other household members if one person is infected and can household risk factors be identified? |
| cord-316232-7w1vrx96 | How high is the risk of infection for other inhabitants of the same apartment building if one person is infected? |
| cord-316232-7w1vrx96 | How long are SARS- CoV-2 specific antibodies detectable after infections of varying severity? |
| cord-316232-7w1vrx96 | How many of the initially seropositive individuals in the baseline- study were previously tested by pharyngeal swab and nucleic acid amplification( PCR)( positively or negatively) and/or had symptoms suggestive for COVID-19( yes or no)? |
| cord-316232-7w1vrx96 | Is there a change in antibody titers of those who initially tested positive, which is potentially necessary to discriminate from cross- reactivity with other corona viruses?. |
| cord-316232-7w1vrx96 | What are the risk factors for SARS- CoV-2 infections? |
| cord-316232-7w1vrx96 | What is the SARS- CoV-2 antibody prevalence in the Munich general population? |
| cord-316232-7w1vrx96 | What is the distribution of symptom severity in each of the groups described above? |
| cord-316232-7w1vrx96 | What is the impact of individual behaviour on the incidence of infection? |
| cord-316232-7w1vrx96 | What is the socio- economic impact of the pandemic and the measures to combat it, especially on the employment situation and psychosocial endpoints? |
| cord-316232-7w1vrx96 | Which risk factors are associated with SARS- CoV-2 incidence? |
| cord-316232-7w1vrx96 | • How does the spread of the disease develop and what influence do public health measures have on the incidence? |
| cord-325213-e6i6buow | Can posttraumatic stress disorder be prevented with glucocorticoids? |
| cord-325213-e6i6buow | Was SARS a mental health catastrophe? |
| cord-325172-a8ntxnmm | -how worried should we be? |
| cord-325172-a8ntxnmm | a mechanism for the unusual severity of human disease? |
| cord-314051-dr27bsvt | Can providers safely discontinue infection prevention and control measures? |
| cord-314051-dr27bsvt | Comment faut- il conseiller les patients concernant les résultats de leur test? |
| cord-314051-dr27bsvt | Comment les systèmes de santé gèreront- ils ces résultats? |
| cord-314051-dr27bsvt | How should patients be counselled about their test results? |
| cord-314051-dr27bsvt | How will health systems deal with these results? |
| cord-314051-dr27bsvt | Le personnel médical peut- il en toute sécurité ne prendre aucune mesure de prévention et de contrôle des infections? |
| cord-314051-dr27bsvt | Preoperative SARS- CoV-2 screening: Can it really rule out COVID-19? |
| cord-314051-dr27bsvt | Quel est leur risque de COVID-19 postopératoire? |
| cord-314051-dr27bsvt | Should these patients proceed to surgery? |
| cord-314051-dr27bsvt | What is their risk of postoperative COVID-19? |
| cord-314051-dr27bsvt | devraient- ils subir leur chirurgie? |
| cord-314051-dr27bsvt | la présence de COVID-19? |
| cord-323822-jtbfpx88 | Do ocular secretions contain live virus? |
| cord-323822-jtbfpx88 | Does ocular inoculation of virus result in systemic infection? |
| cord-323822-jtbfpx88 | Incidence and risk factors of MERS- CoV seropositivity Seroprevalence of Middle East respiratory syndrome coronavirus( MERS- CoV) in public health workers responding to a MERS outbreak in Seoul, Republic of Korea Which preventive measures might protect health care workers from SARS? |
| cord-323822-jtbfpx88 | What precautions or treatments should be introduced to mitigate questions 1 or 2? |
| cord-321800-0h28pg3b | : Have we investigated enough about coronaviruses? |
| cord-321800-0h28pg3b | A potential tool for studying journals? |
| cord-321800-0h28pg3b | But the question arises whether this is a short- term effect which, once CoVID-19 is contained, will lead to an equally sharp decline in publication numbers as was observed with the earlier CoV pandemics SARS and MERS? |
| cord-321800-0h28pg3b | But what about the sense of all these undertakings and what can be learned about the future for a better understanding? |
| cord-321800-0h28pg3b | Can we learn from previous research patterns regarding CoV? |
| cord-321800-0h28pg3b | How can we use past efforts, their intensification and the influences of research on CoV positively to better understand the needs for sustainable and appropriate research? |
| cord-321800-0h28pg3b | What influence do they have on future research? |
| cord-325134-z9n17z72 | : what have we learned two years later? |
| cord-325134-z9n17z72 | SARS plague: duty of care or medical heroism? |
| cord-326706-75mjs6vm | What is already known on this topic? |
| cord-321598-ae241pmd | How should potential recipients be managed, both pre- and post- transplantation? |
| cord-321598-ae241pmd | Is it safe to perform transplants from live donors? |
| cord-321598-ae241pmd | Main questions that need to be addressed include the following: Under which circumstances can organ donation from deceased donors take place? |
| cord-321598-ae241pmd | What are additional risks for transplant recipients in terms of immunosuppression and COVID-19? |
| cord-321598-ae241pmd | What are logistic implications and, most importantly, what is the impact of the outbreak on donation and transplant volumes and waitlist outcomes? |
| cord-321598-ae241pmd | Which treatments should be considered for transplant recipients with COVID-19? |
| cord-326150-cf4rlqe5 | First report from the Middle East Are chilblain- like acral skin lesions really indicative of COVID-19? |
| cord-326150-cf4rlqe5 | Patients Observed in the Metropolitan Area of Histological pattern in Covid-19 induced viral rash Cutaneous lesions in a patient with COVID-19: are they related? |
| cord-326929-ytix4l1o | JorgeSolizab Does the pathogenesis of SARS- CoV-2 virus decrease at high- altitude? |
| cord-326320-flfrdrbi | A potential antiviral drug for the treatment of SARS- CoV-2 by blocking the trimerization of viral spike glycoprotein? |
| cord-325936-rwxg187r | 2020; www.theco vidch allen ge.org Coronavirus: would you volunteer to be exposed? |
| cord-325936-rwxg187r | Why are n't people living with HIV at higher risk for developing severe coronavirus disease 2019( COVID-19)? |
| cord-327169-sz4ildnd | Practice Statement from an International Expert Panel Bronchoscopy to assess patients with hemoptysis: which is the optimal timing? |
| cord-326721-2v5wkjrq | national health commission of the peoples republic of china Destinations of the five million passengers from wuhan? |
| cord-320646-xk77u4g0 | : lessons learned? |
| cord-320646-xk77u4g0 | COVID-19: what is next for public health? |
| cord-320646-xk77u4g0 | However, several questions remain to be answered for optimal infection control measures and management of COVID-19 patients in hospitals: How to limit spread to HCWs especially in light of reports of asymptomatic and minimally symptomatic HCWs with SARS- CoV-2 infection? |
| cord-320646-xk77u4g0 | The COVID-19 epidemic may follow the path of SARS and die out within the next 12 months or will it pan out to be like seasonal influenza or other respiratory tract viral illnesses, manifesting as self- limiting disease and severe disease among older people or those with comorbidities? |
| cord-320646-xk77u4g0 | What are the risks of noninvasive ventilation in COVID-19 patients to HCWs, and when should we intubate and how can we minimize risks to those who do the intubation? |
| cord-320646-xk77u4g0 | What is the impact of quarantine after exposure and does this reduces the spread of SARS- CoV-2, or does this add to the risk for those who are quarantined? |
| cord-320646-xk77u4g0 | What is the role for steroids and of combination antiviral agents for severe lung disease and will they be helpful or harmful? |
| cord-325449-fl6ob5ja | Can We Do More on Glycemic Control? |
| cord-325449-fl6ob5ja | in vitro inhibition of SARS- CoV-2 replication by mefloquine- artesunate Clinical Characteristics of Coronavirus Disease 2019 in China Clinical features of patients infected with 2019 novel coronavirus in Wuhan COVID-19 and diabetes: knowledge in progress COVID-19 and diabetes: Can DPP4 inhibition play a role? |
| cord-326833-boxgt4kb | National AIDS Control Organization| MoHFW| GoI Could HIV infection alter the clinical course of SARS- CoV-2 infection? |
| cord-321797-2xhusfth | Do their ways of managing their fear of SARS affect their ability to engage in adaptive health behaviors? |
| cord-321797-2xhusfth | Instructions to respondents for the coping items were'To what extent have you managed whatever concerns or fears you might have about SARS in each of the ways listed below?' |
| cord-321797-2xhusfth | Instructions to respondents for the health behavior items were'To avoid getting SARS, I have personally …'and specifically for the Avoiding people subscale,'How likely are you to avoid the following people?' |
| cord-321797-2xhusfth | That is, how has the general public reacted psychologically, socially and behaviorally to news of the disease? |
| cord-321797-2xhusfth | The application and implications of information technologies in the home: Where are the data and what do they say? |
| cord-321797-2xhusfth | To what extent does the general public feel threatened by the possibility of the disease spreading, and how do they cope with these fears? |
| cord-326730-aprb819p | The Role of Antibody Testing for SARS- CoV-2: Is There One? |
| cord-327005-7zgolyqf | A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person- to- person transmission: a study of a family cluster Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection COVID-19 faecal- oral transmission: are we asking the right questions? |
| cord-324246-liyk6mna | Can vitamin B12 be an adjuvant to COVID-19 treatment? |
| cord-324246-liyk6mna | Can we use interleukin-6( IL-6) blockade for coronavirus disease 2019( COVID-19)-induced cytokine release syndrome( CRS)? |
| cord-324246-liyk6mna | The role of folic acid in the management of respiratory disease caused by COVID-19 In silico virtual screening- based study of nutraceuticals predicts the therapeutic potentials of folic acid and its derivatives against COVID-19 Is there a Link between Vitamin B and Multiple Sclerosis? |
| cord-324246-liyk6mna | Tocilizumab may be the key to reduce the mortality Middle East respiratory syndrome Coronavirus envelope protein: current knowledge Immune boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: could they help against COVID-19? |
| cord-325595-y9ae6zbr | Are anti- androgens a potential treatment for COVID-19? |
| cord-325595-y9ae6zbr | The Y chromosome: a blueprint for men's health? |
| cord-325614-e9hnhzfg | Is prevention of adverse health effects on the horizon? |
| cord-325614-e9hnhzfg | The coronavirus is mutating- does it matter? |
| cord-327247-dbcacphq | : what do we know and understand Clinical features and short- term outcomes of 144 patients with SARS in the greater Toronto area Identification and containment of an outbreak of SARS in a community hospital Surveying physicians: do components of the"total design approach"to optimizing survey response rates apply to physicians? |
| cord-326864-i1r3bv4p | The COVID-19 vaccine development landscape Can Chinese medicine be used for prevention of corona virus disease 2019( COVID-19)? |
| cord-327349-rxb6zfoc | Is checkpoint blockade a friend or foe in the context of COVID-19? |
| cord-327214-kcbxyhhh | Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages Immunosuppression for hyperinflammation in COVID-19: a double- edged sword? |
| cord-324752-t50bg7pq | : what should dermatologists know? |
| cord-324752-t50bg7pq | Different or shared etiology and pathophysiology as Kawasaki Disease? |
| cord-324752-t50bg7pq | Varicella- like exanthem associated with COVID-19 in an 8-year- old girl: A diagnostic clue? |
| cord-324752-t50bg7pq | Why children fare better than adults? |
| cord-327240-nohxk3y6 | Ribavirin in the treatment of SARS: a new trick for an old drug? |
| cord-324919-ciamusjs | ( H1N1) 2009 virus determined by carbohydrate microarray Expression of intercellular adhesion molecule-1( ICAM-1) in nasal epithelial cells of atopic subjects: a mechanism for increased rhinovirus infection? |
| cord-324919-ciamusjs | Interferons and viruses induce a novel truncated ACE2 isoform and not the full- length SARS- CoV-2 receptor Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination? |
| cord-324919-ciamusjs | acute respiratory distress syndrome Inhibition of SARS- CoV-2 infections in engineered human tissues using clinical- grade soluble human ACE2 Decoy ACE2-expressing extracellular vesicles that competitively bind SARS- CoV-2 as a possible COVID-19 therapy Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China Apelin- potential therapy for COVID-19? |
| cord-324919-ciamusjs | severe sepsis Attenuation of pulmonary ACE2 activity impairs inactivation of des- Arg 9 bradykinin/ BKB1R axis and facilitates LPSinduced neutrophil infiltration Kallikrein- kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome Understanding the renin- angiotensin- aldosterone- SARS- CoV axis: a comprehensive review Angiotensin- converting enzyme-2: a molecular and cellular perspective Snake venom- derived bradykinin- potentiating peptides: a promising therapy for COVID-19? |
| cord-325966-0g7a9s5z | A narrative review COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-325966-0g7a9s5z | Can we use interleukin-6( IL-6) blockade for coronavirus disease 2019( COVID-19)-induced cytokine release syndrome( CRS)? |
| cord-327575-5pcnuqgy | A randomized trial of hydroxychloroquine as postexposure prophylaxis for COVID-19 Prevalence of hydroxychloroquine- induced side- effects in dermatology patients: a retrospective survey of 102 patients Ranking self- reported gastrointestinal side effects of pharmacotherapy in sarcoidosis Increased incidence of gastrointestinal side effects in patients taking hydroxychloroquine: a brand- related issue? |
| cord-325991-dktffiaa | Can COVID-19 cause nephritis, and how might nephritis predict complications? |
| cord-325991-dktffiaa | authors: Gross, Oliver; Moerer, Onnen; Weber, Manfred; Huber, Tobias B; Scheithauer, Simone title: COVID-19-associated nephritis: early warning for disease severity and complications? |
| cord-325991-dktffiaa | dktffiaa nan COVID-19-associated nephritis: early warning for disease severity and complications? |
| cord-327028-dbvucvy3 | COVID-19) situation report-39 Time to use the p- word? |
| cord-327028-dbvucvy3 | In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-325971-volbaipv | The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta- analysis A report of clinical diagnosis and treatment of nine cases of coronavirus disease 2019 High- dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with Coronavirus Disease Angiotensin receptor blockers as tentative SARS- CoV-2 therapeutics Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-327454-o1mrpgvj | COVID-19 and the cardiovascular system Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-327520-qj7coqfr | Antiretroviral Restriction Factors in Pteropid Bats as Revealed by APOBEC3 Gene Are pangolins the intermediate host of the 608 2019 novel coronavirus( SARS- CoV-2)? |
| cord-324619-y7gilopu | Covid-19 in patients presenting with influenza- like symptoms Self- reported olfactory and taste disorders in SARS- CoV-2 patients: a cross- sectional study Olfactory and gustatory dysfunctions as a clinical presentation of mild- to- moderate forms of the coronavirus disease( COVID-19): a multicenter European study Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? |
| cord-324619-y7gilopu | Smooth or Risky Revisit of an Old Malaria Drug for COVID-19? |
| cord-324619-y7gilopu | The gut as a neurological organ Can the enteric nervous system be an alternative entrance door in SARS- CoV2 neuroinvasion? |
| cord-324619-y7gilopu | a strategy for viral dissemination Enterovirus infections of the central nervous system Flaviviruses are neurotropic, but how do they invade the CNS? |
| cord-324619-y7gilopu | long- term neurologic effects of COVID-19? |
| cord-326882-bbn1tfq5 | : What Is the Evidence? |
| cord-326882-bbn1tfq5 | Jama Soluble angiotensin- converting enzyme 2: a potential approach for coronavirus infection therapy? |
| cord-327661-osx42wdh | To obtain information on COVID-19 data for the states in the US and world- wide data, we accessed the CDC website on September 1, 2020, https://www.cdc.gov/covid-data-tracker/index.html#testing, as well as the website https://www.worldometers.info/coronavirus/? |
| cord-323216-rgj8vs9z | Can vaccines give long- lasting or only temporary immunity? |
| cord-323216-rgj8vs9z | There are many important issues that must be answered in these trials, including: Can vaccination prevent infection as well as disease? |
| cord-323216-rgj8vs9z | What are the immunologic correlates of protection? |
| cord-323216-rgj8vs9z | Will evolution of the SARS- CoV-2 virus require changes in vaccine antigens? |
| cord-323216-rgj8vs9z | Will neutralizing antibodies suffice, or are T- cell responses necessary? |
| cord-323216-rgj8vs9z | Will vaccines generate enhancing as well as protective immune responses? |
| cord-327601-4uqgwlnx | authors: Bangash, Mansoor N.; Patel, Jaimin M.; Parekh, Dhruv; Murphy, Nicholas; Brown, Rachel M.; Elsharkawy, Ahmed M.; Mehta, Gautam; Armstrong, Matthew J.; Neil, Desley title: SARS- CoV-2: is the liver merely a bystander to severe disease? |
| cord-327920-51s4figy | False negative tests for SARS- CoV-2 infection- challenges and implications Waiting for certainty on COVID-19 antibody tests- at what cost? |
| cord-322451-cwpz4akv | As those scary stories are repeated numerous times among HCWs, can medical ethics overcome their emotions? |
| cord-322451-cwpz4akv | Can someone who makes an involuntary sacrifice be called as a hero? |
| cord-322451-cwpz4akv | Could we expect nurses who were called when they are needed and paid by working hour to devote themselves to the full professional code and make all efforts when their life is threatened? |
| cord-322451-cwpz4akv | Does the accepted norm of responsibility mean they must put their own lives at risk? |
| cord-322451-cwpz4akv | However, could we regard the HCW as a soldier in an army, as quoted in a China Daily report? |
| cord-322451-cwpz4akv | What have we experienced and learned from the outbreak of SARS in Beijing? |
| cord-322451-cwpz4akv | Will the public accept a health professional to exercise their right to remain off the job in this critical moment? |
| cord-325324-kh2aal5n | -Authors'reply Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-325324-kh2aal5n | After Myocardial Infarction Angiotensin-(1- 9) prevents cardiomyocyte hypertrophy by controlling mitochondrial dynamics via miR-129- 3p/ PKIA pathway Antihypertensive drugs and risk of COVID-19? |
| cord-325324-kh2aal5n | The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel? |
| cord-325324-kh2aal5n | an updated meta- analysis involving 11,051 subjects Updated understanding of the outbreak of 2019 novel coronavirus( 2019-nCoV) in Wuhan Covid-19: death rate is 0.66% and increases with age, study estimates Estimates of the severity of coronavirus disease 2019: a model- based analysis Protecting older people from COVID-19: should the United Kingdom start at age 60? |
| cord-327622-ezgufe24 | Cases, data and surveillance Exhaled air dispersion and removal is influenced by isolation room size and ventilation settings during oxygen delivery via nasal cannula Airflow and droplet spreading around oxygen masks: a simulation model for infection control research Airflows around oxygen masks: a potential source of infection? |
| cord-327622-ezgufe24 | anesthetic concerns, including airway management and infection control High- flow nasal cannula therapy as apneic oxygenation during endotracheal intubation in critically ill patients in the intensive care unit: a systematic review and metaanalysis Mask ventilation and dispersion of exhaled air Effect of ventilator circuit changes on ventilator- associated pneumonia: a systematic review and meta- analysis Trends in tracheostomy for mechanically ventilated patients in the United States Tracheotomy in ventilated patients with COVID-19 CORONA- steps for tracheotomy in COVID-19 patients: a staff- safe method for airway management Negativepressure aerosol cover for COVID-19 tracheostomy Does endotracheal tube clamping prevent air leaks and maintain positive endexpiratory pressure during the switching of a ventilator in a patient in an intensive care unit? |
| cord-327681-c2kmog0g | Epidemiological models with non- exponentially distributed disease stages and applications to disease control Factors that make infectious disease outbreaks controllable Faster y, but fast enough? |
| cord-326169-delehk6x | Baricitinib as potential treatment for 2019-nCoV acute 576 respiratory disease COVID-19: combining antiviral and anti- inflammatory 578 treatments Host- Directed Antiviral Therapy Closing the gap: increases in life expectancy among treated 581 HIV- positive individuals in the United States and Canada Hepatitis C treatment: where are we now? |
| cord-326169-delehk6x | HiJAKing SARS- CoV-2? |
| cord-326169-delehk6x | Rhabdomyolysis as Potential Late Complication Associated with COVID-19 New players in the field of immune-587 mediated diseases, beyond rheumatoid arthritis Feasibility and biological rationale of repurposing sunitinib and 589 erlotinib for dengue treatment Baricitinib for COVID-19: a suitable treatment? |
| cord-326169-delehk6x | Should we stimulate or suppress immune responses in 568 COVID-19? |
| cord-328242-afof417h | Bats, coronaviruses, and deforestation: toward the emergence of novel infectious diseases? |
| cord-319580-awtp0mpg | Are certain therapies more effective for treatment of severe COVID-19 in obese pregnant women compared to lean or non- pregnant women? |
| cord-319580-awtp0mpg | Are the kinetics of viral clearance different in obese versus lean pregnant women? |
| cord-319580-awtp0mpg | Are viral loads higher of SARS- CoV-2 in obese versus lean pregnant women? |
| cord-319580-awtp0mpg | Can adipose tissue serve as a reservoir for SARS- CoV-2 viral infection through adipocyte ACE2 expression? |
| cord-319580-awtp0mpg | Can we design epidemiologic studies to further assess whether the risk of severe COVID-19 infection in obese pregnancy is directly related to obesity itself or to associated socioeconomic factors? |
| cord-319580-awtp0mpg | Does increased surveillance for COVID-19 in obese pregnant women improve health outcomes? |
| cord-319580-awtp0mpg | Does the second and third trimester of pregnancy represent a time of increased risk for severe COVID-19? |
| cord-319580-awtp0mpg | If yes, how does gestational age modify the effect of obesity on COVID-19 disease severity? |
| cord-319580-awtp0mpg | Is preterm birth more common in obese pregnant women with COVID-19 due to concern for respiratory compromise? |
| cord-319580-awtp0mpg | The role of adipose tissue immune cells in obesity and low- grade inflammation Adipocytes properties and crosstalk with immune system in obesity- related inflammation Inflamed fat: what starts the fire? |
| cord-319580-awtp0mpg | What is the mechanism of increased risk for severe COVID-19 disease in obese nonpregnant and pregnant women? |
| cord-328069-a9fi9ssg | Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population Emergence of Novel Coronavirus and COVID-19: whether to stay or die out? |
| cord-326956-oz047qmf | A first step in understanding SARS pathogenesis Detection of Severe Acute Respiratory Syndrome Coronavirus in the Brain: Potential Role of the Chemokine Mig in Pathogenesis Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease Updates on What ACS Reported: Emerging Evidences of COVID-19 with Nervous System Involvement Cerebral Venous Thrombosis associated with COVID-19 infection: causality or coincidence? |
| cord-326956-oz047qmf | Does SARS- CoV-2 infection cause chronic neurological complications? |
| cord-326883-j7pbe50g | : why should we learn? |
| cord-326883-j7pbe50g | COVID-19) Cardiovascular manifestations and treatment considerations in covid-19 COVID-19-related myocarditis in a 21-year- old female patient Myocarditis revealing COVID-19 infection in a young patient COVID-19 in the heart and the lungs: could we"Notch"the inflammatory storm? |
| cord-326883-j7pbe50g | can novel echocardiographic techniques assist with diagnosis? |
| cord-328000-i9tzr13z | Am I ready for CRISPR? |
| cord-328113-eczjjc2v | ( COVID-19)-Induced Cytokine Release Syndrome( CRS)? |
| cord-327084-r12copka | The mental health of hospital workers dealing with severe acute respiratory syndrome Healthcare workers'duty concerns of working in the isolation ward during the novel H1N1 pandemic Shift work and sleep: medical implications and management Coping responses of emergency physicians and nurses to the 2003 severe acute respiratory syndrome outbreak Risk perception and impact of Severe Acute Respiratory Syndrome( SARS) on work and personal lives of healthcare workers in Singapore: what can we learn? |
| cord-327084-r12copka | can it be carried out over the telephone? |
| cord-327894-b0bsseui | COVID-19) Advice on the use of point- of- care immunodiagnostic tests for COVID-19 An Outbreak of Human Coronavirus OC43 Infection and Serological Cross- Reactivity with SARS Coronavirus Assa'ad A. Clinical Testing For Covid-19 Antibody responses to SARS- CoV-2 in patients of novel coronavirus disease Rapid antigen- based testing for respiratory syncytial virus: moving diagnostics from bench to bedside? |
| cord-327890-ocisq7e4 | : what decides the outcome? |
| cord-328644-odtue60a | The latter originated RGTFPDL on one side, and the ancestor of Radiation 2( RGTLLGL) that originated both KRTLLGL( through KG unfit strains?) and later RGILLGL. |
| cord-328712-7q9mg2tu | what to expect for COVID-19? |
| cord-328683-zvabpty9 | An Effective Intervention at the Global Level? |
| cord-327799-ngzvdd8c | Gates Open Research Neglected Tropical Diseases as a'litmus test'for Universal Health Coverage? |
| cord-327799-ngzvdd8c | The SARS- CoV-2 crisis and its impact on neglected tropical diseases: Threat or opportunity? |
| cord-324856-hf969tav | : What Lessons Have We Learned? Covid-19-Knowledge |
| cord-324856-hf969tav | Are you currently or have you been in( domestic/ home) quarantine because of COVID-19? |
| cord-324856-hf969tav | How do you feel about the quarantine? |
| cord-324856-hf969tav | How much worried are you because of COVID-19? |
| cord-324856-hf969tav | Please rate your chances of personal risk of infection with COVID-19 for each of the following? |
| cord-328853-0iqdqcp6 | COVID-19: a case for inhibiting IL-17? |
| cord-328557-f6o1aynz | COVID-19: What is next for public health? |
| cord-328395-2cakgmsj | What Is An Inflammation? |
| cord-327095-y2zsm8sc | After less than 2 months, the simulations that drove the world to strict lockdown appear to be wrong, the same of the policies they generated COVID-19 fatality rate for Saudi Arabia? |
| cord-327095-y2zsm8sc | COVID-19? T-705( favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro Favipiravir, an anti- influenza drug against life- threatening RNA virus infections T-705( favipiravir) and related compounds: novel broad- spectrum inhibitors of RNA viral infections Orally efficacious broad- spectrum ribonucleoside analog inhibitor of influenza and respiratory syncytial viruses Barnard DL. |
| cord-327095-y2zsm8sc | Engineering A review of the safety of favipiravir- a potential treatment in the COVID-19 pandemic? |
| cord-326888-0p8nctpy | Chlorhexidine Prevent Alveolar Osteitis After Third Molar Extractions? |
| cord-326888-0p8nctpy | Insights into Environmental Resistance and Its Influence on the Development of New Antiseptic Strategies Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents Is 0.5% Hydrogen Peroxide Effective against SARS- CoV-2? |
| cord-326888-0p8nctpy | title: What is the best mouthrinse against Coronaviruses? |
| cord-328471-oz99upzz | The pharmacology of ornipressin( POR-8): a local vasoconstrictor used in surgery Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis: effects on renal hemodynamics and atrial natriuretic factor Management of preterm labor: atosiban or nifedipine? |
| cord-328003-yovp8squ | What Are the Most Powerful Immunogen Design Vaccine Strategies? |
| cord-328003-yovp8squ | What Are the Most Powerful Immunogen Design Vaccine Strategies? |
| cord-328287-3qgzulgj | Tb and diabetes mellitus, hiv and metabolic syndrome, and the impact of globalization Cancer risk in people infected with human immunodeficiency virus in the united states Hepatocellular cancer in hiv- infected individuals: tomorrow's problem? |
| cord-328064-7owd28rr | An introduction to PCR inhibitors Patient- collected tongue, nasal, and midturbinate swabs for SARS- CoV-2 yield equivalent sensitivity to health care worker collected nasopharyngeal swabs Saliva is a reliable tool to detect SARS- CoV-2 Nasal swab sampling for SARS- CoV-2: a convenient alternative in time of nasopharyngeal swab shortage 3D- printing techniques in a medical setting: a systematic literature review Prize- based contests can provide solutions to computational biology problems Use of crowd innovation to develop an artificial intelligence- Bbsed solution for radiation therapy targeting The effect of organizational structure on open innovation: a quadratic equation BD Gram stain kits and reagents Preparation of viral transport medium Development of Four New 3D- Printed Swabs Changing swabs: to validate or not to validate? |
| cord-328064-7owd28rr | The latest obstacle to getting tested? |
| cord-329710-vqorb6j7 | Why are lopinavir and ritonavir effective against the newly emerged coronavirus 2019? |
| cord-326017-qw4qynqv | ( COVID-19) Lessons for the Future Telemedicine in the Era of COVID-19 Artificial intelligence: Who is responsible for the diagnosis? |
| cord-326017-qw4qynqv | It Is Pneumonia? |
| cord-326017-qw4qynqv | New evidence for an old therapeutic tool? |
| cord-326017-qw4qynqv | in Human Nasopharyngeal Swab Specimens Using Field- Effect Transistor- Based Biosensor Cross- reactive Antibody Response between SARS- CoV-2 and SARS- CoV Infections Clinical Characteristics of Coronavirus Disease 2019 in China Chest radiograph vs. computed tomography scan in the evaluation for pneumonia Middle East respiratory syndrome corona virus: Can radiology be of help? |
| cord-326017-qw4qynqv | the culprit in the autoimmune haemolytic anaemia affecting patients with COVID-19? |
| cord-327086-u3l8nr73 | A question then arises as to what biological factors are protective in women compared to men, and how can we harness these modifiable factors to mitigate COVID-19 morbidity and mortality? |
| cord-327086-u3l8nr73 | Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? |
| cord-327086-u3l8nr73 | Hormone replacement therapy reduces the reactivity of monocytes and platelets in whole blood- a beneficial effect on atherogenesis and thrombus formation? |
| cord-327086-u3l8nr73 | The complex role of estrogens in inflammation Role of cytokines in bone resorption Role of estrogen in hepatocellular carcinoma: is inflammation the key? |
| cord-329102-2y49kcwu | Transcriptome Global or local? |
| cord-329392-fufattj8 | medRxiv The role of antibody testing for SARS- CoV-2: is there one? |
| cord-329318-eo8auo1f | While We Wait for a Vaccine Against SARS- CoV-2, Why Not Think About Available Drugs? |
| cord-328409-px92ff89 | A Report of 1014 Cases Diagnosis of the Coronavirus disease( COVID-19): rRT- PCR or CT? |
| cord-328865-ekgqdjlk | a population- based study Post- stratification or non- response adjustment? |
| cord-319780-rfj9t99r | A molecular docking study Can angiotensin receptor- blocking drugs perhaps be harmful in the COVID-19 pandemic? |
| cord-319780-rfj9t99r | For example, what are the mechanism/ s underlying why some sufferers of hypertension and/or diabetes might be at higher risk( https://www.immunopaedia.org.za/breakingnews/why-are-hypertension-and-diabetes-patients-at-high-risk-of-severe-covid-19/)? |
| cord-319780-rfj9t99r | How will the evolution of the virus alter rates of infection and the severity of symptoms? |
| cord-319780-rfj9t99r | Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population? |
| cord-319780-rfj9t99r | Is there evidence from the SARS and MERS outbreaks to suggest a commonality of susceptibility? |
| cord-319780-rfj9t99r | Is there evidence that patients on ACE inhibitors or angiotensin receptor blockers were at higher risk with SARS- CoV and MERS- CoV infections and, currently, for SARS- CoV-2 infection? |
| cord-319780-rfj9t99r | N is a receptor for human coronavirus 229E Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-319780-rfj9t99r | Underestimated Opportunistic Pathogens of the Central Nervous System? |
| cord-319780-rfj9t99r | What factor/ s determine resistance to infection? |
| cord-319780-rfj9t99r | What is the impact of contracting the virus on individuals with other underlying conditions? |
| cord-329193-xuxbqbsf | Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-328074-pcvdr052 | Is CPI therapy an independent risk factor for lethal SARS CoV-2 virus infection? |
| cord-328074-pcvdr052 | Should CPI therapy delayed/ modified until the SARS CoV-2 pandemic is under control? |
| cord-328074-pcvdr052 | Similarly, the management of patients who are either receiving or scheduled for checkpoint inhibitor( CPI) therapy in general deserves special attention[ 7] and three major questions should be addressed: What are the similarities between CPI- induced pneumonitis and COVID-10 pneumonia? |
| cord-329504-91te3nu8 | Why were just over half of all reflections that could have been measured at this resolution recorded? |
| cord-330198-pwkxgbxk | summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention Are children less susceptible to COVID-19? |
| cord-330337-d41imvo7 | it matter? |
| cord-329308-ipui7lo6 | EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus Emerging WuHan( COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26 COVID-19 and diabetes: can DPP4 inhibition play a role? |
| cord-329308-ipui7lo6 | intestinal inflammation Angiotensin- converting enzyme 2 is a functional receptor for the SARS coronavirus COVID-19, ACE2, and the cardiovascular consequences Angiotensin- converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS- CoV-2: a double- edged sword? |
| cord-316095-jzyb4jn5 | Are you experiencing uncontrolled bleeding? |
| cord-316095-jzyb4jn5 | Can pain or discomfort be tolerated or managed at home for 2- 3 weeks? |
| cord-316095-jzyb4jn5 | Do you need biopsy of abnormal tissue? |
| cord-316095-jzyb4jn5 | Do you need dental treatment required prior to medical treatment( e.g., radiotherapy)? |
| cord-316095-jzyb4jn5 | Do you need denture repair or adjustment prior to medical treatment or due to trouble eating? |
| cord-316095-jzyb4jn5 | If yes, when did it start? |
| cord-316095-jzyb4jn5 | If yes, when did you first notice the swelling? |
| cord-316095-jzyb4jn5 | In vitro bactericidal and virucidal efficacy of povidone- iodine gargle/ mouthwash against respiratory and oral tract pathogens Aerosol and splatter contamination from the operative site during ultrasonic scaling How to make choice of the carious removal methods, Carisolv or traditional drilling? |
| cord-316095-jzyb4jn5 | This paper focused on dental management during the COVID-19 pandemic in order to answer the following four questions: • Which procedures are allowed to perform during the COVID-19 outbreak? |
| cord-316095-jzyb4jn5 | What are the conditions and necessities for patient admission, waiting room, and operatory room? |
| cord-316095-jzyb4jn5 | What is the efficacy of standard face masks compared to respirator masks in preventing COVID- type respiratory illnesses in primary care staff? |
| cord-316095-jzyb4jn5 | What is your pain level on a scale of 1- 10? |
| cord-316095-jzyb4jn5 | What personal protective equipment( PPE) is necessary for dental clinicians and the office staff? |
| cord-316095-jzyb4jn5 | Which patients are in priority to receive dental care services? |
| cord-316095-jzyb4jn5 | the gingiva is irritated? |
| cord-330200-l6bnxi40 | A novel coronavirus from patients with pneumonia in China Emergence of novel coronavirus and COVID-19: whether to stay or die out? |
| cord-330315-upcf15q5 | Do viruses subvert cholesterol homeostasis to induce host cubic membranes? |
| cord-329853-kf3kh26y | Preliminary Report Recovery Collaborative Group Will complement inhibition be the new target in treating COVID-19 related systemic thrombosis? |
| cord-330121-eadu2ba3 | Is the oral cavity relevant in SARS- CoV-2 pandemic? |
| cord-325197-j1uo8qmf | , angiotensin I converting enzyme 2 gene( ACE2) in the respiratory system reveal age and gender differences Pulmonary embolism or pulmonary thrombosis in COVID-19? |
| cord-325197-j1uo8qmf | A Review Can COVID 2019 disease induce a specific cardiovascular damage or it exacerbates pre- existing cardiovascular diseases? |
| cord-325197-j1uo8qmf | A crucial role of angiotensin converting enzyme 2( ACE2) in SARS coronavirusinduced lung injury DPP4, the Middle East respiratory syndrome coronavirus receptor, is upregulated in lungs of smokers and chronic obstructive pulmonary disease patients Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus Distinct immune response in two MERS- CoV- infected patients: can we go from bench to bedside? |
| cord-325197-j1uo8qmf | Immunomodulators and antivirals: could they impact on epigenetic pathways underlying cardiovascular dysfunction in COVID-19? |
| cord-325197-j1uo8qmf | Is the recommendation to use high- dose heparin for thromboprophylaxis justified? |
| cord-325197-j1uo8qmf | a randomized clinical trial Epigenetic- sensitive challenges of cardio- hepatic interactions: clinical and therapeutic implications in heart failure patients Clinical features of COVID-19-related liver damage Liver injury during highly pathogenic human coronavirus infections Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide Atorvastatin attenuates myocardial remodeling induced by chronic intermittent hypoxia in rats: partly involvement of TLR-4/ MYD88 pathway Metformin- induced suppression of IFN- a via mTORC1 signalling following seasonal vaccination is associated with impaired antibody responses in type 2 diabetes Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy Coronavirus disease 2019( COVID-19) and cardiovascular disease Precision medicine in distinct heart failure phenotypes: focus on clinical epigenetics New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-330387-7lci44w5 | Is Ethnicity Linked to Incidence or Outcomes of covid-19? |
| cord-330715-olypwdoq | spike glycoprotein Cryo- EM analysis of a feline coronavirus spike protein reveals a unique structure and camouflaging glycans Virus glycosylation: role in virulence and immune interactions Emergence of novel coronavirus and COVID-19: whether to stay or die out? |
| cord-330478-g9n2mfni | New York city COVID-19 resident physician exposure during exponential phase of pandemic Personal protection and delivery of rhinologic and endoscopic skull base procedures during the COVID-19 outbreak Ophthalmology and SARS- coV-2: blind toward those who fight blindness? |
| cord-330827-gu2mt6zp | -Are we there yet? |
| cord-330022-n3d130t8 | Early Experience and Forecast During an Emergency Response Race'and'ethnicity'in biomedical research: How do scientists construct and explain differences in health? |
| cord-330022-n3d130t8 | The impact of migration on tuberculosis epidemiology and control in high- income countries: A review Does BCG bolster one's immunity against COVID-19? |
| cord-331039-qgom2e3n | Which Route Should We Take? |
| cord-331283-bfyoavon | Another Decade, Another Coronavirus Anti- CD20 monoclonal antibodies in multiple sclerosis Ocrelizumab: eficacia y seguridad en la esclerosis múltiple P36 Serum immunoglobulin levels and risk of serious infections in the pivotal phase III trials of ocrelizumab in multiple sclerosis and their open- label extensions Rituximab: its efficacy, effectiveness and safety in the treatment of multiple sclerosis Ocrelizumab does not impair B- and T- cell responses to primary VZV infection in a patient with MS Learning from other autoimmunities to understand targeting of B cells to control multiple sclerosis Long- term coexistence of SARS- CoV-2 with antibody response in COVID-19 patients Two X- linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role? |
| cord-331066-ediowz4s | How many N proteins are needed for the complete packaging of the SARS- CoV and SARS- CoV-2 ssRNA genomes? |
| cord-331147-numz9onx | Hydroxychloroquine is much less active than chloroquine against chloroquine- resistant Plasmodium falciparum, in agreement with its physicochemical properties Protein binding: do we ever learn? |
| cord-331193-33cyvidx | Visit casereports.bmj Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-328246-boxsf2sz | ( ACE2) gene play a role in coronavirus disease 2019( COVID-19)? |
| cord-328246-boxsf2sz | Angiotensin- Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients With Coronavirus Disease 2019: Friend or Foe? |
| cord-328246-boxsf2sz | COVID-19): Do Angiotensin- Converting Journal of Proteome Research pubs Enzyme Inhibitors/ Angiotensin Receptor Blockers Have a Biphasic Effect? |
| cord-328246-boxsf2sz | Similarities and Subfamily- Specific Differences The Discovery of a Putative Allosteric Site in the SARS- CoV-2 Spike Protein Using an Integrated Structural/ Dynamic Approach COVID-19 and renin- angiotensin system inhibition: role of angiotensin converting enzyme 2( ACE2)-Is there any scientific evidence for controversy? |
| cord-330814-7incf20e | How Tablighi Jamaat event became India's worst coronavirus vector Flattening the much- talked COVID-19 curve- How close are we in India? |
| cord-331022-tek4u751 | Can We Benefit from the SARS- CoV and MERS- CoV Pandemic Experience? |
| cord-331472-kd4uxcve | Chloroquine is a potent inhibitor of SARS coronavirus infection and spread? |
| cord-331558-6rqd3fmj | The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases( COVID-19) in China COVID-19) Situation Report-35 What to do next to control the 2019-nCoV epidemic? |
| cord-325019-hznnoxw6 | , what was the dose response? |
| cord-325019-hznnoxw6 | Can statins improve neutrophil functions and clinical outcomes in COPD? |
| cord-325019-hznnoxw6 | Can you teach old drugs new tricks? |
| cord-325019-hznnoxw6 | Likewise, when researching new molecules in humans, it is necessary to ask several questions that could improve the designs, and avoid some failures, such as, for example, did the drug hit the target?, did the medication change the target? |
| cord-325019-hznnoxw6 | Likewise, when researching new molecules in humans, it is necessary to ask several questions that could improve the designs, and avoid some failures, such as, for example, did the drug hit the target?, did the medication change the target? |
| cord-325019-hznnoxw6 | The drug repurposing hub: a nextgeneration drug library and information resource Drug repositioning for COVID-19 Drug repurposing from the perspective of pharmaceutical companies Drug repurposing in cancer Drug Repurposing in anticancer reagent development Repurposing vitamin D as an anticancer drug Drug repurposing in Parkinson's disease Drug repurposing for viral infectious diseases: how far are we? |
| cord-325019-hznnoxw6 | and what are the characteristics of the study patients?. |
| cord-330583-ltkpt80u | Focus on the Marine Environmental Damage by Oil Pollution in South Korea and Japan Management of Emergent Networks during Disasters- A Meta synthesis Relationship between Effectiveness of Disaster Management and Cooperative Factors of Agencies in Disaster Management MERS Isolation Patient- A Public Enemy? |
| cord-330583-ltkpt80u | How did MERS Outbreak Become a Political Matter?: |
| cord-331423-5wpx0bd0 | Guillain- Barré syndrome associated with SARS- CoV-2 Guillain Barre syndrome associated with COVID-19 infection: a case report Guillain- Barré syndrome associated with SARSCoV-2 infection: causality or coincidence? |
| cord-331547-uqmjhhna | COVID-19 infected patients exhibit increased clot waveform analysis parameters consistent with hypercoagulability Associations between immune- suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting? |
| cord-330129-izr62c68 | Accessed 24 Disinfecting your home if someone is sick COVID-19) situation summary Novel corona virus disease( COVID-19) in pregnancy: what clinical recommendations to follow? |
| cord-330129-izr62c68 | What are the risks of COVID-19 infection in pregnant women? |
| cord-330779-mso2zfom | Are there any sustainable remedies? |
| cord-330779-mso2zfom | Temporal detection and phylogenetic assessment of SARS Is 2030 too soon for Africa to achieve the water and sanitation sustainable development goal? |
| cord-330131-yfhrmbvx | The SARS case study: an alarm clock? |
| cord-330131-yfhrmbvx | Then, what about their degradation and salvage? |
| cord-329328-c6svx4qa | How can science be well- ordered in times of crisis? |
| cord-329328-c6svx4qa | How can we do better next time? |
| cord-329328-c6svx4qa | What, then, was the common good in the SARS- CoV-2 pandemic? |
| cord-330800-s91zfzfi | Molecular diagnosis of infectious diseases using cytological specimens Point- counterpoint: is the era of viral culture over in the clinical microbiology laboratory? |
| cord-330800-s91zfzfi | Where do we go from here? |
| cord-330597-nftwj0d5 | Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19 Pulmonary Vascular Pathology in Covid-19 Pulmonary Vascular Pathology in Covid-19 SARS- CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19 SARS- CoV-2: Is the liver merely a bystander to severe disease? |
| cord-330597-nftwj0d5 | SARS- CoV-2 Causes a Specific Dysfunction of the Kidney Proximal Tubule Visualization of putative coronavirus in kidney Multivesicular bodies mimicking SARS- CoV-2 in patients without COVID-19 Electron microscopic investigations in COVID-19: not all crowns are coronas Am I a coronavirus? |
| cord-331300-u5fltc10 | Are faecal bio- aerosols a route of transmission for SARS- CoV-2? |
| cord-331496-5xak7z6b | : what do we know so far? |
| cord-331094-22366b81 | www.who.int/medicines/ebola-treatment/WHO-list-of-top-emerging-diseases/en Emerging virus diseases: Can we ever expect the unexpected? |
| cord-330287-bkqjkhwu | Despite this knowledge, many questions remain: Which of the multiple SARS- CoV-2 introductions resulted in sustained local transmission? |
| cord-330287-bkqjkhwu | How did the virus spread across the state? |
| cord-330287-bkqjkhwu | What was the magnitude of the virus's reproduction potential within Israel, and to what extent did control measures mitigate its spread through March- April? |
| cord-331563-4yvfdqbq | The New England Hournal of Medicine Do N95 respirators provide 95% protection level against airborne viruses, and how adequate are surgical masks? |
| cord-331666-iwkuwnun | COVID-19 Outbreak: Is It a Health Crisis or Economic Crisis or Both? |
| cord-331243-0u65qguq | Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome( ARDS)? |
| cord-331055-5ni0jxij | Should we favour orthopaedic treatments or surgery taking into account the risk/ benefit balance? |
| cord-331055-5ni0jxij | title: Were protective procedures against SARS- CoV-2 effective in an orthopaedic and trauma centre during the lockdown period? |
| cord-319248-ynoxec7k | Are genetic polymorphisms of STAT1, STAT3, PAI-1, HA, or EGFR related to the severity of COVID-19? |
| cord-319248-ynoxec7k | How does the STAT3/ PAI-1 axis contribute to other disease conditions, including cancer? |
| cord-319248-ynoxec7k | Is IFN production different between asymptomatic carriers, and patients with less or more severe cases of COVID-19? |
| cord-319248-ynoxec7k | Is IFN production different between people infected with SARS- CoV-2, SARS- CoV-1, MERS coronavirus, or other coronaviruses? |
| cord-319248-ynoxec7k | Is STAT3 activated in SARS- CoV-2-infected tissues? |
| cord-319248-ynoxec7k | Public and Global Health Hyaluronan in acute respiratory distress syndrome( ARDS): simply a biomarker or a deeper insight into ARDS mechanisms? |
| cord-319248-ynoxec7k | Temporal dynamics in viral shedding and transmissibility of COVID-19 COVID-19, SARS and MERS: are they closely related? |
| cord-319248-ynoxec7k | Will inhibition of EGFR signaling ameliorate the disease severity? |
| cord-319248-ynoxec7k | Will inhibition of EGFR signaling potentiate the antiviral activity of IFN- I against SARS- CoV-2? |
| cord-319248-ynoxec7k | Will inhibition of the STAT3/ PAI-1 axis decrease the severities of the cytokine storm and thrombosis/ coagulopathy in COVID-19? |
| cord-319248-ynoxec7k | Will prophylactic activation of STAT1 protect against the severe symptoms of COVID-19? |
| cord-319248-ynoxec7k | reveals IL-6 and IL-10 are disease severity predictors Alveolar macrophages regulate neutrophil recruitment in endotoxin- induced lung injury Monocyte- derived alveolar macrophages: the dark side of lung repair? |
| cord-331277-fjsuo3yy | Enhanced lateral flow immunoassay using gold nanoparticles loaded with enzymes Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Good IgA Bad IgG in SARS- CoV-2 Infection? |
| cord-332268-x30svp5y | Is lithium a potential treatment for the novel Wuhan( 2019-nCoV) coronavirus? |
| cord-332185-a96r1k7a | 437 pangolins Isolation of SARS- CoV-2-related coronavirus from Malayan 439 pangolins Are pangolins the intermediate host of the 2019 novel 441 coronavirus( SARS- CoV-2)? |
| cord-332134-88wfcc3y | How good are my data and what is the resolution? |
| cord-331517-o5ejfq86 | Guillain- Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case- control study Guillain- Barré syndrome related to COVID-19 infection Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-331517-o5ejfq86 | SARS- CoV-2-associated Guillain- Barré syndrome with dysautonomia Ganglioside complexes as new target antigens in Guillain- Barré syndrome Assessment of current diagnostic criteria for Guillain- Barré syndrome Guillain- Barré syndrome in the COVID-19 era: just an occasional cluster? |
| cord-331428-6pvr2vew | Delivering Benefits at Speed Through Real- World Repurposing of Off- Patent Drugs: The COVID-19 Pandemic as a Case in Point Exercise as medicine for COVID-19: An ACE in the hole? |
| cord-331428-6pvr2vew | downregulates airway inflammation induced by lipopolysaccharide in the mouse Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single- centre, cross- sectional study Endothelial cell infection and endotheliitis in COVID-19 Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19 Endothelial cell dysfunction: a major player in SARS- CoV-2 infection( COVID-19)? |
| cord-331835-nuhrd92z | : what lessons have we learned? |
| cord-327721-y39751g4 | A systematic review Will novel virus go pandemic or be contained? |
| cord-327721-y39751g4 | Respiratory medicine Does acute stress disorder predict post- traumatic stress disorder in traffic accident victims? |
| cord-327721-y39751g4 | The course of PTSD, major depression, substance abuse, and somatization after a natural disaster Students'emotions of enjoyment and boredom and their use of cognitive learning strategies-How do they affect one another? |
| cord-327721-y39751g4 | The lancet Geographical distance to the epicenter of Covid-19 predicts the burnout of the working population: Ripple effect or typhoon eye effect? |
| cord-327721-y39751g4 | What good are positive emotions in crises? |
| cord-332537-rtdu4jae | How contagious are common respiratory tract infections? |
| cord-332276-gs80celr | : An introduction Transmissible gastroenteritis virus induced apoptosis in swine testes cell cultures Is there an ideal animal model for SARS? |
| cord-331010-4phhz79k | Information for healthcare professionals Maternal health care management during the outbreak of coronavirus disease 2019( COVID-19) 2019-nCoV epidemic: what about pregnancies? |
| cord-331010-4phhz79k | challenges and recommendations Is ethnicity linked to incidence or outcomes of covid-19? Ethnicity and COVID-19: an urgent public health research priority Influenza epidemiology and immunization during pregnancy: |
| cord-330093-asba80bi | ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19 COVID-19 and smoking: is nicotine the hidden link? |
| cord-330093-asba80bi | COVID-19 and nicotine as a mediator of ACE-2 Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? |
| cord-330093-asba80bi | COVID-19 and vaping: risk for increased susceptibility to SARS- CoV-2 infection? |
| cord-330093-asba80bi | statista.com/statistics/673619/smoking-prevalence-among-men-us-by-age/ Date last accessed COVID-19 and smoking: is nicotine the hidden link? |
| cord-332457-gan10za0 | Fourth national climate assessment, volume II Influenza seasonality in the tropics and subtropicswhen to vaccinate? |
| cord-331520-o9e4qqn4 | 2008 update by the Infectious Diseases Society of America Does universal testing for COVID-19 work for everyone? |
| cord-331520-o9e4qqn4 | COVID-19 antimicrobial prescribing Does adherence to the Loeb minimum criteria reduce antibiotic prescribing rates in nursing homes? |
| cord-331520-o9e4qqn4 | The need to include assisted living in responding to the COVID-19 pandemic Department Of Labor Issues Alert to Keep Nursing Home and Long- Term Care Facility Workers Safe During Coronavirus Pandemic Shortages of staff in nursing homes during the COVID-19 pandemic: what are the driving factors? |
| cord-333176-6v7ficfk | a report from China Endothelial cell infection and endotheliitis in COVID-19 Endothelial dysfunction: a marker of atherosclerotic risk Interactions between the innate immune and blood coagulation systems Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19 Immune Thrombocytopenic Purpura in a Patient with Covid-19 Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases Will Complement Inhibition Be the New Target in Treating COVID-19-Related Systemic Thrombosis? |
| cord-331910-s474ecvk | A brand- related issue? |
| cord-331910-s474ecvk | A retrospective study Does Carica papaya leaf- extract increase the platelet count? |
| cord-328289-3h3kmjlz | Can Covid Damage the Brain? |
| cord-328289-3h3kmjlz | Does the brain contribute to respiratory failure and hypertension? |
| cord-328289-3h3kmjlz | Does the brain contribute to the immune dysregulation? |
| cord-328289-3h3kmjlz | Here are some of the outstanding questions: Do the neurological manifestations of COVID-19 reflect brain invasion? |
| cord-328289-3h3kmjlz | What are the long- term neurological and neuropsychiatric consequences of COVID-19? |
| cord-330807-abi8pra7 | Do chronic respiratory diseases or their treatment affect the risk of SARS- CoV-2 infection? |
| cord-330807-abi8pra7 | Interim guidance Do chronic respiratory diseases or their treatment affect the risk of SARS- CoV-2 infection? |
| cord-330807-abi8pra7 | Prevalence of viral respiratory infections amongst asthmatics: Results of a meta- regression analysis Patterns of systemic and local inflammation in patients with asthma hospitalised with influenza Asthma and COVID-19: is asthma a risk factor for severe outcomes? |
| cord-330807-abi8pra7 | The authors declare the following financial interests/ personal relationships which may be considered as potential competing interests: Viral infections and asthma: an inflammatory interface? |
| cord-331673-xv1tcugl | Far from Clinical Use? |
| cord-331673-xv1tcugl | Hypericin- Loaded Graphene Oxide Protects Ducks against a Novel Duck Reovirus Graphene- Based"Hot Plate"for the Capture and Destruction of the Herpes Simplex Virus Type 1 Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias? |
| cord-332962-8y3t0r2d | what does a radiologist need to know? |
| cord-333089-ufyzqgqk | Circulating plasma concentrations of angiotensin- converting enzyme 2 in men and women with heart failure and effects of renin- angiotensin- aldosterone inhibitors Predictors of mortality in hospitalized COVID-19 patients: a systematic review and meta- analysis Impact of sex and gender on COVID-19 outcomes in Europe Are sex discordant outcomes in COVID-19 related to sex hormones? |
| cord-330849-yt44k88m | : what was the impact of the 2007 economic recession? |
| cord-330849-yt44k88m | Questions we hoped to answer included the following: What mental health sequelae emerged following pre- COVID-19 twenty- first- century pandemics? |
| cord-330849-yt44k88m | a randomized controlled trial Is exposure necessary? |
| cord-330849-yt44k88m | and What does preliminary data on the psychological effects of COVID-19 reveal? |
| cord-324265-j3v3i8vm | COVID-19 and VTE/ Anticoagulation: frequently asked questions Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum Prevention, diagnosis and treatment of venous thromboembolism in patients with COVID-19: CHEST guideline and expert panel report Pulmonary embolism or pulmonary thrombosis in COVID-19? |
| cord-324265-j3v3i8vm | How do we frame the COVID-19 associated coagulopathy? |
| cord-324265-j3v3i8vm | How do we frame the COVID-19-associated coagulopathy, that is, DIC, SIC, CAC or PIC? |
| cord-324265-j3v3i8vm | How do we gather these puzzling data on a unified clinicopathological picture, helpful to improve the management of CAC? |
| cord-324265-j3v3i8vm | How do we tackle COVID-19 coagulopathy? |
| cord-324265-j3v3i8vm | Is the recommendation to use high- dose heparin for thromboprophylaxis justified? |
| cord-324265-j3v3i8vm | The role of heparin in sepsis: much more than just an anticoagulant The versatile heparin in COVID-19 Both UFH and NAH alleviate shedding of endothelial glycocalyx and coagulopathy in LPS- induced sepsis Human coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cells Pulmonary thrombosis in 2019-nCoV pneumonia? |
| cord-324265-j3v3i8vm | This review is particularly focused on four clinical questions: What is the incidence of VTE in COVID-19 patients? |
| cord-324265-j3v3i8vm | Which role, if any, do antiphospolipid antibodies have? |
| cord-324265-j3v3i8vm | an update on experimental models and clinical data Tissue factor: an essential mediator of hemostasis and trigger of thrombosis Clinical and immunologic features in severe and moderate Coronavirus Disease COVID-19 gone bad: a new character in the spectrum of the hyperferritinemic syndrome? |
| cord-332654-nav15g8k | Can we use interleukin-6( IL-6) blockade for coronavirus disease 2019( COVID-19)-induced cytokine release syndrome( CRS)? |
| cord-332654-nav15g8k | hsa- miR-25- 3p suppresses the expression and drug induction of CYP2B6 in human hepatocytes Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy: key diagnostic features and literature review Impact of OATP transporters on pharmacokinetics Phagocytosis of retinal rod and cone photoreceptors Retinopathy due to antimalarial drugs in patients with connective tissue diseases: are they so innocent? |
| cord-328396-p2gvpe8i | A meta- analysis Neutrophilto- lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19 COVID- ARDS clarified: a vascular endotype? |
| cord-328396-p2gvpe8i | COVID-19 pneumonia: different respiratory treatments for different phenotypes? |
| cord-328396-p2gvpe8i | The endothelium in hypoxic pulmonary vasoconstriction Is the reason of increased D- dimer levels in COVID-19 because of ACE-2-induced apoptosis in endothelium? |
| cord-328396-p2gvpe8i | The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? |
| cord-328396-p2gvpe8i | a comprehensive evaluation of clinical and basic evidence Is COVID-19 an endothelial disease? |
| cord-328396-p2gvpe8i | related coagulopathy: a distinct entity? |
| cord-331465-humpwwk2 | But, in the context of COVID-19, what should we expect from a vaccine that in older and other high risk groups will likely experience a 40% or higher failure rate? |
| cord-331465-humpwwk2 | But, what type of protection can we realistically expect to achieve from vaccines and when? |
| cord-331465-humpwwk2 | Will the vaccine nevertheless help mitigate disease and prevent hospitalization, mechanical ventilation, or even transmission in those who still get infected? |
| cord-326498-8oa5gkrp | A novel prognostic biomarker? |
| cord-326498-8oa5gkrp | Another co- evolutionary adaptation? |
| cord-326498-8oa5gkrp | Compared to the Single X- Chromosome in Males? |
| cord-326498-8oa5gkrp | Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? |
| cord-326498-8oa5gkrp | Is Nicotine the Hidden Link? |
| cord-326498-8oa5gkrp | The international imperative to rapidly and inexpensively monitor community- wide Covid-19 infection status and trends Shelter hospital mode: How to prevent novel coronavirus infection 2019( COVID-19) hospital- acquired infection? |
| cord-326498-8oa5gkrp | The tobacco industry in the time of COVID-19: Time to shut it down? |
| cord-330701-k68b0wqe | A storm is raging SARS- CoV2: should inhibitors of the renin- angiotensin systeme withdrawn in patients with COVID-19? |
| cord-330701-k68b0wqe | Even before the COVID-19 vaccine is found, national leaders are faced with the dilemma of whether to immunize as much of the population as possible or whether compulsory vaccination carries the risk of movement, which is already prone to conspiracy theories about pharmaceutical companies and government authoritarian tendencies? |
| cord-330701-k68b0wqe | On the Occasion of the COVID-19 Pandemic-One of the Most Important Dilemma: Vaccinate or Not? |
| cord-330701-k68b0wqe | The Nrf2 Activator( DMF) and Covid-19: is there a Possible Role? |
| cord-330701-k68b0wqe | What are the factors that correlate with a poor patient prognosis? |
| cord-332178-0xyrmk5a | Is SARS- CoV-2 receptor, angiotensin- converting enzyme 2( ACE 2) expressed in the human endometrium during the menstrual cycle, and does it participate in endometrial decidualization? |
| cord-332178-0xyrmk5a | angiotensin I to angiotensin 1- 9 2019-nCoV epidemic: what about pregnancies? |
| cord-332970-atwz3rgf | Current Knowledge and Future Perspectives Human Oral Stem Cells, Biomaterials and Extracellular Vesicles: A Promising Tool in Bone Tissue Repair Plasticity of adipose tissue: A promising therapeutic avenue in the treatment of cardiovascular and blood diseases? |
| cord-332970-atwz3rgf | What Is the Best Method? |
| cord-327063-ea7a1xfl | Avian influenza and sialic acid receptors: more than meets the eye? |
| cord-327063-ea7a1xfl | Based on SARS- CoV Immunological Studies Is COVID-19 receiving ADE from other coronaviruses? |
| cord-327063-ea7a1xfl | COVID-19: what is next for public health? |
| cord-327063-ea7a1xfl | Companion Animal Pets Is COVID-19 the first pandemic that evolves into a panzootic? |
| cord-327063-ea7a1xfl | First respiratory transmitted food borne outbreak? |
| cord-327063-ea7a1xfl | The Indian journal of animal sciences MERS- CoV and now the 2019-novel CoV: Have we investigated enough about coronaviruses? |
| cord-327063-ea7a1xfl | The SARS, MERS and novel coronavirus( COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
| cord-327063-ea7a1xfl | What can animal coronaviruses tell us about emerging human coronaviruses? |
| cord-332716-1d89j7jh | Enzyme Inhibitors/ Angiotensin Receptor Blockers Have a Biphasic Effect? |
| cord-332716-1d89j7jh | and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein Clinical relevance and role of neuronal AT1 receptors in ADAM17-mediated ACE2 shedding in neurogenic hypertension Antihypertensive drugs and risk of COVID-19? |
| cord-333453-v3gap8kj | Molecular diagnosis of a novel coronavirus( 2019-nCoV) causing an outbreak of pneumonia Detection of SARS- CoV-2 in human breastmilk Structure, function, and antigenicity of the SARS- CoV-2 spike glycoprotein Angiotensin- converting enzyme 2( ACE2) as a SARS- CoV-2 receptor: molecular mechanisms and potential therapeutic target Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation Flowchart showing the reverse transcription polymerase chain reaction test results of the newborns and their mothers Correlation of chest CT and RT- PCR testing in coronavirus disease 2019( COVID-19) in China: a report of 1014 cases Clinical characteristics of fatal and recovered cases of coronavirus disease 2019( COVID-19) in Wuhan, China: a retrospective study Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow- up Epidemiology and prevention of neonatal candidiasis: fluconazole for all neonates? |
| cord-325055-todb1d4x | ( COVID-19) The impact of COVID-19 on bariatric surgery: re- defining psychosocial care Does high cardiorespiratory fitness confer some protection against proinflammatory responses after infection by SARS- CoV-2? |
| cord-325055-todb1d4x | American Heart Association Addresses Concerns Re: using RAAS antagonists in COVID-19-American College of Cardiology Obesity: the"Achilles heel"for COVID-19? |
| cord-325055-todb1d4x | Diabetes Metab Syndr Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic Vitamin D and obesity in adults: a pathophysiological and clinical update Could vitamin D reduce obesity- associated inflammation? |
| cord-325055-todb1d4x | Does COVID-19 disprove the obesity paradox in ARDS? |
| cord-325055-todb1d4x | Does workout intensity matter? |
| cord-325055-todb1d4x | High positive end- expiratory pressure is associated with improved survival in obese patients with acute respiratory distress syndrome Tracheal trauma after difficult airway management in morbidly obese patients with COVID-19 Obesity- induced adipokine imbalance impairs mouse pulmonary vascular endothelial function and primes the lung for injury Obesity and susceptibility to severe outcomes following respiratory viral infection Obesity and respiratory infections: does excess adiposity weigh down host defense? |
| cord-325055-todb1d4x | Iwona title: Should patients with obesity be more afraid of COVID‐19? date: 2020- 06- 24 journal: |
| cord-325055-todb1d4x | Krela- Kaźmierczak I. Should patients with obesity be more afraid of COVID-19? |
| cord-325055-todb1d4x | Obesity Respiratory function and the obesity paradox BMI is associated with FEV1 decline in chronic obstructive pulmonary disease: a meta- analysis of clinical trials Should we treat obesity in COPD? |
| cord-325055-todb1d4x | Obesity phenotypes and their paradoxical association with cardiovascular diseases Are metabolically healthy obese patients also hemorheologically healthy? |
| cord-325055-todb1d4x | Targeting the adipose tissue in COVID-19 COVID-19, SARS and MERS: are they closely related? |
| cord-332480-3uodkrkp | A Future H5N1 Treatment? |
| cord-332480-3uodkrkp | Intravenous immunoglobulin for infectious diseases: back to the pre- antibiotic and passive prophylaxis era? |
| cord-332480-3uodkrkp | medRxiv Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19 Intravenous immunoglobulin therapy: how does IgG modulate the immune system? |
| cord-333532-vrfduv5a | Effective Enough? |
| cord-333713-nz36i2oa | China COVID-19 pneumonia: what has CT taught us? |
| cord-332592-bfqsyiyf | How I treat disseminated intravascular coagulation Causes of elevated Ddimer in patients admitted to a large urban emergency department Coagulopathy and antiphospholipid antibodies in patients with COVID-19 Viral hemorrhagic fever- a vascular disease? |
| cord-332592-bfqsyiyf | Will complement inhibition be the new target in treating COVID-19-related systemic thrombosis? |
| cord-328262-hw8swbt5 | BCG- induced trained immunity: can it offer protection against COVID-19? |
| cord-328262-hw8swbt5 | Clinical features of patients infected with 2019 novel coronavirus in Wuhan The non- specific effects of vaccines Randomized trial of BCG vaccination at birth to low- birth- weight children: beneficial nonspecific effects in the neonatal period? |
| cord-328262-hw8swbt5 | Is global BCG vaccination- induced trained immunity relevant to the progression of SARS- CoV-2 pandemic? |
| cord-328262-hw8swbt5 | Might this be deleterious, considering the fact that an exaggerated cytokine response has been associated with complications in patients with COVID-19( reF. 16)? |
| cord-328262-hw8swbt5 | Will it protect against severe acute respiratory syndrome coronavirus 2( SARS- CoV-2)? |
| cord-331617-1ytcd0ax | ( ELISA) Product Catalogue Evaluation of nine commercial SARS- CoV-2 immunoassays Antibody tests in detecting SARS- CoV-2 infection: a meta- analysis? |
| cord-331617-1ytcd0ax | Antibody responses to viral infections: a structural perspective across three different enveloped viruses IgM in microbial infections: taken for granted? |
| cord-331617-1ytcd0ax | How reliable are inferences from positive or negative test results regarding the actual presence of SARS- CoV-2 specific antibodies? |
| cord-331617-1ytcd0ax | Issue: How reliable are inferences from positive or negative test results regarding the actual presence of SARS- CoV-2 specific antibodies? |
| cord-334049-r3rlykli | How does coronavirus kill? |
| cord-333018-2h8y118z | Is neuraxial anaesthesia safe for COVID-19 patients? |
| cord-333018-2h8y118z | Should we reconsider neuraxial anaesthesia because of reported neurological symptoms in these patients? |
| cord-333234-yvixy77x | COVID-19: a role for angiotensin axis inhibition in SARS- CoV-2 infection? |
| cord-333234-yvixy77x | inhibitors/ angiotensin receptor blockers have a biphasic effect? |
| cord-333738-3xtb8gye | This similarity opens the question whether infection with one coronavirus will confer resistance to other coronaviruses? |
| cord-333863-mtljy3s6 | Can 7 or 30-day recall questions capture self- reported lower urinary tract symptoms accurately? |
| cord-333262-xvfl7ycj | ( G?) means an optional glycine insertion. |
| cord-325112-7ie23c7f | But if China had no formal obligation to report, why was it so soundly condemned for its delay in transmitting information to the WHO? |
| cord-325112-7ie23c7f | But is SARS simply a useful case on which to hang the argument? |
| cord-325112-7ie23c7f | Did the deficiencies of the information order in fact prevent the WHO from acting quickly and appropriately to contain the disease? |
| cord-325112-7ie23c7f | Do these changes then signal the end of the gap between actionable, socially sufficient information and technically sufficient information in global health governance? |
| cord-325112-7ie23c7f | How Does the Reality Match the Predictions? |
| cord-325112-7ie23c7f | How did this happen? |
| cord-325112-7ie23c7f | How well did this imperfect, outdated information order function when the IHR encountered SARS, a new, deadly infectious disease that seemed poised to spread rapidly around the world? |
| cord-325112-7ie23c7f | Or could the argument have been built around HIV/ AIDS, H1N1, Ebola, Zika, or some other infectious disease? |
| cord-325112-7ie23c7f | The Challenger Launch Decision: Risky Technology, Culture, and Deviance at NASA GPHIN, GOARN, GONE? |
| cord-325112-7ie23c7f | Were the 1969 IHR ever an effective information order? |
| cord-333391-6l0cpvgr | : What might we learn from natural sequence variants? |
| cord-332832-kjppd6uz | ( COVID-19) SARS vaccines: where are we? |
| cord-332832-kjppd6uz | What are the roles of antibodies versus a durable, high quality T- cell 515 response in protective immunity against SARS- CoV-2? |
| cord-332827-gll4nqdd | Angiotensin- converting enzyme 2: an ally or a Trojan horse? |
| cord-332827-gll4nqdd | EASL- ESCMID position paper Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis? |
| cord-333420-qqyg9um9 | When a marker is covered by fewer than 10 130 reads, the marker is deemed as undetermined and denoted as a question mark(?). |
| cord-333099-hy4nmy7l | Deltacoronavirus supports bat coronaviruses as the gene source of Alphacoronavirus and Betacoronavirus and avian coronaviruses as the gene source of Gammacoronavirus and Deltacoronavirus Origin and evolution of pathogenic coronaviruses Human coronaviruses: What do they cause? |
| cord-333099-hy4nmy7l | For example, how can the virus overcome the Nsp1-mediated block of translation for the production of its own viral proteins? |
| cord-334099-rtv6xm90 | Our early, multi- organ ultrasound first strategy in the evaluation of the severely dyspneic patient centers on not assuming all patients who arrive in our ED during this large wave of patients are purely pulmonary in nature( even though we recognize the high prevalence of disease), and How might this improve emergency medicine practice? |
| cord-333703-1ku3jc9s | The Heart in COVID-19: Primary Target or Secondary Bystander? |
| cord-333703-1ku3jc9s | different from other PVOD? |
| cord-320663-xypg6evo | Activating KIRs and NKG2C in viral infections: toward NK cell memory? |
| cord-320663-xypg6evo | Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-320663-xypg6evo | COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting? |
| cord-320663-xypg6evo | Does COVID-19 spread through droplets alone? |
| cord-320663-xypg6evo | Have I found the missing ingredient in a coronavirus vaccine? |
| cord-320663-xypg6evo | How is immunosuppressive status affecting children and adults in SARS- CoV-2 infection? |
| cord-320663-xypg6evo | The SARS, MERS and novel coronavirus( COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
| cord-320663-xypg6evo | The innate immune system: fighting on the front lines or fanning the flames of COVID-19? |
| cord-320663-xypg6evo | The role of the interleukin-1 family in trained immunity Training the trainable cells of the immune system and beyond BCG- induced trained immunity: can it offer protection against COVID-19? |
| cord-320663-xypg6evo | The trafficking of natural killer cells Keeping NK cells in highly regulated antiviral warfare Human NK cell lytic granules and regulation of their exocytosis Natural killer cells: development, maturation, and clinical utilization Natural killer cell memory in infection, inflammation and cancer About training and memory: NK- cell adaptation to viral infections Is there natural killer cell memory and can it be harnessed by vaccination? |
| cord-320663-xypg6evo | The use of antiinflammatory drugs in the treatment of people with severe coronavirus disease 2019( COVID-19): the perspectives of clinical immunologists from China Adjunct immunotherapies for the management of severely Ill COVID-19 patients HiJAKing SARS- CoV-2? |
| cord-320663-xypg6evo | interferon responses: from friend to foe in the battle against chronic viral infection NK cells and interferons Innate or adaptive immunity? |
| cord-334188-bggt1i2e | How will country- based mitigation measures influence the course of the COVID-19 epidemic? |
| cord-333042-icgsbelo | What are the implications for public health practice? |
| cord-333042-icgsbelo | What is added by this report? |
| cord-333042-icgsbelo | What is already known about the topic? |
| cord-333200-yka7wfbi | COVID-19, SARS and MERS: are they closely related? |
| cord-333200-yka7wfbi | Main point: Hydroxychloroquine was found to be more potent than chloroquine at inhibiting SARS- CoV-2 in vit Re- evaluation of antimalarials in treating rheumatic diseases: Reappreciation and insights into new mechanisms of action Effects of chloroquine on viral infections: An old drug against today's diseases? |
| cord-332948-h297ukuu | Can We Rely on Computational Predictions To Correctly Identify Ligand Binding Sites on Novel Protein Drug Targets? |
| cord-332948-h297ukuu | r o o f resolution silico assessment of potential druggable pockets on the surface of?? |
| cord-332948-h297ukuu | r o o f resolution silico assessment of potential druggable pockets on the surface of?? |
| cord-333999-k92fmnq7 | Could it be a promising therapeutic pption for COVID-19? |
| cord-325669-6kjlcakt | : Is COVID-19 an Endothelial Disease? |
| cord-325669-6kjlcakt | A casecontrolled study comparing clinical course and outcomes of pregnant and nonpregnant women with severe acute respiratory syndrome 2019-nCoV epidemic: what about pregnancies? |
| cord-325669-6kjlcakt | COVID-19 and pregnancy-where are we now? |
| cord-325669-6kjlcakt | Hypertension Inhibition of inflammation induced shedding of the endothelial glycocalyx with low molecular weight heparin Macrolide treatment for COVID-19: Will this be the way forward? |
| cord-325669-6kjlcakt | What are the risks of COVID-19 infection in pregnant women? |
| cord-325669-6kjlcakt | Why are pregnant women susceptible to COVID-19? |
| cord-325669-6kjlcakt | Why we should not stop giving aspirin to pregnant women during the COVID-19 pandemic MAP kinase phosphatase 1: a novel mediator of biological effects of glucocorticoids? |
| cord-325669-6kjlcakt | vitro Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus( 2019-nCoV) in vitro Novel corona virus disease( COVID-19) in pregnancy: What clinical recommendations to follow? |
| cord-332179-du1zjupf | A common CD4 gene variant is associated with an increased risk of HIV-1 infection in Kenyan female commercial sex workers DPP4 inhibition: preventing SARS- CoV-2 infection and/or progression of COVID-19? |
| cord-332179-du1zjupf | Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus- EMC COVID-19 and diabetes: Can DPP4 inhibition play a role? |
| cord-332179-du1zjupf | Epub ahead of print Is it fair to hope that patients with Type 1 Diabetes( autoimmune) may be spared by the infection of Covid-19? Med Hypotheses Telemedicine- Opportunities and developments in member states Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians Clinical- and cost- effectiveness of telemedicine in type 2 diabetes mellitus: a systematic review and meta- analysis |
| cord-332179-du1zjupf | why the b cells? |
| cord-334175-x10bbv7y | The Emerging Role of Neutrophil Extracellular Traps in Respiratory Disease Neutrophil extracellular traps in pulmonary diseases: Too much of a good thing? |
| cord-334268-n2hon61o | A cluster randomized clinical trial comparing fit- tested and non- fit- tested N95 respirators to medical masks to prevent respiratory virus infection in health care workers Physical distancing, face masks, and eye protection to prevent person- to- person transmission of SARS- CoV-2 and COVID-19: a systematic review and meta- analysis COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
| cord-334268-n2hon61o | In The United States How deadly is COVID-19? |
| cord-334425-6zrmavps | What do we know about the SARS- CoV-2 coronavirus in the 761 environment? |
| cord-332150-j76726no | : what does viral RNA load really mean? |
| cord-332150-j76726no | A dynamic COVID-19 immune signature includes associations with poor prognosis Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia? |
| cord-332150-j76726no | A first step in understanding SARS pathogenesis ACE2 at the centre of COVID-19 from paucisymptomatic infections to severe pneumonia Clinical features of patients infected with 2019 novel coronavirus in Wuhan Longitudinal analyses reveal immunological misfiring in severe COVID-19 Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity Viral dynamics in mild and severe cases of COVID-19 The role of interleukin 6 during viral infections Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19 The Innate Immune System: Fighting on the Front Lines or Fanning the Flames of COVID-19? |
| cord-332150-j76726no | Should we stimulate or suppress immune responses in COVID-19? |
| cord-320092-0qnvydux | A basic question that might arise is: what exactly makes the pathobiology and disease course of these particular viruses unique? |
| cord-320092-0qnvydux | And, could it be that, in addition to viral replication inside the particular types of human host cells, other intracellular processes specific to these viruses are involved? |
| cord-320092-0qnvydux | COVID-19 does not Lead to a"typical"acute respiratory distress syndrome Biochemical and molecular identification of a novel hepcidin type 2-like antimicrobial peptide in the skin mucus of the pufferfish Takifugu pardalis Hyperferritinemia in critically ill COVID-19 patients-is ferritin the product of inflammation or a pathogenic mediator? |
| cord-320092-0qnvydux | COVID-19-related coagulopathy- is transferrin a missing link? |
| cord-320092-0qnvydux | Could systemic changes in serum iron levels[ 60, 114, 126, 141]( with a possible view on the degree of abovenormal serum ferritin in patients[ 25, 26]) or levels of hepcidin itself be detected in patients with varying COVID-19 severities? |
| cord-320092-0qnvydux | Could the cytoplasmic tail even coordinate and bind iron? |
| cord-320092-0qnvydux | Could, for instance, clinical evidence be gathered to clarify if disorders of iron homeostasis might exacerbate symptoms in COVID-19 patients? |
| cord-320092-0qnvydux | Does pathological iron overload impair the function of human lungs? |
| cord-320092-0qnvydux | Does the pathogenesis of SARS- CoV-2 virus decrease at high- altitude? |
| cord-320092-0qnvydux | Given the prominence of cysteines in the aligned motif( Fig. 1a), how are they utilized in the respective similar domains? |
| cord-320092-0qnvydux | How could these relate to hepcidin biology? |
| cord-320092-0qnvydux | If the sequence similarity reported here is actually playing a significant role at the cellular level, could it be that, although the cellular localizations appear to be different based on current knowledge, the SARS- CoV-2 spike protein cytoplasmic tail can partly mimic the structure of hepcidin and interact with ferroportin? |
| cord-320092-0qnvydux | Multisystem inflammatory syndrome in children in New York state Lack of association between New Haven coronavirus and Kawasaki disease Iron: innocent bystander or vicious culprit in COVID-19 pathogenesis? |
| cord-320092-0qnvydux | [ 95]) be explainable in part by a link to hepcidin? |
| cord-320092-0qnvydux | a descriptive study Is the prevalence of anemia in children living at high altitudes real? |
| cord-320092-0qnvydux | first, does the spike protein, similar to hepcidin, potentially promote iron sequestration in( alveolar) macrophages[ 85] and hence impede the host's initial immunological response? |
| cord-332680-zfn81hew | Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-332680-zfn81hew | Can angiotensin receptor- blocking drugs perhaps be harmful in the COVID-19 pandemic? |
| cord-332680-zfn81hew | Diabetes, Obes Metabolism Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state Antihypertensive drugs and risk of COVID-19? ACEI/ ARB use and risk of infection or severity or mortality of COVID-19: a systematic review and meta- analysis Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients Angiotensin- converting enzyme 2 protects from severe acute lung failure Renin- angiotensin- aldosterone system inhibitors in patients with COVID-19 Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury Discontinuation of and changes in drug therapy for hypertension among newly- treated patients: a population- based study in Italy |
| cord-333654-8rg99di5 | Imaging Features Acute myelitis after SARS- CoV-2 infection: a case report Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-333654-8rg99di5 | We first formulated the research question:"How significant is thromboembolism in the morbidity and mortality of COVID-19?"and focused on answering it. |
| cord-333487-zem2d4y6 | A Call for Actions Managing COVID-19 in Low- and Middle- Income Countries What is the role of Primary Health Care in the COVID-19 pandemic? |
| cord-333487-zem2d4y6 | Epidemiology, public policies and Covid-19 pandemics in Brazil: what can we expect? |
| cord-333487-zem2d4y6 | If I have diabetes, what do I need to know about COVID-19? |
| cord-334717-zg9f19p8 | Helpful or harmful? |
| cord-331375-tbuijeje | But how many days in the past? |
| cord-331375-tbuijeje | In consequence, are low detection rates in developed countries simply a management failure, or are there long- run incentives that promoted this behavior among many rich countries? |
| cord-331375-tbuijeje | It is clear that during the ongoing pandemic, improving detection rates is a race against time, but are there institutional and/or technological constraints that hamper detection improvements that can save lives? |
| cord-331375-tbuijeje | medRxiv Bacille Calmette- Guérin( BCG) vaccination and COVID-19 BCG vaccines may not reduce COVID-19 mortality rates Time- adjusted analysis shows weak associations between BCG vaccination policy and COVID-19 disease progression Significantly improved COVID-19 outcomes in countries with higher BCG vaccination coverage: a multivariable analysis COVID-19 related mortality: is the BCG vaccine truly effective? |
| cord-333041-69n2wwn3 | Can atmospheric pollution be considered a co- factor in extremely high level of SARS- CoV-2 lethality in Northern Italy? |
| cord-333041-69n2wwn3 | Specialized pro- resolving lipid mediators regulate ozone- induced pulmonary and systemic inflammation Exacerbation of nanoparticle- induced acute pulmonary inflammation in a mouse model of metabolic syndrome Inflammation resolution: a dual- pronged approach to averting cytokine storms in COVID-19? Pro- resolving lipid mediators are leads for resolution physiology SARS- CoV-2 infection: |
| cord-333041-69n2wwn3 | The specialized proresolving mediator 17-HDHA enhances the antibody- mediated immune response against influenza virus: a new class of adjuvant? |
| cord-334228-n69iewmx | when multiple strategies for enzyme activity regulation are available? |
| cord-333897-isodrtly | How low does it go? |
| cord-333897-isodrtly | authors: Shenoy, Niraj; Luchtel, Rebecca; Gulani, Perminder title: Considerations for target oxygen saturation in COVID-19 patients: are we under- shooting? |
| cord-334891-4jgtxg07 | Targeting human TLRs to combat COVID-19: A solution? |
| cord-334858-wxexl0qy | Why do n't some coronavirus patients sense their alarmingly low oxygen levels? |
| cord-335156-l4jie8g6 | So specific? |
| cord-335155-x9az3twa | Few obvious clues were given by the genome sequence to answer an important question: what is the origin of SARS- CoV? |
| cord-333520-v2sb90rc | : Is there enough evidence? |
| cord-333520-v2sb90rc | Could Mesenchymal Stem Cell- Derived Exosomes Be a Therapeutic Option for Critically Ill COVID-19 Patients? |
| cord-333520-v2sb90rc | Do Angiotensin- Converting Enzyme Inhibitors/ Angiotensin Receptor Blockers Have a Biphasic Effect? |
| cord-334976-53cd16w5 | Aggregating behavior of phenolic compounds- a source of false bioassay results? |
| cord-332153-fczf3lzc | -A novel"virus sink"that is defective in asthma? |
| cord-332153-fczf3lzc | COVID-19-what should anaethesiologists and intensivists know about it? |
| cord-332153-fczf3lzc | COVID-19: faecal- oral transmission? |
| cord-332153-fczf3lzc | Is global BCG vaccination- induced treained immunity relevant to the progression of the SARS.CoV-2 pandemic? |
| cord-332153-fczf3lzc | Rationale and study design Can melatonin reduce the severity of COVID-19 pandemic? |
| cord-334300-hnrmaytm | Type 2 are Expressed in the Human Endometrium SARS- CoV-2 and the next 1049 generations: which impact on reproductive tissues? |
| cord-334300-hnrmaytm | What can we expect from first- generation COVID-19 899 vaccines? |
| cord-333144-gyuh2fvl | An alternative drug for the treatment of COVID-19? |
| cord-333144-gyuh2fvl | Another zoonotic betacoronavirus causing SARS- like disease Efficacy of hydroxychloroquine in patients with COVID-19: Results of a randomized clinical trial Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: Trends, scope and relevance Doxycycline, a widely used antibiotic in dermatology with a possible anti- inflammatory action against IL-6 in COVID-19 outbreak MERS- CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte- derived antigen- presenting cells Favipiravir, an antiviral for COVID-19? |
| cord-333144-gyuh2fvl | The COVID-19 vaccine development landscape Dexamethasone for COVID-19? |
| cord-333144-gyuh2fvl | What is new on its pathogenesis and complications? |
| cord-334884-ig6n9cet | First respiratory transmitted food borne outbreak? |
| cord-334628-axon4jdc | : can we confidently link bats with emerging deadly viruses? |
| cord-334628-axon4jdc | : what can they teach us about the severe acute respiratory syndrome? |
| cord-332300-5osg046o | How many times? |
| cord-332300-5osg046o | How will countrybased mitigation measures influence the course of the COVID-19 epidemic? |
| cord-332300-5osg046o | The effects of temperature and relative humidity on the viability of the SARS coronavirus Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-332300-5osg046o | Understanding the epidemiology of COVID-19 Asymptomatic and presymptomatic SARS- CoV-2 infections in residents of a long- term care skilled nursing facility Cryo- EM structure of the 2019-nCoV spike in the prefusion conformation Asymptomatic and human- to- human transmission of SARS- CoV-2 in a 2-family cluster Clinical and epidemiological features of COVID-19 family clusters in Beijing Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Can N95 respirators be reused after disinfection? |
| cord-333498-d25qfq0f | A trial of lopinavir- ritonavir in adults hospitalized with severe Covid-19 Potential interventions for novel coronavirus in China: a systematic review Induction of pro- inflammatory cytokines( IL-1 and IL-6) and lung inflammation by Coronavirus-19( COVI-19 or SARS- CoV-2): anti- inflammatory strategies Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths Does vitamin D status impact mortality from SARS- CoV-2 infection? |
| cord-333498-d25qfq0f | Can the coronavirus disease 2019( COVID-19) affect the eyes? |
| cord-333498-d25qfq0f | The SARS epidemic in Hong Kong: what lessons have we learned? |
| cord-333498-d25qfq0f | over Ready to submit your research? |
| cord-332992-8rmqg4rf | : what do we know so far? |
| cord-332992-8rmqg4rf | Front Public Health Trained immunity: a tool for reducing susceptibility to and the severity of SARS- CoV-2 infection Complement as a target in COVID-19? |
| cord-332992-8rmqg4rf | Indeed, demographic differences as well as differences in health status, health care, COVID-19 treatment and cause of death assessment( i.e. did a person die with or die from COVID-19?), may explain the differences in reported case- fatality rates between different countries. |
| cord-332992-8rmqg4rf | SARS- CoV-2 Are pangolins the intermediate host of the 2019 novel coronavirus( SARS- CoV-2)? |
| cord-332992-8rmqg4rf | The possible mechanisms of action of 4-aminoquinolines( chloroquine/ hydroxychloroquine) against SARS- CoV-2 infection( COVID-19): a role for iron homeostasis? |
| cord-334378-dqtnj3y3 | How does RBD of the SARS- CoV-2 spike protein binds to the human receptor ACE2? |
| cord-334378-dqtnj3y3 | What are other therapeutic targets beyond the receptorbinding domain of the SARS- CoV-2 spike protein? |
| cord-335597-anrzcsrt | Is there a difference in local disease control between a VATS and thoracotomy approach? |
| cord-335492-od3c25qg | NL63 Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus- EMC Targeted recombination demonstrates that the spike gene of transmissible gastroenteritis coronavirus is a determinant of its enteric tropism and virulence Codon usage: mutational bias, translational selection, or both? |
| cord-334582-ccg27nmf | What was learned from the study? |
| cord-334582-ccg27nmf | Why carry out this study? |
| cord-325559-di8lljoi | Does SARS- CoV-2 Trigger Stress- Induced Autoimmunity by Molecular Mimicry? |
| cord-325559-di8lljoi | Furthermore, can there be protective factors? |
| cord-325559-di8lljoi | Furthermore, can there be protective factors? |
| cord-325559-di8lljoi | Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena? |
| cord-325559-di8lljoi | It Is Pneumonia? |
| cord-325559-di8lljoi | The Columbus'egg? |
| cord-325559-di8lljoi | What are the main clues that epidemiology and the clinics provide to date? |
| cord-325559-di8lljoi | What are the predisposing factors? |
| cord-325559-di8lljoi | What are the predisposing factors? |
| cord-325559-di8lljoi | What proteins? |
| cord-325559-di8lljoi | What proteins? |
| cord-325559-di8lljoi | Which cells? |
| cord-325559-di8lljoi | Which cells? |
| cord-325559-di8lljoi | Why should severe acute respiratory syndrome coronavirus 2( SARS- CoV-2) not be considered one of these? |
| cord-333547-88dkh6xd | State of the knowledge and research needs Computational analysis of SARS- CoV-2/ COVID-19 surveillance by wastewater- based epidemiology locally and globally: Feasibility, economy, opportunities and challenges Characteristics of pediatric SARS- CoV-2 infection and potential evidence for persistent fecal viral shedding Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Prolonged presence of SARS- CoV-2 viral RNA in faecal samples Evidence for Gastrointestinal Infection of SARS- CoV-2 COVID-19: faecal- oral transmission? |
| cord-333547-88dkh6xd | What Protocols for Biosafety, Molecular Detection and Serological Diagnostics? |
| cord-333547-88dkh6xd | What do we know? |
| cord-335648-lbmhprjn | impact of opening and closing decisions by stateda look at how social distancing measures may have influenced trends in COVID-19 cases and deaths Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-334550-xb0alubj | Emerg Could an unrelated live attenuated vaccine serve as a preventive measure to dampen septic inflammation associated with COVID-19 infection? |
| cord-334550-xb0alubj | How Do the Indian SARS- CoV-2 Strains Differ From the Strains Elsewhere? |
| cord-334550-xb0alubj | So what is that"X"factor apparently safeguarding the Indian population from the wrath of this pandemic? |
| cord-333805-xmqs2ax7 | A Retrospective Multicenter Study Guillain- Barre syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-333805-xmqs2ax7 | Does SARD- CoV-2 invade the brain? |
| cord-333805-xmqs2ax7 | The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America Guillain- Barre syndrome following COVID-19: new infection, old complication? |
| cord-333805-xmqs2ax7 | causative or coincidental? |
| cord-335338-wzxjn5ip | How the SARS coronavirus causes disease: host or organism? |
| cord-335338-wzxjn5ip | how, why, and so what? |
| cord-335859-k37jivp6 | The incidence of COVID infection in Canada? |
| cord-335293-pac6wbgz | With COVID-19 Gastrointestinal features in children with COVID-19: an observation of varied presentation in eight children Kawasaki- like disease: emerging complication during the COVID-19 pandemic Where have all the children gone? |
| cord-335302-6wsx0jby | How many more might still be undetected? |
| cord-334495-7y1la856 | * Is There a Role for Lung Ultrasound During the COVID-19 Pandemic? |
| cord-334495-7y1la856 | An Information Statement from ASNC Management of Acute Myocardial Infarction During the COVID-19 Pandemic Virtually Perfect? |
| cord-334495-7y1la856 | COVID-19 pneumonia: a random association? |
| cord-336094-ssr5y4u3 | : What is the Optimal Definition? |
| cord-335137-5qt286kc | Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites SARS- CoV-2 and the pathophysiology of coronavirus disease 2019 Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS- CoV-2 A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person- to- person transmission: a study of a family cluster Detection of 2019 novel coronavirus( 2019-nCoV) by real- time RT- PCR Coronaviruses as the cause of respiratory infections WHO Declares COVID-19 a Pandemic Molecular docking as a popular tool in drug design, an in silico travel Mannose- binding lectin deficiency and respiratory tract infection Coronavirus and obesity: could insulin resistance mediate the severity of Covid-19 infection? |
| cord-334603-yt2pmxi3 | ( CLEC4 M) plays a protective role in SARS coronavirus infection Black/ white differences in leukocyte subpopulations in men HLA studies in the context of coronavirus outbreaks Guillain- Barre syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-334603-yt2pmxi3 | Is ethnicity linked to incidence or outcomes of covid-19? Association of HLA class I with severe acute respiratory syndrome coronavirus infection Association of human- leukocyteantigen class |
| cord-336150-l8w7xk0b | hospitalists'perspective Broad- spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses Coronavirus: epidemiology, genome replication and the interactions with their hosts Characterization of the receptorbinding domain( RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine Differential stepwise evolution of SARS coronavirus functional proteins in different host species Dexamethasone for COVID-19? |
| cord-335308-5kh7wgvx | Why does the wild- type HCoV-229E Nsp9, but not the SARS- CoV protein, form a disulfide- linked homodimer even though it has Cys69(73) conserved? |
| cord-335308-5kh7wgvx | [ 53] What is the relevance of these in vitro studies to the situation in the infected host cell? |
| cord-336093-ic6q6ke8 | Yeast mRNA cap methyltransferase is a 50-kilodalton protein encoded by an essential gene Flaviviral methyltransferase/ RNA interaction: structural basis for enzyme inhibition Discovery of an RNA virus 3 0? |
| cord-333730-qsx0m68e | An open pilot study On chikungunya acute infection and chloroquine treatment Confronting an influenza pandemic with inexpensive generic agents: can it be done? |
| cord-333730-qsx0m68e | Anti- malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model Influenza A/ H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy? |
| cord-333730-qsx0m68e | inhibition with baricitinib in the treatment of autoinflammatory interferonopathies Baricitinib for COVID-19: a suitable treatment? |
| cord-333696-3ci9re9a | Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population? |
| cord-333696-3ci9re9a | Leukoencephalopathy Associated with Severe COVID-19 Infection: Sequela of Hypoxemia? |
| cord-333696-3ci9re9a | Nicotine Modulates the Renin- Angiotensin System of Cultured Neurons and Glial Cells from Cardiovascular Brain Areas of Wistar Kyoto and Spontaneously Hypertensive Rats Nicotine and the renin- angiotensin system Brain renin- angiotensin system and dopaminergic cell vulnerability Angiotensins in Alzheimer's disease&# x2013; friend or foe? |
| cord-333696-3ci9re9a | Why now? |
| cord-335567-ssnvr6nj | Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients Clinical impact and diagnosis of human metapneumovirus infection Emerging respiratory agents: New viruses for old diseases? |
| cord-335567-ssnvr6nj | Passenger or pathogen in acute respiratory tract infections? |
| cord-336447-hpnkou41 | A systematic review of asymptomatic infections with COVID-19 Evaluation of COVID-19 RT- q PCR test in multi- sample pools Preliminary prediction of the basic reproduction number of the Wuhan novel coronavirus 2019-nCoV Diagnosis of the coronavirus disease( COVID-19): rRT- PCR or CT? |
| cord-335916-fh28qrt7 | Should we stimulate or suppress immune responses in COVID-19? |
| cord-334624-chnibsa1 | Are the viral 390 immune manipulation strategies ineffective? |
| cord-334624-chnibsa1 | However, an important question remains: Why 389 are some innate immune pathways, such as IFN- γ signaling less antagonized( Fig. 1)? |
| cord-334624-chnibsa1 | Why would multiple effective proteins target the same pathway? |
| cord-336481-vrnxu217 | : cord-336481-vrnxu217 authors: Bonifácio, Lívia Pimenta; Pereira, Ana Paula Sulino; Araújo, Daniel Cardoso de Almeida e; Balbão, Viviane da Mata Pasti; da Fonseca, Benedito Antônio Lopes; Passos, Afonso Dinis Costa; Bellissimo- Rodrigues, Fernando title: Are SARS- CoV-2 reinfection and Covid-19 recurrence possible? |
| cord-335538-thd5oaef | Another road for RAS? |
| cord-335538-thd5oaef | Why do we need a selective angiotensin II type 2 receptor agonist? |
| cord-335386-eflyypev | When children leave a"shelter- in- place"environment and return to school, how will this impact more- vulnerable populations? |
| cord-335386-eflyypev | Where are influenza virus and rhinovirus/ enterovirus? |
| cord-334612-lxqcvqca | Did children really need to face the wall while eating their snack? |
| cord-334612-lxqcvqca | Did preschool teachers really need to wear aprons with carry alcohol spray, tissues and gloves? |
| cord-334612-lxqcvqca | Was it necessary for children to wash hands 5 times within 3 hours? |
| cord-336053-cjq7szcn | G Italy Cardiol Acute pulmonary embolism and COVID-19 pneumonia: A random association? |
| cord-336053-cjq7szcn | key: cord-336053-cjq7szcn authors: Mottola, Filiberto Fausto; Verde, Nicoletta; Ricciolino, Riccardo; Di Mauro, Marco; Migliaccio, Marco Giuseppe; Carfora, Vincenzo; Spiniello, Giorgio; Coppola, Nicola title: Cardiovascular System in COVID-19: Simply a Viewer or a Leading Actor? |
| cord-333092-78vo7i6v | Have the authors used any cardiac biomarkers, such as troponin- T or echocardiography( tissue Doppler imaging), to assess myocardial function in the infants? |
| cord-333092-78vo7i6v | Have they noticed any signs of malnutrition( wasting or stunting) in these infants? |
| cord-333092-78vo7i6v | Have they ruled out the congenital heart defects in all the infants with SARS- CoV-2 infection? |
| cord-333092-78vo7i6v | What about the rest of them? |
| cord-333092-78vo7i6v | Whether they received only antiviral and traditional Chinese medication? |
| cord-334277-g3go3u02 | How Well Do They Actually Perform? |
| cord-334277-g3go3u02 | Should RT- PCR be considered a gold standard in the diagnosis of Covid-19? Antibody Responses to Sars- Cov-2 in Patients with Covid-19 Value of Diagnostic Testing for Sars- Cov-2/ Covid-19 Role of Serology in the Covid-19 Pandemic |
| cord-334277-g3go3u02 | The Role of Antibody Testing for Sars- Cov-2: Is There One? |
| cord-334277-g3go3u02 | Will Antibody Tests for the Coronavirus Really Change Everything? |
| cord-336119-8g37xsys | An open- source molecular graphics tool New insights on the antiviral effects of chloroquine against coronavirus: What to expect for COVID-19? |
| cord-336119-8g37xsys | Exploring anti- rheumatic drugs to reduce immune hyperactivation in HIV/ AIDS Does zinc supplementation enhance the clinical efficacy of chloroquine/ hydroxychloroquine to win todays battle against COVID-19? |
| cord-337026-osgi06o4 | Can the coronavirus disease 2019( COVID-19) affect the eyes? |
| cord-334564-bqh9jkds | Evidence from a population- based eleven- year survey in Japan Is living alone"aging alone"? |
| cord-334564-bqh9jkds | If the increase in cytokine levels and the manifestation of psychiatric symptoms are related to the severity of the symptoms of SARS- CoV infection, the"cytokine storm"might also be related to the"mental health thunderstorms"seen in patients with COVID-19? |
| cord-334564-bqh9jkds | Traumatic memories, post- traumatic stress disorder and serum cortisol levels in long- term survivors of the acute respiratory distress syndrome Disrupted glucocorticoid- Immune interactions during stress response in schizophrenia Life events and high- trait reactivity together predict psychotic symptom increases in schizophrenia Increased serum interleukin-6 levels in early stages of psychosis: associations with at- risk mental states and the severity of psychotic symptoms Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population- based register study The psychological impact of quarantine and how to reduce it: rapid review of the evidence Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease( COVID-19) epidemic among the general population in china Living alone and depressive symptoms: the influence of gender, physical disability, and social support among Hispanic and non- Hispanic older adults Living alone and depression: the modifying role of the perceived neighborhood environment Living alone or with others and depressive symptoms, and effect modification by residential social cohesion among older adults in Japan: the JAGES longitudinal study Living arrangements and risk for late life depression: a meta- analysis of published literature Which is riskier for mental health, living alone or not participating in any social activity? |
| cord-334564-bqh9jkds | the epidemic and the challenges Anosmia and ageusia: common findings in COVID-19 patients Posttraumatic stress symptoms and attitude toward crisis mental health services among clinically stable patients with COVID-19 in China Prevalence and factors associated with depression and anxiety of hospitalized patients with COVID-19 A first case of meningitis/ encephalitis associated with SARS- Coronavirus-2 Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? |
| cord-336782-0zkb39v1 | Task force of the European Society of Intensive Care Medicine Position paper for the organization of ECMO programs for cardiac failure in adults Echocardiography: do we need new standards for ECMO patients? |
| cord-336870-nirg3269 | The SARS, MERS and novel coronavirus( COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
| cord-337297-fkw8780t | Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-335467-0b0m8v5r | Transcriptome analysis of infected and bystander type 2 alveolar epithelial cells during influenza a virus infection reveals in vivo Wnt pathway Downregulation Innate immune response of human alveolar type II cells infected with severe acute respiratory syndromecoronavirus Innate immune response to influenza a virus in differentiated human alveolar type II cells 19: what happens inside the body? |
| cord-335467-0b0m8v5r | Transdifferentiation of alveolar epithelial type II to type I cells is controlled by opposing TGF- β and BMP signalling Infection and rapid transmission of SARS- CoV-2 in ferrets Alteration of inflammatory mediators in the upper and lower airways under chronic intermittent hypoxia: preliminary animal study Evaluation of activation and inflammatory activity of myeloid cells during pathogenic human coronavirus infection How much oxygen does the human lung consume? |
| cord-336677-h62angfw | The Washington Post Clinical Characteristics of Coronavirus Disease 2019 in China Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019( COVID-19) Ocular manifestation as first sign of Coronavirus Disease 2019( COVID-19): Interest of telemedicine during the pandemic context 2019-nCoV transmission through the ocular surface must not be ignored Hand hygiene and facemasks against COVID-19: Should we consider alternate strategies? |
| cord-337339-0vkigjv2 | Infection and Rapid Transmission of SARS- CoV-2 in Ferrets Is there an ideal animal model for SARS? |
| cord-337208-6rs1sgx1 | Of the 4 people of SARS- CoV-2 positive infection in the Case 1 family, who was the first to be infected and transmitted the virus to the other 3 people? |
| cord-335172-5ig907on | Finally, and more controversially, should we evaluate the modulating effects of AngII on ACE2 for the treatment of COVID-19 in patients without shock? |
| cord-335172-5ig907on | For instance, should AngII be used for all COVID-19 patients in shock? |
| cord-335172-5ig907on | Should it be considered earlier in the course of disease, perhaps as a first- line vasopressor? |
| cord-335172-5ig907on | key: cord-335172- 5ig907on authors: Busse, Laurence W.; Chow, Jonathan H.; McCurdy, Michael T.; Khanna, Ashish K. title: COVID-19 and the RAAS — a potential role for angiotensin II? |
| cord-337137-0ey40gzw | How the SARS coronavirus causes disease: host or organism? |
| cord-334849-8rblgq9b | COVID-19 pandemic: is a gender- defined dosage effect responsible for the high mortality rate among males? |
| cord-334849-8rblgq9b | Could Genetic Factors Be Relevant in the Clinical Course of COVID-19? |
| cord-334849-8rblgq9b | SARS- CoV-2 and Influenza B- cell engineering: A promising approach towards vaccine development for COVID-19 After the Storm-A Responsible Path for Genome Editing COVID-19 vaccine development: Time to consider SARS- CoV-2 challenge studies? |
| cord-337430-c2vdnml7 | Can exercise affect immune function to increase susceptibility to infection? |
| cord-336605-d4loia11 | authors: Zhang, Xue Wu; Yap, Yee Leng title: Old drugs as lead compounds for a new disease? |
| cord-331790-0w0pjjg1 | ( 43) Is there a role for serologic testing? |
| cord-331790-0w0pjjg1 | And finally, will COVID-19 be around until we have evidence- based answers to all these questions? |
| cord-331790-0w0pjjg1 | COVID-19-related mortality with mortality on the waiting list? |
| cord-331790-0w0pjjg1 | Does the presence of antibodies confer complete protection against re- infection? |
| cord-331790-0w0pjjg1 | What can we learn from allograft biopsies about the susceptibility of kidney tissue for direct infection by SARS- CoV-2? |
| cord-331790-0w0pjjg1 | What is the optimal immunosuppression management strategy? |
| cord-331790-0w0pjjg1 | When is it safe to accept kidneys from COVID-19 individuals who have recovered? |
| cord-337557-ct43uoir | A possible role for B cells in COVID-19?: |
| cord-335784-v7nbck0n | And Operational feasibility-can we technically and logistically implement the pooling scheme and quickly adapt it to changes in infection prevalence rates? |
| cord-335784-v7nbck0n | Sensitivity-can we detect samples with lower viral load of clinical significance despite sample dilution? |
| cord-335784-v7nbck0n | When considering any of the SARS- CoV-2 pooling schemes, there are three crucial concerns: Efficiency-how many tests are spared in practice and its relation to the prevalence rate? |
| cord-337179-qytruuif | to Prevent Lung Damage in SARSCoV2 Infection? |
| cord-333368-kjrk8nn9 | : Why Children Fare Better than Adults? |
| cord-333368-kjrk8nn9 | COVID-19? Association between BMI and COVID-19 hospitalization by age Meta- inflammaging at the crossroad of geroscience Pathophysiology of COVID-19 |
| cord-333368-kjrk8nn9 | Does hyperglycemia worsen COVID-19 or does COVID-19 lead to immune pancreatic damage leading to hyperglycemia? |
| cord-333368-kjrk8nn9 | Is testosterone a key factor? |
| cord-333368-kjrk8nn9 | Sex differences in obesity, lipid metabolism, and inflammation- A role for the sex chromosomes? |
| cord-333368-kjrk8nn9 | The species Severe acute respiratory syndrome- related coronavirus: classifying 2019-nCoV and naming it SARS- CoV-2 COVID-19 and comorbidities: A role for dipeptidyl peptidase 4( DPP4) in disease severity? |
| cord-333368-kjrk8nn9 | factors associated with COVID-19 death in 17 million patients Can body mass index predict clinical outcomes for patients with acute lung injury/ acute respiratory distress syndrome? |
| cord-336909-nnxa5ant | : is there one? |
| cord-337674-mb6ue2hl | Has a new era begun? |
| cord-315598-qwh72inx | A Missing Link? |
| cord-315598-qwh72inx | Ann Intensive Care Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta- analysis Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome and Posterior Probability of Mortality Benefit in a Post Hoc Bayesian Analysis of a Randomized Clinical Trial Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis- Associated Organ Dysfunction in Children Use of ECMO in ARDS: does the EOLIA trial really help? |
| cord-315598-qwh72inx | COVID-19 pneumonia: ARDS or not? |
| cord-315598-qwh72inx | COVID-19 pneumonia: different respiratory treatment for different phenotypes? |
| cord-315598-qwh72inx | Can Lung US Help Critical Care Clinicians in the Early Diagnosis of Novel Coronavirus( COVID-19) Pneumonia? |
| cord-315598-qwh72inx | Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients? |
| cord-315598-qwh72inx | Cómo podemos medir la calidad de vida, en los pacientes con COVID-19 que egresan de la uci? |
| cord-315598-qwh72inx | Documento de Rionegro Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019( COVID-19) COVID-19 pneumonia: different respiratory treatments for different phenotypes? |
| cord-315598-qwh72inx | Does COVID19 Infect the Brain? |
| cord-315598-qwh72inx | Does SARS- Cov-2 invade the brain? |
| cord-315598-qwh72inx | Does central venous pressure predict fluid responsiveness? |
| cord-315598-qwh72inx | Heart Lung Patient selfproning with high- flow nasal cannula improves oxygenation in COVID-19 pneumonia Expert Recommendations for Tracheal Intubation in Critically ill Patients with Noval Coronavirus Disease Intubation and Ventilation amid the COVID-19 Outbreak: Wuhan's Experience Sedation for critically ill patients with COVID-19: Which specificities? |
| cord-315598-qwh72inx | How should health systems prepare for the evolving COVID-19 pandemic? |
| cord-315598-qwh72inx | How will countrybased mitigation measures influence the course of the COVID-19 epidemic? |
| cord-315598-qwh72inx | Incidence, clinical course, and outcome in 217 patients with acute respiratory distress syndrome Driving pressure and survival in the acute respiratory distress syndrome Driving pressure: a marker of severity, a safety limit, or a goal for mechanical ventilation? |
| cord-315598-qwh72inx | Management of COVID-19 Respiratory Distress Stages or phenotypes? |
| cord-315598-qwh72inx | Noninvasive ventilation in acute cardiogenic pulmonary edema Noninvasive Ventilation in Acute Heart Failure Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure Is there a role for noninvasive ventilation in acute respiratory distress syndrome? |
| cord-315598-qwh72inx | Pautas COVID-19 HiSpaFlow) endGEMdTdScAFeA. Respiratory support therapy after extubation: Who and how? |
| cord-315598-qwh72inx | Pdlr An international survey of training in adult intensive care medicine Do intensivist staffing patterns influence hospital mortality following ICU admission? |
| cord-315598-qwh72inx | Por qué seguimos buscando métodos alternativos? |
| cord-315598-qwh72inx | Radiography( Lond) Point- of- Care Lung Ultrasound Findings in Patients with COVID-19 Pneumonia Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic D- dimer in patients infected with COVID-19 and suspected pulmonary embolism Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy Anticoagulation in COVID-19 Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections Procalcitonin to Distinguish Viral From Bacterial Pneumonia: A Systematic Review and Meta- analysis Procalcitonin in patients with severe coronavirus disease 2019( COVID-19): A meta- analysis Viral load of SARS- CoV-2 in clinical samples Discharge criteria for confirmed COVID-19 cases-When is it safe to discharge COVID-19 cases from the hospital or end home isolation? |
| cord-315598-qwh72inx | The SARS, MERS and novel coronavirus( COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
| cord-315598-qwh72inx | Underestimated Opportunistic Pathogens of the Central Nervous System? |
| cord-315598-qwh72inx | What are the effects of multimodal campaigns to improve hand hygiene of healthcare workers? |
| cord-315598-qwh72inx | Will This Hemodynamically Unstable Patient Respond to a Bolus of Intravenous Fluids? |
| cord-315598-qwh72inx | a la bata manga larga con antifluido durante la atención del paciente con COVID-19? |
| cord-315598-qwh72inx | beneficios en desenlaces clínicos de interés? |
| cord-315598-qwh72inx | convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? |
| cord-315598-qwh72inx | de COVID-19? |
| cord-315598-qwh72inx | why, when and how? |
| cord-337673-1nau263l | nature abhors a double- strand Role for a bidentate ribonuclease in the initiation step of RNA interference RNA interference is mediated by 21-and 22-nucleotide RNAs Argonaute2, a link between genetic and biochemical analyses of RNAi Single- stranded antisense siRNAs guide target RNA cleavage in RNAi Transgenes and gene suppression: telling us something new? |
| cord-337372-y43prnko | Which preventive measures might protect health care workers from SARS? |
| cord-337896-mct29erg | Refreshingly, we have relearned what our beloved mentor, Dan Present, would say in his inimitable Brooklyn accent,"If you wanna know how a patient is doin'all you need to do is say,'how you doin'?" |
| cord-336560-m5u6ryy9 | Interferon- Stimulated Genes: What Do They All Do? |
| cord-336560-m5u6ryy9 | New treatment options for delta virus: Is a cure in sight? |
| cord-332109-ont0tqpn | A Nationwide Case- Control Study Overdose and risk factors for coronavirus disease 2019 Alcohol use and misuse during the COVID-19 pandemic: A potential public health crisis? |
| cord-332109-ont0tqpn | A multicenter, single- blind, randomized controlled trial Favipiravir, an antiviral for COVID-19? |
| cord-332109-ont0tqpn | Cardiovascular effects of marijuana and synthetic cannabinoids: The good, the bad, and the ugly Marijuana use and brain immune mechanisms Harmful Effects of Smoking Cannabis: A Cerebrovascular and Neurological Perspective Marijuana and chronic obstructive lung disease: A population- based study Does smoking marijuana increase the risk of chronic obstructive pulmonary disease? |
| cord-332109-ont0tqpn | Chronic nicotine treatment induces T cell anergy Are healthy smokers really healthy? |
| cord-332109-ont0tqpn | The Relationship between Alcohol Consumption and Vascular Complications and Mortality in Individuals With Type 2 Diabetes Habitual alcohol consumption is associated with lower cardiovascular stress responses- A novel explanation for the known cardiovascular benefits of alcohol? |
| cord-332109-ont0tqpn | The blood- brain barrier and methamphetamine: Open sesame? |
| cord-332109-ont0tqpn | Why is parkinsonism not a feature of human methamphetamine users? |
| cord-337753-olc00glo | An interactive web- based dashboard to track COVID-19 in real time Early transmission of SARS- CoV-2 in South Africa: An epidemiological and phylogenetic report Characterization of SARS- CoV-2 viral diversity within and across hosts Emergence of genomic diversity and recurrent mutations in SARS- CoV-2 Genetic susceptibility to infectious diseases: big is beautiful, but will bigger be even better? |
| cord-337089-ksh62ni0 | Probable pangolin origin of SARS- CoV-2 associated with the COVID-19 outbreak Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross- species transmission from snake to human A novel bat coronavirus closely related to SARS- CoV-2 contains natural insertions at the S1/ S2 cleavage site of the spike protein Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade- long structural studies of SARS coronavirus Genomic characterization of a novel SARS- CoV-2 Clinical manifestations and outcome of SARS- CoV-2 infection during pregnancy Do pets protect their owners in the COVID-19 era? |
| cord-337089-ksh62ni0 | a comparative serological study Antibodies against MERS coronavirus in dromedary camels Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe Bats may be SARS reservoir Infection and rapid transmission of SARS- CoV-2 in ferrets COVID-19, SARS and MERS: are they closely related? |
| cord-336628-0evl3wnd | Can we use interleukin-6( IL-6) blockade for coronavirus disease 2019( COVID-19)-induced cytokine release syndrome( CRS)? |
| cord-336628-0evl3wnd | Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy Dexamethasone for COVID-19? |
| cord-336628-0evl3wnd | Signaling NF- kappaB and virus infection: who controls whom Who's Driving? |
| cord-337663-ow1l18li | Impact of antiandrogenic therapies on COVID-19: an observational study in male population from a COVID-19 regional centre of Lombardy( Italy) Urologic surgery and invasive procedures during coronavirus pandemic: retrospective comparison of risk infection in a referral Covid hospital and in a free- Covid hospital COVID19 pandemic impacts on anxiety of French urologist in training: outcomes from a national survey Impact of the COVID-19 pandemic on urology residency training in Italy Teleurology in the time of Covid-19 pandemic: here to Stay? |
| cord-337663-ow1l18li | cord-337663-ow1l18li authors: Qu, Liang G.; Perera, Marlon; Lawrentschuk, Nathan; Umbas, Rainy; Klotz, Laurence title: Scoping review: hotspots for COVID-19 urological research: what is being published and from where? |
| cord-336563-hwemigk7 | A Trial of Lopinavir- Ritonavir in Adults Hospitalized with Severe Covid-19 Medication patterns and disease progression among 165 patients with coronavirus disease 2019( COVID-19) in Wuhan, China: a single- centered, retrospective, observational study Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease SARS: systematic review of treatment effects Effective treatment of severe COVID-19 patients with Tocilizumab Clinical course and outcomes of critically ill patients with SARS- CoV-2 pneumonia in Wuhan, China: a single- centered, retrospective, observational study ACTEMRA ®( tocilizumab) injection, for intravenous or subcutaneous use Interleukin-6 and cytochrome- P450, reason for concern? |
| cord-336563-hwemigk7 | Should ACE and ARB's for hypertension be stopped in patients infected with COVID19? |
| cord-336563-hwemigk7 | Should NSAIDS be stopped in patients infected with COVID-19? |
| cord-338647-dtuohsf5 | Possible role of imatinib in clinical pulmonary veno- occlusive disease Complete resolution of life threatening bleomycininduced pneumonitis after treatment with imatinib mesylate in a patient with Hodgkin's lymphoma: hope for severe chemotherapy- induced toxicity? |
| cord-337200-2qwty2jp | To PAPR or not to PAPR? |
| cord-337200-2qwty2jp | i m Gesundheitswesen eine Rolle? |
| cord-338243-njkhwkwk | Novel Wuhan( 2019-nCoV) Coronavirus A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person- to- person transmission: a study of a family cluster Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China Technical solution for emergency treatment of medical sewage contaminated by novel coronavirus Developmental toxicity of disinfection by- product monohaloacetamides in embryo- larval stage of zebrafish Association of Occupational Exposure to Disinfectants With Incidence of Chronic Obstructive Pulmonary Disease Among US Female Nurses Trihalomethanes in Drinking Water and Bladder Cancer Burden in the European Union Disinfection Byproducts in Rajasthan, India: Are Trihalomethanes a Sufficient Indicator of Disinfection Byproduct Exposure in Low- Income Countries? |
| cord-338351-y1t9emu1 | Ora, Josuel; Puxeddu, Ermanno; Cavalli, Francesco; Giorgino, Federica Maria; Girolami, Andrea; Chiocchi, Marcello; Sergiacomi, Giaunluigi; Federici, Massimo; Rogliani, Paola title: Does bronchoscopy help the diagnosis in Covid-19 infection? |
| cord-337396-g69bb60d | gold Open Access which fosters wider collaboration and increased citations maximum visibility for Ready to submit your research? |
| cord-337396-g69bb60d | infected rhesus macaques Duration of severe acute respiratory syndrome Coronavirus( SARS- CoV-2) infectivity: When is it safe to discontinue isolation? |
| cord-338468-c0jv3i1t | The trinity of COVID-19: Immunity, inflammation and intervention On the molecular determinants of the SARS- CoV-2 attack Are the universes of antibodies and antigens symmetrical? |
| cord-332610-t99l3zii | How do emerging diseases come to be categorized as'emerging'? |
| cord-332610-t99l3zii | If certain populations have long been afflicted by these disorders, why are the diseases considered''new''or''emerging''? |
| cord-332610-t99l3zii | If this is the case, what is the concern over avian influenza? |
| cord-332610-t99l3zii | In his critical analysis of emerging infection, Farmer asks,''Emerging for whom?'' |
| cord-332610-t99l3zii | Is it simply because they have come to afflict more visible-read more''valuable''persons? |
| cord-332610-t99l3zii | Nor does it answer the question''what drives the overall worldwide trends in such problems?'' |
| cord-332610-t99l3zii | Should toxic shock syndrome be considered to be an emerging disease? |
| cord-332610-t99l3zii | The 1969 outbreak was publicized in the United States through the news media, perhaps because it was an'exotic'or newsworthy event, and once again, the social amplification of risk was responsible for exaggerated fears of'what if it spreads here?' |
| cord-332610-t99l3zii | not answer either the micro- scale questions such as''why is there an outbreak here, now, of this size, affecting these people?''nor does it answer the macro- questions such as''why are there more( or fewer) outbreaks this decade than last?'' |
| cord-332610-t99l3zii | not answer either the micro- scale questions such as''why is there an outbreak here, now, of this size, affecting these people?''nor does it answer the macro- questions such as''why are there more( or fewer) outbreaks this decade than last?'' |
| cord-337220-yv7qdvzi | One Health, emerging infectious diseases 807 and wildlife: two decades of progress? |
| cord-337220-yv7qdvzi | Potential rapid diagnostics, vaccine and therapeutics for 519 2019 novel coronavirus( 2019-nCoV): a systematic review Performance of radiologists in differentiating COVID-19 from viral pneumonia on 523 chest CT CT features of coronavirus disease 2019( COVID-19) 526 pneumonia in 62 patients in Wuhan, China Development and clinical application of a rapid IgM- IgG combined antibody test for SARS-575 CoV-2 infection diagnosis Correlation of 578 chest CT and RT- PCR testing in coronavirus disease 2019( COVID-19) in China: a report of 579 1014 cases Biosensors and bio- based methods for the separation and detection of 582 foodborne pathogens One day to one hour: how quickly can foodborne pathogens be detected? |
| cord-336000-v88bq4bx | Autopsy findings in eight patients with fatal H1N1 influenza H1N1-Induced Venous Thromboembolic Events? |
| cord-336000-v88bq4bx | Due to Occurrence of Pulmonary Vascular Thrombosis? |
| cord-336000-v88bq4bx | Results of a Single- Institution Case Series Acute Pulmonary Embolism and COVID-19 Pneumonia: A Random Association? |
| cord-336000-v88bq4bx | What Is the Evidence? |
| cord-338001-jig46hsk | The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus- infected pneumonia in Angiotensin- converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus Are children less susceptible to COVID-19? |
| cord-333909-uco4c946 | But how long can sports stay inside? |
| cord-333909-uco4c946 | Two metres or one: what is the evidence for physical distancing in covid-19? |
| cord-333909-uco4c946 | What are the implications for public health practice? |
| cord-333909-uco4c946 | What is added by this report? |
| cord-333909-uco4c946 | What is already known about this topic? |
| cord-333909-uco4c946 | What settings have been linked to SARS- CoV-2 transmission clusters? |
| cord-338901-1kzy7rts | a retrospective cohort study Use of chloroquine in viral diseases Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-338798-xsun927w | Chloroquine as a prophylactic agent against COVID-19? |
| cord-337572-kx5hihnr | WHAT ARE CORONAVIRUSES AND WHERE DO THEY COME FROM? |
| cord-337572-kx5hihnr | an overview of their replication and pathogenesis Structural insights into coronavirus entry ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia Rates of evolutionary change in viruses: patterns and determinants RNA recombination in animal and plant viruses Cultivation of the virus of infectious bronchitis Animal coronaviruses: what can they teach us about the severe acute respiratory syndrome? |
| cord-338741-gy3ovkrt | This study demonstrated that the administration of convalescent plasma to hospitalized patients might? be redundant, according to the authors[ 25]. |
| cord-339241-e2nl766y | The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures Time to use the p- word? |
| cord-339352-c9uh8vjx | Covid-19? |
| cord-338055-2d6n4cve | From gene structure to pathogenic mechanisms and potential therapy Sars coronavirus accessory gene expression and function Understanding genomic diversity, pan- genome, and evolution of sars- cov-2 Immune evasion via sars- cov-2 orf8 protein? |
| cord-338055-2d6n4cve | would a rose by another name smell as 420 sweet? |
| cord-336604-2auhkxce | Are the conclusions drawn adequately supported by the results? |
| cord-336604-2auhkxce | If applicable, is the statistical analysis and its interpretation appropriate? |
| cord-336604-2auhkxce | Yes Are all the source data underlying the results available to ensure full reproducibility? |
| cord-336604-2auhkxce | Yes Are the conclusions drawn adequately supported by the results? |
| cord-336177-p7b7yw28 | An augmented passive immune therapy to treat fulminant bacterial infections Position paper on use of convalescent plasma, serum or immune globulin concentrates as an element in response to an emerging virus Meta- analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? |
| cord-336177-p7b7yw28 | Could intravenous immunoglobulin collected from recovered coronavirus patients protect against COVID-19 and strengthen the immune system of new patients? |
| cord-336177-p7b7yw28 | new evidence for an old therapeutic tool? |
| cord-339093-mwxkvwaz | Engineered Autonomous Human Variable Domains Antiviral Monoclonal Antibodies: Can They Be More Than Simple Neutralizing Agents? |
| cord-337712-ylqgraos | Can we contain the COVID-19 outbreak with the same measures as for SARS? |
| cord-337712-ylqgraos | The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin- like cleavage site absent in CoV of the same clade A genomic perspective on the origin and emergence of SARS- coV-2 Structure of the SARS- CoV-2 spike receptor- binding domain bound to the ACE2 receptor Structural and functional basis of SARS- coV-2 entry by using human ACE2 SARS- coV-2 ORF3b is a potent interferon antagonist whose activity is increased by a naturally occurring elongation variant A pneumonia outbreak associated with a new coronavirus of probable bat origin Evolutionary origins of the SARS- CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic Arepangolins the intermediate host of the 2019 novel coronavirus( SARS- CoV-2)? |
| cord-337712-ylqgraos | numerous options, no certainty for a versatile virus Antivirals against Coronaviruses: candidate drugs for SARS- coV-2 treatment? |
| cord-338140-p88fgojk | It suggested that all the potential interventions be implemented to control the emerging COVID-19 if the infection is uncontrollable and proposed to verify the nutritional status of COVID-19 Immune- boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: could they help against COVID-19? |
| cord-338140-p88fgojk | Optimal nutritional status for a well- functioning immune system is an important factor to protect against viral infections Vitamin D for COVID-19: a case to answer? |
| cord-338589-1ent68fx | the beginning of another SARS- like pandemic? |
| cord-338980-pygykil7 | With inserts and changing structural dynamics between clades or viruses, the questions become 1) which sequence motif are displayed and 2) to what extent are these sequence motifs displayed? |
| cord-339012-4juhmjaj | COVID-19-induced acute respiratory failure: an exacerbation of organspecific autoimmunity? |
| cord-339172-210dwhgj | if RNA synthesis would indeed occur inside closed DMVs or VPs, how then are import and export across the double membrane achieved? |
| cord-339303-feiy6xed | Will SARS hurt the world's poor? |
| cord-339506-pkusvf82 | Does SARS- CoV-2 has a longer incubation period than SARS and MERS? |
| cord-338544-eph89g47 | COVID-19: is it just a lung disease? |
| cord-338544-eph89g47 | Int Forum Allergy Rhinol Guillain Barre syndrome associated with COVID-19 infection: a case report Guillain- Barré syndrome following COVID-19: new infection, old complication? |
| cord-337646-gkcm6ds0 | Environ Pollut Seasonality of respiratory viral infections Environmental engineers and scientists have important roles to play in stemming outbreaks and pandemics caused by enveloped viruses Environmental perspective of COVID-19 Respiratory virus shedding in exhaled breath and efficacy of face masks Covid-19 airborne transmission and its prevention: waiting for evidence or applying the precautionary principle? |
| cord-337646-gkcm6ds0 | The SARS, MERS and novel coronavirus( COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
| cord-337646-gkcm6ds0 | state of the knowledge and research needs Water, sanitation, hygiene, and waste management for the COVID-19 virus: interim guidance Can atmospheric pollution be considered a co- factor in extremely high level of SARS- CoV-2 lethality in Northern Italy? |
| cord-338684-po3hfibp | Ocular involvement and COVID-19 Tears and conjunctival scrapings for coronavirus in patients with SARS Conjunctiva- upper respiratory tract irrigation for early diagnosis of severe acute respiratory syndrome Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade- long structural studies of SARS coronavirus Isolation and characterization of a bat SARS- like coronavirus that uses the ACE2 receptor Can the coronavirus disease 2019( COVID-19) affect the eyes? |
| cord-338684-po3hfibp | what we know and what we do not know A Rashomon Moment? |
| cord-339386-sxyeuiw1 | The adaptation of two human coronavirus strains( OC38 and OC43) to growth in cell monolayers Detection of the new human coronavirus HKU1: a report of 6 cases Culturing the unculturable: human coronavirus HKU1 infects, replicates, and produces progeny virions in human ciliated airway epithelial cell cultures Pleomorphic virus- like particles in human faeces Chronic enterocyte infection with coronavirus: one possible cause of the syndrome of tropical sprue? |
| cord-333670-qv1orlv5 | : What Are We Learning in a Country With High Mortality Rate? |
| cord-333670-qv1orlv5 | COVID-19 Pulmonary Involvement: is really an interstitial pneumonia? |
| cord-333670-qv1orlv5 | Could PD-1/ PDL1 immune checkpoints be linked to HLA signature? |
| cord-333670-qv1orlv5 | Is the recommendation to use high- dose heparin for thromboprophylaxis justified? |
| cord-333670-qv1orlv5 | Pulmonary embolism or pulmonary thrombosis in COVID-19? |
| cord-333670-qv1orlv5 | The autopsy debate during the COVID-19 emergency: the Italian experience COVID-19 deaths: are we sure it is pneumonia? |
| cord-333670-qv1orlv5 | The use of antiinflammatory drugs in the treatment of people with severe coronavirus disease 2019( COVID-19): the experience of clinical immunologists from China Is COVID evolution due to occurrence of pulmonary vascular thrombosis? |
| cord-338541-0yiuh017 | Coronavirus: covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate COVID-19, SARS and MERS: are they closely related? |
| cord-338541-0yiuh017 | The relationship between autophagy and the immune system and its applications for tumor immunotherapy Plasma cells require autophagy for sustainable immunoglobulin production Mammalian Autophagy: How Does It Work? |
| cord-339772-q814d6l7 | Which lab animals can help defeat the new coronavirus? |
| cord-336775-d4hi9myk | Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding A comparison of bats and rodents as reservoirs of zoonotic viruses: are bats special? |
| cord-336775-d4hi9myk | Insights into the structure of the coronavirion Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein Modulation of murine dendritic cell function by adenine nucleotides and adenosine: involvement of the A(2B) receptor Environmental Contamination and Viral Shedding in MERS Patients During MERS- CoV Outbreak in South Korea Emergence of Novel Coronavirus and COVID-19: whether to stay or die out? |
| cord-336775-d4hi9myk | Really'Special'as Viral Reservoirs? |
| cord-336775-d4hi9myk | what can they teach us about the severe acute respiratory syndrome? |
| cord-337302-fpz2jfuj | ; how do we manage cancer optimally through a public health crisis? |
| cord-337302-fpz2jfuj | Blood Advances Immune checkpoint inhibitors in SARS- CoV-2 infected cancer patients: the spark that ignites the fire? |
| cord-337302-fpz2jfuj | Which cancer type has the highest risk of COVID-19 infection? |
| cord-338023-gb5jgqcg | Air contamination with SARS- CoV-2 in the operating room Human papillomavirus DNA in surgical smoke during cervical loop electrosurgical excision procedures and its impact on the surgeon Electrocautery, diathermy, and surgical energy devices: are surgical teams at risk during the COVID-19 pandemic? |
| cord-338023-gb5jgqcg | COVID-19: are we ready for the second wave? |
| cord-339558-li65qvq9 | The presented review aims at confronting the question: ‘ how proteomics can help in tackling SARS- CoV-2? ’ |
| cord-339665-nwwutduy | : where are we? |
| cord-336373-xb3jrg75 | Could that draining chronic ear wait a few weeks, or a month or two? |
| cord-336373-xb3jrg75 | Tympanoplasties or cochlear implants? |
| cord-336373-xb3jrg75 | What about vestibular schwannoma surgery or repair of CSF leaks? |
| cord-336373-xb3jrg75 | When would it be safe to offer stapedectomies? |
| cord-339329-8yvre7qc | How do we manage this under eased movement restrictions? |
| cord-339329-8yvre7qc | spread? |
| cord-336769-5x6xjuew | What are the implications for public health practice? |
| cord-336769-5x6xjuew | What is added by this report? |
| cord-336769-5x6xjuew | What is already known about this topic? |
| cord-323905-ayufx3wv | , should we cancel the operation? |
| cord-323905-ayufx3wv | -Modification or reorganization of hospital wards( patient density, bed density, medical and nursing staff density, etc.)? |
| cord-323905-ayufx3wv | -Should we only select patients as candidates who also consent to regional/ spinal anaesthesia? |
| cord-323905-ayufx3wv | Are new triage/ patient selection criteria needed for hip and knee arthroplasty patients once elective surgery is resumed? |
| cord-323905-ayufx3wv | Are special adjustments needed for post- op SARS- CoV-2 prophylaxis? |
| cord-323905-ayufx3wv | Are special adjustments needed for post- op SARS- CoV-2 prophylaxis? |
| cord-323905-ayufx3wv | Is pre- operative tracking of patients, staff and relatives necessary? |
| cord-323905-ayufx3wv | Is there a need for extra disinfecting environmental procedures in between surgeries? |
| cord-323905-ayufx3wv | Patient numbers in the clinical areas( wards, waiting areas, outpatient clinics) should be halved, with the patients spaced at least 2 m apart-Separation of elective and trauma orthopaedic surgery( with regard to the general orthopaedic departments)? |
| cord-323905-ayufx3wv | Should relatives/ visitors or other supportive personnel be allowed onto the orthopaedic wards and operating suite? |
| cord-323905-ayufx3wv | Should spinal anaesthesia be routine? |
| cord-323905-ayufx3wv | Should spinal anaesthesia be routine? |
| cord-323905-ayufx3wv | What are the priority indications for elective adult hip and knee reconstruction? |
| cord-323905-ayufx3wv | What is the advice for patients who develop SARS- CoV-2 symptoms? |
| cord-323905-ayufx3wv | What is the advice for patients who develop SARS- CoV-2 symptoms? |
| cord-323905-ayufx3wv | What is the appropriate pre- operative clinical and laboratory screening and timeline for patients? |
| cord-323905-ayufx3wv | What is the appropriate preoperative clinical and laboratory screening and timeline for patients? |
| cord-323905-ayufx3wv | What is the impact of delaying hip and knee arthroplasty for the patients themselves and for society? |
| cord-323905-ayufx3wv | What is the role of outpatient hip and knee arthroplasty/ enhanced recovery protocols in light of the SARS- CoV-2 pandemic? |
| cord-323905-ayufx3wv | What kind of back- up plan is needed to guarantee quality care and patient safety in this pandemic situation? |
| cord-323905-ayufx3wv | What role do ultra- clean operating theatres, orthopaedic exhaust suits and ultraviolet light systems play in both the wards/ beds and the theatre? |
| cord-323905-ayufx3wv | When should elective hip and knee arthroplasty be resumed? |
| cord-339934-g6ufz29l | COVID-19 pneumonia: a random association? |
| cord-338979-ew046wcr | The art of medicine:"an inexpressible dread": psychoses of influenza at fin- de- siècle Outcome of delirium in critically ill patients: systematic review and meta- analysis Psychological impact on SARS sur- vivors: critical review of the English language literature Fear and stigma: the epidemic within the SARS outbreak Timely mental health care for the 2019 novel corona virus outbreak is urgently needed Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? |
| cord-338979-ew046wcr | The neuroinvasive potential of SARS- CoV2 may play a role in the respiratory failure of COVID-19 patients Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-339711-f7xifne8 | Can neutralizing antibodies 372 help? |
| cord-337692-b89ow1mf | How many EU citizens die from influenza? |
| cord-337692-b89ow1mf | The burden of influenza: a Complex problem How comparable is COVID-19 mortality across countries? |
| cord-337692-b89ow1mf | The inverse care law How many individuals must be screened to reduce oral cancer mortality rate in the western context? |
| cord-337692-b89ow1mf | Whose coronavirus strategy worked best? |
| cord-338578-e0aiknb6 | : What lessons have we learned? |
| cord-338578-e0aiknb6 | World Health Organ Follow- up study on pulmonary function and lung radiographic changes in rehabilitating severe acute respiratory syndrome patients after discharge Long- term sequelae of SARS: Physical, neuropsychiatric, and quality- of- life Does COVID-2019 have an Impact on the Purchase Intention of Commercial Long- Term Care Insurance among the Elderly in China? |
| cord-340042-intxyu46 | Structural basis of receptor recognition by SARS- CoV-2 Vaccination against Toxoplasma gondii: an increasing priority for collaborative research? |
| cord-337599-dyxfsojh | How did coronavirus start and where did it come from? |
| cord-337599-dyxfsojh | Teicoplanin potently blocks 1192 the cell entry of 2019-nCoV Teicoplanin: an alternative 1195 drug for the treatment of COVID-19? |
| cord-337599-dyxfsojh | Was it really 762 Wuhan's animal market? |
| cord-337599-dyxfsojh | Will novel virus go pandemic or be contained? |
| cord-339968-s1kmipir | The global response to the COVID-19 pandemic: how have immunology societies contributed? |
| cord-339817-qqitdrz6 | COVID-19-what should anaethesiologists and intensivists know about it? |
| cord-339762-lh8czr0a | Do corticosteroids reduce the mortality of influenza A( H1N1) infection? |
| cord-340103-dc3wye9s | The optimal evaluation and management of patients with a gradual onset of olfactory loss Are microglia minding us? |
| cord-339976-tg2jkss7 | The big question now: will it be back? |
| cord-339686-oybnk1j8 | : what are the remaining choices? |
| cord-340240-dk48pdqa | [ retrieved 05 Responding to Covid-19-a once- in- a- century pandemic? |
| cord-340049-6rqmc89u | : potent neutralization of SARS coronavirus Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus Structure, function, and antigenicity of the SARS- CoV-2 spike glycoprotein Characterization of the receptor- binding domain( RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine Is COVID-19 receiving ADE from other coronaviruses? |
| cord-339077-pxf2u68u | Deep venous thrombosis in medical- surgical critically ill patients: prevalence, incidence, and risk factors Deep vein thrombosis during prolonged mechanical ventilation despite prophylaxis Scoring für disseminierte intravaskuläre Gerinnung( DIC) in der Intensivmedizin Pulmonary embolism or pulmonary thrombosis in COVID-19? |
| cord-339077-pxf2u68u | Is the recommendation to use highdose heparin for thromboprophylaxis justified? |
| cord-339077-pxf2u68u | authors: Zerwes, Sebastian; Hernandez Cancino, F.; Liebetrau, D.; Gosslau, Y.; Warm, T.; Märkl, B.; Hyhlik- Dürr, A. title: Erhöhtes Risiko für tiefe Beinvenenthrombosen bei Intensivpatienten mit CoViD-19-Infektion? – |
| cord-340619-3tjquzx8 | The enlightenment from two cases of asymptomatic infection with SARS- CoV-2: is it safe after 14 days of isolation? |
| cord-336554-n8n5ii5k | An analysis based on decade- long structural studies of SARS Do viral infections mimic bacterial sepsis? |
| cord-336554-n8n5ii5k | COVID-19 treatment by repurposing drugs until the vaccine is in sight Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: role of epigenetic histone modifications ACE 2: more of Ang 1- 7 or less Ang II? |
| cord-336554-n8n5ii5k | COVID-19? |
| cord-336554-n8n5ii5k | Dexamethasone for COVID-19? |
| cord-336554-n8n5ii5k | Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS- CoV-2 RNA dependent RNA polymerase( RdRp): a molecular docking study Computational target- based drug repurposing of elbasvir, an antiviral drug predicted to bind multiple SARS- CoV-2 proteins COVID-19 and chronological aging: senolytics and other anti- aging drugs for the treatment or prevention of corona virus infection? |
| cord-336554-n8n5ii5k | an open- label, randomised, phase 2 trial Mechanisms of coronavirus cell entry mediated by the viral spike protein SARS- CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-338790-rvdoq616 | How does continuous renal replacement therapy affect septic acute kidney injury? |
| cord-338790-rvdoq616 | KDIGO clinical practice guideline for acute kidney injury Epidemiology of acute kidney injury in children worldwide, including developing countries Should COVID-19 concern nephrologists? |
| cord-338790-rvdoq616 | Structural basis of receptor recognition by SARS- CoV-2 Cytokine storms in COVID-19 cases? |
| cord-338790-rvdoq616 | Why and to what extent? |
| cord-340028-6oicmeam | Can physical activity ameliorate immunosenescence and thereby reduce age- related multi- morbidity? |
| cord-340028-6oicmeam | Should We Treat Aging as a Disease? |
| cord-337462-9mvk86q6 | H ow did we end up here? |
| cord-337462-9mvk86q6 | Mass testing would also provide valuable data to pressing unknowns: what are the infection rates across locations and populations? |
| cord-337462-9mvk86q6 | SureScreen Diagnostics Virus test results in minutes? |
| cord-337462-9mvk86q6 | What fraction of the population is immune? |
| cord-337462-9mvk86q6 | and how does it depend on age and on the severity of infection? |
| cord-340201-ai4apr4w | The possibility of COVID-19 transmission from eye to nose Immunohistochemical localization of angiotensin- converting enzyme, angiotensin II and AT1 receptor in human ocular tissues Can the Coronavirus Disease 2019( COVID-19) Affect the Eyes? |
| cord-340629-1fle5fpz | Novel human astroviruses: Novel human diseases? |
| cord-339344-qd73h1ie | ( ii) Travel to risk areas: Have you been in a risk area( e.g. Northern Italy, Tyrol) in the last 8 weeks or have you had direct contact with a confirmed or suspected case of COVID-19? |
| cord-339344-qd73h1ie | : Have you had contact with people who had a feverish respiratory infection during the last 8 weeks? |
| cord-339344-qd73h1ie | Working outside home: Have you been working in the home office during the last 8 weeks? |
| cord-340651-g3518bq2 | Updated SARS case definition using laboratory criteria Is traditional Chinese medicine useful in the treatment of SARS? |
| cord-340516-9dfaqsv7 | ( COVID-19) Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-336543-ydrmlujj | A possible role for B cells in cOVId-19? |
| cord-336543-ydrmlujj | In the eye of the cOVId-19 cytokine storm complement associated microvascular injury and thrombosis in the pathogenesis of severe cOVId-19 infection: A report of five cases complement as a target in cOVId-19? |
| cord-336543-ydrmlujj | Lupus anticoagulant is frequent in patients with covid-19 Lupus anticoagulant and abnormal coagulation tests in patients with covid-19 cRIcS TRIggERSEP group( clinical Research in Intensive care and Sepsis Trial group for global Evaluation and Research in Sepsis): high risk of thrombosis in patients with severe SARS- coV-2 infection: A multicenter prospective cohort study high frequency of antiphospholipid antibodies in critically- ill cOVId-19 patients: a link with hypercoagulability? |
| cord-336543-ydrmlujj | Related coagulopathy: A distinct entity? |
| cord-336543-ydrmlujj | The treatment of anti- phospholipid syndrome: a comprehensive clinical approach coagulopathy and antiphospholipid antibodies in patients with covid-19 Acute cerebral stroke with multiple infarctions and cOVId-19 cOVId-19 and ischemic stroke: Should we systematically look for lupus anticoagulant and antiphospholipid antibodies? |
| cord-336543-ydrmlujj | Will complement inhibition be the new target in treating cOVId-19-related systemic thrombosis? |
| cord-340537-pdvpmydk | The pathologist Novel human virus? |
| cord-341000-9xs8aukq | WHO Director- General's opening remarks at the media briefing on COVID-19-11 Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? |
| cord-340085-ywg4rhnn | An overview of viral structure and host response SARS- CoV-2, bacterial co- infections, and AMR: the deadly trio in COVID-19? |
| cord-341416-6bh08901 | Why do we need antibody tests for COVID-19? |
| cord-339726-eg0hajzl | Science Magazine Ethical comparators in coronavirus vaccine trials Human challenge studies to accelerate coronavirus vaccine licensure Responding to Covid-19-A once- in- a- century pandemic? |
| cord-339726-eg0hajzl | The time course of the immune response to experimental coronavirus infection of man Speed coronavirus vaccine testing by deliberately infecting volunteers? |
| cord-340015-x9frt0jh | : Should We Worry? |
| cord-340015-x9frt0jh | Can SARS- CoV-2 Infection Be Acquired in Utero?: |
| cord-339752-o6atz33c | ACE2: The Key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel? |
| cord-339752-o6atz33c | COVID-19 and the cardiovascular system Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-338755-f5g2r4n9 | A number of studies A spike with which to beat COVID-19? |
| cord-338755-f5g2r4n9 | A spike with which to beat COVID-19? |
| cord-338755-f5g2r4n9 | But do we need the whole spike? |
| cord-338755-f5g2r4n9 | So, what does this mean for design of a vaccine? |
| cord-338317-ro041w5l | How might the metabolic state of obesity intersect with and exacerbate pathological mechanisms 147 in COVID-19? 148 Enhanced production of cytokines. |
| cord-338317-ro041w5l | Might AT2 271 cells that have excess lipid be less able to switch to aerobic glycolysis and thus be more prone to cell 272 death during viral infection? |
| cord-338317-ro041w5l | What are obese patients with COVID-19 dying from? |
| cord-338317-ro041w5l | When two pandemics meet: Why is obesity associated with increased COVID-19 mortality? |
| cord-338317-ro041w5l | have a similar impact on other forms of viral pneumonia? |
| cord-338498-3238fz73 | Can an effective SARS- CoV-2 vaccine be developed for the older population? |
| cord-338498-3238fz73 | Canadian Immunization Guide Mucosal- local, USP Drug Information for the Healthcare Professional Oncolology Drug Information BCG- different strains, different vaccines? |
| cord-338498-3238fz73 | Is COVID-19 receiving ADE from other coronaviruses? |
| cord-338498-3238fz73 | The efficacy of bacillus calmette- guerin vaccinations for the prevention of acute upper respiratory tract infection in the elderly BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity BCG- induced trained immunity: can it offer protection against COVID-19? |
| cord-338498-3238fz73 | The non- specific effects of vaccines Randomized trial of BCG vaccination at birth to low- birth- weight children: beneficial nonspecific effects in the neonatal period? |
| cord-338498-3238fz73 | how we age: insights into inflammaging Patients with cancer appear more vulnerable to SARS- CoV-2: a multicenter study during the COVID-19 outbreak Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study Relative and absolute effectiveness of high- dose and standard- dose influenza vaccine against influenza- related hospitalization among older adults- United States Is innate immunity our best weapon for flattening the curve? |
| cord-330717-uzrxtgrg | ( 2) how does disease severity in LMICs, particularly among vulnerable populations, differ from observations elsewhere? |
| cord-330717-uzrxtgrg | ( 3) what will be the impact of pandemic prevention and response measures on the health and wellbeing of the diverse individuals and communities found in LMICs? |
| cord-330717-uzrxtgrg | Does the higher prevalence of these risk factors affect COVID-19 disease severity? |
| cord-330717-uzrxtgrg | How and when should NPIs be relaxed in such settings? |
| cord-330717-uzrxtgrg | How do governments and civil society overcome challenges to implementing physical distancing measures in contexts where there is weak governance, low trust in government, inadequate physical infrastructure, and low levels of literacy? |
| cord-330717-uzrxtgrg | How will the loss of employment, income, or disruption of food or water affect people's ability to adhere to lockdown conditions or affect their health and wellbeing? |
| cord-330717-uzrxtgrg | In a broader sense, does a lack of clean water and soap or hand sanitizer modify transmission through established routes? |
| cord-330717-uzrxtgrg | Is SARS- CoV-2 transmission different in dense living conditions and larger household sizes common in many LMICs? |
| cord-330717-uzrxtgrg | To what extent are these factors exacerbated in LMICs and do they contribute to greater social and economic insecurity for women? |
| cord-330717-uzrxtgrg | To what extent has limited transportation, the closure of outpatient services, or other disruptions limited access to essential curative health services, whether for COVID-19 or otherwise? |
| cord-330717-uzrxtgrg | We propose three broad research questions to inform public health and policy responses to COVID-19 in LMICs:( 1) how do the patterns of SARS- CoV-2 transmission differ in resource- poor settings? |
| cord-330717-uzrxtgrg | What factors are associated with effective implementation and adherence to these policies in such settings? |
| cord-337825-ujq9mxk7 | Does this peptide loop impact on the entry pathway type of SARS- CoV-2, compared to other known betacoronavirus lineage B? |
| cord-337825-ujq9mxk7 | Is it possible that it invades host cells via additional novel routes, not limited to ACE2? |
| cord-337825-ujq9mxk7 | Is there an S- like protein involved in invasion? |
| cord-337825-ujq9mxk7 | The SARS, MERS and novel coronavirus( COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
| cord-337825-ujq9mxk7 | Therefore, which are exactly the cell types that SARS- CoV-2 may attack? |
| cord-337825-ujq9mxk7 | the global RNA virome Classify viruses- the gain is worth the pain Detection of a group 2 coronavirus in dogs with canine infectious respiratory disease Human coronaviruses: what do they cause? |
| cord-341176-83khavoh | An updated evolutionary classification of CRISPR- Cas systems Diversity and evolution of class 2 CRISPR- Cas systems Cas13b is a type VI- B CRISPR- associated RNA- guided RNase differentially regulated by accessory proteins Csx27 and Csx28 Structural basis for the RNAguided ribonuclease activity of CRISPR- Cas13d Discovery and Functional Characterization of Diverse Class 2 CRISPR- Cas Systems New variants of CRISPR RNA- guided genome editing enzymes CRISPR- Cas13 Precision Transcriptome Engineering in Cancer RNA Interference in the Age of CRISPR: Will CRISPR Interfere with RNAi? |
| cord-341331-l24oe2pd | Is COVID-19 receiving ADE from other coronaviruses? |
| cord-338517-1mxcssjj | ( H1N1) 2009 virus infection Read in the Section on Diseases of Children, at the Forty- fourth Annual Meeting of the American Medical Association Meta- Analysis: Convalescent Blood Products for Spanish Influenza Pneumonia: A Future H5N1 Treatment? |
| cord-338517-1mxcssjj | A possible role for B cells in COVID-19?: |
| cord-338517-1mxcssjj | Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients? |
| cord-338517-1mxcssjj | Is COVID-19 receiving ADE from other coronaviruses? |
| cord-340260-z13aa1wk | Can the new arrival infer anything about the number of tramcars, say N, in the town? |
| cord-340260-z13aa1wk | Copyright? |
| cord-340260-z13aa1wk | when is an exposed individual known to be disease free? |
| cord-340656-ltd6ueoi | SARS- CoV-2 infection in 86 healthcare workers in two Dutch Clinical characteristics of 50404 patients with 2019-nCoV infection Real- time tracking of self- reported symptoms to predict potential COVID-19 A framework for identifying regional outbreak and spread of COVID-19 from one- minute population- wide surveys Can Meta- analysis Be Salvaged? |
| cord-341284-jmqdnart | A novel coronavirus from patients with pneumonia in China WHO Director- General's opening remarks at the media briefing on COVID-19 COVID-19)-overview Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-340942-oatf59k0 | so what? |
| cord-340523-wujzihbn | authors: Ravelli, Angelo; Martini, Alberto title: Kawasaki disease or Kawasaki syndrome? |
| cord-340523-wujzihbn | macrophage activation syndrome in Kawasaki disease underrecognized? |
| cord-340627-xyvzgkxl | : what does viral RNA load really mean? |
| cord-340627-xyvzgkxl | Needed on All Labor and Delivery Units? |
| cord-341648-z4lflkmo | To what extent do children transmit SARS‐CoV‐2 virus? |
| cord-341531-w788qwya | General or regional anaesthesia? |
| cord-342383-ckswlo9o | Considering BCG vaccination to reduce the impact of COVID-19 Can existing live vaccines prevent COVID-19? OPV as Potential Protection Against COVID-19 |
| cord-342013-k54u2q0d | Matern Should infants be separated from mothers with COVID-19? |
| cord-340811-w4x4falm | Military COVID-19 and Italy: what next? |
| cord-340811-w4x4falm | What happens to people ’s lungs when they get coronavirus disease 2019? |
| cord-341783-e7xz4utr | Characteristics of and important lessons from the coronavirus disease 2019( Covid-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention Functional assessment of cell entry and receptor usage for SARS- CoV-2 and other lineage B betacoronaviruses Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-339459-z22a5yzo | Does use of ACEIs or ARBs among adults before infection with SARS- CoV-2 increase the risk for COVID-19? |
| cord-339459-z22a5yzo | Is the use of these medications before infection associated with more severe COVID-19 disease and worse outcomes? |
| cord-339459-z22a5yzo | Preventing a covid-19 pandemic Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-339459-z22a5yzo | What are the benefits and harms of initiating these drugs as treatment for patients with COVID-19? |
| cord-339459-z22a5yzo | insights into the endogenous counter- regulatory pathway of the renin- angiotensinaldosterone system Brain angiotensinconverting enzyme type 2 shedding contributes to the development of neurogenic hypertension Angiotensin- converting enzyme 2 is a functional receptor for the SARS coronavirus Soluble angiotensin- converting enzyme 2: a potential approach for coronavirus infection therapy? |
| cord-342340-q6j7vy8u | How will country- based mitigation measures influence the course of the COVID-19 epidemic? |
| cord-340984-blkhfhe2 | Did pangolins spread the China coronavirus to people? |
| cord-340984-blkhfhe2 | Taste and smell Olfactory and gustatory dysfunctions as a clinical presentation of mildto- moderate forms of the coronavirus disease( COVID-19): a multicenter European study Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-341838-lkz8ro90 | Do people living with HIV experience greater age advancement than their HIV- negative counterparts? |
| cord-339436-0k73tlna | 2019 patients with coagulopathy Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? |
| cord-339436-0k73tlna | Does COVID-19 Disprove the Obesity Paradox in ARDS? |
| cord-339436-0k73tlna | The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS- CoV-2 ACE2 in Brain Physiology and Pathophysiology: Evidence from Transgenic Animal Models ACE2 and diabetes: ACE of ACEs? |
| cord-339436-0k73tlna | The conundrum Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-339436-0k73tlna | Worse progression of COVID‐19 in men: Is Testosterone a key factor? |
| cord-342220-lrqt2gcw | An R library for the calculation of population differentiation statistics Predicting evolution from the shape of genealogical trees Measuring asymmetry in time- stamped phylogenies A metric on phylogenetic tree shapes Characterizing and comparing phylogenies from their Laplacian spectrum A non- parametric analytic framework for within- host viral phylogenies and a test for HIV-1 founder multiplicity Diversity considerations in HIV-1 vaccine selection Structure, function, and antigenicity of the SARS- CoV-2 spike glycoprotein SARS vaccines: Where are we? |
| cord-340687-99ad1rwq | COVID-19, SARS- CoV-2 and pregnancy: does the past predict the present? |
| cord-340687-99ad1rwq | Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France Hydroxychloroquine and azithromycin as a treatment of COVID-19: preliminary results of an open- label non- randomized clinical trial Safety and efficacy of different anesthetic regimens for parturients with COVID-19 undergoing Cesarean delivery: a case series of 17 patients Evidence for and against vertical transmission for severe acute respiratory syndrome coronavirus 2 Unlikely SARS- CoV-2 vertical transmission from mother to child: a case report Possible vertical transmission of SARS- CoV-2 from an infected mother to her newborn Severe COVID-19 during pregnancy and possible vertical transmission Coronavirus disease 2019( COVID-19) pandemic and pregnancy Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records Perinatal transmission of COVID-19 associated SARS- CoV-2: should we worry? |
| cord-342144-awtiqxx5 | Are 1- 2 dangerous? |
| cord-342091-xus5kxs0 | NL63: a clinically important virus? |
| cord-341101-5yvjbr5q | A new virus isolated from the human respiratory tract Identification of a new human coronavirus Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia Coronavirus as a possible cause of severe acute respiratory syndrome Identification of a novel coronavirus in patients with severe acute respiratory syndrome Koch's postulates fulfilled for SARS virus Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia A Novel Coronavirus from Patients with Pneumonia in China Severe acute respiratory syndrome- related coronavirus: The species and its viruses-a statement of the Coronavirus Study Group Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle Drug treatment options for the 2019-new coronavirus( 2019-nCoV) Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies Chloroquine and hydroxychloroquine as available weapons to fight COVID-19 COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression Comparison of the antiviral activity in vitro of some non- steroidal antiinflammatory drugs Antihistaminics, local anesthetics, and other amines as antiviral agents Effect of chloroquine on the growth of animal viruses Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-341101-5yvjbr5q | Focus on recent advancements Pharmacokinetics and cellular uptake of 4-aminoquinoline antimalarials Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases Melanin: blackguard or red herring? |
| cord-339152-wfakzb6w | : where are we? |
| cord-339152-wfakzb6w | COVID-19 Trained innate immunity not always amicable Scores of coronavirus vaccines are in competition-how will scientists choose the best? |
| cord-339152-wfakzb6w | Covid-19: what do we know so far about a vaccine? |
| cord-339152-wfakzb6w | How severe and prevalent are Ebola and Marburg viruses? |
| cord-341776-y7kpp10x | , verläuft dann die Erkrankung auch anders? |
| cord-342569-ja96xfns | COVID-19: Implications for the Cardiovascular System Cardiovascular disease and COVID-19 COVID-19 in the heart and the lungs: could we"Notch"the inflammatory storm? |
| cord-342139-t2tukk0z | The cognitive consequences of the COVID-19 epidemic: collateral damage? |
| cord-342139-t2tukk0z | The many estimates of the COVID-19 case fatality rate COVID-19 in the UK: how many coronavirus cases are there in your area? |
| cord-342344-jjnf4yje | Does COVID-19 transmit via expiratory particles? |
| cord-342254-vdovpfu1 | Should SARS- CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases? |
| cord-342765-rw8valjp | Testing the repatriated for SARS- Cov2: Should laboratory- based quarantine replace traditional quarantine? |
| cord-342204-9tgxijvn | Acute and Persistent Infection of Human Neural Cell Lines by Human Coronavirus OC43 Neuroinvasion by human respiratory coronaviruses Does the Interdependence between Oxidative Stress and Inflammation Explain the Antioxidant Paradox? |
| cord-342204-9tgxijvn | the key players in the neurodegenerative diseases? |
| cord-343029-85ga6r7d | COVID-19, an infertility risk? |
| cord-342942-1s32o9m8 | SARS- CoV-2 infection- induced immune responses: friends or foes? |
| cord-342776-hkjhqgie | The involvement of natural killer cells in the pathogenesis of severe acute respiratory syndrome Dysregulation of immune response in patients with COVID-19 in Wuhan, China Editorial overview: tumour immunology: are we on the path to win the battle against cancer through immunotherapy? |
| cord-342084-fbtx7rwi | A COMPLEMENTARY TREATMENT OPTION FOR COVID-19? |
| cord-342084-fbtx7rwi | This study has many obvious limitations including its non- comparative retrospective observational nature, the small simple size, the short follow up, the lack of TDM and the impossibility of Teicoplanin: an alternative drug for the treatment of COVID-19? Structure- activity relationship studies of lipophilic teicoplanin pseudoaglycon derivatives as new anti- influenza virus agents Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/ Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus( MERS- CoV), and Severe Acute Respiratory Syndrome Coronavirus |
| cord-335122-8s3bcyo8 | : What do we know? |
| cord-335122-8s3bcyo8 | Are HEPA filters required in air filtration/ air purification systems for effective reduction of aerosols generated during orthodontic debonding? |
| cord-335122-8s3bcyo8 | Do N95 respirators provide 95% protection level against airborne viruses, and how adequate are surgical masks? |
| cord-335122-8s3bcyo8 | Does aerosol generation differ when debonding is performed with a slow- speed vs. high- speed hand piece, or when debonding is performed with water vs. without water? |
| cord-335122-8s3bcyo8 | How much aerosol is generated during orthodontic debonding? |
| cord-335122-8s3bcyo8 | Portable HEPA air filtration system properly situated Are air filtration/ air purification systems effective in reducing aerosols generated during orthodontic debonding? |
| cord-335122-8s3bcyo8 | The Journal of Infectious Diseases Is the oral cavity relevant in SARS- CoV-2 pandemic? |
| cord-335122-8s3bcyo8 | The effectiveness of an aerosol reduction device for ultrasonic sealers A study to evaluate and compare the efficacy of preprocedural mouthrinsing and high volume evacuator attachment alone and in combination in reducing the amount of viable aerosols produced during ultrasonic scaling procedure Efficacy of High- volume Evacuator in Aerosol Reduction: Truth or Myth? |
| cord-335122-8s3bcyo8 | What PPE is most appropriate during aerosol generating procedures vs. non- aerosol generating procedures? |
| cord-335122-8s3bcyo8 | When should PPE be discarded and replaced during patient care? |
| cord-335122-8s3bcyo8 | o f How much time should be allocated between patients when aerosol generating procedures are performed? |
| cord-343136-kftffes0 | Zika … what next? |
| cord-340305-jtvn9tlm | As the authors suggest, are these examples simply ones of persistence or re- infection? |
| cord-340305-jtvn9tlm | Does neutralization antibody ensure protection? |
| cord-340305-jtvn9tlm | How would this dilemma then be potentially overcome? |
| cord-340305-jtvn9tlm | If neutralizing antibody correlates with protection, is there a threshold at which the prediction can be confident? |
| cord-340305-jtvn9tlm | viral relapse, reinfection or inflammatory rebound? |
| cord-342380-lihz7h1k | Till Now? |
| cord-343415-lj2trn85 | Clinical and epidemiological features of 36 children with coronavirus disease 2019( COVID-19) in Zhejiang, China: an observational cohort study How to interpret elevated plasmatic level of high- sensitive troponin T in newborns and infants? |
| cord-342857-vj6sw2ne | A randomized, double- blind, placebo- controlled trial Can Zn Be a Critical Element in COVID-19 Treatment? |
| cord-342857-vj6sw2ne | Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors Can steroids reverse the severe COVID-19 induced"cytokine storm"? |
| cord-342024-kaku49xd | Double- edged spike: are SARS- CoV-2 serologic tests safe right now? |
| cord-342024-kaku49xd | Global profiling of SARS- CoV-2 specific IgG/ IgM responses of convalescents using a proteome microarray The role of antibody testing for SARS- CoV-2: is there one? |
| cord-342024-kaku49xd | Rapid serologic test have a role in asymptomatic health workers COVID-19 screening COVID-19 Antibody seroprevalence in Significance of serology testing to assist timely diagnosis of SARS- CoV-2 infections: implication from a family cluster Antibody testing for COVID-19: can it be used as a screening tool in areas with low prevalence? |
| cord-343330-wuzts3mt | Macrophages: a Trojan horse in COVID-19? |
| cord-342983-7o0slu0z | While this is a considerable achievement, it begs the question why these countries would not build upon their successes by further improving their epidemic response intervention packages to steepen the downslope they now find themselves on and then pursue the sequential goals of elimination and exclusion? |
| cord-342983-7o0slu0z | medRxiv preprint Asymptomatic Transmission, the Achilles'Heel of Current Strategies to Control Covid-19 Why lockdown? |
| cord-340063-nmx91h0a | As normalcy returns, can China keep COVID-19 at bay? |
| cord-340063-nmx91h0a | COVID-19 and Italy: what next? |
| cord-340063-nmx91h0a | How will country- based mitigation measures influence the course of the COVID-19 epidemic? |
| cord-340063-nmx91h0a | The COVID-19 pandemic in the USA: what might we expect? |
| cord-340063-nmx91h0a | The lockdowns worked- but what comes next? |
| cord-342996-honeavwj | CRD's guidance for undertaking reviews in health care Influenza vaccination for immunocompromised patients: systematic review and meta- analysis from a public health policy perspective Use of serum in the treatment of influenza- pneumonia Treatment of influenza with injections of blood from convalescents Treatment of influenza pneumonia with serum from convalescents Treatment of influenza pneumonia by use of convalescent human serum Meta- analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? |
| cord-342996-honeavwj | Serum treatment of postinfluenzal bronchopneumonia Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A( H1N1) 2009 virus infection Treatment of Severe Pandemic Influenza A/ H1N1 Infection Convalescent transfusion for pandemic influenza: preparing blood banks for a new plasma product? |
| cord-343043-piyt3i0h | Enzyme 2 Human intestine luminal ACE2 and amino acid transporter expression increased by ACE- inhibitors Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-343043-piyt3i0h | Why does COVID-19 disproportionately affect older people? |
| cord-343566-epvswt7f | Age- and gender- related difference of ACE2 expression in rat lung Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications Pulmonary angiotensin- converting enzyme 2( ACE2) and inflammatory lung disease COVID-19 and the RAAS- a potential role for angiotensin II? |
| cord-343919-n8884bli | , trial finds Effects of low- dose prednisone on bone metabolism Potential enhancement of osteoclastogenesis by severe acute respiratory syndrome coronavirus 3a/ X1 protein Latitude dependence of the COVID-19 mortality rate- a possible relationship to vitamin D deficiency? |
| cord-340960-abanr641 | 182 pediatric COVID-19 patients with different severities and allergic status Blood Myeloperoxidase- DNA, a biomarker of early response to SARS- CoV-2 infection? |
| cord-340960-abanr641 | Allergy Clinical characteristics of 140 patients infected with SARS- CoV-2 in Wuhan Is global BCG vaccination- induced trained immunity relevant to the progression of SARS- CoV-2 pandemic? |
| cord-340960-abanr641 | do we know so far? |
| cord-340583-kjrxrk50 | Are asthma medications( particularly ICS and systemic steroids) or their doses protective or detrimental? |
| cord-340583-kjrxrk50 | Do asthma severity or control modify the course of the disease? |
| cord-340583-kjrxrk50 | Does asthma constitute a risk factor for COVID-19 in children? |
| cord-340583-kjrxrk50 | From an American Thoracic Society- led International Task Force Accepted Article 62 Do chronic respiratory diseases or their treatment affect the risk of SARS- CoV-2 infection? |
| cord-340583-kjrxrk50 | How many are at increased risk of severe COVID-19 disease? |
| cord-344454-hs3tthzi | risque pour l’Homme? |
| cord-341883-eh0aw3re | Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? |
| cord-341883-eh0aw3re | The role of antibody testing for SARS- CoV-2: is there one? |
| cord-341883-eh0aw3re | a narrative review on the effect of cigarette smoking on male sexuality and reproduction Does cigarette smoking protect against SARS- CoV-2 infection? |
| cord-343502-1n0o4akm | Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? |
| cord-343502-1n0o4akm | Treatment of severe chloroquine poisoning Darunavir does not prevent SARS- CoV-2 infection in HIV patients Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-343766-hlg7t5i5 | A putative AOP for pneumonia linked to COVID-19 Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation COVID-19 infection and oxidative stress: an under- explored approach for prevention and treatment? |
| cord-343766-hlg7t5i5 | Adverse outcome pathways: a concise introduction for toxicologists ACE2: the key molecule for understanding the pathophysiology of severe and critical conditions of COVID-19: demon or angel? |
| cord-338928-y5l7cf31 | CT and MRI features Rhabdomyolysis as potential late complication associated with COVID-19 Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-338928-y5l7cf31 | Is hyposmia or anosmia part of a prodrome of symptoms in COVID-19? |
| cord-338928-y5l7cf31 | Second, what is the mechanism of action causing the neurological symptoms seen in patients with COVID-19? |
| cord-338928-y5l7cf31 | Third, is SARS- CoV-2 a neurotropic virus? |
| cord-338928-y5l7cf31 | We identified three key priority areas for NeuroCOVID: First, are patients with COVID-19 in other countries experiencing neurologic symptoms and do these symptoms affect the severity and course of the illness, specifically are they associated with increased respiratory failure or death? |
| cord-343864-0258nh92 | when COVID-19 desease is suspected The epidemiological characteristics of an outbreak of 2019 Novel coronavirus diseases( COVID-19) in China Coronavirus: older persons with Cancer in Italy in the COVID-19 pandemic COVID-19 infection in Cancer patients: how can oncologists Deal with these patients? |
| cord-344236-qp3ianzf | Science( 80-.) Are Patients with Hypertension and Diabetes Mellitus at Increased Risk for COVID-19 Infection? |
| cord-341987-lsvifqyo | Neonatal early- onset infection with SARS- CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan Perinatal transmission of COVID-19 associated SARS- CoV-2: should we worry? |
| cord-341987-lsvifqyo | The impact of the current SARS- CoV-2 pandemic on neonatal care Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records Coronavirus disease 2019( COVID-19) in neonates and children from China: a review Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome Coronavirus infection and pregnancy Impact of COVID-19 on neonatal health: are we causing more harm than good? |
| cord-342362-j7vuoer6 | , diarrea o cefalea? |
| cord-342362-j7vuoer6 | COVID-19 and Chloroquine/ Hydroxychloroquine: is there Ophthalmological Concern? |
| cord-342362-j7vuoer6 | picor ocular o fotofobia de forma aguda? |
| cord-343712-gn7fw891 | CoV-2? |
| cord-343712-gn7fw891 | The expression and localization of 354 the human placental prorenin/ renin- angiotensin system throughout pregnancy: roles in 355 trophoblast invasion and angiogenesis? |
| cord-338365-9sd62a2w | : is there a solution with new removal technologies and policy actions? |
| cord-338365-9sd62a2w | A blessing in disguise? |
| cord-338365-9sd62a2w | Do microplastics affect the zoanthid Zoanthus sociatus? |
| cord-338365-9sd62a2w | Microplastic pollution in the surface waters of the Laurentian Great Lakes The Gyres Institute, San Francisco Bay Microplastics Project Nonwoven Materials and Technologies for Medical Application Impact of Microplastic Fibers from the Degradation of Nonwoven Synthetic Textiles to the Magdalena River Water Column and River Sediments by the City of Neiva, Huila( Colombia) Are we speaking the same language? |
| cord-338365-9sd62a2w | State of the knowledge and research needs COVID-19 faecal- oral transmission: Are we asking the right questions? |
| cord-338365-9sd62a2w | What do we know and where should we focus our efforts in the future? |
| cord-338365-9sd62a2w | What impacts on household food wastage? |
| cord-338365-9sd62a2w | one month into the SARS- CoV-2 epidemic COVID-19 as a factor influencing air pollution? |
| cord-338365-9sd62a2w | the road ahead Environmental Deterioration of Biodegradable, Oxo- biodegradable, Compostable, and Conventional Plastic Carrier Bags in the Sea, Soil, and Open- Air Over a 3-Year Period Are biodegradable plastics a promising solution to solve the global plastic pollution? |
| cord-339727-q8pjwl3s | COVID-19 patients: the case for compassionate use Stem cell therapy for preventing neonatal diseases in the 21st century: Current understanding and challenges Mesenchymal stem cells for coronavirus( COVID-19)-induced pneumonia: revisiting the paracrine hypothesis with new hopes? |
| cord-339727-q8pjwl3s | Managing sickle cell patients with COVID-19 infection: the need to pool our collective experience COVID-19 pandemic and impact on hematopoietic stem cell transplantation Cancer treatment during COVID-19 pandemic Clinical review: stem cell therapies for acute lung injury/ acute respiratory distress syndromehope or hype? |
| cord-339727-q8pjwl3s | Oct-4+ cells is the major target for SARS coronavirus in human lung Should we stimulate or suppress immune responses in COVID-19? |
| cord-339727-q8pjwl3s | a singlecentered, retrospective, observational study Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-344064-l3u4l3se | The GROMOS force- field parameter sets 53A5 and 53A6 Natural products as potential leads against Coronaviruses: Could they be encouraging structural models against SARS- CoV-2? |
| cord-344316-mwnnmwnw | -what's the future? |
| cord-341620-nmrkhx5t | Are we going in the right direction? |
| cord-341620-nmrkhx5t | COVID-19-What should anaethesiologists and intensivists know about it? |
| cord-341620-nmrkhx5t | Can atmospheric pollution be considered a co- factor in extremely high level of SARS- CoV-2 lethality in Northern Italy? |
| cord-341620-nmrkhx5t | Can nanotechnology and materials science help the fight against SARS- CoV-2? |
| cord-341620-nmrkhx5t | cord-341620-nmrkhx5 t authors: Chirico, Francesco; Sacco, Angelo; Bragazzi, Nicola Luigi; Magnavita, Nicola title: Can Air- Conditioning Systems Contribute to the Spread of SARS/ MERS/ COVID-19 Infection? |
| cord-342739-iy9vjpuh | A critical question that must be answered at this stage- with a clear view of the potential deleterious effects of a new coronavirus in pregnancy- is will maternal immunization be a priority in research and development? |
| cord-342739-iy9vjpuh | Has modern technology improved maternal and fetal outcome? |
| cord-342739-iy9vjpuh | What lessons have we learned? |
| cord-342739-iy9vjpuh | When is it acceptable to vaccinate pregnant women? |
| cord-342796-f7n8sxbu | : Where Are Influenza Virus and Rhinovirus/ Enterovirus? |
| cord-342796-f7n8sxbu | Are co- infections with COVID-19 and Influenza low or underreported? |
| cord-343357-5nhyumxl | Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area Immunosuppression for hyperinflammation in COVID-19: a double- edged sword? |
| cord-343357-5nhyumxl | what can they teach us about the severe acute respiratory syndrome? |
| cord-344270-874i31h8 | The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome Incidence of thrombotic complications in critically ill ICU patients with COVID-19 Acute pulmonary embolism and COVID-19 pneumonia: a random association? |
| cord-343818-pj1oludh | China Chest CT findings and clinical features of coronavirus disease 2019 in children Do children need a longer time to shed SARS- CoV-2 in stool than adults? |
| cord-332778-rf47ptj6 | ( 2) are ICIs, in particular, a risk factor for SARS- CoV-2 infection rate and/or development of severe symptoms? |
| cord-332778-rf47ptj6 | : What do we really know? |
| cord-332778-rf47ptj6 | About COVID-19 Potential Antiviral Drugs for SARS- Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research Acute respiratory failure in COVID-19: Is it"typical"ARDS? |
| cord-332778-rf47ptj6 | Based on these observations, is it acceptable to continue ICIs to cancer patients during COVID-19 acute pandemic phase? |
| cord-332778-rf47ptj6 | Based on these observations, is it acceptable to continue ICIs to cancer patients during COVID-19 acute pandemic phase? |
| cord-332778-rf47ptj6 | Do ICIs compromise cancer patients'immunity and increase the vulnerability to COVID-19 infection? |
| cord-332778-rf47ptj6 | Do checkpoint inhibitors compromise the cancer patients'immunity and increase the vulnerability to COVID-19 infection? |
| cord-332778-rf47ptj6 | Do patients with cancer have a poorer prognosis of COVID-19? |
| cord-332778-rf47ptj6 | From these two studies some questions remain unsolved:( 1) is any type of anti- cancer therapy a positive or a negative risk factor for SARS- CoV-2 infection? |
| cord-332778-rf47ptj6 | Is ICIs administration harmful or beneficial for cancer patients during the COVID-19 pandemic? |
| cord-332778-rf47ptj6 | Is Immune Checkpoint Inhibitors- Based Immunotherapy Harmful or Beneficial? |
| cord-332778-rf47ptj6 | Or, on the contrary, do ICIs potentiate their immune system? |
| cord-332778-rf47ptj6 | The Innate Immune System: Fighting on the Front Lines or Fanning the Flames of COVID-19? |
| cord-332778-rf47ptj6 | The spark that ignites the fire? |
| cord-344213-j3yextjl | Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods before and after Symptom Onset Temporal dynamics in viral shedding and transmissibility of COVID-19 Suppression of a SARS- CoV-2 outbreak in the Italian municipality of Vo'Isolation of 2019-nCoV from a Stool Specimen of a Laboratory- Confirmed Case of the Coronavirus Disease 2019( COVID-19) Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus- Infected Pneumonia in Wuhan, China Can the SARS- CoV-2 PCR Cycle threshold value and time from symptom onset to testing predict infectivity? |
| cord-343333-4krrmjio | Cuál es la relación de COVID-19 con la enfermedad cardiovascular? |
| cord-343333-4krrmjio | Enzyme Inhibitors/ Angiotensin Receptor Blockers Have a Biphasic Effect? |
| cord-343333-4krrmjio | Typical takotsubo syndrome triggered by SARS- CoV-2 infection Transient complete heart block in a patient with critical COVID-19 COVID-19 and Cardiovascular Disease SARS- CoV2: should inhibitors of the renin- angiotensin system be withdrawn in patients with COVID-19? |
| cord-344419-3wcfpw2z | Is ethnicity linked to incidence or outcomes of covid-19? Ethnicity and family: |
| cord-338972-uq2ha8xs | Are there potential risks with endoscopy or laparoscopy? |
| cord-338972-uq2ha8xs | On this Resumption of elective surgery during the COVID-19 pandemic: what lessons can we apply? |
| cord-338972-uq2ha8xs | We asked the experts: How do we maintain surgical quality standards for enhanced recovery programs after cancer surgery during the COVID-19 outbreak? |
| cord-338972-uq2ha8xs | What challenges exist with preventive measures, and what can be done to prioritize vulnerable patients? |
| cord-338972-uq2ha8xs | What happened? |
| cord-338972-uq2ha8xs | What is the appropriate use of laparoscopy over open procedures in the current COVID-19 climate? |
| cord-338972-uq2ha8xs | authors: Olson, Michael T.; Triantafyllou, Tania; Singhal, Saurabh title: Resumption of elective surgery during the COVID-19 pandemic: what lessons can we apply? |
| cord-338972-uq2ha8xs | it appropriate to return to a normal- capacity surgical practice? |
| cord-344006-0iq9s94n | In patients of COVID-19, what are the symptoms and clinical features of mild and moderate cases? |
| cord-344006-0iq9s94n | what next? |
| cord-343970-anocx4y1 | Can We Do More on Glycemic Control? |
| cord-343970-anocx4y1 | Managing diabetes during the COVID-19 pandemic Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era Coronavirus Infections and Type 2 Diabetes- Shared Pathways with Therapeutic Implications COVID-19 and Diabetes: can DPP4 inhibition play a role? |
| cord-343876-2inr4mcy | What does the PANSS mean? |
| cord-343876-2inr4mcy | infectious H. COVID-19: what is next for public health? |
| cord-344446-5d7yuoz1 | Can atmospheric pollution be considered a co- factor in extremely high level of SARS- CoV-2 lethality in Northern Italy? |
| cord-345183-80rflm7u | : how can we test a test? |
| cord-343691-sjz5og78 | A comparative study of the USA and Asia Epidemiology of metabolic syndrome in Asia Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta- analysis Chronic kidney disease is associated with severe coronavirus disease 2019( COVID-19) infection Considerations for obesity, vitamin D, and physical activity amidst the COV- ID-19 pandemic Coronavirus disease 2019( COVID-19): do angiotensin- converting enzyme inhibitors/ angiotensin receptor blockers have a biphasic effect? |
| cord-343691-sjz5og78 | Knowledge in progress Are patients with hypertension and diabetes mellitus at increased risk for COV- ID-19 infection? |
| cord-343691-sjz5og78 | a case- control study Is a single definition of the metabolic syndrome appropriate? |
| cord-343128-sh77c0af | -Which is the best search engine for an effective literature research in laser medicine? |
| cord-343128-sh77c0af | A systematic review of burden and risk factors Are healthcare workers'intentions to vaccinate related to their knowledge, beliefs and attitudes? |
| cord-341804-rnj3wtg4 | A Systematic 11 Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an 15 increased risk for candidemia? |
| cord-341804-rnj3wtg4 | A potential antiviral drug for the treatment of SARS- CoV-2 by blocking the 22 trimerization of viral spike glycoprotein? |
| cord-341804-rnj3wtg4 | The 2 Return of the Coronavirus: 2019-nCoV ADMET in silico modelling: towards prediction paradise? |
| cord-341804-rnj3wtg4 | Why tocilizumab could be an effective treatment for severe COVID-19? |
| cord-341701-zropd3mo | An interactive web- based dashboard to track COVID-19 in real time How will country- based mitigation measures influence the course of the COVID-19 epidemic? |
| cord-341701-zropd3mo | Can MALDI- TOF mass spectrometry reasonably type bacteria? |
| cord-341701-zropd3mo | Database allows unpublished, preliminary or proprietary data( e.g., antibody, MS, cell biology and genetic studies CHESS: a new human gene catalog curated from thousands of large- scale RNA sequencing experiments reveals extensive transcriptional noise Dynamic visualization of multi- level molecular data: the Director package in R Can we predict protein from mRNA levels? |
| cord-341701-zropd3mo | The human protein atlas: a spatial map of the human proteome Multiproteases combined with high- pH reverse- phase separation strategy verified fourteen missing proteins in human testis tissue Open- pFind enhances the identification of missing proteins from human testis tissue Proteoform: a single term describing protein complexity How many human proteoforms are there? |
| cord-344798-q34j4zxu | Should we stimulate or suppress immune responses in COVID-19? |
| cord-345275-h0hvaxgx | The level of CRP and IL-6 also recovered to the normal range Emerging novel coronavirus( 2019-nCoV): current scenario, evolutionary perspective based on genome analysis and recent developments Convalescent transfusion for pandemic influenza: preparing blood banks for a new plasma product SARS: systematic review of treatment effects Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol Meta- analysis: convalescent blood products for Spanish inflfluenza pneumonia: a future H5N1 treatment? |
| cord-344949-9zyz4hll | IL-17 have a role in COVID-19 infection? |
| cord-344949-9zyz4hll | Regulation of IL-17A production is distinct from IL-17F in a primary human cell co- culture model of T cell- mediated B cell activation Cytokine release syndrome in severe COVID-19 On dihydroorotate dehydrogenases and their inhibitors and uses COVID-19: a case for inhibiting IL-17? |
| cord-343836-daqrym0b | A missing link between SARS- CoV-2 and the eye?: |
| cord-343836-daqrym0b | Bindehaut als möglicher Übertragungsweg für eine SARS- CoV-2-Infektion? |
| cord-343836-daqrym0b | The novel coronavirus 2019( 2019-nCoV) uses the SARS- coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells Transmission of hepatitis C by blood splash into conjunctiva in a nurse Tropism, replication competence, and innate immune responses of the coronavirus SARS- CoV-2 in human respiratory tract and conjunctiva: an analysis in ex- vivo and in- vitro cultures A Rashomon moment? |
| cord-344614-5zcylf6k | The association between body- mass index and patient outcome shock: A retrospective cohort study Obesity paradox in cardiovascular disease: where do we stand? |
| cord-344614-5zcylf6k | The impact of confounding on the associations of different adiposity measures with the incidence of cardiovascular disease: a cohort study of 296 535 adults of white European descent Neurodegenerative disease and obesity: what is the role of weight loss and bariatric interventions? |
| cord-300791-417tzufc | , well you know how it is when everyone just is able to get along, know what to do, and help out along the way? |
| cord-300791-417tzufc | , you know? |
| cord-300791-417tzufc | And even if one was opendyou know how busy they'd be? |
| cord-300791-417tzufc | Can you tell me a little bit about your pharmacy practice during SARS? |
| cord-300791-417tzufc | Casey: How are we supposed to deal with this? |
| cord-300791-417tzufc | Did living through SARS help you prepare for the blackout? |
| cord-300791-417tzufc | How did the pharmacy respond to SARS? |
| cord-300791-417tzufc | How did you first learn about SARS? |
| cord-300791-417tzufc | How did you think it would affect you? |
| cord-300791-417tzufc | How did your pharmacy respond to the blackout? |
| cord-300791-417tzufc | How well do you think your pharmacy coped with SARS? |
| cord-300791-417tzufc | How well do you think your pharmacy coped with the blackout? |
| cord-300791-417tzufc | How? |
| cord-300791-417tzufc | I had? |
| cord-300791-417tzufc | I know we're not allowed to diagnose, but what choice do you have when everything else is closed? |
| cord-300791-417tzufc | I wishdwell, we should have learned our lesson, you know? |
| cord-300791-417tzufc | Interviewer: Did you receive any comments about this from your customers, or( head office)? |
| cord-300791-417tzufc | James: Some of the younger pharmacists, I mean, well of course they're really bright and keen, right? |
| cord-300791-417tzufc | Looking When the lights went out that day in August, what did you think? |
| cord-300791-417tzufc | Looking back on the blackout, had your pharmacy learned any lessons from SARS? |
| cord-300791-417tzufc | Nothing from the customersdI mean I think they probably thought it was a good idea too, right? |
| cord-300791-417tzufc | Rationally, well logically you know that not everyone who has a cold or a cough has SARS, right? |
| cord-300791-417tzufc | So of course, what happens? |
| cord-300791-417tzufc | Tell him to come back next week when the Ohio Energy Authority restores some( power) line somewhere? |
| cord-300791-417tzufc | We all, well, it was just like another new thing, you know? |
| cord-300791-417tzufc | We lived through SARS which was such a disaster because no one knew what to do and no one was talking to anyone else and thought that, okay, someone will just tell me what I'm supposed to do, right? |
| cord-300791-417tzufc | Were any new ones created? |
| cord-300791-417tzufc | Were any new ones created? |
| cord-300791-417tzufc | Were there any specific policies or procedures in place to deal with a situation like this? |
| cord-300791-417tzufc | Were there any specific policies or procedures in place to deal with a situation like this? |
| cord-300791-417tzufc | What advice would you give an educator or a regulator or an employer about preparing pharmacists and pharmacies for something else like SARS or the blackout? |
| cord-300791-417tzufc | What advice would you give another pharmacist regarding surviving a situation like the blackout or SARS? |
| cord-300791-417tzufc | What are you supposed to do? |
| cord-300791-417tzufc | What did the pharmacy do differently? |
| cord-300791-417tzufc | What did the pharmacy do differently? |
| cord-300791-417tzufc | What did you do differently as a pharmacist during this time? |
| cord-300791-417tzufc | What did you do differently as a pharmacist during this time? |
| cord-300791-417tzufc | What did you technicians do differently? |
| cord-300791-417tzufc | What did your technicians do differently? |
| cord-300791-417tzufc | What kind of patients did you have, what kind of technician support did you have, and what sort of resources did you have available? |
| cord-300791-417tzufc | What was the response of technicians and other staff members to SARS? |
| cord-300791-417tzufc | What was the response of technicians and other staff members to the blackout? |
| cord-300791-417tzufc | When you found out it was a province- and continent- wide blackout, how did you think it would affect you and your work as a pharmacist? |
| cord-300791-417tzufc | Where else are they supposed to go, right? |
| cord-300791-417tzufc | quality health care Interprofessional teamwork: professional cultures as barriers Embedded intergroup relations in interdisciplinary teams: effects on perceptions of level of team integration Front line care providers'professional worlds: the need for qualitative approaches to cultural interfaces Interprofessionalism and ethics: consensus or clash of cultures? |
| cord-344217-kci4uw7u | Coronaviruses of man Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus Occurrence and frequency of coronavirus infections in humans as determined by enzyme- linked immunosorbent assay Human coronaviruses: what do they cause? |
| cord-344217-kci4uw7u | Emerg Infect Dis Wet markets- a continuing source of severe acute respiratory syndrome and influenza? |
| cord-345679-ydwcp75s | The role of antibody testing for SARS- CoV-2: is there one? |
| cord-338889-7hd3iibk | But what exactly is the role of research ethics? |
| cord-338889-7hd3iibk | Key criteria for the ethical acceptability of COVID-19 human challenge studies Human Challenge Trials for a COVID-19 Vaccine: Should we bother about exploitation? |
| cord-338889-7hd3iibk | Rose title: Back to WHAT? |
| cord-338889-7hd3iibk | Should we accept the'neo- Krugman'ian'views advocated by proponents of Covid-19 CHIs, or should we rely on the normative principles that were formulated as a reaction to the kind of studies Southam and Krugman had conducted? |
| cord-338889-7hd3iibk | Should we infect healthy people with coronavirus? |
| cord-338889-7hd3iibk | So where does all this lead us? |
| cord-338889-7hd3iibk | The Authority of the Investigator, Subject, Profession, and State in the Human Experimentation Process Vulnerability: What kind of principle is it? |
| cord-338889-7hd3iibk | Time to consider SARS- CoV-2 challenge studies? |
| cord-345304-n74m5ucs | Why is SARS- CoV-2 infection milder among children? |
| cord-329890-wg23sa1u | Belief in effective HIV/ AIDS prevention"Is there an effective way of protecting yourself from AIDS"? |
| cord-329890-wg23sa1u | I ascertained perceived severity of HIV/ AIDS in terms of the respondents'subjective perception of the likelihood of death using the close- ended question"When you think about AIDS, how serious do you feel it is? |
| cord-329890-wg23sa1u | I include social constructs from the HBM and the SCT and some relevant contextual social factors, to explore the research question"What can we learn from the SARS experience about effective prevention of HIV/ AIDS"? |
| cord-329890-wg23sa1u | In the case of epidemics, competence is typically found at the community level and this brings us to the question of governance: how does a government deal with the health crisis represented by an infectious disease epidemic? |
| cord-329890-wg23sa1u | In the study of SARS, perceived susceptibility was ascertained through the question"How likely do you think it is for you to contract SARS"? |
| cord-329890-wg23sa1u | More specifically, why were the efforts to contain and prevent the spread of a new epidemic like SARS successful while it has taken 25 years so far to contain the spread of HIV/ AIDS and no effective solution is yet in sight? |
| cord-329890-wg23sa1u | Referring the respondents to the measures implemented to prevent the spread of SARS, they were asked their level of agreement( strongly agree to strongly disagree) with these statements:"People should be willing to make some personal sacrifices";"People have mostly been socially responsible";"If you did not develop symptoms of SARS after having close contact with someone diagnosed with SARS, would you agree to be quarantined for 10 days?";"If you did not develop symptoms of SARS after having non- close contact with someone diagnosed with SARS, would you agree to be quarantined for 10 days"? |
| cord-329890-wg23sa1u | Referring the respondents to the measures implemented to prevent the spread of SARS, they were asked their level of agreement( strongly agree to strongly disagree) with these statements:"People should be willing to make some personal sacrifices";"People have mostly been socially responsible";"If you did not develop symptoms of SARS after having close contact with someone diagnosed with SARS, would you agree to be quarantined for 10 days?";"If you did not develop symptoms of SARS after having non- close contact with someone diagnosed with SARS, would you agree to be quarantined for 10 days"? |
| cord-329890-wg23sa1u | The main research question is: what can we learn from the SARS experience about effective prevention of HIV/ AIDS? |
| cord-329890-wg23sa1u | The perceived severity of HIV/ AIDS was ascertained through the question"When you think about AIDS, how serious do you feel it is? |
| cord-329890-wg23sa1u | The perception of severity of SARS was measured by the question"If you have contracted SARS, what is the likelihood of survival"? |
| cord-329890-wg23sa1u | The public image of HIV/ AIDS was ascertained through one open- ended question about persons living with HIV/ AIDS:"What kind of people do you think are most likely to get AIDS"? |
| cord-329890-wg23sa1u | WHO global conference on severe acute respiratory syndrome( SARS)-where do we go from here? |
| cord-329890-wg23sa1u | What can we learn from the SARS experience about effective prevention of HIV/ AIDS? |
| cord-329890-wg23sa1u | What kind of people do you think are most likely to get HIV/ AIDS?" |
| cord-329890-wg23sa1u | When does the problem begin and when does it end and who is involved? |
| cord-329890-wg23sa1u | Would people's sense of susceptibility to these diseases and their severity contribute to that difference? |
| cord-345754-mgixsfcc | Socio- demographic heterogeneity in the prevalence of COVID-19 during lockdown is associated with ethnicity and household size: results from an observational cohort study Beware of the second wave of COVID-19 COVID-19: are we ready for the second wave? |
| cord-345405-ngpsgn63 | Are RNA Viruses Candidate Agents for the Next Global Pandemic? |
| cord-345405-ngpsgn63 | The Lancet Microbe Protease inhibitors: Silver bullets for chronic hepatitis C infection? |
| cord-345499-hq5um68k | A Future H5N1 Treatment? |
| cord-343362-4u2re1cu | What Are the Limitations? |
| cord-343362-4u2re1cu | What Did They Find? |
| cord-343362-4u2re1cu | What Did the Researchers Do? |
| cord-343362-4u2re1cu | What Next? |
| cord-343362-4u2re1cu | Why Was This Study Done? |
| cord-345717-ktajrf7d | Emerging Infectious Disease Bushmeat Hunting, Deforestation, and Prediction of Zoonotic Disease Wet markets- a continuing source of severe acute respiratory syndrome and influenza? |
| cord-345841-pq5f82gf | ACE2 receptor matter? |
| cord-345841-pq5f82gf | What are the key findings? |
| cord-344246-sf9cymhc | A report based on 116 cases Analysis of pregnancy outcomes of pregnant women during the epidemic of new coronavirus pneumonia in Hubei Clinical course of severe and critical COVID-19 in hospitalized pregnancies: a US cohort study Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia Possible vertical transmission of SARS- CoV-2 from an infected mother to her newborn Perinatal transmission of COVID-19 associated SARS- CoV-2: should we worry? |
| cord-344246-sf9cymhc | What are the risks of COVID-19 infection in pregnant women? |
| cord-344486-iu5flbcl | 2) Does the presence of any underlying medical condition or characteristic warrant different criteria for remdesivir use based on an increased risk of COVID-19-related morbidity or mortality? |
| cord-344486-iu5flbcl | 3) Should any other agents with potential antiviral activity be used to treat COVID-19? |
| cord-344486-iu5flbcl | The panel considered three major questions: 1) What criteria define the pediatric population in whom remdesivir should be prescribed? |
| cord-344382-vge4ho2v | Treasure Medical and dietary uses of N- acetylcysteine Mechanisms of N- acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking- related end- points Glutathione depletion is associated with augmenting a proinflammatory signal: evidence for an antioxidant/ pro- oxidant mechanism regulating cytokines in the alveolar epithelium Role of glutathione in immunity and inflammation in the lung New insights into the role of glutathione in the mechanism of fever Does complement or the contact system have a role in protection or pathogenesis of COVID-19? |
| cord-344382-vge4ho2v | What is the role of supplementation with ascorbic acid, zinc, vitamin D, or N- acetylcysteine for prevention or treatment of COVID-19? |
| cord-344970-ud1lhkyi | Coronavirus replication complex formation utilizes components of cellular autophagy Regulation of cAMP- mediated signal transduction via interaction of caveolins with the catalytic subunit of protein kinase A Membrane rafts in host- pathogen interactions Statins: could an old friend help the fight against COVID-19? |
| cord-344970-ud1lhkyi | The role of lipid metabolism in COVID-19 virus infection and as a drug target Use of statins in patients with chronic Hepatitis C Natural small molecules as inhibitors of coronavirus lipiddependent attachment to host cells: a possible strategy for reducing SARS- COV-2 infectivity? |
| cord-346512-y5d8q5b9 | Age Matter? |
| cord-340857-teq5txm9 | : how close are we? |
| cord-340857-teq5txm9 | Are negative pressure rooms really necessary? |
| cord-340857-teq5txm9 | Emerg Infect Dis Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests Symbiotic gut microbes modulate human metabolic phenotypes A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person- to- person transmission: a study of a family cluster Aerosol and Surface Stability of SARS- CoV-2 as Compared with SARS- CoV-1 Hot air? |
| cord-340857-teq5txm9 | How to organize the Endoscopy Unit spaces? |
| cord-340857-teq5txm9 | How to organize the staff workstations and workflow? |
| cord-340857-teq5txm9 | What do we have to do before endoscopic procedures? |
| cord-340857-teq5txm9 | Which patients must undergo endoscopy? |
| cord-345014-qp13h0un | 2009 pandemic: a retrospective evaluation Border screening for SARS in Australia: what has been learnt? |
| cord-345014-qp13h0un | : looking for evidence on public health impact Public health interventions and SARS spread Use of quarantine to prevent transmission of severe acute respiratory syndrome- Taiwan Border screening for SARS Effectiveness of traveller screening for emerging pathogens is shaped by epidemiology and natural history of infection Prediction and prevention of the next pandemic zoonosis Infectious diseases are spreading more rapidly than ever before, WHO warns Emerging virus diseases: can we ever expect the unexpected? |
| cord-346530-o65m0whe | CT and MRI features Guillain- Barré syndrome associated with SARS- CoV-2 Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-344647-jr85915d | COVID-19 gone bad: a new character in the spectrum of the hyperferritinemic syndrome? |
| cord-344647-jr85915d | COVID-19 pneumonia: different respiratory treatments for different phenotypes? |
| cord-344647-jr85915d | The case of Complement activation in COVID-19 multiorgan impact Effective treatment of severe COVID-19 patients with tocilizumab Complement as a target in COVID-19? |
| cord-345689-5ns1onkw | How to manipulate these pathogens that are highly pathogenic, in large quantities? |
| cord-338417-7kw9lws0 | Antihypertensive drugs and risk of COVID-19? |
| cord-338417-7kw9lws0 | Antihypertensive drugs and risk of COVID-19? |
| cord-338417-7kw9lws0 | Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-338417-7kw9lws0 | JAMA Antihypertensive drugs and risk of COVID-19? |
| cord-338417-7kw9lws0 | Time to use the p- word? |
| cord-338417-7kw9lws0 | What is the evidence? |
| cord-338417-7kw9lws0 | Why and to what extent? |
| cord-338417-7kw9lws0 | mBio Should COVID-19 concern nephrologists? |
| cord-346370-jdfsacds | medRxiv Effectiveness of Surgical and Cotton Masks in Blocking SARS- CoV-2: A Controlled Comparison in 4 Patients High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2 Masks for all? |
| cord-340581-ngwgb3y0 | ( Ciaglia et al., 2020) and reduce viral attachment to target cells as suggested in Figure 3? |
| cord-340581-ngwgb3y0 | ( Kai and Kai, 2020), or can we inhibit binding of SARS spike proteins to ACE2, for instance by antibodies, without hampering its catalytic capacities to generate Ang 1- 7? |
| cord-340581-ngwgb3y0 | Does it exert systemic vasodilation or improve the microcirculation? |
| cord-340581-ngwgb3y0 | Hemnes et al., 2018)? |
| cord-340581-ngwgb3y0 | Is there a role for testosterone? |
| cord-340581-ngwgb3y0 | The COVID-19 outbreak and the angiotensin- converting enzyme 2: too little or too much? |
| cord-340581-ngwgb3y0 | The lung macrophage in SARS- CoV-2 infection: a friend or a foe? |
| cord-340581-ngwgb3y0 | Why does COVID-19 kill more elderly men than women? |
| cord-340581-ngwgb3y0 | angiotensin- converting enzyme 2: an ally or a trojan horse? |
| cord-347079-1zbsbcdd | Do family physicians make good sentinels for influenza? |
| cord-346763-xdfl659q | Variability in the clinical pattern of cutaneous side- effects of drugs with systemic symptoms: does a DRESS syndrome really exist? |
| cord-344003-oul2hdyq | Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? |
| cord-344003-oul2hdyq | Might the double X- chromosome in females be protective against SARS- CoV-2 compared to the single X- Chromosome in males? |
| cord-344003-oul2hdyq | What are the Possible Causes? |
| cord-344003-oul2hdyq | and COVID-19: serendipity or opportunity for intervention? |
| cord-343715-y594iewi | COVID-19 pneumonia: different respiratory treatments for different phenotypes? |
| cord-343715-y594iewi | CT and MRI features Guillain- Barré syndrome associated with SARS- CoV-2 Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-343715-y594iewi | Can the coronavirus disease 2019( COVID-19) affect the eyes? |
| cord-343715-y594iewi | The Heart in COVID19: primary target or secondary bystander? |
| cord-346197-7g5d9x57 | ; Luconi, E. title: Is nasopharyngeal swab comparable with nasopharyngeal aspirate to detect SARS- CoV-2 in children? |
| cord-346197-7g5d9x57 | Which Nasal Sampling Method Is Best? |
| cord-345356-gn1iwis0 | Coronavirus disease Coronavirus vaccine: when will it be ready? |
| cord-345356-gn1iwis0 | What are these pathways? |
| cord-345356-gn1iwis0 | What is the relative contribution of different endocytic pathways to SARS- CoV-2 infection? |
| cord-346441-b1r6i0wq | COVID-19 pneumonia: different respiratory treatments for different phenotypes? |
| cord-346441-b1r6i0wq | It is conceivable that, upon cigarette smoke( or nicotine?) |
| cord-345033-guisyj11 | SARS- CoV-2 in the semen: where does it come from? |
| cord-345033-guisyj11 | The novel angiotensinconverting enzyme( ACE) homolog, ACE2, is selectively expressed by adult Leydig cells of the testis Structure analysis of the receptor binding of 2019-nCoV Does COVID-19 affect male fertility? |
| cord-345033-guisyj11 | and COVID-19: Serendipity or Opportunity for Intervention? |
| cord-345033-guisyj11 | where does it come from? |
| cord-346960-3empldlo | Timeline of WHO's response to COVID-19 Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019( COVID-19) Analytical performances of a chemiluminescence immunoassay for SARS- CoV-2 IgM/ IgG and antibody kinetics IgA- Ab response to spike glycoprotein of SARS- CoV-2 in patients with COVID-19: A longitudinal study Diagnostic performances and thresholds: the key to harmonization in serological SARS- CoV-2 assays? |
| cord-347048-qqft4yc9 | The case of complement activation in COVID-19 multiorgan impact Complement as a target in COVID-19? |
| cord-345730-bxwsup70 | A brief perspective from the front line Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS- CoV, MERS- CoV, and 2019-nCoV Familial hypercholesterolemia and COVID-19: Have a Biphasic Effect? |
| cord-345730-bxwsup70 | The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target Nuclear receptors, cholesterol homeostasis and the immune system Nonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid Deregulation Natural small molecules as inhibitors of coronavirus lipid- dependent attachment to host cells: A possible strategy for reducing SARS- COV-2 infectivity? |
| cord-345730-bxwsup70 | a potential approach for coronavirus infection therapy High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa Are certain drugs associated with enhanced mortality in COVID-19? |
| cord-346894-iy35298o | Put succinctly, the current concern for most pediatric radiologists is this: what level of PPE is required for a mask- off, likely aerosol- generating procedure in a child of uncertain COVID-19 status? |
| cord-344884-dcoq9srf | -COVID-19: What are we talking about? |
| cord-344884-dcoq9srf | CT and MRI Features Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-344884-dcoq9srf | nan Neuro- COVID-19: What are we talking about? |
| cord-342786-dl8vjwfn | COVID-19 in the heart and the lungs: could we"Notch"the inflammatory storm? |
| cord-342786-dl8vjwfn | Can we use interleukin-6( IL-6) blockade for coronavirus disease 2019( COVID-19)-induced cytokine release syndrome( CRS)? |
| cord-342786-dl8vjwfn | Cardiovascular manifestations and treatment considerations in covid-19 Cardiac Involvement in a Patient With Coronavirus Disease 2019( COVID-19) Cardiac Valves: Another"Disaster- Hit Area"of COVID-19 Patients? |
| cord-342786-dl8vjwfn | The Myocarditis Treatment Trial Investigators The Imperfect Cytokine Storm: Severe COVID-19 with ARDS in Patient on Durable LVAD Support Corticosteroids for viral myocarditis Controlled Trial of Intravenous Immune Globulin in Recent- Onset Dilated Cardiomyopathy Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma Statin therapy in COVID-19 infection COVID-19, hypertension and cardiovascular diseases: Should we change the therapy? |
| cord-342786-dl8vjwfn | The possible mechanisms of action of 4-aminoquinolines( chloroquine/ hydroxychloroquine) against Sars- Cov-2 infection( COVID-19): A role for iron homeostasis? |
| cord-343127-n3fs8ph8 | COVID-19-11 Should COVID-19 concern nephrologists? |
| cord-343127-n3fs8ph8 | Is Kawasaki disease an infectious disorder? |
| cord-343127-n3fs8ph8 | The immune system of children: the key to understanding SARS- CoV-2 susceptibility? |
| cord-343127-n3fs8ph8 | What we know so far about coronavirus disease 2019 in children: a meta- analysis of 551 laboratory- confirmed cases Renal dysfunction in hospitalised children with COVID-19 Kidney disease is associated with in- hospital death of patients with COVID-19 The kidney in COVID-19: protagonist or figurant? |
| cord-343127-n3fs8ph8 | Why and to what extent? |
| cord-346345-jc9bq0zu | A SARS- CoV-2 protein interaction map reveals targets for drug repurposing Broad anti- coronaviral activity of FDA approved drugs against SARS- CoV-2 in vitro and SARS- CoV in vivo Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? neuropsychiatric symptoms and potential immunologic mechanisms Practice guideline for the treatment of patients with schizophrenia |
| cord-346345-jc9bq0zu | Madrid COVID-19 psychosis: a potential new neuropsychiatric condition triggered by novel coronavirus infection and the inflammatory response? |
| cord-338973-73a7uvyz | Apart from droplet transmission and contact transmission, are there other methods to transmit SARS- CoV-2? |
| cord-338973-73a7uvyz | Can the susceptibility of asymptomatic carriers be judged by detecting the serum reactivity level of N protein? |
| cord-338973-73a7uvyz | Do any environmental factors, such as regional conditions or climate, affect SARS- CoV-2 transmission? |
| cord-338973-73a7uvyz | Do ethnic differences affect the transmissibility and pathogenicity of SARS- CoV-2? |
| cord-338973-73a7uvyz | Does SARS- CoV-2 orf8 and orf10 proteins, which have no homology proteins in SARS- CoV, play roles in the infectivity and pathogenicity of SARS- CoV-2? |
| cord-338973-73a7uvyz | Does traditional Chinese medicine have any effect on the treatment of COVID-19 caused by SARS- CoV-2? |
| cord-338973-73a7uvyz | Is there an effective specific anti- SARS- CoV-2 solution? |
| cord-338973-73a7uvyz | Is there any effect of SARS- CoV vaccine designed according to S protein on SARS- CoV-2? |
| cord-338973-73a7uvyz | What is the effect of the surface epitope and receptor binding domain of S protein of SARS- CoV-2 on the virus'infectivity? |
| cord-338973-73a7uvyz | What is the percentage of COVID-19 patients have been infected with SARS and produced antibodies? |
| cord-346546-yffwd0dc | How Significant Are Unusual 660 Protein- Ligand Interactions? |
| cord-347366-0gier0lu | Can Chinese medicine be used for prevention of Corona virus disease 2019( COVID-19)? |
| cord-346299-2s9j01q7 | Can an effective SARS- CoV-2 vaccine be developed for the older 400 population? |
| cord-346299-2s9j01q7 | the EDI enzyme linked immunosorbent assays for the detection of SARS- CoV-2 IgM and 378 IgG antibodies in human plasma Detection of IgM and IgG 381 antibodies in patients with coronavirus disease 2019 Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals COVID-19) Confirmed using an IgM- IgG Antibody Test SARS- CoV-2 390 infection serology: a useful tool to overcome lockdown? |
| cord-347516-linjv64o | Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4 Coronavirus infection of the central nervous system: host- virus stand- off Chemokine CXCL10 and coronavirusinduced neurologic disease Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? |
| cord-346998-01i6zxv8 | medRxiv. Epub ahead of print 11 Virtually perfect? |
| cord-347767-aq9niccc | Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019( COVID-19)? |
| cord-345288-qyz83xx2 | Also an Enteric Pathogen With Potential Fecal- Oral Transmission? |
| cord-345288-qyz83xx2 | The Presence of SARS- CoV-2 RNA in Feces of COVID-19 Patients Telemedicine in postoperative follow- up of STOMa PAtients: a randomized clinical trial( the STOMPA trial) Effects of a home care mobile app on the outcomes of discharged patients with a stoma: A randomised controlled trial Italian Federation of Incontinent and Stoma Patients( FAIS) Getting your workplace ready for COVID-19 Advice on the use of masks in the context of COVID-19 ESGE and ESGENA position statement on gastrointestinal endoscopy and the COVID-19 Outpatient and Ambulatory Care Settings: Responding to Community Transmission of COVID-19 in the Italian Society of Surgery and Association of Stoma Care Nurses Joint Position Statement on Preoperative Stoma Siting Implementation of an easy in- hospital educational stoma pathway results in decrease of home nursing care services after discharge COVID-19 integrated surveillance: key national data Persistent viral shedding of SARS- CoV-2 in faeces-a rapid review Detection of SARS- CoV-2 in Different Types of Clinical Specimens COVID-19: faecal- oral transmission? |
| cord-345288-qyz83xx2 | la AECP ante COVID-19 Laparoscopy at all costs? |
| cord-347428-2isuaiyx | N95 respirators vs. medical masks for preventing influenza among health care personnel: a randomized clinical trial Are healthcare personnel at higher risk of seasonal influenza than other working adults? |
| cord-344012-npob20n0 | A first step in understanding SARS pathogenesis Restructuring of the gut microbiome by intermittent fasting prevents retinopathy and prolongs survival in db/ db mice Microbiome and diabetes: where are we now? |
| cord-344012-npob20n0 | COVID-19) A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person- to- person transmission: a study of a family cluster Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome Enteric involvement of severe acute respiratory syndrome- associated coronavirus infection Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus Brain- gut- bone marrow axis: implications for hypertension and related therapeutics Prolonged presence of Sars- CoV-2 viral rna in faecal samples Enteric involvement of coronaviruses: is faecaloral transmission of SARS- CoV-2 possible? |
| cord-344012-npob20n0 | The renin- angiotensin system: going beyond the classical paradigms Emerging evidence for a functional angiotensin- converting enzyme 2-angiotensin-(1- 7)-MAS receptor axis: more than regulation of blood pressure? |
| cord-344012-npob20n0 | should inhibitors of the renin- angiotensin system be withdrawn in patients with covid-19? |
| cord-345879-nbfg47x5 | COVID-19 and smoking: is nicotine the hidden link? |
| cord-345879-nbfg47x5 | Neuroimmune regulation of ventilator- induced lung injury Faecal calprotectin indicates intestinal inflammation in COVID-19 Efficacy of vagus nerve stimulation over time: review of 65 consecutive patients with treatment- resistant epilepsy treated with VNS> 10 years Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? |
| cord-345879-nbfg47x5 | Targeting the cholinergic anti- inflammatory pathway with vagus nerve stimulation in patients with Covid-19? date: 2020- 07- 29 journal: |
| cord-346331-d0s028wl | ; Williams, Janet E.; Bode, Lars; Donovan, Sharon M.; Järvinen, Kirsi M.; Seppo, Antti E.; Raiten, Daniel J.; Meehan, Courtney L.; McGuire, Mark A.; McGuire, Michelle K. title: SARS‐CoV‐2 and human milk: What is the evidence? |
| cord-346331-d0s028wl | Born to Mothers With COVID-19 Pneumonia Postnatal transmission of aids- associated retrovirus from mother to infant SARS- CoV-2 and human milk: What is the evidence? |
| cord-346331-d0s028wl | The Lancet Cytomegalovirus infection of breast milk and transmission in infancy Perinatal transmission of COVID-19 associated SARS- CoV-2: Should we worry? |
| cord-346859-r1v6ir8u | At what times during infection is SARS- CoV-2 detectable and no longer detectable using RT- PCR- based tests? |
| cord-346859-r1v6ir8u | However, if participants had only faecal virus, would they have been included in the studies? |
| cord-344829-adlp2rjy | ( COVID-19) affect the eyes? |
| cord-344829-adlp2rjy | : a therapeutic target in severe pulmonary inflammation including COVID-19? |
| cord-344829-adlp2rjy | COVID-19: consider cytokine storm syndromes and immunosuppression Clinical features of patients infected with 2019 novel coronavirus in Wuhan Is a"Cytokine Storm"relevant to COVID-19? |
| cord-344829-adlp2rjy | inflammasome signaling promotes atrial fibrillation Increased serum levels of interleukin-1beta in the systemic circulation of patients with essential hypertension: additional risk factor for atherogenesis in hypertensive patients? |
| cord-344829-adlp2rjy | severe acute respiratory syndrome SARS- CoV-2 infects human neural progenitor cells and brain organoids Extracellular vesicles and viruses: are they close relatives? |
| cord-344714-0cam9ipf | Anti- inflammatory effects of flavonoids in neurodegenerative disorders Phytochemicals in cancer prevention and therapy: truth or dare? |
| cord-344714-0cam9ipf | Coagulation and inflammation cross- talking Dexamethasone in the management of covid-19 Antioxidant polyphenols in cancer treatment: Friend, foe or foil? |
| cord-344714-0cam9ipf | The effect of quercetin on different viruses Activity of some flavonoids against viruses Antiviral effect of flavonoids on human viruses Vanden Berghe, Can ethnopharmacology contribute to the development of antiviral drugs? |
| cord-344714-0cam9ipf | food health dis COVID-19 and chronological aging: senolytics and other anti- aging drugs for the treatment or prevention of corona virus infection? |
| cord-347289-3yi5tz04 | Has modern technology improved maternal and fetal outcome? |
| cord-347804-kxhasabe | The importance of naturally attenuated SARS- CoV-2 in the fight against COVID-19 Cytosine drives evolution of SARS- CoV-2 SARS- CoV-2 variants: Relevance for symptom granularity, epidemiology, immunity( herd, vaccines), virus origin and containment? |
| cord-347308-l19snjyf | A systematic review Non- febrile illness seizures: a unique seizure category? |
| cord-347308-l19snjyf | Clinical features of benign convulsions with mild gastroenteritis Are afebrile seizures associated with minor infections a single seizure category? |
| cord-345628-a4c46m2w | A Review COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia? |
| cord-345628-a4c46m2w | JM is also supported by R01HLHL122238, 2R01HL102368- 06A1 Immune activation in severe heart failure: Does etiology play a role? |
| cord-345628-a4c46m2w | Pressure Overload COVID-19, SARS and MERS: are they closely related? |
| cord-345628-a4c46m2w | With Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? |
| cord-344330-zsx7wfyj | A previously undescribed coronavirus associated with respiratory disease in humans Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children Understanding human coronavirus HCoV- NL63 Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia More and more coronaviruses: human coronavirus HKU1 Clinical and molecular epidemiological features of coronavirus HKU1-associated community- acquired pneumonia Coronavirus HKU1 and other coronavirus infections in Hong Kong Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real- time PCR method Coronavirus HKU1 infection in the United States Evidence of human coronavirus HKU1 and human bocavirus in Australian children Detection of the new human coronavirus HKU1: a report of 6 cases Coronavirus HKU1 in children, Brazil Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia Middle East respiratory syndrome Middle East respiratory syndrome coronavirus: a case- control study of hospitalized patients Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection MERS in South Korea and China: a potential outbreak threat? |
| cord-344330-zsx7wfyj | Can coronavirus undergo recombination in animal hosts other than camels? |
| cord-344330-zsx7wfyj | Does IBV change slowly despite the capacity of the spike protein to vary greatly? |
| cord-344330-zsx7wfyj | Is there a way to predict the potential emergence of a novel recombinant coronavirus in the human population? |
| cord-344330-zsx7wfyj | the prevalence of HCoVs already circulating within the animal population,( ii) the commonality of coronavirus recombination in animals,( iii) animals which may potentially serve as mixing vessels for the generation of novel recombinant How common is coronavirus recombination in animals? |
| cord-347734-0z2kin6r | : Is There One? |
| cord-345887-ymo4mxx7 | Are we still missing out on the relevant information available with the scientists/ clinicians? |
| cord-345887-ymo4mxx7 | COVID-19: what is next for public health? |
| cord-345887-ymo4mxx7 | Despite these drug modalities under consideration, the question remains the same: Do we have a definitive treatment available for this infection? |
| cord-345887-ymo4mxx7 | Representative image showing the powdered form of exosomes after freeze- drying results to consider the application of these exosomes as a potential treatment for COVID-19 in the current situation? |
| cord-348777-pk9y6vfp | What should the world do now? |
| cord-347262-q88g1561 | Toward understanding the risk of secondary airborne infection: emission of respirable pathogens Evaluation of bioaerosol exposures during hospital bronchoscopy examinations Droplet fate in indoor environments, or can we prevent the spread of infection? |
| cord-347262-q88g1561 | as compared with SARS- CoV-1 Evidence of airborne transmission of the severe acute respiratory syndrome virus Cluster of SARS among medical students exposed to single patient, Hong Kong Epidemiology: Dimensions of superspreading A pandemic in times of global tourism: superspreading and exportation of COVID-19 cases from a ski area in Austria Airborne Transmission of Communicable Infection-The Elusive Pathway Personal protective equipment during the coronavirus disease( COVID) 2019 pandemic-a narrative review Infection Control: Severe acute respiratory syndrome coronavirus 2( SARS- CoV-2) Which preventive measures might protect health care workers from SARS? |
| cord-347121-5drl3xas | Version 4.2 Specification Health data privacy and confidentiality rights: Crisis or redemption? |
| cord-347121-5drl3xas | Why do some people get severely sick and die while others do not show any symptoms? |
| cord-346445-hgqohdct | Could the D614 G substitution in the SARS- CoV-2 spike( S) protein be associated with higher COVID-19 mortality? |
| cord-346445-hgqohdct | Is BCG vaccination affecting the spread and severity of COVID-19? |
| cord-346445-hgqohdct | higher case fatality rate Is global BCG vaccination- induced trained immunity relevant to the progression of SARS- CoV-2 pandemic? |
| cord-349365-2ot1kf2k | The involvement of human ribonucleases H1 and H2 in the variation of response of cells to antisense phosphorothioate oligonucleotides Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier WHO confirms SARS in Chinese journalist Comparative full- length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection Identification of a novel coronavirus in patients with severe acute respiratory syndrome Proliferative grown of SARS coronavirus in Vero E6 cells Antisense oligonucleotides as therapeutic agents-is the bullet really magical? |
| cord-348283-7xorq5ce | Can we contain the COVID-19 outbreak with the same measures as for SARS? |
| cord-348283-7xorq5ce | Does urbanization make emergence of zoonosis more likely? |
| cord-349392-r71g2e9y | Laboratory diagnosis of four recent sporadic cases of community- acquired SARS Pathology of guinea pigs experimentally infected with a novel reovirus and coronavirus isolated from SARS patients Animal- to- human SARS- associated coronavirus transmission? |
| cord-347818-93ixqyfp | Can we use interleukin-6( IL-6) blockade for coronavirus disease 2019( COVID-19)-induced cytokine release syndrome( CRS)? |
| cord-348696-86nbwon2 | The ocular surface and the coronavirus disease 2019: does a dual''ocular route''exist? |
| cord-346978-ubkqny8j | : What can saliva tell us? |
| cord-346978-ubkqny8j | Do Not Rule Out COVID Saliva is a non- negligible factor in the spread of COVID-19 Clinical Significance of a High SARS- CoV-2 Viral Load in the Saliva Could SARS- CoV-2 be transmitted via speech droplets? |
| cord-346978-ubkqny8j | Saliva- Friend and Foe in the COVID-19 Outbreak Rapid detection of SARS- CoV-2 in saliva: can an endodontist take the lead in point- of- care COVID-19 testing? |
| cord-349501-p1fttfpr | papain- like proteinase 2 activity Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain- like protease activity Deubiquitination, a new function of the severe acute respiratory syndrome coronavirus papain- like protease? |
| cord-349428-i2s41kl7 | COVID-19 Dashboard Perinatal aspects on the covid-19 pandemic: a practical resource for perinatal- neonatal specialists Can SARS- CoV-2 infection be acquired in utero? |
| cord-348202-6we8e60b | Can Lung US Help Critical Care Clinicians in the Early Diagnosis of Novel Coronavirus( COVID-19) Pneumonia? |
| cord-348202-6we8e60b | Emergence and implications for emergency care COVID-19: what is next for public health? |
| cord-349744-8cg5yj20 | -sixth update The standard coronavirus test, if available, works well- but can new diagnostics help in this pandemic? |
| cord-347553-d7q6u7vj | : new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases Structural and molecular modeling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS- CoV-2 infection Should chloroquine and hydroxychloroquine be used to treat Covid-19? Recalcitrant livedoid vasculopathy associated with hyperhomocysteinaemia responding to folic acid and |
| cord-347553-d7q6u7vj | : response to danazol Analysis of serum levels and cutaneous expression of lipoprotein( a) in 38 patients with livedoid vasculopathy Livedo vasculopathy vs small vessel cutaneous vasculitis: cytokine and platelet P- selectin studies Association between peripheral vascular endothelial dysfunction and livedoid vasculopathy Lipoprotein(a) and livedoid vasculopathy: a new thrombophilic factor? |
| cord-347553-d7q6u7vj | what can we learn from severe acute respiratory syndrome? |
| cord-349684-2tioh80m | How Long Do Nosocomial Pathogens Persist on Inanimate Surfaces? |
| cord-344204-qq2vqzc2 | An insight into the sex differences in COVID-19 patients: what are the possible causes? |
| cord-344204-qq2vqzc2 | High- glucose- induced nuclear factor κB activation in vascular smooth muscle cells COVID-19: a new virus, but a familiar receptor and cytokine release syndrome Acute kidney injury in patients hospitalized with COVID-19 Understanding the renin- angiotensin- aldosterone- SARS- CoV- axis: a comprehensive review COVID-19 as a STING disorder with delayed over- secretion of interferon- beta Thrombotic microangiopathy in a patient with COVID-19 COVID-19: what treatments are being investigated? |
| cord-344204-qq2vqzc2 | NF- kB signaling is the molecular culprit of inflammaging Tranmer GK Taming the cytokine storm: repurposing montelukast for the attenuation and prophylaxis of severe COVID-19 symptoms NF- κB in renal inflammation COVID-19: risk for cytokine targeting in chronic inflammatory diseases? |
| cord-344204-qq2vqzc2 | SARS- coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum Coronavirus infection( SARS- CoV-2) in obesity and diabetes comorbidities: is heat shock response determinant for the disease complications? |
| cord-344204-qq2vqzc2 | What is the role of supplementation with ascorbic acid, zinc, vitamin D, or N- acetylcysteine for prevention or treatment of COVID-19? |
| cord-344204-qq2vqzc2 | Why does COVID-19 disproportionately affect older people? |
| cord-344204-qq2vqzc2 | a clue from innate immunity Azithromycin for COVID-19: more than just an antimicrobial? |
| cord-349838-p6vfzbla | Coronavirus and Haematopoietic Stem Cell Transplantation Acute respiratory distress syndrome Granulocyte- colony stimulating factor in COVID-19: Is it stimulating more than just the bone marrow? |
| cord-349821-5ykwwq75 | The role of WHO and recommendations for national measures before and during pandemics Influenza pandemic planning and guidance How prepared is Europe for pandemic influenza? |
| cord-347221-g98q9cga | Front Immunol Immune response in severe infection: could life- saving drugs be potentially harmful? |
| cord-347221-g98q9cga | Hype or Hope? 2020: |
| cord-347221-g98q9cga | J o u r n a l P r e-p r o o f Epidemiologic clues to SARS origin in China Surveillance of influenza pandemic( H1N1) 2009 in Spain Middle East respiratory syndrome coronavirus: epidemic potential or a storm in a teacup? |
| cord-348192-ibohbjfb | ( SARS- CoV-2) viral RNA in septic tanks of fangcang hospital Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission COVID-19 faecal- oral transmission: are we asking the right questions? |
| cord-348192-ibohbjfb | Could Water and Sanitation Shortfalls Exacerbate SARS- CoV-2 Transmission Risks? |
| cord-348192-ibohbjfb | Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-349912-em1abdrg | Aerodynamic analysi s of SARS- CoV-2 in two Wuhan hospitals Smartphone- enabled wireless otoscope- assisted online telemedicine during the COVID-19 outbreak Anosmia and ageusia: common findings in COVID-19 patients Anosmia and dysgeusia in the absence of other respiratory diseases: should COVID-19 infection be considered? |
| cord-346008-6v2gdz4a | ( 2) Have you had contact with someone diagnosed or suspected with COVID-19? |
| cord-346008-6v2gdz4a | ( 3) Do you have cough or shortness of breath? |
| cord-346008-6v2gdz4a | Can the coronavirus disease 2019( COVID-19) affect the eyes? |
| cord-346008-6v2gdz4a | To all visitors, the following questions are asked:( 1) Have you travelled abroad in the last 14 days? |
| cord-350352-wgppovfx | The proximal origin of SARS- CoV-2 SARS- CoV-2 is transmitted via contact and via the air between ferrets Antiviral Efficacies of FDA- Approved Drugs against SARS- CoV-2 Infection in Ferrets Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts Which animals are at risk? |
| cord-349029-zyfop43z | Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus( SARS- CoV-2) Estimating the asymptomatic proportion of coronavirus disease 2019( COVID-19) cases on board the Diamond Princess cruise ship Estimation of the asymptomatic ratio of novel coronavirus infections( COVID-19) Evidence of SARS- CoV-2 Infection in Returning Travelers from Wuhan, China Covid-19: Identifying and isolating asymptomatic people helped eliminate virus in Italian village Asymptomatic and Presymptomatic SARS- CoV-2 Infections in Residents of a Long- Term Care Skilled Nursing Facility Characteristics of COVID-19 infection in Beijing Familial cluster of COVID-19 infection from an asymptomatic Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany Implications of asymptomatic carriers for infectious disease transmission and control Analysis of an SVIC model with age- dependent infection and asymptomatic carriers Global dynamics of a vaccination model for infectious diseases with asymptomatic carriers Pathology of human influenza revisited Factors that make an infectious disease outbreak controllable Who is the infector? |
| cord-349029-zyfop43z | The basic reproduction number of SARS- CoV-2 in Wuhan is about to die out, how about the rest of the World? |
| cord-349504-oqpjqgv4 | ( SARS- CoV-2) from a symptomatic patient Airborne or droplet precautions for health workers treating COVID-19? |
| cord-346138-ip42zcld | Are they related to the symptoms? |
| cord-346138-ip42zcld | How do these values change during the course of the disease? |
| cord-346138-ip42zcld | In particular, it is necessary to understand when the SARS- CoV-2 positive subject is capable of infecting others or when this possibility is greater? |
| cord-346138-ip42zcld | In which biological materials is the virus present and in what quantities? |
| cord-347472-n6811ens | Controls are useful; why not add more? |
| cord-347472-n6811ens | Why change the assay when one could fix the input? |
| cord-349690-hgdjbeht | Recurrence of positive SARS- CoV-2 in patients recovered from COVID-19 Recurrence of positive SARS- CoV-2 RNA in COVID-19: A case report Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation Retest positive for SARS- CoV-2 RNA of"recovered"patients with COVID-19: Persistence, sampling issues, or re- infection? |
| cord-350130-c4u0gxp5 | 21 Will anti- HIV drugs affect the 2019-nCoV treatment outcome? |
| cord-350134-gl3qtoug | title: COVID-19—White matter and globus pallidum lesions: Demyelination or small- vessel vasculitis? |
| cord-347968-jhnr8k3j | Could oral antiseptics have an impact on the transmission and pathogenicity of SARS- CoV-2? |
| cord-347968-jhnr8k3j | Is the oral cavity relevant in the transmission and pathogenicity of SARS- CoV-2? |
| cord-347968-jhnr8k3j | Mariano title: Is the oral cavity relevant in SARS- CoV-2 pandemic? |
| cord-349656-baoqgu8v | Can SARS- CoV-2 Infection Be Acquired In Utero? |
| cord-348384-8cvt1fo6 | In response to the question"Are you afraid of getting infected with COVID-19?"more than half( 55.2%) of HCWs responded"no"compared to their unemployed( 46.4%) or non- HCW counterparts( 44.3%, p<0.0001). |
| cord-348384-8cvt1fo6 | In response to the question"Are you afraid of getting infected with SARS- COV-2?" |
| cord-348384-8cvt1fo6 | Regarding preparations, we asked"have you stocked up on food for current situation related to coronavirus epidemic?" |
| cord-349682-kpg0vley | ) A Study of a Candidate COVID-19 Vaccine( COV001) Can a century- old TB vaccine steel the immune system against the new coronavirus? |
| cord-350095-hsl1hfds | key: cord-350095-hsl1hfds authors: Shiu, Stephen Y. W.; Reiter, Russel J.; Tan, Dun‐Xian; Pang, Shiu F. title: Urgent search for safe and effective treatments of severe acute respiratory syndrome: is melatonin a promising candidate drug? |
| cord-349645-6o8773c5 | The delayed effect of wildfire season particulate matter on subsequent influenza season in a mountain west region of the USA Exposure to combustion generated environmentally persistent free radicals enhances severity of influenza virus infection Association between air pollution and upper respiratory tract infection in hospital outpatients aged 0- 14 years in Hefei, China: a time series study Temperature, nitrogen dioxide, circulating respiratory viruses and acute upper respiratory infections among children in Taipei, Taiwan: a population- based study Distribution of airborne influenza virus and respiratory syncytial virus in an urgent care medical clinic Particulate matter air pollution exposure: role in the development and exacerbation of chronic obstructive pulmonary disease Seasonality of SARS- CoV-2: Will COVID-19 go away on its own in warmer weather? |
| cord-349645-6o8773c5 | What are the Air Quality Standards for PM? |
| cord-348899-vynk8q8c | Aggregating behavior of phenolic compounds- a source of false bioassay results? |
| cord-346819-11fkgzaa | Severe acute respiratory syndrome coronavirus sequence characteristics and evolutionary rate estimate from maximum likelihood analysis Prediction of protein stability changes for single- site mutations using support vector machines Comparative Protein Structure Modeling Using MODELLER Python: a programming language for software integration and development Systematic validation of protein force fields against experimental data Are Protein Force Fields Getting Better? |
| cord-346819-11fkgzaa | The establishment of reference sequence for SARS- CoV-2 and variation analysis Characterization of the receptor- binding domain( RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine The spike protein of SARS- CoV- a target for vaccine and therapeutic development Angiotensin- converting enzyme 2: a functional receptor for SARS coronavirus Can one predict protein stability? |
| cord-346819-11fkgzaa | Why are RNA virus mutation rates so damn high? |
| cord-340189-jo38hjqa | Are people usually diagnosed before or after they are contagious? |
| cord-340189-jo38hjqa | How can we relate these two values? |
| cord-340189-jo38hjqa | How is it that 10 genes code for> 20 proteins? |
| cord-340189-jo38hjqa | How long does it take a single infected person to yield one million infected people? |
| cord-340189-jo38hjqa | How much is known about the SARS- CoV-2 genome and proteome? |
| cord-340189-jo38hjqa | How similar is SARS- CoV-2 to the common cold and flu viruses? |
| cord-340189-jo38hjqa | How so? |
| cord-340189-jo38hjqa | If everybody continued to behave as usual, how long would it take the pandemic to spread from one person to a million infected victims? |
| cord-340189-jo38hjqa | What are the meanings of R 0,'latent period'and'infectious period'? |
| cord-340189-jo38hjqa | What is the difference between the case fatality rate and the infection fatality rate? |
| cord-340189-jo38hjqa | Why have detailed distributions of these parameters across people not been published? |
| cord-340189-jo38hjqa | Why was the initial quarantine period two weeks? |
| cord-350437-dq1il88y | a cohort study Do patients with cancer have a poorer prognosis of COVID-19? |
| cord-350451-lf27iuwk | Why are RNA virus mutation rates so damn high? |
| cord-350686-q2bu7o4i | However, this research[ 1] and similar research of others[ 2][ 3] missed answering a very important question: How does one choose the most efficient pool size relative to SARS- CoV-2 prevalence in samples? |
| cord-350101-t34myl7l | What can saliva tell us? |
| cord-349210-8t4a5qqo | COVID-19: a case for inhibiting IL-17? |
| cord-349210-8t4a5qqo | Can we use interleukin-6( IL-6) blockade for coronavirus disease 2019( COVID-19)-induced cytokine release syndrome( CRS)? |
| cord-349210-8t4a5qqo | FDA Commissioner Says Agency Wants to Develop Master Protocol Trials to Test Multiple COVID-19 Drug and Vaccine Candidates at Once 79 Treatment for COVID-19 in High- Risk Adult Outpatients Clinical characteristics of coronavirus disease 2019 in China Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China Cardiovascular Impairment in COVID-19: Learning From Current Options for Cardiovascular Anti- Inflammatory Therapy Pulmonary fibrosis secondary to COVID-19: a call to arms? |
| cord-350753-qbm145tr | Comparison of four new commercial serologic assays for determination of SARS- CoV-2 IgG Will antibody tests for the coronavirus really change everything? |
| cord-350401-suefuurq | COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? |
| cord-350679-69lv4wbz | Waiting time from diagnosis to treatment has no impact on survival in patients with esophageal cancer Time to surgery and breast cancer survival in the United States Delay to curative surgery greater than 12 weeks is associated with increased mortality in patients with colorectal and breast cancer but not lung or thyroid cancer Evaluating the effect of time from prostate cancer diagnosis to radical prostatectomy on cancer control: can surgery be postponed safely? |
| cord-347128-6lyoz8nn | More than meets the eye? |
| cord-347128-6lyoz8nn | New insights into the antiviral effects of chloroquine New insights on the antiviral effects of chloroquine against coronavirus: What to expect for COVID-19? |
| cord-347128-6lyoz8nn | Why are Oseltamivir and Zanamivir effective against the newly emerged influenza A virus( A/ H1N1)? |
| cord-350104-b99y6n43 | How serious( on a scale from 1 to 10) would it be for you if you got[ disease] in the next year?"); |
| cord-350104-b99y6n43 | The impact of community psychological responses on outbreak control for severe acute respiratory syndrome in Hong Kong SARS risk perception, knowledge, precautions, and information sources, the Netherlands Psychosocial factors predicting SARSpreventive behaviors in four major SARS- affected regions Optimism across cultures: in response to the severe acute respiratory syndrome outbreak Knowledge, attitudes, and practices of avian influenza, poultry workers Avian influenza risk perception, Hong Kong Public understanding of pandemic influenza, United Kingdom Avian influenza risk perception Risicoperceptie van infecties van mensen door het vogelgriepvirus in Nederland SARS knowledge, perceptions, and behaviors: a comparison between Finns and the Dutch during the SARS Outbreak in 2003 Cultural variations in optimistic bias: do Easterns really expect the worst and Westerns really expect the best when predicting future life events? |
| cord-349031-tbof9yqi | A randomized, double- blind, placebo- controlled, multicentre trial Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS- CoV Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19 Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus( 2019-nCoV) in vitro Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open- label non- randomized clinical trial Chloroquine and hydroxychloroquine as available weapons to fight COVID-19 Case of the index patient who caused tertiary transmission of coronavirus disease 2019 in Korea: The application of lopinavir/ ritonavir for the treatment of COVID-19 pneumonia monitored by quantitative RT- PCR A trial of lopinavir- Ritonavir in adults hospitalized with severe Covid-19 A review of the safety of favipiravir- A potential treatment in the COVID-19 pandemic? |
| cord-349031-tbof9yqi | The presence of SARS- CoV-2 RNA in the feces of COVID-19 patients Review article: Gastrointestinal features in COVID-19 and the possibility of faecal transmission Presumed asymptomatic carrier transmission of COVID-19 Covid-19: Identifying and isolating asymptomatic people helped eliminate virus in Italian village Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing COVID-19 herd immunity and convalescent plasma transfer therapy High- flow nasal oxygen versus noninvasive ventilation for hypoxemic respiratory failure: Do we know enough? |
| cord-349031-tbof9yqi | Why and how? |
| cord-350821-0qfoc553 | What do we know about the SARS- CoV-2 coronavirus in the environment? |
| cord-347104-h168kqjn | A Hypothesis Could Sarscoronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects? |
| cord-347104-h168kqjn | A Hypothesis Could Sarscoronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects? |
| cord-347104-h168kqjn | Molecular mimicry may explain multi- organ damage in COVID-19 Neurological injuries in COVID-19 patients: direct viral invasion or a bystander injury after infection of epithelial/ endothelial cells Potential neuroinvasive pathways of SARS- CoV-2: Deciphering the spectrum of neurological deficit seen in coronavirus disease-2019( COVID-19) Does SARS- CoV-2 Trigger Stress- Induced Autoimmunity by Molecular Mimicry? |
| cord-347104-h168kqjn | Trigger Stress- InducedAutoimmunity by Molecular Mimicry? |
| cord-349477-3qhpu7v0 | Can atmospheric pollution be considered a co- factor in extremely high level of sars- cov-2 lethality in northern italy? |
| cord-349477-3qhpu7v0 | How many contact tracers the u.k. has hired? |
| cord-350935-p6euuop3 | A new coronavirus associated with human respiratory disease in China Liver diseases in COVID-19: Etiology, treatment and prognosis Controversial treatments: an updated understanding of the Coronavirus Disease Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases Enrichment or depletion of a GO category within a class of genes: which test? |
| cord-351092-b01o6f69 | Alberici, Federico; Bossini, Nicola; Scolari, Francesco; Pascucci, Federico; Tomasoni, Gabriele; Caruso, Arnaldo title: Pneumocystis jirevocii and SARS- CoV-2 Co- Infection: A Common Feature in Transplant Recipients? |
| cord-348855-lnltoj1n | : what to expect for COVID-19? |
| cord-348855-lnltoj1n | Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients? |
| cord-348855-lnltoj1n | Should we stimulate or suppress immune responses in COVID-19? |
| cord-348855-lnltoj1n | should inhibitors of the reninangiotensin system be withdrawn in patients with COVID-19? |
| cord-350957-10wcqgaq | Multichain immune recognition receptor signaling: different players, same game? |
| cord-351115-dy81dtnk | How much promising? |
| cord-351225-dq0xu85c | The big question now: will it be back? |
| cord-351116-jwy6k0ih | what next? |
| cord-350286-n7ylgqfu | Do Viral Proteins Possess Unique Features? |
| cord-350286-n7ylgqfu | Intrinsic disorderedness and functionality of HIF-1α along with its interacting proteins Why are"natively unfolded"proteins unstructured under physiologic conditions? |
| cord-350317-a9qd3xdr | If skin is a target of SARS- CoV-2, what might be the consequence of using the IL-17 antibody? |
| cord-350317-a9qd3xdr | Should biologics for psoriasis be interrupted in the era of COVID-19? |
| cord-351691-3egwvb59 | COVID-19: What is next for public health? |
| cord-346146-yal0ctpq | 20 weeks'gestation infected with COVID-19? |
| cord-346146-yal0ctpq | A prospective cohort study Outcome of coronavirus spectrum infections( SARS, MERS, COVID-19) during pregnancy: a systematic review and meta- analysis Preeclampsia- like syndrome induced by severe COVID-19: a prospective observational study Proteinuria in Covid-19 pregnant women: Preeclampsia or severe infection? |
| cord-346146-yal0ctpq | Does COVID-19 transmit via expiratory particles? |
| cord-346146-yal0ctpq | Fact or Fantasy Evidence and possible mechanisms of rare maternal- fetal transmission of SARS- CoV-2 Vertical Transmission of SARS- CoV-2( COVID-19): Are Hypotheses More than Evidences? |
| cord-346146-yal0ctpq | Lessons from SARS, MERS, and Other Human Coronavirus Infections Pneumonia during pregnancy Pneumonia during pregnancy: has modern technology improved maternal and fetal outcome? |
| cord-346146-yal0ctpq | The rate of SARS- CoV-2 positivity in asymptomatic pregnant women admitted to hospital for delivery: Experience of a pandemic center in Turkey Screening for COVID-19 at childbirth: is it effective? |
| cord-346146-yal0ctpq | living systematic review and meta- analysis Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records Complications and outcomes of SARS- CoV-2 in pregnancy: where and what is the evidence? |
| cord-351489-tzmev77c | An old drug against today's diseases? |
| cord-349954-bozgrzvf | The aftermath of coronavirus disease of 2019: devastation or a new dawn for nephrology? |
| cord-349954-bozgrzvf | what next? |
| cord-349159-rndtf508 | Airborne or droplet precautions for health workers treating coronavirus disease 2019? |
| cord-349159-rndtf508 | O*NET online summary report for: 43- 5081.03-stock clerks- stockroom, warehouse, or storage yard COVID-19 among workers in meat and poultry processing facilities-19 states Infection prevention and control for COVID-19 in healthcare settings- third update Preventing intra- hospital infection and transmission of COVID-19 in healthcare workers Infectious disease risks associated with occupational exposure: a systematic review of the literature Transmission of COVID-19 to health care personnel during exposures to a hospitalized patient High COVID-19 attack rate among attendees at events at a church- Arkansas Asymptomatic and presymptomatic SARS- CoV-2 infections in residents of a long- term care skilled nursing facility- King County Prisons and custodial settings are part of a comprehensive response to COVID-19 Occupational risks for COVID-19 infection Occupational health responses to COVID-19: what lessons can we learn from SARS? |
| cord-349159-rndtf508 | The coronavirus pandemic and aerosols: does COVID-19 transmit via expiratory particles? |
| cord-351100-llyl97ry | A Retrospective Cohort Study Temporal dynamics in viral shedding and transmissibility of COVID-19 False- negative of RT- PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence Should RT- PCR be considered a gold standard in the diagnosis of Covid-19? Viral load dynamics and disease severity in patients infected with SARS- CoV-2 in Zhejiang province Evidence for Gastrointestinal Infection of SARS- CoV-2 Virological assessment of hospitalized patients with COVID-2019 Funding: |
| cord-351100-llyl97ry | The Allplex 2019-nCoV( Seegene) assay: Which performances are for SARS- CoV-2 infection diagnosis? |
| cord-351567-ifoe8x28 | Did pangolins spread the China coronavirus to people? |
| cord-351651-6dbt99h0 | How could this likely single source of virus quickly infect so many people in such large geographic area? |
| cord-351002-msjurww1 | Does BCG protect against SARS- CoV-2 infection?: |
| cord-350622-8tgxdbyi | Angiotensin- Converting Enzyme 2 and Antihypertensives( Angiotensin Receptor Blockers and Angiotensin- Converting Enzyme Inhibitors) in Coronavirus Disease Current pharmacological treatments for COVID-19: what's next? |
| cord-350622-8tgxdbyi | Nima title: Phytopharmaceuticals mediated Furin and TMPRSS2 receptor blocking: can it be a potential therapeutic option for Covid-19? date |
| cord-350949-ystkjdwk | During the COVID-19 Pandemic A case report of neonatal COVID-19 infection in China Possible Vertical Transmission of SARS- CoV-2 From an Infected Mother to Her Newborn Antibodies in Infants Born to Mothers With COVID-19 Pneumonia Pregnant women with new coronavirus infection: a clinical characteristics and placental pathological analysis of three cases Perinatal transmission of COVID-19 associated SARS- CoV-2: should we worry? |
| cord-350949-ystkjdwk | Prior and novel coronaviruses, coronavirus disease 2019( COVID-19), and human reproduction: what is known? |
| cord-351845-bli3qm8w | The innate immune system: fighting on the front lines or fanning the flames of COVID-19? |
| cord-351430-bpv7p7zo | Agência Nacional de Aviação Civil How will country- based mitigation measures influence the course of the COVID-19 epidemic? |
| cord-352080-3rcqbgl7 | How long can the virus that causes COVID-19 live on surfaces? |
| cord-351503-2f0sk24j | Is your interventional radiology service ready for SARS?: the Singapore experience Interim infection prevention and control recommendations for patients with confirmed coronavirus disease 2019( COVID-19) or persons under investigation for COVID-19 in healthcare settings. |
| cord-351503-2f0sk24j | What Is Needed to Make Interventional Radiology Ready for COVID-19? |
| cord-352146-i4ezsclf | Stability of SARS- CoV-2 in different environmental conditions Features of enteric disease from human coronaviruses: Implications for COVID-19 Environmental and decontamination issues for human coronaviruses and their potential surrogates Inclusion of polyvinylpyrrolidone in the polymerase chain reaction reverses the inhibitory effects of polyphenolic contamination of RNA Is povidone- iodine mouthwash effective against SARS- CoV-2? |
| cord-352096-cc3dzycl | The innate immune system: fighting on the front lines or fanning the flames of COVID-19? |
| cord-352296-rpjehijd | Saliva is a reliable tool to detect SARS- CoV-2 SARS- CoV-2: What can saliva tell us? |
| cord-350904-wyg8ikph | Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? |
| cord-350904-wyg8ikph | Functional angiotensin- converting enzyme 2 is expressed in human cardiac myofibroblasts COVID-19 and chronological aging: senolytics and other antiaging drugs for the treatment or prevention of corona virus infection? |
| cord-346389-gbmnoo84 | COVID-19 and diabetes: can DPP4 inhibition play a role? |
| cord-346389-gbmnoo84 | COVID-19) The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS- CoV-2 Pulmonary embolism or pulmonary thrombosis in COVID-19? |
| cord-346389-gbmnoo84 | Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS- CoV Remdesivir in adults with severe COVID-19: a randomised, double- blind, placebo- controlled, multicentre trial Gilead Announces Results From Phase 3 Trial of Remdesivir in Patients With Moderate COVID-19 Available online at Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus Survival after mesenchymal stromal cell therapy in steroidrefractory acute graft- versus- host disease: systematic review and metaanalysis Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia Extraordinary GUrich single- strand RNA identified from SARS coronavirus contributes an excessive innate immune response Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment Effective treatment of severe COVID-19 patients with tocilizumab Favorable changes of CT findings in a patient with COVID-19 pneumonia after treatment with tocilizumab Tocilizumab, an anti- IL6 receptor antibody, to treat Covid-19-related respiratory failure: a case report Rapid and severe Covid-19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab Dissection of the effects of jak and btk inhibitors on the functionality of healthy and malignant lymphocytes COVID-19: combining antiviral and anti- inflammatory treatments Baricitinib for COVID-19: a suitable treatment? |
| cord-346389-gbmnoo84 | Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? |
| cord-346389-gbmnoo84 | Is the recommendation to use high- dose heparin for thromboprophylaxis justified? |
| cord-346389-gbmnoo84 | Where are we? |
| cord-346389-gbmnoo84 | the battle continues Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-352562-qfb478sf | infections in paediatric patients on anticancer treatment e65 SARS- CoV-2 infections with emphasis on pediatric patients: a narrative review How is immunosuppressive status affecting children and adults in SARS- CoV-2 infection? |
| cord-350505-uh8r2vyz | Aging and the Microbiome: Implications for Asthma in the Elderly? |
| cord-350505-uh8r2vyz | Krajmalnik- Brown, R. Human Gut Microbiota in Obesity and after Gastric Bypass Insights Into the Role of the Microbiome in Obesity and Type 2 Diabetes Are Significant False Negatives in the Usually Sensitive RT- PCR Detection of SARS- CoV2 Happening as the Usually RNA- Stranded Bacteria is now DNA within a Bacteria( Prevotella?) |
| cord-350505-uh8r2vyz | The Influence of Commensal Bacteria on Infection with Enteric Viruses Nutrition and the Gut Microbiome in the Elderly Composition, Variability, and Temporal Stability of the Intestinal Microbiota of the Elderly Do Chronic Respiratory Diseases or Their Treatment Affect the Risk of SARS- CoV-2 Infection? |
| cord-352379-q5inrxcm | On the other hand, feline coronavirus vaccines have been proven to be not only inefficacious; worse yet, the?, have been shown to lead to even more severe viral infections in the vaccinated cats[ 78]. |
| cord-350211-vuxs5wtt | A shortcut for influenza and other viral diseases into the central nervous system Isolated sudden onset anosmia in COVID-19 A novel syndrome? |
| cord-350211-vuxs5wtt | Minerva Anestesiol Is the brain a reservoir organ for SARS2-CoV2? |
| cord-350211-vuxs5wtt | Should we expect neurological symptoms in the SARS- CoV-2 epidemic? |
| cord-350211-vuxs5wtt | What it comes down to? |
| cord-350211-vuxs5wtt | Would a rose by another name smell as sweet? |
| cord-348567-rvwxysvc | A proof of concept Prospective population based study of the association between vitamin D status and incidence of autoimmune disease Association of vitamin D receptor gene polymorphisms with systemic lupus erythematosus: a meta- analysis Vitamin D receptor gene polymorphism as possible risk factor in rheumatoid arthritis and rheumatoid related osteoporosis Vitamin D and autoimmune diseases: is vitamin D receptor( VDR) polymorphism the culprit? |
| cord-348567-rvwxysvc | Does vitamin D play a role in autoimmune endocrine disorders? |
| cord-348567-rvwxysvc | Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus( SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? |
| cord-348567-rvwxysvc | The association between vitamin D deficiency and community- acquired pneumonia: a meta- analysis of observational studies Vitamin D and influenza- prevention or therapy? |
| cord-348567-rvwxysvc | an observational cohort study Severe vitamin D deficiency in patients with Kawasaki disease: a potential role in the risk to develop heart vascular abnormalities? |
| cord-348567-rvwxysvc | what next? |
| cord-352123-0bflqj1c | Potential role for zoonotic spread of COVID-19 in older adults? |
| cord-352123-0bflqj1c | e w Y o rk Dogs caught coronavirus from their owners, genetic analysis suggests Infection of dogs with SARS- CoV-2 Vertebral heart scores in eight dog breeds Ferret models of viral pathogenesis SARS- CoV-2 is transmitted via contact and via the air between ferrets Infection and rapid transmission of SARS- CoV-2 in ferrets Coronavirus rips through Dutch mink farms, triggering culls Minipigs and potbellied pigs as pets in the veterinary practice- a retrospective study Comparison of severe acute respiratory syndrome coronavirus 2 spike protein binding to ACE2 receptors from human, pets, farm animals, and putative intermediate hosts Coronavirus disease 2019( COVID-19) outbreak: could pigs be vectors for human infections? |
| cord-351687-6otr8zl3 | Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? |
| cord-351687-6otr8zl3 | Underestimated Opportunistic Pathogens of the Central Nervous System? |
| cord-351340-7y19ystp | There's a real paucity of data out there.How very true these observations are? |
| cord-351340-7y19ystp | Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-351340-7y19ystp | What is currently known about these differences in disease risk and fatality rates? |
| cord-346263-8znpqcth | Have We Learned? |
| cord-346263-8znpqcth | In other words, is it a top- down order or is it caused by bottom- up concerns and/or discrimination? |
| cord-346263-8znpqcth | The Location of Culture Shangdong's Swine Flu Virus Carrier Deliberately Lied about His Symptoms and Spread the Virus on Train: What is His Intention? |
| cord-346263-8znpqcth | What motivates such quarantine practices: scientifically driven public health measures, concerns with self or communal survival, or politically and ideologically motivated stigmatization? |
| cord-346263-8znpqcth | Where does the quarantine order come from, i.e., governmental orders, local policies, social pressure, and/or individual will? |
| cord-346263-8znpqcth | Who Are on the Way Home? |
| cord-351446-j4ambec5 | : what should be taken into account? |
| cord-351446-j4ambec5 | Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-351011-v4zmksio | The pathogenesis and treatment of the` Cytokine Storm'in COVID-19 The many faces of the anti- COVID immune response Neuromechanisms of SARS- CoV-2: A Review Early recovery following new onset anosmia during the COVID-19 pandemic-an observational cohort study Does SARS- Cov-2 invade the brain? |
| cord-351011-v4zmksio | The use of anti- inflammatory drugs in the treatment of people with severe coronavirus disease 2019( COVID-19): The 590 Perspectives of clinical immunologists from China Severe COVID-19 and aging: are monocytes the key? |
| cord-351011-v4zmksio | increases lung inflammation and activates pulmonary microvascular endothelial cells via an IL-4-dependent mechanism Protection of LPS- induced murine acute lung injury by sphingosine-1-phosphate lyase suppression Sphingolipids in Ventilator Induced Lung Injury: Role of Sphingosine-1-Phosphate Lyase Endothelial cell infection and endotheliitis in COVID-19 Effective treatment of severe COVID-19 patients with tocilizumab Macrophages: a Trojan horse in COVID-19? |
| cord-351974-1najtyui | How serious are the pressures in social care? |
| cord-348391-xytmq2f2 | Are they closely related? |
| cord-348391-xytmq2f2 | Characteristics of pediatric SARS- CoV-2 infection and potential evidence for persistent fecal viral shedding The immunology of COVID-19: Is immune modulation an option for treatment? |
| cord-348391-xytmq2f2 | Recombination and complementation between orthomyxoviruses under conditions of abortive infection Why is the flu vaccine so mediocre? |
| cord-348391-xytmq2f2 | The mechanism of cell death during West Nile virus infection is dependent on initial infectious dose Mechanism of cell death during infectious salmon anemia virus infection is cell type- specific Dengue virus infection induces passive release of high mobility group box 1 protein by epithelial cells Systemic release of high mobility group box 1 protein during severe murine influenza HMG-1 as a Late Mediator of Endotoxin Lethality in Mice Pathogenic role of HMGB1 in SARS? |
| cord-348391-xytmq2f2 | Why do RNA viruses recombine? |
| cord-352322-tsjwnvkk | Investigating the introduction of porcine epidemic diarrhea virus into an Ohio swine operation Molecular analysis of Brazilian strains of bovine coronavirus( BCoV) reveals a deletion within the hypervariable region of the S1 subunit of the spike glycoprotein also found in human coronavirus OC43 New porcine coronavirus? |
| cord-352909-s11tpfoq | How stable is the virus in different environment? |
| cord-352720-z1cvjc2y | The Allplex 2019-nCoV( Seegene) assay: which performances are for SARS- CoV-2 infection diagnosis? |
| cord-350925-1h6pbfwp | : It May Be Molecular methods used to estimate thermal inactivation of a prototype human norovirus: More heat resistant than previously believed? |
| cord-350925-1h6pbfwp | Possible role of Dewar photoproducts in solar mutagenesis COVID-19, SARS and MERS: are they closely related? |
| cord-350925-1h6pbfwp | The SARS, MERS and novel coronavirus( COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
| cord-352365-b9cmviny | a case report Complete resolution of life- threatening bleomycin- induced pneumonitis after treatment with imatinib mesylate in a patient with Hodgkin's lymphoma: hope for severe chemotherapy- induced toxicity? |
| cord-352863-6cttilm8 | The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation SARS- CoV-2 and human milk: What is the evidence? |
| cord-351719-xqmir1ca | Can nanotechnology and materials science help the fight against SARS- CoV-2? |
| cord-351719-xqmir1ca | Consumers Asymptomatic cases in a family cluster with SARS- CoV-2 infection COVID-19, SARS and MERS: are they closely related? |
| cord-352779-zdtpnip0 | The immunology of COVID-19: is immune modulation an option for treatment? |
| cord-352230-8mazd3eu | IIB inhibits antibody- dependent enhancement of dengue virus infection Immunomodulation by IVIg and the role of Fc- gamma receptors: classic mechanisms of action after all? |
| cord-352230-8mazd3eu | Is the anti- psychotic, 10-(3-(dimethylamino) propyl) phenothiazine( promazine), a potential drug with which to treat SARS infections? |
| cord-353274-wozwpvpq | The copyright holder for this preprint this version posted Viral Kinetics and Antibody Responses in Patients with COVID-19 The Role of Antibody Testing for SARS- CoV-2: Is There One? |
| cord-351218-ei8dyxfg | Dear Sir, I read with great interest the article by Pitocco et al titled"Lack of type 1 diabetes( T1D) involvement in the SARS- CoV-2 population: Only a particular coincidence?". |
| cord-351218-ei8dyxfg | Lack of type 1 diabetes( T1D) involvement in the SARS- CoV-2 population: Only a particular coincidence? |
| cord-351218-ei8dyxfg | SARS- CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids Is COVID-19 Triggering Type 1 and Type 2 Diabetes? |
| cord-351218-ei8dyxfg | key: cord-351218-ei8dyxfg authors: Charles Bronson, Stephen title: Letter to the Editor in response to the article “ Lack of type 1 diabetes involvement in the SARS- CoV-2 population: Only a particular coincidence? |
| cord-350029-1y5ex4d5 | For example, are higher rates of COVID-19 mortality among African- Americans a product of increased exposure to SARS- CoV-2, or increased vulnerability to disease following exposure? |
| cord-350029-1y5ex4d5 | Is the 1918 influenza pandemic over? |
| cord-350029-1y5ex4d5 | Longterm effects of in utero Evaluation of antibody testing for SARS- Cov-2 using ELISA and lateral flow immunoassays Does the pathogenesis of SAR- CoV-2 virus decrease at high- altitude? |
| cord-350029-1y5ex4d5 | Why are older people more vulnerable, while children are largely spared? |
| cord-350029-1y5ex4d5 | Why do infections tend to be mild in pregnancy, in contrast to the 1918 influenza pandemic when mortality was particularly high for pregnant women( Taubenberger& Morens, 2006)? |
| cord-350618-rtilfnzi | : An update for the recent coronavirus pandemic( COVID-19) Drugs in Pregnancy and Lactation Drugs During Pregnancy and Lactation-3rd Edition Role of lopinavir/ ritonavir in the treatment of SARS: initial virological and clinical findings Safety and efficacy of Society of Critical Care Medicine( SCCM) Should we stop aspirin prophylaxis in pregnant women diagnosed with COVID-19? |
| cord-350618-rtilfnzi | Can SARS- CoV-2 Infection Be Acquired In Utero?: |
| cord-350618-rtilfnzi | JAMA Pediatr Clinical manifestations and outcome of SARS- CoV-2 infection during pregnancy Clinical Features and Outcomes of Pregnant Women Suspected of Coronavirus Disease Perinatal Transmission of COVID-19 Associated SARS- CoV-2: Should We Worry? |
| cord-353229-k3zerr83 | The factors affecting the disease course in Kawasaki disease Endothelial cell infection and endotheliitis in COVID-19 Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population Could MEFV mutation carriage status have a protective role for COVID-19 pandemia? |
| cord-350182-s10nong7 | Chikungunya and diabetes, what do we know? |
| cord-350182-s10nong7 | Clinical and basic evidence Risk factors of critical& mortal COVID-19 cases: A systematic literature review and meta- analysis Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-350182-s10nong7 | Is there a link? |
| cord-350182-s10nong7 | Pathogenesis, management and relationship to glycaemic control COVID-19 and diabetes: Knowledge in progress Is COVID-19 an endothelial disease? |
| cord-352911-9wbq9qo2 | Osteoarthr Cartil analysis with dexamethasone, methotrexate and anti- TNF protocols Characterization of the receptor- binding domain( RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Structural basis for the recognition of SARS- CoV-2 by full- length human ACE2 Comparative genetic analysis of the novel coronavirus( 2019-nCoV/ SARS- CoV-2) receptor ACE2 in different populations Polymorphisms of angiotensin- converting A rush to judgment? |
| cord-352577-h3652seb | Early noninvasive ventilation averts extubation failure in patients at risk: a randomized trial Non- invasive ventilation in community- acquired pneumonia and severe acute respiratory failure Utilization of noninvasive ventilation in acute care hospitals Noninvasive versus conventional mechanical ventilation: an epidemiologic survey Should noninvasive ventilation be considered a high- risk procedure during an epidemic? |
| cord-352577-h3652seb | Why did outbreaks of severe respiratory syndrome occur in some hospital wards but not in others? |
| cord-352943-ztonp62x | Although conventional topic modeling has been utilized to understand Covid-19 from literature data 5, can it be applied to obtain additional insights from sequenced SARS- CoV-2 genomes and to rather classify them? |
| cord-352943-ztonp62x | What if we perceive SARS- CoV-2 genomes as documents? |
| cord-353329-ju3vwlow | molecular mechanisms and potential therapeutic target Is COVID-19 an endothelial disease? |
| cord-342756-rgm9ffpk | -What happens next? |
| cord-342756-rgm9ffpk | : what to expect for COVID-19? |
| cord-342756-rgm9ffpk | COVID-19 and diabetes: Can DPP4 inhibition play a role? |
| cord-342756-rgm9ffpk | COVID-19, SARS and MERS: are they closely related? |
| cord-342756-rgm9ffpk | DPP4 inhibition: preventing SARS- CoV-2 infection and/or progression of COVID-19? |
| cord-342756-rgm9ffpk | Protein- protein interactions of viroporins in coronaviruses and paramyxoviruses: new targets for antivirals? |
| cord-342756-rgm9ffpk | The importance of hypertension as a risk factor for severe illness and mortality in COVID-19 Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study Diabetes is a risk factor for the progression and prognosis of COVID-19 Older people and COVID-19: isolation, risk and ageism Asymptomatic carriers of COVID-19 as a concern for disease prevention and control: more testing, more follow- up Drug repositioning: identifying and developing new uses for existing drugs Drug repurposing from the perspective of pharmaceutical companies Drug repurposing: progress, challenges and recommendations Emerging virus diseases: can we ever expect the unexpected? |
| cord-342756-rgm9ffpk | and COVID-19: serendipity or opportunity for intervention? |
| cord-342756-rgm9ffpk | should inhibitors of the renin- angiotensin system be withdrawn in patients with COVID-19? |
| cord-342756-rgm9ffpk | what lessons have we learned? |
| cord-353548-kf4om6iu | , China Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-353479-kwi8zxo6 | Does the sedative agent facilitate emergency rapid sequence intubation? |
| cord-353742-k4gxww2c | Ivermectin: a systematic review from antiviral 451 effects to COVID-19 complementary regimen Ivermectin as a Broad- Spectrum Host Antiviral: The Real Deal? |
| cord-353373-zhkqnu0w | Obesity could shift severe COVID-19 disease to younger ages Prevalence of comorbidities and its effects in patients infected with SARS- CoV-2: a systematic review and meta- analysis Department of Health Health consequences of visceral obesity Abdominal adiposity and cardiometabolic risk: do we have all the answers? |
| cord-353628-f6ew980g | cord-353628-f6ew980 g authors: Zayet, Souheil; Ben Abdallah, Yousri; Royer, Pierre‐Yves; Toko‐Tchiundzie, Lynda; Gendrin, Vincent; Klopfenstein, Timothee title: Encephalopathy in patients with COVID‐19: ‘ Causality or coincidence? ’ |
| cord-350235-yoy3hj3j | W hat is COVID-19? |
| cord-350235-yoy3hj3j | What are the causes, parameters, and effects of this disease? |
| cord-350235-yoy3hj3j | What are the causes, parameters, and effects of this disease? |
| cord-350235-yoy3hj3j | What are the shortand long- term prospects? |
| cord-350235-yoy3hj3j | What are the short‐ and long‐term prospects? |
| cord-350235-yoy3hj3j | What is COVID‐19? |
| cord-353748-y1a52z8e | Bacteriocins-a viable alternative to antibiotics? |
| cord-353731-7xn7m662 | Severe Acute Respiratory Syndrome Coronavirus 2 from 472 Patient with Coronavirus Disease, United States Improved vectors and genome- wide 475 libraries for CRISPR screening MAGeCK enables robust identification of essential genes from 478 genome- scale CRISPR/ Cas9 knockout screens Protein kinases-- the major drug targets of the twenty- first century? |
| cord-350103-liwvhuzj | A Phase III randomized trial to evaluate the influence of BCG strain differences and T cell priming with intradermal BCG before intravesical therapy for BCG- naïve high- grade non- muscle- invasive bladder cancer COVID-19 and Bacillus Calmette- Guérin: What is the link? cord-350103-liwvhuzj : What is the link? cord-350103-liwvhuzj An interactive web- based dashboard to track COVID-19 in real time How will country- based mitigation measures influence the course of the COVID-19 epidemic? cord-350103-liwvhuzj Reinfection or Residual? cord-350103-liwvhuzj The potential impact of BCG vaccine supply shortages on global paediatric tuberculosis mortality Bacille Calmette- Guérin( BCG) vaccination and COVID-19: scientific brief Randomized trial of BCG vaccination at birth to low- birth- weght cildren: beneficial nnspecific efects in the nonatal priod? cord-353509-yfkiaq80 Does SARS- CoV-2 has a longer incubation period than SARS and MERS? cord-334773-yw2qgv13 COVID-19 and diabetes management: What should be considered? cord-334773-yw2qgv13 COVID-19: consider cytokine storm syndromes and immunosuppression COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? cord-334773-yw2qgv13 Can we use interleukin-6( IL-6) blockade for coronavirus disease 2019( COVID-19)-induced cytokine release syndrome( CRS)? cord-334773-yw2qgv13 Considerations for obesity, vitamin D, and physical activity amid the COVID-19 pandemic Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms Does high cardiorespiratory fitness confer some protection against pro- inflammatory responses after infection by SARS- CoV-2? cord-334773-yw2qgv13 Dipeptidyl peptidase 4 distribution in the human respiratory tract implications for the middle east respiratory syndrome COVID-19 and diabetes: can DPP4 inhibition play a role? cord-334773-yw2qgv13 Does coronavirus disease 2019 disprove the obesity paradox in acute respiratory distress syndrome? cord-334773-yw2qgv13 F1000Prime Rep Is there a role for statin therapy in acute viral infections? cord-334773-yw2qgv13 Functional assessment of cell entry and receptor usage for SARS- CoV-2 and other lineage B betacoronaviruses COVID-19 and comorbidities: a role for dipeptidyl peptidase 4( DPP4) in disease severity? cord-334773-yw2qgv13 Hollingsworth, How will country- based mitigation measures influence the course of the COVID-19 epidemic? cord-334773-yw2qgv13 Is the ACE2 overexpression a risk factor for COVID-19 infection? cord-334773-yw2qgv13 Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in Potential effects of coronaviruses on the cardiovascular system: a review Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? cord-334773-yw2qgv13 Should anti- diabetic medications be reconsidered amid COVID-19 pandemic? cord-334773-yw2qgv13 Sliding Scale Insulin Use: Myth or Insanity? cord-334773-yw2qgv13 The etiology of lower respiratory tract infections in people with diabetes Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus( MERS- CoV): a systematic review and meta- analysis Benefits of flu vaccination for persons with diabetes mellitus: a review COVID-19 and diabetes: knowledge in progress Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study Influenza virus and glycemic variability in diabetes: a killer combination? cord-334773-yw2qgv13 Worse progression of COVID-19 in men: is testosterone a key factor? cord-334773-yw2qgv13 inhibitors/ angiotensin receptor blockers have a biphasic effect? cord-334773-yw2qgv13 medRxiv ACE2 in BRain physiology and pathophysiology: evidence from transgenic animal models ACE2 and diabetes: ACE of ACEs? cord-334773-yw2qgv13 the conundrum Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? cord-352256-qxdakdk0 -α What can we predict about viral evolution and emergence? cord-352256-qxdakdk0 What to expect for COVID-19? cord-352905-ge3u32hm The CoV-2 outbreak: how hematologists could help to fight Covid-19 European LeukemiaNet recommendations for the management of chronic myeloid leukemia Dynamics of persistent TT virus infection, as determined in patients treated with alpha interferon for concomitant hepatitis C virus infection Molecular monitoring of chronic myeloid leukemia: principles and interlaboratory standardization Torque Teno Virus viremia kinetics after autologous stem cell transplantation are predictable and may serve as a surrogate marker of functional immune reconstitution Torque Teno Virus: any pathological role in liver transplanted patients? cord-352905-ge3u32hm what can we lea rn from severe acute respiratory syndrome? cord-347351-emdj66vj : how much do we really know? cord-347351-emdj66vj : what does viral RNA load really mean? cord-347351-emdj66vj A Case Report Surgical mask partition reduces the risk of non- contact transmission in a golden Syrian hamster model for Coronavirus Disease 2019( COVID-19) Australian Government releases face masks to protect against coronavirus Rapid assessment of regional SARS- CoV-2 community transmission through a convenience sample of healthcare workers, the Netherlands Universal Masking in Hospitals in the Covid-19 Era Mass masking in the COVID-19 epidemic: people need guidance Covid-19: should the public wear face masks? cord-347351-emdj66vj A SARS- CoV-2 familial cluster infection reveals asymptomatic transmission to children Familial cluster of SARS- CoV-2 infection associated with a railway journey What settings have been linked to SARS- CoV-2 transmission clusters? cord-347351-emdj66vj Clinical infectious diseases: an official publication of the Infectious Diseases Society of Viral kinetics of SARS- CoV-2 in asymptomatic carriers and presymptomatic patients Clinical infectious diseases: an official publication of the Infectious Diseases Society of Viral Load Kinetics of SARS- CoV-2 Infection in First Two Patients in Korea A field indoor air measurement of SARS- CoV-2 in the patient rooms of the largest hospital in Iran Asymptomatic COVID-19 Patients Can Contaminate Their Surroundings: an Environment Sampling Study Environmental contamination by SARS- CoV-2 in a designated hospital for coronavirus disease 2019 Do established infection prevention and control measures prevent spread of SARS- CoV-2 to the hospital environment beyond the patient room? cord-347351-emdj66vj Temporal dynamics in viral shedding and transmissibility of COVID-19 Clearance and persistence of SARS- CoV-2 RNA in patients with COVID-19 Journal of clinical virology: the official publication of the Pan American Society for Airborne or droplet precautions for health workers treating COVID-19? Transmission routes of respiratory viruses among humans Aerobiology and its role in the transmission of infectious diseases Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations On air- borne infection: study II. cord-347351-emdj66vj an official publication of the Infectious Diseases Society of How will country- based mitigation measures influence the course of the COVID-19 epidemic? cord-347351-emdj66vj the Spread of the Novel Coronavirus? cord-349313-2gupfqnl Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019( COVID-19)? cord-349313-2gupfqnl Public Health Coronavirus mapping in scientific publications: When science advances rapidly and collectively, is access to this Knowledge open to society? cord-349313-2gupfqnl SARS- CoV-2 Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? cord-349313-2gupfqnl Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019( COVID-19) COVID-19 and Italy: What next? cord-349313-2gupfqnl What lessons have we learned? cord-353572-b4mdiont -Social medicine, network medicine, and the limits of reductionism The$ 2.6 billion pill-- methodologic and policy considerations silico oncology drug repositioning and polypharmacology Individualized network- based drug repositioning infrastructure for precision oncology in the panomics era Drug repurposing: New treatments for Zika virus infection? cord-353963-d3gk3519 : cord-353963-d3gk3519 authors: Karampela, Irene; Dalamaga, Maria title: Could Respiratory Fluoroquinolones, Levofloxacin and Moxifloxacin, Prove to be Beneficial as an Adjunct Treatment in COVID-19? cord-354261-gdvawnp6 Can SARS- CoV-2 infection be acquired in utero? cord-353524-3w970ycx Therefore, is there a hope for a Q11 rapid drug to come to the market? cord-353524-3w970ycx What are the issues and chances for a rapid approval of a new medicine to treat COVID-19? cord-350015-mg5wiihj : why are children overwhelmingly spared? cord-350015-mg5wiihj A comparative analysis of control measures on- board ship against COVID-19 and similar novel viral respiratory disease outbreak: Quarantine ship or disembark suspects? cord-350015-mg5wiihj But does it matter? cord-350015-mg5wiihj COVID-19 Is aberrant CD8+ T cell activation by hypertension associated with cardiac injury in severe cases of COVID-19? Antibody responses to SARS- CoV-2 in patients of novel coronavirus disease 2019 Epidemiology and cause of severe acute respiratory syndrome( SARS) in Guangdong, People's Republic of China Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: cord-350015-mg5wiihj The Pathway to a Universal Influenza Vaccine Age and immunity: What isimmunosenescence Can an effective SARS- CoV-2 vaccine be developed for the older population? |
| cord-350015-mg5wiihj | The ancient and the new": is there an interaction between cytomegalovirus and SARS- CoV-2 infection? |
| cord-354372-vfvnjmv1 | Autopsy- a procedure of medical history? |
| cord-353551-un4jw7aw | May these drugs expose POMS to a greater risk of SARS- Cov-2 infection as well as to a symptomatic and potentially more severe COVID-19 or to longterm autoimmune severe adverse events? |
| cord-353551-un4jw7aw | What does first- line therapy mean for paediatric multiple sclerosis in the current era? |
| cord-353862-7xe3fvd5 | ( COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention 2019-nCoV epidemic: what about pregnancies? |
| cord-353862-7xe3fvd5 | Reuters Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding What are the risks of COVID-19 infection in pregnant women? |
| cord-353812-4oxbczqe | Associated with SARS- CoV-2 International consensus diagnostic criteria for neuromyelitis optica spectrum disorders Nervous system involvement after infection with COVID-19 and other coronaviruses Encephalitis as a clinical manifestation of COVID-19 Clinical analysis of multiple organ dysfunction syndrome in patients suffering from SARS SARS- CoV-2 can induce brain and spine demyelinating lesions Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-353537-skeajydw | Pneumonia diagnosis and treatment of novel coronavirus infection Correlation of chest CT and RT- PCR testing in coronavirus disease 2019( COVID-19) in China: a report of 1014 cases Development and multicenter performance evaluation of the first fully automated SARA- CoV-2 IgM and IgG immunoassays Droplets and aerosols in the transmission of SARS- CoV-2 Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-353391-o0s2h0y0 | Can N95 Respirators Be Reused after Disinfection? |
| cord-353391-o0s2h0y0 | How Many Times? |
| cord-354582-fniymnmf | The SARS, MERS and novel coronavirus( COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
| cord-353484-q7d0ysbo | Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus( 2019-nCoV) in vitro First Case of 2019 Novel Coronavirus in the United States Compassionate Use of Remdesivir for Patients with Severe Covid-19 Remdesivir in adults with severe COVID-19: a randomised, double- blind, placebo- controlled, multicentre trial Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-353484-q7d0ysbo | What Do We Know? |
| cord-354209-g1zynbul | Stigma and Global Health: Developing a Research Agenda SARS: is global panic justified? |
| cord-354534-0b7zwzjv | COVID-19? |
| cord-352678-8f2ygul2 | COVID-19 and chloroquine/ hydroxychloroquine: is there ophthalmological concern? |
| cord-352678-8f2ygul2 | Is the coronavirus airborne? |
| cord-352678-8f2ygul2 | Where We Are Heading? |
| cord-343966-bfon094h | Are there other field ratio values that could be used to disambiguate isolation values? |
| cord-343966-bfon094h | How is possible that in Madrid isolation to vulnerable was lower than isolation to healthy< 60? |
| cord-343966-bfon094h | In what scenario can Iso2 be different than Iso? |
| cord-343966-bfon094h | Now we can answer the initial question, can Madrid have the same immunity level as Stockholm? |
| cord-343966-bfon094h | That Did n't Hit Earth Influential Covid-19 model uses flawed methods and should n't guide U.S. policies, critics say Is Our Fight Against Coronavirus Worse Than the Disease? |
| cord-343966-bfon094h | What are the alternatives? |
| cord-343966-bfon094h | What happens if a vaccine is available in the future? |
| cord-343966-bfon094h | What happens if a virus is so contagious( high Ro) and so damaging( high IFR_vul) to large proportions of the population( high P_vul) that no solution exists to minimize damages and no insurers pool can cover the risk of exempting isolations? |
| cord-343966-bfon094h | What happens when the N- day long 3rd phase ends? |
| cord-343966-bfon094h | What went wrong? |
| cord-343966-bfon094h | Why do we use this lower value of IFR_vul anyway? |
| cord-343966-bfon094h | he will never see? |
| cord-353612-9ux181xg | Experimental%20Metadata/ HCoV- EMC%20 infection%20in%20Calu-3%20cells/ begin.view?. |
| cord-353612-9ux181xg | The respiratory syncytial virus small hydrophobic protein is phosphorylated via a mitogen- activated protein kinase p38-dependent tyrosine kinase activity during virus infection Activation of the HIV-1 long terminal repeat by cytokines and environmental stress requires an active CSBP/ p38 MAP kinase Mitogen activated protein kinase inhibitors: where are we now and where are we going? |
| cord-352796-6einbent | Chloroquine paradox may cause more damage than help fight COVID-19 Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-352796-6einbent | The Effect of Chloroquine Hydroxychloroquine retinopathy Macular toxicity after short- term hydroxychloroquine therapy Analysis of the ABCR( ABCA4) gene in 4-aminoquinoline retinopathy: Is retinal toxicity by chloroquine and hydroxychloroquine related to Stargardt disease? |
| cord-352796-6einbent | The history of optical instruments for the examination of the eye Dispersal of exhaled air and personal exposure in displacement ventilated rooms Slit lamps and lenses: a potential source of nosocomial infections? |
| cord-353237-rob4ems7 | : what is the link? |
| cord-353237-rob4ems7 | Might hyperbaric oxygen therapy( HBOT) reduce renal injury in diabetic people with diabetes mellitus? |
| cord-353237-rob4ems7 | The end of the story? |
| cord-353716-gxgvhhv1 | A case series Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19 Abnormal coagulation parameters are associated with 14 poor prognosis in patients with novel coronavirus pneumonia Liver injury in COVID-19: management and challenges Effects of acute liver injury on blood coagulation Viral and host factors related to the clinical outcome of COVID-19 Review: Viral infections and mechanisms of thrombosis and bleeding Risk factors for venous and arterial thrombosis Covid-19, induced activation of hemostasis, and immune reactions: Can an auto- immune reaction contribute to the delayed severe complications observed in some patients? |
| cord-353716-gxgvhhv1 | Zhonghua Xue Ye Xue Za Zhi Endothelial cell infection and endotheliitis in COVID-19 Endothelial cell dysfunction: a major player in SARS- CoV-2 infection( COVID-19)? |
| cord-354536-c9v9kbw8 | The Ebola epidemic crystallizes the potential of passive antibody therapy for infectious diseases Selection of Vaccinia Virus- Neutralizing Antibody from a Phage- Display Human- Antibody Library Screening of FDA- approved drugs using a MERS- CoV clinical isolate from South Korea identifies potential therapeutic options for Passive Immunotherapy: Assessment of Convalescent Serum Against Ebola Virus Makona Infection in Nonhuman Primates Enhancement of infectivity of a non- syncytium inducing HIV-1 by sCD4 and by human antibodies that neutralize syncytium inducing HIV-1 Convalescent plasma: new evidence for an old therapeutic tool? |
| cord-350328-wu1ygt6w | For example, why did the individuals staying on the same hotel floor as the index case in Hotel M get infected but none of the staff? |
| cord-350328-wu1ygt6w | How contagious are common respiratory infections? |
| cord-350328-wu1ygt6w | Is quarantine really necessary? |
| cord-350328-wu1ygt6w | The SARS outbreak: how many reminders do we need? |
| cord-350328-wu1ygt6w | These include: what are the conditions required for the airborne transmission of the SARS coronavirus? |
| cord-350328-wu1ygt6w | What makes a super- spreading event? |
| cord-350328-wu1ygt6w | When can we be sure that transmission does not occur? |
| cord-350328-wu1ygt6w | When can we get a good rapid diagnostic test that is positive early in the course of the illness? |
| cord-353704-lfndq85x | Why are RNA virus mutation rates so damn high? |
| cord-350992-l6l24pco | : Is Ferritinophagy the Link? |
| cord-350992-l6l24pco | New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-350992-l6l24pco | The authors declare the following financial interests/ personal relationships which may be considered as Of chloroquine and COVID-19 Viral infection and iron metabolism Hepcidin and the iron- infection axis Iron and infection Guidelines for the use and interpretation of assays for monitoring autophagy Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-350992-l6l24pco | The possible mechanisms of action of 4-aminoquinolines( chloroquine/ hydroxychloroquine) against Sars- Cov-2 infection( COVID-19): A role for iron homeostasis? |
| cord-350992-l6l24pco | Will Complement Inhibition be the New Target in Treating COVID-19 Related Systemic Thrombosis? |
| cord-352065-960xqft4 | : Who Will Live and Who Will Die? |
| cord-352065-960xqft4 | Severe COVID-19 and healthcare- associated infections on the ICU: time to remember the basics? |
| cord-352065-960xqft4 | The epidemiology and clinical information about COVID-19 Estimates of the severity of coronavirus disease 2019: a model- based analysis Bacterial and fungal co- infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times? |
| cord-352557-l7sahv5t | A first step in understanding SARS pathogenesis Temporal dynamics in viral shedding and transmissibility of COVID-19 Appraising the evidence: What is selection bias? |
| cord-352557-l7sahv5t | In line with the PICOT format( Riva et al., 2012) of framing subjects for clinical research, this study centres on answering the question:'In patients suspected of, and diagnosed with, COVID-19, How efficacious, relative to standard symptomatic care, and safe are CQ and HCQ in patients at risk or suspected of, and diagnosed with, COVID-19?' |
| cord-352557-l7sahv5t | What Clinicians Should Know about the QT Interval Chloroquine and COVID-19: A Light at the End of the Tunnel, or is it Another Train? |
| cord-352557-l7sahv5t | What is your research question? |
| cord-353594-z1vxamvp | COVID-19: risk for cytokine targeting in chronic inflammatory diseases? |
| cord-353594-z1vxamvp | PR3 and MPO antigen microdots improve the laboratory diagnostics of ANCA- associated vasculitis From ANA to ENA: how to proceed? |
| cord-349500-603v8lfb | Harnessing the natural inhibitory domain to control TNFα converting enzyme( TACE) activity in vivo Soluble angiotensin- converting enzyme 2: a potential approach for coronavirus infection therapy? |
| cord-349500-603v8lfb | Is there a theoretical rationale to assume that patients with IBD might be less susceptible to inflammation? |
| cord-349500-603v8lfb | Is there an increased or a decreased risk for patients with IBD to suffer from covid-19? |
| cord-349500-603v8lfb | What is the effect of biological agents and cytokine blockers on covid-19? |
| cord-349500-603v8lfb | What is the effect of corticosteroids and classical immunosuppressive agents such as methotrexate( MTX) and azathioprine on covid-19? |
| cord-349500-603v8lfb | What is the evidence for intestinal covid-19 disease and how does covid-19 induce mucosal immune cell activation and a cytokine release syndrome? ► |
| cord-349500-603v8lfb | a distinct entity leading to early death in sepsis Human T cell immunosenescence and inflammation in aging Dysregulation of immune response in patients with COVID-19 in Wuhan, China Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center's observational study Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19 Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme Imbalance of the renin- angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target? |
| cord-349500-603v8lfb | binding site prediction Are patients with inflammatory bowel disease at increased risk for Covid-19 infection? |
| cord-353092-4hz2yyl5 | Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-353092-4hz2yyl5 | Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? |
| cord-353092-4hz2yyl5 | Hypothesis: angiotensin- converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19 SARS- CoV2: should inhibitors of the renin- angiotensin system be withdrawn in patients with COVID-19? |
| cord-351512-h4vigeuy | How has academia, and especially Chinese academia, reacted to the early stages of the current COVID-19 pandemic? |
| cord-351512-h4vigeuy | If so, what are the features of publication dynamics and distribution by country/ region and research discipline? |
| cord-351512-h4vigeuy | In other words, what are the characteristics of the response of the global research community on the challenge? |
| cord-351512-h4vigeuy | Is there any identifiable response from academia to public health emergencies? |
| cord-351512-h4vigeuy | What kinds of research institutions and funding agencies are the main actors in research relating to public health emergencies? |
| cord-353161-mtq6yh25 | Can structural modeling predict cross- species transmission of SARS- CoV-2? |
| cord-353161-mtq6yh25 | Ready To Predict Interactomes? |
| cord-354868-pqn59ojj | The protein complex crystallography beamline( BL19U1) at the Shanghai 545 Synchrotron Radiation Facility How good are my data and what is the resolution? |
| cord-336142-jmetfa6x | 10 Was Toronto ready for a possible pandemic? |
| cord-336142-jmetfa6x | And what about the citizens? |
| cord-336142-jmetfa6x | But did public perceptions of the disease change? |
| cord-336142-jmetfa6x | But is it the historian's responsibility to point out the"lessons of the past"? |
| cord-336142-jmetfa6x | But was there perhaps another reason? |
| cord-336142-jmetfa6x | But what could be done to stop it? |
| cord-336142-jmetfa6x | But what part was Toronto's Health Department to play in an international health crisis? |
| cord-336142-jmetfa6x | But would Toronto Public Health, as the new entity was known, be able to maintain its national and international reputation for innovative community- responsive public health services in the face of the province's mandatory programs and limited funding? |
| cord-336142-jmetfa6x | But would this client- specific approach prove effective against a future pandemic? |
| cord-336142-jmetfa6x | But would this voluntary program be sufficient to protect Torontonians from the feared pandemic? |
| cord-336142-jmetfa6x | Does this signal the senior governments'recognition of the crucial importance of prevention? |
| cord-336142-jmetfa6x | Has the balance of power within the biomedical world shifted, or will the SARS outbreak fade from memory as quickly as the events of 1918? |
| cord-336142-jmetfa6x | How should it be treated? |
| cord-336142-jmetfa6x | How was it spread? |
| cord-336142-jmetfa6x | If so, to whom should her observations be addressed? |
| cord-336142-jmetfa6x | Should these conventional tactics be used against the flu? |
| cord-336142-jmetfa6x | So just how Big a Risk Is SARS? |
| cord-336142-jmetfa6x | Were reporters and newscasters seeking reassurance that all would be well and that civilization would survive? |
| cord-336142-jmetfa6x | Were the anti- vaccinationists reflecting concern at the inability of the medical profession to prevent the flu epidemic through immunization, or was their opposition to compulsory vaccination a postwar rejection of the social and moral authority of Progressive experts and their domination of the war effort? |
| cord-336142-jmetfa6x | What role would municipal health departments be expected to play in the event of such outbreaks? |
| cord-336142-jmetfa6x | What was its cause? |
| cord-336142-jmetfa6x | What was the incubation period? |
| cord-336142-jmetfa6x | Where was it most likely to be contracted? |
| cord-336142-jmetfa6x | Who should be responsible for informing the public, provincial and federal authorities, and the WHO about suspected and probable cases? |
| cord-336142-jmetfa6x | killer or simply as an annual nuisance that appeared in North America every fall and winter, after it had completed its attacks on the Southern Hemisphere and Australasia? |
| cord-352871-0xgjpd80 | Can the coronavirus disease 2019( COVID-19) affect the eyes? |
| cord-352871-0xgjpd80 | Is There Ophthalmological Concern? |
| cord-352871-0xgjpd80 | What Ophthalmologists Should Know About Conjunctivitis in the COVID-19 Pandemic? |
| cord-352871-0xgjpd80 | Why is COVID-19 so mild in children? |
| cord-353887-f4yd7guj | Intravenous immunoglobulin therapy: how does IgG modulate the immune system? |
| cord-353887-f4yd7guj | the Guangzhou experience Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia Decoding the enigma of antiviral crisis: does one target molecule regulate all? |
| cord-354101-8a7tohcx | : What do we currently know? |
| cord-354101-8a7tohcx | : what 711 decides the outcome? |
| cord-353996-slnyun4l | How will country- based mitigation measures influence the course of the COVID-19 epidemic? |
| cord-353996-slnyun4l | The Case of South Korea Modeling and forecasting the early evolution of the Covid-19 pandemic in Brazil Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel Power and Centrality: A Family of Measures Numerical ecology with R Will Coronavirus Pandemic Diminish by Summer? |
| cord-354780-yzyixucr | The SARS, MERS and novel coronavirus( COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
| cord-354762-3a3a3ku9 | Protected? |
| cord-354950-kmpbdvof | : where are we? |
| cord-355283-ny1ju7vc | Preliminary report on seven patients Massive Pulmonary Thromboembolism in Patients with COVID-19; Report of Three Cases Acute pulmonary embolism and COVID-19 pneumonia: a random association? |
| cord-355528-y4a1g6km | Accessed on The SARS, MERS and novel coronavirus( COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
| cord-355122-x3v80bdp | Why tocilizumab could be an effective treatment for severe COVID-19? |
| cord-355356-g7lvb8b4 | COVID-19 perspective Safety, tolerability, and pharmacokinetics of remdesivir, an antiviral for treatment of COVID-19, in healthy subjects What do we know about remdesivir drug interactions? |
| cord-354608-1me3nopu | COVID-19 pathophysiology: a review Pathophysiology of COVID-19: Why children fare better than adults? |
| cord-354608-1me3nopu | The immune system of children: the key to understanding SARS- CoV-2 susceptibility? |
| cord-351896-j6h02ab5 | COVID-19 may induce Guillain- Barré syndrome Guillain- Barré syndrome following COVID-19: new infection, old complication? |
| cord-351896-j6h02ab5 | Should we stimulate or suppress immune responses in COVID-19? |
| cord-351896-j6h02ab5 | a retrospective multicenter study How to carry out and interpret EEG recordings in COVID-19 patients in ICU? |
| cord-351896-j6h02ab5 | causative or coincidental? |
| cord-351896-j6h02ab5 | encephalopathy Lessons of the month 1: a case of rhombencephalitis as a rare complication of acute COVID-19 infection Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
| cord-351896-j6h02ab5 | the fragile balance between infections and autoimmunity Guillain- Barré Syndrome Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena? |
| cord-353599-cw29edwr | A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19( COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality Treatment with ACE- inhibitors is associated with less severe disease with SARS- Covid-19 infection in a multi- site UK acute Hospital Trust Safety of Ibuprofen in Patients With COVID-19: Causal or Confounded? |
| cord-353599-cw29edwr | COVID-19 telemedicine five days protocol Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-353599-cw29edwr | Does Ibuprofen Worsen COVID-19? |
| cord-354349-hbk2p6ej | : The need for combination therapy with non- anti- SARS- CoV-2 agents? |
| cord-354349-hbk2p6ej | Co- infection with SARS- CoV-2 and Influenza A Virus in Patient with Pneumonia Varicella- like exanthem associated with COVID-19 in an 8-year- old girl: A diagnostic clue? |
| cord-354349-hbk2p6ej | Roles and challenges of primary care physicians facing a dual outbreak of COVID-19 and dengue in Singapore Malaria and Parasitic Neglected Tropical Diseases: Potential Syndemics with COVID-19? |
| cord-355439-eqtk51q3 | Could HIV infection alter the clinical course of SARS- CoV-2 infection? |
| cord-355577-w1yhtbz8 | Covid-19: what's the current advice for UK doctors? |
| cord-354893-tku1dr32 | ( 2) Can the SARS- CoV use any bat ACE2 as a functional receptor to satisfy the precondition for bats acting as the natural reservoir of SARS- CoV or a closely related progenitor virus? |
| cord-354893-tku1dr32 | What is the functional receptor for SL- CoVs and do these viruses have the potential to spill over into other animals and humans to cause disease like SARs- CoV? |
| cord-354900-bzv4yhqi | Can drinking microfiltered raw immune milk from cows immunized against SARS- CoV-2 provide short- term protection against COVID-19? |
| cord-354900-bzv4yhqi | Could intravenous immunoglobulin collected from recovered coronavirus patients protect against COVID-19 and strengthen the immune system of new patients? |
| cord-355807-q3bngari | : Where are we? |
| cord-354353-hyz0gmpz | COVID-19 outbreaks? |
| cord-354353-hyz0gmpz | Can PM- virus composites induce infection? |
| cord-354353-hyz0gmpz | Can infectious viruses survive on PM? |
| cord-355734-pz64534w | medRxiv Analysis of the infection status of the health care workers in Wuhan during the COVID-19 outbreak: A cross- sectional study SARS- CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients Deaths from COVID-19 in healthcare workers in Italy- What can we learn? |
| cord-355718-7dafsxp9 | Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? |
| cord-355039-qi4fwqbc | A multibasic cleavage site in the spike protein of SARS- CoV-2 is essential for infection of human lung cells COVID-19, diabetes mellitus and ACE2: the conundrum Angiotensin receptor blockers as tentative SARS- CoV-2 therapeutics Angiotensin- converting enzyme 2( ACE2) as a SARS- CoV-2 receptor: molecular mechanisms and potential therapeutic target Soluble angiotensin- converting enzyme 2: a potential approach for coronavirus infection therapy? |
| cord-355039-qi4fwqbc | physiology and pathology Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-353923-ou7w3zkv | The SARS, MERS and novel coronavirus( COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
| cord-353923-ou7w3zkv | Time to Revisit Infection Control Strategies? |
| cord-353923-ou7w3zkv | heating and UV irradiation First respiratory transmitted food borne outbreak? |
| cord-350733-0zghspb8 | Beliefs underlying UK parents'views towards MMR promotion interventions: a qualitative study A systematic review of interventions for reducing parental vaccine refusal and vaccine hesitancy On the benefits of explaining herd immunity in vaccine advocacy Vaccinating to help ourselves and others Inviting free- riders or appealing to prosocial behavior? |
| cord-350733-0zghspb8 | Can this strategy be improved by taking an EBM+ approach? |
| cord-350733-0zghspb8 | Do genetic polymorphisms, 37- 39 physiological variables, diseases, and drug interactions alter it predictably? |
| cord-350733-0zghspb8 | Do strategic lesions cause predictable changes? |
| cord-350733-0zghspb8 | Does it change in response to interventions such as upregulation or downregulation? |
| cord-350733-0zghspb8 | Is hypertension in African- descent populations contributed to by an imbalance in the activities of the ACE2/ Ang-(1- 7)/Mas and the ACE/ Ang II/ AT1 axes? |
| cord-350733-0zghspb8 | a Bayesian framework for causal assessment in pharmacosurveillance Drugs and the renin- angiotensin system in covid-19 Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-350733-0zghspb8 | should inhibitors of the renin- angiotensin system be withdrawn in patients with COVID-19? |
| cord-350733-0zghspb8 | • When any changes occur, is dose- responsiveness maintained? |
| cord-356174-40k6m7l0 | How the SARS coronavirus causes disease: host or organism? |
| cord-353749-2vlc11rx | A randomized clinical trial Hydroxychloroquine as pre- exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial Beyond the randomized controlled trial: a review of alternatives in mHealth clinical trial methods Effect of a US National Institutes of Health programme of clinical trials on public health and costs Characteristics and strength of evidence of COVID-19 studies registered on ClinicalTrials.gov COVID-19: real- time dissemination of scientific information to fight a public health emergency of international concern Mefloquine at the crossroads? |
| cord-353749-2vlc11rx | A randomized clinical trial Lessons learned from early compassionate use of convalescent plasma on critically ill patients with Covid-19 Potent neutralizing antibodies directed to multiple epitopes on SARS- CoV-2 spike Antibody therapies could be a bridge to a coronavirus vaccine-but will the world benefit? |
| cord-353749-2vlc11rx | Where can we find a prophylactic treatment that is easy to use, inexpensive and already available? |
| cord-355175-uo9fx6jy | An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal- fetal transmission of SARS- CoV-2: maternal coronavirus infections and pregnancy outcomes Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus( COVID-19) infection Clinical management of severe acute respiratory infection when novel coronavirus( nCoV) infection is suspected: interim guidance Home care for patients with suspected novel coronavirus( nCoV) infection presenting with mild symptoms and management of contacts Coronavirus in pregnancy and delivery: rapid review COVID-19, SARS- CoV-2 and pregnancy: Does the past predict the present? |
| cord-355175-uo9fx6jy | Can SARS- CoV-2 infection be acquired in utero? |
| cord-356154-ifb3qiz7 | In this study, we found unnormal changes of viral nucleic acid and antibodies in two Notes: ND, no data;? |
| cord-354619-pftjhtpo | A possible strategy for reducing SARS- COV-2 infectivity? |
| cord-354619-pftjhtpo | COVID-19: Faecal- oral transmission? |
| cord-354619-pftjhtpo | Is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-355567-60sfv60p | How can airborne transmission of COVID-19 indoors be minimised? |
| cord-355567-60sfv60p | How long do nosocomial pathogens persist on inanimate surfaces? |
| cord-353293-vjdwh19x | Children are not infected, or most of them are asymptomatic, but do they spread the infection in family clusters? |
| cord-353293-vjdwh19x | Do children play a role in this pandemic? |
| cord-353293-vjdwh19x | Do they play a role in the contagion chain? |
| cord-353293-vjdwh19x | The most important open question to be answered is as follows:"Once recovered from COVID-19 what happens to patients, and how has the virus impacted their body?" |
| cord-356364-ipi81ce3 | the beginning of another SARS- like pandemic? |
| cord-356195-5pcaxpp9 | The Lancet 11 Use of SARS CoV 2--infected deceased organ donors: Should we always"just say no? |
| cord-355589-3zdv9zim | ( COVID-19) Patients Psychosocial factors and hospitalisations for COVID-19: Prospective cohort study of the general population Clinical predictors of donor antibody titer and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial Chronic ACE Inhibitor use is Associated with Decreased Odds of Severe Disease in Patients with COVID-19 Intraluminal Carotid Artery Thrombus in COVID-19: Another Danger of Cytokine Storm? |
| cord-355589-3zdv9zim | a comparison of patients with and without COVID-19 Clinical and Genetic Characteristics of Covid-19 Patients from UK Biobank Is sleep apnoea a risk factor for Covid-19? Findings from a retrospective cohort study Cardiac Structural and Functional Characteristics in Patients with Coronavirus Disease |
| cord-352668-qjlqsb2k | A call for contributions to ANDROLOGY Understanding the Impact of COVID-19 on Latino Sexual Minority Men in a US HIV Hot Spot Survey of stress reactions among health care workers involved with the SARS outbreak Is there a case for quarantine? |
| cord-352668-qjlqsb2k | COVID-19: Faecal- oral transmission? |
| cord-352668-qjlqsb2k | Pandemic DNA methylation: Conducting the orchestra from exposure to phenotype? |
| cord-352668-qjlqsb2k | Secrets of the Super Young Is good sex good for you? |
| cord-352668-qjlqsb2k | The COVID-19 pandemics: Shall we expect andrological consequences? |
| cord-352668-qjlqsb2k | The psychological impact of the SARS epidemic on hospital employees in China: Exposure, risk perception, and altruistic acceptance of risk Sexual activity and life satisfaction in older adults Sexuality and Mental Health: The Need for Mutual Development and Research Depression and loneliness during COVID-19 restrictions in the United States, and their associations with frequency of social and sexual connections Sexual transmission of SARS- CoV-2: A new possible route of infection? |
| cord-352668-qjlqsb2k | What about pregnant women? |
| cord-355181-affuyn8z | : Can an endodontist take the lead in point- of- care COVID-19 testing? |
| cord-355181-affuyn8z | Can Antimicrobial Copper- Based Alloys Help Suppress Infectious Transmission of Viruses Originating from Human Contact with High- Touch Surfaces? |
| cord-355181-affuyn8z | What does viral RNA load really mean? |
| cord-355899-wd00f8cw | : Is There One? |
| cord-355899-wd00f8cw | How Related is SARS- CoV-2 to Other Coronaviruses? |
| cord-354881-7o20cn1x | Is social and behavioural science evidence ready for application and dissemination? |
| cord-354881-7o20cn1x | The Marmot review Socioeconomic inequality of access to healthcare: does choice explain the gradient? |
| cord-354881-7o20cn1x | Waiting for certainty on Covid-19 antibody tests- at what cost? |
| cord-356150-ivso91ln | : how to manage? |
| cord-356150-ivso91ln | Ready to start again? |
| cord-355475-kdubhh73 | A Systematic Review Oral Manifestations in Patients with COVID-19: A Living Systematic Review Oral lesions in patients with SARS- CoV-2 infection: could the oral cavity be a target organ? |
| cord-355475-kdubhh73 | Are they a true sign of COVID-19 disease? |
| cord-355475-kdubhh73 | Will there be oral toxicities or benefits of COVID-19 treatments particularly as treatments target the cytokine storm, a procoagulant state, and local and systemic activation of inflammation? |
| cord-345371-pjbviagq | : Are we asking the right questions? |
| cord-345371-pjbviagq | An Individual Patient Data Systematic Review Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia? |
| cord-345371-pjbviagq | An Overview of Severe Acute Respiratory Syndrome- Coronavirus( SARS- CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad- Spectrum Therapeutic Strategy Old drugs as lead compounds for a new disease? |
| cord-345371-pjbviagq | Baricitinib: a chance to treat COVID-19? |
| cord-345371-pjbviagq | Bleeding and Thrombotic Manifestations of SARS- CoV2 Infection COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow- up Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? |
| cord-345371-pjbviagq | Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
| cord-345371-pjbviagq | Increased cardiovascular mortality in African Americans with COVID-19 Will Complement Inhibition Be the New Target in Treating COVID-19-Related Systemic Thrombosis? |
| cord-345371-pjbviagq | Inhibitory Mechanisms A Trial of Lopinavir- Ritonavir in Adults Hospitalized with Severe Covid-19 Owa Lopinavir/ ritonavir use in Covid-19 infection: is it completely non- beneficial? |
| cord-345371-pjbviagq | Is teicoplanin a complementary treatment option for COVID-19? |
| cord-345371-pjbviagq | Justified? |
| cord-345371-pjbviagq | Teicoplanin: an alternative drug for the treatment of COVID-19? |
| cord-345371-pjbviagq | The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells Cardiac arrest caused by nafamostat mesilate Three cases of treatment with Nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy Potential new treatment strategies for COVID-19: is there a role for bromhexine as add- on therapy? |
| cord-345371-pjbviagq | Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? |
| cord-345371-pjbviagq | Why drugs fail in clinical trials in pulmonary arterial hypertension, and strategies to succeed in the future Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both AT1 and AT2 receptors Angiotensin- I converting enzyme inhibitors as potential anti- angiogenic agents for cancer therapy Our ACE in the HOLE: Justifying the Use of Angiotensin- converting Enzyme Inhibitors as Adjuvants to Standard Chemotherapy Vascular endothelial growth factor( VEGF) in acute lung injury( ALI) and acute respiratory distress syndrome( ARDS): paradox or paradigm? |
| cord-345371-pjbviagq | Why tocilizumab could be an effective treatment for severe COVID-19? |
| cord-354030-8tfg881h | ( http://unafold.rna.albany.edu/? |
| cord-354030-8tfg881h | Immunoinformatics approach The use of databases, data mining, and immunoinformatics in vaccinology: where are we? |
| cord-354030-8tfg881h | The restriction enzyme cutting sites of Xho? |
| cord-354030-8tfg881h | and BamH? were then appended to the N and C terminals, respectively. |
| cord-355294-gifsqph6 | Choose BMC and benefit from:? |
| cord-355294-gifsqph6 | Do patients with cancer have a poorer prognosis of COVID-19? |
| cord-355294-gifsqph6 | Ready to submit your research Ready to submit your research? |
| cord-354538-vqi67h6a | How many of the asymptomatic healthcare workers developed antibodies? |
| cord-354538-vqi67h6a | Were there demographic differences among antibody- positive healthcare workers? |
| cord-354538-vqi67h6a | What departments had the highest number of positive antibody tests? |
| cord-354538-vqi67h6a | What is the prevalence of antibodies in those healthcare workers with self- reported positive and negative SARS- CoV-2 PCR tests? |
| cord-354538-vqi67h6a | What is the prevalence of antibody positivity in symptomatic healthcare workers? |
| cord-354453-uze6ze8o | However, the imposition of these dramatic measures does also raise a wider question: if there is an impact from these measures, what other countries would( or could) implement such measures? |
| cord-354453-uze6ze8o | Is it reasonable to consider that national governments would close down public transport into and out of London, New York or Paris in the week before Christmas even if it were shown to be an effective control measure? |
| cord-354453-uze6ze8o | This response is one of the swiftest, coordinated global responses to an emerging infectious disease the world has seen in modern times, but is it the appropriate response, will it be effective and is it sustainable? |
| cord-354453-uze6ze8o | Would other countries accept the self- imposed economic damage that China has accepted to try and contain this outbreak? |
| cord-354453-uze6ze8o | can we measure that will provide an answer to that question? |
| cord-350959-bsbz3a1l | : extra caution needed for patients with diabetes Are patients with cancer at higher risk of COVID-19? |
| cord-350959-bsbz3a1l | : what we know? |
| cord-350959-bsbz3a1l | Coronavirus COVID-19 exaggerated threat U.S opinion by gender China: gender distribution of novel coronavirus patients Italy: coronavirus cases distribution by gender Who is getting sick? |
| cord-350959-bsbz3a1l | I Do patients with cancer have a poorer prognosis of COVID-19? |
| cord-350959-bsbz3a1l | Infectious mononucleosis, other infections and prostate- specific antigen concentration as a marker of prostate involvement during infection Evidence for gastrointestinal infection of SARS- CoV-2 Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients Evaluating the effect of time from prostate cancer diagnosis to radical prostatectomy on cancer control: can surgery be postponed safely? |
| cord-350959-bsbz3a1l | SARS- CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China Immunotherapy for prostate cancer: where we are headed The role of telehealth in the medical response to disasters Virtually perfect? |
| cord-350959-bsbz3a1l | Telemedicine for COVID-19 Coronavirus pandemic in South Korea Coronavirus: why did infections shoot up in South Korea? |
| cord-350959-bsbz3a1l | a systematic review of the evidence Association of smoking status with recurrence, metastasis, and mortality among patients with localized prostate cancer undergoing prostatectomy or radiotherapy: a systematic review and metaanalysis Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-350959-bsbz3a1l | micromechanics reassemble the signaling machinery of TMPRSS2-ERG positive prostate cancer cells Influenza vaccination and chemotherapy: a shot in the dark? |
| cord-352737-3ttrx3lf | A review of potential options for therapeutic intervention Ageing of lymphocytes and lymphocytes in the aged Immunosenescence: impact in the young as well as the old? |
| cord-352737-3ttrx3lf | From cell senescence to age- related diseases: differential mechanisms of action of senescenceassociated secretory phenotypes Aging of the human metaorganism: the microbial counterpart The role of oxidative and inflammatory stress and persistent viral infections in immunosenescence Inflammaging and'Garb- aging Telomere dynamics in immune senescence and exhaustion triggered by chronic viral infection Effect of ageing on CMV- specific CD8 T cells from CMV seropositive healthy donors T- cell dysregulation caused by chronic antigenic stress: the role of CMV in immunosenescence? |
| cord-352737-3ttrx3lf | Immunosenescence and inflamm- aging as two sides of the same coin: friends or foes? |
| cord-352737-3ttrx3lf | Immunosenescence and its hallmarks: how to oppose aging strategically? |
| cord-352737-3ttrx3lf | National Institutes of Health( 2020) Estimates of the severity of coronavirus disease 2019: a model- based analysis Aging of the immune system: how much can the adaptive immune system adapt? |
| cord-352737-3ttrx3lf | Physical activity and diet shape the immune system during aging Can physical activity ameliorate immunosenescence and thereby reduce age- related multi- morbidity? |
| cord-352737-3ttrx3lf | The role of immunosenescence in the development of age- related diseases Immune- endocrine biomarkers as predictors of frailty and mortality: a 10-year longitudinal study in community- dwelling older people Predicting death from tumour necrosis factor- alpha and interleukin-6 in 80-year- old people Associations of elevated interleukin-6 and C- reactive protein levels with mortality in the elderly Hallmarks of human"immunosenescence": adaptation or dysregulation? |
| cord-355935-psnqrdo2 | How Much of China and World GDP has the Coronavirus Reduced? |
| cord-355935-psnqrdo2 | Is the Impact of Social Distancing on Coronavirus Growth Rates Effective Across Different Settings? |
| cord-355935-psnqrdo2 | The Emergence of a Basque Global City? |
| cord-355935-psnqrdo2 | What do these effects mean? |
| cord-351555-hsgsuor2 | -ninth update The novel coronavirus disease( COVID-19) threat for patients with cardiovascular disease and cancer Covid-19 and cancer patients: delving into burning questions Nosocomial infections in patients with cancer Immunological effects of conventional chemotherapy and targeted anticancer agents Are cancer patients at higher risk of death with COVID-19? |
| cord-351555-hsgsuor2 | : what to expect for COVID-19? |
| cord-351555-hsgsuor2 | Are there any specific measures to prevent infection? |
| cord-351555-hsgsuor2 | How soon should patients with colon cancer undergo definitive resection? |
| cord-351555-hsgsuor2 | Managing COVID-19 in the oncology clinic and avoiding the distraction effect Rischio infettivo da Coronavirus COVID 19: indicazioni per l'Oncologia da parte del Presidente AIOM, del Presidente eletto AIOM, del Presidente CIPOMO e del Presidente COMU Virtually perfect? |
| cord-351555-hsgsuor2 | Several suggestion of operation for colorectal cancer under the outbreak of Corona Virus Disease 19 in China Cancer care in the time of COVID-19 Clinical guide for the management of cancer patients during the coronavirus pandemic Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease? |
| cord-351555-hsgsuor2 | Should any specific measures be taken during treatment? |
| cord-351555-hsgsuor2 | Some of the questions addressed are the following: Should the cancer patients'management be continued or deferred and under| 3 which conditions? |
| cord-354720-fu19u2b0 | : evidence from a meta- analysis Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China Inhibition of SARS- coronavirus infection in vitro by S- nitroso- N- acetylpenicillamine, a nitric oxide donor compound Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-354720-fu19u2b0 | COVID-19 and angiotensin- converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence? |
| cord-354720-fu19u2b0 | Is the prone position helpful during spontaneous breathing in patients with COVID-19? |
| cord-354720-fu19u2b0 | The perils of premature phenotyping in COVID: a call for caution Management of COVID-19 respiratory distress Use of non- invasive ventilation for patients with COVID-19: a cause for concern? |
| cord-354720-fu19u2b0 | angiotensin receptor blockers have a biphasic effect? |
| cord-354824-7fdcu2f0 | Evaluation of the efficacy and safety of sarilumab in hospitalized patients with COVID-19 Overview of the IL-1 family in innate inflammation and acquired immunity Personalised immunotherapy for SARS- CoV-2( COVID-19) associated with organ dysfunction Clinical course and outcomes of critically ill patients with SARS- CoV-2 pneumonia in Wuhan, China: a single- centered, retrospective, observational study Clinical characteristics of coronavirus disease 2019 in China Clinical characteristics of 140 patients infected with SARS- CoV-2 in Wuhan Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-354824-7fdcu2f0 | Investigating mechanism of Qingfei Dayuan granules for treatment of COVID-19 based on network pharmacology and molecular docking Study on screening potential traditional Chinese medicines against 2019-nCoV based on Mpro and PLP Chinese herbal medicine for severe acute respiratory syndrome: a systematic review and metaanalysis Traditional Chinese herbal medicine as a source of molecules with antiviral activity Can Chinese medicine be used for prevention of corona virus disease 2019( COVID-19)? |
| cord-354824-7fdcu2f0 | The host immune response in respiratory virus infection: balancing virus clearance and immunopathology Groups at higher risk for severe illness Coronavirus and COVID-19: who is at higher risk? |
| cord-354824-7fdcu2f0 | Why tocilizumab could be an effective treatment for severe COVID-19? |
| cord-354824-7fdcu2f0 | identifies potential anti- coronavirus drugs Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus Meta- analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? |
| cord-352969-rpt7xja6 | COVID-19 and calcineurin inhibitors: should they get left out in the storm? |
| cord-352969-rpt7xja6 | COVID-19? |
| cord-352969-rpt7xja6 | Clinical characteristics and immunosuppressant management of coronavirus disease 2019 in solid organ transplant recipients Severe COVID-19 in a renal transplant recipient: a focus on pharmacokinetics First case of COVID-19 in a kidney transplant recipient treated with belatacept SARS- CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor Pharmacologic modulation of ACE2 expression Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-352969-rpt7xja6 | Renin- angiotensinaldosterone system inhibitors in patients with Covid-19 Post- mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction Incidence of thrombotic complications in critically ill ICU patients with COVID-19 Where do we stand with antithrombotic prophylaxis in patients with COVID-19? |
| cord-352969-rpt7xja6 | Solid organ transplantation programs facing lack of empiric evidence in the COVID-19 pandemic: a by- proxy society recommendation consensus approach Virtually perfect? |
| cord-352969-rpt7xja6 | The COVID-19 outbreak in Italy: initial implications for organ transplantation programs Early impact of COVID-19 on transplant center practices and policies in the United States Organ procurement and transplantation during the COVID-19 pandemic COVID-19: a global transplant perspective on successfully navigating a pandemic Use of SARS- CoV-2 infected deceased organ donors: should we always"just say no? |
| cord-352969-rpt7xja6 | UNOS website COVID-19-associated nephritis: early warning for disease severity and complications? |
| cord-352969-rpt7xja6 | Utilization of deceased donors during a pandemic: argument against using SARS- CoV-2 positive donors What is the appropriate use of laparoscopy over open procedures in the current COVID-19 climate? |
| cord-352969-rpt7xja6 | mBio Complement as a target in COVID-19? |
| cord-349445-yh6ndtgm | : What Is the Evidence? |
| cord-349445-yh6ndtgm | Are certain drugs associated with enhanced mortality in COVID-19? |
| cord-349445-yh6ndtgm | COVID-19: Epidemiology, Evolution, and Cross- Disciplinary Perspectives COVID-19 and the Renin- Angiotensin System SARS- CoV2: should inhibitors of the renin- angiotensin system be withdrawn in patients with COVID-19? |
| cord-349445-yh6ndtgm | Close to a Cure? |
| cord-349445-yh6ndtgm | Covid-19 Can angiotensin receptor- blocking drugs perhaps be harmful in the COVID-19 pandemic? |
| cord-349445-yh6ndtgm | Evidence- Based Med New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-349445-yh6ndtgm | Hence, the question now, may the reviewed actions of NEP pathways be sufficient to impose a new effective strategy for COVID-19 management as compared to the suggested repurposed drugs? |
| cord-349445-yh6ndtgm | Modulators of inflammation in acute lung injury? |
| cord-349445-yh6ndtgm | Neprilysin inhibition: a new therapeutic option for type 2 diabetes? |
| cord-349445-yh6ndtgm | Role in reducing β- amyloid levels Estrogen regulation of the neprilysin gene through a hormone- responsive element Influence of Selected Natural Products on Neutral Endopeptidase Activity and β- Amyloid Production in SK- N- SH Cells Possible role of Resveratrol targeting Estradiol and Neprilysin pathways in Lipopolysaccharide model of Alzheimer disease Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer's disease model mice by upregulating neprilysin expression Effects of Naoerkang on expressions of β- amyloid peptide 1- 42 and neprilysin in hippocampus in a rat model of Alzheimer's disease Decoding the enigma of antiviral crisis: Does one target molecule regulate all? |
| cord-349445-yh6ndtgm | So Far, Pathogens Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study COVID-19: consider cytokine storm syndromes and immunosuppression Correspondence Use of antiviral drugs to reduce COVID-19 Therapeutic options for the 2019 novel coronavirus( 2019-nCoV) Drug treatment options for the 2019-new coronavirus( 2019-nCoV) Molecular immune pathogenesis and diagnosis of COVID-19 Cytokinstormer ved covid-19? |
| cord-349445-yh6ndtgm | v2, ArXiv Prepr Acute respiratory distress syndrome leads to reduced ratio of ACE/ ACE2 activities and is prevented by angiotensin-(1- 7) or an angiotensin II receptor antagonist The Angiotensin- Converting Enzyme 2/ Angiogenesis-(1- 7)/Mas Axis Confers Cardiopulmonary Protection against Lung Fibrosis and Pulmonary Hypertension Decreased levels of serum Angiotensin-(1- 7) in patients with pulmonary arterial hypertension due to congenital heart disease Reninangiotensin- system, a potential pharmacological candidate, in acute respiratory distress syndrome during mechanical ventilation Dose- dependent, therapeutic potential of angiotensin-(1- 7) for the treatment of pulmonary arterial hypertension Angiotensin II type 2 receptor( AT2R) in renal and cardiovascular disease Angiotensin-(1- 7): A Novel Peptide to Treat Hypertension and Nephropathy in Diabetes? |
| cord-354658-v451z3jq | : what to expect for COVID-19? |
| cord-354658-v451z3jq | How to approach therapeutic futility for termination? |
| cord-354658-v451z3jq | Left ventricular distension in veno- arterial extracorporeal membrane oxygenation: From mechanics to therapies Mechanical unloading in heart failure Incidence and implications of left ventricular distention during venoarterial extracorporeal membrane oxygenation support How small is enough for the left heart decompression cannula during extracorporeal membrane oxygenation? |
| cord-354658-v451z3jq | Should ECMO be considered for COVID-19 patients? |
| cord-354658-v451z3jq | Should ECMO during CPR( E- CPR) be considered for COVID-19 patients? |
| cord-354658-v451z3jq | The Wuhan coronavirus Real- time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 Epidemiology and cause of severe acute respiratory syndrome( SARS) in Guangdong, people's republic of China, in february Characteristics of and important lessons from the Coronavirus Disease 2019( COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese center for disease control and prevention Structural and functional basis of SARS- CoV-2 entry by using human ACE2 A pneumonia outbreak associated with a new coronavirus of probable bat origin Bats: Important reservoir hosts of emerging viruses Probable pangolin origin of 2019-nCoV associated with outbreak of COVID-19 The emergence of a novel coronavirus( SARS- CoV-2), their biology and therapeutic options Structural basis for the recognition of SARS- CoV-2 by full- length human ACE2 Cryo- EM structure of the 2019-nCoV spike in the prefusion conformation Structure of the SARS- CoV-2 spike receptorbinding domain bound to the ACE2 receptor Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: A descriptive study COVID-19): A perspective from China COVID-19 Retrospective Study of Chest CTs from China: What is the Relationship to Duration of Infection? |
| cord-354658-v451z3jq | What protective measures for the team should be used? |
| cord-343365-4y9fedcr | Autoimmune Lung Diseases- Biomarkers and Biologics- Sparing the Steroids? |
| cord-343365-4y9fedcr | But how will this be done? |
| cord-343365-4y9fedcr | But where did this virus come from and how did it suddenly cause so much havoc? |
| cord-343365-4y9fedcr | Cystic Fibrosis- What Happened to Gene Therapy? |
| cord-343365-4y9fedcr | How close are we to implementing gene targeting in animals other than the mouse? |
| cord-343365-4y9fedcr | Is this a failure of an immunization program? |
| cord-343365-4y9fedcr | Molecular basis of binding between novel human coronavirus MERS- CoV and its receptor CD26 Anti- neutrophil cytoplasmic antibody( ANCA)-associated vasculitis: where to go? |
| cord-343365-4y9fedcr | Respiratory Syncytial Virus- How to Develop an Effective Vaccine? |
| cord-343365-4y9fedcr | So can SARS happen again? |
| cord-343365-4y9fedcr | So, what happened to gene therapy? |
| cord-343365-4y9fedcr | The genomics of autoimmune disease in the era of genome- wide association studies and beyond The genomics and Personalized Medicine Act of Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases? |
| cord-343365-4y9fedcr | The role of environmental estrogens and autoimmunity Systemic lupus erythematosus one disease or many? |
| cord-343365-4y9fedcr | The role of the environment in the development of pediatric inflammatory bowel disease Do infections facilitate the emergence of systemic sclerosis? |
| cord-343365-4y9fedcr | Treatment of ANCA- associated vasculitis, where to go? |
| cord-343365-4y9fedcr | Tuberculosis vaccines: time to reset the paradigm? |
| cord-343365-4y9fedcr | What are the prospects for gene therapy in the twenty- first century? |
| cord-343365-4y9fedcr | What happened to all that promise that buoyed the cystic fibrosis community back in the 1980s? |
| cord-343365-4y9fedcr | how are they detected and what is their use for diagnosis, classification and follow- up? |
| cord-356009-emn2w8if | : Does SARS- CoV-2 Cause Viral Cystitis? |
| cord-356009-emn2w8if | However, it is important to notice that it is the naso- pharyngeal specimens,? |
| cord-356009-emn2w8if | Moreover, the findings in our review? suggest that a larger population size may reveal more positive urinary cases possibly by? |
| cord-356009-emn2w8if | Moreover, the findings in our review? suggest that a larger population size may reveal more positive urinary cases possibly by? |
| cord-356009-emn2w8if | Our review concludes that not only the SARS- CoV-2 can be excreted in the urine in eight? |
| cord-356009-emn2w8if | What Specimen Urologists Should Be Most Concerned About? |
| cord-356009-emn2w8if | What kind of systematic review should I conduct? |
| cord-356009-emn2w8if | percent of patients but also its incidence may have associations with the severity of the? systemic disease, ICU admission, and fatality rates. |
| cord-352799-qmzh976f | Are there alternative approaches? |
| cord-352799-qmzh976f | Can burdens be minimized? |
| cord-352799-qmzh976f | How can the benefits and burdens of a program be fairly balanced? |
| cord-352799-qmzh976f | How effective is the program in achieving its stated goals? |
| cord-352799-qmzh976f | Is the program implemented fairly? |
| cord-352799-qmzh976f | L'avertissement aux voyageurs a- t- il été mis en oeuvre équitablement? |
| cord-352799-qmzh976f | This raises the sixth, and final, step in Kass's analysis-how can the benefits and burdens of the program be fairly balanced? |
| cord-352799-qmzh976f | Was WHO SARS- related Travel Advisory for Toronto Ethical? |
| cord-352799-qmzh976f | Was the 2003 SARS outbreak in Toronto one such circumstance? |
| cord-352799-qmzh976f | Was the travel advisory implemented fairly? |
| cord-352799-qmzh976f | What are the known or potential burdens of the program? |
| cord-352799-qmzh976f | What are the public health goals of the proposed program? |
| cord-352799-qmzh976f | Était- ce le cas lors de la crise du SRAS à Toronto en 2003? |
| cord-355854-hksq8gy4 | A Key Also in 2019 Coronavirus Disease( Covid-19)? |
| cord-355854-hksq8gy4 | Angiotensinconverting enzyme 2: an ally or a Trojan horse? |
| cord-355854-hksq8gy4 | Are these subjects with a higher ACE2 and lower ACE/ ACE2 ratio also protected against Covid-19 exacerbation? |
| cord-355854-hksq8gy4 | COVID and the renin- angiotensin system: are hypertension or its treatments deleterious? |
| cord-355854-hksq8gy4 | Is ACE2 like a Trojan horse( 1)? |
| cord-355854-hksq8gy4 | Is it a gift of nature that also allows the enemy to enter into cells? |
| cord-355854-hksq8gy4 | Is it worthwhile to try to re- establish an appropriate ACE/ ACE2 ratio? |
| cord-355854-hksq8gy4 | Metabolic alkalosis is the most common acid- base disorder in ICU patients Oxidative stress markers to investigate the effects of hyperoxia in anesthesia Hyperoxia and oxidative stress in anesthesia and critical care medicine Oxygen in the critically ill: friend or foe? |
| cord-355854-hksq8gy4 | Should we therefore say"timeo Danaos et dona ferentes"? |
| cord-355854-hksq8gy4 | Which cells in the lungs mediate this inflammatory response? |
| cord-355318-qm79gz8w | : Insights into environmental resistance and its influence on the development of new antiseptic strategies Survival of human coronaviruses 229E and OC43 in suspension and after drying onsurfaces: A possible source of hospital- acquired infections Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: The possible role of dry surface contamination How long do nosocomial pathogens persist on inanimate surfaces? |
| cord-355318-qm79gz8w | A retrospective analysis of influence of environmental/ air temperature and relative humidity on SARS- CoV-2 outbreak Effects of temperature and humidity on the daily new cases and new deaths of COVID-19 in 166 countries Preliminary evidence that higher temperatures are associated with lower incidence of COVID-19, for cases reported globally up to 29th Is temperature reducing the transmission of COVID-19? High Temperature and high humidity reduce the transmission of COVID-19 Possible environmental effects on the spread of COVID-19 in China |
| cord-355318-qm79gz8w | Do latitude and ozone concentration predict COVID-2019 cases in 34 countries? |
| cord-355318-qm79gz8w | Does the pathogenesis of SARS- CoV-2 virus decrease at high- altitude? |
| cord-355318-qm79gz8w | Healthcare Reform and Poverty in Latin America Shortage of healthcare workers in developing countries- Africa Health- system reform and universal health coverage in Latin America Informal m- health: How are young people using mobile phones to bridge healthcare gaps in Sub- Saharan Africa? |
| cord-355318-qm79gz8w | The story behind the statistics Influenza seasonality in the tropics and subtropics- When to vaccinate? |
| cord-355318-qm79gz8w | Underlying causes and modeling theories Are meteorological parameters associated with acute respiratory tract Infections? |
| cord-355318-qm79gz8w | Understanding patterns of emergence and transmission Drivers of MERS- CoV transmission: What do we know? |
| cord-355318-qm79gz8w | What are the differences? |
| cord-355318-qm79gz8w | What do studies to date tell us? |
| cord-355318-qm79gz8w | Which metric of SARS- CoV-2 transmission to use as dependent variable is critical in addressing the central question,"do environmental variables modulate the transmission of the virus? |
| cord-355318-qm79gz8w | Will coronavirus pandemic diminish by summer? |
| cord-346539-kxnrf5g5 | -An updated interim review and lessons from SARS- CoV and MERS- CoV Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-346539-kxnrf5g5 | 152 pandemic? |
| cord-346539-kxnrf5g5 | 50,153 endotype is associated with severe asthma in obese patients, are obese asthmatic patients more likely to develop severe COVID-19? |
| cord-346539-kxnrf5g5 | : why might they be hazardous? |
| cord-346539-kxnrf5g5 | Advances in Diagnosis and Treatment BCG- induced trained immunity: can it offer protection against COVID-19? |
| cord-346539-kxnrf5g5 | Advice for Healthcare Professionals Treating People with Asthma( adults) in relation to COVID-19 COVID-19 Related Genes in Sputum Cells in Asthma: Relationship to Demographic Features and Corticosteroids Asthma and COVID-19: is asthma a risk factor for severe outcomes? |
| cord-346539-kxnrf5g5 | Covid-19-Navigating the Uncharted COVID-19, SARS and MERS: are they closely related? |
| cord-346539-kxnrf5g5 | Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS- CoV-2 infection is associated with disease severity and fatal outcome Immunosuppression for hyperinflammation in COVID-19: a double- edged sword? |
| cord-346539-kxnrf5g5 | IgG1(+) B- cell immunity predates IgE responses in epicutaneous sensitization to foods Laundry detergents and detergent residue after rinsing directly disrupt tight junction barrier integrity in human bronchial epithelial cells Emerging concepts and challenges in implementing the exposome paradigm in allergic diseases and asthma: a Practall document Will changes in alcohol and tobacco use be seen during the COVID-19 lockdown? |
| cord-346539-kxnrf5g5 | Is BCG vaccination affecting the spread and severity of COVID-19? |
| cord-346539-kxnrf5g5 | Is global BCG vaccination- induced trained immunity relevant to the progression of SARS- CoV-2 pandemic? |
| cord-346539-kxnrf5g5 | The Multifaceted B Cell Response in Allergen Immunotherapy COVID-19 Autopsies EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity Lung eosinophils- A novel"virus sink"that is defective in asthma? |
| cord-346539-kxnrf5g5 | The iceberg of COVID-19: are there asymptomatic cases below the surface? |
| cord-346539-kxnrf5g5 | These zoonotic beta- coronaviruses share structural and genomic similarities that are useful to patients? |
| cord-346539-kxnrf5g5 | Twelve Years after Pathogenesis of Acute Respiratory Distress Syndrome Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19 Immunology of COVID-19: mechanisms, clinical outcome, diagnostics and perspectives-a report of the 1 COVID-19 pneumonia: ARDS or not? |
| cord-346539-kxnrf5g5 | What specific therapies can be suggested for ARDS? |
| cord-346539-kxnrf5g5 | Which cytokines are most elevated during CSS? |
| cord-346539-kxnrf5g5 | Will helminth co- infection modulate COVID-19 severity in endemic regions? |
| cord-346539-kxnrf5g5 | [ 277][ 278][ 279] What is the evidence supporting social distancing and face mask to prevent SARS- CoV-2 infection? |
| cord-346539-kxnrf5g5 | an urgent public health research priority Is ethnicity linked to incidence or outcomes of covid-19? |
| cord-346539-kxnrf5g5 | pandemic? |